,project_id,fiscal_year,report_title,principal_investigator,supervisor,research_org,lab_staff_within_org,extramural_collab,collab_other_NCI,collab_other_NIH,publications,url
0,BC004496-34,"October 01, 2010 -  September 30, 2011",Chromosomal Proteins and Chromosomal Functions,Michael  Bustin; PhD|IRP Faculty Profile,NULL,"Protein Section, NCI",Liron  Abuhatzira; PhD|Tao  Deng|Takashi  Furusawa|Tamar Klara Kleinberger|Jamie Elyse Kugler|Cedric  Malicet|Show all 8,"Melinda K Duncan; PhD (Biological Sciences, The University of Delaware)|Jefferey  Hayes (University of Rochester medical Center)|Eran  Meshorer (Hebrew University)|Leon  Mullenders (Radiation Genetics, University of Leiden)|Joseph  Orly (Hebrew University)|Vasily  Studitsky (Department of Pharmacology, University of Medicine and Dentistry of New Jersey)",Joost J Oppenheim; MD (Laboratory of Molecular Immunoregulation),Rafael Cristian Casellas; PhD (NIAMS) |David  Landsman; PhD (NLM),"1. Bustin M (2010). High mobility group proteins. Biochim Biophys Acta  1799, 1-2.   https://doi.org/10.1016/j.bbagrm.2010.01.006|2. Gerlitz G, Bustin M (2010). Efficient cell migration requires global chromatin condensation. J Cell Sci  123, 2207-17.   https://doi.org/10.1242/jcs.058271",https://intramural.nih.gov/search/searchview.taf?ipid=68094
1,BC004504-39,"October 01, 2010 -  September 30, 2011",Interacting Signaling Pathways that Initiate Squamous Cell Carcinogenesis,Stuart H Yuspa; MD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Joanna  Anders|Glenn  Merlino; PhD|Megan Rose Ansbro|Christophe  Cataisson|Lalage  Wakefield; PhD|Christopher G Keith|Show all 14,"David  Threadgill; PhD (Department of Genetics, University of North Carolina School of Medicine)|Ronald  Wolf",Giorgio  Trinchieri (Cancer Inflammation Program),NULL,"1. Wolf R, Mascia F, Dharamsi A, Howard OM, Cataisson C, Bliskovski V, Winston J, Feigenbaum L, Lichti U, Ruzicka T, Chavakis T, Yuspa SH (2010). Gene from a psoriasis susceptibility locus primes the skin for inflammation. Sci Transl Med  2, 61ra90.   https://doi.org/10.1126/scitranslmed.3001108",https://intramural.nih.gov/search/searchview.taf?ipid=68095
2,BC004517-35,"October 01, 2010 -  September 30, 2011",DNA Repair in Human Cancer-Prone Genetic Diseases,Kenneth H Kraemer; MD|IRP Faculty Profile,NULL,"Dermatology Branch, NCI",John  Digiovanna|Sikandar  Khan|Christiane  Kuschal|Thomas J Hornyak|Taro  Masaki|Deborah E Schmidt|Show all 9,"Esther  Azzizi (Tel Aviv Univ)|Douglas  Brash (Neurology, Yale Univ)|Steffen  Emmert|Engin  Gozukara (Malatya Univ)|Yuko  Hirai (Genetics, Radiation Effects Research Foundation)|N G  Jaspers (Genetics, Erasmus Univ)|Show all 15","Margaret Anne Tucker (Human Genetics Program)|Alisa  Goldstein; PhD (Genetic Epidemiology Branch)|Charles E. Land; PhD (Radiation Epidemiology Branch)|Michael  Bustin; PhD (Protein Section)|Yves  Pommier; PhD (Developmental Therapeutics Branch)|Phillip A Dennis; MD, PhD (Medical Oncology Branch)","Carl C Baker; MD, PhD (NIAMS) |Nicholas  Patronas; MD (CC) |Raphael  Schiffmann; MD (NINDS) |Ira W Levin; PhD (NIDDK) |Vilhelm A Bohr; MD, PhD (NIA) |Brian Patrick Brooks; MD, PhD (NEI)","1. Kraemer K, Ruenger T (2010) Genome instability, DNA repair and cancer, in Fitzpatrick's Dermatology in General Medicine., in press.|2. Ruenger T, DiGiovanna J, Kraemer K (2010) Hereditary diseases of genome instability and DNA repair, in Fitzpatrick's Dermatology in General Medicine., in press.|3. Tamura D, DiGiovanna J, Kraemer K (2010) Xeroderma pigmentosum, in Treatment of Skin Disease - comprehensive Therapeutic Strategies. .  Volume third edition,  pp. 78-9792.|4. Khan SG, Yamanegi K, Zheng ZM, Boyle J, Imoto K, Oh KS, Baker CC, Gozukara E, Metin A, Kraemer KH (2010). XPC branch-point sequence mutations disrupt U2 snRNP binding, resulting in abnormal pre-mRNA splicing in xeroderma pigmentosum patients. Hum Mutat  31, 167-75.   https://doi.org/10.1002/humu.21166|5. Moslehi R, Signore C, Tamura D, Mills JL, Digiovanna JJ, Tucker MA, Troendle J, Ueda T, Boyle J, Khan SG, Oh KS, Goldstein AM, Kraemer KH (2010). Adverse effects of trichothiodystrophy DNA repair and transcription gene disorder on human fetal development. Clin Genet  77, 365-73.   https://doi.org/10.1111/j.1399-0004.2009.01336.x|6. Ramkumar HL, Brooks BP, Cao X, Tamura D, Digiovanna JJ, Kraemer KH, Chan CC (2011). Ophthalmic manifestations and histopathology of xeroderma pigmentosum: two clinicopathological cases and a review of the literature. Surv Ophthalmol  56, 348-61.   https://doi.org/10.1016/j.survophthal.2011.03.001|7. Tamura D, DiGiovanna JJ, Kraemer KH (2010). Founder mutations in xeroderma pigmentosum. J Invest Dermatol  130, 1491-3.   https://doi.org/10.1038/jid.2010.76|8. Wang Y, Tan XH, DiGiovanna JJ, Lee CC, Stern JB, Raffeld M, Jaffe ES, Kraemer KH (2010). Genetic diversity in melanoma metastases from a patient with xeroderma pigmentosum. J Invest Dermatol  130, 1188-91.   https://doi.org/10.1038/jid.2009.377|9. Zhou X, Khan SG, Tamura D, Patronas NJ, Zein WM, Brooks BP, Kraemer KH, DiGiovanna JJ (2010). Brittle hair, developmental delay, neurologic abnormalities, and photosensitivity in a 4-year-old girl. J Am Acad Dermatol  63, 323-8.   https://doi.org/10.1016/j.jaad.2010.03.041",https://intramural.nih.gov/search/searchview.taf?ipid=68096
3,BC005093-33,"October 01, 2010 -  September 30, 2011",GrowthDifferentiation Factors in Organogenesis,Alan O Perantoni; PhD,NULL,"Cancer and Developmental Biology Laboratory, NCI",Hyung-Gwan  Bae|Michael David Hall|Nirmala D Sharma|Shunsuke  Tanigawa|Yili D Yang|Kangsun  Yun,Frank  Costantini; PhD (Columbia University)|Edwin  Cuppen (Hubrecht Institute)|Harold  Lovvorn (Vanderbilt University)|Olga  Timofeeva (Georgetown University),Terence P Yamaguchi; PhD (Cell Signaling in Vertebrate Development Section)|Mark B Lewandoski (Genetics of Vertebrate Development Section)|Arthur A Hurwitz (Laboratory of Molecular Immunoregulation)|Nadya I Tarasova; PhD (Cancer Inflammation Program),Lothar  Hennighausen; PhD (NIDDK),"1. Wang H, Yang Y, Sharma N, Tarasova NI, Timofeeva OA, Winkler-Pickett RT, Tanigawa S, Perantoni AO (2010). STAT1 activation regulates proliferation and differentiation of renal progenitors. Cell Signal  22, 1717-26.   https://doi.org/10.1016/j.cellsig.2010.06.012",https://intramural.nih.gov/search/searchview.taf?ipid=68097
4,BC005148-32,"October 01, 2010 -  September 30, 2011",Mammary Tumorigenesis in Inbred and Feral Mice,Robert  Callahan; PhD,NULL,"Mammary Biology and Tumorigenesis Laboratory, NCI",Sharon A Bargo|Barry  Chestnut|David M Mccurdy|Ahmed M Raafat|Massod  Rahimi,"Spyros  Artavanis-Tsakonas (Developmental Biology and Cancer, Harvard Medical School)|Sean M Egan|Robert  Rhoads (LSU Shreveport)","Jeffrey S Rubin; MD, PhD (Laboratory of Cellular and Molecular Biology)",NULL,"1. Bargo S, Raafat A, McCurdy D, Amirjazil I, Shu Y, Traicoff J, Plant J, Vonderhaar BK, Callahan R (2010). Transforming acidic coiled-coil protein-3 (Tacc3) acts as a negative regulator of Notch signaling through binding to CDC10/Ankyrin repeats. Biochem Biophys Res Commun  400, 606-12.   https://doi.org/10.1016/j.bbrc.2010.08.111|2. Chiluiza D, Bargo S, Callahan R, Rhoads RE (2011). Expression of truncated eukaryotic initiation factor 3e (eIF3e) resulting from integration of mouse mammary tumor virus (MMTV) causes a shift from cap-dependent to cap-independent translation. J Biol Chem  286, 31288-96.   https://doi.org/10.1074/jbc.M111.267294|3. Raafat A, Goldhar AS, Klauzinska M, Xu K, Amirjazil I, McCurdy D, Lashin K, Salomon D, Vonderhaar BK, Egan S, Callahan R (2011). Expression of Notch receptors, ligands, and target genes during development of the mouse mammary gland. J Cell Physiol  226, 1940-52.   https://doi.org/10.1002/jcp.22526|4. Sun Y, Klauzinska M, Lake RJ, Lee JM, Santopietro S, Raafat A, Salomon D, Callahan R, Artavanis-Tsakonas S (2011). Trp53 regulates Notch 4 signaling through Mdm2. J Cell Sci  124, 1067-76.   https://doi.org/10.1242/jcs.068965",https://intramural.nih.gov/search/searchview.taf?ipid=68098
5,BC005177-31,"October 01, 2010 -  September 30, 2011",Interaction of Chemical Carcinogens and Chemotherapeutic Agents with DNA,Miriam Christine Poirier; PhD,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Elena Estela Hernandez-Ramon|Karthik  John,"Maria Eugenia  Gonsebatt (UNAM)|Francis  Martin (Biological Sciences, Lancaster University)|Igor  Pogribny (National Center for Toxicological Research, FDA)|Radim  Sram; MD (Prague Institutes for Advanced Studies)",Qing  Lan (Occupational and Environmental Epidemiology Branch)|Nathaniel C Rothman; MD (Occupational and Environmental Epidemiology Branch),NULL,"1. John K, Divi RL, Keshava C, Orozco CC, Schockley ME, Richardson DL, Poirier MC, Nath J, Weston A (2010). CYP1A1 and CYP1B1 gene expression and DNA adduct formation in normal human mammary epithelial cells exposed to benzo[a]pyrene in the absence or presence of chlorophyllin. Cancer Lett  292, 254-60.   https://doi.org/10.1016/j.canlet.2009.12.008|2. Obolenskaya MY, Teplyuk NM, Divi RL, Poirier MC, Filimonova NB, Zadrozna M, Pasanen MJ (2010). Human placental glutathione S-transferase activity and polycyclic aromatic hydrocarbon DNA adducts as biomarkers for environmental oxidative stress in placentas from pregnant women living in radioactivity- and chemically-polluted regions. Toxicol Lett  196, 80-6.   https://doi.org/10.1016/j.toxlet.2010.03.1115|3. Pratt M, John K, MacLean A, Afework S, Phillips D, Poirier M (2011) Polycyclic aromatic hydrocarbon (PAH) exposure and DNA adduct semi-quantitation in archived human tissues. International Journal of Environmental Research and Public Health 8:2675-2691.",https://intramural.nih.gov/search/searchview.taf?ipid=68099
6,BC005258-32,"October 01, 2010 -  September 30, 2011",Molecular Studies of Eukaryotic Gene Regulation,Bruce  Paterson; PhD|IRP Faculty Profile,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",Lili  Qin|Yikang  Rong|Ananda  Ravulapalli|Qin  Wei|Xiaomin  Yu,NULL,NULL,NULL,"1. Lipardi C, Paterson BM (2010). Identification of an RNA-dependent RNA polymerase in Drosophila establishes a common theme in RNA silencing. Fly (Austin)  4, 30-5.   https://doi.org/10.4161/fly.4.1.10777",https://intramural.nih.gov/search/searchview.taf?ipid=68100
7,BC005263-30,"October 01, 2010 -  September 30, 2011",Eukaryotic Chromatin Structure and Gene Regulation,Carl  Wu; PhD|IRP Faculty Profile,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",Yawen  Bai; PhD|Yingzi  Huang|Joseph W Landry|Edward E Luk|Manabu  Mizuguchi|Anand  Ranjan|Show all 9,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68101
8,BC005268-24,"October 01, 2010 -  September 30, 2011",Mechanism of Meiotic Recombination,Michael Joseph Lichten; PhD|IRP Faculty Profile,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",Yaron  Dayani|Yikang  Rong|Tamara  Goldfarb|Darpan Kaustuv Medhi|Robert A Shroff,Alastair  Goldman (University of Sheffield)|Galina  Petukhova (USUHS),NULL,"Rafael  Camerini-Otero; MD, PhD (NIDDK)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68102
9,BC005270-30,"October 01, 2010 -  September 30, 2011",Molecular Mechanism of Action of Phorbol Ester,Peter  Blumberg; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Tamas  Geczy|Noemi  Kedei|Stuart H Yuspa; MD|Nancy E Lewin|Emanuel S Lubart|Taiyabah Ahmed Naeem|Show all 10,Tamas  Biro (Debrecen Medical School)|Derek C Braun|Chaya  Brodie (Henry Ford Hospital)|Sun J Choi|Julieta  Comin (University of Buenos Aires)|Senena  Corbalan-Garcia (University of Murcia)|Show all 19,Paul  Goldsmith; PhD (Office of the Director)|Victor  Marquez; PhD (Chemical Biology Laboratory)|Megan L Peach (Chemical Biology Laboratory)|Susan H Garfield (Laboratory of Experimental Carcinogenesis),NULL,"1. Blumberg P, Kedei N, Lewin N, Yang D, Tao J, Telek A, Geczy T (2010) PKC enaymes - receptors for diacylglycerol and phorbol esters, in Protein Kinase C in Cancer Signaling and Therayp. Springer Publishing Co (New York), pp. 25-53.|2. Gal N, Kolusheva S, Kedei N, Telek A, Naeem T, Lewin N, Lim L, Mannan P, Garfield S, El Kazzouli S, Sigano D, Marquez V, Blumberg P, Jelinek R (2011) N-Methyl-substituted fluorescent DAG-indolactone isomers exhibit dramatic differences in membrane interactions and biological activity. ChemBioChem, in press.|3. Gal N, Kolusheva S, Kedei N, Telek A, Naeem TA, Lewin NE, Lim L, Mannan P, Garfield SH, El Kazzouli S, Sigano DM, Marquez VE, Blumberg PM, Jelinek R (2011). N-methyl-substituted fluorescent DAG-indololactone isomers exhibit dramatic differences in membrane interactions and biological activity. Chembiochem  12, 2331-40.   https://doi.org/10.1002/cbic.201100246|4. Kang DW, Kim YS, Lim KS, Kim MS, Pearce LV, Pavlyukovets VA, Tao AK, Lang-Kuhs KA, Blumberg PM, Lee J (2010). Halogenation of 4-hydroxy/amino-3-methoxyphenyl acetamide TRPV1 agonists showed enhanced antagonism to capsaicin. Bioorg Med Chem  18, 8092-105.   https://doi.org/10.1016/j.bmc.2010.09.001|5. Kang JH, Kim Y, Won SH, Park SK, Lee CW, Kim HM, Lewin NE, Perry NA, Pearce LV, Lundberg DJ, Surawski RJ, Blumberg PM, Lee J (2010). Polar 3-alkylidene-5-pivaloyloxymethyl-5'-hydroxymethyl-gamma-lactones as protein kinase C ligands and antitumor agents. Bioorg Med Chem Lett  20, 1008-12.   https://doi.org/10.1016/j.bmcl.2009.12.058|6. Keck GE, Poudel YB, Rudra A, Stephens JC, Kedei N, Lewin NE, Peach ML, Blumberg PM (2010). Molecular modeling, total synthesis, and biological evaluations of C9-deoxy bryostatin 1. Angew Chem Int Ed Engl  49, 4580-4.   https://doi.org/10.1002/anie.201001200|7. Nomura W, Narumi T, Ohashi N, Serizawa Y, Lewin N, Blumberg P, Furuta T, Tamamura H (2011) Synthetic caged DAG-lactones for photochemically controlled activation of protein kinase C. ChemBioChem 12(4):535-539.|8. Raifman O, Kolusheva S, Comin MJ, Kedei N, Lewin NE, Blumberg PM, Marquez VE, Jelinek R (2010). Membrane anchoring of diacylglycerol lactones substituted with rigid hydrophobic acyl domains correlates with biological activities. FEBS J  277, 233-43.   https://doi.org/10.1111/j.1742-4658.2009.07477.x|9. Raifman O, Kolusheva S, El Kazzouli S, Sigano DM, Kedei N, Lewin NE, Lopez-Nicolas R, Ortiz-Espin A, Gomez-Fernandez JC, Blumberg PM, Marquez VE, Corbalan-Garcia S, Jelinek R (2010). Membrane-surface anchoring of charged diacylglycerol-lactones correlates with biological activities. Chembiochem  11, 2003-9.   https://doi.org/10.1002/cbic.201000343|10. Yang D, Kedei N, Li L, Tao J, Velasquez JF, Michalowski AM, Tóth BI, Marincsák R, Varga A, Bíró T, Yuspa SH, Blumberg PM (2010). RasGRP3 contributes to formation and maintenance of the prostate cancer phenotype. Cancer Res  70, 7905-17.   https://doi.org/10.1158/0008-5472.CAN-09-4729",https://intramural.nih.gov/search/searchview.taf?ipid=68103
10,BC005271-20,"October 01, 2010 -  September 30, 2011",Gene Regulation and Function: The B-ZIP Proteins,Charles  Vinson; PhD|IRP Faculty Profile,NULL,"Nucleic Acids Section, NCI",Raghunath  Chatterjee|Ximiao  He|Ishminder  Mann|Eric V Rios-Doria|Jianfei  Zhao,NULL,Shioko  Kimura; PhD (Endocrinology Section)|Gordon Lee Hager; PhD (Laboratory of Receptor Biology and Gene Expression)|Michael  Bustin; PhD (Protein Section)|Frank Jess Gonzalez; PhD (Laboratory of Metabolism),NULL,"1. Chatterjee R, Bhattacharya P, Gavrilova O, Glass K, Moitra J, Myakishev M, Pack S, Jou W, Feigenbaum L, Eckhaus M, Vinson C (2011). Suppression of the C/EBP family of transcription factors in adipose tissue causes lipodystrophy. J Mol Endocrinol  46, 175-92.   https://doi.org/10.1530/JME-10-0172|2. Jeong MY, Walker JS, Brown RD, Moore RL, Vinson CS, Colucci WS, Long CS (2010). AFos inhibits phenylephrine-mediated contractile dysfunction by altering phospholamban phosphorylation. Am J Physiol Heart Circ Physiol  298, H1719-26.   https://doi.org/10.1152/ajpheart.00937.2009|3. Kido T, Tomita T, Okamoto M, Cai Y, Matsumoto Y, Vinson C, Maru Y, Kimura S (2011). FOXA1 plays a role in regulating secretoglobin 1a1 expression in the absence of CCAAT/enhancer binding protein activities in lung in vivo. Am J Physiol Lung Cell Mol Physiol  300, L441-52.   https://doi.org/10.1152/ajplung.00435.2009|4. Rishi V, Bhattacharya P, Chatterjee R, Rozenberg J, Zhao J, Glass K, Fitzgerald P, Vinson C (2010). CpG methylation of half-CRE sequences creates C/EBPalpha binding sites that activate some tissue-specific genes. Proc Natl Acad Sci U S A  107, 20311-6.   https://doi.org/10.1073/pnas.1008688107",https://intramural.nih.gov/search/searchview.taf?ipid=68104
11,BC005317-28,"October 01, 2010 -  September 30, 2011",Role of Selenium in Development and Health,Dolph Lee Hatfield; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Prevention, NCI",Bradley A Carlson|Salvador  Naranjo Suarez; PhD|Ryuta  Tobe|Petra Akiko Tsuji|Min-Hyuk  Yoo,"Melinda  Beck (University of North Carolina)|Marcus  Conrad (Institute of Clinical Molecular Biology and Tumor Genetics)|Vadim  Gladyshev (Brigham and Womenâs Hospital and Harvard Medical School)|Jin Mo  Park (Massachusetts General Hospital and Harvard Medical School)|Ulrich  Schweizer (Neuroscience Research Center and, Charit-Universittsmedizin Berlin)",Cindy D Davis (Nutritional Science Research Group)|Jeffrey E Green; MD (Laboratory of Cancer Biology and Genetics)|Stuart H Yuspa; MD (Laboratory of Cancer Biology and Genetics)|Frank Jess Gonzalez; PhD (Laboratory of Metabolism),NULL,"1. Hatfield D (2011) Selenium: Its molecular biology and role in human health. Springer Science+Business Media, LLC (New York), in press.|2. Carlson BA, Yoo MH, Shrimali RK, Irons R, Gladyshev VN, Hatfield DL, Park JM (2010). Role of selenium-containing proteins in T-cell and macrophage function. Proc Nutr Soc  69, 300-10.   https://doi.org/10.1017/S002966511000176X|3. Irons R, Tsuji PA, Carlson BA, Ouyang P, Yoo MH, Xu XM, Hatfield DL, Gladyshev VN, Davis CD (2010). Deficiency in the 15-kDa selenoprotein inhibits tumorigenicity and metastasis of colon cancer cells. Cancer Prev Res (Phila)  3, 630-9.   https://doi.org/10.1158/1940-6207.CAPR-10-0003|4. Kim JY, Lee KH, Shim MS, Shin H, Xu XM, Carlson BA, Hatfield DL, Lee BJ (2010). Human selenophosphate synthetase 1 has five splice variants with unique interactions, subcellular localizations and expression patterns. Biochem Biophys Res Commun  397, 53-8.   https://doi.org/10.1016/j.bbrc.2010.05.055|5. Novoselov SV, Kim HY, Hua D, Lee BC, Astle CM, Harrison DE, Friguet B, Moustafa ME, Carlson BA, Hatfield DL, Gladyshev VN (2010). Regulation of selenoproteins and methionine sulfoxide reductases A and B1 by age, calorie restriction, and dietary selenium in mice. Antioxid Redox Signal  12, 829-38.   https://doi.org/10.1089/ars.2009.2895|6. Sengupta A, Lichti UF, Carlson BA, Ryscavage AO, Gladyshev VN, Yuspa SH, Hatfield DL (2010). Selenoproteins are essential for proper keratinocyte function and skin development. PLoS One  5, e12249.   https://doi.org/10.1371/journal.pone.0012249|7. Shchedrina VA, Zhang Y, Labunskyy VM, Hatfield DL, Gladyshev VN (2010). Structure-function relations, physiological roles, and evolution of mammalian ER-resident selenoproteins. Antioxid Redox Signal  12, 839-49.   https://doi.org/10.1089/ars.2009.2865|8. Shim MS, Kim JY, Lee KH, Jung HK, Carlson BA, Xu XM, Hatfield DL, Lee BJ (2011). l(2)01810 is a novel type of glutamate transporter that is responsible for megamitochondrial formation. Biochem J  439, 277-86.   https://doi.org/10.1042/BJ20110582|9. Turanov AA, Kehr S, Marino SM, Yoo MH, Carlson BA, Hatfield DL, Gladyshev VN (2010). Mammalian thioredoxin reductase 1: roles in redox homoeostasis and characterization of cellular targets. Biochem J  430, 285-93.   https://doi.org/10.1042/BJ20091378|10. Wirth EK, Conrad M, Winterer J, Wozny C, Carlson BA, Roth S, Schmitz D, Bornkamm GW, Coppola V, Tessarollo L, Schomburg L, Köhrle J, Hatfield DL, Schweizer U (2010). Neuronal selenoprotein expression is required for interneuron development and prevents seizures and neurodegeneration. FASEB J  24, 844-52.   https://doi.org/10.1096/fj.09-143974",https://intramural.nih.gov/search/searchview.taf?ipid=68105
12,BC005367-28,"October 01, 2010 -  September 30, 2011",Comparative Genomics and Structure of Humans and Related Model Organisms,Stephen J O'Brien; PhD,NULL,"Laboratory of Genomic Diversity, NCI",Sher L Hendrickson|Klaus-Peter  Koepfli; PhD|Warren  Johnson|Victor A David,Agustinho  Antunes (Universidad de Porto)|Belinda  Appleton (University of Melbourne)|Keith  Barker (University of Minnesota)|Carlos  Bustamante (Stanford University)|Jason  Chin (Taipei Zoo)|William  Clark (Iowa State University)|Show all 39,NULL,Alejandro Alberto Schaffer; PhD (NLM),"1. Luo S, Johnson W, Smith J, O'Brian SJ (2010) What is a Tiger? Genetics and Phylogeny, in Tigers of the World: The Science, Politics and Conservation of Panthera tigris. Academic Press (London), pp. 35-52.|2. Werdelin L, O'Brian SJ, Johnson W, Yamaguchi N (2010) Phylogeny and Evolution of Cats (Felidae), in Biology and Conservation of Wild Felids. Oxford University Press (Oxford), pp. 59-82.|3. da Fonseca RR, Johnson WE, O'Brien SJ, Vasconcelos V, Antunes A (2010). Molecular evolution and the role of oxidative stress in the expansion and functional diversification of cytosolic glutathione transferases. BMC Evol Biol  10, 281.   https://doi.org/10.1186/1471-2148-10-281|4. Hostetler JA, Onorato DP, Bolker BM, Johnson WE, O'Brien SJ, Jansen D, Oli MK (2012). Does genetic introgression improve female reproductive performance? A test on the endangered Florida panther. Oecologia  168, 289-300.   https://doi.org/10.1007/s00442-011-2083-0|5. Hostetler JA, Onorato DP, Nichols JD, Johnson WE, Roelke ME, O'Brien SJ, Jansen D, Oli MK (2010). Genetic Introgression and the Survival of Florida Panther Kittens. Biol Conserv  143, 2789-2796.   https://doi.org/10.1016/j.biocon.2010.07.028|6. Perelman P, Johnson WE, Roos C, Seuánez HN, Horvath JE, Moreira MA, Kessing B, Pontius J, Roelke M, Rumpler Y, Schneider MP, Silva A, O'Brien SJ, Pecon-Slattery J (2011). A molecular phylogeny of living primates. PLoS Genet  7, e1001342.   https://doi.org/10.1371/journal.pgen.1001342",https://intramural.nih.gov/search/searchview.taf?ipid=68107
13,BC005385-28,"October 01, 2010 -  September 30, 2011",The Development of the Domestic Cat as an Animal Model for Genetic Analysis,Stephen J O'Brien; PhD,NULL,"Laboratory of Genomic Diversity, NCI",Andrea Brynne Coots|Victor A David|Marilyn  Raymond; PhD,"Greg  Barsh (Howard Hughes Medical Institute, Stanford University School of Medicine)|Eduardo  Eizirik (Biosciences Department, Pontifcia Universidade Catlica do Rio Grande do Sul)|Matthew  Ellinwood (Iowa State University)|Steven  Hannah (Nestle Purina PetCare Co.)|Kristina  Narfstrom; DVM (Veterinary Medicine, University of Missouri)|Solveig  Pflueger (Dept of Vet Med & Surgery, Baystate Medical Center)|Show all 7",NULL,NULL,"1. Eizirik E, David VA, Buckley-Beason V, Roelke ME, Schäffer AA, Hannah SS, Narfström K, O'Brien SJ, Menotti-Raymond M (2010). Defining and mapping mammalian coat pattern genes: multiple genomic regions implicated in domestic cat stripes and spots. Genetics  184, 267-75.   https://doi.org/10.1534/genetics.109.109629|2. Menotti-Raymond M, Deckman KH, David V, Myrkalo J, O'Brien SJ, Narfström K (2010). Mutation discovered in a feline model of human congenital retinal blinding disease. Invest Ophthalmol Vis Sci  51, 2852-9.   https://doi.org/10.1167/iovs.09-4261",https://intramural.nih.gov/search/searchview.taf?ipid=68108
14,BC005445-27,"October 01, 2010 -  September 30, 2011",Pathways that Suppress or Accelerate Premalignant Progression of Squamous Cancer,Stuart H Yuspa; MD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Joanna  Anders|Peter  Blumberg; PhD|Megan Rose Ansbro|Christophe  Cataisson|Kasey L Jividen|Luowei  Li|Show all 14,NULL,Suresh V Ambudkar; PhD (Transport Biochemistry Section)|Lino  Tessarollo (Neural Development Section)|Dolph Lee Hatfield; PhD (Laboratory of Cancer Prevention),NULL,"1. Sengupta A, Lichti UF, Carlson BA, Ryscavage AO, Gladyshev VN, Yuspa SH, Hatfield DL (2010). Selenoproteins are essential for proper keratinocyte function and skin development. PLoS One  5, e12249.   https://doi.org/10.1371/journal.pone.0012249|2. Wright LN, Ryscavage A, Merlino G, Yuspa SH (2012). Modeling the transcriptional consequences of epidermal growth factor receptor ablation in Ras-initiated squamous cancer. Clin Cancer Res  18, 170-83.   https://doi.org/10.1158/1078-0432.CCR-11-1349|3. Yang D, Kedei N, Li L, Tao J, Velasquez JF, Michalowski AM, Tóth BI, Marincsák R, Varga A, Bíró T, Yuspa SH, Blumberg PM (2010). RasGRP3 contributes to formation and maintenance of the prostate cancer phenotype. Cancer Res  70, 7905-17.   https://doi.org/10.1158/0008-5472.CAN-09-4729|4. Yang D, Tao J, Li L, Kedei N, Tóth ZE, Czap A, Velasquez JF, Mihova D, Michalowski AM, Yuspa SH, Blumberg PM (2011). RasGRP3, a Ras activator, contributes to signaling and the tumorigenic phenotype in human melanoma. Oncogene  30, 4590-4600.   https://doi.org/10.1038/onc.2011.166",https://intramural.nih.gov/search/searchview.taf?ipid=68111
15,BC005450-28,"October 01, 2010 -  September 30, 2011",Chromatin Structure and Gene Expression,Gordon Lee Hager; PhD|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Songjoon  Baek|Lars  Grontved|Sam  John|Thomas A Johnson|Raffaella  Nativio; PhD|Rodney Louis Schiltz; PhD|Show all 8,"Dafna  Benayahu (Sackler School of Medicine Tel Aviv University)|Michael J Garabedian; PhD (Microbiology and Kaplan Cancer Center, New York University Medical Center)|Susanne  Mandrup (University of Southern Denmark)|Ken  Pearce (Gene Expression and Protein Biochemistry, GlaxoSmithKline Discovery Research)|Fahri  Saatcioglu (Department of Biology, University of Oslo)|Michael  Stallcup (Univ of Southern California)|Show all 8","Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Charles  Vinson; PhD (Nucleic Acids Section)|David  Levens; PhD (Laboratory of Pathology)|John Carl Oberholtzer (Laboratory of Pathology)",Kenneth Steven Korach; PhD (NIEHS),"1. Biddie SC, John S, Hager GL (2010). Genome-wide mechanisms of nuclear receptor action. Trends Endocrinol Metab  21, 3-9.   https://doi.org/10.1016/j.tem.2009.08.006|2. Qiu Y, Stavreva DA, Luo Y, Indrawan A, Chang M, Hager GL (2011). Dynamic interaction of HDAC1 with a glucocorticoid receptor-regulated gene is modulated by the activity state of the promoter. J Biol Chem  286, 7641-7.   https://doi.org/10.1074/jbc.M110.185488|3. Sahu G, Wang D, Chen CB, Zhurkin VB, Harrington RE, Appella E, Hager GL, Nagaich AK (2010). p53 binding to nucleosomal DNA depends on the rotational positioning of DNA response element. J Biol Chem  285, 1321-32.   https://doi.org/10.1074/jbc.M109.081182|4. Wiench M, Hager GL (2010). Expanding horizons for nuclear receptors. EMBO Rep  11, 569-71.   https://doi.org/10.1038/embor.2010.111|5. Zheng Y, John S, Pesavento JJ, Schultz-Norton JR, Schiltz RL, Baek S, Nardulli AM, Hager GL, Kelleher NL, Mizzen CA (2010). Histone H1 phosphorylation is associated with transcription by RNA polymerases I and II. J Cell Biol  189, 407-15.   https://doi.org/10.1083/jcb.201001148",https://intramural.nih.gov/search/searchview.taf?ipid=68112
16,BC005453-27,"October 01, 2010 -  September 30, 2011",Cellular and Molecular Biology of the Hepatic Stem Cell Compartment,"Snorri S. Thorgeirsson; MD, PhD",NULL,"Laboratory of Experimental Carcinogenesis, NCI","Seung Bum  Lee|Daekwan  Seo; PhD, MS, BA|Valentina  Factor|Phuongnga  Ton|Tanya N Hoang","Hanne  Bisgaard (Medical Biochemistry and Genetics, University of Copenhagen)|Steve  Duncan (Medical College of Wisconsin)|Peter  Nagy (Pathology, Sammelweiss University)|Aranzazu  Sanchez-munoz (Biochemsitry and Molecular Biology, Complutense University of Madrid)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68113
17,BC005480-26,"October 01, 2010 -  September 30, 2011",Molecular Epidemiology of Human Lung Cancer,Curtis  Harris; MD|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Elise Dawn Bowman|Mohammed A. Khan; PhD|Leah E Mechanic|Sharon R Pine|Brid Mairead Ryan|Aaron Joseph Schetter|Show all 8,NULL,"Neil Edward Caporaso; MS, MD (Genetic Epidemiology Branch)|Stephen J Chanock; MD, PhD (Laboratory Translational Genomics)",NULL,"1. Hinch A, et al, Harris C, Zanetti K, Myers S (2011) The landscape of recombination in African Americans. Nature 476:170-5.|2. Li Y, Sheu CC, Ye Y, de Andrade M, Wang L, Chang SC, Aubry MC, Aakre JA, Allen MS, Chen F, Cunningham JM, Deschamps C, Jiang R, Lin J, Marks RS, Pankratz VS, Su L, Li Y, Sun Z, Tang H, Vasmatzis G, Harris CC, Spitz MR, Jen J, Wang R, et al. [4 more authors] (2010). Genetic variants and risk of lung cancer in never smokers: a genome-wide association study. Lancet Oncol  11, 321-30.   https://doi.org/10.1016/S1470-2045(10)70042-5|3. Meinhold CL, Berrington de González A, Bowman ED, Brenner AV, Jones RT, Lacey JV, Loffredo CA, Perlmutter D, Schonfeld SJ, Trivers GE, Harris CC (2011). Reproductive and hormonal factors and the risk of nonsmall cell lung cancer. Int J Cancer  128, 1404-13.   https://doi.org/10.1002/ijc.25434|4. Olivo-Marston SE, Mechanic LE, Mollerup S, Bowman ED, Remaley AT, Forman MR, Skaug V, Zheng YL, Haugen A, Harris CC (2010). Serum estrogen and tumor-positive estrogen receptor-alpha are strong prognostic classifiers of non-small-cell lung cancer survival in both men and women. Carcinogenesis  31, 1778-86.   https://doi.org/10.1093/carcin/bgq156|5. Pine S, Mechanic L, Enewold L, Chaturvedi A, Katki H, Zheng Y, Bowman E, Engels E, Caporaso N, Harris C (2011) Increased Levels of Circulating Interleukin-6, Interleukin-8, C-Reactive Protein, and Risk of Lung Cancer. JNCI 103:1112-22.|6. Pine SR, Ryan BM, Varticovski L, Robles AI, Harris CC (2010). Microenvironmental modulation of asymmetric cell division in human lung cancer cells. Proc Natl Acad Sci U S A  107, 2195-200.   https://doi.org/10.1073/pnas.0909390107|7. Ryan BM, Robles AI, Harris CC (2010). Genetic variation in microRNA networks: the implications for cancer research. Nat Rev Cancer  10, 389-402.   https://doi.org/10.1038/nrc2867",https://intramural.nih.gov/search/searchview.taf?ipid=68114
18,BC005522-24,"October 01, 2010 -  September 30, 2011",Thyroid StemProgenitor Cells,Shioko  Kimura; PhD|IRP Faculty Profile,NULL,"Endocrinology Section, NCI",Suguru  Hayase|Tsubasa  Murata,NULL,"Snorri S. Thorgeirsson; MD, PhD (Laboratory of Experimental Carcinogenesis)",NULL,"1. Flandin P, Kimura S, Rubenstein JL (2010). The progenitor zone of the ventral medial ganglionic eminence requires Nkx2-1 to generate most of the globus pallidus but few neocortical interneurons. J Neurosci  30, 2812-23.   https://doi.org/10.1523/JNEUROSCI.4228-09.2010|2. Ozaki T, Nagashima K, Kusakabe T, Kakudo K, Kimura S (2011). Development of thyroid gland and ultimobranchial body cyst is independent of p63. Lab Invest  91, 138-46.   https://doi.org/10.1038/labinvest.2010.137",https://intramural.nih.gov/search/searchview.taf?ipid=68116
19,BC005562-24,"October 01, 2010 -  September 30, 2011",Xenobiotic-Metabolizing Enzymes,Frank Jess Gonzalez; PhD|IRP Faculty Profile,NULL,"Laboratory of Metabolism, NCI",Linda G Byrd|Jie  Cheng|Caroline Helen Johnson|Jung Hwan  Kim|Kristopher W Krausz|Fei  Li|Show all 9,"Toshifumi  Aoyama (Department of Metabolic Regulation, Shinshu University, Institute on Aging and Adaptation)|Renke  Dai (NCI)|Jeffrey  Idle (University of Bern)|Tami  Nakajima (Nagoya University)",Curtis  Harris; MD (Laboratory of Human Carcinogenesis),Byoungjoon  Song; PhD (NIAAA),"1. Abdelmegeed MA, Moon KH, Chen C, Gonzalez FJ, Song BJ (2010). Role of cytochrome P450 2E1 in protein nitration and ubiquitin-mediated degradation during acetaminophen toxicity. Biochem Pharmacol  79, 57-66.   https://doi.org/10.1016/j.bcp.2009.07.016|2. Jennings BL, Sahan-Firat S, Estes AM, Das K, Farjana N, Fang XR, Gonzalez FJ, Malik KU (2010). Cytochrome P450 1B1 contributes to angiotensin II-induced hypertension and associated pathophysiology. Hypertension  56, 667-74.   https://doi.org/10.1161/HYPERTENSIONAHA.110.154518|3. Johnson CH, Patterson AD, Krausz KW, Lanz C, Kang DW, Luecke H, Gonzalez FJ, Idle JR (2011). Radiation metabolomics. 4. UPLC-ESI-QTOFMS-Based metabolomics for urinary biomarker discovery in gamma-irradiated rats. Radiat Res  175, 473-84.   https://doi.org/10.1667/RR2437.1|4. Li F, Patterson AD, Höfer CC, Krausz KW, Gonzalez FJ, Idle JR (2010). Comparative metabolism of cyclophosphamide and ifosfamide in the mouse using UPLC-ESI-QTOFMS-based metabolomics. Biochem Pharmacol  80, 1063-74.   https://doi.org/10.1016/j.bcp.2010.06.002|5. Lindemer BJ, Bongard RD, Hoffmann R, Baumgardt S, Gonzalez FJ, Merker MP (2011). Genetic evidence for NAD(P)H:quinone oxidoreductase 1-catalyzed quinone reduction on passage through the mouse pulmonary circulation. Am J Physiol Lung Cell Mol Physiol  300, L773-80.   https://doi.org/10.1152/ajplung.00394.2010|6. Lu H, Gonzalez FJ, Klaassen C (2010). Alterations in hepatic mRNA expression of phase II enzymes and xenobiotic transporters after targeted disruption of hepatocyte nuclear factor 4 alpha. Toxicol Sci  118, 380-90.   https://doi.org/10.1093/toxsci/kfq280|7. Niu S, Li F, Tan DX, Zhang L, Idle JR, Gonzalez FJ, Ma X (2010). Analysis of N1-acetyl-N2-formyl-5-methoxykynuramine/N1-acetyl-5-methoxy-kynuramine formation from melatonin in mice. J Pineal Res  49, 106-14.   https://doi.org/10.1111/j.1600-079X.2010.00771.x|8. Patterson AD, Gonzalez FJ, Idle JR (2010). Xenobiotic metabolism: a view through the metabolometer. Chem Res Toxicol  23, 851-60.   https://doi.org/10.1021/tx100020p|9. Shi Z, Dragin N, Miller ML, Stringer KF, Johansson E, Chen J, Uno S, Gonzalez FJ, Rubio CA, Nebert DW (2010). Oral benzo[a]pyrene-induced cancer: two distinct types in different target organs depend on the mouse Cyp1 genotype. Int J Cancer  127, 2334-50.   https://doi.org/10.1002/ijc.25222",https://intramural.nih.gov/search/searchview.taf?ipid=68118
20,BC005597-22,"October 01, 2010 -  September 30, 2011",Biochemistry of Energy-Dependent (Intracellular) Protein Degradation,Michael  Maurizi; PhD|IRP Faculty Profile,NULL,"Biochemistry of Proteins Section, NCI",Poorva  Dharkar|Ramatoulaye Kane Deme|Jeong Han  Kang|Serhiy Volodymirovych Surkov; PhD|Yang  Zhang,"Sun-Shin  Cha (Korea Ocean Research and Development Institute)|Anuradha  Janakiraman (The City College of CUNY)|Sung Gyun Kang; PhD|Joaquin  Ortega (McMaster University Health Sciences Centre)|Carolyn  Suzuki (Biochemistry and Molecular Biology, University of Medicine and Dentistry of New Jersey)","Di S Xia; PhD, MS, BS (Crystallography Section)|Alexander  Wlodawer; PhD (Macromolecular Crystallography Laboratory)|Susan  Gottesman; PhD (Biochemical Genetics Section)|Timothy D Veenstra (Office Of The Director)",Alasdair C Steven; PhD (NIAMS) |Grzegorz  Piszczek; PhD (NHLBI),"1. Cha S, An Y, Lee C, Lee H, Kim Y, Kim S, Kwon K, De Donatis G, Lee J, Maurizi M, Kang S (2010) The crystal structure of hexameric Lon Protease: dynamics of the AAA+ module controls access to a sequestered proteolytic chamber. EMBO Journal Inpress.|2. De Donatis GM, Singh SK, Viswanathan S, Maurizi MR (2010). A single ClpS monomer is sufficient to direct the activity of the ClpA hexamer. J Biol Chem  285, 8771-81.   https://doi.org/10.1074/jbc.M109.053736|3. Effantin G, Ishikawa T, De Donatis GM, Maurizi MR, Steven AC (2010). Local and global mobility in the ClpA AAA+ chaperone detected by cryo-electron microscopy: functional connotations. Structure  18, 553-62.   https://doi.org/10.1016/j.str.2010.02.016|4. Effantin G, Maurizi MR, Steven AC (2010). Binding of the ClpA unfoldase opens the axial gate of ClpP peptidase. J Biol Chem  285, 14834-40.   https://doi.org/10.1074/jbc.M109.090498|5. Li D, Chung Y, Gloyd M, Joseph E, Ghirlando R, Wright G, Cheng Y, Maurizi M, Guarne A, Ortega J (2010) Crystal structure of ClpP with bound antibiotic, ADEP: A model for the ClpXClpA Bound State of ClpP. Chemistry and Biology Inpress.|6. Li M, Gustchina A, Rasulova FS, Melnikov EE, Maurizi MR, Rotanova TV, Dauter Z, Wlodawer A (2010). Structure of the N-terminal fragment of Escherichia coli Lon protease. Acta Crystallogr D Biol Crystallogr  66, 865-73.   https://doi.org/10.1107/S0907444910019554",https://intramural.nih.gov/search/searchview.taf?ipid=68119
21,BC005598-22,"October 01, 2010 -  September 30, 2011",Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells,Michael Marc Gottesman; MD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",NULL,NULL,"Di S Xia; PhD, MS, BS (Crystallography Section)|Suresh V Ambudkar; PhD (Transport Biochemistry Section)","Rita Nkengasong Anu (OD) |Carol O Cardarelli (OD) |King Leung Fung (OD) |Christopher P Austin; AB, MD (NHGRI) |Jean-Pierre  Gillet (OD) |Andrew Simon Goldsborough (OD)","1. Kannan P, Brimacombe KR, Zoghbi SS, Liow JS, Morse C, Taku AK, Pike VW, Halldin C, Innis RB, Gottesman MM, Hall MD (2010). N-desmethyl-loperamide is selective for P-glycoprotein among three ATP-binding cassette transporters at the blood-brain barrier. Drug Metab Dispos  38, 917-22.   https://doi.org/10.1124/dmd.109.031161|2. Lund PE, Hunt RC, Gottesman MM, Kimchi-Sarfaty C (2010). Pseudovirions as vehicles for the delivery of siRNA. Pharm Res  27, 400-20.   https://doi.org/10.1007/s11095-009-0012-2",https://intramural.nih.gov/search/searchview.taf?ipid=68120
22,BC005599-21,"October 01, 2010 -  September 30, 2011","Tumor Suppressor Protein, p53",Ettore  Appella; MD|IRP Faculty Profile,NULL,"Chemical Immunology Section, NCI",Hidetsugu  Fujigaki|Ryo  Hayashi|Lisa Marie Jenkins|Sharlyn  Mazur; PhD|Michael Zeev Stern,"Or  Gozani (Stanford Cancer Center, Stanford University)|Donald  Hunt (Department of Chemistry, University of Minnesota)|Tatiana  Kutateladze (University of Colorado Denver School of Medicine)|Yang  Xu (University of California)","Stewart  Durell (Laboratory of Cell Biology)|Curtis  Harris; MD (Laboratory of Human Carcinogenesis)|Howard A Fine; MD, PhD (Neuro-Oncology Branch)|Yawen  Bai; PhD (Laboratory Of Biochemistry & Molecular Biology)",NULL,"1. Fujita K, Horikawa I, Mondal AM, Jenkins LM, Appella E, Vojtesek B, Bourdon JC, Lane DP, Harris CC (2010). Positive feedback between p53 and TRF2 during telomere-damage signalling and cellular senescence. Nat Cell Biol  12, 1205-12.   https://doi.org/10.1038/ncb2123|2. Niida H, Murata K, Shimada M, Ogawa K, Ohta K, Suzuki K, Fujigaki H, Khaw AK, Banerjee B, Hande MP, Miyamoto T, Miyoshi I, Shirai T, Motoyama N, Delhase M, Appella E, Nakanishi M (2010). Cooperative functions of Chk1 and Chk2 reduce tumour susceptibility in vivo. EMBO J  29, 3558-70.   https://doi.org/10.1038/emboj.2010.218|3. Roy S, Musselman CA, Kachirskaia I, Hayashi R, Glass KC, Nix JC, Gozani O, Appella E, Kutateladze TG (2010). Structural insight into p53 recognition by the 53BP1 tandem Tudor domain. J Mol Biol  398, 489-96.   https://doi.org/10.1016/j.jmb.2010.03.024|4. Sahu G, Wang D, Chen CB, Zhurkin VB, Harrington RE, Appella E, Hager GL, Nagaich AK (2010). p53 binding to nucleosomal DNA depends on the rotational positioning of DNA response element. J Biol Chem  285, 1321-32.   https://doi.org/10.1074/jbc.M109.081182|5. West LE, Roy S, Lachmi-Weiner K, Hayashi R, Shi X, Appella E, Kutateladze TG, Gozani O (2010). The MBT repeats of L3MBTL1 link SET8-mediated p53 methylation at lysine 382 to target gene repression. J Biol Chem  285, 37725-32.   https://doi.org/10.1074/jbc.M110.139527",https://intramural.nih.gov/search/searchview.taf?ipid=68121
23,BC005643-21,"October 01, 2010 -  September 30, 2011",Mechanism and Regulation of mRNA Export,Ravi  Dhar; PhD,NULL,"Basic Research Laboratory, NCI",NULL,NULL,Andrew  Patterson (Nucleic Acids Section)|Timothy D Veenstra (Office Of The Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68122
24,BC005645-22,"October 01, 2010 -  September 30, 2011",T-cell Transformation by Oncoviruses,Genoveffa  Franchini; MD|IRP Faculty Profile,NULL,"Vaccine Branch, NCI",Maria Fernanda  Amarante|Cody R Buchmann|Claudio  Fenizia|Heather Lauren Gold|Robyn M Washington Parks,"Vincenzo  Ciminale (Department of Oncology and Surgical Sciences, University of Padova)|Christophe  Nicot (-, University of Kansas Medical Center)",Kathryn  Jones; PhD (Laboratory of Experimental Immunology)|Francis W Ruscetti; PhD (Laboratory of Experimental Immunology)|Cynthia  Masison (Laboratory of Cellular Oncology),Steven J Jacobson; PhD (NINDS),"1. Edwards D, Fenizia C, Gold H, Amarante M, Buchmann C, Pise-Masison C, Franchini G (2011) Orf-I and Orf-II-Encoded Proteins in HTLV-1 Infection and Persistence. Viruses MDPI Open Access 3:861-885.|2. Franchini G (2010). HTLV-1 and HIV-1 ""accessory"" proteins: a misleading misnomer. Mol Aspects Med  31, 331-2.   https://doi.org/10.1016/j.mam.2010.08.001|3. Gordon SN, Weissman AR, Cecchinato V, Fenizia C, Ma ZM, Lee TH, Zaffiri L, Andresen V, Parks RW, Jones KS, Heraud JM, Ferrari MG, Chung HK, Venzon D, Mahieux R, Murphy EL, Jacobson S, Miller CJ, Ruscetti FW, Franchini G (2010). Preexisting infection with human T-cell lymphotropic virus type 2 neither exacerbates nor attenuates simian immunodeficiency virus SIVmac251 infection in macaques. J Virol  84, 3043-58.   https://doi.org/10.1128/JVI.01655-09|4. Silic-Benussi M, Biasiotto R, Andresen V, Franchini G, D'Agostino DM, Ciminale V (2010). HTLV-1 p13, a small protein with a busy agenda. Mol Aspects Med  31, 350-8.   https://doi.org/10.1016/j.mam.2010.03.001|5. Valeri VW, Hryniewicz A, Andresen V, Jones K, Fenizia C, Bialuk I, Chung HK, Fukumoto R, Parks RW, Ferrari MG, Nicot C, Cecchinato V, Ruscetti F, Franchini G (2010). Requirement of the human T-cell leukemia virus p12 and p30 products for infectivity of human dendritic cells and macaques but not rabbits. Blood  116, 3809-17.   https://doi.org/10.1182/blood-2010-05-284141|6. Van Prooyen N, Andresen V, Gold H, Bialuk I, Pise-Masison C, Franchini G (2010). Hijacking the T-cell communication network by the human T-cell leukemia/lymphoma virus type 1 (HTLV-1) p12 and p8 proteins. Mol Aspects Med  31, 333-43.   https://doi.org/10.1016/j.mam.2010.07.001|7. Van Prooyen N, Gold H, Andresen V, Schwartz O, Jones K, Ruscetti F, Lockett S, Gudla P, Venzon D, Franchini G (2010). Human T-cell leukemia virus type 1 p8 protein increases cellular conduits and virus transmission. Proc Natl Acad Sci U S A  107, 20738-43.   https://doi.org/10.1073/pnas.1009635107",https://intramural.nih.gov/search/searchview.taf?ipid=68123
25,BC005657-22,"October 01, 2010 -  September 30, 2011",Molecular Basis for the Pathogenesis of Murine Retroviruses,Sandra  Ruscetti; PhD,NULL,"Laboratory of Cancer Prevention, NCI",Joan L Cmarik|Valentyna  Fesenkova|Charlotte A Hanson|David E Kaiser-Jones|Jami A Wolfe,Judy  Mikovits (Whittemore Peterson Institute)|Kazuo  Nishigaki,Larry K Keefer; PhD (Laboratory of Comparative Carcinogenesis)|Francis W Ruscetti; PhD (Laboratory of Experimental Immunology),NULL,"1. Cmarik J, Ruscetti S (2010) Friend spleen focus-forming virus activates the tyrosine kinase sf-Stk and the transcription factor PU.1 to cause a multi-stage erythroleukemia in mice. Viruses 2:2235-2257.|2. Umehara D, Watanabe S, Ochi H, Anai Y, Ahmed N, Kannagi M, Hanson C, Ruscetti S, Nishigaki K (2010). Role of phosphatidylinositol 3-kinase in friend spleen focus-forming virus-induced erythroid disease. J Virol  84, 7675-82.   https://doi.org/10.1128/JVI.00488-10",https://intramural.nih.gov/search/searchview.taf?ipid=68124
26,BC005673-21,"October 01, 2010 -  September 30, 2011",Using Diazeniumdiolate Chemistry to Design Nitric Oxide-Based Therapies,Larry K Keefer; PhD,NULL,"Laboratory of Comparative Carcinogenesis, NCI",Debanjan  Biswas|Zhao  Cao|James Ming Phang; MD|Kenyatta Meticeo Cosby; MD|Ryan John Holland; PhD|Joseph A. Hrabie; PhD|Show all 9,"Jeffrey  Deschamps (Naval Research Laboratory)|Sonia  Donzelli|Khosrow  Kashfi (CUNY Med School)|Melina  Kibbe (Division of Vascular Surgery, Northwestern University)|Mark  Meyerhoff (Department of Chemistry, University of Michigan)|Katrina  Miranda (University of Arizona)|Show all 8","Regina Gale Ziegler; PhD, MPH (Epidemiology and Biostatistics Program)|David Anderson Wink (Radiation Biology Branch)",Michael  Waalkes; PhD (NIEHS),"1. Andrei D, Salmon DJ, Donzelli S, Wahab A, Klose JR, Citro ML, Saavedra JE, Wink DA, Miranda KM, Keefer LK (2010). Dual mechanisms of HNO generation by a nitroxyl prodrug of the diazeniumdiolate (NONOate) class. J Am Chem Soc  132, 16526-32.   https://doi.org/10.1021/ja106552p|2. Biswas D, Deschamps JR, Keefer LK, Hrabie JA (2010). Nitrogen-bound diazeniumdiolated amidines. Chem Commun (Camb)  46, 5799-801.   https://doi.org/10.1039/c0cc00849d|3. Chattopadhyay M, Velazquez CA, Pruski A, Nia KV, Abdellatif KR, Keefer LK, Kashfi K (2010). Comparison between 3-Nitrooxyphenyl acetylsalicylate (NO-ASA) and O2-(acetylsalicyloxymethyl)-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate (NONO-ASA) as safe anti-inflammatory, analgesic, antipyretic, antioxidant prodrugs. J Pharmacol Exp Ther  335, 443-50.   https://doi.org/10.1124/jpet.110.171017|4. Faupel-Badger JM, Fuhrman BJ, Xu X, Falk RT, Keefer LK, Veenstra TD, Hoover RN, Ziegler RG (2010). Comparison of liquid chromatography-tandem mass spectrometry, RIA, and ELISA methods for measurement of urinary estrogens. Cancer Epidemiol Biomarkers Prev  19, 292-300.   https://doi.org/10.1158/1055-9965.EPI-09-0643|5. Fuhrman BJ, Xu X, Falk RT, Hankinson SE, Veenstra TD, Keefer LK, Ziegler RG (2010). Stability of 15 estrogens and estrogen metabolites in urine samples under processing and storage conditions typically used in epidemiologic studies. Int J Biol Markers  25, 185-94.|6. Hogg ME, Varu VN, Vavra AK, Popowich DA, Banerjee MN, Martinez J, Jiang Q, Saavedra JE, Keefer LK, Kibbe MR (2011). Effect of nitric oxide on neointimal hyperplasia based on sex and hormone status. Free Radic Biol Med  50, 1065-74.   https://doi.org/10.1016/j.freeradbiomed.2011.01.016|7. Hong SY, Borchert GL, Maciag AE, Nandurdikar RS, Saavedra JE, Keefer LK, Phang JM, Chakrapani H (2010). The Nitric Oxide Prodrug V-PROLI/NO Inhibits Cellular Uptake of Proline. ACS Med Chem Lett  1, 386-389.   https://doi.org/10.1021/ml1000905|8. Kogias E, Osterberg N, Baumer B, Psarras N, Koentges C, Papazoglou A, Saavedra JE, Keefer LK, Weyerbrock A (2012). Growth-inhibitory and chemosensitizing effects of the glutathione-S-transferase-π-activated nitric oxide donor PABA/NO in malignant gliomas. Int J Cancer  130, 1184-94.   https://doi.org/10.1002/ijc.26106|9. Nandurdikar RS, Maciag AE, Hong SY, Chakrapani H, Citro ML, Keefer LK, Saavedra JE (2010). Glycosylated PROLI/NO derivatives as nitric oxide prodrugs. Org Lett  12, 56-9.   https://doi.org/10.1021/ol902481s|10. Oladeinde OA, Hong SY, Holland RJ, Maciag AE, Keefer LK, Saavedra JE, Nandurdikar RS (2010). ""Click"" reaction in conjunction with diazeniumdiolate chemistry: developing high-load nitric oxide donors. Org Lett  12, 4256-9.   https://doi.org/10.1021/ol101645k|11. Qu W, Cheng L, Dill A, Saavedra J, Hong S, Keefer L, Waalkes M (2011) Nitric oxide donor, V-PROLINO, provides protection against arsenical induced toxicity in rat liver cells: requirement for Cyp1a1. Chem. Biol. Interact, in press.|12. Reynolds M, Saavedra J, Showalter B, Valdez C, Shanklin A, Oh B, Keefer L, Meyerhoff M (2010) Tailored synthesis of nitric oxide-releasing polyurethanes using Osup2sup-protected diazeniumdiolated chain extenders. J. Mater. Chem 20:3107-14.|13. Serrano MC, Vavra AK, Jen M, Hogg ME, Murar J, Martinez J, Keefer LK, Ameer GA, Kibbe MR (2011). Poly(diol-co-citrate)s as novel elastomeric perivascular wraps for the reduction of neointimal hyperplasia. Macromol Biosci  11, 700-9.   https://doi.org/10.1002/mabi.201000509|14. Tsihlis ND, Murar J, Kapadia MR, Ahanchi SS, Oustwani CS, Saavedra JE, Keefer LK, Kibbe MR (2010). Isopropylamine NONOate (IPA/NO) moderates neointimal hyperplasia following vascular injury. J Vasc Surg  51, 1248-59.   https://doi.org/10.1016/j.jvs.2009.12.028|15. Tsihlis ND, Oustwani CS, Vavra AK, Jiang Q, Keefer LK, Kibbe MR (2011). Nitric oxide inhibits vascular smooth muscle cell proliferation and neointimal hyperplasia by increasing the ubiquitination and degradation of UbcH10. Cell Biochem Biophys  60, 89-97.   https://doi.org/10.1007/s12013-011-9179-3|16. Varu VN, Ahanchi SS, Hogg ME, Bhikhapurwala HA, Chen A, Popowich DA, Vavra AK, Martinez J, Jiang Q, Saavedra JE, Hrabie JA, Keefer LK, Kibbe MR (2010). Insulin enhances the effect of nitric oxide at inhibiting neointimal hyperplasia in a rat model of type 1 diabetes. Am J Physiol Heart Circ Physiol  299, H772-9.   https://doi.org/10.1152/ajpheart.01234.2009|17. Vavra AK, Havelka GE, Martinez J, Lee VR, Fu B, Jiang Q, Keefer LK, Kibbe MR (2011). Insights into the effect of nitric oxide and its metabolites nitrite and nitrate at inhibiting neointimal hyperplasia. Nitric Oxide  25, 22-30.   https://doi.org/10.1016/j.niox.2011.04.013|18. Velazquez C, Lynn G, Kumar V, Keefer L, Malhotra S (2010) Arylation of sensitive 1-(pyrrolidin-1-yl)-diazen-1-ium-diolate in ionic liquids. Synth. Commun 40:1322-32.|19. Ziegler RG, Faupel-Badger JM, Sue LY, Fuhrman BJ, Falk RT, Boyd-Morin J, Henderson MK, Hoover RN, Veenstra TD, Keefer LK, Xu X (2010). A new approach to measuring estrogen exposure and metabolism in epidemiologic studies. J Steroid Biochem Mol Biol  121, 538-45.   https://doi.org/10.1016/j.jsbmb.2010.03.068",https://intramural.nih.gov/search/searchview.taf?ipid=68125
27,BC005688-21,"October 01, 2010 -  September 30, 2011",Understanding the Role of the Host Response in HIVSIV Infection,Genoveffa  Franchini; MD|IRP Faculty Profile,NULL,"Vaccine Branch, NCI",Shari  Gordon; PhD|Monica  Vaccari|Robyn M Washington Parks,"Savita  Pahwa (Miller School of Medicine, University of Miami)|Eckhard  Podack (Department of Microbiology, University of Miami)",Gene  Shearer; PhD (Lymphocyte Development Section),Vanessa  Hirsch (NIAID),"1. Gordon SN, Cecchinato V, Andresen V, Heraud JM, Hryniewicz A, Parks RW, Venzon D, Chung HK, Karpova T, McNally J, Silvera P, Reimann KA, Matsui H, Kanehara T, Shinmura Y, Yokote H, Franchini G (2011). Smallpox vaccine safety is dependent on T cells and not B cells. J Infect Dis  203, 1043-53.   https://doi.org/10.1093/infdis/jiq162|2. Moutaftsi M, Tscharke DC, Vaughan K, Koelle DM, Stern L, Calvo-Calle M, Ennis F, Terajima M, Sutter G, Crotty S, Drexler I, Franchini G, Yewdell JW, Head SR, Blum J, Peters B, Sette A (2010). Uncovering the interplay between CD8, CD4 and antibody responses to complex pathogens. Future Microbiol  5, 221-39.   https://doi.org/10.2217/fmb.09.110",https://intramural.nih.gov/search/searchview.taf?ipid=68126
28,BC005708-20,"October 01, 2010 -  September 30, 2011",Xenobiotic Receptors,Frank Jess Gonzalez; PhD|IRP Faculty Profile,NULL,"Laboratory of Metabolism, NCI",Linda G Byrd|Jie  Cheng|Changtao  Jiang|Jung Hwan  Kim|Kristopher W Krausz|Soumen Kanti Manna|Show all 9,"Toshifumi  Aoyama (Department of Metabolic Regulation, Shinshu University, Institute on Aging and Adaptation)|Dongsheng  Cai (Albert Einstein College of Medicine)|Jeffrey  Idle (University of Bern)|Tatsuhiko  Kodama (Laboratory of Systems Biology and Medicine, Research Center for Advanced               Science and Technology, Tokyo University)|Gert  Kostner (Medical University of Graz)|Tami  Nakajima (Nagoya University)|Show all 12",NULL,NULL,"1. Abdelmegeed MA, Yoo SH, Henderson LE, Gonzalez FJ, Woodcroft KJ, Song BJ (2011). PPARalpha expression protects male mice from high fat-induced nonalcoholic fatty liver. J Nutr  141, 603-10.   https://doi.org/10.3945/jn.110.135210|2. Akita N, Tsujita M, Yokota T, Gonzalez FJ, Ohte N, Kimura G, Yokoyama S (2010). High density lipoprotein turnover is dependent on peroxisome proliferator-activated receptor α in mice. J Atheroscler Thromb  17, 1149-59.   https://doi.org/10.5551/jat.4820|3. Bility MT, Zhu B, Kang BH, Gonzalez FJ, Peters JM (2010). Ligand activation of peroxisome proliferator-activated receptor-beta/delta and inhibition of cyclooxygenase-2 enhances inhibition of skin tumorigenesis. Toxicol Sci  113, 27-36.   https://doi.org/10.1093/toxsci/kfp212|4. Cheng J, Shah YM, Ma X, Pang X, Tanaka T, Kodama T, Krausz KW, Gonzalez FJ (2010). Therapeutic role of rifaximin in inflammatory bowel disease: clinical implication of human pregnane X receptor activation. J Pharmacol Exp Ther  335, 32-41.   https://doi.org/10.1124/jpet.110.170225|5. Cheng K, Ho K, Stokes R, Scott C, Lau SM, Hawthorne WJ, O'Connell PJ, Loudovaris T, Kay TW, Kulkarni RN, Okada T, Wang XL, Yim SH, Shah Y, Grey ST, Biankin AV, Kench JG, Laybutt DR, Gonzalez FJ, Kahn CR, Gunton JE (2010). Hypoxia-inducible factor-1alpha regulates beta cell function in mouse and human islets. J Clin Invest  120, 2171-83.   https://doi.org/10.1172/JCI35846|6. Cho JY, Matsubara T, Kang DW, Ahn SH, Krausz KW, Idle JR, Luecke H, Gonzalez FJ (2010). Urinary metabolomics in Fxr-null mice reveals activated adaptive metabolic pathways upon bile acid challenge. J Lipid Res  51, 1063-74.   https://doi.org/10.1194/jlr.M002923|7. Feige JN, Gerber A, Casals-Casas C, Yang Q, Winkler C, Bedu E, Bueno M, Gelman L, Auwerx J, Gonzalez FJ, Desvergne B (2010) The pollutant diethylhexyl phthalate regulates hepatic energy metabolism via species-specific PPARalpha-dependent mechanisms. Environ Health Perspect 118:234-41.|8. Genovese S, Foreman JE, Borland MG, Epifano F, Gonzalez FJ, Curini M, Peters JM (2010). A natural propenoic acid derivative activates peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta). Life Sci  86, 493-8.   https://doi.org/10.1016/j.lfs.2010.02.008|9. Hondares E, Rosell M, Gonzalez FJ, Giralt M, Iglesias R, Villarroya F (2010). Hepatic FGF21 expression is induced at birth via PPARalpha in response to milk intake and contributes to thermogenic activation of neonatal brown fat. Cell Metab  11, 206-12.   https://doi.org/10.1016/j.cmet.2010.02.001|10. Kurobe H, Urata M, Ueno M, Ueki M, Ono S, Izawa-Ishizawa Y, Fukuhara Y, Lei Y, Ripen AM, Kanbara T, Aihara K, Ishizawa K, Akaike M, Gonzalez FJ, Tamaki T, Takahama Y, Yoshizumi M, Kitagawa T, Tomita S (2010). Role of hypoxia-inducible factor 1alpha in T cells as a negative regulator in development of vascular remodeling. Arterioscler Thromb Vasc Biol  30, 210-7.   https://doi.org/10.1161/ATVBAHA.109.192666|11. Lee JH, Wada T, Febbraio M, He J, Matsubara T, Lee MJ, Gonzalez FJ, Xie W (2010). A novel role for the dioxin receptor in fatty acid metabolism and hepatic steatosis. Gastroenterology  139, 653-63.   https://doi.org/10.1053/j.gastro.2010.03.033|12. Liu A, Yang J, Gonzalez FJ, Cheng GQ, Dai R (2011). Biphasic regulation of intracellular calcium by gemfibrozil contributes to inhibiting L6 myoblast differentiation: implications for clinical myotoxicity. Chem Res Toxicol  24, 229-37.   https://doi.org/10.1021/tx100312h|13. Martinez-Jimenez CP, Kyrmizi I, Cardot P, Gonzalez FJ, Talianidis I (2010). Hepatocyte nuclear factor 4alpha coordinates a transcription factor network regulating hepatic fatty acid metabolism. Mol Cell Biol  30, 565-77.   https://doi.org/10.1128/MCB.00927-09|14. Matsubara T, Tanaka N, Patterson AD, Cho JY, Krausz KW, Gonzalez FJ (2011). Lithocholic acid disrupts phospholipid and sphingolipid homeostasis leading to cholestasis in mice. Hepatology  53, 1282-93.   https://doi.org/10.1002/hep.24193|15. Minata M, Harada KH, Kärrman A, Hitomi T, Hirosawa M, Murata M, Gonzalez FJ, Koizumi A (2010). Role of peroxisome proliferator-activated receptor-alpha in hepatobiliary injury induced by ammonium perfluorooctanoate in mouse liver. Ind Health  48, 96-107.   https://doi.org/10.2486/indhealth.48.96|16. Palkar PS, Anderson CR, Ferry CH, Gonzalez FJ, Peters JM (2010). Effect of prenatal peroxisome proliferator-activated receptor alpha (PPARalpha) agonism on postnatal development. Toxicology  276, 79-84.   https://doi.org/10.1016/j.tox.2010.07.008|17. Palkar PS, Borland MG, Naruhn S, Ferry CH, Lee C, Sk UH, Sharma AK, Amin S, Murray IA, Anderson CR, Perdew GH, Gonzalez FJ, Müller R, Peters JM (2010). Cellular and pharmacological selectivity of the peroxisome proliferator-activated receptor-beta/delta antagonist GSK3787. Mol Pharmacol  78, 419-30.   https://doi.org/10.1124/mol.110.065508|18. Qu A, Shah YM, Matsubara T, Yang Q, Gonzalez FJ (2010). PPARalpha-dependent activation of cell cycle control and DNA repair genes in hepatic nonparenchymal cells. Toxicol Sci  118, 404-10.   https://doi.org/10.1093/toxsci/kfq259|19. Ramdhan DH, Kamijima M, Wang D, Ito Y, Naito H, Yanagiba Y, Hayashi Y, Tanaka N, Aoyama T, Gonzalez FJ, Nakajima T (2010). Differential response to trichloroethylene-induced hepatosteatosis in wild-type and PPARalpha-humanized mice. Environ Health Perspect  118, 1557-63.   https://doi.org/10.1289/ehp.1001928|20. Reyes-Hernández OD, Mejía-García A, Sánchez-Ocampo EM, Cabañas-Cortés MA, Ramírez P, Chávez-González L, Gonzalez FJ, Elizondo G (2010). Ube2l3 gene expression is modulated by activation of the aryl hydrocarbon receptor: implications for p53 ubiquitination. Biochem Pharmacol  80, 932-40.   https://doi.org/10.1016/j.bcp.2010.05.007|21. Stroeve JH, Brufau G, Stellaard F, Gonzalez FJ, Staels B, Kuipers F (2010). Intestinal FXR-mediated FGF15 production contributes to diurnal control of hepatic bile acid synthesis in mice. Lab Invest  90, 1457-67.   https://doi.org/10.1038/labinvest.2010.107|22. Tanaka N, Zhang X, Sugiyama E, Kono H, Horiuchi A, Nakajima T, Kanbe H, Tanaka E, Gonzalez FJ, Aoyama T (2010). Eicosapentaenoic acid improves hepatic steatosis independent of PPARα activation through inhibition of SREBP-1 maturation in mice. Biochem Pharmacol  80, 1601-12.   https://doi.org/10.1016/j.bcp.2010.07.031|23. Wang T, Shah YM, Matsubara T, Zhen Y, Tanabe T, Nagano T, Fotso S, Krausz KW, Zabriskie TM, Idle JR, Gonzalez FJ (2010). Control of steroid 21-oic acid synthesis by peroxisome proliferator-activated receptor alpha and role of the hypothalamic-pituitary-adrenal axis. J Biol Chem  285, 7670-85.   https://doi.org/10.1074/jbc.M109.090175|24. Wang XX, Jiang T, Shen Y, Caldas Y, Miyazaki-Anzai S, Santamaria H, Urbanek C, Solis N, Scherzer P, Lewis L, Gonzalez FJ, Adorini L, Pruzanski M, Kopp JB, Verlander JW, Levi M (2010). Diabetic nephropathy is accelerated by farnesoid X receptor deficiency and inhibited by farnesoid X receptor activation in a type 1 diabetes model. Diabetes  59, 2916-27.   https://doi.org/10.2337/db10-0019|25. Zhang Y, Yin L, Anderson J, Ma H, Gonzalez FJ, Willson TM, Edwards PA (2010). Identification of novel pathways that control farnesoid X receptor-mediated hypocholesterolemia. J Biol Chem  285, 3035-43.   https://doi.org/10.1074/jbc.M109.083899|26. Zhu B, Bai R, Kennett MJ, Kang BH, Gonzalez FJ, Peters JM (2010). Chemoprevention of chemically induced skin tumorigenesis by ligand activation of peroxisome proliferator-activated receptor-beta/delta and inhibition of cyclooxygenase 2. Mol Cancer Ther  9, 3267-77.   https://doi.org/10.1158/1535-7163.MCT-10-0820",https://intramural.nih.gov/search/searchview.taf?ipid=68127
29,BC005740-19,"October 01, 2010 -  September 30, 2011",Transgenic Models for Prostate and Breast Cancer,Jeffrey E Green; MD,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Christina  Bennett|Isabel  Chu|Ziyao M Liu|Aleksandra M Michalowska|Tinghu  Qiu|Christine  Tomlinson|Show all 8,Thorkel  Andresson (NCI-FCRDC)|Eleanor  Blakely (Lawrence Berkeley National Laboratory)|Alfonso  Calvo (University of Pamplona)|Kartiki  Desai (Genome Institute of Singapore)|Joe  Gray (Lawrence Berkeley National Labs)|Tamaro  Hudson (Howard University)|Show all 8,"Melinda  Hollingshead (Biological Testing Branch)|Stanley  Lipkowitz; MD, PhD (Laboratory of Cellular and Molecular Biology)|Dolph Lee Hatfield; PhD (Laboratory of Cancer Prevention)|Frank Jess Gonzalez; PhD (Laboratory of Metabolism)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)","Chuxia  Deng; PhD (NIDDK) |Mark  Hoenerhoff; DVM, PhD (NIEHS)","1. Barkan D, El Touny LH, Michalowski AM, Smith JA, Chu I, Davis AS, Webster JD, Hoover S, Simpson RM, Gauldie J, Green JE (2010). Metastatic growth from dormant cells induced by a col-I-enriched fibrotic environment. Cancer Res  70, 5706-16.   https://doi.org/10.1158/0008-5472.CAN-09-2356|2. Calvo A, Perez-Stable C, Segura V, Catena R, Guruceaga E, Nguewa P, Blanco D, Parada L, Reiner T, Green JE (2010) Molecular characterization of the Ggamma-globin-Tag transgenic mouse model of hormone refractory prostate cancer: comparison to human prostate cancer. Prostate 70:630-45.|3. Chu I, Michalowski A, Hoenerhoff M, Szauter K, Luger D, Sato M, Flanders K, Oshima A, Csiszar K, Green J (2011) GATA3 Inhibits Lysyl Oxidase Mediated Metastases of Human Basal Triple-Negative Breast Cancer Cells. Oncogene, in press.|4. Das S, Bosley AD, Ye X, Chan KC, Chu I, Green JE, Issaq HJ, Veenstra TD, Andresson T (2010). Comparison of strong cation exchange and SDS-PAGE fractionation for analysis of multiprotein complexes. J Proteome Res  9, 6696-704.   https://doi.org/10.1021/pr100843x|5. Hoenerhoff MJ, Shibata MA, Bode A, Green JE (2011). Pathologic progression of mammary carcinomas in a C3(1)/SV40 T/t-antigen transgenic rat model of human triple-negative and Her2-positive breast cancer. Transgenic Res  20, 247-59.   https://doi.org/10.1007/s11248-010-9406-5|6. Liu B, Liu L, Tsykin A, Goodall GJ, Green JE, Zhu M, Kim CH, Li J (2010). Identifying functional miRNA-mRNA regulatory modules with correspondence latent dirichlet allocation. Bioinformatics  26, 3105-11.   https://doi.org/10.1093/bioinformatics/btq576|7. Mendoza A, Hong SH, Osborne T, Khan MA, Campbell K, Briggs J, Eleswarapu A, Buquo L, Ren L, Hewitt SM, Dakir el H, Dakir el-H, Garfield S, Walker R, Merlino G, Green JE, Hunter KW, Wakefield LM, Khanna C (2010). Modeling metastasis biology and therapy in real time in the mouse lung. J Clin Invest  120, 2979-88.   https://doi.org/10.1172/JCI40252",https://intramural.nih.gov/search/searchview.taf?ipid=68128
30,BC005785-17,"October 01, 2010 -  September 30, 2011",TGF-betas in breast cancer progression,Lalage  Wakefield; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Samuel Lee Dengler|Kent W Hunter; PhD|Kathleen C Flanders; PhD|Yoshiko  Nagano|Misako  Sato|Binwu  Tang,NULL,Miriam R Anver (Office Of The Director)|Christina  Stuelten (Laboratory of Cellular and Molecular Biology)|Chand  Khanna; MD (Pediatric Oncology Branch)|Mark E Sherman; MD (Hormonal and Reproductive Epidemiology Branch)|Dominic  Esposito; PhD (Office Of The Director)|Paul  Goldsmith; PhD (Office of the Director),Ashok Balkrishna Kulkarni; PhD (NIDCR),"1. Figueroa JD, Flanders KC, Garcia-Closas M, Anderson WF, Yang XR, Matsuno RK, Duggan MA, Pfeiffer RM, Ooshima A, Cornelison R, Gierach GL, Brinton LA, Lissowska J, Peplonska B, Wakefield LM, Sherman ME (2010). Expression of TGF-beta signaling factors in invasive breast cancers: relationships with age at diagnosis and tumor characteristics. Breast Cancer Res Treat  121, 727-35.   https://doi.org/10.1007/s10549-009-0590-z|2. Kadota M, Yang HH, Gomez B, Sato M, Clifford RJ, Meerzaman D, Dunn BK, Wakefield LM, Lee MP (2010). Delineating genetic alterations for tumor progression in the MCF10A series of breast cancer cell lines. PLoS One  5, e9201.   https://doi.org/10.1371/journal.pone.0009201|3. Kohn EA, Du Z, Sato M, Van Schyndle CM, Welsh MA, Yang YA, Stuelten CH, Tang B, Ju W, Bottinger EP, Wakefield LM (2010). A novel approach for the generation of genetically modified mammary epithelial cell cultures yields new insights into TGFβ signaling in the mammary gland. Breast Cancer Res  12, R83.   https://doi.org/10.1186/bcr2728|4. Mendoza A, Hong SH, Osborne T, Khan MA, Campbell K, Briggs J, Eleswarapu A, Buquo L, Ren L, Hewitt SM, Dakir el H, Dakir el-H, Garfield S, Walker R, Merlino G, Green JE, Hunter KW, Wakefield LM, Khanna C (2010). Modeling metastasis biology and therapy in real time in the mouse lung. J Clin Invest  120, 2979-88.   https://doi.org/10.1172/JCI40252|5. Stuelten CH, Busch JI, Tang B, Flanders KC, Oshima A, Sutton E, Karpova TS, Roberts AB, Wakefield LM, Niederhuber JE (2010). Transient tumor-fibroblast interactions increase tumor cell malignancy by a TGF-Beta mediated mechanism in a mouse xenograft model of breast cancer. PLoS One  5, e9832.   https://doi.org/10.1371/journal.pone.0009832",https://intramural.nih.gov/search/searchview.taf?ipid=68129
31,BC005793-17,"October 01, 2010 -  September 30, 2011",Mechanism of viral hepatitis-mediated hepatocarcinogenesis,Xin Wei Wang; PhD|IRP Faculty Profile,NULL,"Molecular Genetics and Carcinogenesis Section, NCI",Xuelian  Zhao|Anuradha Samantha Budhu|Marshonna J Forgues,NULL,Curtis  Harris; MD (Laboratory of Human Carcinogenesis)|Robert  Wiltrout; PhD (Laboratory of Experimental Immunology)|Howard A Young; PhD (Laboratory of Experimental Immunology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68130
32,BC005795-17,"October 01, 2010 -  September 30, 2011",p53 Tumor Suppressor Pathway,Curtis  Harris; MD|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Kaori  Fujita|Izumi  Horikawa|Abdul Matin Mondal|Giang Huong Nguyen|Sharon R Pine|Brid Mairead Ryan|Show all 10,NULL,NULL,NULL,"1. Fujita K, Horikawa I, Mondal AM, Jenkins LM, Appella E, Vojtesek B, Bourdon JC, Lane DP, Harris CC (2010). Positive feedback between p53 and TRF2 during telomere-damage signalling and cellular senescence. Nat Cell Biol  12, 1205-12.   https://doi.org/10.1038/ncb2123|2. Jiang W, Wang XW, Unger T, Forgues M, Kim JW, Hussain SP, Bowman E, Spillare EA, Lipsky MM, Meck JM, Cavalli LR, Haddad BR, Harris CC (2010). Cooperation of tumor-derived HBx mutants and p53-249(ser) mutant in regulating cell proliferation, anchorage-independent growth and aneuploidy in a telomerase-immortalized normal human hepatocyte-derived cell line. Int J Cancer  127, 1011-20.   https://doi.org/10.1002/ijc.25118|3. Robles AI, Harris CC (2010). Clinical outcomes and correlates of TP53 mutations and cancer. Cold Spring Harb Perspect Biol  2, a001016.   https://doi.org/10.1101/cshperspect.a001016|4. Tsuchiya N, Izumiya M, Ogata-Kawata H, Okamoto K, Fujiwara Y, Nakai M, Okabe A, Schetter AJ, Bowman ED, Midorikawa Y, Sugiyama Y, Aburatani H, Harris CC, Nakagama H (2011). Tumor suppressor miR-22 determines p53-dependent cellular fate through post-transcriptional regulation of p21. Cancer Res  71, 4628-39.   https://doi.org/10.1158/0008-5472.CAN-10-2475|5. Woo HG, Wang XW, Budhu A, Kim YH, Kwon SM, Tang ZY, Sun Z, Harris CC, Thorgeirsson SS (2011). Association of TP53 mutations with stem cell-like gene expression and survival of patients with hepatocellular carcinoma. Gastroenterology  140, 1063-70.   https://doi.org/10.1053/j.gastro.2010.11.034",https://intramural.nih.gov/search/searchview.taf?ipid=68131
33,BC006140-35,"October 01, 2010 -  September 30, 2011",Studies of Histone Functions in Chromatin; H2AX and DNA DSBs,William M Bonner; PhD|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI",Palak Rajendra Parekh|Christophe  Redon|Olga A Sedelnikova; PhD|Yves  Pommier; PhD|Urbain Sossou  Weyemi|Mirit I Aladjem; PhD|Show all 8,Sergey  Andreev (Russian Academy of Sciences)|Valeria  Audoshina (Georgetown University)|William F Blakely; PhD (Armed Forces Radiobiological Research Institute)|David  Brenner (Columbia University)|Michael  Cheezum (Walter Reed Army Medical Center)|Sean  Collins (Georgetown University)|Show all 17,Scott Michael Lawrence (Toxicology and Pharmacology Branch)|Lionel  Feigenbaum (Office Of The Director)|Jiuping  Ji (Office of the Director)|Susan  Bates; MD (Medical Oncology Branch)|Martin W Brechbiel; PhD (Radiation Oncology Branch),"Ronald D Neumann; MD (CC) |Igor  Panyutin; PhD (CC) |Irina  Panyutin; MD (CC) |Karen P Usdin; PhD (NIDDK) |Daman  Kumari; PhD (NIDDK) |Alexander L Kovalchuk; MD, PhD (NIAID)","1. Redon C, Nakamura A, Sordet O, Dickey J, Gouliaeva K, Tabb B, Lawrence S, Kinders R, Bonner W, Sedelnikova O (2011) g-H2AX Detection in Peripheral Blood Lymphocytes, Splenocytes, Bone Marrow, Xenografts, and Skin, in DNA Damage Detection In Situ, Ex Vivo, and In Vivo., in press.|2. Blagosklonny MV, Campisi J, Sinclair DA, Bartke A, Blasco MA, Bonner WM, Bohr VA, Brosh RM, Brunet A, Depinho RA, Donehower LA, Finch CE, Finkel T, Gorospe M, Gudkov AV, Hall MN, Hekimi S, Helfand SL, Karlseder J, Kenyon C, Kroemer G, Longo V, Nussenzweig A, Osiewacz HD, Peeper DS, et al. [10 more authors] (2010). Impact papers on aging in 2009. Aging (Albany NY)  2, 111-21.   https://doi.org/10.18632/aging.100132|3. Ivashkevich A, Redon CE, Nakamura AJ, Martin RF, Martin OA (2012). Use of the γ-H2AX assay to monitor DNA damage and repair in translational cancer research. Cancer Lett  327, 123-33.   https://doi.org/10.1016/j.canlet.2011.12.025|4. Kinders RJ, Hollingshead M, Lawrence S, Ji J, Tabb B, Bonner WM, Pommier Y, Rubinstein L, Evrard YA, Parchment RE, Tomaszewski J, Doroshow JH, National Cancer Institute Phase 0 Clinical Trials Team (2010). Development of a validated immunofluorescence assay for γH2AX as a pharmacodynamic marker of topoisomerase I inhibitor activity. Clin Cancer Res  16, 5447-57.   https://doi.org/10.1158/1078-0432.CCR-09-3076|5. Kovalchuk O, Zemp FJ, Filkowski JN, Altamirano AM, Dickey JS, Jenkins-Baker G, Marino SA, Brenner DJ, Bonner WM, Sedelnikova OA (2010). microRNAome changes in bystander three-dimensional human tissue models suggest priming of apoptotic pathways. Carcinogenesis  31, 1882-8.   https://doi.org/10.1093/carcin/bgq119|6. Nakamura AJ, Rao VA, Pommier Y, Bonner WM (2010). The complexity of phosphorylated H2AX foci formation and DNA repair assembly at DNA double-strand breaks. Cell Cycle  9, 389-97.   https://doi.org/10.4161/cc.9.2.10475|7. Peddi P, Loftin CW, Dickey JS, Hair JM, Burns KJ, Aziz K, Francisco DC, Panayiotidis MI, Sedelnikova OA, Bonner WM, Winters TA, Georgakilas AG (2010). DNA-PKcs deficiency leads to persistence of oxidatively induced clustered DNA lesions in human tumor cells. Free Radic Biol Med  48, 1435-43.   https://doi.org/10.1016/j.freeradbiomed.2010.02.033|8. Redon C, Dickey J, Nakamura A, Kareva I, Naf D, Nowsheen S, Kalogerinis P, Kryston T, Bonner W, Georgakilas A, Sedelnikova O (2010) Tumors induce complex DNA damage in distant proliferating tissues in vivo. Proceedings of the National Academy of Sciences, in press.|9. Redon C, Nakamura A, Zhang Y, Ji J, Bonner W, Kinders R, Parchment R, Doroshow J, Pommier Y (2010) Histone #947;H2AX and Poly(ADP Ribose) as Clinical Pharmacodynamic Biomarkers. Clinical Cancer Research, in press.|10. Redon CE, Dickey JS, Nakamura AJ, Kareva IG, Naf D, Nowsheen S, Kryston TB, Bonner WM, Georgakilas AG, Sedelnikova OA (2010). Tumors induce complex DNA damage in distant proliferative tissues in vivo. Proc Natl Acad Sci U S A  107, 17992-7.   https://doi.org/10.1073/pnas.1008260107|11. Redon CE, Nakamura AJ, Gouliaeva K, Rahman A, Blakely WF, Bonner WM (2010). The use of gamma-H2AX as a biodosimeter for total-body radiation exposure in non-human primates. PLoS One  5, e15544.   https://doi.org/10.1371/journal.pone.0015544|12. Redon CE, Nakamura AJ, Zhang YW, Ji JJ, Bonner WM, Kinders RJ, Parchment RE, Doroshow JH, Pommier Y (2010). Histone gammaH2AX and poly(ADP-ribose) as clinical pharmacodynamic biomarkers. Clin Cancer Res  16, 4532-42.   https://doi.org/10.1158/1078-0432.CCR-10-0523",https://intramural.nih.gov/search/searchview.taf?ipid=68132
34,BC006150-30,"October 01, 2010 -  September 30, 2011","DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer Drugs",Yves  Pommier; PhD|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI",Keli  Agama|Sheena Margie-Ann Aris|Ilaria  Dalla Rosa|Benu Brata  Das|Kurt  Kohn; PhD|Mirit I Aladjem; PhD|Show all 25,"Mark  Cushman (Medicinal Chemistry, Purdue University)|William  Gmeiner (PHARMACOLOGY, WAKE FOREST UNIVERSITY)|William  Jorgensen (CHEMISTRY, Yale University)|Gary  Olson (Provid Pharma)|Christopher  Self (Provide Pharma)|Yoshi  Shiloh (Tel Aviv University)",Robert  Shoemaker (Screening Technologies Branch)|Robert J Fisher (Office Of The Director)|Alexander  Wlodawer; PhD (Macromolecular Crystallography Laboratory)|Marc C Nicklaus (Chemical Biology Laboratory)|James Halpern Doroshow (Office of the Director)|Joseph E Tomaszewski (Office of the Director),"Christopher P Austin; AB, MD (NHGRI) |Weidong  Wang; PhD (NIA)","1. Baranello L, Bertozzi D, Fogli MV, Pommier Y, Capranico G (2010). DNA topoisomerase I inhibition by camptothecin induces escape of RNA polymerase II from promoter-proximal pause site, antisense transcription and histone acetylation at the human HIF-1alpha gene locus. Nucleic Acids Res  38, 159-71.   https://doi.org/10.1093/nar/gkp817|2. Conti C, Leo E, Eichler GS, Sordet O, Martin MM, Fan A, Aladjem MI, Pommier Y (2010). Inhibition of histone deacetylase in cancer cells slows down replication forks, activates dormant origins, and induces DNA damage. Cancer Res  70, 4470-80.   https://doi.org/10.1158/0008-5472.CAN-09-3028|3. Das BB, Dexheimer TS, Maddali K, Pommier Y (2010). Role of tyrosyl-DNA phosphodiesterase (TDP1) in mitochondria. Proc Natl Acad Sci U S A  107, 19790-5.   https://doi.org/10.1073/pnas.1009814107|4. Dexheimer TS, Stephen AG, Fivash MJ, Fisher RJ, Pommier Y (2010). The DNA binding and 3'-end preferential activity of human tyrosyl-DNA phosphodiesterase. Nucleic Acids Res  38, 2444-52.   https://doi.org/10.1093/nar/gkp1206|5. Eddy J, Vallur AC, Varma S, Liu H, Reinhold WC, Pommier Y, Maizels N (2011). G4 motifs correlate with promoter-proximal transcriptional pausing in human genes. Nucleic Acids Res  39, 4975-83.   https://doi.org/10.1093/nar/gkr079|6. Gmeiner WH, Reinhold WC, Pommier Y (2010). Genome-wide mRNA and microRNA profiling of the NCI 60 cell-line screen and comparison of FdUMP[10] with fluorouracil, floxuridine, and topoisomerase 1 poisons. Mol Cancer Ther  9, 3105-14.   https://doi.org/10.1158/1535-7163.MCT-10-0674|7. Kahn AB, Zeeberg BR, Ryan MC, Jamison DC, Rockoff DM, Pommier Y, Weinstein JN (2010). Ontogenomic study of the relationship between number of gene splice variants and GO categorization. Bioinformatics  26, 1945-9.   https://doi.org/10.1093/bioinformatics/btq335|8. Kim N, Huang SN, Williams JS, Li YC, Clark AB, Cho JE, Kunkel TA, Pommier Y, Jinks-Robertson S (2011). Mutagenic processing of ribonucleotides in DNA by yeast topoisomerase I. Science  332, 1561-4.   https://doi.org/10.1126/science.1205016|9. Kinders RJ, Hollingshead M, Lawrence S, Ji J, Tabb B, Bonner WM, Pommier Y, Rubinstein L, Evrard YA, Parchment RE, Tomaszewski J, Doroshow JH, National Cancer Institute Phase 0 Clinical Trials Team (2010). Development of a validated immunofluorescence assay for γH2AX as a pharmacodynamic marker of topoisomerase I inhibitor activity. Clin Cancer Res  16, 5447-57.   https://doi.org/10.1158/1078-0432.CCR-09-3076|10. Liu H, D'Andrade P, Fulmer-Smentek S, Lorenzi P, Kohn KW, Weinstein JN, Pommier Y, Reinhold WC (2010). mRNA and microRNA expression profiles of the NCI-60 integrated with drug activities. Mol Cancer Ther  9, 1080-91.   https://doi.org/10.1158/1535-7163.MCT-09-0965|11. Nakamura AJ, Rao VA, Pommier Y, Bonner WM (2010). The complexity of phosphorylated H2AX foci formation and DNA repair assembly at DNA double-strand breaks. Cell Cycle  9, 389-97.   https://doi.org/10.4161/cc.9.2.10475|12. Nakamura K, Kogame T, Oshiumi H, Shinohara A, Sumitomo Y, Agama K, Pommier Y, Tsutsui KM, Tsutsui K, Hartsuiker E, Ogi T, Takeda S, Taniguchi Y (2010). Collaborative action of Brca1 and CtIP in elimination of covalent modifications from double-strand breaks to facilitate subsequent break repair. PLoS Genet  6, e1000828.   https://doi.org/10.1371/journal.pgen.1000828|13. Oussedik K, François JC, Halby L, Senamaud-Beaufort C, Toutirais G, Dallavalle S, Pommier Y, Pisano C, Arimondo PB (2010). Sequence-specific targeting of IGF-I and IGF-IR genes by camptothecins. FASEB J  24, 2235-44.   https://doi.org/10.1096/fj.09-132324|14. Redon CE, Nakamura AJ, Zhang YW, Ji JJ, Bonner WM, Kinders RJ, Parchment RE, Doroshow JH, Pommier Y (2010). Histone gammaH2AX and poly(ADP-ribose) as clinical pharmacodynamic biomarkers. Clin Cancer Res  16, 4532-42.   https://doi.org/10.1158/1078-0432.CCR-10-0523|15. Reinhold WC, Mergny JL, Liu H, Ryan M, Pfister TD, Kinders R, Parchment R, Doroshow J, Weinstein JN, Pommier Y (2010). Exon array analyses across the NCI-60 reveal potential regulation of TOP1 by transcription pausing at guanosine quartets in the first intron. Cancer Res  70, 2191-203.   https://doi.org/10.1158/0008-5472.CAN-09-3528|16. Reinhold WC, Reimers MA, Lorenzi P, Ho J, Shankavaram UT, Ziegler MS, Bussey KJ, Nishizuka S, Ikediobi O, Pommier YG, Weinstein JN (2010). Multifactorial regulation of E-cadherin expression: an integrative study. Mol Cancer Ther  9, 1-16.   https://doi.org/10.1158/1535-7163.MCT-09-0321|17. Solier S, Barb J, Zeeberg BR, Varma S, Ryan MC, Kohn KW, Weinstein JN, Munson PJ, Pommier Y (2010). Genome-wide analysis of novel splice variants induced by topoisomerase I poisoning shows preferential occurrence in genes encoding splicing factors. Cancer Res  70, 8055-65.   https://doi.org/10.1158/0008-5472.CAN-10-2491|18. Wu N, Wu XW, Agama K, Pommier Y, Du J, Li D, Gu LQ, Huang ZS, An LK (2010). A novel DNA topoisomerase I inhibitor with different mechanism from camptothecin induces G2/M phase cell cycle arrest to K562 cells. Biochemistry  49, 10131-6.   https://doi.org/10.1021/bi1009419|19. Zoppoli G, Douarre C, Dalla Rosa I, Liu H, Reinhold W, Pommier Y (2011). Coordinated regulation of mitochondrial topoisomerase IB with mitochondrial nuclear encoded genes and MYC. Nucleic Acids Res  39, 6620-32.   https://doi.org/10.1093/nar/gkr208|20. Pommier Y, Dexheimer T, Maddali K, Marchand C, Selvam P (submitted in 2010) Fluoroquinolone Derivatives Or Sulfonamide Moiety-containing Compounds As Inhibitors Of Tyrosyl-dnaphosphodiesterase (tdp1). Patent issued: 8,716,295 (US in 2014).",https://intramural.nih.gov/search/searchview.taf?ipid=68133
35,BC006161-28,"October 01, 2010 -  September 30, 2011",DNA Topoisomerases as Target of Action of Anticancer Drugs,Yves  Pommier; PhD|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI","Keli  Agama|Kurt  Kohn; PhD|Sheena Margie-Ann Aris|Ilaria  Dalla Rosa|John N Weinstein; MD, PhD|William M Bonner; PhD|Show all 19","Mark  Cushman (Medicinal Chemistry, Purdue University)|Takehiro  Yasukawa (University College of London)",Melinda  Hollingshead (Biological Testing Branch)|James Halpern Doroshow (Office of the Director)|Joseph E Tomaszewski (Office of the Director)|Susan  Bates; MD (Medical Oncology Branch),NULL,"1. Baranello L, Bertozzi D, Fogli MV, Pommier Y, Capranico G (2010). DNA topoisomerase I inhibition by camptothecin induces escape of RNA polymerase II from promoter-proximal pause site, antisense transcription and histone acetylation at the human HIF-1alpha gene locus. Nucleic Acids Res  38, 159-71.   https://doi.org/10.1093/nar/gkp817|2. Cinelli MA, Morrell AE, Dexheimer TS, Agama K, Agrawal S, Pommier Y, Cushman M (2010). The structure-activity relationships of A-ring-substituted aromathecin topoisomerase I inhibitors strongly support a camptothecin-like binding mode. Bioorg Med Chem  18, 5535-52.   https://doi.org/10.1016/j.bmc.2010.06.040|3. Dexheimer TS, Stephen AG, Fivash MJ, Fisher RJ, Pommier Y (2010). The DNA binding and 3'-end preferential activity of human tyrosyl-DNA phosphodiesterase. Nucleic Acids Res  38, 2444-52.   https://doi.org/10.1093/nar/gkp1206|4. Gheeya J, Johansson P, Chen QR, Dexheimer T, Metaferia B, Song YK, Wei JS, He J, Pommier Y, Khan J (2010). Expression profiling identifies epoxy anthraquinone derivative as a DNA topoisomerase inhibitor. Cancer Lett  293, 124-31.   https://doi.org/10.1016/j.canlet.2010.01.004|5. Gmeiner WH, Reinhold WC, Pommier Y (2010). Genome-wide mRNA and microRNA profiling of the NCI 60 cell-line screen and comparison of FdUMP[10] with fluorouracil, floxuridine, and topoisomerase 1 poisons. Mol Cancer Ther  9, 3105-14.   https://doi.org/10.1158/1535-7163.MCT-10-0674|6. Huang SN, Pommier Y, Marchand C (2011). Tyrosyl-DNA Phosphodiesterase 1 (Tdp1) inhibitors. Expert Opin Ther Pat  21, 1285-92.   https://doi.org/10.1517/13543776.2011.604314|7. Kiselev E, DeGuire S, Morrell A, Agama K, Dexheimer TS, Pommier Y, Cushman M (2011). 7-azaindenoisoquinolines as topoisomerase I inhibitors and potential anticancer agents. J Med Chem  54, 6106-16.   https://doi.org/10.1021/jm200719v|8. Kummar S, Chen A, Ji J, Zhang Y, Reid JM, Ames M, Jia L, Weil M, Speranza G, Murgo AJ, Kinders R, Wang L, Parchment RE, Carter J, Stotler H, Rubinstein L, Hollingshead M, Melillo G, Pommier Y, Bonner W, Tomaszewski JE, Doroshow JH (2011). Phase I study of PARP inhibitor ABT-888 in combination with topotecan in adults with refractory solid tumors and lymphomas. Cancer Res  71, 5626-34.   https://doi.org/10.1158/0008-5472.CAN-11-1227|9. Nakamura K, Kogame T, Oshiumi H, Shinohara A, Sumitomo Y, Agama K, Pommier Y, Tsutsui KM, Tsutsui K, Hartsuiker E, Ogi T, Takeda S, Taniguchi Y (2010). Collaborative action of Brca1 and CtIP in elimination of covalent modifications from double-strand breaks to facilitate subsequent break repair. PLoS Genet  6, e1000828.   https://doi.org/10.1371/journal.pgen.1000828|10. Reinhold WC, Mergny JL, Liu H, Ryan M, Pfister TD, Kinders R, Parchment R, Doroshow J, Weinstein JN, Pommier Y (2010). Exon array analyses across the NCI-60 reveal potential regulation of TOP1 by transcription pausing at guanosine quartets in the first intron. Cancer Res  70, 2191-203.   https://doi.org/10.1158/0008-5472.CAN-09-3528|11. Solier S, Barb J, Zeeberg BR, Varma S, Ryan MC, Kohn KW, Weinstein JN, Munson PJ, Pommier Y (2010). Genome-wide analysis of novel splice variants induced by topoisomerase I poisoning shows preferential occurrence in genes encoding splicing factors. Cancer Res  70, 8055-65.   https://doi.org/10.1158/0008-5472.CAN-10-2491|12. Song Y, Shao Z, Dexheimer TS, Scher ES, Pommier Y, Cushman M (2010). Structure-based design, synthesis, and biological studies of new anticancer norindenoisoquinoline topoisomerase I inhibitors. J Med Chem  53, 1979-89.   https://doi.org/10.1021/jm901649x|13. Wu N, Wu XW, Agama K, Pommier Y, Du J, Li D, Gu LQ, Huang ZS, An LK (2010). A novel DNA topoisomerase I inhibitor with different mechanism from camptothecin induces G2/M phase cell cycle arrest to K562 cells. Biochemistry  49, 10131-6.   https://doi.org/10.1021/bi1009419|14. Zhang YW, Regairaz M, Seiler JA, Agama KK, Doroshow JH, Pommier Y (2011). Poly(ADP-ribose) polymerase and XPF-ERCC1 participate in distinct pathways for the repair of topoisomerase I-induced DNA damage in mammalian cells. Nucleic Acids Res  39, 3607-20.   https://doi.org/10.1093/nar/gkq1304",https://intramural.nih.gov/search/searchview.taf?ipid=68134
36,BC006192-23,"October 01, 2010 -  September 30, 2011",Investigating Regulatory Networks that Control Cell Proliferation and Apoptosis,Kurt  Kohn; PhD|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI",Mirit I Aladjem; PhD|Sohyoung  Kim|Augustin  Luna|Geoffrey B Mcfadden,Evrim Itir Karac|Martijn  van Iersel (Netherlands Consortium for Systems Biology),Ruth  Nussinov; PhD (Center for Cancer Research Nanobiology Program),NULL,"1. Kim S, Aladjem MI, McFadden GB, Kohn KW (2010). Predicted functions of MdmX in fine-tuning the response of p53 to DNA damage. PLoS Comput Biol  6, e1000665.   https://doi.org/10.1371/journal.pcbi.1000665|2. Luna A, Karac EI, Sunshine M, Chang L, Nussinov R, Aladjem MI, Kohn KW (2011). A formal MIM specification and tools for the common exchange of MIM diagrams: an XML-Based format, an API, and a validation method. BMC Bioinformatics  12, 167.   https://doi.org/10.1186/1471-2105-12-167|3. Luna A, Sunshine ML, van Iersel MP, Aladjem MI, Kohn KW (2011). PathVisio-MIM: PathVisio plugin for creating and editing Molecular Interaction Maps (MIMs). Bioinformatics  27, 2165-6.   https://doi.org/10.1093/bioinformatics/btr336",https://intramural.nih.gov/search/searchview.taf?ipid=68135
37,BC006198-22,"October 01, 2010 -  September 30, 2011",Inhibitors of Tyrosine Kinase-Dependent Signalling as Anti-Cancer Agents,Terrence R Burke; PhD|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Medhanit  Bahta|Sung-Eun  Kim|Christopher George Nelson; PhD|Wen-Jian  Qian; PhD|Xue Zhi  Zhao,"Stephan  Feller (Oxford University)|Robert  Ulrich (Molecular Immunology, USAMRIID)|Michael  Yaffe (Massachusetts Institute of Technology)",David S Waugh; PhD (Protein Engineering Section)|Donald P Bottaro; PhD (Urologic Oncology Branch)|Christoph  Rader; PhD (Experimental Transplantation and Immunology Branch)|Robert J Fisher (Office Of The Director)|Kyung  Lee; PhD (Chemistry Section)|Robert Andrew Byrd (Structural Biophysics Laboratory),NULL,"1. Bahta M, Burke T (2011) Oxime-based click chemistry in the development of 3-isoxazolecarboxylic acid-containing inhibitors of Yersinia pestis protein tyrosine phosphatase, YopH. ChemMedChem 6:1363-1370.|2. Kim S, Bahta M, Lountos G, Ulrich R, Burke T, Waugh D (2011) Isothiazolidinone (IZD) as a phosphoryl mimetic in inhibitors of the Yersinia pestis protein tyrosine phosphatase, YopH. Acta Crystallog. D67:639-645.|3. Liu F, Giubellini A, Simister P, Qian W, Giano M, Feller S, Bottaro D, Burke T (2011) Application of ring-closing metathesis to Grb2 SH2 domain-binding peptides. Biopolymers Peptide Science, in press.|4. Liu F, Hakami RM, Dyas B, Bahta M, Lountos GT, Waugh DS, Ulrich RG, Burke TR (2010). A rapid oxime linker-based library approach to identification of bivalent inhibitors of the Yersinia pestis protein-tyrosine phosphatase, YopH. Bioorg Med Chem Lett  20, 2813-6.   https://doi.org/10.1016/j.bmcl.2010.03.058|5. Liu F, Park J, Qian W, Lim D, Graber M, Berg T, Yaffe M, Lee K, Burke T (2011) Serendipitous alkylation of a Plk1 ligand uncovers a new binding channel. Nature Chemical Biology 7:759-601.|6. Muus U, Hose C, Yao W, Kosakowska-Cholody T, Farnsworth D, Dyba M, Lountos GT, Waugh DS, Monks A, Burke TR, Michejda CJ (2010). Development of antiproliferative phenylmaleimides that activate the unfolded protein response. Bioorg Med Chem  18, 4535-41.   https://doi.org/10.1016/j.bmc.2010.04.057|7. Thomas J, Burke T (2011) Application of a water-soluble pyridyl disulfide amine linker for use in Cu-free click bioconjugation. Tetrahedron Lett. 52:4316-4319.|8. Qian W, Liu F, Giubellino A, Simister P, Giano M, Feller S, Bottaro D, Burke T (2011) Application of ring-closing metathesis to Grb2 SH2 domain-binding peptides. 22nd American Peptide Symposium, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=68136
38,BC007333-20,"October 01, 2010 -  September 30, 2011",Pharmacology of HIV Viral DNA & Retroviral Integrases,Yves  Pommier; PhD|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI",Keli  Agama|Kasthuraiah  Maddali|Christophe R Marchand|Mathieu Albert Metifiot|Ann  Orr,"Peter  Cherepanov (Imperial College London)|Roberto  Di Santo (Univerty of Roma ""La Sapienza"")|A. Jun  Komano (AIDS Research Center)|Yuk  Sham (University of Minnesota)|ZhengQuiang  Wang (University of Minnesota)",Stuart F J Le Grice; PhD (Retroviral Replication Laboratory)|Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch)|Terrence R Burke; PhD (Chemical Biology Laboratory)|Marc C Nicklaus (Chemical Biology Laboratory)|Stephen H Hughes; PhD (HIV Drug Resistance Program),NULL,"1. Métifiot M, Maddali K, Naumova A, Zhang X, Marchand C, Pommier Y (2010). Biochemical and pharmacological analyses of HIV-1 integrase flexible loop mutants resistant to raltegravir. Biochemistry  49, 3715-22.   https://doi.org/10.1021/bi100130f|2. Métifiot M, Marchand C, Maddali K, Pommier Y (2010). Resistance to integrase inhibitors. Viruses  2, 1347-66.   https://doi.org/10.3390/v2071347|3. Michelini Z, Galluzzo CM, Negri DR, Leone P, Amici R, Bona R, Summa V, Di Santo R, Costi R, Pommier Y, Marchand C, Palmisano L, Vella S, Cara A (2010) Evaluation of HIV-1 integrase inhibitors on human primary macrophages using a luciferase-based single-cycle phenotypic assay. J Virol Methods 168:272-6.|4. Suzuki S, Urano E, Hashimoto C, Tsutsumi H, Nakahara T, Tanaka T, Nakanishi Y, Maddali K, Han Y, Hamatake M, Miyauchi K, Pommier Y, Beutler JA, Sugiura W, Fuji H, Hoshino T, Itotani K, Nomura W, Narumi T, Yamamoto N, Komano JA, Tamamura H (2010). Peptide HIV-1 integrase inhibitors from HIV-1 gene products. J Med Chem  53, 5356-60.   https://doi.org/10.1021/jm1003528",https://intramural.nih.gov/search/searchview.taf?ipid=68137
39,BC007363-17,"October 01, 2010 -  September 30, 2011",Design and Synthesis of HIV Integrase as Potential Anti-AIDS Drugs,Terrence R Burke; PhD|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Sung-Eun  Kim|Wen-Jian  Qian; PhD|Xue Zhi  Zhao,"Peter  Cherepanov (Imperial College London)|Serge  Fermandjian (CNRS)|Mamuka  Kvaratskhelia; PhD (College of Pharmacy, Ohio State University)",Yves  Pommier; PhD (Developmental Therapeutics Branch)|Eric O Freed; PhD (Retroviral Replication Laboratory)|Robert J Fisher (Office Of The Director)|Stephen H Hughes; PhD (HIV Drug Resistance Program),James H Hurley; PhD (NIDDK),"1. Hobaika Z, Zargarian L, Maroun RG, Mauffret O, Burke TR, Fermandjian S (2010). HIV-1 integrase and virus and cell DNAs: complex formation and perturbation by inhibitors of integration. Neurochem Res  35, 888-93.   https://doi.org/10.1007/s11064-009-0098-2|2. Im YJ, Kuo L, Ren X, Burgos PV, Zhao XZ, Liu F, Burke TR, Bonifacino JS, Freed EO, Hurley JH (2010). Crystallographic and functional analysis of the ESCRT-I /HIV-1 Gag PTAP interaction. Structure  18, 1536-47.   https://doi.org/10.1016/j.str.2010.08.010|3. Liao C, Marchand C, Burke T, Pommier Y, Nicklaus M (2010) Authentic HIV-1 integrase inhibitors. Future Med. Chem. 2:1107-1122.|4. Liao C, Marchand C, Burke TR, Pommier Y, Nicklaus MC (2010). Authentic HIV-1 integrase inhibitors. Future Med Chem  2, 1107-22.   https://doi.org/10.4155/fmc.10.199|5. Liu F, Stephen AG, Waheed AA, Freed EO, Fisher RJ, Burke TR (2010). Application of ring-closing metathesis macrocyclization to the development of Tsg101-binding antagonists. Bioorg Med Chem Lett  20, 318-21.   https://doi.org/10.1016/j.bmcl.2009.10.105|6. Metifiot M, Johnson B, Smith S, Zhao X, Marchand C, Burke T, Hughes S, Pommier Y (2011) MK-0536 inhibits HIV-1 integrases that are resistant to raltegravir. Antimicrob. Agents Chemother, in press.|7. Kim S, Stephen A, Im Y, BIndu L, Liu F, Fivash M, Waheed A, Freed E, Fisher R, Hurley J, Burke T (2011) Optimization of TSG101-binding peptides using X-ray structure data and library diversification. Fifth International Peptide Symposium.",https://intramural.nih.gov/search/searchview.taf?ipid=68138
40,BC007365-17,"October 01, 2010 -  September 30, 2011",Regulation of ADP-ribosylation factor,"Paul A Randazzo; MD, PhD|IRP Faculty Profile",NULL,"Laboratory of Cellular and Molecular Biology, NCI",Pei-Wen  Chen|Xiaoying  Jian; PhD|Ruibai  Luo|Yoko  Shiba|Marek  Sramko|Emily Frances Winterbottom|Show all 7,Sylvain  Bourgain (University of Laval)|Richard  Kahn (Emory University)|Wolfgang  Losert (University of Maryland)|Elizabeth  Sztul (University of Alabama),Lino  Tessarollo (Neural Development Section)|Ira  Daar; PhD (Laboratory of Cell and Developmental Signaling)|Robert Andrew Byrd (Structural Biophysics Laboratory),"J Silvio  Gutkind; PhD (NIDCR) |James  Gruschus; PhD (NHLBI) |Kenneth Manao Yamada; MD, PhD (NIDCR)","1. Chen PW, Randazzo PA, Parent CA (2010). ACAP-A/B are ArfGAP homologs in dictyostelium involved in sporulation but not in chemotaxis. PLoS One  5, e8624.   https://doi.org/10.1371/journal.pone.0008624|2. Jian X, Cavenagh M, Gruschus JM, Randazzo PA, Kahn RA (2010). Modifications to the C-terminus of Arf1 alter cell functions and protein interactions. Traffic  11, 732-42.   https://doi.org/10.1111/j.1600-0854.2010.01054.x|3. Kang SA, Lee ES, Yoon HY, Randazzo PA, Lee ST (2010). PTK6 inhibits down-regulation of EGF receptor through phosphorylation of ARAP1. J Biol Chem  285, 26013-21.   https://doi.org/10.1074/jbc.M109.088971|4. Sakurai A, Gavard J, Annas-Linhares Y, Basile JR, Amornphimoltham P, Palmby TR, Yagi H, Zhang F, Randazzo PA, Li X, Weigert R, Gutkind JS (2010). Semaphorin 3E initiates antiangiogenic signaling through plexin D1 by regulating Arf6 and R-Ras. Mol Cell Biol  30, 3086-98.   https://doi.org/10.1128/MCB.01652-09|5. Spang A, Shiba Y, Randazzo PA (2010). Arf GAPs: gatekeepers of vesicle generation. FEBS Lett  584, 2646-51.   https://doi.org/10.1016/j.febslet.2010.04.005",https://intramural.nih.gov/search/searchview.taf?ipid=68139
41,BC008303-39,"October 01, 2010 -  September 30, 2011",Mechanisms of Viral Fusion and Inactivation,Robert  Blumenthal; PhD|IRP Faculty Profile,NULL,"Center for Cancer Research Nanobiology Program, NCI",Julie M Belanger|Eliahu  Heldman|Yossef  Raviv|Mathias  Viard|Amichai  Yavlovich,"Javad  Aman (Medicine, USAMRID)|Assaf  Friedler (Hebrew University)|Jeeseong  Hwang (NIST)|Thomas  Luke; MD (Naval Medical Research Institute)|Radha  Maheshwari (Dept of Pathology, Uniformed Services University of the Health Sciences)|Yechiel  Shai (Biological Chemistry, Weizmann  Institute, Israel)|Show all 8","Ji Ming  Wang; MD, PhD (Laboratory of Molecular Immunoregulation)|Sriram  Subramaniam; PhD (Laboratory of Cell Biology)|Francis W Ruscetti; PhD (Laboratory of Experimental Immunology)|Jeffrey D Lifson; MD (Office Of The Director)|Stephen J Lockett; PhD (Office Of The Director)|Timothy D Veenstra (Office Of The Director)","Bernard  Moss; MD, PhD (NIAID) |Alasdair C Steven; PhD (NIAMS)","1. Belanger JM, Raviv Y, Viard M, Jason de la Cruz M, Nagashima K, Blumenthal R (2010). Characterization of the effects of aryl-azido compounds and UVA irradiation on the viral proteins and infectivity of human immunodeficiency virus type 1. Photochem Photobiol  86, 1099-108.   https://doi.org/10.1111/j.1751-1097.2010.00780.x|2. Rosa Borges A, Wieczorek L, Johnson B, Benesi AJ, Brown BK, Kensinger RD, Krebs FC, Wigdahl B, Blumenthal R, Puri A, McCutchan FE, Birx DL, Polonis VR, Schengrund CL (2010). Multivalent dendrimeric compounds containing carbohydrates expressed on immune cells inhibit infection by primary isolates of HIV-1. Virology  408, 80-8.   https://doi.org/10.1016/j.virol.2010.09.004|3. Wexler-Cohen Y, Ashkenazi A, Viard M, Blumenthal R, Shai Y (2010). Virus-cell and cell-cell fusion mediated by the HIV-1 envelope glycoprotein is inhibited by short gp41 N-terminal membrane-anchored peptides lacking the critical pocket domain. FASEB J  24, 4196-202.   https://doi.org/10.1096/fj.09-151704",https://intramural.nih.gov/search/searchview.taf?ipid=68141
42,BC008382-28,"October 01, 2010 -  September 30, 2011",Computational Approaches for RNA StructureFunction Determination,Bruce Allen Shapiro; PhD|IRP Faculty Profile,NULL,"Image Processing Section, NCI",Eckart  Bindewald|Kazimierz Wojcieck Kasprzak|Tae Jin  Kim|Shu Yun  Le|Praneet Sai Puppala|Arti  Santhanam,"Juan  Arroyo (Developmental Biology, Mitre Corporation)|Hugo  Martinez (Consultant, SAIC)|R  Padmanabhan (Department of Microbiology and Immunology, Geogetown University School of Medicine)|Luiz  Penalva (Cellular and Structural Biology, Research Institute, University of Texas Health Science Center at San Antonio)|Anne  Simon (Cell Biology and Molecular Genetics, University of Maryland)",Nancy H Colburn; PhD (Laboratory of Cancer Prevention)|Yun Xing M Wang (Structural Biophysics Laboratory)|Stuart F J Le Grice; PhD (Retroviral Replication Laboratory)|Howard A Young; PhD (Laboratory of Experimental Immunology),NULL,"1. Bindewald E, Kluth T, Shapiro BA (2010). CyloFold: secondary structure prediction including pseudoknots. Nucleic Acids Res  38, W368-72.   https://doi.org/10.1093/nar/gkq432|2. Kim T, Barchi JJ, Marquez VE, Shapiro BA (2011). Understanding the effects of carbocyclic sugars constrained to north and south conformations on RNA nanodesign. J Mol Graph Model  29, 624-34.   https://doi.org/10.1016/j.jmgm.2010.11.007|3. Le S, Shapiro B (2011) Data mining of functional RNA structures in genomic sequences. WIREs Data Mining and Knowledge Discovery 1:88-95.|4. Vogel C, Abreu Rde S, Ko D, Le SY, Shapiro BA, Burns SC, Sandhu D, Boutz DR, Marcotte EM, Penalva LO (2010). Sequence signatures and mRNA concentration can explain two-thirds of protein abundance variation in a human cell line. Mol Syst Biol  6, 400.   https://doi.org/10.1038/msb.2010.59|5. Zuo X, Wang J, Yu P, Eyler D, Xu H, Starich MR, Tiede DM, Simon AE, Kasprzak W, Schwieters CD, Shapiro BA, Wang YX (2010). Solution structure of the cap-independent translational enhancer and ribosome-binding element in the 3' UTR of turnip crinkle virus. Proc Natl Acad Sci U S A  107, 1385-90.   https://doi.org/10.1073/pnas.0908140107|6. Le S, Shapiro B (2011) Characterization of structural features for small regulatory RNAs in Escherichia coli genomes. IEEE Conference on Bioinformatics and Biomedicine, BIBM 2010.",https://intramural.nih.gov/search/searchview.taf?ipid=68142
43,BC008710-34,"October 01, 2010 -  September 30, 2011",Molecular Chaperones and DNA Replication,Sue H Wickner; PhD|IRP Faculty Profile,NULL,"DNA Molecular Biology Section, NCI",Jodi  Camberg|Shannon M Doyle|Olivier Patrick Genest|Joel R Hoskins|Danielle M Johnston|Marie-Caroline  Miot,David  Agard (UCSF)|George  Stan (University of Cincinnati),Susan  Gottesman; PhD (Biochemical Genetics Section)|Yawen  Bai; PhD (Laboratory Of Biochemistry & Molecular Biology)|Leonard  Neckers; PhD (Urologic Oncology Branch),"Daniel C Masison; PhD (NIDDK) |Kenneth Manao Yamada; MD, PhD (NIDCR)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68090
44,BC008714-34,"October 01, 2010 -  September 30, 2011",Bacterial Functions Involved in Cell Growth Control,Susan  Gottesman; PhD|IRP Faculty Profile,NULL,"Biochemical Genetics Section, NCI",Nicholas  de Lay|Hyun-Jung  Lee|Nadim  Majdalani|Kyung  Moon|David G Packer|Daniel Joseph Schu|Show all 7,"Maude  Guillier|Linda  Kenney (Microbiology, U. of Illinois School of Medicine)|Sarah  Woodson (Department of Biophysics, Johns Hopkins University)",Peter C Fitzgerald (Office of the Director),Gisela  Storz; PhD (NICHD) |Stephen H Leppla; PhD (NIAID),"1. Coornaert A, Lu A, Mandin P, Springer M, Gottesman S, Guillier M (2010). MicA sRNA links the PhoP regulon to cell envelope stress. Mol Microbiol  76, 467-79.   https://doi.org/10.1111/j.1365-2958.2010.07115.x|2. Gottesman S, Storz G (2011). Bacterial small RNA regulators: versatile roles and rapidly evolving variations. Cold Spring Harb Perspect Biol  3.   https://doi.org/10.1101/cshperspect.a003798|3. Mandin P, Gottesman S (2010). Integrating anaerobic/aerobic sensing and the general stress response through the ArcZ small RNA. EMBO J  29, 3094-107.   https://doi.org/10.1038/emboj.2010.179|4. McCullen CA, Benhammou JN, Majdalani N, Gottesman S (2010). Mechanism of positive regulation by DsrA and RprA small noncoding RNAs: pairing increases translation and protects rpoS mRNA from degradation. J Bacteriol  192, 5559-71.   https://doi.org/10.1128/JB.00464-10|5. Soper T, Mandin P, Majdalani N, Gottesman S, Woodson SA (2010). Positive regulation by small RNAs and the role of Hfq. Proc Natl Acad Sci U S A  107, 9602-7.   https://doi.org/10.1073/pnas.1004435107",https://intramural.nih.gov/search/searchview.taf?ipid=68144
45,BC008751-31,"October 01, 2010 -  September 30, 2011",Regulation of Gene Transcription,Sankar  Adhya; PhD|IRP Faculty Profile,NULL,"Developmental Genetics Section, NCI",Zsolt  Csiszovszki|Amlanjyoti  Dhar|Phuoc  Le|Dale  Lewis; PhD|Mirjana Tomislav Macvanin; PhD|Francisco Jesus Malagon Bautista|Show all 8,"Laura  Finzi (University of Milan)|Kim  Sneppen (Center for Models of Life, Niels Bohr Institute)",Victor  Zhurkin; PhD (Laboratory of Cell Biology)|Peter C Fitzgerald (Office of the Director),NULL,"1. Finzi L, Manzo C, Zurla C, Wang H, Lewis D, Adhya S, David D (2010) The Lambda bacteriophage epigenetic switch: new insight from single-molecule microscopy, in Biophysics of DNA-Protein Interactions., in press.|2. Lewis D, Lee S, Semsey S, Virnik K, Finzi L, Adhya S (2010) Role of HU in regulation of gal promoters, in Bacterial Chromatin., pp. 395-417.",https://intramural.nih.gov/search/searchview.taf?ipid=68145
46,BC008752-31,"October 01, 2010 -  September 30, 2011",Thyroid Hormone Receptors in Health and Disease,Sheueyann  Cheng; PhD|IRP Faculty Profile,NULL,"Gene Regulation Section, NCI",Laura  Fozzatti|Dong Wook  Kim; PhD|Won Gu  Kim|Changxue  Lu|Jeong-Won  Park|Li  Zhao|Show all 7,"Anneke  Alkemade (University of Amsterdam Medical Center)|Anthony  Hollenberg (Harvard University)|James  Lechleiter (University of Texas Health Science Center at San Antonio)|G.R.  Williams (Imperial College London, Imperial College London)","Gordon Lee Hager; PhD (Laboratory of Receptor Biology and Gene Expression)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",NULL,"1. Cheng SY, Leonard JL, Davis PJ (2010). Molecular aspects of thyroid hormone actions. Endocr Rev  31, 139-70.   https://doi.org/10.1210/er.2009-0007|2. Lu C, Cheng SY (2010). Thyroid hormone receptors regulate adipogenesis and carcinogenesis via crosstalk signaling with peroxisome proliferator-activated receptors. J Mol Endocrinol  44, 143-54.   https://doi.org/10.1677/JME-09-0107|3. Mishra A, Zhu XG, Ge K, Cheng SY (2010). Adipogenesis is differentially impaired by thyroid hormone receptor mutant isoforms. J Mol Endocrinol  44, 247-55.   https://doi.org/10.1677/JME-09-0137|4. Ribeiro MO, Bianco SD, Kaneshige M, Schultz JJ, Cheng SY, Bianco AC, Brent GA (2010). Expression of uncoupling protein 1 in mouse brown adipose tissue is thyroid hormone receptor-beta isoform specific and required for adaptive thermogenesis. Endocrinology  151, 432-40.   https://doi.org/10.1210/en.2009-0667|5. Zhu X, Cheng SY (2010). New insights into regulation of lipid metabolism by thyroid hormone. Curr Opin Endocrinol Diabetes Obes  17, 408-13.   https://doi.org/10.1097/MED.0b013e32833d6d46",https://intramural.nih.gov/search/searchview.taf?ipid=68146
47,BC008753-29,"October 01, 2010 -  September 30, 2011",Immunotoxin Therapy of Solid and Hematopoietic Tumors:  Preclinical Studies,Ira H Pastan; MD|IRP Faculty Profile,NULL,"Molecular Biology Section, NCI",Peter  Acs|Richard A Beers|Tapan K Bera|Xing  Du|Jaime  Eberle|Song Jin  Ha; PhD|Show all 15,"Ralph  Alderson (Cambridge Antibody Technology, Inc)|Itai  Benhar (Tel Aviv University)|DARELL  BIGNER (Duke University Medical Center, Dept. of Pathology)|Ulrich  Brinkmann (NCI)|Dario  Campana (St Jude Children's Research Hospital)|Nai-Kong  Cheung (Memorial Sloan Kettering Cancer Center)|Show all 18","Alan S Wayne; MD (Pediatric Oncology Branch)|Raffit  Hassan (Laboratory of Molecular Biology)|Robert J Kreitman; MD, PhD (Clinical Immunotherapy Section)|David J Fitzgerald; PhD (Biotherapy Section)|Byungkook  Lee; PhD (Molecular Modeling Section)|Dimiter Stanchev Dimitrov; PhD (Membrane Structure and Function Section)",Chang Hum  Paik; PhD (CC) |Richard James Youle; PhD (NINDS),"1. Berger EA, Pastan I (2010). Immunotoxin complementation of HAART to deplete persisting HIV-infected cell reservoirs. PLoS Pathog  6, e1000803.   https://doi.org/10.1371/journal.ppat.1000803|2. Bogner C, Dechow T, Ringshausen I, Wagner M, Oelsner M, Lutzny G, Licht T, Peschel C, Pastan I, Kreitman RJ, Decker T (2010). Immunotoxin BL22 induces apoptosis in mantle cell lymphoma (MCL) cells dependent on Bcl-2 expression. Br J Haematol  148, 99-109.   https://doi.org/10.1111/j.1365-2141.2009.07939.x|3. Cereda V, Poole DJ, Palena C, Das S, Bera TK, Remondo C, Gulley JL, Arlen PM, Yokokawa J, Pastan I, Schlom J, Tsang KY (2010). New gene expressed in prostate: a potential target for T cell-mediated prostate cancer immunotherapy. Cancer Immunol Immunother  59, 63-71.   https://doi.org/10.1007/s00262-009-0723-6|4. Du X, Youle RJ, FitzGerald DJ, Pastan I (2010). Pseudomonas exotoxin A-mediated apoptosis is Bak dependent and preceded by the degradation of Mcl-1. Mol Cell Biol  30, 3444-52.   https://doi.org/10.1128/MCB.00813-09|5. Hassan R, Schweizer C, Lu KF, Schuler B, Remaley AT, Weil SC, Pastan I (2010). Inhibition of mesothelin-CA-125 interaction in patients with mesothelioma by the anti-mesothelin monoclonal antibody MORAb-009: Implications for cancer therapy. Lung Cancer  68, 455-9.   https://doi.org/10.1016/j.lungcan.2009.07.016|6. Ho M, Feng M, Fisher RJ, Rader C, Pastan I (2011). A novel high-affinity human monoclonal antibody to mesothelin. Int J Cancer  128, 2020-30.   https://doi.org/10.1002/ijc.25557|7. Luther N, Cheung NK, Souliopoulos EP, Karampelas I, Karempelas I, Bassiri D, Edgar MA, Guo HF, Pastan I, Gutin PH, Souweidane MM (2010). Interstitial infusion of glioma-targeted recombinant immunotoxin 8H9scFv-PE38. Mol Cancer Ther  9, 1039-46.   https://doi.org/10.1158/1535-7163.MCT-09-0996|8. Matsusaka T, Asano T, Niimura F, Kinomura M, Shimizu A, Shintani A, Pastan I, Fogo AB, Ichikawa I (2010). Angiotensin receptor blocker protection against podocyte-induced sclerosis is podocyte angiotensin II type 1 receptor-independent. Hypertension  55, 967-73.   https://doi.org/10.1161/HYPERTENSIONAHA.109.141994|9. Zhang Y, Hansen JK, Xiang L, Kawa S, Onda M, Ho M, Hassan R, Pastan I (2010). A flow cytometry method to quantitate internalized immunotoxins shows that taxol synergistically increases cellular immunotoxins uptake. Cancer Res  70, 1082-9.   https://doi.org/10.1158/0008-5472.CAN-09-2405",https://intramural.nih.gov/search/searchview.taf?ipid=68147
48,BC008756-24,"October 01, 2010 -  September 30, 2011",Genetically Engineered Mouse Models to Study RTK Function in Melanoma,Glenn  Merlino; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Chi-Ping  Day|Pravin J Mishra|Prasun J Mishra|Jennifer D Rieker|Yanlin  Yu|Muhammad R Zaidi|Show all 7,"Boris  Bastian (UCSF)|Dot  Bennett (St. George's Hospital Medical School)|Lynda  Chin (Harvard Medical School)|Chris  Counter (Duke University)|Edward  De Fabo (GWU)|Ron  DePinho (Dana Farber, Harvard)|Show all 11","Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Thomas J Hornyak (Dermatology Branch)|Kathleen  Kelly; PhD (Laboratory Of Genitourinary Cancer Pathogenesis)|Miriam R Anver (Office Of The Director)|Giorgio  Trinchieri (Cancer Inflammation Program)|Margaret Anne Tucker (Human Genetics Program)","Heinz  Arnheiter; MD (NINDS) |Francis S Collins; MD, PhD (OD)","1. Fisher DE, Barnhill R, Hodi FS, Herlyn M, Merlino G, Medrano E, Bastian B, Landi MT, Landi TM, Sosman J (2010). Melanoma from bench to bedside: meeting report from the 6th international melanoma congress. Pigment Cell Melanoma Res  23, 14-26.   https://doi.org/10.1111/j.1755-148X.2009.00655.x|2. Klug HL, Tooze JA, Graff-Cherry C, Anver MR, Noonan FP, Fears TR, Tucker MA, De Fabo EC, Merlino G (2010). Sunscreen prevention of melanoma in man and mouse. Pigment Cell Melanoma Res  23, 835-7.   https://doi.org/10.1111/j.1755-148X.2010.00756.x|3. Mishra PJ, Ha L, Rieker J, Sviderskaya EV, Bennett DC, Oberst MD, Kelly K, Merlino G (2010). Dissection of RAS downstream pathways in melanomagenesis: a role for Ral in transformation. Oncogene  29, 2449-56.   https://doi.org/10.1038/onc.2009.521|4. Yu Y, Zeng P, Xiong J, Liu Z, Berger SL, Merlino G (2010). Epigenetic drugs can stimulate metastasis through enhanced expression of the pro-metastatic Ezrin gene. PLoS One  5, e12710.   https://doi.org/10.1371/journal.pone.0012710|5. Zaidi MR, Hornyak TJ, Merlino G (2011). A genetically engineered mouse model with inducible GFP expression in melanocytes. Pigment Cell Melanoma Res  24, 393-4.   https://doi.org/10.1111/j.1755-148X.2011.00832.x",https://intramural.nih.gov/search/searchview.taf?ipid=68148
49,BC008757-24,"October 01, 2010 -  September 30, 2011",Bio-Therapies for the Treatment of Cancer and Infectious Disease,David J Fitzgerald; PhD|IRP Faculty Profile,NULL,"Biotherapy Section, NCI","Antonella  Antignani; BS, PhD|Abid Rasheed Mattoo; PhD|Robert J Sarnovsky|Ashima K Sharma",NULL,Ira H Pastan; MD (Molecular Biology Section)|Peter C Fitzgerald (Office of the Director)|Alan S Wayne; MD (Pediatric Oncology Branch),Scott E Martin (NHGRI) |Craig Joseph Thomas (NHGRI),"1. Du X, Youle RJ, FitzGerald DJ, Pastan I (2010). Pseudomonas exotoxin A-mediated apoptosis is Bak dependent and preceded by the degradation of Mcl-1. Mol Cell Biol  30, 3444-52.   https://doi.org/10.1128/MCB.00813-09|2. Sharma AK, FitzGerald D (2010). Pseudomonas exotoxin kills Drosophila S2 cells via apoptosis. Toxicon  56, 1025-34.   https://doi.org/10.1016/j.toxicon.2010.07.007|3. Traini R, Ben-Josef G, Pastrana DV, Moskatel E, Sharma AK, Antignani A, Fitzgerald DJ (2010). ABT-737 overcomes resistance to immunotoxin-mediated apoptosis and enhances the delivery of pseudomonas exotoxin-based proteins to the cell cytosol. Mol Cancer Ther  9, 2007-15.   https://doi.org/10.1158/1535-7163.MCT-10-0257|4. Wayne AS, Kreitman RJ, Findley HW, Lew G, Delbrook C, Steinberg SM, Stetler-Stevenson M, Fitzgerald DJ, Pastan I (2010). Anti-CD22 immunotoxin RFB4(dsFv)-PE38 (BL22) for CD22-positive hematologic malignancies of childhood: preclinical studies and phase I clinical trial. Clin Cancer Res  16, 1894-903.   https://doi.org/10.1158/1078-0432.CCR-09-2980",https://intramural.nih.gov/search/searchview.taf?ipid=68149
50,BC008905-30,"October 01, 2010 -  September 30, 2011",Tumor gene expression in vitro and in vivo,Douglas  Lowy; MD|IRP Faculty Profile,NULL,"Office Of The Director, NCI","Xiao-Li  Du|Xi  Liu|Alexander G Papageorge|Xiaolan  Qian; MD, PhD|Brajendra  Tripathi; MS, PhD|William C Vass|Show all 7",NULL,Kent W Hunter; PhD (Laboratory of Cancer Biology and Genetics)|Nicolae C Popescu; PhD (Molecular Cytogenetics Section),NULL,"1. de la Luz Sierra M, Sakakibara S, Gasperini P, Salvucci O, Jiang K, McCormick PJ, Segarra M, Stone J, Maric D, Zhu J, Qian X, Lowy DR, Tosato G (2010). The transcription factor Gfi1 regulates G-CSF signaling and neutrophil development through the Ras activator RasGRP1. Blood  115, 3970-9.   https://doi.org/10.1182/blood-2009-10-246967",https://intramural.nih.gov/search/searchview.taf?ipid=68150
51,BC009003-29,"October 01, 2010 -  September 30, 2011",The Role of Cripto in the Pathogenesis of Breast and Colon Cancer,David  Salomon; PhD,NULL,"Mammary Biology and Tumorigenesis Laboratory, NCI",Caterina  Bianco; MD|Nadia  Castro|Monica I Gonzales|Natalie P Held|Tadahiro  Nagaoka|Maria Cristina Rangel|Show all 7,"Gabriella  Minchiotti (CNR, Institute of Genetics)|Masaharu  Seno (Biotechnology, Okayama University)",NULL,NULL,"1. Bianco C, Rangel MC, Castro NP, Nagaoka T, Rollman K, Gonzales M, Salomon DS (2010). Role of Cripto-1 in stem cell maintenance and malignant progression. Am J Pathol  177, 532-40.   https://doi.org/10.2353/ajpath.2010.100102|2. Bianco C, Salomon DS (2010). Targeting the embryonic gene Cripto-1 in cancer and beyond. Expert Opin Ther Pat  20, 1739-49.   https://doi.org/10.1517/13543776.2010.530659|3. de Castro NP, Rangel MC, Nagaoka T, Salomon DS, Bianco C (2010). Cripto-1: an embryonic gene that promotes tumorigenesis. Future Oncol  6, 1127-42.   https://doi.org/10.2217/fon.10.68|4. Watanabe K, Meyer MJ, Strizzi L, Lee JM, Gonzales M, Bianco C, Nagaoka T, Farid SS, Margaryan N, Hendrix MJ, Vonderhaar BK, Salomon DS (2010). Cripto-1 is a cell surface marker for a tumorigenic, undifferentiated subpopulation in human embryonal carcinoma cells. Stem Cells  28, 1303-14.   https://doi.org/10.1002/stem.463|5. Watanabe K, Salomon DS (2010). Intercellular transfer regulation of the paracrine activity of GPI-anchored Cripto-1 as a Nodal co-receptor. Biochem Biophys Res Commun  403, 108-13.   https://doi.org/10.1016/j.bbrc.2010.10.128",https://intramural.nih.gov/search/searchview.taf?ipid=68151
52,BC009052-22,"October 01, 2010 -  September 30, 2011",Papillomavirus Virion Proteins and Vaccines,John  Schiller; PhD|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI",Rebecca  Cerio|Nicolas  Cuburu; PhD|Patricia  Day; PhD|Alessandra  Handisurya|Christopher  Buck|Yuk Ying S Pang|Show all 7,"Bryce  Chackerian (University of New Mexico)|Reinhard  Glueck (Etna Biotech)|Ari  Helenius (Institute of Biochemistry, ETH)|Denise  Nardelli-Haefliger (Centre Hospitalier Universitaire Vaudois)|Richard  Roden (Johns Hopkins University)",Ligia  Pinto (Infection & Immunoepidemiology Branch)|Allan  Hildesheim; PhD (Infection & Immunoepidemiology Branch)|Peter L Choyke; MD (Molecular Imaging Program)|Genoveffa  Franchini; MD (Vaccine Branch),"Barney S Graham; MD, PhD (NIAID)","1. Caldeira Jdo C, Medford A, Kines RC, Lino CA, Schiller JT, Chackerian B, Peabody DS (2010). Immunogenic display of diverse peptides, including a broadly cross-type neutralizing human papillomavirus L2 epitope, on virus-like particles of the RNA bacteriophage PP7. Vaccine  28, 4384-93.   https://doi.org/10.1016/j.vaccine.2010.04.049|2. Day PM, Kines RC, Thompson CD, Jagu S, Roden RB, Lowy DR, Schiller JT (2010). In vivo mechanisms of vaccine-induced protection against HPV infection. Cell Host Microbe  8, 260-70.   https://doi.org/10.1016/j.chom.2010.08.003|3. Graham BS, Kines RC, Corbett KS, Nicewonger J, Johnson TR, Chen M, LaVigne D, Roberts JN, Cuburu N, Schiller JT, Buck CB (2010). Mucosal delivery of human papillomavirus pseudovirus-encapsidated plasmids improves the potency of DNA vaccination. Mucosal Immunol  3, 475-86.   https://doi.org/10.1038/mi.2010.31|4. Schiller JT, Day PM, Kines RC (2010). Current understanding of the mechanism of HPV infection. Gynecol Oncol  118, S12-7.   https://doi.org/10.1016/j.ygyno.2010.04.004|5. Schiller JT, Lowy DR (2010). Vaccines to prevent infections by oncoviruses. Annu Rev Microbiol  64, 23-41.   https://doi.org/10.1146/annurev.micro.112408.134019",https://intramural.nih.gov/search/searchview.taf?ipid=68152
53,BC009101-19,"October 01, 2010 -  September 30, 2011",Design of Antiviral Drugs Effective Against the HIV-1 Virus,Ettore  Appella; MD|IRP Faculty Profile,NULL,"Chemical Immunology Section, NCI",Ryo  Hayashi|Lisa Marie Jenkins|Kan  Tanoue,"Cecilia  Cheng-Mayer (The Aaron Diamond AIDS Research Center, Rockefeller University)|James  Smith (CDC)|Thomas  Smith (Auritec Pharmaceuticals)",Stewart  Durell (Laboratory of Cell Biology)|David E Ott (Office Of The Director),NULL,"1. Cheng-Mayer C, Huang Y, Gettie A, Tsai L, Ren W, Shakirzyanova M, Sina ST, Trunova N, Blanchard J, Jenkins LM, Lo Y, Schito ML, Appella E (2011). Delay of simian human immunodeficiency virus infection and control of viral replication in vaccinated macaques challenged in the presence of a topical microbicide. AIDS  25, 1833-41.   https://doi.org/10.1097/QAD.0b013e32834a1d94|2. Denton PW, Othieno F, Martinez-Torres F, Zou W, Krisko JF, Fleming E, Zein S, Powell DA, Wahl A, Kwak YT, Welch BD, Kay MS, Payne DA, Gallay P, Appella E, Estes JD, Lu M, Garcia JV (2011). One percent tenofovir applied topically to humanized BLT mice and used according to the CAPRISA 004 experimental design demonstrates partial protection from vaginal HIV infection, validating the BLT model for evaluation of new microbicide candidates. J Virol  85, 7582-93.   https://doi.org/10.1128/JVI.00537-11|3. Miller Jenkins LM, Ott DE, Hayashi R, Coren LV, Wang D, Xu Q, Schito ML, Inman JK, Appella DH, Appella E (2010). Small-molecule inactivation of HIV-1 NCp7 by repetitive intracellular acyl transfer. Nat Chem Biol  6, 887-9.   https://doi.org/10.1038/nchembio.456",https://intramural.nih.gov/search/searchview.taf?ipid=68153
54,BC009254-37,"October 01, 2010 -  September 30, 2011",Structure and Function of Toll-like Receptors,David M Segal; PhD,NULL,"Immune Targeting Section, NCI",Christopher James Schwartz; BA|Yan  Wang,NULL,NULL,David R Davies; PhD (NIDDK),"1. Wang Y, Liu L, Davies DR, Segal DM (2010). Dimerization of Toll-like receptor 3 (TLR3) is required for ligand binding. J Biol Chem  285, 36836-41.   https://doi.org/10.1074/jbc.M110.167973",https://intramural.nih.gov/search/searchview.taf?ipid=68154
55,BC009257-36,"October 01, 2010 -  September 30, 2011",Mechanisms of Cellular Immune Responses,James Stephen Shaw; PhD|IRP Faculty Profile,NULL,"Human Immunology Section, NCI",Genaro  Patino Lopez,NULL,Michael John Kruhlak; PhD (Experimental Immunology Branch)|Lino  Tessarollo (Neural Development Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68155
56,BC009262-29,"October 01, 2010 -  September 30, 2011",Immunophysiological Mechanisms in the Biological Therapy of Cancer,Robert  Wiltrout; PhD,NULL,"Laboratory of Experimental Immunology, NCI",Timothy  Back|Tim  Chan|Howard A Young; PhD|Qun  Jiang|Thomas Joseph Sayers; PhD|John R Ortaldo; PhD|Show all 8,"Bruce  Blazar (University of Minnesota)|Sylvie  Guichard (AstraZeneca)|Bill  Murphy (Clinical Research, University of Nevada at Reno)|Jon Marc Wigginton; MD (NCI)",Curtis  Harris; MD (Laboratory of Human Carcinogenesis)|William Marston Linehan; MD (Urologic Oncology Branch)|Syed Perwez  Hussain (Molecular Genetics and Carcinogenesis Section)|David Anderson Wink (Radiation Biology Branch)|Larry K Keefer; PhD (Laboratory of Comparative Carcinogenesis),NULL,"1. Jiang Q, Weiss JM, Back T, Chan T, Ortaldo JR, Guichard S, Wiltrout RH (2011). mTOR kinase inhibitor AZD8055 enhances the immunotherapeutic activity of an agonist CD40 antibody in cancer treatment. Cancer Res  71, 4074-84.   https://doi.org/10.1158/0008-5472.CAN-10-3968|2. Weiss JM, Ridnour LA, Back T, Hussain SP, He P, Maciag AE, Keefer LK, Murphy WJ, Harris CC, Wink DA, Wiltrout RH (2010). Macrophage-dependent nitric oxide expression regulates tumor cell detachment and metastasis after IL-2/anti-CD40 immunotherapy. J Exp Med  207, 2455-67.   https://doi.org/10.1084/jem.20100670",https://intramural.nih.gov/search/searchview.taf?ipid=68156
57,BC009264-28,"October 01, 2010 -  September 30, 2011",Cytokine Regulation of Normal and Neoplastic Hematopoietic Cell Growth,Francis W Ruscetti; PhD,NULL,"Laboratory of Experimental Immunology, NCI",Daniel C Bertolette|Tao  Fu|Yi  Huang|Sadowski  Cari,"Steven  Bartelmez (stem cell biology, Betastem Therapeutics)|Pat  Iversen (AVI-Biopharma)|John  Letterio (Case Western Medical Center)",NULL,NULL,"1. Bhatwadekar AD, Guerin EP, Jarajapu YP, Caballero S, Sheridan C, Kent D, Kennedy L, Lansang MC, Ruscetti FW, Pepine CJ, Higgins PJ, Bartelmez SH, Grant MB (2010). Transient inhibition of transforming growth factor-beta1 in human diabetic CD34+ cells enhances vascular reparative functions. Diabetes  59, 2010-9.   https://doi.org/10.2337/db10-0287",https://intramural.nih.gov/search/searchview.taf?ipid=68157
58,BC009265-29,"October 01, 2010 -  September 30, 2011",Analysis of the T Cell Repertoire,Richard J Hodes; MD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",NULL,"Gail  Bishop (University of Iowa)|Ferenc  Livak (School of Medicine, University of Maryland)|Yousuke  Takahama (Tokushima)",Lionel  Feigenbaum (Office Of The Director)|Lino  Tessarollo (Neural Development Section),Steven Edward Bowen (NIA) |Ranjan  Sen; PhD (NIA) |Chiharu  Fujihara (NIA) |Karen  Hathcock (NIA) |Sarah Rhiannon Jenkinson (NIA) |Masashi  Watanabe (NIA),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68158
59,BC009273-24,"October 01, 2010 -  September 30, 2011",T Cell Differentiation and Repertoire Selection,Alfred  Singer; MD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Amala Shenai Alag|James  Disanto; PhD|Terry I Guinter|Jung-Hyun  Park,"Wilfried  Ellmeier (Immunology, University of Vienna)|Batu M Erman|Deitmar  Kappes (Immunology, Fox Chase Cancer Center)|Ed  Palmer (University of Basel)|Sophia D Sarafova (NCI)|Arlene  Sharpe (Dept of Pathology, Harvard Medical School)|Show all 7","Remy J Bosselut; MD, PhD (Laboratory of Immune Cell Biology)|Lionel  Feigenbaum (Office Of The Director)|Dinah  Singer; PhD (Office of the Director)|Carl  Wu; PhD (Laboratory Of Biochemistry & Molecular Biology)","Paul E Love; MD, PhD (NICHD) |Lothar  Hennighausen; PhD (NIDDK)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68159
60,BC009279-26,"October 01, 2010 -  September 30, 2011",Regulation of Expression of MHC Class I Genes,Dinah  Singer; PhD|IRP Faculty Profile,NULL,"Office of the Director, NCI",Devaiah Nanjappa Ballachanda|Zohar Sara Barbash|Namhoon  Lee|Jie  Mu|Jocelyn D Weissman,NULL,Brian  Lewis (Lymphoid Malignancies Branch)|Susan  Sharrow (Experimental Immunology Branch),NULL,"1. Giuliani C, Bucci I, Montani V, Singer DS, Monaco F, Kohn LD, Napolitano G (2010). Regulation of major histocompatibility complex gene expression in thyroid epithelial cells by methimazole and phenylmethimazole. J Endocrinol  204, 57-66.   https://doi.org/10.1677/JOE-09-0172|2. Lee N, Iyer SS, Mu J, Weissman JD, Ohali A, Howcroft TK, Lewis BA, Singer DS (2010). Three novel downstream promoter elements regulate MHC class I promoter activity in mammalian cells. PLoS One  5, e15278.   https://doi.org/10.1371/journal.pone.0015278",https://intramural.nih.gov/search/searchview.taf?ipid=68160
61,BC009281-25,"October 01, 2010 -  September 30, 2011",Receptor Mediated T and B Cell Activation,Richard J Hodes; MD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",NULL,NULL,Lionel  Feigenbaum (Office Of The Director),Sumeena  Bhatia (NIA) |Yungping  Chiang (NIA),"1. Bhatia S, Sun K, Almo SC, Nathenson SG, Hodes RJ (2010). Dynamic equilibrium of B7-1 dimers and monomers differentially affects immunological synapse formation and T cell activation in response to TCR/CD28 stimulation. J Immunol  184, 1821-8.   https://doi.org/10.4049/jimmunol.0902869",https://intramural.nih.gov/search/searchview.taf?ipid=68161
62,BC009283-27,"October 01, 2010 -  September 30, 2011",Control of Cytokine Gene Expression in LymphoidMyeloid Cells,Howard A Young; PhD|IRP Faculty Profile,NULL,"Laboratory of Experimental Immunology, NCI","Deborah L Hodge|Robert  Wiltrout; PhD|Madeleine M Jacob|Daniel  McVicar; PhD|Fan Ching  Lin|Dennis M Klinman; MD, PhD|Show all 8",NULL,"George N Pavlakis; MD, PhD (Vaccine Branch)|Lino  Tessarollo (Neural Development Section)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68162
63,BC009285-25,"October 01, 2010 -  September 30, 2011",Responses of MHC Class I Genes to Exogeneous Stimuli,Dinah  Singer; PhD|IRP Faculty Profile,NULL,"Office of the Director, NCI",Devaiah Nanjappa Ballachanda|Aparna  Kotekar|Jie  Mu|Katherine Chelsea Soe|Jocelyn D Weissman,NULL,Xuguang C Tai (Lymphocyte Development Section)|Kenneth  Buetow; PhD (Laboratory of Population Genetics)|Robert  Clifford (Laboratory of Population Genetics)|Maxwell P Lee; PhD (Laboratory of Population Genetics)|Brian  Lewis (Lymphoid Malignancies Branch),NULL,"1. Devaiah BN, Lu H, Gegonne A, Sercan Z, Zhang H, Clifford RJ, Lee MP, Singer DS (2010). Novel functions for TAF7, a regulator of TAF1-independent transcription. J Biol Chem  285, 38772-80.   https://doi.org/10.1074/jbc.M110.173864|2. Lee N, Iyer SS, Mu J, Weissman JD, Ohali A, Howcroft TK, Lewis BA, Singer DS (2010). Three novel downstream promoter elements regulate MHC class I promoter activity in mammalian cells. PLoS One  5, e15278.   https://doi.org/10.1371/journal.pone.0015278",https://intramural.nih.gov/search/searchview.taf?ipid=68163
64,BC009287-27,"October 01, 2010 -  September 30, 2011",Cytokines and T Cell Development,Scott K Durum; PhD|IRP Faculty Profile,NULL,"Laboratory of Molecular Immunoregulation, NCI",Julie  Hixon|Arthur A Hurwitz|Wenqing  Li,Joao  Barata (U.Lisbon)|andrew  farr (university of washington)|Richard  Hotchkiss (Wash U),Jonathan  Keller; PhD (Laboratory of Cancer Prevention),Warren J Leonard; MD (NHLBI),"1. Kittipatarin C, Li W, Durum SK, Khaled AR (2010). Cdc25A-driven proliferation regulates CD62L levels and lymphocyte movement in response to interleukin-7. Exp Hematol  38, 1143-56.   https://doi.org/10.1016/j.exphem.2010.08.010|2. Li WQ, Guszczynski T, Hixon JA, Durum SK (2010). Interleukin-7 regulates Bim proapoptotic activity in peripheral T-cell survival. Mol Cell Biol  30, 590-600.   https://doi.org/10.1128/MCB.01006-09|3. Zenatti P, Ribeiro D, Li W, Zuurbier L, Silva M, Paganin M, Tritapoe J, Hixon J, Silveira A, Cardoso B, Sarmento L, Correia N, Toribio M, Korbarg J, Horstmann M, Pieters R, Brandalise S, Ferrando A, Meijerink J, Durum S, Yunes A, Barata J (2011) Oncogenic IL-7R gain-of-function mutations in childhood T-cell acute lymphoblastic leukemia. Nature Genetics, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=68164
65,BC009297-20,"October 01, 2010 -  September 30, 2011",Ubiquitin And SUMO Post-Translational Modifications In Development And Disease,Michael Robert Kuehn; PhD,NULL,"Laboratory of Protein Dynamics and Signaling, NCI",Margaret M O'Toole-Lualdi|Allan M Weissman; MD|Prashant  Sharma,NULL,Stephen J Lockett; PhD (Office Of The Director),NULL,"1. Sharma P, Murillas R, Zhang H, Kuehn MR (2010). N4BP1 is a newly identified nucleolar protein that undergoes SUMO-regulated polyubiquitylation and proteasomal turnover at promyelocytic leukemia nuclear bodies. J Cell Sci  123, 1227-34.   https://doi.org/10.1242/jcs.060160",https://intramural.nih.gov/search/searchview.taf?ipid=68165
66,BC009304-17,"October 01, 2010 -  September 30, 2011",Structure-Function Studies and Design of Novel Glycosyltransferases,Pradman  Qasba; PhD,NULL,"Structural Glycobiology Section, NCI",Boopathy  Ramakrishna|Yuko  Tsutsui; PhD,NULL,NULL,NULL,"1. Pasek M, Ramakrishnan B, Boeggeman E, Mercer N, Dulcey A, Griffiths G, Qasba P (2011) The N-acetyl binding pocket of N-acetylglucosaminyltransferases also accommodates a sugar analogue with chemical handle at C-2. Glycobiology [Epubaheadofprint].|2. Ramakrishnan B, Qasba PK (2010). Crystal structure of the catalytic domain of Drosophila beta1,4-Galactosyltransferase-7. J Biol Chem  285, 15619-26.   https://doi.org/10.1074/jbc.M109.099564|3. Ramakrishnan B, Qasba PK (2010). Structure-based evolutionary relationship of glycosyltransferases: a case study of vertebrate β1,4-galactosyltransferase, invertebrate β1,4-N-acetylgalactosaminyltransferase and α-polypeptidyl-N-acetylgalactosaminyltransferase. Curr Opin Struct Biol  20, 536-42.   https://doi.org/10.1016/j.sbi.2010.07.004",https://intramural.nih.gov/search/searchview.taf?ipid=68166
67,BC009322-23,"October 01, 2010 -  September 30, 2011",Mechanisms of Leukocyte Migration Following Cytokine Administration to Mice,Robert  Wiltrout; PhD,NULL,"Laboratory of Experimental Immunology, NCI",Timothy  Back|Tim  Chan|John R Ortaldo; PhD|Jeffrey J Subleski|Howard A Young; PhD,NULL,"Curtis  Harris; MD (Laboratory of Human Carcinogenesis)|Snorri S. Thorgeirsson; MD, PhD (Laboratory of Experimental Carcinogenesis)|William Marston Linehan; MD (Urologic Oncology Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68167
68,BC009369-21,"October 01, 2010 -  September 30, 2011",Studies of Chemokine-Receptor Interactions with Chemokines and alarmins,Joost J Oppenheim; MD|IRP Faculty Profile,NULL,"Laboratory of Molecular Immunoregulation, NCI",Ola Mae Zack Howard|Poonam  Tewary|Anna Lee  Trivett|Feng  Wei|De  Yang|Nathan Joseph Kadan,Robert  Goldman (Peprotech)|Johannes  Rohrl (University of Regensburg)|Sergei  Tarasova (SAIC)|Ronald  Wolf|Ning  Zhang (Tianjin Cancer Hospital),"Michael  Bustin; PhD (Protein Section)|Dennis M Klinman; MD, PhD (Laboratory of Experimental Immunology)|Nadya I Tarasova; PhD (Cancer Inflammation Program)",NULL,"1. Buzas K, Oppenheim JJ, Zack Howard OM (2011). Myeloid cells migrate in response to IL-24. Cytokine  55, 429-34.   https://doi.org/10.1016/j.cyto.2011.05.018|2. Chertov O, Zhang N, Chen X, Oppenheim JJ, Lubkowski J, McGrath C, Sowder RC, Crise BJ, Malyguine A, Kutzler MA, Steele AD, Henderson EE, Rogers TJ (2011). Novel peptides based on HIV-1 gp120 sequence with homology to chemokines inhibit HIV infection in cell culture. PLoS One  6, e14474.   https://doi.org/10.1371/journal.pone.0014474|3. Tarasov SG, Gaponenko V, Howard OM, Chen Y, Oppenheim JJ, Dyba MA, Subramaniam S, Lee Y, Michejda C, Tarasova NI (2011). Structural plasticity of a transmembrane peptide allows self-assembly into biologically active nanoparticles. Proc Natl Acad Sci U S A  108, 9798-803.   https://doi.org/10.1073/pnas.1014598108|4. Yoshimura T, Oppenheim JJ (2011). Chemokine-like receptor 1 (CMKLR1) and chemokine (C-C motif) receptor-like 2 (CCRL2); two multifunctional receptors with unusual properties. Exp Cell Res  317, 674-84.   https://doi.org/10.1016/j.yexcr.2010.10.023",https://intramural.nih.gov/search/searchview.taf?ipid=68168
69,BC009392-19,"October 01, 2010 -  September 30, 2011",Determining the Fate of Transmembrane Proteins,Allan M Weissman; MD|IRP Faculty Profile,NULL,"Laboratory of Protein Dynamics and Signaling, NCI",Jennifer B Mariano|Meredith Boyle Metzger; PhD|Daniel Kenneth Stringer|Yien-Che  Tsai|Gaye L Wilson|Mei  Yang; MD,"Robert  Coffey (Vanderbilt University)|Michael  Glickman (Technion)|Kazuhiro  Iwai (Department of Molecular Cell Biology, Osaka City Medical University)|J  McCaffery (Johns Hopkins University)|Janet  Shaw (University of Utah)",Robert Andrew Byrd (Structural Biophysics Laboratory)|Chand  Khanna; MD (Pediatric Oncology Branch)|Stefan  Ambs (Laboratory of Human Carcinogenesis),Juan S Bonifacino; PhD (NICHD),"1. Ishikura S, Weissman AM, Bonifacino JS (2010). Serine residues in the cytosolic tail of the T-cell antigen receptor alpha-chain mediate ubiquitination and endoplasmic reticulum-associated degradation of the unassembled protein. J Biol Chem  285, 23916-24.   https://doi.org/10.1074/jbc.M110.127936|2. Lipkowitz S, Weissman AM (2011). RINGs of good and evil: RING finger ubiquitin ligases at the crossroads of tumour suppression and oncogenesis. Nat Rev Cancer  11, 629-43.   https://doi.org/10.1038/nrc3120|3. Tsai Y, Weissman A (2011) Dissecting the diverse functions of the metastasis suppressor CD82KAI1. FEBS Letters, in press.|4. Tsai YC, Weissman AM (2010). The Unfolded Protein Response, Degradation from Endoplasmic Reticulum and Cancer. Genes Cancer  1, 764-778.   https://doi.org/10.1177/1947601910383011|5. Weissman AM, Shabek N, Ciechanover A (2011). The predator becomes the prey: regulating the ubiquitin system by ubiquitylation and degradation. Nat Rev Mol Cell Biol  12, 605-20.   https://doi.org/10.1038/nrm3173",https://intramural.nih.gov/search/searchview.taf?ipid=68082
70,BC009404-17,"October 01, 2010 -  September 30, 2011",Regulation of MHC Class II Trafficking in Antigen Presenting Cells,Paul A Roche; PhD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Karis  Faust|Kazuyuki  Furuta|Erica Lynn Heipertz|Sharad Kumar Mittal; PhD,"Oddmund  Bakke (Biology, Univ. of Oslo)|Lisa  Denzin (Immunology Program, Sloan-Kettering Institute)|Satoshi  Ishido (Riken Center for Allergy and Immunology)|Laura  Santambrogio (Memorial Sloan Kettering)",Lionel  Feigenbaum (Office Of The Director),NULL,"1. Walseng E, Furuta K, Bosch B, Weih KA, Matsuki Y, Bakke O, Ishido S, Roche PA (2010). Ubiquitination regulates MHC class II-peptide complex retention and degradation in dendritic cells. Proc Natl Acad Sci U S A  107, 20465-70.   https://doi.org/10.1073/pnas.1010990107|2. Walseng E, Furuta K, Goldszmid RS, Weih KA, Sher A, Roche PA (2010). Dendritic cell activation prevents MHC class II ubiquitination and promotes MHC class II survival regardless of the activation stimulus. J Biol Chem  285, 41749-54.   https://doi.org/10.1074/jbc.M110.157586",https://intramural.nih.gov/search/searchview.taf?ipid=68169
71,BC009405-17,"October 01, 2010 -  September 30, 2011",Regulation of Lymphocyte Proliferation and Replicative Capacity,Richard J Hodes; MD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",NULL,NULL,Lionel  Feigenbaum (Office Of The Director)|Lino  Tessarollo (Neural Development Section)|Karl Thomas Ried; MD (Cancer Genetics Branch),Yungping  Chiang (NIA) |Masashi  Watanabe (NIA) |Karen  Hathcock (NIA) |Neal S Young; MD (NHLBI) |Herbert Carpenter Morse; MD (NIAID),"1. Chiang YJ, Calado RT, Hathcock KS, Lansdorp PM, Young NS, Hodes RJ (2010). Telomere length is inherited with resetting of the telomere set-point. Proc Natl Acad Sci U S A  107, 10148-53.   https://doi.org/10.1073/pnas.0913125107",https://intramural.nih.gov/search/searchview.taf?ipid=68170
72,BC010001-16,"October 01, 2010 -  September 30, 2011",MolecularCellular Regulation of Hematopoiesis,Jonathan  Keller; PhD,NULL,"Laboratory of Cancer Prevention, NCI",Satyanarayana  Ande|Emily  Bowers|Bjorg  Gudmundsdottir|Ming  Ji|Peter F Johnson; PhD|Wonil  Kim|Show all 9,NULL,Laura  Schmidt (Urologic Oncology Branch)|Serguei V Kozlov (Office of the Director)|Timothy D Veenstra (Office Of The Director)|Masaya  Baba (Urologic Oncology Branch)|Pengnian Charles Lin; PhD (Mouse Cancer Genetics Program)|Philipp  Oberdoerffer (Mouse Cancer Genetics Program),NULL,"1. Li H, Ji M, Klarmann KD, Keller JR (2010). Repression of Id2 expression by Gfi-1 is required for B-cell and myeloid development. Blood  116, 1060-9.   https://doi.org/10.1182/blood-2009-11-255075|2. Satyanarayana A, Gudmundsson KO, Chen X, Coppola V, Tessarollo L, Keller JR, Hou SX (2010). RapGEF2 is essential for embryonic hematopoiesis but dispensable for adult hematopoiesis. Blood  116, 2921-31.   https://doi.org/10.1182/blood-2010-01-262964",https://intramural.nih.gov/search/searchview.taf?ipid=68171
73,BC010006-16,"October 01, 2010 -  September 30, 2011",Mechanisms of Cross-talk Between EphrinB and Alternate Signaling Pathways,Ira  Daar; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell and Developmental Signaling, NCI",Gretchen Lee Dollar; PhD|Kathleen T Soria|Emily Frances Winterbottom,"Ken  Cho (University of California, Irvine)|Sally  Moody (George Washington University Medical Center)|Christof  Niehrs; PhD (DKFZ Heidelberg)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68172
74,BC010008-16,"October 01, 2010 -  September 30, 2011",The Genetics of Susceptibility to Mouse Plasma Cell Tumors,Beverly  Mock; PhD|IRP Faculty Profile,NULL,"Office of the Director, NCI","Margaret R Pruitt|Richard C Robinson|Kaori  Sakakibara|John K Simmons|Dena Hoa Tran|Shuling  Zhang; MD, PhD|Show all 7",NULL,Carole A Parent; PhD (Laboratory of Cellular and Molecular Biology),"Pamela Lee Schwartzberg; MD, PhD (NHGRI)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68173
75,BC010012-16,"October 01, 2010 -  September 30, 2011",Mechanisms of Immune-mediated Tumor Cell Destruction,Thomas Joseph Sayers; PhD,NULL,"Laboratory of Experimental Immunology, NCI",Alan  Brooks|Robert  Wiltrout; PhD,"Hyam  Levitsky (Department of Oncology, Johns Hopkins University)|William  Murphy (University of Nevada)|Linda A Sherman|Hideo  Yagita (Immunology, Juntendo University)",William  Farrar (Laboratory of Cancer Prevention),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68174
76,BC010013-16,"October 01, 2010 -  September 30, 2011",Molecular Studies of Cellular Cytotoxicity,Stephen K Anderson; PhD,NULL,"Laboratory of Experimental Immunology, NCI","Allison Lee Bierly; PhD|Mary  Carrington; MS, PhD|Kevin Jessen Ho|Daniel  McVicar; PhD|Michael  Dean; PhD|Hong-Chuan  Li|Show all 8","Colin  Brooks (School of Biosciences, University of Newcastle)|Kerry  Campbell (Immunobiology, Fox Chase Cancer Institute)|Dan  Kaufman (Division of Hematology, Oncology and Transplantation, University of Minnesota Cancer Center)|Andrew  Makrigiannis (ICRM)|Jeffrey  Miller (University of Minnesota Cancer Center)",NULL,NULL,"1. Cichocki F, Lenvik T, Sharma N, Yun G, Anderson SK, Miller JS (2010). Cutting edge: KIR antisense transcripts are processed into a 28-base PIWI-like RNA in human NK cells. J Immunol  185, 2009-12.   https://doi.org/10.4049/jimmunol.1000855|2. Li H, Wright PW, Anderson SK (2010). Identification and analysis of novel transcripts and promoters in the human killer cell immunoglobulin-like receptor (KIR) genes. Methods Mol Biol  612, 377-91.   https://doi.org/10.1007/978-1-60761-362-6_26",https://intramural.nih.gov/search/searchview.taf?ipid=68175
77,BC010014-16,"October 01, 2010 -  September 30, 2011",Epigenetic control during embryogenesis,Kathrin  Muegge; MD,NULL,"Laboratory of Cancer Prevention, NCI",Victorino Cristito Robles Briones|Theresa M Geiman|Eunice Yoon Lee,NULL,Robert M Leighty (Office Of The Director)|Robert  Stephens (Office Of The Director),Keji  Zhao; PhD (NHLBI),"1. Tao Y, Liu S, Briones V, Geiman TM, Muegge K (2011). Treatment of breast cancer cells with DNA demethylating agents leads to a release of Pol II stalling at genes with DNA-hypermethylated regions upstream of TSS. Nucleic Acids Res  39, 9508-20.   https://doi.org/10.1093/nar/gkr611|2. Tao Y, Xi S, Shan J, Maunakea A, Che A, Briones V, Lee EY, Geiman T, Huang J, Stephens R, Leighty RM, Zhao K, Muegge K (2011). Lsh, chromatin remodeling family member, modulates genome-wide cytosine methylation patterns at nonrepeat sequences. Proc Natl Acad Sci U S A  108, 5626-31.   https://doi.org/10.1073/pnas.1017000108",https://intramural.nih.gov/search/searchview.taf?ipid=68176
78,BC010015-16,"October 01, 2010 -  September 30, 2011",The Role of Cellular Receptors Involved in Inflammation and Tumor Progression,"Ji Ming  Wang; MD, PhD|IRP Faculty Profile",NULL,"Laboratory of Molecular Immunoregulation, NCI",Wang Hua  Gong|Ying  Liu|Ming Yong  Liu; MD,"Xiuwu  Bian (Southwest Hospital, Institute of Pathology)|Yingying  Le (Immunology, Institute for Nutritional Sciences)|Thomas  Rogers (Temple University)|Chunfu  Wu (Medicinal Chemistry, Shenyang Pharmaceutical University)",Keqiang  Chen (Laboratory of Molecular Immunoregulation),Philip M Murphy; MD (NIAID),"1. Huang J, Chen K, Chen J, Gong W, Dunlop NM, Howard OM, Gao Y, Bian XW, Wang JM (2010). The G-protein-coupled formylpeptide receptor FPR confers a more invasive phenotype on human glioblastoma cells. Br J Cancer  102, 1052-60.   https://doi.org/10.1038/sj.bjc.6605591",https://intramural.nih.gov/search/searchview.taf?ipid=68177
79,BC010017-16,"October 01, 2010 -  September 30, 2011","Use of Bacteriophages to Prevent, Diagnose, and Treat Diseases",Sankar  Adhya; PhD|IRP Faculty Profile,NULL,"Developmental Genetics Section, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68178
80,BC010020-16,"October 01, 2010 -  September 30, 2011",Clinical Trials with Immunotoxins,Ira H Pastan; MD|IRP Faculty Profile,NULL,"Molecular Biology Section, NCI",Barbara  Debrah|Sonya C Duke|Natasha L Kormanik|Elizabeth J Maestri|Yvonne D Mallory|Rita  Mincemoyer; RN|Show all 7,"Steven  Albelda (University of PA Medical Center)|DARELL  BIGNER (Duke University Medical Center, Dept. of Pathology)|Luigi  Grasso (Morphoteck, Inc)|Ramy A Ibrahim|Carl  June (University of PA School of Medicine)|JOHN  SAMPSON (Div of Neurosurgery, Duke University Medical Center, Div. of Neurosurgery)","Wyndham H Wilson; MD, PhD (Lymphoid Malignancies Branch)|Alan S Wayne; MD (Pediatric Oncology Branch)|Raffit  Hassan (Laboratory of Molecular Biology)|Robert J Kreitman; MD, PhD (Clinical Immunotherapy Section)|Maryalice  Stetler-Stevenson; MD, PhD (Laboratory of Pathology)|Thomas Alexander Waldmann; MD, PhD (Lymphoid Malignancies Branch)",NULL,"1. Hassan R, Cohen SJ, Phillips M, Pastan I, Sharon E, Kelly RJ, Schweizer C, Weil S, Laheru D (2010). Phase I clinical trial of the chimeric anti-mesothelin monoclonal antibody MORAb-009 in patients with mesothelin-expressing cancers. Clin Cancer Res  16, 6132-8.   https://doi.org/10.1158/1078-0432.CCR-10-2275|2. Wayne AS, Kreitman RJ, Findley HW, Lew G, Delbrook C, Steinberg SM, Stetler-Stevenson M, Fitzgerald DJ, Pastan I (2010). Anti-CD22 immunotoxin RFB4(dsFv)-PE38 (BL22) for CD22-positive hematologic malignancies of childhood: preclinical studies and phase I clinical trial. Clin Cancer Res  16, 1894-903.   https://doi.org/10.1158/1078-0432.CCR-09-2980",https://intramural.nih.gov/search/searchview.taf?ipid=68179
81,BC010021-16,"October 01, 2010 -  September 30, 2011",Biology of Mammary Gland Development and Tumorigenesis,Gilbert  Smith; PhD|IRP Faculty Profile,NULL,"Mammary Biology and Tumorigenesis Laboratory, NCI",Corinne A Boulanger-Espeut|David  Salomon; PhD|Robert D Bruno|Barbara V Vonderhaar; PhD|Karen  Bussard|Robert  Callahan; PhD,Cathrin  Brisken (ISREC/EPFL)|Christine  Watson (Cambridge Univ.),NULL,NULL,"1. Anderson LH, Boulanger CA, Smith GH, Carmeliet P, Watson CJ (2011). Stem cell marker prominin-1 regulates branching morphogenesis, but not regenerative capacity, in the mammary gland. Dev Dyn  240, 674-81.   https://doi.org/10.1002/dvdy.22539|2. Booth BW, Boulanger CA, Anderson LH, Jimenez-Rojo L, Brisken C, Smith GH (2010). Amphiregulin mediates self-renewal in an immortal mammary epithelial cell line with stem cell characteristics. Exp Cell Res  316, 422-32.   https://doi.org/10.1016/j.yexcr.2009.11.006|3. Booth BW, Boulanger CA, Anderson LH, Smith GH (2011). The normal mammary microenvironment suppresses the tumorigenic phenotype of mouse mammary tumor virus-neu-transformed mammary tumor cells. Oncogene  30, 679-89.   https://doi.org/10.1038/onc.2010.439|4. Bruno RD, Boulanger CA, Smith GH (2012). Notch-induced mammary tumorigenesis does not involve the lobule-limited epithelial progenitor. Oncogene  31, 60-7.   https://doi.org/10.1038/onc.2011.215|5. Bruno RD, Smith GH (2011). Functional characterization of stem cell activity in the mouse mammary gland. Stem Cell Rev Rep  7, 238-47.   https://doi.org/10.1007/s12015-010-9191-9|6. Bussard KM, Boulanger CA, Booth BW, Bruno RD, Smith GH (2010). Reprogramming human cancer cells in the mouse mammary gland. Cancer Res  70, 6336-43.   https://doi.org/10.1158/0008-5472.CAN-10-0591|7. Bussard KM, Boulanger CA, Kittrell FS, Behbod F, Medina D, Smith GH (2010). Immortalized, pre-malignant epithelial cell populations contain long-lived, label-retaining cells that asymmetrically divide and retain their template DNA. Breast Cancer Res  12, R86.   https://doi.org/10.1186/bcr2754|8. Visvader JE, Smith GH (2011). Murine mammary epithelial stem cells: discovery, function, and current status. Cold Spring Harb Perspect Biol  3.   https://doi.org/10.1101/cshperspect.a004879",https://intramural.nih.gov/search/searchview.taf?ipid=68180
82,BC010022-16,"October 01, 2010 -  September 30, 2011",Genetics of Renal Disease in African Americans,Cheryl Ann Winkler,NULL,"Basic Research Laboratory, NCI",Ping  An; PhD|Elizabeth  Binns-Roemer|Yu-Chun  Zhou|Sophie Mh Limou|Kaitlyn R Culley|Sarah Catherine Johnson,"Barry  Freedman (Wake Forest University)|David  Gasser (Department of Genetics, University of Pennsylvania)|Sudha  Iyengar (Case Western Reserve University)|Linda  Kao (Dept. of Epidemiology, Johns Hopkins University)|Gregory D Kirk|Rulan  Parekh (Johns Hopkins University)|Show all 8",George  Nelson (Office of the Director)|Michael W Smith (Office Of The Director),Jeffrey Burnett Kopp; MD (NIDDK),"1. Behar DM, Rosset S, Tzur S, Selig S, Yudkovsky G, Bercovici S, Kopp JB, Winkler CA, Nelson GW, Wasser WG, Skorecki K (2010). African ancestry allelic variation at the MYH9 gene contributes to increased susceptibility to non-diabetic end-stage kidney disease in Hispanic Americans. Hum Mol Genet  19, 1816-27.   https://doi.org/10.1093/hmg/ddq040|2. Freedman BI, Edberg JC, Comeau ME, Murea M, Bowden DW, Divers J, Alarcón GS, Brown EE, McGwin G, Kopp JB, Winkler CA, Nelson GW, Illei G, Petri M, Ramsey-Goldman R, Reveille JD, Vilá LM, Langefeld CD, Kimberly RP, PROFILE Study Group (2010). The non-muscle Myosin heavy chain 9 gene (MYH9) is not associated with lupus nephritis in African Americans. Am J Nephrol  32, 66-72.   https://doi.org/10.1159/000314688|3. Genovese G, Friedman DJ, Ross MD, Lecordier L, Uzureau P, Freedman BI, Bowden DW, Langefeld CD, Oleksyk TK, Uscinski Knob AL, Bernhardy AJ, Hicks PJ, Nelson GW, Vanhollebeke B, Winkler CA, Kopp JB, Pays E, Pollak MR (2010). Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science  329, 841-5.   https://doi.org/10.1126/science.1193032|4. Johnson RC, Nelson GW, Troyer JL, Lautenberger JA, Kessing BD, Winkler CA, O'Brien SJ (2010). Accounting for multiple comparisons in a genome-wide association study (GWAS). BMC Genomics  11, 724.   https://doi.org/10.1186/1471-2164-11-724|5. Kopp JB, Winkler CA, Nelson GW (2010). MYH9 genetic variants associated with glomerular disease: what is the role for genetic testing? Semin Nephrol  30, 409-17.   https://doi.org/10.1016/j.semnephrol.2010.06.007|6. Nelson GW, Freedman BI, Bowden DW, Langefeld CD, An P, Hicks PJ, Bostrom MA, Johnson RC, Kopp JB, Winkler CA (2010). Dense mapping of MYH9 localizes the strongest kidney disease associations to the region of introns 13 to 15. Hum Mol Genet  19, 1805-15.   https://doi.org/10.1093/hmg/ddq039|7. Oleksyk TK, Nelson GW, An P, Kopp JB, Winkler CA (2010). Worldwide distribution of the MYH9 kidney disease susceptibility alleles and haplotypes: evidence of historical selection in Africa. PLoS One  5, e11474.   https://doi.org/10.1371/journal.pone.0011474|8. Winkler CA, Nelson G, Oleksyk TK, Nava MB, Kopp JB (2010). Genetics of focal segmental glomerulosclerosis and human immunodeficiency virus-associated collapsing glomerulopathy: the role of MYH9 genetic variation. Semin Nephrol  30, 111-25.   https://doi.org/10.1016/j.semnephrol.2010.01.003",https://intramural.nih.gov/search/searchview.taf?ipid=68181
83,BC010025-16,"October 01, 2010 -  September 30, 2011",The Role of AP-1 and Other Transcription Factors in Cancer Cause and Prevention,Nancy H Colburn; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Prevention, NCI",Alyson R Baker|Christopher  Dextras|Glenn  Hegamyer|Qiou  Wei|Matthew R Young; PhD,"Powel  Brown (Baylor Breast Center, Baylor College of Medicine)|Myung  Cho (Laboratory of Toxicology, Seoul National University)",James  McMahon; PhD (Molecular Targets Laboratory)|Curtis  Henrich (Molecular Targets Laboratory)|John A Beutler (Molecular Targets Laboratory)|Kirk R Gustafson; PhD (Molecular Targets Laboratory)|Joel Patrick Schneider; PhD (Chemical Biology Laboratory),NULL,"1. Camalier CE, Young MR, Bobe G, Perella CM, Colburn NH, Beck GR (2010). Elevated phosphate activates N-ras and promotes cell transformation and skin tumorigenesis. Cancer Prev Res (Phila)  3, 359-70.   https://doi.org/10.1158/1940-6207.CAPR-09-0068|2. Gamero AM, Young MR, Mentor-Marcel R, Bobe G, Scarzello AJ, Wise J, Colburn NH (2010). STAT2 contributes to promotion of colorectal and skin carcinogenesis. Cancer Prev Res (Phila)  3, 495-504.   https://doi.org/10.1158/1940-6207.CAPR-09-0105|3. Tichelaar JW, Yan Y, Tan Q, Wang Y, Estensen RD, Young MR, Colburn NH, Yin H, Goodin C, Anderson MW, You M (2010). A dominant-negative c-jun mutant inhibits lung carcinogenesis in mice. Cancer Prev Res (Phila)  3, 1148-56.   https://doi.org/10.1158/1940-6207.CAPR-10-0023",https://intramural.nih.gov/search/searchview.taf?ipid=68182
84,BC010026-16,"October 01, 2010 -  September 30, 2011","The Role of Pdcd4 in Translation, Tumorigenesis and Tumor Progression",Nancy H Colburn; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Prevention, NCI",Alyson R Baker|Glenn  Hegamyer|Soon-Kyung  Hwang|Noriko  Yoshikawa; PhD|Matthew R Young; PhD,"Heike  Allgayer (University of Munich)|Myung  Cho (Laboratory of Toxicology, Seoul National University)|Arti  Gaur (Dartmouth Med Sch)|Michele  Pagano (New York Univ)|Tobias  Schmid|Nahum  Sonenberg (McGill University)",Bruce Allen Shapiro; PhD (Image Processing Section)|James  McMahon; PhD (Molecular Targets Laboratory)|Curtis  Henrich (Molecular Targets Laboratory),NULL,"1. Blees JS, Schmid T, Thomas CL, Baker AR, Benson L, Evans JR, Goncharova EI, Colburn NH, McMahon JB, Henrich CJ (2010). Development of a high-throughput cell-based reporter assay to identify stabilizers of tumor suppressor Pdcd4. J Biomol Screen  15, 21-9.   https://doi.org/10.1177/1087057109351028|2. Santhanam AN, Baker AR, Hegamyer G, Kirschmann DA, Colburn NH (2010). Pdcd4 repression of lysyl oxidase inhibits hypoxia-induced breast cancer cell invasion. Oncogene  29, 3921-32.   https://doi.org/10.1038/onc.2010.158|3. Yasuda M, Schmid T, Rübsamen D, Colburn NH, Irie K, Murakami A (2010). Downregulation of programmed cell death 4 by inflammatory conditions contributes to the generation of the tumor promoting microenvironment. Mol Carcinog  49, 837-48.   https://doi.org/10.1002/mc.20660|4. Young MR, Santhanam AN, Yoshikawa N, Colburn NH (2010). Have tumor suppressor PDCD4 and its counteragent oncogenic miR-21 gone rogue? Mol Interv  10, 76-9.   https://doi.org/10.1124/mi.10.2.5",https://intramural.nih.gov/search/searchview.taf?ipid=68183
85,BC010027-17,"October 01, 2010 -  September 30, 2011",Function of Steroid Receptors in Subcellular Compartments,Gordon Lee Hager; PhD|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Ofir  Hakim|Thomas A Johnson|Ty Cole Voss,"Ken  Pearce (Gene Expression and Protein Biochemistry, GlaxoSmithKline Discovery Research)|Paolo  Sassone-Corsi; PhD (IGBMC)",Angie  Dull (Molecular Targets Laboratory)|Kevin A Camphausen; MD (Radiation Oncology Branch)|Andre A Nussenzweig; PhD (Experimental Immunology Branch)|Philipp  Oberdoerffer (Mouse Cancer Genetics Program),John J O'Shea; MD (NIAMS) |Rafael Cristian Casellas; PhD (NIAMS),"1. Hakim O, Sung MH, Hager GL (2010). 3D shortcuts to gene regulation. Curr Opin Cell Biol  22, 305-13.   https://doi.org/10.1016/j.ceb.2010.04.005|2. Hakim O, Sung MH, Voss TC, Splinter E, John S, Sabo PJ, Thurman RE, Stamatoyannopoulos JA, de Laat W, Hager GL (2011). Diverse gene reprogramming events occur in the same spatial clusters of distal regulatory elements. Genome Res  21, 697-706.   https://doi.org/10.1101/gr.111153.110|3. Wiench M, Hager GL (2010). Expanding horizons for nuclear receptors. EMBO Rep  11, 569-71.   https://doi.org/10.1038/embor.2010.111|4. Wiench M, Miranda TB, Hager GL (2011). Control of nuclear receptor function by local chromatin structure. FEBS J  278, 2211-30.   https://doi.org/10.1111/j.1742-4658.2011.08126.x",https://intramural.nih.gov/search/searchview.taf?ipid=68184
86,BC010030-16,"October 01, 2010 -  September 30, 2011",Biochemical Analysis of Multidrug Resistance-linked Transport Proteins,Suresh V Ambudkar; PhD|IRP Faculty Profile,NULL,"Transport Biochemistry Section, NCI",Jaya  Bhatnagar|Eduardo Emilio Chufan; PhD|John E Golin|Khyati  Kapoor; PhD|Candice  Schwartz|Suneet  Shukla|Show all 7,"Catherine  Booth-Genthe (Pharamcokinetics and drug metabolism, Amgen, Inc.)|Zhe-Sheng  Chen (Pharmaceutical Sciences, St. John's University)|John E Golin|Rajendra  Prasad (Jawaharlal Nehru University)","Di S Xia; PhD, MS, BS (Crystallography Section)|Susan  Bates; MD (Medical Oncology Branch)|Lyuba  Varticovski (Laboratory of Human Carcinogenesis)|Stewart  Durell (Laboratory of Cell Biology)",Michael Marc Gottesman; MD (OD),"1. Ananthaswamy N, Rutledge R, Sauna ZE, Ambudkar SV, Dine E, Nelson E, Xia D, Golin J (2010). The signaling interface of the yeast multidrug transporter Pdr5 adopts a cis conformation, and there are functional overlap and equivalence of the deviant and canonical Q-loop residues. Biochemistry  49, 4440-9.   https://doi.org/10.1021/bi100394j|2. Calcagno AM, Ambudkar SV (2010). Analysis of expression of drug resistance-linked ABC transporters in cancer cells by quantitative RT-PCR. Methods Mol Biol  637, 121-32.   https://doi.org/10.1007/978-1-60761-700-6_6|3. Calcagno AM, Ambudkar SV (2010). Molecular mechanisms of drug resistance in single-step and multi-step drug-selected cancer cells. Methods Mol Biol  596, 77-93.   https://doi.org/10.1007/978-1-60761-416-6_5|4. Calcagno AM, Salcido CD, Gillet JP, Wu CP, Fostel JM, Mumau MD, Gottesman MM, Varticovski L, Ambudkar SV (2010). Prolonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristics. J Natl Cancer Inst  102, 1637-52.   https://doi.org/10.1093/jnci/djq361|5. Dohse M, Scharenberg C, Shukla S, Robey RW, Volkmann T, Deeken JF, Brendel C, Ambudkar SV, Neubauer A, Bates SE (2010). Comparison of ATP-binding cassette transporter interactions with the tyrosine kinase inhibitors imatinib, nilotinib, and dasatinib. Drug Metab Dispos  38, 1371-80.   https://doi.org/10.1124/dmd.109.031302|6. Gillet JP, Wang J, Calcagno AM, Green LJ, Varma S, Bunkholt Elstrand M, Trope CG, Ambudkar SV, Davidson B, Gottesman MM (2011). Clinical relevance of multidrug resistance gene expression in ovarian serous carcinoma effusions. Mol Pharm  8, 2080-8.   https://doi.org/10.1021/mp200240a|7. Kucka M, Kretschmannova K, Murano T, Wu CP, Zemkova H, Ambudkar SV, Stojilkovic SS (2010). Dependence of multidrug resistance protein-mediated cyclic nucleotide efflux on the background sodium conductance. Mol Pharmacol  77, 270-9.   https://doi.org/10.1124/mol.109.059386|8. Li L, Shukla S, Lee A, Garfield SH, Maloney DJ, Ambudkar SV, Yuspa SH (2010). The skin cancer chemotherapeutic agent ingenol-3-angelate (PEP005) is a substrate for the epidermal multidrug transporter (ABCB1) and targets tumor vasculature. Cancer Res  70, 4509-19.   https://doi.org/10.1158/0008-5472.CAN-09-4303|9. Mi YJ, Liang YJ, Huang HB, Zhao HY, Wu CP, Wang F, Tao LY, Zhang CZ, Dai CL, Tiwari AK, Ma XX, To KK, Ambudkar SV, Chen ZS, Fu LW (2010). Apatinib (YN968D1) reverses multidrug resistance by inhibiting the efflux function of multiple ATP-binding cassette transporters. Cancer Res  70, 7981-91.   https://doi.org/10.1158/0008-5472.CAN-10-0111|10. Shukla S, Ohnuma S, Ambudkar SV (2011). Improving cancer chemotherapy with modulators of ABC drug transporters. Curr Drug Targets  12, 621-30.|11. Tam J, Vemuri VK, Liu J, Bátkai S, Mukhopadhyay B, Godlewski G, Osei-Hyiaman D, Ohnuma S, Ambudkar SV, Pickel J, Makriyannis A, Kunos G (2010). Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity. J Clin Invest  120, 2953-66.   https://doi.org/10.1172/JCI42551|12. Wu CP, Ohnuma S, Ambudkar SV (2011). Discovering natural product modulators to overcome multidrug resistance in cancer chemotherapy. Curr Pharm Biotechnol  12, 609-20.   https://doi.org/10.2174/138920111795163887",https://intramural.nih.gov/search/searchview.taf?ipid=68185
87,BC010033-16,"October 01, 2010 -  September 30, 2011",Inflammation and  Cancer,Curtis  Harris; MD|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Elise Dawn Bowman|Mohammed A. Khan; PhD|Aaron Joseph Schetter|Jane J Sohn|Elisa A Spillare|Judith A Welsh,NULL,Robert  Wiltrout; PhD (Laboratory of Experimental Immunology)|David Anderson Wink (Radiation Biology Branch),NULL,"1. Weiss JM, Ridnour LA, Back T, Hussain SP, He P, Maciag AE, Keefer LK, Murphy WJ, Harris CC, Wink DA, Wiltrout RH (2010). Macrophage-dependent nitric oxide expression regulates tumor cell detachment and metastasis after IL-2/anti-CD40 immunotherapy. J Exp Med  207, 2455-67.   https://doi.org/10.1084/jem.20100670",https://intramural.nih.gov/search/searchview.taf?ipid=68186
88,BC010038-16,"October 01, 2010 -  September 30, 2011",Molecular Cytogenetics of Solid Tumors,Nicolae C Popescu; PhD,NULL,"Molecular Cytogenetics Section, NCI",Veenu  Tripathi; PhD|Xu-Yu  Yang|Xiaoling  Zhou|Drazen  Zimonjic; PhD,Ragbir  Athwal (Temple University School of Medicine)|Qian  Tao (Department of Clinical Oncology),NULL,NULL,"1. Low JS, Tao Q, Ng KM, Goh HK, Shu XS, Woo WL, Ambinder RF, Srivastava G, Shamay M, Chan AT, Popescu NC, Hsieh WS (2011). A novel isoform of the 8p22 tumor suppressor gene DLC1 suppresses tumor growth and is frequently silenced in multiple common tumors. Oncogene  30, 1923-35.   https://doi.org/10.1038/onc.2010.576|2. Yang X, Popescu NC, Zimonjic DB (2011). DLC1 interaction with S100A10 mediates inhibition of in vitro cell invasion and tumorigenicity of lung cancer cells through a RhoGAP-independent mechanism. Cancer Res  71, 2916-25.   https://doi.org/10.1158/0008-5472.CAN-10-2158",https://intramural.nih.gov/search/searchview.taf?ipid=68187
89,BC010251-16,"October 01, 2010 -  September 30, 2011","R-spondins, Secreted Frizzled-Related Proteins and the Regulation of Wnt Signali","Jeffrey S Rubin; MD, PhD",NULL,"Laboratory of Cellular and Molecular Biology, NCI",Bolormaa  Baljinnyam|Maria  Melikova; PhD|Juhi Hitendra Patel|Charles Peter Xavier,NULL,Robert  Callahan; PhD (Mammary Biology and Tumorigenesis Laboratory)|David D Roberts; PhD (Laboratory of Pathology),NULL,"1. Jones MB, Chu CH, Pendleton JC, Betenbaugh MJ, Shiloach J, Baljinnyam B, Rubin JS, Shamblott MJ (2010). Proliferation and pluripotency of human embryonic stem cells maintained on type I collagen. Stem Cells Dev  19, 1923-35.   https://doi.org/10.1089/scd.2009.0326",https://intramural.nih.gov/search/searchview.taf?ipid=68189
90,BC010252-16,"October 01, 2010 -  September 30, 2011",Pathogenic Effects of Human Retroviruses on Hematopoietic and Adherent Cells.,Francis W Ruscetti; PhD,NULL,"Laboratory of Experimental Immunology, NCI",Daniel C Bertolette|Tao  Fu|Matthew Andrew Hadiono|Yi  Huang|Stig Moelgaard Rask Jensen; PhD|Kathryn  Jones; PhD|Show all 7,Pat  Green (Ohio State University)|Judy  Mikovits (whittemore peterson inst)|Claudine  Pique (Inserm),Robert  Blumenthal; PhD (Center for Cancer Research Nanobiology Program)|Gene  Shearer; PhD (Lymphocyte Development Section)|Genoveffa  Franchini; MD (Vaccine Branch)|Rachel  Beyer (Office Of The Director)|Vineet Narain KewalRamani; PhD (Retroviral Replication Laboratory)|Sandra  Ruscetti; PhD (Laboratory of Cancer Prevention),Steven J Jacobson; PhD (NINDS),"1. Gordon SN, Weissman AR, Cecchinato V, Fenizia C, Ma ZM, Lee TH, Zaffiri L, Andresen V, Parks RW, Jones KS, Heraud JM, Ferrari MG, Chung HK, Venzon D, Mahieux R, Murphy EL, Jacobson S, Miller CJ, Ruscetti FW, Franchini G (2010). Preexisting infection with human T-cell lymphotropic virus type 2 neither exacerbates nor attenuates simian immunodeficiency virus SIVmac251 infection in macaques. J Virol  84, 3043-58.   https://doi.org/10.1128/JVI.01655-09|2. Mikovits JA, Lombardi VC, Pfost MA, Hagen KS, Ruscetti FW (2010). Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Virulence  1, 386-90.   https://doi.org/10.4161/viru.1.5.12486|3. Valeri VW, Hryniewicz A, Andresen V, Jones K, Fenizia C, Bialuk I, Chung HK, Fukumoto R, Parks RW, Ferrari MG, Nicot C, Cecchinato V, Ruscetti F, Franchini G (2010). Requirement of the human T-cell leukemia virus p12 and p30 products for infectivity of human dendritic cells and macaques but not rabbits. Blood  116, 3809-17.   https://doi.org/10.1182/blood-2010-05-284141",https://intramural.nih.gov/search/searchview.taf?ipid=68190
91,BC010253-16,"October 01, 2010 -  September 30, 2011",Molecular Mechanisms of Growth Factor Modulated Proliferation,William  Farrar,NULL,"Laboratory of Cancer Prevention, NCI",NULL,NULL,Victor  Marquez; PhD (Chemical Biology Laboratory),NULL,"1. Crea F, Duhagon Serrat MA, Hurt EM, Thomas SB, Danesi R, Farrar WL (2011). BMI1 silencing enhances docetaxel activity and impairs antioxidant response in prostate cancer. Int J Cancer  128, 1946-54.   https://doi.org/10.1002/ijc.25522",https://intramural.nih.gov/search/searchview.taf?ipid=68191
92,BC010256-16,"October 01, 2010 -  September 30, 2011",The Nodal Signaling Pathway In Embryonic Development,Michael Robert Kuehn; PhD,NULL,"Laboratory of Protein Dynamics and Signaling, NCI",Oyvind  Dahle|Margaret M O'Toole-Lualdi|Acong  Yang,NULL,NULL,Amit  Kumar; PhD (NIDDK),"1. Dahle Ø, Kumar A, Kuehn MR (2010). Nodal signaling recruits the histone demethylase Jmjd3 to counteract polycomb-mediated repression at target genes. Sci Signal  3, ra48.   https://doi.org/10.1126/scisignal.2000841",https://intramural.nih.gov/search/searchview.taf?ipid=68192
93,BC010276-14,"October 01, 2010 -  September 30, 2011",Protein Folding Mechanism,Yawen  Bai; PhD|IRP Faculty Profile,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68194
94,BC010277-14,"October 01, 2010 -  September 30, 2011",Mechanisms of Chromosome Maintenance in Bacteria,Dhruba K Chattoraj; PhD|IRP Faculty Profile,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",Jonghwan  Baek|Jyoti Krishna Jha|Tatiana B Venkova-Canova,"Petra  Levin; PhD (Biology, Washington U)|Rajagopala  Venkatappa (J Craig Ventor Institute)",NULL,Emilios K Dimitriadis; PhD (NIBIB) |Aravind L Iyer; PhD (NLM),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68195
95,BC010278-14,"October 01, 2010 -  September 30, 2011",Imaging cellular assemblies with three-dimensional electron microscopy,Sriram  Subramaniam; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI","Alberto  Bartesaghi|Michael Jason de la Cruz|Thao Phuong Do|Lisa M. Hartnell|Martin  Kessel; BSc, PhD|Gavin Erick Murphy|Show all 8","Mark  Hildebrand (Scripps Institute of Oceanography)|Guillermo  Sapiro (Electrical Engineering, Uinversity of Minnesota)|John Henry  Scott (NIST)|Chris  Szakal (NIST)",Vincent J. Hearing; PhD (Pigment Cell Biology Section),Donald F Bliss (NLM) |Terry S Yoo; PhD (NLM),"1. Felts RL, Narayan K, Estes JD, Shi D, Trubey CM, Fu J, Hartnell LM, Ruthel GT, Schneider DK, Nagashima K, Bess JW, Bavari S, Lowekamp BC, Bliss D, Lifson JD, Subramaniam S (2010). 3D visualization of HIV transfer at the virological synapse between dendritic cells and T cells. Proc Natl Acad Sci U S A  107, 13336-41.   https://doi.org/10.1073/pnas.1003040107|2. Murphy GE, Lowekamp BC, Zerfas PM, Chandler RJ, Narasimha R, Venditti CP, Subramaniam S (2010). Ion-abrasion scanning electron microscopy reveals distorted liver mitochondrial morphology in murine methylmalonic acidemia. J Struct Biol  171, 125-32.   https://doi.org/10.1016/j.jsb.2010.04.005",https://intramural.nih.gov/search/searchview.taf?ipid=68196
96,BC010283-14,"October 01, 2010 -  September 30, 2011",DNA Repair,Andre A Nussenzweig; PhD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",NULL,NULL,NULL,NULL,"1. Blagosklonny MV, Campisi J, Sinclair DA, Bartke A, Blasco MA, Bonner WM, Bohr VA, Brosh RM, Brunet A, Depinho RA, Donehower LA, Finch CE, Finkel T, Gorospe M, Gudkov AV, Hall MN, Hekimi S, Helfand SL, Karlseder J, Kenyon C, Kroemer G, Longo V, Nussenzweig A, Osiewacz HD, Peeper DS, et al. [10 more authors] (2010). Impact papers on aging in 2009. Aging (Albany NY)  2, 111-21.   https://doi.org/10.18632/aging.100132|2. Boboila C, Jankovic M, Yan CT, Wang JH, Wesemann DR, Zhang T, Fazeli A, Feldman L, Nussenzweig A, Nussenzweig M, Alt FW (2010). Alternative end-joining catalyzes robust IgH locus deletions and translocations in the combined absence of ligase 4 and Ku70. Proc Natl Acad Sci U S A  107, 3034-9.   https://doi.org/10.1073/pnas.0915067107|3. Boboila C, Yan C, Wesemann DR, Jankovic M, Wang JH, Manis J, Nussenzweig A, Nussenzweig M, Alt FW (2010). Alternative end-joining catalyzes class switch recombination in the absence of both Ku70 and DNA ligase 4. J Exp Med  207, 417-27.   https://doi.org/10.1084/jem.20092449|4. Bothmer A, Robbiani DF, Feldhahn N, Gazumyan A, Nussenzweig A, Nussenzweig MC (2010). 53BP1 regulates DNA resection and the choice between classical and alternative end joining during class switch recombination. J Exp Med  207, 855-65.   https://doi.org/10.1084/jem.20100244|5. Bunting SF, Callén E, Wong N, Chen HT, Polato F, Gunn A, Bothmer A, Feldhahn N, Fernandez-Capetillo O, Cao L, Xu X, Deng CX, Finkel T, Nussenzweig M, Stark JM, Nussenzweig A (2010). 53BP1 inhibits homologous recombination in Brca1-deficient cells by blocking resection of DNA breaks. Cell  141, 243-54.   https://doi.org/10.1016/j.cell.2010.03.012|6. Bunting SF, Nussenzweig A (2010). Dangerous liaisons: Fanconi anemia and toxic nonhomologous end joining in DNA crosslink repair. Mol Cell  39, 164-6.   https://doi.org/10.1016/j.molcel.2010.07.016|7. Daniel JA, Santos MA, Wang Z, Zang C, Schwab KR, Jankovic M, Filsuf D, Chen HT, Gazumyan A, Yamane A, Cho YW, Sun HW, Ge K, Peng W, Nussenzweig MC, Casellas R, Dressler GR, Zhao K, Nussenzweig A (2010). PTIP promotes chromatin changes critical for immunoglobulin class switch recombination. Science  329, 917-23.   https://doi.org/10.1126/science.1187942|8. Jankovic M, Robbiani DF, Dorsett Y, Eisenreich T, Xu Y, Tarakhovsky A, Nussenzweig A, Nussenzweig MC (2010). Role of the translocation partner in protection against AID-dependent chromosomal translocations. Proc Natl Acad Sci U S A  107, 187-92.   https://doi.org/10.1073/pnas.0908946107|9. Nussenzweig A, Nussenzweig MC (2010). Origin of chromosomal translocations in lymphoid cancer. Cell  141, 27-38.   https://doi.org/10.1016/j.cell.2010.03.016|10. Santos MA, Huen MS, Jankovic M, Chen HT, López-Contreras AJ, Klein IA, Wong N, Barbancho JL, Fernandez-Capetillo O, Nussenzweig MC, Chen J, Nussenzweig A (2010). Class switching and meiotic defects in mice lacking the E3 ubiquitin ligase RNF8. J Exp Med  207, 973-81.   https://doi.org/10.1084/jem.20092308",https://intramural.nih.gov/search/searchview.taf?ipid=68197
97,BC010292-14,"October 01, 2010 -  September 30, 2011",Enzymes and Substrates of the Ubiquitin Conjugating System,Allan M Weissman; MD|IRP Faculty Profile,NULL,"Laboratory of Protein Dynamics and Signaling, NCI",Ventzislava Alexandrova Hristova; PhD|Tanuja R Kashyap|Michael Robert Kuehn; PhD|Shengjian  Li|Jennifer B Mariano|Daniel Kenneth Stringer|Show all 9,"Robert  Coffey (Vanderbilt University)|David  Fushman (Biochemistry, University of Maryland)|Karen H Vousden",Robert Andrew Byrd (Structural Biophysics Laboratory)|Barry R O'Keefe (Molecular Targets Laboratory)|Stefan  Ambs (Laboratory of Human Carcinogenesis)|Xinhua  Ji; PhD (Biomolecular Structure Section),NULL,"1. Cohen MM, Amiott EA, Day AR, Leboucher GP, Pryce EN, Glickman MH, McCaffery JM, Shaw JM, Weissman AM (2011). Sequential requirements for the GTPase domain of the mitofusin Fzo1 and the ubiquitin ligase SCFMdm30 in mitochondrial outer membrane fusion. J Cell Sci  124, 1403-10.   https://doi.org/10.1242/jcs.079293|2. Metzger MB, Weissman AM (2010). Working on a chain: E3s ganging up for ubiquitylation. Nat Cell Biol  12, 1124-6.   https://doi.org/10.1038/ncb1210-1124|3. Tsai YC, Maditz R, Kuo CL, Fishman PS, Shoemaker CB, Oyler GA, Weissman AM (2010). Targeting botulinum neurotoxin persistence by the ubiquitin-proteasome system. Proc Natl Acad Sci U S A  107, 16554-9.   https://doi.org/10.1073/pnas.1008302107|4. Tsai YC, Weissman AM (2010). The Unfolded Protein Response, Degradation from Endoplasmic Reticulum and Cancer. Genes Cancer  1, 764-778.   https://doi.org/10.1177/1947601910383011",https://intramural.nih.gov/search/searchview.taf?ipid=68083
98,BC010297-14,"October 01, 2010 -  September 30, 2011",Identification of Gene Polymorphisms Associated with Infectious Diseases,Cheryl Ann Winkler,NULL,"Basic Research Laboratory, NCI",Ping  An; PhD|Elizabeth  Binns-Roemer|Yu-Chun  Zhou|Sophie Mh Limou|Kaitlyn R Culley|Sarah Catherine Johnson|Show all 7,"Sharyne  Donfield (Hemophilia Growth and Development Study, Rho, Inc.)|Max  Essex (Department of Immuology and Infectious Diseases, Harvard Medical School)|Gregory D Kirk|James  Mullins; PhD (Microbiology, University of Washington)|John P Phair|Jean-Francois  Zagury (Conservatoire National des Arts et MÃ©tiers)",James Jerome Goedert; MD (Infection & Immunoepidemiology Branch)|Stephen J O'Brien; PhD (Laboratory of Genomic Diversity),NULL,"1. An P, Winkler CA (2010). Host genes associated with HIV/AIDS: advances in gene discovery. Trends Genet  26, 119-31.   https://doi.org/10.1016/j.tig.2010.01.002|2. Genovese G, Friedman DJ, Ross MD, Lecordier L, Uzureau P, Freedman BI, Bowden DW, Langefeld CD, Oleksyk TK, Uscinski Knob AL, Bernhardy AJ, Hicks PJ, Nelson GW, Vanhollebeke B, Winkler CA, Kopp JB, Pays E, Pollak MR (2010). Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science  329, 841-5.   https://doi.org/10.1126/science.1193032|3. Herbeck JT, Gottlieb GS, Winkler CA, Nelson GW, An P, Maust BS, Wong KG, Troyer JL, Goedert JJ, Kessing BD, Detels R, Wolinsky SM, Martinson J, Buchbinder S, Kirk GD, Jacobson LP, Margolick JB, Kaslow RA, O'Brien SJ, Mullins JI (2010). Multistage genomewide association study identifies a locus at 1q41 associated with rate of HIV-1 disease progression to clinical AIDS. J Infect Dis  201, 618-26.   https://doi.org/10.1086/649842|4. Johnson RC, Nelson GW, Troyer JL, Lautenberger JA, Kessing BD, Winkler CA, O'Brien SJ (2010). Accounting for multiple comparisons in a genome-wide association study (GWAS). BMC Genomics  11, 724.   https://doi.org/10.1186/1471-2164-11-724|5. Oleksyk TK, Nelson GW, An P, Kopp JB, Winkler CA (2010). Worldwide distribution of the MYH9 kidney disease susceptibility alleles and haplotypes: evidence of historical selection in Africa. PLoS One  5, e11474.   https://doi.org/10.1371/journal.pone.0011474|6. Reddy K, Winkler CA, Werner L, Mlisana K, Abdool Karim SS, Ndung'u T, CAPRISA Acute Infection Study Team (2010). APOBEC3G expression is dysregulated in primary HIV-1 infection and polymorphic variants influence CD4+ T-cell counts and plasma viral load. AIDS  24, 195-204.   https://doi.org/10.1097/QAD.0b013e3283353bba|7. Tang M, Zeng Y, Poisson A, Marti D, Guan L, Zheng Y, Deng H, Liao J, Guo X, Sun S, Nelson G, de Thé G, Winkler CA, O'Brien SJ, Carrington M, Gao X (2010). Haplotype-dependent HLA susceptibility to nasopharyngeal carcinoma in a Southern Chinese population. Genes Immun  11, 334-42.   https://doi.org/10.1038/gene.2009.109|8. Winkler CA, Nelson G, Oleksyk TK, Nava MB, Kopp JB (2010). Genetics of focal segmental glomerulosclerosis and human immunodeficiency virus-associated collapsing glomerulopathy: the role of MYH9 genetic variation. Semin Nephrol  30, 111-25.   https://doi.org/10.1016/j.semnephrol.2010.01.003",https://intramural.nih.gov/search/searchview.taf?ipid=68198
99,BC010298-14,"October 01, 2010 -  September 30, 2011",Growth Regulation Section,Ira H Pastan; MD|IRP Faculty Profile,NULL,"Molecular Biology Section, NCI",Tapan K Bera|Xiu Fen Liu|Gregory  Raciti,NULL,NULL,"Eva M Mezey; MD, PhD (NIDCR) |Oksana  Gavrilova; PhD (NIDDK)","1. Ding D, Kanaly CW, Bigner DD, Cummings TJ, Herndon JE, Pastan I, Raghavan R, Sampson JH (2010). Convection-enhanced delivery of free gadolinium with the recombinant immunotoxin MR1-1. J Neurooncol  98, 1-7.   https://doi.org/10.1007/s11060-009-0046-7",https://intramural.nih.gov/search/searchview.taf?ipid=68199
100,BC010300-14,"October 01, 2010 -  September 30, 2011",Signal Transduction of Paired Inhibitory Receptors of NK Cells and Macrophages,Daniel  McVicar; PhD|IRP Faculty Profile,NULL,"Laboratory of Experimental Immunology, NCI",Geraldine Martina O'Connor|Selinda Jane Orr|Laura Ann R Quigley,"James  Finke (Cleveland Clinic)|Neil  Gow (Unversity of Aberdeen)|Mary  Nakamura (Laboratoire d'Hematologie, UCSF)|Philip  Taylor (Cardiff University)|Valance  Washington (Anatomy and Cell biology, Universidad Central del Caribe)|Thomas  Yankee (Microbiology, Univ. Kansas Medical Center)|Show all 7",Oleg Y Chertov (Office Of The Director)|Giorgio  Trinchieri (Cancer Inflammation Program)|Stefan  Ambs (Laboratory of Human Carcinogenesis)|William Marston Linehan; MD (Urologic Oncology Branch)|Shyam K Sharan (Genetics of Cancer Susceptibility Section),"Ivo  Francischetti; MD, PhD (NIAID) |Pamela Lee Schwartzberg; MD, PhD (NHGRI) |Igal  Gery; PhD (NEI) |Suk See De Ravin; MD, PhD (NIAID) |Alasdair M Gilfillan; PhD (NIAID) |Doug B Kuhns; PhD (NIAID)","1. Orr SJ, McVicar DW (2011). LAB/NTAL/Lat2: a force to be reckoned with in all leukocytes? J Leukoc Biol  89, 11-9.   https://doi.org/10.1189/jlb.0410221|2. Orr SJ, Roessler S, Quigley L, Chan T, Ford JW, O'Connor GM, McVicar DW (2010). Implications for gene therapy-limiting expression of IL-2R gamma c delineate differences in signaling thresholds required for lymphocyte development and maintenance. J Immunol  185, 1393-403.   https://doi.org/10.4049/jimmunol.0903528|3. Smrz D, Iwaki S, McVicar DW, Metcalfe DD, Gilfillan AM (2010). TLR-mediated signaling pathways circumvent the requirement for DAP12 in mast cells for the induction of inflammatory mediator release. Eur J Immunol  40, 3557-69.   https://doi.org/10.1002/eji.201040573|4. Whittaker GC, Orr SJ, Quigley L, Hughes L, Francischetti IM, Zhang W, McVicar DW (2010). The linker for activation of B cells (LAB)/non-T cell activation linker (NTAL) regulates triggering receptor expressed on myeloid cells (TREM)-2 signaling and macrophage inflammatory responses independently of the linker for activation of T cells. J Biol Chem  285, 2976-85.   https://doi.org/10.1074/jbc.M109.038398",https://intramural.nih.gov/search/searchview.taf?ipid=68200
101,BC010301-14,"October 01, 2010 -  September 30, 2011",Development of Recombinant Toxins to Treat Hematologic Malignancies,"Robert J Kreitman; MD, PhD|IRP Faculty Profile",NULL,"Clinical Immunotherapy Section, NCI",Evgeny  Arons|Barbara  Debrah|Sonya C Duke|Natasha L Kormanik|Elizabeth J Maestri|Rita  Mincemoyer; RN|Show all 9,NULL,"Alan S Wayne; MD (Pediatric Oncology Branch)|Wyndham H Wilson; MD, PhD (Lymphoid Malignancies Branch)|Thomas Alexander Waldmann; MD, PhD (Lymphoid Malignancies Branch)|Maryalice  Stetler-Stevenson; MD, PhD (Laboratory of Pathology)|Constance M Yuan (Laboratory of Pathology)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",NULL,"1. Kreitman R, FitzGerald D (2010) Recombinant immunotoxins for the treatment of cancer, in Targeted Drug Delivery in Cancer Therapeutics., pp. 127-157.|2. Bogner C, Dechow T, Ringshausen I, Wagner M, Oelsner M, Lutzny G, Licht T, Peschel C, Pastan I, Kreitman RJ, Decker T (2010). Immunotoxin BL22 induces apoptosis in mantle cell lymphoma (MCL) cells dependent on Bcl-2 expression. Br J Haematol  148, 99-109.   https://doi.org/10.1111/j.1365-2141.2009.07939.x|3. Wayne AS, Kreitman RJ, Findley HW, Lew G, Delbrook C, Steinberg SM, Stetler-Stevenson M, Fitzgerald DJ, Pastan I (2010). Anti-CD22 immunotoxin RFB4(dsFv)-PE38 (BL22) for CD22-positive hematologic malignancies of childhood: preclinical studies and phase I clinical trial. Clin Cancer Res  16, 1894-903.   https://doi.org/10.1158/1078-0432.CCR-09-2980",https://intramural.nih.gov/search/searchview.taf?ipid=68201
102,BC010304-13,"October 01, 2010 -  September 30, 2011",Biochemical Basis of T Cell Activation,Lawrence Elliot Samelson; MD|IRP Faculty Profile,NULL,"Laboratory of Cellular and Molecular Biology, NCI",Lakshmi  Balagopalan|Nathan  Coussens|King Lam  Hui|Robert L Kortum|Wenmei  Li; PhD|Robert Kent Merrill|Show all 10,NULL,"Ettore  Appella; MD (Chemical Immunology Section)|Robert Mark Simpson; DVM, PhD (Laboratory of Cancer Biology and Genetics)","Peter W Schuck; PhD (NIBIB) |Paul E Love; MD, PhD (NICHD) |Jennifer A Lippincott Schwartz; PhD (NICHD)","1. Balagopalan L, Ashwell BA, Bernot KM, Akpan IO, Quasba N, Barr VA, Samelson LE (2011). Enhanced T-cell signaling in cells bearing linker for activation of T-cell (LAT) molecules resistant to ubiquitylation. Proc Natl Acad Sci U S A  108, 2885-90.   https://doi.org/10.1073/pnas.1007098108|2. Balagopalan L, Coussens NP, Sherman E, Samelson LE, Sommers CL (2010). The LAT story: a tale of cooperativity, coordination, and choreography. Cold Spring Harb Perspect Biol  2, a005512.   https://doi.org/10.1101/cshperspect.a005512|3. Balagopalan L, Sherman E, Barr VA, Samelson LE (2011). Imaging techniques for assaying lymphocyte activation in action. Nat Rev Immunol  11, 21-33.   https://doi.org/10.1038/nri2903|4. Barda-Saad M, Shirasu N, Pauker MH, Hassan N, Perl O, Balbo A, Yamaguchi H, Houtman JC, Appella E, Schuck P, Samelson LE (2010). Cooperative interactions at the SLP-76 complex are critical for actin polymerization. EMBO J  29, 2315-28.   https://doi.org/10.1038/emboj.2010.133|5. Kortum RL, Sommers CL, Alexander CP, Pinski JM, Li W, Grinberg A, Lee J, Love PE, Samelson LE (2011). Targeted Sos1 deletion reveals its critical role in early T-cell development. Proc Natl Acad Sci U S A  108, 12407-12.   https://doi.org/10.1073/pnas.1104295108|6. Sherman E, Barr V, Manley S, Patterson G, Balagopalan L, Akpan I, Regan CK, Merrill RK, Sommers CL, Lippincott-Schwartz J, Samelson LE (2011). Functional nanoscale organization of signaling molecules downstream of the T cell antigen receptor. Immunity  35, 705-20.   https://doi.org/10.1016/j.immuni.2011.10.004",https://intramural.nih.gov/search/searchview.taf?ipid=68202
103,BC010307-12,"October 01, 2010 -  September 30, 2011",Molecular Mechanisms Regulating Mouse Mammary Gland and Human Breast Tumor Cells,Gisela Esta Sterneck; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell and Developmental Signaling, NCI",Su-Ryun  Kim|Balamurugan  Kuppusamy|Tapasree  Roysarkar|Shikha  Sharan,"Carlos  Caldas (Cancer Research UK Cambridge Research Institute)|Nigel  Jones (University of Liverpool)|Zdenek  Kleibel (Dept. of Biochemistry and Experimental Oncology, Charles University in Prague)|Snehalata Anil Pawar|Ju-Ming  Wang (National Cheng Kung University)",Melinda  Hollingshead (Biological Testing Branch)|Jonathan  Keller; PhD (Laboratory of Cancer Prevention),NULL,"1. Balamurugan K, Wang JM, Tsai HH, Sharan S, Anver M, Leighty R, Sterneck E (2010). The tumour suppressor C/EBPδ inhibits FBXW7 expression and promotes mammary tumour metastasis. EMBO J  29, 4106-17.   https://doi.org/10.1038/emboj.2010.280|2. Hour TC, Lai YL, Kuan CI, Chou CK, Wang JM, Tu HY, Hu HT, Lin CS, Wu WJ, Pu YS, Sterneck E, Huang AM (2010). Transcriptional up-regulation of SOD1 by CEBPD: a potential target for cisplatin resistant human urothelial carcinoma cells. Biochem Pharmacol  80, 325-34.   https://doi.org/10.1016/j.bcp.2010.04.007|3. Pawar SA, Sarkar TR, Balamurugan K, Sharan S, Wang J, Zhang Y, Dowdy SF, Huang AM, Sterneck E (2010). C/EBP{delta} targets cyclin D1 for proteasome-mediated degradation via induction of CDC27/APC3 expression. Proc Natl Acad Sci U S A  107, 9210-5.   https://doi.org/10.1073/pnas.0913813107|4. Wang J, Sarkar TR, Zhou M, Sharan S, Ritt DA, Veenstra TD, Morrison DK, Huang AM, Sterneck E (2010). CCAAT/enhancer binding protein delta (C/EBPdelta, CEBPD)-mediated nuclear import of FANCD2 by IPO4 augments cellular response to DNA damage. Proc Natl Acad Sci U S A  107, 16131-6.   https://doi.org/10.1073/pnas.1002603107",https://intramural.nih.gov/search/searchview.taf?ipid=68092
104,BC010308-13,"October 01, 2010 -  September 30, 2011",In vivo Imaging Analysis of SteroidNuclear Receptor Function,Gordon Lee Hager; PhD|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Songjoon  Baek|Anuja  George|Tina Branscombe Miranda|Rodney Louis Schiltz; PhD|Diana  Stavreva|Ty Cole Voss|Show all 7,Luke  Iwanowicz (USGS-BRD)|Stafford  Lightman (University of Bristol),Angie  Dull (Molecular Targets Laboratory)|James  McMahon; PhD (Molecular Targets Laboratory),NULL,"1. Biddie SC, John S, Sabo PJ, Thurman RE, Johnson TA, Schiltz RL, Miranda TB, Sung MH, Trump S, Lightman SL, Vinson C, Stamatoyannopoulos JA, Hager GL (2011). Transcription factor AP1 potentiates chromatin accessibility and glucocorticoid receptor binding. Mol Cell  43, 145-55.   https://doi.org/10.1016/j.molcel.2011.06.016|2. Dull A, Goncharova E, Hager G, McMahon JB (2010). Development of an image analysis screen for estrogen receptor alpha (ERα) ligands through measurement of nuclear translocation dynamics. J Steroid Biochem Mol Biol  122, 341-51.   https://doi.org/10.1016/j.jsbmb.2010.08.009",https://intramural.nih.gov/search/searchview.taf?ipid=68205
105,BC010309-13,"October 01, 2010 -  September 30, 2011",Nuclear Architecture and Disease,Thomas A Misteli; PhD|IRP Faculty Profile,NULL,"Hormone Action and Oncogenesis Section, NCI",Rebecca Catherine Burgess; PhD|Bharat  Burman|Travis  Dittmer|Maria Reina Fernandez De Luco|Patricia  Fernandez Ferri; PhD|Leonard Pieter Kubben|Show all 12,"John  Elliott (NIST)|Neal  Rosen (Medicine, Memorial Sloan Kettering Cancer Center)|Bas  van Steensel (Netherlands Cancer Center)",Stephen J Lockett; PhD (Office Of The Director),"Christopher P Austin; AB, MD (NHGRI) |James  Inglese (NHGRI) |Scott E Martin (NHGRI) |Keji  Zhao; PhD (NHLBI)","1. Kubben N, Voncken JW, Demmers J, Calis C, van Almen G, Pinto Y, Misteli T (2010). Identification of differential protein interactors of lamin A and progerin. Nucleus  1, 513-25.   https://doi.org/10.4161/nucl.1.6.13512|2. Kubben N, Voncken JW, Misteli T (2010). Mapping of protein- and chromatin-interactions at the nuclear lamina. Nucleus  1, 460-71.   https://doi.org/10.4161/nucl.1.6.13513|3. Luco RF, Pan Q, Tominaga K, Blencowe BJ, Pereira-Smith OM, Misteli T (2010). Regulation of alternative splicing by histone modifications. Science  327, 996-1000.   https://doi.org/10.1126/science.1184208|4. Méjat A, Misteli T (2010). LINC complexes in health and disease. Nucleus  1, 40-52.   https://doi.org/10.4161/nucl.1.1.10530|5. Misteli T (2010). Higher-order genome organization in human disease. Cold Spring Harb Perspect Biol  2, a000794.   https://doi.org/10.1101/cshperspect.a000794|6. Rosenthal AS, Tanega C, Shen M, Mott BT, Bougie JM, Nguyen DT, Misteli T, Auld DS, Maloney DJ, Thomas CJ (2011). Potent and selective small molecule inhibitors of specific isoforms of Cdc2-like kinases (Clk) and dual specificity tyrosine-phosphorylation-regulated kinases (Dyrk). Bioorg Med Chem Lett  21, 3152-8.   https://doi.org/10.1016/j.bmcl.2011.02.114|7. Roukos V, Misteli T, Schmidt CK (2010). Descriptive no more: the dawn of high-throughput microscopy. Trends Cell Biol  20, 503-6.   https://doi.org/10.1016/j.tcb.2010.06.008|8. Scaffidi P, Misteli T (2010). Cancer epigenetics: from disruption of differentiation programs to the emergence of cancer stem cells. Cold Spring Harb Symp Quant Biol  75, 251-8.   https://doi.org/10.1101/sqb.2010.75.007",https://intramural.nih.gov/search/searchview.taf?ipid=68206
106,BC010313-13,"October 01, 2010 -  September 30, 2011",Molecular signatures for liver cancer diagnosis and treatment stratification,Xin Wei Wang; PhD|IRP Faculty Profile,NULL,"Molecular Genetics and Carcinogenesis Section, NCI",Anuradha Samantha Budhu|Marshonna J Forgues|Junfang  Ji|Naoki  Oishi|Stephanie  Roessler|Zhipeng  Yu|Show all 7,Yidong  Chen; PhD|Carlo  Croce (Ohio State University)|Christoffer  Loffredo (Georgetown University)|Masao  Omata (University of Tokyo)|Lun-Xiu  Qin (Liver Cancer Institute)|Mathuros  Ruchirawat (Chulabhorn Research Institute)|Show all 9,"Curtis  Harris; MD (Laboratory of Human Carcinogenesis)|Robert Mark Simpson; DVM, PhD (Laboratory of Cancer Biology and Genetics)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Snorri S. Thorgeirsson; MD, PhD (Laboratory of Experimental Carcinogenesis)|Robert  Wiltrout; PhD (Laboratory of Experimental Immunology)|Howard A Young; PhD (Laboratory of Experimental Immunology)",NULL,"1. Budhu A, Ji J, Wang XW (2010). The clinical potential of microRNAs. J Hematol Oncol  3, 37.   https://doi.org/10.1186/1756-8722-3-37|2. Budhu A, Wang XW (2011). Power play: scoring our goals for liver cancer with better GWAS study design. J Hepatol  54, 823-4.   https://doi.org/10.1016/j.jhep.2010.10.035|3. Kumar M, Zhao X, Wang XW (2011). Molecular carcinogenesis of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: one step closer to personalized medicine? Cell Biosci  1, 5.   https://doi.org/10.1186/2045-3701-1-5|4. Nguyen GH, Schetter AJ, Chou DB, Bowman ED, Zhao R, Hawkes JE, Mathé EA, Kumamoto K, Zhao Y, Budhu A, Hagiwara N, Wang XW, Miyashita M, Casson AG, Harris CC (2010). Inflammatory and microRNA gene expression as prognostic classifier of Barrett's-associated esophageal adenocarcinoma. Clin Cancer Res  16, 5824-34.   https://doi.org/10.1158/1078-0432.CCR-10-1110|5. Roessler S, Jia HL, Budhu A, Forgues M, Ye QH, Lee JS, Thorgeirsson SS, Sun Z, Tang ZY, Qin LX, Wang XW (2010). A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients. Cancer Res  70, 10202-12.   https://doi.org/10.1158/0008-5472.CAN-10-2607",https://intramural.nih.gov/search/searchview.taf?ipid=68208
107,BC010317-13,"October 01, 2010 -  September 30, 2011",Rapid Analysis of Single Nucleotide Polymorphism Genotypes in AIDS Cohorts,Stephen J O'Brien; PhD,NULL,"Laboratory of Genomic Diversity, NCI",Victor A David|Xiuchan  Guo|Sher L Hendrickson|Warren  Johnson|Efe  Sezgin,"Kerstin  Lindblad-Toh (Genome Sequencing and Analysis Program, Broad Institute of Harvard and Massachusetts Insititute of Technology)|Thanh  Truong (University of Utah)|Wesley  Warren (Washington University School of Medicine)",Robert  Stephens (Office Of The Director)|James Jerome Goedert; MD (Infection & Immunoepidemiology Branch)|James  Lautenberger; PhD (Office of the Director)|Jennifer L Troyer (Office Of The Director),NULL,"1. Chinn LW, Tang M, Kessing BD, Lautenberger JA, Troyer JL, Malasky MJ, McIntosh C, Kirk GD, Wolinsky SM, Buchbinder SP, Gomperts ED, Goedert JJ, O'Brien SJ (2010). Genetic associations of variants in genes encoding HIV-dependency factors required for HIV-1 infection. J Infect Dis  202, 1836-45.   https://doi.org/10.1086/657322|2. Guo X, Zhang Y, Li J, Ma J, Wei Z, Tan W, O'Brien SJ (2011). Strong influence of human leukocyte antigen (HLA)-DP gene variants on development of persistent chronic hepatitis B virus carriers in the Han Chinese population. Hepatology  53, 422-8.   https://doi.org/10.1002/hep.24048|3. Hendrickson SL, Lautenberger JA, Chinn LW, Malasky M, Sezgin E, Kingsley LA, Goedert JJ, Kirk GD, Gomperts ED, Buchbinder SP, Troyer JL, O'Brien SJ (2010). Genetic variants in nuclear-encoded mitochondrial genes influence AIDS progression. PLoS One  5, e12862.   https://doi.org/10.1371/journal.pone.0012862|4. Herbeck JT, Gottlieb GS, Winkler CA, Nelson GW, An P, Maust BS, Wong KG, Troyer JL, Goedert JJ, Kessing BD, Detels R, Wolinsky SM, Martinson J, Buchbinder S, Kirk GD, Jacobson LP, Margolick JB, Kaslow RA, O'Brien SJ, Mullins JI (2010). Multistage genomewide association study identifies a locus at 1q41 associated with rate of HIV-1 disease progression to clinical AIDS. J Infect Dis  201, 618-26.   https://doi.org/10.1086/649842",https://intramural.nih.gov/search/searchview.taf?ipid=68209
108,BC010319-13,"October 01, 2010 -  September 30, 2011",Structural Analysis of Biological Membrane Proteins,"Di S Xia; PhD, MS, BS|IRP Faculty Profile",NULL,"Crystallography Section, NCI",Lothar  Esser|Jichun  Ma|Wenting  Ma|Ajeet  Mandal; PhD|Robert M Rutledge|Wai-Kwan  Tang,NULL,Suresh V Ambudkar; PhD (Transport Biochemistry Section)|Susan  Bates; MD (Medical Oncology Branch),Michael Marc Gottesman; MD (OD),"1. Yu C, Yu L, Xia D (2011) Ubiquinol-cytochrome c oxidoreductase, in Encyclopedia of Biophysics., in press.|2. Ananthaswamy N, Rutledge R, Sauna ZE, Ambudkar SV, Dine E, Nelson E, Xia D, Golin J (2010). The signaling interface of the yeast multidrug transporter Pdr5 adopts a cis conformation, and there are functional overlap and equivalence of the deviant and canonical Q-loop residues. Biochemistry  49, 4440-9.   https://doi.org/10.1021/bi100394j|3. Esser L, Xia D (2011) A program for displaying images of crystallization trials, rapid comparisons and analysis. Journal of Applied Crystallography, in press.|4. Polgar O, Ierano C, Tamaki A, Stanley B, Ward Y, Xia D, Tarasova N, Robey RW, Bates SE (2010). Mutational analysis of threonine 402 adjacent to the GXXXG dimerization motif in transmembrane segment 1 of ABCG2. Biochemistry  49, 2235-45.   https://doi.org/10.1021/bi902085q|5. Shen DW, Ma J, Okabe M, Zhang G, Xia D, Gottesman MM (2010). Elevated expression of TMEM205, a hypothetical membrane protein, is associated with cisplatin resistance. J Cell Physiol  225, 822-8.   https://doi.org/10.1002/jcp.22287",https://intramural.nih.gov/search/searchview.taf?ipid=68211
109,BC010326-12,"October 01, 2010 -  September 30, 2011","Biomolecular Structure and Mechanism, Structure-Based Drug Design",Xinhua  Ji; PhD|IRP Faculty Profile,NULL,"Biomolecular Structure Section, NCI",Smita  Kakar; PhD|Yuhe  Liang; PhD|Gary X Shaw|Genbin  Shi|Jason R Stagno,Jorge  Cruz-Reyes (Texas A&M University)|Honggao  Yan,Donald L Court; PhD (Molecular Control and Genetics Section)|Ding Jun Jin (Gene Regulation and Chromosome Biology Laboratory)|Larry K Keefer; PhD (Laboratory of Comparative Carcinogenesis)|David S Waugh; PhD (Protein Engineering Section)|Allan M Weissman; MD (Laboratory of Protein Dynamics and Signaling)|Robert Andrew Byrd (Structural Biophysics Laboratory),NULL,"1. Subburaman P, Austin BP, Shaw GX, Waugh DS, Ji X (2010). Cloning, expression, purification, crystallization and preliminary X-ray diffraction analysis of macrophage growth locus A (MglA) protein from Francisella tularensis. Acta Crystallogr Sect F Struct Biol Cryst Commun  66, 554-7.   https://doi.org/10.1107/S1744309110009711",https://intramural.nih.gov/search/searchview.taf?ipid=68212
110,BC010328-12,"October 01, 2010 -  September 30, 2011",Role of CEBP transcription factors in regulating cell growth and tumorigenesis,Peter F Johnson; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Prevention, NCI",Christopher Jack  Huggins|Jonathan  Keller; PhD|Sook  Lee|Nancy C Martin|Jacqueline  Salotti; PhD|Karen Lynn Saylor,"Maria  Hatzoglou (Dept of Nutrition, Case Western Reserve University School of Medicine)|Richard  Schwartz (Michigan State University)|Robert  Smart (North Carolina State University)",Alexander  Wlodawer; PhD (Macromolecular Crystallography Laboratory)|Maria  Miller (Protein Structure Section)|Timothy D Veenstra (Office Of The Director),NULL,"1. Lee S, Miller M, Shuman JD, Johnson PF (2010). CCAAT/Enhancer-binding protein beta DNA binding is auto-inhibited by multiple elements that also mediate association with p300/CREB-binding protein (CBP). J Biol Chem  285, 21399-410.   https://doi.org/10.1074/jbc.M110.128413|2. Lee S, Shuman JD, Guszczynski T, Sakchaisri K, Sebastian T, Copeland TD, Miller M, Cohen MS, Taunton J, Smart RC, Xiao Z, Yu LR, Veenstra TD, Johnson PF (2010). RSK-mediated phosphorylation in the C/EBP{beta} leucine zipper regulates DNA binding, dimerization, and growth arrest activity. Mol Cell Biol  30, 2621-35.   https://doi.org/10.1128/MCB.00782-09",https://intramural.nih.gov/search/searchview.taf?ipid=68213
111,BC010329-12,"October 01, 2010 -  September 30, 2011",Regulation of Ras-Dependent Signal Transduction Pathways,Deborah K Morrison|IRP Faculty Profile,NULL,"Laboratory of Cell and Developmental Signaling, NCI",Alyson Kara Freeman|Melissa M Mckay|Daniel A Ritt,NULL,Timothy D Veenstra (Office Of The Director),NULL,"1. McKay MM, Morrison DK (2010). Proteomic analysis of scaffold proteins in the ERK cascade. Methods Mol Biol  661, 323-34.   https://doi.org/10.1007/978-1-60761-795-2_19|2. Ritt DA, Monson DM, Specht SI, Morrison DK (2010). Impact of feedback phosphorylation and Raf heterodimerization on normal and mutant B-Raf signaling. Mol Cell Biol  30, 806-19.   https://doi.org/10.1128/MCB.00569-09",https://intramural.nih.gov/search/searchview.taf?ipid=68214
112,BC010331-12,"October 01, 2010 -  September 30, 2011",Phospholipid and Sphingolipid Signaling in Drosophila,"Jairaj K Acharya; MBBS, PhD|IRP Faculty Profile",NULL,"Laboratory of Cell and Developmental Signaling, NCI",Diwash  Acharya|Teresa  Kosakowska Cholo|Jingjing  Ma|Razi  Raziuddin|Meena  Sharma,"Usha  Acharya (University of Mass. Medical School)|joost  holthuis (University of Utrecht)|Pedro  Labarca (Arturo Prat 514, Centro de Estudios Cientificos)",Lino  Tessarollo (Neural Development Section)|Shyam K Sharan (Genetics of Cancer Susceptibility Section),NULL,"1. Masood MA, Yuan C, Acharya JK, Veenstra TD, Blonder J (2010). Quantitation of ceramide phosphorylethanolamines containing saturated and unsaturated sphingoid base cores. Anal Biochem  400, 259-69.   https://doi.org/10.1016/j.ab.2010.01.033",https://intramural.nih.gov/search/searchview.taf?ipid=68215
113,BC010333-12,"October 01, 2010 -  September 30, 2011",The Segregation of Bacterial Chromosomes to Daughter Cells,Stuart J Austin|IRP Faculty Profile,NULL,"Cell Cycle Regulation Section, NCI","Therese G Brendler; BS, PhD|Sujatha B Gowda|Manjistha  Sengupta|Brenda L Youngren","Alba  Guarne; PhD|Flemming  Hansen (BioCentrum, Technical University of Denmank)",Donald L Court; PhD (Molecular Control and Genetics Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68216
114,BC010334-12,"October 01, 2010 -  September 30, 2011",Posttranscriptional control of gene expression,Barbara K Felber|IRP Faculty Profile,NULL,"Vaccine Branch, NCI","Jenifer L Bear|George N Pavlakis; MD, PhD|Guy Robert Pilkington|Rachel Elizabeth Kelly Beach|Rashmi  Jalah|Candido  Alicea; PhD",NULL,"Stuart F J Le Grice; PhD (Retroviral Replication Laboratory)|Zhi Ming  Zheng; MD, PhD (HIV and AIDS Malignancy Branch)|Giorgio  Trinchieri (Cancer Inflammation Program)|Howard A Young; PhD (Laboratory of Experimental Immunology)|Scott K Durum; PhD (Laboratory of Molecular Immunoregulation)",NULL,"1. Legiewicz M, Zolotukhin AS, Pilkington GR, Purzycka KJ, Mitchell M, Uranishi H, Bear J, Pavlakis GN, Le Grice SF, Felber BK (2010). The RNA transport element of the murine musD retrotransposon requires long-range intramolecular interactions for function. J Biol Chem  285, 42097-104.   https://doi.org/10.1074/jbc.M110.182840",https://intramural.nih.gov/search/searchview.taf?ipid=68217
115,BC010336-12,"October 01, 2010 -  September 30, 2011",Lambda Genetic Networks and Lambda Red-Mediated Recombination,Donald L Court; PhD|IRP Faculty Profile,NULL,"Molecular Control and Genetics Section, NCI",Teresa L Baker|Mikhail G Bubunenko|Nina C Costantino|Xintian  Li|James A Sawitzke|Lynn C Thomason|Show all 7,"David  Friedman (University of Michigan School of Medicine)|Max  Gottesman (Institute of Cancer Research, Columbia University)|William  Margolin (Microbiology and Molecular Genetics, University of Texas Medical School)|Kenon  Murphy (Molecular Genetics and Microbiology, University of Massachusetts Med. School)|Markus  Wahl (X-Ray Crystallography, Max-Planck-Institute for Biophysical Chemistry)",Mikhail V Kashlev (Molecular Mechanisms of Transcription Section)|Sankar  Adhya; PhD (Developmental Genetics Section)|Ding Jun Jin (Gene Regulation and Chromosome Biology Laboratory)|Xinhua  Ji; PhD (Biomolecular Structure Section)|David S Waugh; PhD (Protein Engineering Section),NULL,"1. Martínez-Trujillo M, Sánchez-Trujillo A, Ceja V, Avila-Moreno F, Bermúdez-Cruz RM, Court D, Montañez C (2010). Sequences required for transcription termination at the intrinsic lambdatI terminator. Can J Microbiol  56, 168-77.   https://doi.org/10.1139/w09-123|2. Stagno JR, Altieri AS, Bubunenko M, Tarasov SG, Li J, Court DL, Byrd RA, Ji X (2011). Structural basis for RNA recognition by NusB and NusE in the initiation of transcription antitermination. Nucleic Acids Res  39, 7803-15.   https://doi.org/10.1093/nar/gkr418|3. Swingle B, Markel E, Costantino N, Bubunenko MG, Cartinhour S, Court DL (2010). Oligonucleotide recombination in Gram-negative bacteria. Mol Microbiol  75, 138-48.   https://doi.org/10.1111/j.1365-2958.2009.06976.x|4. Tu C, Zhou X, Tarasov SG, Tropea JE, Austin BP, Waugh DS, Court DL, Ji X (2011). The Era GTPase recognizes the GAUCACCUCC sequence and binds helix 45 near the 3' end of 16S rRNA. Proc Natl Acad Sci U S A  108, 10156-61.   https://doi.org/10.1073/pnas.1017679108",https://intramural.nih.gov/search/searchview.taf?ipid=68218
116,BC010338-12,"October 01, 2010 -  September 30, 2011",The Role of Fgf Signaling in Vertebrate Development,Mark B Lewandoski|IRP Faculty Profile,NULL,"Genetics of Vertebrate Development Section, NCI",Cynthia M Elder|Naiche L Adler|Matthew J Anderson,"Gregg  Duester (Department of OncoDevelopmental Biology, Burnham Institute)|Trevor  Williams (University of Colarado)",Terence P Yamaguchi; PhD (Cell Signaling in Vertebrate Development Section)|Alan O Perantoni; PhD (Cancer and Developmental Biology Laboratory),NULL,"1. Kawakami Y, Marti M, Kawakami H, Itou J, Quach T, Johnson A, Sahara S, OâLeary D, Nakagawa Y, Lewandoski M, Pfaff S, Evans S, Izpisua Belmonte J (2011) Islet1-mediated activation of the beta-catenin pathway is necessary for hindlimb initiation in mice. Development, in press.|2. Naiche L, Arora R, Kania A, Lewandoski M, Papaioannou V (2011) Identity and fate of Tbx4-expressing cells reveal developmental cell fate decisions in the allantois, limb, and external genitalia. Developmental Dynamics, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=68220
117,BC010341-12,"October 01, 2010 -  September 30, 2011",Protein Expression and Purification in the Fast Lane,David S Waugh; PhD|IRP Faculty Profile,NULL,"Protein Engineering Section, NCI",Brian P Austin|Patricia Esther Dunford|Danielle  Needle|Sreejith  Raran Kurussi; PhD|Jozsef  Tozser,Jozsef  Tozser|James  Williams (Nature Technology Corp.),NULL,NULL,"1. Sun P, Austin BP, Tözsér J, Waugh DS (2010). Structural determinants of tobacco vein mottling virus protease substrate specificity. Protein Sci  19, 2240-51.   https://doi.org/10.1002/pro.506",https://intramural.nih.gov/search/searchview.taf?ipid=68222
118,BC010342-12,"October 01, 2010 -  September 30, 2011",Structural Proteomics of the Yersinia Yop Virulon,David S Waugh; PhD|IRP Faculty Profile,NULL,"Protein Engineering Section, NCI",Edward Okezie Irobi|George T Lountos|Danielle  Needle,"Gregory  Plano; PhD (Microbiology and Immunology, University of Miami School of Medicine)|Robert  Ulrich (Molecular Immunology, USAMRIID)",Terrence R Burke; PhD (Chemical Biology Laboratory)|Xinhua  Ji; PhD (Biomolecular Structure Section)|Alexander  Wlodawer; PhD (Macromolecular Crystallography Laboratory),NULL,"1. Liu F, Hakami RM, Dyas B, Bahta M, Lountos GT, Waugh DS, Ulrich RG, Burke TR (2010). A rapid oxime linker-based library approach to identification of bivalent inhibitors of the Yersinia pestis protein-tyrosine phosphatase, YopH. Bioorg Med Chem Lett  20, 2813-6.   https://doi.org/10.1016/j.bmcl.2010.03.058|2. Lountos GT, Tropea JE, Waugh DS (2011). Structure of human dual-specificity phosphatase 27 at 2.38 Å resolution. Acta Crystallogr D Biol Crystallogr  67, 471-9.   https://doi.org/10.1107/S090744491100970X|3. Subburaman P, Austin BP, Shaw GX, Waugh DS, Ji X (2010). Cloning, expression, purification, crystallization and preliminary X-ray diffraction analysis of macrophage growth locus A (MglA) protein from Francisella tularensis. Acta Crystallogr Sect F Struct Biol Cryst Commun  66, 554-7.   https://doi.org/10.1107/S1744309110009711",https://intramural.nih.gov/search/searchview.taf?ipid=68223
119,BC010345-12,"October 01, 2010 -  September 30, 2011",The Role of Wnt Genes in Vertebrate Development and Cancer,Terence P Yamaguchi; PhD|IRP Faculty Profile,NULL,"Cell Signaling in Vertebrate Development Section, NCI",Kristin K Biris|Ravindra Babu  Chalamalasetty|Mark William Lorne Kennedy; PhD,Deborah  Chapman (U. Pittsburgh)|Michael  Kyba (University of Minnesota)|Ed  Morrissey (U. Pennsylvania)|Jeong Seon Yoon,Mark B Lewandoski (Genetics of Vertebrate Development Section),Benjamin  Feldman; PhD (NHGRI),"1. Chalamalasetty RB, Dunty WC, Biris KK, Ajima R, Iacovino M, Beisaw A, Feigenbaum L, Chapman DL, Yoon JK, Kyba M, Yamaguchi TP (2011). The Wnt3a/β-catenin target gene Mesogenin1 controls the segmentation clock by activating a Notch signalling program. Nat Commun  2, 390.   https://doi.org/10.1038/ncomms1381",https://intramural.nih.gov/search/searchview.taf?ipid=68224
120,BC010346-12,"October 01, 2010 -  September 30, 2011",Structural Biology of Proteins Involved in Signal Transduction and Regulation of,Robert Andrew Byrd|IRP Faculty Profile,NULL,"Structural Biophysics Laboratory, NCI",Yinghua  Chen|Yun Xing M Wang|Aaren  Gonzales|Jess R Li,NULL,NULL,Charles  Schwieters; PhD (CIT),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68225
121,BC010348-12,"October 01, 2010 -  September 30, 2011",Protein Structure,Alexander  Wlodawer; PhD|IRP Faculty Profile,NULL,"Macromolecular Crystallography Laboratory, NCI",Prasenjit  Bhaumik|Jamaine S Davis|Alla E Gustchina|Zachary Jason Miknis|Maria E Miller|Tinoush  Moulaei|Show all 8,"David  Baker (University of Washington)|Ben  Dunn (Biochem. & Mol. Biol., University of Florida)|Mariusz  Jaskolski (Adam Mickiewicz University)|Yoshiaki  Kiso (Kyoto Pharmaceutical University)|Kohei  Oda (Dept. Applied Biology, Kyoto Inst. of Technology)|Jan  Pohl (CDC)",Barry R O'Keefe (Molecular Targets Laboratory)|Zbigniew  Dauter (Synchrotron Radiation Research Section),NULL,"1. Chruszcz M, Domagalski M, Osinski T, Wlodawer A, Minor W (2010). Unmet challenges of structural genomics. Curr Opin Struct Biol  20, 587-97.   https://doi.org/10.1016/j.sbi.2010.08.001|2. Dauter Z, Jaskolski M, Wlodawer A (2010). Impact of synchrotron radiation on macromolecular crystallography: a personal view. J Synchrotron Radiat  17, 433-44.   https://doi.org/10.1107/S0909049510011611|3. Gustchina E, Li M, Louis JM, Anderson DE, Lloyd J, Frisch C, Bewley CA, Gustchina A, Wlodawer A, Clore GM (2010). Structural basis of HIV-1 neutralization by affinity matured Fabs directed against the internal trimeric coiled-coil of gp41. PLoS Pathog  6, e1001182.   https://doi.org/10.1371/journal.ppat.1001182|4. Li M, Gustchina A, Rasulova FS, Melnikov EE, Maurizi MR, Rotanova TV, Dauter Z, Wlodawer A (2010). Structure of the N-terminal fragment of Escherichia coli Lon protease. Acta Crystallogr D Biol Crystallogr  66, 865-73.   https://doi.org/10.1107/S0907444910019554|5. Magracheva E, Pletnev S, Kotenko S, Li W, Wlodawer A, Zdanov A (2010). Purification, crystallization and preliminary crystallographic studies of the complex of interferon-lambda1 with its receptor. Acta Crystallogr Sect F Struct Biol Cryst Commun  66, 61-3.   https://doi.org/10.1107/S1744309109048817|6. Miknis ZJ, Magracheva E, Li W, Zdanov A, Kotenko SV, Wlodawer A (2010). Crystal structure of human interferon-λ1 in complex with its high-affinity receptor interferon-λR1. J Mol Biol  404, 650-64.   https://doi.org/10.1016/j.jmb.2010.09.068|7. Moulaei T, Shenoy SR, Giomarelli B, Thomas C, McMahon JB, Dauter Z, O'Keefe BR, Wlodawer A (2010). Monomerization of viral entry inhibitor griffithsin elucidates the relationship between multivalent binding to carbohydrates and anti-HIV activity. Structure  18, 1104-15.   https://doi.org/10.1016/j.str.2010.05.016|8. Moulaei T, Stuchlik O, Reed M, Yuan W, Pohl J, Lu W, Haugh-Krumpe L, O'Keefe BR, Wlodawer A (2010). Topology of the disulfide bonds in the antiviral lectin scytovirin. Protein Sci  19, 1649-61.   https://doi.org/10.1002/pro.445|9. Pletnev S, Subach FV, Dauter Z, Wlodawer A, Verkhusha VV (2010). Understanding blue-to-red conversion in monomeric fluorescent timers and hydrolytic degradation of their chromophores. J Am Chem Soc  132, 2243-53.   https://doi.org/10.1021/ja908418r|10. Pletneva NV, Pletnev VZ, Lukyanov KA, Gurskaya NG, Goryacheva EA, Martynov VI, Wlodawer A, Dauter Z, Pletnev S (2010). Structural evidence for a dehydrated intermediate in green fluorescent protein chromophore biosynthesis. J Biol Chem  285, 15978-84.   https://doi.org/10.1074/jbc.M109.092320|11. Robbins AH, Coman RM, Bracho-Sanchez E, Fernandez MA, Gilliland CT, Li M, Agbandje-McKenna M, Wlodawer A, Dunn BM, McKenna R (2010). Structure of the unbound form of HIV-1 subtype A protease: comparison with unbound forms of proteases from other HIV subtypes. Acta Crystallogr D Biol Crystallogr  66, 233-42.   https://doi.org/10.1107/S0907444909054298|12. Satoh T, Li M, Nguyen JT, Kiso Y, Gustchina A, Wlodawer A (2010). Crystal structures of inhibitor complexes of human T-cell leukemia virus (HTLV-1) protease. J Mol Biol  401, 626-41.   https://doi.org/10.1016/j.jmb.2010.06.052|13. Wlodawer A, Lubkowski J, Minor W, Jaskolski M (2010). Is too 'creative' language acceptable in crystallography? Acta Crystallogr D Biol Crystallogr  66, 1041-2.   https://doi.org/10.1107/S090744491002799X",https://intramural.nih.gov/search/searchview.taf?ipid=68226
122,BC010350-12,"October 01, 2010 -  September 30, 2011",Prevention of AIDS,Barbara K Felber|IRP Faculty Profile,NULL,"Vaccine Branch, NCI","Candido  Alicea; PhD|George N Pavlakis; MD, PhD|Genoveffa  Franchini; MD|Rachel Elizabeth Kelly Beach|Jenifer L Bear|Marjorie  Robert-Guroff; PhD|Show all 9","J. Thomas  August (Molecular Biology and Genetics Department, Johns Hopkins University School of Medicine)|Ronald  Desrosiers (New England Primate Research Center)|Bart  Haynes (Duke Human Vaccine Institute)|Amitinder  Kaur (New England Primate Research Center)|David  Knipe; PhD (Microbiology, Harvard Medical School)|Bette  Korber; PhD (Los Alamos National Laboratory)|Show all 15",Jeffrey D Lifson; MD (Office Of The Director),NULL,"1. Kulkarni V, Jalah R, Ganneru B, Bergamaschi C, Alicea C, von Gegerfelt A, Patel V, Zhang GM, Chowdhury B, Broderick KE, Sardesai NY, Valentin A, Rosati M, Felber BK, Pavlakis GN (2011). Comparison of immune responses generated by optimized DNA vaccination against SIV antigens in mice and macaques. Vaccine  29, 6742-54.   https://doi.org/10.1016/j.vaccine.2010.12.056|2. Minang JT, Trivett MT, Bolton DL, Trubey CM, Estes JD, Li Y, Smedley J, Pung R, Rosati M, Jalah R, Pavlakis GN, Felber BK, Piatak M, Roederer M, Lifson JD, Ott DE, Ohlen C (2010). Distribution, persistence, and efficacy of adoptively transferred central and effector memory-derived autologous simian immunodeficiency virus-specific CD8+ T cell clones in rhesus macaques during acute infection. J Immunol  184, 315-26.   https://doi.org/10.4049/jimmunol.0902410|3. Patel V, Valentin A, Kulkarni V, Rosati M, Bergamaschi C, Jalah R, Alicea C, Minang JT, Trivett MT, Ohlen C, Zhao J, Robert-Guroff M, Khan AS, Draghia-Akli R, Felber BK, Pavlakis GN (2010). Long-lasting humoral and cellular immune responses and mucosal dissemination after intramuscular DNA immunization. Vaccine  28, 4827-36.   https://doi.org/10.1016/j.vaccine.2010.04.064|4. Santra S, Liao HX, Zhang R, Muldoon M, Watson S, Fischer W, Theiler J, Szinger J, Balachandran H, Buzby A, Quinn D, Parks RJ, Tsao CY, Carville A, Mansfield KG, Pavlakis GN, Felber BK, Haynes BF, Korber BT, Letvin NL (2010). Mosaic vaccines elicit CD8+ T lymphocyte responses that confer enhanced immune coverage of diverse HIV strains in monkeys. Nat Med  16, 324-8.   https://doi.org/10.1038/nm.2108|5. Valentin A, von Gegerfelt A, Rosati M, Miteloudis G, Alicea C, Bergamaschi C, Jalah R, Patel V, Khan AS, Draghia-Akli R, Pavlakis GN, Felber BK (2010). Repeated DNA therapeutic vaccination of chronically SIV-infected macaques provides additional virological benefit. Vaccine  28, 1962-74.   https://doi.org/10.1016/j.vaccine.2009.10.099|6. Witko SE, Johnson JE, Kalyan NK, Felber BK, Pavlakis GN, Sidhu MK, Hendry RM, Udem SA, Parks CL (2010). Refined methods for propagating vesicular stomatitis virus vectors that are defective for G protein expression. J Virol Methods  164, 43-50.   https://doi.org/10.1016/j.jviromet.2009.11.023",https://intramural.nih.gov/search/searchview.taf?ipid=68227
123,BC010378-12,"October 01, 2010 -  September 30, 2011",Macromolecular Crystallography Research with Synchrotron Radiation,Zbigniew  Dauter|IRP Faculty Profile,NULL,"Synchrotron Radiation Research Section, NCI",Krzysztof  Brzezinski|John  Cobuzzi|Sergei V Pletnev|Vladimir Z Pletnev|Miroslawa  Dauter,"Mariusz  Jaskolski (University of  Poznan)|Andrzej  Joachimiak (Biosciences, Argonne Natl. Lab.)|Jozef  Kur (Microbiology, University of Technology)|Wladek  Minor|Zbyszek  Otwinowski (Biomedical Sciences, Southwestern Medical School)|Gerold  Rosenbaum (SER-CAT, Univeresity of Georgia)|Show all 7",Alexander  Wlodawer; PhD (Macromolecular Crystallography Laboratory),NULL,"1. Baker EN, Dauter Z, Einspahr H, Weiss MS (2010). In defence of our science - validation now! Acta Crystallogr Sect F Struct Biol Cryst Commun  66, 112.   https://doi.org/10.1107/S1744309110001326|2. Brzezinski K, Tomkiel AM, Lotowski Z, Morzycki J, Dauter Z (2010). Bis[3α,7α,12α-tris-(4-nitro-benzo-yloxy)-5β-cholan-24-yl] disulfide-ethyl acetate-n-hexane (4/4/1). Acta Crystallogr Sect E Struct Rep Online  67, o74-5.   https://doi.org/10.1107/S1600536810050385|3. Czerwinski A, Valenzuela F, Afonine P, Dauter M, Dauter Z (2010). N-{N-[2-(3,5-Difluorophenyl)acetyl]-(S)-alanyl}-(S)-phenylglycine tert-butyl ester (DAPT): an inhibitor of γ-secretase, revealing fine electronic and hydrogen-bonding features. Acta Crystallogr C  66, o585-8.   https://doi.org/10.1107/S0108270110044136|4. Dauter Z (2010). Carrying out an optimal experiment. Acta Crystallogr D Biol Crystallogr  66, 389-92.   https://doi.org/10.1107/S0907444909038578|5. Dauter Z, Jaskolski M, Wlodawer A (2010). Impact of synchrotron radiation on macromolecular crystallography: a personal view. J Synchrotron Radiat  17, 433-44.   https://doi.org/10.1107/S0909049510011611|6. Li M, Gustchina A, Rasulova FS, Melnikov EE, Maurizi MR, Rotanova TV, Dauter Z, Wlodawer A (2010). Structure of the N-terminal fragment of Escherichia coli Lon protease. Acta Crystallogr D Biol Crystallogr  66, 865-73.   https://doi.org/10.1107/S0907444910019554|7. Moulaei T, Shenoy SR, Giomarelli B, Thomas C, McMahon JB, Dauter Z, O'Keefe BR, Wlodawer A (2010). Monomerization of viral entry inhibitor griffithsin elucidates the relationship between multivalent binding to carbohydrates and anti-HIV activity. Structure  18, 1104-15.   https://doi.org/10.1016/j.str.2010.05.016|8. Pletnev S, Subach FV, Dauter Z, Wlodawer A, Verkhusha VV (2010). Understanding blue-to-red conversion in monomeric fluorescent timers and hydrolytic degradation of their chromophores. J Am Chem Soc  132, 2243-53.   https://doi.org/10.1021/ja908418r|9. Pletneva NV, Pletnev VZ, Lukyanov KA, Gurskaya NG, Goryacheva EA, Martynov VI, Wlodawer A, Dauter Z, Pletnev S (2010). Structural evidence for a dehydrated intermediate in green fluorescent protein chromophore biosynthesis. J Biol Chem  285, 15978-84.   https://doi.org/10.1074/jbc.M109.092320|10. Weiss MS, Einspahr H, Baker EN, Dauter Z, Kaysser-Pyzalla AR, Kostorz G, Larsen S (2010). Citations in supplementary material. Acta Crystallogr Sect F Struct Biol Cryst Commun  66, 1550-1.   https://doi.org/10.1107/S1744309110041825",https://intramural.nih.gov/search/searchview.taf?ipid=68228
124,BC010379-12,"October 01, 2010 -  September 30, 2011",Search for the Structural Basis of Biomacromolecular Function and Activity,Yun Xing M Wang|IRP Faculty Profile,NULL,"Structural Biophysics Laboratory, NCI","Xianyang  Fang|Yu  Liu|Jinbu  Wang|Ping  Yu; MD, PhD",NULL,Bruce Allen Shapiro; PhD (Image Processing Section)|Stuart F J Le Grice; PhD (Retroviral Replication Laboratory)|Alan  Rein; PhD (Retroviral Replication Laboratory),Adriaan  Bax; PhD (NIDDK),"1. Liao JC, Lam R, Brazda V, Duan S, Ravichandran M, Ma J, Xiao T, Tempel W, Zuo X, Wang YX, Chirgadze NY, Arrowsmith CH (2011). Interferon-inducible protein 16: insight into the interaction with tumor suppressor p53. Structure  19, 418-29.   https://doi.org/10.1016/j.str.2010.12.015|2. Nady N, Lemak A, Walker JR, Avvakumov GV, Kareta MS, Achour M, Xue S, Duan S, Allali-Hassani A, Zuo X, Wang YX, Bronner C, Chédin F, Arrowsmith CH, Dhe-Paganon S (2011). Recognition of multivalent histone states associated with heterochromatin by UHRF1 protein. J Biol Chem  286, 24300-11.   https://doi.org/10.1074/jbc.M111.234104|3. Wang YX, Zuo X, Wang J, Yu P, Butcher SE (2010). Rapid global structure determination of large RNA and RNA complexes using NMR and small-angle X-ray scattering. Methods  52, 180-91.   https://doi.org/10.1016/j.ymeth.2010.06.009|4. Zuo X, Wang J, Yu P, Eyler D, Xu H, Starich MR, Tiede DM, Simon AE, Kasprzak W, Schwieters CD, Shapiro BA, Wang YX (2010). Solution structure of the cap-independent translational enhancer and ribosome-binding element in the 3' UTR of turnip crinkle virus. Proc Natl Acad Sci U S A  107, 1385-90.   https://doi.org/10.1073/pnas.0908140107",https://intramural.nih.gov/search/searchview.taf?ipid=68229
125,BC010380-12,"October 01, 2010 -  September 30, 2011",Recombination and Regulation,Jeffrey N Strathern,NULL,"Gene Regulation and Chromosome Biology Laboratory, NCI",Deanna R Gotte|Alison J Rattray|Brenda K Shafer|Hui  Yang,"Tanya  Paull (University of Texas, Austin)|Hisashi  Tanaka (Lerner Research Institute)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68230
126,BC010381-12,"October 01, 2010 -  September 30, 2011",Studies on Silencing,Amar J S Klar; PhD,NULL,"Developmental Genetics Section, NCI",Michael J Bonaduce|Chuanhe  Yu|Ken  Ishikawa,NULL,NULL,NULL,"1. Klar AJ (2010). The yeast mating-type switching mechanism: a memoir. Genetics  186, 443-9.   https://doi.org/10.1534/genetics.110.122531",https://intramural.nih.gov/search/searchview.taf?ipid=68231
127,BC010385-12,"October 01, 2010 -  September 30, 2011",Studies on Imat1I Imprinting,Amar J S Klar; PhD,NULL,"Developmental Genetics Section, NCI",Michael J Bonaduce|Sharon P Moore|Chuanhe  Yu|Ken  Ishikawa,NULL,NULL,NULL,"1. Klar AJ (2010). The yeast mating-type switching mechanism: a memoir. Genetics  186, 443-9.   https://doi.org/10.1534/genetics.110.122531",https://intramural.nih.gov/search/searchview.taf?ipid=68232
128,BC010386-12,"October 01, 2010 -  September 30, 2011",Human Handedness Psychosis Etiology Studies,Amar J S Klar; PhD,NULL,"Developmental Genetics Section, NCI",Stephan  Sauer,NULL,NULL,NULL,"1. Klar AJ (2010). A proposal for re-defining the way the aetiology of schizophrenia and bipolar human psychiatric diseases is investigated. J Biosci  35, 11-5.   https://doi.org/10.1007/s12038-010-0002-x",https://intramural.nih.gov/search/searchview.taf?ipid=68233
129,BC010387-12,"October 01, 2010 -  September 30, 2011",Functional Analysis of Breast Cancer Susceptibility Genes in Mice,Shyam K Sharan|IRP Faculty Profile,NULL,"Genetics of Cancer Susceptibility Section, NCI",Suhwan  Chang|Rajani Kant Chittela|Betty K Martin|Alok  Mishra|Susan L North|Stacey S Stauffer|Show all 7,"Stephen  Byers (Georgetown University)|William  Foulkes (McGill University)|Debananda  Pati (Texas Children's Cancer Center, Baylor College of Medicine)",Andre A Nussenzweig; PhD (Experimental Immunology Branch)|Robert Andrew Byrd (Structural Biophysics Laboratory)|Mark H Greene; MD (Clinical Genetics Branch),Chuxia  Deng; PhD (NIDDK),"1. Biswas K, Das R, Alter BP, Kuznetsov SG, Stauffer S, North SL, Burkett S, Brody LC, Meyer S, Byrd RA, Sharan SK (2011). A comprehensive functional characterization of BRCA2 variants associated with Fanconi anemia using mouse ES cell-based assay. Blood  118, 2430-42.   https://doi.org/10.1182/blood-2010-12-324541|2. Chang S, Wang R, a K, Kim K, Martin B, Cavallone L, Haines D, Basik M, Mai P, Poggi E, Issacs C, Looi L, Mun K, Greene M, Byers S, Teo S, Deng C, Sharan S (2011) Tumor Suppressor BRCA1 epigenetically controls oncogenic miRNA-155. Nature Medicine, in press.|3. Kuznetsov SG, Chang S, Sharan SK (2010). Functional analysis of human BRCA2 variants using a mouse embryonic stem cell-based assay. Methods Mol Biol  653, 259-80.   https://doi.org/10.1007/978-1-60761-759-4_16",https://intramural.nih.gov/search/searchview.taf?ipid=68234
130,BC010390-12,"October 01, 2010 -  September 30, 2011",Role of Neurotrophins in the Development of the Mammalian Nervous System,Lino  Tessarollo|IRP Faculty Profile,NULL,"Neural Development Section, NCI",Colleen A Barrick|Jodi L Becker|Gianluca  Fulgenzi|Dawn Chin Ing Koh|Mary Ellen  Palko|Francesco  Tomassoni Ardori; PhD|Show all 7,"Juan Carlos  Arevalo (University of Salamanca)|Moses V Chao|Susan  Dorsey (University of Maryland)|Barbara  Hempstead (Cornell University)|Francis  Lee (Bristol Myers Squibb Pharmaceutical Research Institute)|Italo  Mocchetti (Pharmacology, Georgetown University)|Show all 7","Paul A Randazzo; MD, PhD (Laboratory of Cellular and Molecular Biology)",NULL,"1. Arévalo JC, Wu SH, Takahashi T, Zhang H, Yu T, Yano H, Milner TA, Tessarollo L, Ninan I, Arancio O, Chao MV (2010). The ARMS/Kidins220 scaffold protein modulates synaptic transmission. Mol Cell Neurosci  45, 92-100.   https://doi.org/10.1016/j.mcn.2010.06.002",https://intramural.nih.gov/search/searchview.taf?ipid=68235
131,BC010391-12,"October 01, 2010 -  September 30, 2011",Role of Trk Receptors in the Development and Function of Non-neuronal Structures,Lino  Tessarollo|IRP Faculty Profile,NULL,"Neural Development Section, NCI",Colleen A Barrick|Jodi L Becker|Gianluca  Fulgenzi|Sandrine Solange Marie Puverel; PhD|Mary Ellen  Palko,"Susanna  Dolci (University of Tor Vergata)|Susan  Dorsey (University of Maryland)|Gianluca  Fulgenzi|Uri  Saragovi (Pharmacology and Therapeutics, McGill University)","Paul A Randazzo; MD, PhD (Laboratory of Cellular and Molecular Biology)|Ola Mae Zack Howard (Laboratory of Molecular Immunoregulation)",NULL,"1. Bai Y, Shi Z, Zhuo Y, Liu J, Malakhov A, Ko E, Burgess K, Schaefer H, Esteban PF, Tessarollo L, Saragovi HU (2010). In glaucoma the upregulated truncated TrkC.T1 receptor isoform in glia causes increased TNF-alpha production, leading to retinal ganglion cell death. Invest Ophthalmol Vis Sci  51, 6639-51.   https://doi.org/10.1167/iovs.10-5431|2. Lefevre GM, Patel SR, Kim D, Tessarollo L, Dressler GR (2010). Altering a histone H3K4 methylation pathway in glomerular podocytes promotes a chronic disease phenotype. PLoS Genet  6, e1001142.   https://doi.org/10.1371/journal.pgen.1001142|3. Nelson TM, Lopezjimenez ND, Tessarollo L, Inoue M, Bachmanov AA, Sullivan SL (2010). Taste function in mice with a targeted mutation of the pkd1l3 gene. Chem Senses  35, 565-77.   https://doi.org/10.1093/chemse/bjq070",https://intramural.nih.gov/search/searchview.taf?ipid=68236
132,BC010411-12,"October 01, 2010 -  September 30, 2011",Initiation of DNA Replication in Mammalian Cells,Mirit I Aladjem; PhD|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI",Amy Louise Conner|Haiqing  Fu|Yves  Pommier; PhD|Liang  Huang|Chiimei (Cindy) L Tseng|Koichi  Utani|Show all 7,"Eric  Bouhassira (hematology, Albert Einstein College of Medicine)|Elsa  Bronze Da Rocha (University Do Porto)","Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",NULL,"1. Conti C, Leo E, Eichler GS, Sordet O, Martin MM, Fan A, Aladjem MI, Pommier Y (2010). Inhibition of histone deacetylase in cancer cells slows down replication forks, activates dormant origins, and induces DNA damage. Cancer Res  70, 4470-80.   https://doi.org/10.1158/0008-5472.CAN-09-3028",https://intramural.nih.gov/search/searchview.taf?ipid=68237
133,BC010412-12,"October 01, 2010 -  September 30, 2011",Structural Analysis of Macromolecular Complexes by Electron Microscopy,Jacqueline L Milne,NULL,"Laboratory of Cell Biology, NCI",Mario J Borgnia; PhD|Sriram  Subramaniam; PhD,NULL,NULL,NULL,"1. Milne J (2010) Structure and regulation of pyruvate dehydrogenase complexes, in Encyclopedia of Biological Chemistry. M. Daniel Lane and William Lennarz, eds. Elsevier Inc, in press.|2. White TA, Bartesaghi A, Borgnia MJ, Meyerson JR, de la Cruz MJ, Bess JW, Nandwani R, Hoxie JA, Lifson JD, Milne JL, Subramaniam S (2010). Molecular architectures of trimeric SIV and HIV-1 envelope glycoproteins on intact viruses: strain-dependent variation in quaternary structure. PLoS Pathog  6, e1001249.   https://doi.org/10.1371/journal.ppat.1001249",https://intramural.nih.gov/search/searchview.taf?ipid=68238
134,BC010413-11,"October 01, 2010 -  September 30, 2011",Study of hereditary prostate cancer and human artificial chromosomes,"Vladimir L Larionov; PhD, DSc|IRP Faculty Profile",NULL,"Developmental Therapeutics Branch, NCI",William M Bonner; PhD|Indri  Erliandri|Jung-Hyun  Kim|Artem Vadimovich  Kononenko|Natalay  Kouprina|Nicholas Cheng Ooi Lee; PhD|Show all 8,"William  Earnshaw (Laboratory of Cell Biology, Wellcome Trust Centre for Cell Biology)|Hiroshi  Masumoto (NCI)|Mitsuo  Oshimura (Tottori University)|Johanna  Schleutker (Institute of Medical Technology)",NULL,NULL,"1. Iida Y, Kim JH, Kazuki Y, Hoshiya H, Takiguchi M, Hayashi M, Erliandri I, Lee HS, Samoshkin A, Masumoto H, Earnshaw WC, Kouprina N, Larionov V, Oshimura M (2010). Human artificial chromosome with a conditional centromere for gene delivery and gene expression. DNA Res  17, 293-301.   https://doi.org/10.1093/dnares/dsq020",https://intramural.nih.gov/search/searchview.taf?ipid=68093
135,BC010418-12,"October 01, 2010 -  September 30, 2011",Signaling Events Regulating Chemotaxis,Carole A Parent; PhD,NULL,"Laboratory of Cellular and Molecular Biology, NCI",Satarupa  Das|Paul W Kriebel|Wolfgang  Losert; PhD|Colin P Mccann|Erin  Rericha,NULL,NULL,NULL,"1. Cai H, Das S, Kamimura Y, Long Y, Parent CA, Devreotes PN (2010). Ras-mediated activation of the TORC2-PKB pathway is critical for chemotaxis. J Cell Biol  190, 233-45.   https://doi.org/10.1083/jcb.201001129|2. Chen PW, Randazzo PA, Parent CA (2010). ACAP-A/B are ArfGAP homologs in dictyostelium involved in sporulation but not in chemotaxis. PLoS One  5, e8624.   https://doi.org/10.1371/journal.pone.0008624|3. McCann CP, Kriebel PW, Parent CA, Losert W (2010). Cell speed, persistence and information transmission during signal relay and collective migration. J Cell Sci  123, 1724-31.   https://doi.org/10.1242/jcs.060137|4. Shu S, Liu X, Kriebel PW, Hong MS, Daniels MP, Parent CA, Korn ED (2010). Expression of Y53A-actin in Dictyostelium disrupts the cytoskeleton and inhibits intracellular and intercellular chemotactic signaling. J Biol Chem  285, 27713-25.   https://doi.org/10.1074/jbc.M110.116277",https://intramural.nih.gov/search/searchview.taf?ipid=68239
136,BC010419-12,"October 01, 2010 -  September 30, 2011",Molecular Mechanisms of TGF-beta Signaling Pathway,Ying  Zhang|IRP Faculty Profile,NULL,"Laboratory of Cellular and Molecular Biology, NCI",Mary E Heller|Katherine M Sixt|Yi  Tang|Liuya  Tang,"Di  Chen (University of Rochester Medical Center)|YU  LI-RONG (FDA, National Center for Toxicological Research)",Zhenggang  Liu; PhD (Laboratory Of Genitourinary Cancer Pathogenesis),"Sushil Gopal Rane; MS, PhD (NIDDK)","1. Zhang M, Wang M, Tan X, Li TF, Zhang YE, Chen D (2010). Smad3 prevents beta-catenin degradation and facilitates beta-catenin nuclear translocation in chondrocytes. J Biol Chem  285, 8703-10.   https://doi.org/10.1074/jbc.M109.093526",https://intramural.nih.gov/search/searchview.taf?ipid=68240
137,BC010425-12,"October 01, 2010 -  September 30, 2011",Analysis of Human Immune Reponses in Cancer Vaccine Clinical Trials,Jeffrey  Schlom; PhD|IRP Faculty Profile,NULL,"Laboratory of Tumor Immunology and Biology, NCI","Lajuan  Chase|Joseph Raymond Cohen; PhD|Kwong Yok Tsang|Renee Nicole Donahue|James L Gulley; MD, PhD|Benedetto Paolo Farsaci; PhD|Show all 16","David  Apelian (GlobeImmune, Inc.)|Philip  Kantoff (Dana-Farber Cancer Institute)","William Laurence Dahut; MD (Medical Oncology Branch)|Ravi  Madan (Medical Oncology Branch)|Antonio  Fojo; MD, PhD (Medical Oncology Branch)",NULL,"1. Gulley J, Arlen P, Hodge J, Schlom J (2010) Vaccines and Immunostimulants, Chapter 57, in Cancer Medicine 8., pp. 725-736.|2. Madan R, Gulley J, Celestin J, Arlen P, Schlom J (2010) Cancer immunology, immunotherapeutics and vaccine approaches, in Drug Management of Prostate Cancer., pp. 305-319.|3. Gulley J, Madan R, Tsang K, Arlen P, Camphuasen K, Mohebtash M, Kamrava M, Schlom J, Citrin D (2011) A pilot safety trial investigating a vector-based vaccine targeting CEA in combination with radiotherapy in patients with gastrointestinal malignancies metastatic to the liver. Expert Opin Biol Ther, in press.|4. Gulley JL, Arlen PM, Madan RA, Tsang KY, Pazdur MP, Skarupa L, Jones JL, Poole DJ, Higgins JP, Hodge JW, Cereda V, Vergati M, Steinberg SM, Halabi S, Jones E, Chen C, Parnes H, Wright JJ, Dahut WL, Schlom J (2010). Immunologic and prognostic factors associated with overall survival employing a poxviral-based PSA vaccine in metastatic castrate-resistant prostate cancer. Cancer Immunol Immunother  59, 663-74.   https://doi.org/10.1007/s00262-009-0782-8|5. Kantoff PW, Schuetz TJ, Blumenstein BA, Glode LM, Bilhartz DL, Wyand M, Manson K, Panicali DL, Laus R, Schlom J, Dahut WL, Arlen PM, Gulley JL, Godfrey WR (2010). Overall survival analysis of a phase II randomized controlled trial of a Poxviral-based PSA-targeted immunotherapy in metastatic castration-resistant prostate cancer. J Clin Oncol  28, 1099-105.   https://doi.org/10.1200/JCO.2009.25.0597|6. Madan RA, Mohebtash M, Schlom J, Gulley JL (2010). Therapeutic vaccines in metastatic castration-resistant prostate cancer: principles in clinical trial design. Expert Opin Biol Ther  10, 19-28.   https://doi.org/10.1517/14712590903321421|7. Nesslinger NJ, Ng A, Tsang KY, Ferrara T, Schlom J, Gulley JL, Nelson BH (2010). A viral vaccine encoding prostate-specific antigen induces antigen spreading to a common set of self-proteins in prostate cancer patients. Clin Cancer Res  16, 4046-56.   https://doi.org/10.1158/1078-0432.CCR-10-0948|8. Rotow J, Gameiro SR, Madan RA, Gulley JL, Schlom J, Hodge JW (2010). Vaccines as monotherapy and in combination therapy for prostate cancer. Clin Transl Sci  3, 116-22.   https://doi.org/10.1111/j.1752-8062.2010.00186.x|9. Schlom J, Huang J (submitted in 2011) Soluble Cd27 (scd27) And Use Thereof. Patent issued: 9,725,494 (US in 2017).",https://intramural.nih.gov/search/searchview.taf?ipid=68241
138,BC010440-10,"October 01, 2010 -  September 30, 2011","Protein Structure, Stability, and Amyloid Formation",Ruth  Nussinov; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI",Hyunbum  Jang|Buyong  Ma|Yifat  Miller|Yong-Ping  Pan|Chung  Tsai|Yu  Xu|Show all 8,"Carlos  Aleman (Engineering, Univ. Barcelona)|Carlos  Cativiela (Chemistry, Univ. Zaragoza)|Peter  Csermely (Semmelweis University)|Turkan  Haliloglu|Yoshitaka  Ishii|Bruce  Kagan (UCLA)|Show all 13",NULL,NULL,"1. Agemy L, Sugahara KN, Kotamraju VR, Gujraty K, Girard OM, Kono Y, Mattrey RF, Park JH, Sailor MJ, Jimenez AI, Cativiela C, Zanuy D, Sayago FJ, Aleman C, Nussinov R, Ruoslahti E (2010). Nanoparticle-induced vascular blockade in human prostate cancer. Blood  116, 2847-56.   https://doi.org/10.1182/blood-2010-03-274258|2. Ahmad S, Keskin O, Mizuguchi K, Sarai A, Nussinov R (2010). CCRXP: exploring clusters of conserved residues in protein structures. Nucleic Acids Res  38, W398-401.   https://doi.org/10.1093/nar/gkq360|3. Buch I, Fishelovitch D, London N, Raveh B, Wolfson HJ, Nussinov R (2010). Allosteric regulation of glycogen synthase kinase 3β: a theoretical study. Biochemistry  49, 10890-901.   https://doi.org/10.1021/bi100822q|4. Capone R, Mustata M, Jang H, Arce FT, Nussinov R, Lal R (2010). Antimicrobial protegrin-1 forms ion channels: molecular dynamic simulation, atomic force microscopy, and electrical conductance studies. Biophys J  98, 2644-52.   https://doi.org/10.1016/j.bpj.2010.02.024|5. Fishelovitch D, Shaik S, Wolfson HJ, Nussinov R (2010). How does the reductase help to regulate the catalytic cycle of cytochrome P450 3A4 using the conserved water channel? J Phys Chem B  114, 5964-70.   https://doi.org/10.1021/jp101894k|6. Jang H, Arce FT, Ramachandran S, Capone R, Azimova R, Kagan BL, Nussinov R, Lal R (2010). Truncated beta-amyloid peptide channels provide an alternative mechanism for Alzheimer's Disease and Down syndrome. Proc Natl Acad Sci U S A  107, 6538-43.   https://doi.org/10.1073/pnas.0914251107|7. Jang H, Teran Arce F, Ramachandran S, Capone R, Lal R, Nussinov R (2010). Structural convergence among diverse, toxic beta-sheet ion channels. J Phys Chem B  114, 9445-51.   https://doi.org/10.1021/jp104073k|8. Liu J, Nussinov R (2010). Molecular dynamics reveal the essential role of linker motions in the function of cullin-RING E3 ligases. J Mol Biol  396, 1508-23.   https://doi.org/10.1016/j.jmb.2010.01.022|9. Liu J, Nussinov R (2010). Rbx1 flexible linker facilitates cullin-RING ligase function before neddylation and after deneddylation. Biophys J  99, 736-44.   https://doi.org/10.1016/j.bpj.2010.05.021|10. Ma B, Nussinov R (2010). Polymorphic C-terminal beta-sheet interactions determine the formation of fibril or amyloid beta-derived diffusible ligand-like globulomer for the Alzheimer Abeta42 dodecamer. J Biol Chem  285, 37102-10.   https://doi.org/10.1074/jbc.M110.133488|11. Ma B, Tsai CJ, Pan Y, Nussinov R (2010). Why does binding of proteins to DNA or proteins to proteins not necessarily spell function? ACS Chem Biol  5, 265-72.   https://doi.org/10.1021/cb900293a|12. Miller Y, Ma B, Nussinov R (2010). Polymorphism in Alzheimer Abeta amyloid organization reflects conformational selection in a rugged energy landscape. Chem Rev  110, 4820-38.   https://doi.org/10.1021/cr900377t|13. Miller Y, Ma B, Nussinov R (2010). Zinc ions promote Alzheimer Abeta aggregation via population shift of polymorphic states. Proc Natl Acad Sci U S A  107, 9490-5.   https://doi.org/10.1073/pnas.0913114107|14. Miller Y, Ma B, Tsai CJ, Nussinov R (2010). Hollow core of Alzheimer's Abeta42 amyloid observed by cryoEM is relevant at physiological pH. Proc Natl Acad Sci U S A  107, 14128-33.   https://doi.org/10.1073/pnas.1004704107|15. Revilla-López G, Jiménez AI, Cativiela C, Nussinov R, Alemán C, Zanuy D (2010). Conformational profile of a proline-arginine hybrid. J Chem Inf Model  50, 1781-9.   https://doi.org/10.1021/ci100135f|16. Revilla-López G, Torras J, Curcó D, Casanovas J, Calaza MI, Zanuy D, Jiménez AI, Cativiela C, Nussinov R, Grodzinski P, Alemán C (2010). NCAD, a database integrating the intrinsic conformational preferences of non-coded amino acids. J Phys Chem B  114, 7413-22.   https://doi.org/10.1021/jp102092m|17. Yu X, Wang J, Yang JC, Wang Q, Cheng SZ, Nussinov R, Zheng J (2010). Atomic-scale simulations confirm that soluble beta-sheet-rich peptide self-assemblies provide amyloid mimics presenting similar conformational properties. Biophys J  98, 27-36.   https://doi.org/10.1016/j.bpj.2009.10.003",https://intramural.nih.gov/search/searchview.taf?ipid=68203
139,BC010441-10,"October 01, 2010 -  September 30, 2011",Biomolecular Recognition and Binding Mechanisms,Ruth  Nussinov; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI",Buyong  Ma|Yong-Ping  Pan|Chung  Tsai|Yu  Xu|David  Zanuy Gomara|David Yuebao Zhu,"Shandar  Ahmad (National Institute of Biomedical Innovation)|Carlos  Aleman (Engineering, Univ. Barcelona)|Carlos  Cativiela (Chemistry, Univ. Zaragoza)|Peter  Csermely (Semmelweis University)|Attila  Gursoy (Computer Science Dept., Koc University)|Turkan  Haliloglu|Show all 13",Mirit I Aladjem; PhD (Developmental Therapeutics Branch)|Kurt  Kohn; PhD (Developmental Therapeutics Branch),Anna  Panchenko; PhD (NLM) |Teresa M Przytycka (NLM),"1. Agemy L, Sugahara KN, Kotamraju VR, Gujraty K, Girard OM, Kono Y, Mattrey RF, Park JH, Sailor MJ, Jimenez AI, Cativiela C, Zanuy D, Sayago FJ, Aleman C, Nussinov R, Ruoslahti E (2010). Nanoparticle-induced vascular blockade in human prostate cancer. Blood  116, 2847-56.   https://doi.org/10.1182/blood-2010-03-274258|2. Ahmad S, Keskin O, Mizuguchi K, Sarai A, Nussinov R (2010). CCRXP: exploring clusters of conserved residues in protein structures. Nucleic Acids Res  38, W398-401.   https://doi.org/10.1093/nar/gkq360|3. Buch I, Fishelovitch D, London N, Raveh B, Wolfson HJ, Nussinov R (2010). Allosteric regulation of glycogen synthase kinase 3β: a theoretical study. Biochemistry  49, 10890-901.   https://doi.org/10.1021/bi100822q|4. Csermely P, Palotai R, Nussinov R (2010). Induced fit, conformational selection and independent dynamic segments: an extended view of binding events. Trends Biochem Sci  35, 539-46.   https://doi.org/10.1016/j.tibs.2010.04.009|5. Liu J, Nussinov R (2010). Molecular dynamics reveal the essential role of linker motions in the function of cullin-RING E3 ligases. J Mol Biol  396, 1508-23.   https://doi.org/10.1016/j.jmb.2010.01.022|6. Liu J, Nussinov R (2010). Rbx1 flexible linker facilitates cullin-RING ligase function before neddylation and after deneddylation. Biophys J  99, 736-44.   https://doi.org/10.1016/j.bpj.2010.05.021|7. Ma B, Nussinov R (2010). Enzyme dynamics point to stepwise conformational selection in catalysis. Curr Opin Chem Biol  14, 652-9.   https://doi.org/10.1016/j.cbpa.2010.08.012|8. Ma B, Tsai CJ, Pan Y, Nussinov R (2010). Why does binding of proteins to DNA or proteins to proteins not necessarily spell function? ACS Chem Biol  5, 265-72.   https://doi.org/10.1021/cb900293a|9. Mashiach E, Nussinov R, Wolfson HJ (2010). FiberDock: a web server for flexible induced-fit backbone refinement in molecular docking. Nucleic Acids Res  38, W457-61.   https://doi.org/10.1093/nar/gkq373|10. Mashiach E, Schneidman-Duhovny D, Peri A, Shavit Y, Nussinov R, Wolfson HJ (2010). An integrated suite of fast docking algorithms. Proteins  78, 3197-204.   https://doi.org/10.1002/prot.22790|11. Pan Y, Nussinov R (2010). Lysine120 interactions with p53 response elements can allosterically direct p53 organization. PLoS Comput Biol  6.   https://doi.org/10.1371/journal.pcbi.1000878|12. Revilla-López G, Jiménez AI, Cativiela C, Nussinov R, Alemán C, Zanuy D (2010). Conformational profile of a proline-arginine hybrid. J Chem Inf Model  50, 1781-9.   https://doi.org/10.1021/ci100135f|13. Tozluoğlu M, Karaca E, Nussinov R, Haliloğlu T (2010). A mechanistic view of the role of E3 in sumoylation. PLoS Comput Biol  6.   https://doi.org/10.1371/journal.pcbi.1000913|14. Zen A, Micheletti C, Keskin O, Nussinov R (2010). Comparing interfacial dynamics in protein-protein complexes: an elastic network approach. BMC Struct Biol  10, 26.   https://doi.org/10.1186/1472-6807-10-26",https://intramural.nih.gov/search/searchview.taf?ipid=68204
140,BC010442-10,"October 01, 2010 -  September 30, 2011",Method Development: Efficient Computer Vision Based Algorithms,Ruth  Nussinov; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI",Chung  Tsai|David  Zanuy Gomara,"Attila  Gursoy (Computer Science Dept., Koc University)|Turkan  Haliloglu|Ozlem  Keskin (Koc University)|Haim  Wolfson (Tel Aviv Univ)",NULL,NULL,"1. Kifer I, Nussinov R, Wolfson HJ (2011). GOSSIP: a method for fast and accurate global alignment of protein structures. Bioinformatics  27, 925-32.   https://doi.org/10.1093/bioinformatics/btr044|2. Kifer I, Nussinov R, Wolfson HJ (2011). Protein structure prediction using a docking-based hierarchical folding scheme. Proteins  79, 1759-73.   https://doi.org/10.1002/prot.22999|3. Luna A, Karac EI, Sunshine M, Chang L, Nussinov R, Aladjem MI, Kohn KW (2011). A formal MIM specification and tools for the common exchange of MIM diagrams: an XML-Based format, an API, and a validation method. BMC Bioinformatics  12, 167.   https://doi.org/10.1186/1471-2105-12-167|4. Mashiach E, Nussinov R, Wolfson HJ (2010). FiberDock: a web server for flexible induced-fit backbone refinement in molecular docking. Nucleic Acids Res  38, W457-61.   https://doi.org/10.1093/nar/gkq373|5. Mashiach E, Schneidman-Duhovny D, Peri A, Shavit Y, Nussinov R, Wolfson HJ (2010). An integrated suite of fast docking algorithms. Proteins  78, 3197-204.   https://doi.org/10.1002/prot.22790|6. Mashiach-Farkash E, Nussinov R, Wolfson HJ (2011). SymmRef: a flexible refinement method for symmetric multimers. Proteins  79, 2607-23.   https://doi.org/10.1002/prot.23082|7. Revilla-López G, Rodríguez-Ropero F, Curcó D, Torras J, Isabel Calaza M, Zanuy D, Jiménez AI, Cativiela C, Nussinov R, Alemán C (2011). Integrating the intrinsic conformational preferences of noncoded α-amino acids modified at the peptide bond into the noncoded amino acids database. Proteins  79, 1841-52.   https://doi.org/10.1002/prot.23009|8. Tsai CJ, Nussinov R (2011). A unified convention for biological assemblies with helical symmetry. Acta Crystallogr D Biol Crystallogr  67, 716-28.   https://doi.org/10.1107/S0907444911024024|9. Yuan P, Liang K, Ma B, Zheng N, Nussinov R, Huang J (2011). Multiple-targeting and conformational selection in the estrogen receptor: computation and experiment. Chem Biol Drug Des  78, 137-49.   https://doi.org/10.1111/j.1747-0285.2011.01119.x",https://intramural.nih.gov/search/searchview.taf?ipid=68207
141,BC010446-10,"October 01, 2010 -  September 30, 2011",DNA Double Strand Break Repair in Drosophila Melanogaster,Yikang  Rong,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68210
142,BC010448-10,"October 01, 2010 -  September 30, 2011",Genetic Alterations in Lung Cancer,Jonathan S Wiest; PhD,NULL,"Office of the Director, NCI",Monika  Deshpande|Caroline M Garber|Zhihong  Shan,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68242
143,BC010449-10,"October 01, 2010 -  September 30, 2011",Role of Novel Cytokine-like Molecules Secretoglobin (SCGB) 3A1 and 3A2 in Lung,Shioko  Kimura; PhD|IRP Faculty Profile,NULL,"Endocrinology Section, NCI",Yan  Cai|Mitsuhiro  Yoneda,Reiko  Kurotani|Takeshi  Tomita (Tokyo Women's Medical University),Ilona  Linnoila; MD (Laboratory Of Genitourinary Cancer Pathogenesis),NULL,"1. Chiba Y, Goto K, Matsusue K, Kimura S, Misawa M (2010). Identification and characterization of rat RhoA gene promoter. J Pharmacol Sci  112, 467-72.   https://doi.org/10.1254/jphs.09346sc|2. Chiba Y, Tanabe M, Sakai H, Kimura S, Misawa M (2010). A functional interaction between CPI-17 and RACK1 proteins in bronchial smooth muscle cells. Biochem Biophys Res Commun  401, 487-90.   https://doi.org/10.1016/j.bbrc.2010.09.086|3. Goto K, Chiba Y, Matsusue K, Hattori Y, Maitani Y, Sakai H, Kimura S, Misawa M (2010). The proximal STAT6 and NF-kappaB sites are responsible for IL-13- and TNF-alpha-induced RhoA transcriptions in human bronchial smooth muscle cells. Pharmacol Res  61, 466-72.   https://doi.org/10.1016/j.phrs.2009.12.001|4. Kurotani R, Kumaki N, Naizhen X, Ward JM, Linnoila RI, Kimura S (2011). Secretoglobin 3A2/uteroglobin-related protein 1 is a novel marker for pulmonary carcinoma in mice and humans. Lung Cancer  71, 42-8.   https://doi.org/10.1016/j.lungcan.2010.04.001",https://intramural.nih.gov/search/searchview.taf?ipid=68243
144,BC010450-10,"October 01, 2010 -  September 30, 2011",Development of Akt Inhibitors,"Phillip A Dennis; MD, PhD",NULL,"Medical Oncology Branch, NCI",Frances Natalia Cervoni-Curet|Yoon Soo Chang; MD|William D Figg; PharmD|Chun-Te  Chiang|Irem  Dogan|Joell J Gills|Show all 17,"Pasi  Janne (Oncology, Dana-Farber Cancer Center)|Alan  Kozikowski (University of Illinois at Chicago)|William  Pao (Memorial Sloan Kettering Cancer Center)",Ilona  Linnoila; MD (Laboratory Of Genitourinary Cancer Pathogenesis)|Susan L Holbeck (Information Technology Branch)|Melinda  Hollingshead (Biological Testing Branch)|Maria  Tsokos; MD (Laboratory of Pathology)|Mones S Abu Asab (Laboratory of Pathology)|Timothy D Veenstra (Office Of The Director),"J Silvio  Gutkind; PhD (NIDCR) |Carter  Van Waes; MD, PhD (NIDCD)","1. Memmott RM, Mercado JR, Maier CR, Kawabata S, Fox SD, Dennis PA (2010). Metformin prevents tobacco carcinogen--induced lung tumorigenesis. Cancer Prev Res (Phila)  3, 1066-76.   https://doi.org/10.1158/1940-6207.CAPR-10-0055|2. Zhang C, Elkahloun AG, Robertson M, Gills JJ, Tsurutani J, Shih JH, Fukuoka J, Hollander MC, Harris CC, Travis WD, Jen J, Dennis PA (2011). Loss of cytoplasmic CDK1 predicts poor survival in human lung cancer and confers chemotherapeutic resistance. PLoS One  6, e23849.   https://doi.org/10.1371/journal.pone.0023849",https://intramural.nih.gov/search/searchview.taf?ipid=68244
145,BC010451-10,"October 01, 2010 -  September 30, 2011",Carbohydrate Antigen-bearing Nanoparticles for Anti-adhesives and Tumor Vaccines,Joseph John Barchi|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Raymond P Brinas|Jeffrey  Gildersleeve,NULL,Anil K Patri (Office Cancer Nanotechnology Research)|Howard A Young; PhD (Laboratory of Experimental Immunology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68348
146,BC010453-10,"October 01, 2010 -  September 30, 2011",Identify SNPs and Polymorphisms Involved in the Development of Prostate Cancer,William D Figg; PharmD|IRP Faculty Profile,NULL,"Medical Oncology Branch, NCI",William Laurence Dahut; MD|Christian Tyler Kirkland|Douglas K Price|Emily  Richardson|Sarah M Troutman|Tessa J Campbell,Romano  Danesi|Alan  Kristal (Fred Hutchinson Cancer Research Center)|Robin  Leach (UT Health Science Center San Antonio),"James L Gulley; MD, PhD (Laboratory of Tumor Immunology and Biology)|David J Venzon; PhD (Biostatistics and Data Management Section)",NULL,"1. Reece K, Figg W (2010) UGT1A1 Polymorphisms and Mutation in Irinotecan-Induced Toxicity, in Handbook of Therapeutic Biomarkers in Cancer., in press.|2. Baum CE, Ockers SB, English BC, Price DK, Sartor O, Figg WD (2010). Androgen receptor sequence and variations in several common prostate cancer cell lines. Cancer Biol Ther  9, 383-8.   https://doi.org/10.4161/cbt.9.5.10891|3. Baum CE, Price DK, Figg WD (2010). Sarcosine as a potential prostate cancer biomarker and therapeutic target. Cancer Biol Ther  9, 341-2.   https://doi.org/10.4161/cbt.9.5.11310|4. Chau C, Figg W (2011) Novel Androgen Receptor Therapeutic Targets for Advanced Prostate Cancer. Emerging Cancer Therap, in press.|5. Clump DA, Yu JJ, Cho Y, Gao R, Jett J, Zot H, Cunnick JM, Snyder B, Clump AC, Dodrill M, Gannett P, Coad JE, Shurina R, Figg WD, Reed E, Flynn DC (2010). A Polymorphic Variant of AFAP-110 Enhances cSrc Activity. Transl Oncol  3, 276-85.   https://doi.org/10.1593/tlo.10106|6. English BC, Baum CE, Adelberg DE, Sissung TM, Kluetz PG, Dahut WL, Price DK, Figg WD (2010). A SNP in CYP2C8 is not associated with the development of bisphosphonate-related osteonecrosis of the jaw in men with castrate-resistant prostate cancer. Ther Clin Risk Manag  6, 579-83.   https://doi.org/10.2147/TCRM.S14303|7. Gao R, Price DK, Dahut WL, Reed E, Figg WD (2010). Genetic polymorphisms in XRCC1 associated with radiation therapy in prostate cancer. Cancer Biol Ther  10, 13-8.   https://doi.org/10.4161/cbt.10.1.12172|8. Kristal AR, Price DK, Till C, Schenk JM, Neuhouser ML, Ockers S, Lin DW, Thompson IM, Figg WD (2010). Androgen receptor CAG repeat length is not associated with the risk of incident symptomatic benign prostatic hyperplasia: results from the Prostate Cancer Prevention Trial. Prostate  70, 584-90.   https://doi.org/10.1002/pros.21092|9. Pastina I, Giovannetti E, Chioni A, Sissung TM, Crea F, Orlandini C, Price DK, Cianci C, Figg WD, Ricci S, Danesi R (2010). Cytochrome 450 1B1 (CYP1B1) polymorphisms associated with response to docetaxel in Castration-Resistant Prostate Cancer (CRPC) patients. BMC Cancer  10, 511.   https://doi.org/10.1186/1471-2407-10-511|10. Price DK, Chau CH, Till C, Goodman PJ, Baum CE, Ockers SB, English BC, Minasian L, Parnes HL, Hsing AW, Reichardt JK, Hoque A, Tangen CM, Kristal AR, Thompson IM, Figg WD (2010). Androgen receptor CAG repeat length and association with prostate cancer risk: results from the prostate cancer prevention trial. J Urol  184, 2297-302.   https://doi.org/10.1016/j.juro.2010.08.005|11. Troutman SM, Price DK, Figg WD (2010). Prostate cancer genomic signature offers prognostic value. Cancer Biol Ther  10, 1079-80.   https://doi.org/10.4161/cbt.10.11.14086",https://intramural.nih.gov/search/searchview.taf?ipid=68245
147,BC010476-09,"October 01, 2010 -  September 30, 2011",Time Domian Electron Paramagnetic Resonance Imaging,Murali  Krishna; PhD|IRP Faculty Profile,NULL,"Radiation Biology Branch, NCI",Nallathamby  Devasahayam|Shingo  Matsumoto|Keita  Saito|Sankaran  Subramanian; MD|Yoichi  Takakusagi|James B Mitchell; PhD,NULL,NULL,Alan Paul Koretsky; PhD (NINDS) |Calvin A Johnson; PhD (CIT) |Thomas J Pohida; MS (CIT) |Anthony R Fletcher; PhD (CIT) |Jeeva P Munasinghe (NINDS),"1. Matsumoto S, Batra S, Saito K, Yasui H, Choudhuri R, Gadisetti C, Subramanian S, Devasahayam N, Munasinghe JP, Mitchell JB, Krishna MC (2011) Antiangiogenic agent sunitinib transiently increases tumor oxygenation and suppresses cycling hypoxia. Cancer Res 71:6350-9|2. Subramanian S, Devasahayam N, McMillan A, Matsumoto S, Munasinghe JP, Saito K, Mitchell JB, Chandramouli GV, Krishna MC (2012) Reporting of quantitative oxygen mapping in EPR imaging. J Magn Reson 214:244-51",https://intramural.nih.gov/search/searchview.taf?ipid=68261
148,BC010477-09,"October 01, 2010 -  September 30, 2011",Overhauser Enhanced Magnetic Resonance Imaging (OMRI),Murali  Krishna; PhD|IRP Faculty Profile,NULL,"Radiation Biology Branch, NCI",Shingo  Matsumoto|Keita  Saito|James B Mitchell; PhD|Yoichi  Takakusagi,NULL,NULL,Alan Paul Koretsky; PhD (NINDS) |Jeeva P Munasinghe (NINDS),"1. Day S, Kettunen M, Cherukuri M, Mitchell J, Lizak M, Morris H, Matsumoto S, Koretsky A, Brindle K (2011) Detecting response of rat C6 glioma tumors to radiotherapy using hyperpolarized 1- 13Cpyruvate and 13C magnetic resonance spectroscopic imaging. Magn. Reson. Med. 65:557-563.|2. Matsumoto S, Batra S, Saito K, Yasui H, Choudhuri R, Gadisetti C, Subramanian S, Devasahayam N, Munasinghe JP, Mitchell JB, Krishna MC (2011) Antiangiogenic agent sunitinib transiently increases tumor oxygenation and suppresses cycling hypoxia. Cancer Res 71:6350-9",https://intramural.nih.gov/search/searchview.taf?ipid=68259
149,BC010478-09,"October 01, 2010 -  September 30, 2011",Continuous Wave Electron Paramagnetic Resonance Imaging,Murali  Krishna; PhD|IRP Faculty Profile,NULL,"Radiation Biology Branch, NCI",Nallathamby  Devasahayam|Sreya Chowdary Kamineni|James B Mitchell; PhD|Janusz W Koscielniak|Sankaran  Subramanian; MD,NULL,NULL,Thomas J Pohida; MS (CIT),"1. Flores-Santana W, Moody T, Chen W, Gorczynski MJ, Shoman ME, Velázquez C, Thetford A, Mitchell JB, Cherukuri MK, King SB, Wink DA (2012). Nitroxide derivatives of non-steroidal anti-inflammatory drugs exert anti-inflammatory and superoxide dismutase scavenging properties in A459 cells. Br J Pharmacol  165, 1058-67.   https://doi.org/10.1111/j.1476-5381.2011.01527.x",https://intramural.nih.gov/search/searchview.taf?ipid=68260
150,BC010479-09,"October 01, 2010 -  September 30, 2011",Regulation of Melanocyte Development and Differentiation,Thomas J Hornyak,NULL,"Dermatology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68251
151,BC010481-09,"October 01, 2010 -  September 30, 2011",HIV-1 Reverse Transcriptase and Reverse Transcription,Stephen H Hughes; PhD|IRP Faculty Profile,NULL,"HIV Drug Resistance Program, NCI",Paul L Boyer|Patrick K Clark|Caroline A Davis|Linda L Dunn|Andrea L Ferris|Barry  Johnson|Show all 8,"Zandrea  Ambrose (University of Pittsburgh)|Eddy  Arnold; PhD (Chemistry and Chemical Biology, CABM and Rutgers University)|Mark  Federspiel (Mayo Clinic)|Maxine  Linial (University of Washington)|Michael  Parniak; PhD (Department of Medicine, McGill University)",Dwight V Nissley (Genome Recombination and Regulation Section)|Victor  Marquez; PhD (Chemical Biology Laboratory)|Gary T Pauly (Chemical Biology Laboratory)|Jeffrey N Strathern (Gene Regulation and Chromosome Biology Laboratory),Cynthia E Dunbar; MD (NHLBI) |Craig Joseph Thomas (NHGRI),"1. Davis C, Parniak M, Hughes S (2011) The effects of RNase H inhibitors and nevirapine on the susceptibility of HIV-1 to AZT and 3TC. Virology, in press.|2. Tu X, Das K, Han Q, Bauman JD, Clark AD, Hou X, Frenkel YV, Gaffney BL, Jones RA, Boyer PL, Hughes SH, Sarafianos SG, Arnold E (2010). Structural basis of HIV-1 resistance to AZT by excision. Nat Struct Mol Biol  17, 1202-9.   https://doi.org/10.1038/nsmb.1908|3. Vu BC, Boyer PL, Siddiqui MA, Marquez VE, Hughes SH (2011). 4'-C-methyl-2'-deoxyadenosine and 4'-C-ethyl-2'-deoxyadenosine inhibit HIV-1 replication. Antimicrob Agents Chemother  55, 2379-89.   https://doi.org/10.1128/AAC.01290-10",https://intramural.nih.gov/search/searchview.taf?ipid=68255
152,BC010482-09,"October 01, 2010 -  September 30, 2011",Retroviral Integration,Stephen H Hughes; PhD|IRP Faculty Profile,NULL,"HIV Drug Resistance Program, NCI",Patrick K Clark|Caroline A Davis|Linda L Dunn|Andrea L Ferris|Barry  Johnson|Mary J McWilliams|Show all 8,"C. David  Allis (Chromatin Biology, Rockefeller University)|Zandrea  Ambrose (University of Pittsburgh)|Alan  Engelman; PhD (Dana-Farber, Harvard University)|Mark  Federspiel (Mayo Clinic)|Maxine  Linial (University of Washington)",Vineet Narain KewalRamani; PhD (Retroviral Replication Laboratory)|Terrence R Burke; PhD (Chemical Biology Laboratory)|Yves  Pommier; PhD (Developmental Therapeutics Branch),Cynthia E Dunbar; MD (NHLBI),"1. Li Y, Ferris A, Lewis B, Orsulic S, Williams B, Holland E, Hughes S (2011) The RCAS/TVA somatic gene transfer method in modeling human cancer, in Genetically Engineered Mice for Cancer Research., in press.|2. Abram ME, Ferris AL, Shao W, Alvord WG, Hughes SH (2010). Nature, position, and frequency of mutations made in a single cycle of HIV-1 replication. J Virol  84, 9864-78.   https://doi.org/10.1128/JVI.00915-10|3. Hare S, Smith SJ, Métifiot M, Jaxa-Chamiec A, Pommier Y, Hughes SH, Cherepanov P (2011). Structural and functional analyses of the second-generation integrase strand transfer inhibitor dolutegravir (S/GSK1349572). Mol Pharmacol  80, 565-72.   https://doi.org/10.1124/mol.111.073189|4. Lee EG, Roy J, Jackson D, Clark P, Boyer PL, Hughes SH, Linial ML (2011). Foamy retrovirus integrase contains a Pol dimerization domain required for protease activation. J Virol  85, 1655-61.   https://doi.org/10.1128/JVI.01873-09|5. Metifiot M, Johnson B, Smith S, Zhao X, Marchand B, Burke T, Hughes S, Pommier Y (2011) MK-0536 inhibits HIV-1 integrases resistant to raltegravir. Antimicrob Agents Chemother, in press.|6. Zhao XZ, Maddali K, Metifiot M, Smith SJ, Vu BC, Marchand C, Hughes SH, Pommier Y, Burke TR (2011). Development of tricyclic hydroxy-1H-pyrrolopyridine-trione containing HIV-1 integrase inhibitors. Bioorg Med Chem Lett  21, 2986-90.   https://doi.org/10.1016/j.bmcl.2011.03.047",https://intramural.nih.gov/search/searchview.taf?ipid=68254
153,BC010483-09,"October 01, 2010 -  September 30, 2011",TEM5 Ligand Hunt,Bradley D St Croix,NULL,"Mouse Cancer Genetics Program, NCI",Steven  Seaman|Suresh R Volate|Lihong  Xu; PhD|Mary B Hilton,NULL,Frank  Cuttitta; PhD (Radiation Oncology Branch)|Enrique  Zudaire Ubani; PhD (Radiation Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68272
154,BC010484-09,"October 01, 2010 -  September 30, 2011",Functional Analysis of TEM5 and TEM8,Bradley D St Croix,NULL,"Mouse Cancer Genetics Program, NCI",Amit Madhulal Chaudhary|Xiujie  Li|Steven  Seaman|Mi Young  Yang,NULL,Enrique  Zudaire Ubani; PhD (Radiation Oncology Branch)|Frank  Cuttitta; PhD (Radiation Oncology Branch),NULL,"1. Yang MY, Chaudhary A, Seaman S, Dunty J, Stevens J, Elzarrad MK, Frankel AE, St Croix B (2011). The cell surface structure of tumor endothelial marker 8 (TEM8) is regulated by the actin cytoskeleton. Biochim Biophys Acta  1813, 39-49.   https://doi.org/10.1016/j.bbamcr.2010.11.013",https://intramural.nih.gov/search/searchview.taf?ipid=68273
155,BC010485-09,"October 01, 2010 -  September 30, 2011",Mechanism of DC-SIGN-Mediated Transmission of HIV,Vineet Narain KewalRamani; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Ioannis N Kagiampakis|Stuart F J Le Grice; PhD|Kyeongeun  Lee|Hyun Jae  Yu|Wendy  Yuen,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68256
156,BC010486-09,"October 01, 2010 -  September 30, 2011",Search for New Tumor Endothelial Markers,Bradley D St Croix,NULL,"Mouse Cancer Genetics Program, NCI",Steven  Seaman,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68274
157,BC010487-09,"October 01, 2010 -  September 30, 2011",Cytoplasmic-Nuclear Trafficking of HIV-1,Vineet Narain KewalRamani; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Laura Minji Choi|Ioannis N Kagiampakis|Alan  Rein; PhD|Stuart F J Le Grice; PhD|Kyeongeun  Lee|Eric O Freed; PhD|Show all 8,"Zandrea  Ambrose (University of Pittsburgh)|Alan  Engelman; PhD (Dana-Farber, Harvard University)|Derya  Unutmaz (New York University)",Stephen H Hughes; PhD (HIV Drug Resistance Program),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68257
158,BC010488-09,"October 01, 2010 -  September 30, 2011",Animal Models for HIV-1 Replication and Pathogenesis,Vineet Narain KewalRamani; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Ioannis N Kagiampakis|Kyeongeun  Lee|Wendy  Yuen,"Zandrea  Ambrose (University of Pittsburgh)|Paul  Bieniasz (Rockefeller University, Aaron Diamond AIDS Research Center)|Theodora  Hatziioannou (Aaron Diamond AIDS Research Center)|John W Mellors",Jeffrey D Lifson; MD (Office Of The Director)|Mary  Kearney (Host Virus Interaction Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68258
159,BC010493-09,"October 01, 2010 -  September 30, 2011",High-Resolution Protein and Nucleic Acid Footprinting,Stuart F J Le Grice; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Jennifer T Miller|Katarzyna Joanna Purzycka; PhD|Yi  Wang|Joanna  Sztuba-Solinska; PhD,"Eddy  Arnold; PhD (Chemistry and Chemical Biology, CABM and Rutgers University)|Samson  Chow (University of California at Los Angeles)|Dan  Fabris (Chemistry and Biochemistry, University of Maryland, Baltimore County)|Marie-Louise  Hammarskjold (University of Virginia)|John  Marino (Center for Advanced Research in Biotechnology)|David  Rekosh (Myles Thayler AIDS Institute, University of Virginia)|Show all 8","Nancy H Colburn; PhD (Laboratory of Cancer Prevention)|Bruce Allen Shapiro; PhD (Image Processing Section)|Barbara K Felber (Vaccine Branch)|George N Pavlakis; MD, PhD (Vaccine Branch)|Yun Xing M Wang (Structural Biophysics Laboratory)",NULL,"1. Rausch J, Abbondanzieri E, Liu S, XZhuang , Le Grice S (2010) Retrovirus replication: New perspectives on enzyme and substrate dynamics, in Recent Advances in Human Retroviruses: Principles of Replication and Pathogenesis (A.M.L Lever, K.-T. Jeang, and B. Berkhout, eds.)., pp. 307-345.",https://intramural.nih.gov/search/searchview.taf?ipid=68264
160,BC010494-09,"October 01, 2010 -  September 30, 2011",Viral and Host Proteins as Therapeutic Targets,Stuart F J Le Grice; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Marion Karla Bona; PhD|Suhman  Chung|Takashi  Masaoka|Jennifer T Miller|Jason William Rausch|Humeyra  Taskent; PhD,NULL,John A Beutler (Molecular Targets Laboratory)|Yves  Pommier; PhD (Developmental Therapeutics Branch)|Marc C Nicklaus (Chemical Biology Laboratory)|Barry R O'Keefe (Molecular Targets Laboratory)|Stephen H Hughes; PhD (HIV Drug Resistance Program),Robert Joseph Crouch; PhD (NICHD) |Craig Joseph Thomas (NHGRI) |Wei  Yang; PhD (NIDDK),"1. Kearney M, Lee K, Bagni R, Wiegand A, Spindler J, Maldarelli F, Pinto P, Linehan W, Vocke C, Delviks-Frankenberry K, deVere White R, Del Prete G, Mellors J, Lifson J, KewalRamani V, Pathak V, Coffin J, Le Grice S (2011) Nucleic acid, antibody, and virus culture methods to detect xenotropic MLV-related virus (XMRV) in macaque and human blood samples. Adv Virol, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=68262
161,BC010495-09,"October 01, 2010 -  September 30, 2011",Nucleoside and Amino Acid Analogs as Probes of HIV Replication Complexes,Stuart F J Le Grice; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Harsh Shirish Amin|Suhman  Chung|Sabrina  Lusvarghi|Jason William Rausch|Humeyra  Taskent; PhD,"Myron F Goodman; PhD (University of Southern California)|Sidney  Hecht (Lady Davis Institute-Jewish General Hospital, University of Virginia)",Deb  Chatterjee (Office Of The Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68263
162,BC010499-09,"October 01, 2010 -  September 30, 2011",Maryland Prostate Cancer Case-Control Study,Stefan  Ambs|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Tiffany Marie Howe,"Carlo  Croce (Ohio State University)|Chris  Loffredo (Cancer Genetics and Epidemiology Program, Georgetown University)|Arun  Sreekumar (Baylor College of Medicine)|Feng  Wang-Johanning (University of Texas MD Anderson Cancer Center)",Arthur A Hurwitz (Laboratory of Molecular Immunoregulation)|Liudmila  Prokunina-Olsson; PhD (Laboratory Translational Genomics),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68246
163,BC010504-09,"October 01, 2010 -  September 30, 2011","Mechanisms of Retroviral Reverse Transcription, Recombination, and Replication",Wei-Shau  Hu; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Andrea  Galli|Vinay K Pathak; PhD|Olga A Nikolaitchik|John Miller Coffin; PhD|Shih-Han  Tai,"Marie-Louise  Hammarskjold (University of Virginia)|Michael  Jordan (Tufts University)|David  Rekosh (Myles Thayler AIDS Institute, University of Virginia)|Marcelo  Soares; PhD (Instituto Nacional de Cancer do Brasil)",Matthew  Fivash (Office Of The Director)|Frank  Maldarelli (Host Virus Interaction Branch)|Mary  Kearney (Host Virus Interaction Branch),NULL,"1. Burdick R, Smith JL, Chaipan C, Friew Y, Chen J, Venkatachari NJ, Delviks-Frankenberry KA, Hu WS, Pathak VK (2010). P body-associated protein Mov10 inhibits HIV-1 replication at multiple stages. J Virol  84, 10241-53.   https://doi.org/10.1128/JVI.00585-10|2. Delviks-Frankenberry K, Galli A, Nikolaitchik O, Mens H, Pathak V, Hu W (2011) Mechanisms and factors that influence high frequency retroviral recombination. Viruses, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=68253
164,BC010506-09,"October 01, 2010 -  September 30, 2011","Mechanisms of Virus Assembly, Complementation, and Virion Structures",Wei-Shau  Hu; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Kari Ann Dilley|Vinay K Pathak; PhD|Steven Carter Hatch|Na  Ni|Alan  Rein; PhD|Luca  Sardo|Show all 7,John  Briggs (European Molecular Biology Laboratory)|Akira  Ono (University of Michigan)|Volker  Vogt (Cornell University),Kunio  Nagashima (Office Of The Director)|David E Ott (Office Of The Director)|Robert  Gorelick (Office Of The Director)|Stephen J Lockett; PhD (Office Of The Director)|Sriram  Subramaniam; PhD (Laboratory of Cell Biology),George  Patterson; PhD (NIBIB),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68252
165,BC010511-09,"October 01, 2010 -  September 30, 2011",Retrovirus Assembly and Maturation,Alan  Rein; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Amanda  Aloia|Siddhartha  Datta; PhD|Demetria P Harvin|Jane  Mirro,"Bogdan  Dragnea (University of Indiana)|Susan  Krueger (National Institute of Standards and Technology)|Walther  Mothes (Yale University)|Mark  Yeager|Adam  Zlotnick; PhD (Biochemistry and Molecular Biology, University of Oklahoma)",Robert J Fisher (Office Of The Director)|Raul Eduardo Cachau (Office Of The Director)|Kunio  Nagashima (Office Of The Director)|Yun Xing M Wang (Structural Biophysics Laboratory)|Robert  Gorelick (Office Of The Director),NULL,"1. Nanda H, Datta SA, Heinrich F, Lösche M, Rein A, Krueger S, Curtis JE (2010). Electrostatic interactions and binding orientation of HIV-1 matrix studied by neutron reflectivity. Biophys J  99, 2516-24.   https://doi.org/10.1016/j.bpj.2010.07.062|2. Rein A (2010). Nucleic acid chaperone activity of retroviral Gag proteins. RNA Biol  7, 700-5.   https://doi.org/10.4161/rna.7.6.13685|3. Wu T, Datta SA, Mitra M, Gorelick RJ, Rein A, Levin JG (2010). Fundamental differences between the nucleic acid chaperone activities of HIV-1 nucleocapsid protein and Gag or Gag-derived proteins: biological implications. Virology  405, 556-67.   https://doi.org/10.1016/j.virol.2010.06.042",https://intramural.nih.gov/search/searchview.taf?ipid=68270
166,BC010512-09,"October 01, 2010 -  September 30, 2011",Interactions of Retroviral Proteins with Nucleic Acids,Alan  Rein; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Siddhartha  Datta; PhD|Demetria P Harvin|Tania Bibiana Lombo Rodriguez|Jane  Mirro|Wei-Shau  Hu; PhD|Ina  O'Carroll|Show all 7,Karin  Musier-Forsyth (Ohio State University)|Vinayaka  Prasad (Albert Einstein University)|Kevin  Weeks (University of North Carolina)|Mark  Williams (Northeastern University),Robert J Fisher (Office Of The Director)|Robert  Gorelick (Office Of The Director)|Yun Xing M Wang (Structural Biophysics Laboratory),Judith Goldstein Levin; PhD (NICHD),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68271
167,BC010516-09,"October 01, 2010 -  September 30, 2011",Gated Optical DetectorsDose Guided Radiotherapy,Robert W Miller,Kevin A Camphausen; MD,"Radiation Oncology Branch, NCI",NULL,"Wei  Chen (University of Texas)|Alan  Huston (Naval Research Laboratory)|Brian  Justus (Optical Sciences Division, Naval Research Lab (NRL))|Maria  Plazas (Departmento de Fiscia, Universidad Nacional de Colombia)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68277
168,BC010518-09,"October 01, 2010 -  September 30, 2011",Role of BMP and FGF signaling during limb development,Mark B Lewandoski|IRP Faculty Profile,NULL,"Genetics of Vertebrate Development Section, NCI",Cynthia M Elder|Irene Hwang Hung|Maria  Kaltcheva|Ying  Zhang,"Brian  Harfe; PhD (Molecular Genetics and Microbiology, University of Florida)|Xin  Sun (Genetics, University of Wisconsin)",Susan  Mackem; MD (Cancer and Developmental Biology Laboratory),NULL,"1. Kawakami Y, Marti M, Kawakami H, Itou J, Quach T, Johnson A, Sahara S, OâLeary D, Nakagawa Y, Lewandoski M, Pfaff S, Evans S, Izpisua Belmonte J (2011) Islet1-mediated activation of the beta-catenin pathway is necessary for hindlimb initiation in mice. Development, in press.|2. Naiche L, Arora R, Kania A, Lewandoski M, Papaioannou V (2011) Identity and fate of Tbx4-expressing cells reveal developmental cell fate decisions in the allantois, limb, and external genitalia. Developmental Dynamics, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=68282
169,BC010523-09,"October 01, 2010 -  September 30, 2011",RNAi and Epigenetic Control of Higher-Order Chromatin Assembly,Shivinder Singh Grewal|IRP Faculty Profile,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",Ozan  Aygun|Vanivilasini  Balachandran|Venkata Raghavendra Chalamcharla; PhD|Emiko  Matsuda|Sameet Satish Mehta; PhD|Takeshi  Mizuguchi|Show all 11,NULL,Peter C Fitzgerald (Office of the Director),NULL,"1. Grewal SI (2010). RNAi-dependent formation of heterochromatin and its diverse functions. Curr Opin Genet Dev  20, 134-41.   https://doi.org/10.1016/j.gde.2010.02.003|2. Ni T, Tu K, Wang Z, Song S, Wu H, Xie B, Scott KC, Grewal SI, Gao Y, Zhu J (2010). The prevalence and regulation of antisense transcripts in Schizosaccharomyces pombe. PLoS One  5, e15271.   https://doi.org/10.1371/journal.pone.0015271|3. Yamane K, Mizuguchi T, Cui B, Zofall M, Noma K, Grewal SI (2011). Asf1/HIRA facilitate global histone deacetylation and associate with HP1 to promote nucleosome occupancy at heterochromatic loci. Mol Cell  41, 56-66.   https://doi.org/10.1016/j.molcel.2010.12.009",https://intramural.nih.gov/search/searchview.taf?ipid=68085
170,BC010524-09,"October 01, 2010 -  September 30, 2011",HIV Integrase Modeling and Computer-Aided Inhibitor Development,Marc C Nicklaus|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Chenzhong  Liao|Terrence R Burke; PhD,NULL,Yves  Pommier; PhD (Developmental Therapeutics Branch)|Stuart F J Le Grice; PhD (Retroviral Replication Laboratory)|Stephen H Hughes; PhD (HIV Drug Resistance Program),NULL,"1. Druzhilovsky D, Filimonov D, Liao C, Peach M, Nicklaus M, Poroikov V (2010) Computer-Assisted Search and Optimization of New Human Immunodeficiency Virus Integrase Inhibitors. Biochem. (Moscow) Suppl. Ser. B: Biomed. Chem. 4:59-67.|2. Liao C, Marchand C, Burke TR, Pommier Y, Nicklaus MC (2010). Authentic HIV-1 integrase inhibitors. Future Med Chem  2, 1107-22.   https://doi.org/10.4155/fmc.10.199|3. Liao C, Nicklaus MC (2010). Computer tools in the discovery of HIV-1 integrase inhibitors. Future Med Chem  2, 1123-40.   https://doi.org/10.4155/fmc.10.193|4. Liao C, Nicklaus MC (2010). Tautomerism and magnesium chelation of HIV-1 integrase inhibitors: a theoretical study. ChemMedChem  5, 1053-66.   https://doi.org/10.1002/cmdc.201000039",https://intramural.nih.gov/search/searchview.taf?ipid=68278
171,BC010525-09,"October 01, 2010 -  September 30, 2011",Immune Reconstitution,Ronald E Gress; MD|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Catherine Virginia Bare|Kevin  Chua|Francis  Flomerfelt; PhD|Philip J Lucas; PhD|Ruifeng  Teng|Jiun  Wang,NULL,Alfred  Singer; MD (Experimental Immunology Branch),Richard J Hodes; MD (NIA),"1. ElKassar N, Gress RE (2010). An overview of IL-7 biology and its use in immunotherapy. J Immunotoxicol  7, 1-7.   https://doi.org/10.3109/15476910903453296|2. Flomerfelt FA, El Kassar N, Gurunathan C, Chua KS, League SC, Schmitz S, Gershon TR, Kapoor V, Yan XY, Schwartz RH, Gress RE (2010). Tbata modulates thymic stromal cell proliferation and thymus function. J Exp Med  207, 2521-32.   https://doi.org/10.1084/jem.20092759|3. Lee DK, Hakim FT, Gress RE (2010). The thymus and the immune system: layered levels of control. J Thorac Oncol  5, S273-6.   https://doi.org/10.1097/JTO.0b013e3181f20474|4. Park JH, Adoro S, Guinter T, Erman B, Alag AS, Catalfamo M, Kimura MY, Cui Y, Lucas PJ, Gress RE, Kubo M, Hennighausen L, Feigenbaum L, Singer A (2010). Signaling by intrathymic cytokines, not T cell antigen receptors, specifies CD8 lineage choice and promotes the differentiation of cytotoxic-lineage T cells. Nat Immunol  11, 257-64.   https://doi.org/10.1038/ni.1840",https://intramural.nih.gov/search/searchview.taf?ipid=68249
172,BC010530-09,"October 01, 2010 -  September 30, 2011",Molecular Therapeutics for HIVAIDS,Dean H. Hamer; PhD|IRP Faculty Profile,NULL,"Vaccine Branch, NCI",Beda  Brichacek; PhD|Laurel  Lagenaur; PhD,Laurel  Lagenaur; PhD|Dominik  Wodarz (U C Irvine),NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68250
173,BC010532-09,"October 01, 2010 -  September 30, 2011",Role of Connection and RNase H Domains of HIV-1 RT in Antiviral Drug Resistance,Vinay K Pathak; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Ryan C Burdick|John Miller Coffin; PhD|Krista A Delviks-Frankenberry|Narasimhan Jayanth  Venkatachari; PhD|Wei-Shau  Hu; PhD,Jean L Mbisa (NCI)|Julie  Overbaugh (Fred Hutchinson Cancer Research Center)|Marcelo  Soares; PhD (Instituto Nacional de Cancer do Brasil)|Dalton  Wamalwa (University of Nairobi),Robert  Gorelick (Office Of The Director)|Frank  Maldarelli (Host Virus Interaction Branch)|Jeffrey N Strathern (Gene Regulation and Chromosome Biology Laboratory)|Dwight V Nissley (Genome Recombination and Regulation Section),NULL,"1. Delviks-Frankenberry K, Chaipan C, Bagni R, Wyvill K, Yarchoan R, Pathak V (2011) Lack of detection of xenotropic murine leukemia virus-related virus in HIV-1 lymphoma patients. Adv Virol, in press.|2. Delviks-Frankenberry K, Galli A, Nikolaitchik O, Mens H, Pathak V, Hu W (2011) Mechanisms and factors that influence high frequency retroviral recombination. Viruses, in press.|3. Lengruber RB, Delviks-Frankenberry KA, Nikolenko GN, Baumann J, Santos AF, Pathak VK, Soares MA (2011). Phenotypic characterization of drug resistance-associated mutations in HIV-1 RT connection and RNase H domains and their correlation with thymidine analogue mutations. J Antimicrob Chemother  66, 702-8.   https://doi.org/10.1093/jac/dkr005",https://intramural.nih.gov/search/searchview.taf?ipid=68280
174,BC010533-09,"October 01, 2010 -  September 30, 2011",Mechanisms of HIV-1 Reverse Transcription,Vinay K Pathak; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Ryan C Burdick|Wei-Shau  Hu; PhD|Krista A Delviks-Frankenberry|Tobias  Paprotka,NULL,NULL,NULL,"1. Ni N, Nikolaitchik OA, Dilley KA, Chen J, Galli A, Fu W, Prasad VV, Ptak RG, Pathak VK, Hu WS (2011). Mechanisms of human immunodeficiency virus type 2 RNA packaging: efficient trans packaging and selection of RNA copackaging partners. J Virol  85, 7603-12.   https://doi.org/10.1128/JVI.00562-11|2. Nikolaitchik OA, Galli A, Moore MD, Pathak VK, Hu WS (2011). Multiple barriers to recombination between divergent HIV-1 variants revealed by a dual-marker recombination assay. J Mol Biol  407, 521-31.   https://doi.org/10.1016/j.jmb.2011.01.052",https://intramural.nih.gov/search/searchview.taf?ipid=68281
175,BC010538-09,"October 01, 2010 -  September 30, 2011",Molecular Analysis of Breast Cancer Metastasis to the Brain,Patricia  Steeg; PhD|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI",Talha E Anwar|Lynda M Evans|Daniel  Fitzgerald|Brunilde M Gril|Emily  Hua|Devin  Matthews|Show all 7,"Edi  Brogi (Memorial Sloan Kettering Cancer Center)|Paul  Lockman (Texas Tech University)|Steven  Rubin (Oncology, GlaxoSmithKline)|George  Sledge, Jr. (Indiana University)|Quentin  Smith; PhD (Dept. of Pharmacy, Texas Technical University)|Andreas  Stark (University of Schleswig-Holstein Medical Center)|Show all 9",Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Giuseppe  Giaccone; MD (Medical Oncology Branch)|Kevin A Camphausen; MD (Radiation Oncology Branch)|Deedee Kay Smart (Radiation Oncology Branch)|Jo Anne N Zujewski (Clinical Investigations Branch)|Maria  Merino; PhD (Laboratory of Pathology),Mary M. Herman; MD (NIMH) |Jose  Paltan-Ortiz (NIMH),"1. Gril B, Evans L, Palmieri D, Steeg PS (2010). Translational research in brain metastasis is identifying molecular pathways that may lead to the development of new therapeutic strategies. Eur J Cancer  46, 1204-10.   https://doi.org/10.1016/j.ejca.2010.02.033|2. Lockman PR, Mittapalli RK, Taskar KS, Rudraraju V, Gril B, Bohn KA, Adkins CE, Roberts A, Thorsheim HR, Gaasch JA, Huang S, Palmieri D, Steeg PS, Smith QR (2010). Heterogeneous blood-tumor barrier permeability determines drug efficacy in experimental brain metastases of breast cancer. Clin Cancer Res  16, 5664-78.   https://doi.org/10.1158/1078-0432.CCR-10-1564",https://intramural.nih.gov/search/searchview.taf?ipid=68275
176,BC010539-09,"October 01, 2010 -  September 30, 2011",Identification of Modifier Gene of Tumors Associated with NF1 and Astrocytoma,"Karlyne M Reilly; BS, PhD",NULL,"Mouse Cancer Genetics Program, NCI",Georgette Nicole Jones; PhD|Min-Hyung  Lee; PhD|Kelly Lee Haas|Terry Anne Van Dyke|Robert  Tuskan|Jessica Corinne Van Schaick,Keiko  Akagi (NCI)|Melissa  Bondy (MD Anderson)|Karl  Broman (University of Michigan)|Mark  Ellisman (UCSD)|Joel  Garbow (Washington University)|David  Gutmann (Washington University)|Show all 12,"Douglas Russell Stewart; BA, MD (Clinical Genetics Branch)",John Keenam Park (NINDS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68268
177,BC010540-09,"October 01, 2010 -  September 30, 2011",Molecular Mechanisms of Proliferation and Infiltration of Astrocytoma,"Karlyne M Reilly; BS, PhD",NULL,"Mouse Cancer Genetics Program, NCI",Min-Hyung  Lee; PhD|Kelly Lee Haas|Robert  Tuskan|Terry Anne Van Dyke,"David  Gutmann (Washington University)|Joshua  Rubin (Washington University)|David  Wiemer (organic synthesis/molecular target identification, University of Iowa)",John A Beutler (Molecular Targets Laboratory)|Stephen J Lockett; PhD (Office Of The Director)|Thomas J Turbyville (Office Of The Director)|James  McMahon; PhD (Molecular Targets Laboratory)|Serguei V Kozlov (Office of the Director),NULL,"1. Banerjee S, Byrd JN, Gianino SM, Harpstrite SE, Rodriguez FJ, Tuskan RG, Reilly KM, Piwnica-Worms DR, Gutmann DH (2010). The neurofibromatosis type 1 tumor suppressor controls cell growth by regulating signal transducer and activator of transcription-3 activity in vitro and in vivo. Cancer Res  70, 1356-66.   https://doi.org/10.1158/0008-5472.CAN-09-2178|2. Walrath JC, Hawes JJ, Van Dyke T, Reilly KM (2010). Genetically engineered mouse models in cancer research. Adv Cancer Res  106, 113-64.   https://doi.org/10.1016/S0065-230X(10)06004-5",https://intramural.nih.gov/search/searchview.taf?ipid=68269
178,BC010541-09,"October 01, 2010 -  September 30, 2011",Development of Mouse Astrocytoma Model for Preclinical Testing,"Karlyne M Reilly; BS, PhD",NULL,"Mouse Cancer Genetics Program, NCI",Min-Hyung  Lee; PhD|Colin W Platt|Kelly Lee Haas|Robert  Tuskan|Terry Anne Van Dyke,"Yetrib  Hathout|Roger  Packer (CNMC)|David  Wiemer (organic synthesis/molecular target identification, University of Iowa)",Brigitte  Widemann; MD (Pediatric Oncology Branch)|John A Beutler (Molecular Targets Laboratory)|Stephen J Lockett; PhD (Office Of The Director)|Thomas J Turbyville (Office Of The Director)|Curtis  Henrich (Molecular Targets Laboratory)|James  McMahon; PhD (Molecular Targets Laboratory),NULL,"1. Hawes JJ, Reilly KM (2010). Bioluminescent approaches for measuring tumor growth in a mouse model of neurofibromatosis. Toxicol Pathol  38, 123-30.   https://doi.org/10.1177/0192623309357075|2. Turbyville TJ, Gürsel DB, Tuskan RG, Walrath JC, Lipschultz CA, Lockett SJ, Wiemer DF, Beutler JA, Reilly KM (2010). Schweinfurthin A selectively inhibits proliferation and Rho signaling in glioma and neurofibromatosis type 1 tumor cells in a NF1-GRD-dependent manner. Mol Cancer Ther  9, 1234-43.   https://doi.org/10.1158/1535-7163.MCT-09-0834|3. Walrath JC, Hawes JJ, Van Dyke T, Reilly KM (2010). Genetically engineered mouse models in cancer research. Adv Cancer Res  106, 113-64.   https://doi.org/10.1016/S0065-230X(10)06004-5",https://intramural.nih.gov/search/searchview.taf?ipid=68267
179,BC010547-09,"October 01, 2010 -  September 30, 2011",Development of Drugs That Target Prostate Cancer,William D Figg; PharmD|IRP Faculty Profile,NULL,"Medical Oncology Branch, NCI",Cindy Huong-Bich Chau|William Laurence Dahut; MD|Stephen T Pisle|Philip M Arlen; MD|Emily  Richardson|Sarah M Troutman,NULL,"Seth M Steinberg; PhD (Biostatistics and Data Management Section)|James L Gulley; MD, PhD (Laboratory of Tumor Immunology and Biology)|John J Wright (Investigational Drug Branch)",Clara Chi Chen; MD (CC),"1. Reece K, Figg W (2010) UGT1A1 Polymorphisms and Mutation in Irinotecan-Induced Toxicity, in Handbook of Therapeutic Biomarkers in Cancer., in press.|2. Ajiboye S, Sissung TM, Sharifi N, Figg WD (2010). More than an accessory: implications of type III transforming growth factor-beta receptor loss in prostate cancer. BJU Int  105, 913-6.   https://doi.org/10.1111/j.1464-410X.2009.08999.x|3. Figg WD, Woo S, Zhu W, Chen X, Ajiboye AS, Steinberg SM, Price DK, Wright JJ, Parnes HL, Arlen PM, Gulley JL, Dahut WL (2010). A phase I clinical study of high dose ketoconazole plus weekly docetaxel for metastatic castration resistant prostate cancer. J Urol  183, 2219-26.   https://doi.org/10.1016/j.juro.2010.02.020|4. Goodman PJ, Tangen CM, Kristal AR, Thompson IM, Lucia MS, Platz EA, Figg WD, Hoque A, Hsing A, Neuhouser ML, Parnes HL, Reichardt JK, Santella RM, Till C, Lippman SM (2010). Transition of a clinical trial into translational research: the prostate cancer prevention trial experience. Cancer Prev Res (Phila)  3, 1523-33.   https://doi.org/10.1158/1940-6207.CAPR-09-0256|5. Ning YM, Gulley JL, Arlen PM, Woo S, Steinberg SM, Wright JJ, Parnes HL, Trepel JB, Lee MJ, Kim YS, Sun H, Madan RA, Latham L, Jones E, Chen CC, Figg WD, Dahut WL (2010). Phase II trial of bevacizumab, thalidomide, docetaxel, and prednisone in patients with metastatic castration-resistant prostate cancer. J Clin Oncol  28, 2070-6.   https://doi.org/10.1200/JCO.2009.25.4524|6. Sharma H, Sissung TM, Pressler H, Figg WD (2010). Stromal-epithelial interactions are responsible for prostate tumor progression through an androgen-related mechanism. Cancer Biol Ther  9, 163-5.   https://doi.org/10.4161/cbt.9.3.11143|7. Sissung TM, Danesi R, Kirkland CT, Baum CE, Ockers SB, Stein EV, Venzon D, Price DK, Figg WD (2011). Estrogen receptor α and aromatase polymorphisms affect risk, prognosis, and therapeutic outcome in men with castration-resistant prostate cancer treated with docetaxel-based therapy. J Clin Endocrinol Metab  96, E368-72.   https://doi.org/10.1210/jc.2010-2070|8. Sun H, Pisle S, Gardner ER, Figg WD (2010). Bioluminescent imaging study: FAK inhibitor, PF-562,271, preclinical study in PC3M-luc-C6 local implant and metastasis xenograft models. Cancer Biol Ther  10, 38-43.   https://doi.org/10.4161/cbt.10.1.11993|9. Yao S, Till C, Kristal AR, Goodman PJ, Hsing AW, Tangen CM, Platz EA, Stanczyk FZ, Reichardt JK, Tang L, Neuhouser ML, Santella RM, Figg WD, Price DK, Parnes HL, Lippman SM, Thompson IM, Ambrosone CB, Hoque A (2011). Serum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: a nested case-control study. Cancer Causes Control  22, 1121-31.   https://doi.org/10.1007/s10552-011-9787-7",https://intramural.nih.gov/search/searchview.taf?ipid=68248
180,BC010549-09,"October 01, 2010 -  September 30, 2011",Zebrafish Models of Cancer,Dennis D Hickstein|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Lisa J Embree|Champa Damayanthi Golden|Heather R Shive|Robert R West,NULL,NULL,"Paul P. Liu; MD, PhD (NHGRI)","1. Hickstein DD, West RR (2010). A WHIM-sical zebrafish. Blood  116, 2621-2.   https://doi.org/10.1182/blood-2010-07-296426|2. Shive HR, West RR, Embree LJ, Azuma M, Sood R, Liu P, Hickstein DD (2010). brca2 in zebrafish ovarian development, spermatogenesis, and tumorigenesis. Proc Natl Acad Sci U S A  107, 19350-5.   https://doi.org/10.1073/pnas.1011630107",https://intramural.nih.gov/search/searchview.taf?ipid=68086
181,BC010558-09,"October 01, 2010 -  September 30, 2011",The Maintenance of Plasmids in Pathogenic Organisms,Stuart J Austin|IRP Faculty Profile,NULL,"Cell Cycle Regulation Section, NCI","Therese G Brendler; BS, PhD|Sujatha B Gowda|Manjistha  Sengupta|Brenda L Youngren",NULL,NULL,NULL,"1. Sengupta M, Nielsen HJ, Youngren B, Austin S (2010). P1 plasmid segregation: accurate redistribution by dynamic plasmid pairing and separation. J Bacteriol  192, 1175-83.   https://doi.org/10.1128/JB.01245-09",https://intramural.nih.gov/search/searchview.taf?ipid=68346
182,BC010561-08,"October 01, 2010 -  September 30, 2011",Transcription factor mobility,James G McNally; PhD,Gordon Lee Hager; PhD,"Laboratory of Receptor Biology and Gene Expression, NCI",Tatiana  Karpova|Davide  Mazza|Waltraud  Mueller|Dietmar  Rieder|Ronit  Salomon|Tatsuya  Morisaki,David  Auble (Univ. Virginia)|Jason  Lieb (University North Carolina),Charles  Vinson; PhD (Nucleic Acids Section)|Michael  Bustin; PhD (Protein Section),Keiko  Ozato; PhD (NICHD) |Jay Robert Knutson; PhD (NHLBI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68307
183,BC010562-08,"October 01, 2010 -  September 30, 2011",Molecular Interaction Maps and Analysis of Bioregulatory Networks,Mirit I Aladjem; PhD|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI",Geoffrey B Mcfadden|Yves  Pommier; PhD|Kurt  Kohn; PhD,NULL,NULL,NULL,"1. Kim S, Aladjem MI, McFadden GB, Kohn KW (2010). Predicted functions of MdmX in fine-tuning the response of p53 to DNA damage. PLoS Comput Biol  6, e1000665.   https://doi.org/10.1371/journal.pcbi.1000665",https://intramural.nih.gov/search/searchview.taf?ipid=68289
184,BC010564-08,"October 01, 2010 -  September 30, 2011",Large Scale Chromatin Structure,James G McNally; PhD,Gordon Lee Hager; PhD,"Laboratory of Receptor Biology and Gene Expression, NCI",Waltraud  Mueller,NULL,NULL,NULL,"1. Müller WG, Heymann JB, Nagashima K, Guttmann P, Werner S, Rehbein S, Schneider G, McNally JG (2012). Towards an atlas of mammalian cell ultrastructure by cryo soft X-ray tomography. J Struct Biol  177, 179-92.   https://doi.org/10.1016/j.jsb.2011.11.025",https://intramural.nih.gov/search/searchview.taf?ipid=68308
185,BC010565-08,"October 01, 2010 -  September 30, 2011",Determinants of Melanocyte Transformation and Melanoma Progression,Thomas J Hornyak,NULL,"Dermatology Branch, NCI",Tao  Fan|Jennifer Marian Huang|Shunlin  Jiang,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68296
186,BC010566-08,"October 01, 2010 -  September 30, 2011",Tumor and Metastasis Biology,Chand  Khanna; MD,NULL,"Pediatric Oncology Branch, NCI",Anita C Epps|Lee Jay Helman; MD|Radhika Vishwanath Gharpure|Martin  Mendoza; BS|Ling  Ren,"Matthew  Breen; PhD (Veterinary Medicine, North Carolina State University)|Anthony  Bretscher (Cell Biology, Cornell University)|Richard  Gorlick (Laboratory of Cellular Carcinogenesis and Tumor Promotion, Albert Einstein College of Medicine)|Eugenie  Kleinerman (Pediatric Oncology, MD Anderson Cancer Center)|Cheryl  London (Center for Comparative Medicine, University Of California)|Aykut  Uren (Georgetown University Medical Center)|Show all 8","Timothy D Veenstra (Office Of The Director)|Kent W Hunter; PhD (Laboratory of Cancer Biology and Genetics)|Stuart H Yuspa; MD (Laboratory of Cancer Biology and Genetics)|Jeffrey E Green; MD (Laboratory of Cancer Biology and Genetics)|John A Beutler (Molecular Targets Laboratory)|Stephen M Hewitt; MD, PhD (Laboratory of Pathology)",NULL,"1. Mendoza A, Hong SH, Osborne T, Khan MA, Campbell K, Briggs J, Eleswarapu A, Buquo L, Ren L, Hewitt SM, Dakir el H, Dakir el-H, Garfield S, Walker R, Merlino G, Green JE, Hunter KW, Wakefield LM, Khanna C (2010). Modeling metastasis biology and therapy in real time in the mouse lung. J Clin Invest  120, 2979-88.   https://doi.org/10.1172/JCI40252|2. Wu Y, Brodt P, Sun H, Mejia W, Novosyadlyy R, Nunez N, Chen X, Mendoza A, Hong SH, Khanna C, Yakar S (2010). Insulin-like growth factor-I regulates the liver microenvironment in obese mice and promotes liver metastasis. Cancer Res  70, 57-67.   https://doi.org/10.1158/0008-5472.CAN-09-2472",https://intramural.nih.gov/search/searchview.taf?ipid=68303
187,BC010578-08,"October 01, 2010 -  September 30, 2011",Targeting TEMs in Preclinical Tumor Models,Bradley D St Croix,NULL,"Mouse Cancer Genetics Program, NCI",Amit Madhulal Chaudhary|Mary B Hilton|Steven  Seaman,NULL,NULL,Stephen H Leppla; PhD (NIAID),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68089
188,BC010579-08,"October 01, 2010 -  September 30, 2011",Papillomavirus Virion Proteins and Vaccines,Douglas  Lowy; MD|IRP Faculty Profile,NULL,"Office Of The Director, NCI",Alexander G Papageorge|William C Vass,"Joel  Palefsky (Department of Medicine, University of California at San Francisco)|Richard  Roden (Johns Hopkins School of Medicine)",John  Schiller; PhD (Laboratory of Cellular Oncology)|Lauren V Wood; MD (Vaccine Branch)|Allan  Hildesheim; PhD (Infection & Immunoepidemiology Branch)|Ligia  Pinto (Infection & Immunoepidemiology Branch)|Christopher  Buck (Laboratory of Cellular Oncology)|Peter L Choyke; MD (Molecular Imaging Program),NULL,"1. Day PM, Kines RC, Thompson CD, Jagu S, Roden RB, Lowy DR, Schiller JT (2010). In vivo mechanisms of vaccine-induced protection against HPV infection. Cell Host Microbe  8, 260-70.   https://doi.org/10.1016/j.chom.2010.08.003|2. Lowy DR, Munger K (2010). Prognostic implications of HPV in oropharyngeal cancer. N Engl J Med  363, 82-4.   https://doi.org/10.1056/NEJMe1003607|3. Schiller JT, Lowy DR (2010). Vaccines to prevent infections by oncoviruses. Annu Rev Microbiol  64, 23-41.   https://doi.org/10.1146/annurev.micro.112408.134019",https://intramural.nih.gov/search/searchview.taf?ipid=68305
189,BC010580-08,"October 01, 2010 -  September 30, 2011",Phase II Trial of PEG-Intron in Children with Diffuse Pontine Gliomas,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Robyn S Bent|Pamela  Wolters|Ryan J Hanson|Laurie  Steffen,NULL,Kevin A Camphausen; MD (Radiation Oncology Branch)|Alisa Jennifer Prager (Radiation Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68286
190,BC010589-08,"October 01, 2010 -  September 30, 2011",Imaging as a Biomarker for Diffuse Intrinsic Brainstem Gliomas,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Robyn S Bent|Sean Joseph Hipp|Laurie  Steffen,NULL,NULL,"Nicholas  Patronas; MD (CC) |Eva Halle Baker; MD, PhD (CC) |Alan Seth Barnett; PhD (NIMH) |Johan W Van Der Veen; PhD (NIMH) |David M Thomasson; PhD (NIAID) |Joelle  Sarlls; PhD (NINDS)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68284
191,BC010590-08,"October 01, 2010 -  September 30, 2011",Phase II Trial of O6-Benzylguanine and Temozolomide in Pediatric Patients with H,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Robyn S Bent|Roger  Packer,"Susan  Blaney (Baylor University/TCCC)|James  Boyett (St Jude Children's Research Hospital)|Stewart  Goldman (Pediatric Oncology, Children's Memorial Hospital)|Larry  Kun (Radiation Oncology, St. Jude Children's Research Hospital)|Roger  Packer (CNMC)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68285
192,BC010591-08,"October 01, 2010 -  September 30, 2011",Characterization of Xenograft Models of Childhood Cancers,Javed  Khan; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Carol J Thiele|Jun S Wei|Chand  Khanna; MD,NULL,Malcolm A Smith (Clinical Investigations Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68301
193,BC010592-08,"October 01, 2010 -  September 30, 2011",Comparative Genomic Hybridization of Neuroblastoma,Javed  Khan; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Jianjun  Wang,"Daniel  Catchpoole, (The Children's Hospital at Westmead)|John  Maris (Pharmacology, Children's Hospital of Philadelphia)|Andrew  Pearson (Paediatric Section, Institute of Cancer Research)|Manfred  Schwab (German Cancer Research Center)|Robert  Seeger (Division of Pediatric Hematology-Oncology, Children's Hospital of Los Angeles)",NULL,NULL,"1. Liu Z, Yang X, Li Z, McMahon C, Sizer C, Barenboim-Stapleton L, Bliskovsky V, Mock B, Ried T, London WB, Maris J, Khan J, Thiele CJ (2011). CASZ1, a candidate tumor-suppressor gene, suppresses neuroblastoma tumor growth through reprogramming gene expression. Cell Death Differ  18, 1174-83.   https://doi.org/10.1038/cdd.2010.187",https://intramural.nih.gov/search/searchview.taf?ipid=68302
194,BC010595-08,"October 01, 2010 -  September 30, 2011",Structure and Function of APOBEC Proteins,Vinay K Pathak; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Ryan C Burdick|Chawaree  Chaipan|Eric O Freed; PhD|Krista A Delviks-Frankenberry|Taisuke  Izumi; PhD|Salim  Manoharadas|Show all 10,"Reuben  Harris (Biochemistry, University of Minnesota)|Jean L Mbisa (NCI)|Carsten  Munk (Paul-Ehrlich-Institut)",Robert  Gorelick (Office Of The Director)|William  Gillette (Office Of The Director)|Dominic  Esposito; PhD (Office Of The Director)|Robert J Fisher (Office Of The Director)|Andrew G Stephen (Office Of The Director)|Ralph F Hopkins (Office Of The Director),James  Inglese (NHGRI),"1. Burdick R, Smith JL, Chaipan C, Friew Y, Chen J, Venkatachari NJ, Delviks-Frankenberry KA, Hu WS, Pathak VK (2010). P body-associated protein Mov10 inhibits HIV-1 replication at multiple stages. J Virol  84, 10241-53.   https://doi.org/10.1128/JVI.00585-10|2. Smith JL, Pathak VK (2010). Identification of specific determinants of human APOBEC3F, APOBEC3C, and APOBEC3DE and African green monkey APOBEC3F that interact with HIV-1 Vif. J Virol  84, 12599-608.   https://doi.org/10.1128/JVI.01437-10",https://intramural.nih.gov/search/searchview.taf?ipid=68310
195,BC010598-08,"October 01, 2010 -  September 30, 2011",Human T Cell Responses to Tumor Antigens for Cancer Vaccine Development,Jeffrey  Schlom; PhD|IRP Faculty Profile,NULL,"Laboratory of Tumor Immunology and Biology, NCI",Lajuan  Chase|Kwong Yok Tsang|Joseph Raymond Cohen; PhD|Claudia Mercedes Palena|Renee Nicole Donahue|John  Greiner; PhD|Show all 15,"Kenneth  Foon (Hematology-Oncology, University of Pittsburgh Cancer Institute)|Douglas  McNeel (University of Wisconsin)",NULL,NULL,"1. Palena C, Schlom J (2011) Target: Brachyury, a master driver of epithelial-to-mesenchymal transition (EMT), in Encyclopedia of Cancer Therapeutic Targets., in press.|2. Cereda V, Poole DJ, Palena C, Das S, Bera TK, Remondo C, Gulley JL, Arlen PM, Yokokawa J, Pastan I, Schlom J, Tsang KY (2010). New gene expressed in prostate: a potential target for T cell-mediated prostate cancer immunotherapy. Cancer Immunol Immunother  59, 63-71.   https://doi.org/10.1007/s00262-009-0723-6|3. Fernando RI, Litzinger M, Trono P, Hamilton DH, Schlom J, Palena C (2010). The T-box transcription factor Brachyury promotes epithelial-mesenchymal transition in human tumor cells. J Clin Invest  120, 533-44.   https://doi.org/10.1172/JCI38379|4. Heffernan MJ, Zaharoff DA, Fallon JK, Schlom J, Greiner JW (2011). In vivo efficacy of a chitosan/IL-12 adjuvant system for protein-based vaccines. Biomaterials  32, 926-32.   https://doi.org/10.1016/j.biomaterials.2010.09.058|5. Larocca C, Schlom J (2011) Viral vector-based therapeutic cancer vaccines. Cancer Journal, in press.|6. Litzinger MT, Foon KA, Tsang KY, Schlom J, Palena C (2010). Comparative analysis of MVA-CD40L and MVA-TRICOM vectors for enhancing the immunogenicity of chronic lymphocytic leukemia (CLL) cells. Leuk Res  34, 1351-7.   https://doi.org/10.1016/j.leukres.2009.12.013|7. Palena C, Fernando RI, Litzinger MT, Hamilton DH, Huang B, Schlom J (2011). Strategies to target molecules that control the acquisition of a mesenchymal-like phenotype by carcinoma cells. Exp Biol Med (Maywood)  236, 537-45.   https://doi.org/10.1258/ebm.2011.010367|8. Palena C, Schlom J (2010). Vaccines against human carcinomas: strategies to improve antitumor immune responses. J Biomed Biotechnol  2010, 380697.   https://doi.org/10.1155/2010/380697|9. Smith HA, Maricque BB, Eberhardt J, Petersen B, Gulley JL, Schlom J, McNeel DG (2011). IgG responses to tissue-associated antigens as biomarkers of immunological treatment efficacy. J Biomed Biotechnol  2011, 454861.   https://doi.org/10.1155/2011/454861|10. Zaharoff DA, Hance KW, Rogers CJ, Schlom J, Greiner JW (2010). Intratumoral immunotherapy of established solid tumors with chitosan/IL-12. J Immunother  33, 697-705.   https://doi.org/10.1097/CJI.0b013e3181eb826d|11. Schlom J, Huang J (submitted in 2011) Soluble Cd27 (scd27) And Use Thereof. Patent issued: 9,725,494 (US in 2017).",https://intramural.nih.gov/search/searchview.taf?ipid=68087
196,BC010600-08,"October 01, 2010 -  September 30, 2011",Study of AAA proteins by X-ray protein crystallography,"Di S Xia; PhD, MS, BS|IRP Faculty Profile",NULL,"Crystallography Section, NCI",Wai-Kwan  Tang,NULL,Michael  Maurizi; PhD (Biochemistry of Proteins Section),NULL,"1. Tang WK, Li D, Li CC, Esser L, Dai R, Guo L, Xia D (2010). A novel ATP-dependent conformation in p97 N-D1 fragment revealed by crystal structures of disease-related mutants. EMBO J  29, 2217-29.   https://doi.org/10.1038/emboj.2010.104",https://intramural.nih.gov/search/searchview.taf?ipid=68288
197,BC010603-08,"October 01, 2010 -  September 30, 2011",Receptor-directed Therapy,John  Janik; MD,"Thomas Alexander Waldmann; MD, PhD","Lymphoid Malignancies Branch, NCI",Louis  Staudt; MD,NULL,Jane Beth Trepel (Medical Oncology Branch)|Francis W Ruscetti; PhD (Laboratory of Experimental Immunology)|Kathryn  Jones; PhD (Laboratory of Experimental Immunology),Warren J Leonard; MD (NHLBI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68297
198,BC010607-08,"October 01, 2010 -  September 30, 2011",Ras-mediated signals in human epithelial cell transformation and metastasis,Kathleen  Kelly; PhD|IRP Faculty Profile,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Victoria  Seng|Juanjuan  Yin,NULL,Glenn  Merlino; PhD (Laboratory of Cancer Biology and Genetics),Alan Paul Koretsky; PhD (NINDS),"1. Mishra PJ, Ha L, Rieker J, Sviderskaya EV, Bennett DC, Oberst MD, Kelly K, Merlino G (2010). Dissection of RAS downstream pathways in melanomagenesis: a role for Ral in transformation. Oncogene  29, 2449-56.   https://doi.org/10.1038/onc.2009.521|2. Yin JJ, Zhang L, Munasinghe J, Linnoila RI, Kelly K (2010). Cediranib/AZD2171 inhibits bone and brain metastasis in a preclinical model of advanced prostate cancer. Cancer Res  70, 8662-73.   https://doi.org/10.1158/0008-5472.CAN-10-1435",https://intramural.nih.gov/search/searchview.taf?ipid=68300
199,BC010612-08,"October 01, 2010 -  September 30, 2011",The Role of miRNA-mediated RNAI in the Biology of Cancer,Natasha  Caplen|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI","Konrad  Huppi; MD, PhD|Tamara L Jones|Jason James Pitt","Eric A Collisson|Siegfried  Janz (University of Iowa)|Catherine  Park (UCSF)|Carol L Prives|Matthias  Wabl (Dept Microbiology and Immunology, UCSF)","Michael R Emmert-Buck; MD, PhD (Laboratory of Pathology)|Stefan  Ambs (Laboratory of Human Carcinogenesis)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68319
200,BC010613-08,"October 01, 2010 -  September 30, 2011",The Induction of Gene-specific RNAi Against Cancer-associated Genes,Natasha  Caplen|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI","Magdalena Grandin Grandin|Konrad  Huppi; MD, PhD|Paul S Meltzer; MD, PhD|Tamara L Jones|Joshua Nazeer Omade|Karl Thomas Ried; MD|Show all 8","Amanda  Hummon|Eric  Lader (Gene Silencing, Qiagen Inc.)|John  Weinstein (MD Anderson)","Paul  Goldsmith; PhD (Office of the Director)|Stanley  Lipkowitz; MD, PhD (Laboratory of Cellular and Molecular Biology)|Yves  Pommier; PhD (Developmental Therapeutics Branch)|Lee Jay Helman; MD (Pediatric Oncology Branch)|Beverly  Mock; PhD (Office of the Director)|Liudmila  Prokunina-Olsson; PhD (Laboratory Translational Genomics)",Scott E Martin (NHGRI),"1. Grade M, Hummon AB, Camps J, Emons G, Spitzner M, Gaedcke J, Hoermann P, Ebner R, Becker H, Difilippantonio MJ, Ghadimi BM, Beissbarth T, Caplen NJ, Ried T (2011). A genomic strategy for the functional validation of colorectal cancer genes identifies potential therapeutic targets. Int J Cancer  128, 1069-79.   https://doi.org/10.1002/ijc.25453|2. Murrow LM, Garimella SV, Jones TL, Caplen NJ, Lipkowitz S (2010). Identification of WEE1 as a potential molecular target in cancer cells by RNAi screening of the human tyrosine kinome. Breast Cancer Res Treat  122, 347-57.   https://doi.org/10.1007/s10549-009-0571-2",https://intramural.nih.gov/search/searchview.taf?ipid=68320
201,BC010615-08,"October 01, 2010 -  September 30, 2011",RNAi Screening for the Systematic Discovery of Cancer Gene Function,Natasha  Caplen|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Magdalena Grandin Grandin|Tamara L Jones|Karl Thomas Ried; MD|Joshua Nazeer Omade|Lihui  Ou; PhD|Jason James Pitt,NULL,"Stanley  Lipkowitz; MD, PhD (Laboratory of Cellular and Molecular Biology)|Yves  Pommier; PhD (Developmental Therapeutics Branch)|Lee Jay Helman; MD (Pediatric Oncology Branch)|Beverly  Mock; PhD (Office of the Director)","Christopher P Austin; AB, MD (NHGRI) |Scott E Martin (NHGRI)","1. Murrow LM, Garimella SV, Jones TL, Caplen NJ, Lipkowitz S (2010). Identification of WEE1 as a potential molecular target in cancer cells by RNAi screening of the human tyrosine kinome. Breast Cancer Res Treat  122, 347-57.   https://doi.org/10.1007/s10549-009-0571-2",https://intramural.nih.gov/search/searchview.taf?ipid=68321
202,BC010620-08,"October 01, 2010 -  September 30, 2011",Clinical Studies to Circumvent Drug Resistance,Susan  Bates; MD,NULL,"Medical Oncology Branch, NCI","Christine M Bryla|Antonio  Fojo; MD, PhD|Andrea R Eisch|William D Figg; PharmD","John F Deeken|Thomas  Litman (University of Copenhagen)|Wilfred  Stein (Hebrew University, Jerusalem)",Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Yves  Pommier; PhD (Developmental Therapeutics Branch)|James Halpern Doroshow (Office of the Director)|Peter L Choyke; MD (Molecular Imaging Program)|Jo Anne N Zujewski (Clinical Investigations Branch)|Patricia  Steeg; PhD (Developmental Therapeutics Branch),Clara Chi Chen; MD (CC) |Robert  Innis; MD (NIMH),"1. Annunziata CM, Bates SE (2010). PARP inhibitors in BRCA1/BRCA2 germline mutation carriers with ovarian and breast cancer. F1000 Biol Rep  2.   https://doi.org/10.3410/B2-10|2. Arnaud O, Boumendjel A, Gèze A, Honorat M, Matera EL, Guitton J, Stein WD, Bates SE, Falson P, Dumontet C, Di Pietro A, Payen L (2011). The acridone derivative MBLI-87 sensitizes breast cancer resistance protein-expressing xenografts to irinotecan. Eur J Cancer  47, 640-8.   https://doi.org/10.1016/j.ejca.2010.11.019|3. Smith NF, Mani S, Schuetz EG, Yasuda K, Sissung TM, Bates SE, Figg WD, Sparreboom A (2010). Induction of CYP3A4 by vinblastine: Role of the nuclear receptor NR1I2. Ann Pharmacother  44, 1709-17.   https://doi.org/10.1345/aph.1P354",https://intramural.nih.gov/search/searchview.taf?ipid=68292
203,BC010621-08,"October 01, 2010 -  September 30, 2011",Translational Studies of the Histone Deacetylase Inhibitor Romidepsin,Susan  Bates; MD,NULL,"Medical Oncology Branch, NCI","Christine M Bryla|Antonio  Fojo; MD, PhD|Andrea R Eisch|Caterina  Ierano|William D Figg; PharmD|Victoria  Luchenko|Show all 9",NULL,"Patricia A Fetsch (Laboratory of Pathology)|Elaine S Jaffe; MD (Laboratory of Pathology)|Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Maria L Turner; MD (Dermatology Branch)|Maryalice  Stetler-Stevenson; MD, PhD (Laboratory of Pathology)|Yves  Pommier; PhD (Developmental Therapeutics Branch)",Danny L Sackett; PhD (NICHD) |Douglas R Rosing; MD (NHLBI) |Alexander  Ling (CC),"1. Bates SE, Zhan Z, Steadman K, Obrzut T, Luchenko V, Frye R, Robey RW, Turner M, Gardner ER, Figg WD, Steinberg SM, Ling A, Fojo T, To KW, Piekarz RL (2010). Laboratory correlates for a phase II trial of romidepsin in cutaneous and peripheral T-cell lymphoma. Br J Haematol  148, 256-67.   https://doi.org/10.1111/j.1365-2141.2009.07954.x|2. Dunleavy K, Piekarz RL, Zain J, Janik JE, Wilson WH, O'Connor OA, Bates SE (2010). New strategies in peripheral T-cell lymphoma: understanding tumor biology and developing novel therapies. Clin Cancer Res  16, 5608-17.   https://doi.org/10.1158/1078-0432.CCR-09-1995|3. Grant C, Rahman F, Piekarz R, Peer C, Frye R, Robey RW, Gardner ER, Figg WD, Bates SE (2010). Romidepsin: a new therapy for cutaneous T-cell lymphoma and a potential therapy for solid tumors. Expert Rev Anticancer Ther  10, 997-1008.   https://doi.org/10.1586/era.10.88|4. Luchenko V, Salcido C, Zhang Y, Agama K, Komlodi-Pasztor E, Murphy R, Giaccone G, Pommier Y, Bates S, Varticovski L (2011) Schedule-dependent synergy of histone deacetylase inhibitors with DNA damaging agents in small cell lung cancer. Cell Cycle, in press.|5. Panicker J, Li Z, McMahon C, Sizer C, Steadman K, Piekarz R, Bates SE, Thiele CJ (2010). Romidepsin (FK228/depsipeptide) controls growth and induces apoptosis in neuroblastoma tumor cells. Cell Cycle  9, 1830-8.   https://doi.org/10.4161/cc.9.9.11543",https://intramural.nih.gov/search/searchview.taf?ipid=68290
204,BC010622-08,"October 01, 2010 -  September 30, 2011",Investigation of the ABC Half-Transporter ABCG2,Susan  Bates; MD,NULL,"Medical Oncology Branch, NCI",Agnes Marie Therese Basseville|Caterina  Ierano|Robert W Robey|William D Figg; PharmD,"John F Deeken|Thomas  Litman (University of Copenhagen)|Balazs  Sarkadi (Dept Cell Metabolism, National Insitute of Hematology and Immunology)|Alex  Sparreboom|Hendrik  van Veen (Department of Pharmacology, University of Cambridge)","Michael  Dean; PhD (Laboratory of Experimental Immunology)|Di S Xia; PhD, MS, BS (Crystallography Section)|Suresh V Ambudkar; PhD (Transport Biochemistry Section)|Patricia A Fetsch (Laboratory of Pathology)|Curtis  Henrich (Molecular Targets Laboratory)|Yves  Pommier; PhD (Developmental Therapeutics Branch)",NULL,"1. Dohse M, Scharenberg C, Shukla S, Robey RW, Volkmann T, Deeken JF, Brendel C, Ambudkar SV, Neubauer A, Bates SE (2010). Comparison of ATP-binding cassette transporter interactions with the tyrosine kinase inhibitors imatinib, nilotinib, and dasatinib. Drug Metab Dispos  38, 1371-80.   https://doi.org/10.1124/dmd.109.031302|2. Polgar O, Ierano C, Tamaki A, Stanley B, Ward Y, Xia D, Tarasova N, Robey RW, Bates SE (2010). Mutational analysis of threonine 402 adjacent to the GXXXG dimerization motif in transmembrane segment 1 of ABCG2. Biochemistry  49, 2235-45.   https://doi.org/10.1021/bi902085q|3. Robey RW, Lin B, Qiu J, Chan LL, Bates SE (2011). Rapid detection of ABC transporter interaction: potential utility in pharmacology. J Pharmacol Toxicol Methods  63, 217-22.   https://doi.org/10.1016/j.vascn.2010.11.003|4. Robey RW, Massey PR, Amiri-Kordestani L, Bates SE (2010). ABC transporters: unvalidated therapeutic targets in cancer and the CNS. Anticancer Agents Med Chem  10, 625-33.   https://doi.org/10.2174/187152010794473957",https://intramural.nih.gov/search/searchview.taf?ipid=68291
205,BC010624-08,"October 01, 2010 -  September 30, 2011",The Molecular Profile of Prostate Tumors in African-American Men,Stefan  Ambs|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Tiffany Marie Howe|Adrienne Michelle Starks,"William  Isaacs; PhD (Department of Urology, Johns Hopkins School of Medicine)|Chris  Loffredo (Cancer Genetics and Epidemiology Program, Georgetown University)|Jun  Luo (Johns Hopkins University)|Arun  Sreekumar (Baylor College of Medicine)|Feng  Wang-Johanning (University of Texas MD Anderson Cancer Center)",William Marston Linehan; MD (Urologic Oncology Branch)|Arthur A Hurwitz (Laboratory of Molecular Immunoregulation)|Robert H Stephens (Business Operations Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68313
206,BC010625-08,"October 01, 2010 -  September 30, 2011",Microtubule (MT) Interfering Agents (MTAs): Mechanisms of Action and Resistance,"Antonio  Fojo; MD, PhD",NULL,"Medical Oncology Branch, NCI",Lyn Ann J Mickley|Susan  Bates; MD|Marianne  Poruchynsky|William D Figg; PharmD|Shana Y Trostel,NULL,Yvona  Ward; PhD (Laboratory Of Genitourinary Cancer Pathogenesis),Danny L Sackett; PhD (NICHD),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68294
207,BC010626-08,"October 01, 2010 -  September 30, 2011",Adrenocortical Cancer and Thyroid Carcinomas: Models with Unique Properties,"Antonio  Fojo; MD, PhD",NULL,"Medical Oncology Branch, NCI",Marianne  Poruchynsky|Susan  Bates; MD|Julia  Wilkerson|Samuel A Wells,NULL,Richard Lawrence Piekarz (Investigational Drug Branch),"Bradford J Wood; MD (CC) |Karel  Pacak; MD, PhD (NICHD) |Aradhana M Venkatesan (CC)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68448
208,BC010627-08,"October 01, 2010 -  September 30, 2011",Clinical Pharmacogenetics,William D Figg; PharmD|IRP Faculty Profile,NULL,"Medical Oncology Branch, NCI",William Laurence Dahut; MD|Christian Tyler Kirkland|Douglas K Price|Susan  Bates; MD|Emily  Richardson|Tristan  Sissung|Show all 9,Romano  Danesi|John F Deeken|Alex  Sparreboom,Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Frank Jess Gonzalez; PhD (Laboratory of Metabolism)|Heidi H Kong (Dermatology Branch),NULL,"1. Reece K, Figg W (2010) UGT1A1 Polymorphisms and Mutation in Irinotecan-Induced Toxicity, in Handbook of Therapeutic Biomarkers in Cancer., in press.|2. English BC, Baum CE, Adelberg DE, Sissung TM, Kluetz PG, Dahut WL, Price DK, Figg WD (2010). A SNP in CYP2C8 is not associated with the development of bisphosphonate-related osteonecrosis of the jaw in men with castrate-resistant prostate cancer. Ther Clin Risk Manag  6, 579-83.   https://doi.org/10.2147/TCRM.S14303|3. Freedman AN, Sansbury LB, Figg WD, Potosky AL, Weiss Smith SR, Khoury MJ, Nelson SA, Weinshilboum RM, Ratain MJ, McLeod HL, Epstein RS, Ginsburg GS, Schilsky RL, Liu G, Flockhart DA, Ulrich CM, Davis RL, Lesko LJ, Zineh I, Randhawa G, Ambrosone CB, Relling MV, Rothman N, Xie H, Spitz MR, et al. [3 more authors] (2010). Cancer pharmacogenomics and pharmacoepidemiology: setting a research agenda to accelerate translation. J Natl Cancer Inst  102, 1698-705.   https://doi.org/10.1093/jnci/djq390|4. Gao R, Price DK, Dahut WL, Reed E, Figg WD (2010). Genetic polymorphisms in XRCC1 associated with radiation therapy in prostate cancer. Cancer Biol Ther  10, 13-8.   https://doi.org/10.4161/cbt.10.1.12172|5. Hulin-Curtis SL, Petit D, Figg WD, Hsing AW, Reichardt JK (2010). Finasteride metabolism and pharmacogenetics: new approaches to personalized prevention of prostate cancer. Future Oncol  6, 1897-913.   https://doi.org/10.2217/fon.10.149|6. Jain L, Sissung TM, Danesi R, Kohn EC, Dahut WL, Kummar S, Venzon D, Liewehr D, English BC, Baum CE, Yarchoan R, Giaccone G, Venitz J, Price DK, Figg WD (2010). Hypertension and hand-foot skin reactions related to VEGFR2 genotype and improved clinical outcome following bevacizumab and sorafenib. J Exp Clin Cancer Res  29, 95.   https://doi.org/10.1186/1756-9966-29-95|7. Kirkland CT, Price DK, Figg WD (2010). Genetic variant associated with aggressive not indolent prostate cancer. Cancer Biol Ther  9, 957-8.   https://doi.org/10.4161/cbt.9.12.12137|8. Kristal AR, Price DK, Till C, Schenk JM, Neuhouser ML, Ockers S, Lin DW, Thompson IM, Figg WD (2010). Androgen receptor CAG repeat length is not associated with the risk of incident symptomatic benign prostatic hyperplasia: results from the Prostate Cancer Prevention Trial. Prostate  70, 584-90.   https://doi.org/10.1002/pros.21092|9. Liang X, Guo Y, Figg W, Fojo A, Mueller M, Yu J (2011) The Role of Wilde-type p53 in Cisplatin-induced Chk2 Phosphorylation and the Inibition of Platinum Resistance with a Chk2 Inibitor. Cancer Res Practice, in press.|10. Pastina I, Giovannetti E, Chioni A, Sissung TM, Crea F, Orlandini C, Price DK, Cianci C, Figg WD, Ricci S, Danesi R (2010). Cytochrome 450 1B1 (CYP1B1) polymorphisms associated with response to docetaxel in Castration-Resistant Prostate Cancer (CRPC) patients. BMC Cancer  10, 511.   https://doi.org/10.1186/1471-2407-10-511|11. Reece KM, Figg WD (2010). A novel regulator (USP10) of p53: Implications for tumor suppression and therapeutic targeting. Cancer Biol Ther  9, 583-4.   https://doi.org/10.4161/cbt.9.8.11690|12. Sharifi N, Qi J, Bane S, Sharma S, Li R, Robey R, Figg WD, Farrar WL, Kingston DG (2010). Survivin is not induced by novel taxanes. Mol Pharm  7, 2216-23.   https://doi.org/10.1021/mp100211k|13. Sissung TM, Baum CE, Kirkland CT, Gao R, Gardner ER, Figg WD (2010). Pharmacogenetics of membrane transporters: an update on current approaches. Mol Biotechnol  44, 152-67.   https://doi.org/10.1007/s12033-009-9220-6|14. Sissung TM, English BC, Venzon D, Figg WD, Deeken JF (2010). Clinical pharmacology and pharmacogenetics in a genomics era: the DMET platform. Pharmacogenomics  11, 89-103.   https://doi.org/10.2217/pgs.09.154|15. Smith NF, Mani S, Schuetz EG, Yasuda K, Sissung TM, Bates SE, Figg WD, Sparreboom A (2010). Induction of CYP3A4 by vinblastine: Role of the nuclear receptor NR1I2. Ann Pharmacother  44, 1709-17.   https://doi.org/10.1345/aph.1P354",https://intramural.nih.gov/search/searchview.taf?ipid=68293
209,BC010629-08,"October 01, 2010 -  September 30, 2011",Characterization of Signaling Pathways involved in Cell Death and Survival,Srinivasa M Srinivasula,NULL,"Laboratory of Immune Cell Biology, NCI",Ken-Ichi  Fujita|Daisuke  Maeda|Qi  Xiao,"Alison  O'Brien (USUHS)|Stefan  Schütze (Universitatsklinikum Schleswig Holstein, Institut für Immunologie)",Susan H Garfield (Laboratory of Experimental Carcinogenesis)|Timothy D Veenstra (Office Of The Director),Alan  Sher; PhD (NIAID),"1. Samali A, Fulda S, Gorman AM, Hori O, Srinivasula SM (2010). Cell stress and cell death. Int J Cell Biol  2010, 245803.   https://doi.org/10.1155/2010/245803",https://intramural.nih.gov/search/searchview.taf?ipid=68088
210,BC010632-08,"October 01, 2010 -  September 30, 2011",Transcription Regulation in E. coli and H. pylori,Ding Jun Jin,NULL,"Gene Regulation and Chromosome Biology Laboratory, NCI",Cedric Nicolas Lionel Cagliero|Carolyn B McGill|Yan Ning H Zhou|Jeffrey N Strathern,NULL,Xinhua  Ji; PhD (Biomolecular Structure Section)|Mikhail V Kashlev (Molecular Mechanisms of Transcription Section)|Donald L Court; PhD (Molecular Control and Genetics Section),NULL,"1. Yang ZX, Zhou YN, Yang Y, Jin DJ (2010). Polyphosphate binds to the principal sigma factor of RNA polymerase during starvation response in Helicobacter pylori. Mol Microbiol  77, 618-27.   https://doi.org/10.1111/j.1365-2958.2010.07233.x",https://intramural.nih.gov/search/searchview.taf?ipid=68299
211,BC010638-08,"October 01, 2010 -  September 30, 2011",The role of c-met in liver biology,"Snorri S. Thorgeirsson; MD, PhD",NULL,"Laboratory of Experimental Carcinogenesis, NCI","Valentina  Factor|Daekwan  Seo; PhD, MS, BA|Mitsuteru  Kitade|Phuongnga  Ton|Tanya N Hoang",NULL,Glenn  Merlino; PhD (Laboratory of Cancer Biology and Genetics)|Robert  Wiltrout; PhD (Laboratory of Experimental Immunology),NULL,"1. Factor VM, Seo D, Ishikawa T, Kaposi-Novak P, Marquardt JU, Andersen JB, Conner EA, Thorgeirsson SS (2010). Loss of c-Met disrupts gene expression program required for G2/M progression during liver regeneration in mice. PLoS One  5.   https://doi.org/10.1371/journal.pone.0012739",https://intramural.nih.gov/search/searchview.taf?ipid=68283
212,BC010646-08,"October 01, 2010 -  September 30, 2011",Chromatin Remodeling Proteins,Gordon Lee Hager; PhD|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Songjoon  Baek|Mary  Hawkins|Sam  John|Stephanie  Morris|Rodney Louis Schiltz; PhD,NULL,NULL,NULL,"1. Wiench M, Hager GL (2010). Expanding horizons for nuclear receptors. EMBO Rep  11, 569-71.   https://doi.org/10.1038/embor.2010.111|2. Wiench M, Miranda TB, Hager GL (2011). Control of nuclear receptor function by local chromatin structure. FEBS J  278, 2211-30.   https://doi.org/10.1111/j.1742-4658.2011.08126.x",https://intramural.nih.gov/search/searchview.taf?ipid=68295
213,BC010647-07,"October 01, 2010 -  September 30, 2011",Antibody Engineering for Therapy and Diagnosis of Hematologic Malignancies,Christoph  Rader; PhD,NULL,"Experimental Transplantation and Immunology Branch, NCI",Huiting  Cui,NULL,Terrence R Burke; PhD (Chemical Biology Laboratory)|Crystal L. Mackall; MD (Pediatric Oncology Branch),Rose G Mage; PhD (NIAID) |Paul T Wingfield; PhD (NIAMS),"1. Rader C (2011) Monoclonal antibody therapy for cancer, in Experimental and Applied Immunotherapy., pp. 59-83.|2. Beerli RR, Rader C (2010). Mining human antibody repertoires. MAbs  2, 365-78.   https://doi.org/10.4161/mabs.12187|3. DiMattia MA, Watts NR, Stahl SJ, Rader C, Wingfield PT, Stuart DI, Steven AC, Grimes JM (2010). Implications of the HIV-1 Rev dimer structure at 3.2 A resolution for multimeric binding to the Rev response element. Proc Natl Acad Sci U S A  107, 5810-4.   https://doi.org/10.1073/pnas.0914946107|4. Ho M, Feng M, Fisher RJ, Rader C, Pastan I (2011). A novel high-affinity human monoclonal antibody to mesothelin. Int J Cancer  128, 2020-30.   https://doi.org/10.1002/ijc.25557|5. Pérez-Galán P, Mora-Jensen H, Weniger MA, Shaffer AL, Rizzatti EG, Chapman CM, Mo CC, Stennett LS, Rader C, Liu P, Raghavachari N, Stetler-Stevenson M, Yuan C, Pittaluga S, Maric I, Dunleavy KM, Wilson WH, Staudt LM, Wiestner A (2011). Bortezomib resistance in mantle cell lymphoma is associated with plasmacytic differentiation. Blood  117, 542-52.   https://doi.org/10.1182/blood-2010-02-269514|6. Stahl SJ, Watts NR, Rader C, DiMattia MA, Mage RG, Palmer I, Kaufman JD, Grimes JM, Stuart DI, Steven AC, Wingfield PT (2010). Generation and characterization of a chimeric rabbit/human Fab for co-crystallization of HIV-1 Rev. J Mol Biol  397, 697-708.   https://doi.org/10.1016/j.jmb.2010.01.061",https://intramural.nih.gov/search/searchview.taf?ipid=68340
214,BC010648-07,"October 01, 2010 -  September 30, 2011","Discovery of Drugs, Targets, and Target Strategies for Immunotherapy of CLL",Christoph  Rader; PhD,NULL,"Experimental Transplantation and Immunology Branch, NCI","Sivasubramanian  Baskar|Hema  Dave|Steven  Pavletic; MD, MS|Brian Carl Shaffer; MD","JOHN  BYRD (The Ohio State University)|NICHOLAS  CHIORAZZI (The Feinstein Institute for Medical Research)|DANIEL  LEAHY (Department of Biophysics and Biophysical Chemistry, Johns Hopkins University School of Medicine)|Jeffrey A. Medin; PhD (University of Toronto)|Stanley R Riddell (Fred Hutchinson Cancer Research Center)","Wyndham H Wilson; MD, PhD (Lymphoid Malignancies Branch)|Ira H Pastan; MD (Molecular Biology Section)|Alan S Wayne; MD (Pediatric Oncology Branch)","Adrian U Wiestner; MD, PhD (NHLBI)","1. Rader C (2011) Monoclonal antibody therapy for cancer, in Experimental and Applied Immunotherapy., pp. 59-83.|2. Bagnara D, Kaufman MS, Calissano C, Marsilio S, Patten PE, Simone R, Chum P, Yan XJ, Allen SL, Kolitz JE, Baskar S, Rader C, Mellstedt H, Rabbani H, Lee A, Gregersen PK, Rai KR, Chiorazzi N (2011). A novel adoptive transfer model of chronic lymphocytic leukemia suggests a key role for T lymphocytes in the disease. Blood  117, 5463-72.   https://doi.org/10.1182/blood-2010-12-324210|3. Beerli RR, Rader C (2010). Mining human antibody repertoires. MAbs  2, 365-78.   https://doi.org/10.4161/mabs.12187|4. Hudecek M, Schmitt TM, Baskar S, Lupo-Stanghellini MT, Nishida T, Yamamoto TN, Bleakley M, Turtle CJ, Chang WC, Greisman HA, Wood B, Maloney DG, Jensen MC, Rader C, Riddell SR (2010). The B-cell tumor-associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptor. Blood  116, 4532-41.   https://doi.org/10.1182/blood-2010-05-283309|5. Lapalombella R, Andritsos L, Liu Q, May SE, Browning R, Pham LV, Blum KA, Blum W, Ramanunni A, Raymond CA, Smith LL, Lehman A, Mo X, Jarjoura D, Chen CS, Ford R, Rader C, Muthusamy N, Johnson AJ, Byrd JC (2010). Lenalidomide treatment promotes CD154 expression on CLL cells and enhances production of antibodies by normal B cells through a PI3-kinase-dependent pathway. Blood  115, 2619-29.   https://doi.org/10.1182/blood-2009-09-242438|6. Pérez-Galán P, Mora-Jensen H, Weniger MA, Shaffer AL, Rizzatti EG, Chapman CM, Mo CC, Stennett LS, Rader C, Liu P, Raghavachari N, Stetler-Stevenson M, Yuan C, Pittaluga S, Maric I, Dunleavy KM, Wilson WH, Staudt LM, Wiestner A (2011). Bortezomib resistance in mantle cell lymphoma is associated with plasmacytic differentiation. Blood  117, 542-52.   https://doi.org/10.1182/blood-2010-02-269514|7. Salerno E, Yuan Y, Scaglione BJ, Marti G, Jankovic A, Mazzella F, Laurindo MF, Despres D, Baskar S, Rader C, Raveche E (2010) The New Zealand black mouse as a model for the development and progression of chronic lymphocytic leukemia. Cytometry B Clin Cytom 78 Suppl 1:S98-109.|8. Yang J, Baskar S, Kwong KY, Kennedy MG, Wiestner A, Rader C (2011). Therapeutic potential and challenges of targeting receptor tyrosine kinase ROR1 with monoclonal antibodies in B-cell malignancies. PLoS One  6, e21018.   https://doi.org/10.1371/journal.pone.0021018|9. Rader C, Yang J (submitted in 2011) Chimeric Rabbit/human Ror1 Antibodies. Patents issued: 9,758,586 (US in 2017); 2011336650 (AU in 2017); 2646469 (DE in 2018); 2646469 (EP in 2018); 2646469 (ES in 2018); 2646469 (FR in 2018); 2646469 (GB in 2018); 2646469 (IT in 2018). Patents pending: PCT/US2011/062670 (PC application); 15/700,457 (US application); 2818992 (CA application).",https://intramural.nih.gov/search/searchview.taf?ipid=68341
215,BC010649-07,"October 01, 2010 -  September 30, 2011",Immunotherapy Strategies for Gastrointestinal and Hepatocellular Cancer,Udai S Kammula,NULL,"Surgery Branch, NCI",Biman  Paria|Vishant Aswin Ramadorai,NULL,"Snorri S. Thorgeirsson; MD, PhD (Laboratory of Experimental Carcinogenesis)|Xin Wei Wang; PhD (Molecular Genetics and Carcinogenesis Section)",Francesco M. Marincola; MD (CC),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68332
216,BC010652-07,"October 01, 2010 -  September 30, 2011",Lipid-based Nanocapsules and Triggered Chemotherapy,Robert  Blumenthal; PhD|IRP Faculty Profile,NULL,"Center for Cancer Research Nanobiology Program, NCI",Abdul  Akram|Kshitij  Gupta|Eliahu  Heldman|Thy N Le|Anu  Puri; PhD|Yossef  Raviv|Show all 9,Sara  Grinberg (Ben Gurion University)|Angela  Hight Walker|Jeeseong  Hwang (NIST)|Michael  Nantz (University of Louisville)|Paul  Wang,Joseph John Barchi (Chemical Biology Laboratory)|Jacek  Capala; PhD (Radiation Oncology Branch)|Sriram  Subramaniam; PhD (Laboratory of Cell Biology)|Stephen J Lockett; PhD (Office Of The Director)|Timothy D Veenstra (Office Of The Director)|Scott E McNeil (Office Of The Director),Bradford J Wood; MD (CC) |Xiaoyuan  Chen; PhD (NIBIB),"1. Loomis K, Smith B, Feng Y, Garg H, Yavlovich A, Campbell-Massa R, Dimitrov DS, Blumenthal R, Xiao X, Puri A (2010). Specific targeting to B cells by lipid-based nanoparticles conjugated with a novel CD22-ScFv. Exp Mol Pathol  88, 238-49.   https://doi.org/10.1016/j.yexmp.2010.01.006|2. Yavlovich A, Smith B, Gupta K, Blumenthal R, Puri A (2010). Light-sensitive lipid-based nanoparticles for drug delivery: design principles and future considerations for biological applications. Mol Membr Biol  27, 364-81.   https://doi.org/10.3109/09687688.2010.507788",https://intramural.nih.gov/search/searchview.taf?ipid=68318
217,BC010654-07,"October 01, 2010 -  September 30, 2011",Lymphatic Imaging,Peter L Choyke; MD|IRP Faculty Profile,NULL,"Molecular Imaging Program, NCI",Dagane  Daar|Hisataka  Kobayashi|Yolanda L Mckinney|Makoto  Mitsunaga|Takahito  Nakajima; PhD|Ismail Baris Turkbey,NULL,Martin W Brechbiel; PhD (Radiation Oncology Branch),NULL,"1. Bumb A, Brechbiel MW, Choyke P (2010). Macromolecular and dendrimer-based magnetic resonance contrast agents. Acta Radiol  51, 751-67.   https://doi.org/10.3109/02841851.2010.491091|2. Bumb A, Regino CA, Egen JG, Bernardo M, Dobson PJ, Germain RN, Choyke PL, Brechbiel MW (2011). Trafficking of a dual-modality magnetic resonance and fluorescence imaging superparamagnetic iron oxide-based nanoprobe to lymph nodes. Mol Imaging Biol  13, 1163-72.   https://doi.org/10.1007/s11307-010-0424-8|3. Bumb A, Regino CA, Perkins MR, Bernardo M, Ogawa M, Fugger L, Choyke PL, Dobson PJ, Brechbiel MW (2010). Preparation and characterization of a magnetic and optical dual-modality molecular probe. Nanotechnology  21, 175704.   https://doi.org/10.1088/0957-4484/21/17/175704|4. Kojima C, Turkbey B, Ogawa M, Bernardo M, Regino CA, Bryant LH, Choyke PL, Kono K, Kobayashi H (2011). Dendrimer-based MRI contrast agents: the effects of PEGylation on relaxivity and pharmacokinetics. Nanomedicine  7, 1001-8.   https://doi.org/10.1016/j.nano.2011.03.007|5. Kosaka N, McCann TE, Mitsunaga M, Choyke PL, Kobayashi H (2010). Real-time optical imaging using quantum dot and related nanocrystals. Nanomedicine (Lond)  5, 765-76.   https://doi.org/10.2217/nnm.10.49|6. Kosaka N, Mitsunaga M, Bhattacharyya S, Miller SC, Choyke PL, Kobayashi H (2011). Self-illuminating in vivo lymphatic imaging using a bioluminescence resonance energy transfer quantum dot nano-particle. Contrast Media Mol Imaging  6, 55-9.   https://doi.org/10.1002/cmmi.395|7. Ogawa M, Regino CA, Marcelino B, Williams M, Kosaka N, Bryant LH, Choyke PL, Kobayashi H (2010). New nanosized biocompatible MR contrast agents based on lysine-dendri-graft macromolecules. Bioconjug Chem  21, 955-60.   https://doi.org/10.1021/bc9005442|8. Rosenblum LT, Kosaka N, Mitsunaga M, Choyke PL, Kobayashi H (2010). In vivo molecular imaging using nanomaterials: general in vivo characteristics of nano-sized reagents and applications for cancer diagnosis. Mol Membr Biol  27, 274-85.   https://doi.org/10.3109/09687688.2010.481640|9. Sena LM, Fishman SJ, Jenkins KJ, Xu H, Brechbiel MW, Regino CA, Kosaka N, Bernardo M, Choyke PL, Kobayashi H (2010). Magnetic resonance lymphangiography with a nano-sized gadolinium-labeled dendrimer in small and large animal models. Nanomedicine (Lond)  5, 1183-91.   https://doi.org/10.2217/nnm.10.70|10. Tan E, Weiss BM, Mena E, Korde N, Choyke PL, Landgren O (2011). Current and future imaging modalities for multiple myeloma and its precursor states. Leuk Lymphoma  52, 1630-40.   https://doi.org/10.3109/10428194.2011.573036",https://intramural.nih.gov/search/searchview.taf?ipid=68325
218,BC010655-07,"October 01, 2010 -  September 30, 2011",Prostate Cancer Imaging,Peter L Choyke; MD|IRP Faculty Profile,NULL,"Molecular Imaging Program, NCI",Stephen Scott Adler|Harsh Kumar Agarwal|Marcelino  Bernardo|Dagane  Daar|Philip Charles Eclarinal|Hisataka  Kobayashi|Show all 18,Kathleen  Marcozzi (Siemens Medical Systems)|Anwar  Padhani (Mt Vernon Hospital)|Yasuteru  Urano|Jeff  Winick (GE Healthcare),William Marston Linehan; MD (Urologic Oncology Branch)|Kevin A Camphausen; MD (Radiation Oncology Branch)|William Laurence Dahut; MD (Medical Oncology Branch)|Peter A Pinto; MD (Urologic Oncology Branch)|Aradhana  Kaushal (Radiation Oncology Branch)|Maria  Merino; PhD (Laboratory of Pathology),"Bradford J Wood; MD (CC) |Thomas J Pohida; MS (CIT) |Gary Leonard Griffiths; BSc, PhD (NHLBI)","1. Bouchelouche K, Choyke PL, Capala J (2010). Prostate specific membrane antigen- a target for imaging and therapy with radionuclides. Discov Med  9, 55-61.|2. Bouchelouche K, Turkbey B, Choyke P, Capala J (2010). Imaging prostate cancer: an update on positron emission tomography and magnetic resonance imaging. Curr Urol Rep  11, 180-90.   https://doi.org/10.1007/s11934-010-0105-9|3. Housri N, Ning H, Ondos J, Choyke P, Camphausen K, Citrin D, Arora B, Shankavaram U, Kaushal A (2011). Parameters favorable to intraprostatic radiation dose escalation in men with localized prostate cancer. Int J Radiat Oncol Biol Phys  80, 614-20.   https://doi.org/10.1016/j.ijrobp.2010.06.050|4. Turkbey B, Pinto PA, Mani H, Bernardo M, Pang Y, McKinney YL, Khurana K, Ravizzini GC, Albert PS, Merino MJ, Choyke PL (2010). Prostate cancer: value of multiparametric MR imaging at 3 T for detection--histopathologic correlation. Radiology  255, 89-99.   https://doi.org/10.1148/radiol.09090475|5. Turkbey B, Xu S, Kruecker J, Locklin J, Pang Y, Bernardo M, Merino MJ, Wood BJ, Choyke PL, Pinto PA (2011). Documenting the location of prostate biopsies with image fusion. BJU Int  107, 53-7.   https://doi.org/10.1111/j.1464-410X.2010.09483.x|6. Verma S, Rajesh A, Fütterer JJ, Turkbey B, Scheenen TW, Pang Y, Choyke PL, Kurhanewicz J (2010). Prostate MRI and 3D MR spectroscopy: how we do it. AJR Am J Roentgenol  194, 1414-26.   https://doi.org/10.2214/AJR.10.4312",https://intramural.nih.gov/search/searchview.taf?ipid=68326
219,BC010656-07,"October 01, 2010 -  September 30, 2011",Growth Factor Imaging,Peter L Choyke; MD|IRP Faculty Profile,NULL,"Molecular Imaging Program, NCI",Stephen Scott Adler|Marcelino  Bernardo|Dagane  Daar|Philip Charles Eclarinal|Elaine Marie Jagoda; MS|Hisataka  Kobayashi|Show all 19,NULL,"William Marston Linehan; MD (Urologic Oncology Branch)|Kevin A Camphausen; MD (Radiation Oncology Branch)|Peter A Pinto; MD (Urologic Oncology Branch)|Giuseppe  Giaccone; MD (Medical Oncology Branch)|Shivaani  Kummar; PhD (Office of the Director)|Wyndham H Wilson; MD, PhD (Lymphoid Malignancies Branch)","Gary Leonard Griffiths; BSc, PhD (NHLBI)","1. Annunziata CM, Walker AJ, Minasian L, Yu M, Kotz H, Wood BJ, Calvo K, Choyke P, Kimm D, Steinberg SM, Kohn EC (2010). Vandetanib, designed to inhibit VEGFR2 and EGFR signaling, had no clinical activity as monotherapy for recurrent ovarian cancer and no detectable modulation of VEGFR2. Clin Cancer Res  16, 664-72.   https://doi.org/10.1158/1078-0432.CCR-09-2308|2. Kobayashi H, Choyke PL (2011). Target-cancer-cell-specific activatable fluorescence imaging probes: rational design and in vivo applications. Acc Chem Res  44, 83-90.   https://doi.org/10.1021/ar1000633|3. Kosaka N, Mitsunaga M, Longmire MR, Choyke PL, Kobayashi H (2011). Near infrared fluorescence-guided real-time endoscopic detection of peritoneal ovarian cancer nodules using intravenously injected indocyanine green. Int J Cancer  129, 1671-7.   https://doi.org/10.1002/ijc.26113|4. McCann TE, Kosaka N, Mitsunaga M, Choyke PL, Gildersleeve JC, Kobayashi H (2010). Biodistribution and excretion of monosaccharide-albumin conjugates measured with in vivo near-infrared fluorescence imaging. Bioconjug Chem  21, 1925-32.   https://doi.org/10.1021/bc100313p|5. Nakajima T, Mitsunaga M, Bander NH, Heston WD, Choyke PL, Kobayashi H (2011). Targeted, activatable, in vivo fluorescence imaging of prostate-specific membrane antigen (PSMA) positive tumors using the quenched humanized J591 antibody-indocyanine green (ICG) conjugate. Bioconjug Chem  22, 1700-5.   https://doi.org/10.1021/bc2002715|6. Ogawa M, Kosaka N, Regino CA, Mitsunaga M, Choyke PL, Kobayashi H (2010). High sensitivity detection of cancer in vivo using a dual-controlled activation fluorescent imaging probe based on H-dimer formation and pH activation. Mol Biosyst  6, 888-93.   https://doi.org/10.1039/b917876g",https://intramural.nih.gov/search/searchview.taf?ipid=68327
220,BC010657-07,"October 01, 2010 -  September 30, 2011",Intracellular In vivo Imaging,Peter L Choyke; MD|IRP Faculty Profile,NULL,"Molecular Imaging Program, NCI",Hisataka  Kobayashi|Noriko  Sato; PhD,NULL,NULL,NULL,"1. Kobayashi H, Longmire MR, Ogawa M, Choyke PL (2011). Rational chemical design of the next generation of molecular imaging probes based on physics and biology: mixing modalities, colors and signals. Chem Soc Rev  40, 4626-48.   https://doi.org/10.1039/c1cs15077d|2. Kosaka N, Mitsunaga M, Longmire MR, Choyke PL, Kobayashi H (2011). Near infrared fluorescence-guided real-time endoscopic detection of peritoneal ovarian cancer nodules using intravenously injected indocyanine green. Int J Cancer  129, 1671-7.   https://doi.org/10.1002/ijc.26113|3. Regino CA, Ogawa M, Alford R, Wong KJ, Kosaka N, Williams M, Feild BJ, Takahashi M, Choyke PL, Kobayashi H (2010). Two-step synthesis of galactosylated human serum albumin as a targeted optical imaging agent for peritoneal carcinomatosis. J Med Chem  53, 1579-86.   https://doi.org/10.1021/jm901228u",https://intramural.nih.gov/search/searchview.taf?ipid=68328
221,BC010660-07,"October 01, 2010 -  September 30, 2011",The Molecular Profile of Prostate Tumors in Smokers,Stefan  Ambs|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Tiffany Marie Howe,"William  Isaacs; PhD (Department of Urology, Johns Hopkins School of Medicine)|Jun  Luo (Johns Hopkins University)",Arthur A Hurwitz (Laboratory of Molecular Immunoregulation)|Robert H Stephens (Business Operations Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68314
222,BC010661-07,"October 01, 2010 -  September 30, 2011",Vaccine and Drug Combination Therapy for Human Cancers,James W Hodge; PhD|IRP Faculty Profile,NULL,"Laboratory of Tumor Immunology and Biology, NCI",Andressa  Ardiani|Jeffrey  Schlom; PhD|Anna Ruth Kwilas; PhD|Marion G Taylor,"Soldano  Ferrone (University of Pittsburgh)|Alex  Franzusoff (Research and Development, GlobeImmune)",NULL,NULL,"1. Farsaci B, Sabzevari H, Higgins JP, Di Bari MG, Takai S, Schlom J, Hodge JW (2010). Effect of a small molecule BCL-2 inhibitor on immune function and use with a recombinant vaccine. Int J Cancer  127, 1603-13.   https://doi.org/10.1002/ijc.25177",https://intramural.nih.gov/search/searchview.taf?ipid=68343
223,BC010666-07,"October 01, 2010 -  September 30, 2011",Cancer Therapy Clinical Trials Using Novel Recombinant Vaccines,"James L Gulley; MD, PhD|IRP Faculty Profile",NULL,"Laboratory of Tumor Immunology and Biology, NCI",Marijo  Bilusic|Bonnie L Casey|Christopher Ryan Heery; MD|Jennifer L Marte|Jeffrey  Schlom; PhD|Sheri A Mcmahon|Show all 12,"William  Carson (Molecular Virology, Immunology and Medical Genetics, Ohio State University)|Robert  DiPaola (The Cancer Institute of New Jersey)|John  Marshall|Douglas  McNeel (University of Wisconsin)",William Marston Linehan; MD (Urologic Oncology Branch)|William Laurence Dahut; MD (Medical Oncology Branch)|William D Figg; PharmD (Medical Oncology Branch)|Peter A Pinto; MD (Urologic Oncology Branch)|Ravi  Madan (Medical Oncology Branch)|Andrea Borghese Apolo (Medical Oncology Branch),NULL,"1. Gulley J, Arlen P, Hodge J, Schlom J (2010) Vaccines and Immunostimulants  Chapter 57, in Cancer Medicine 8., pp. 725-736.|2. Madan R, Gulley J, Celestin J, Arlen P, Schlom J (2010) Cancer immunology, immunotherapeutics and vaccine approaches, in Drug Management of Prostate Cancer., pp. 305-319.|3. Cereda V, Vergati M, Huen NY, di Bari MG, Jochems C, Intrivici C, Gulley JL, Apelian D, Schlom J, Tsang KY (2011). Maturation of human dendritic cells with Saccharomyces cerevisiae (yeast) reduces the number and function of regulatory T cells and enhances the ratio of antigen-specific effectors to regulatory T cells. Vaccine  29, 4992-9.   https://doi.org/10.1016/j.vaccine.2011.04.101|4. Gulley J (2011) New frontiers in therapy for metastatic prostate cancer (editorial). Drug Discov Today: Ther Strategies 10:743-53.|5. Gulley JL, Arlen PM, Madan RA, Tsang KY, Pazdur MP, Skarupa L, Jones JL, Poole DJ, Higgins JP, Hodge JW, Cereda V, Vergati M, Steinberg SM, Halabi S, Jones E, Chen C, Parnes H, Wright JJ, Dahut WL, Schlom J (2010). Immunologic and prognostic factors associated with overall survival employing a poxviral-based PSA vaccine in metastatic castrate-resistant prostate cancer. Cancer Immunol Immunother  59, 663-74.   https://doi.org/10.1007/s00262-009-0782-8|6. Kantoff PW, Schuetz TJ, Blumenstein BA, Glode LM, Bilhartz DL, Wyand M, Manson K, Panicali DL, Laus R, Schlom J, Dahut WL, Arlen PM, Gulley JL, Godfrey WR (2010). Overall survival analysis of a phase II randomized controlled trial of a Poxviral-based PSA-targeted immunotherapy in metastatic castration-resistant prostate cancer. J Clin Oncol  28, 1099-105.   https://doi.org/10.1200/JCO.2009.25.0597|7. Madan R, Aragon-Ching J, Gulley J, Dahut W (2011) From clinical trials to clinical practice: therapeutic cancer vaccines for the treatment of prostate cancer. Expert Rev. Vaccines, in press.|8. Madan RA, Gulley JL (2010). The current and emerging role of immunotherapy in prostate cancer. Clin Genitourin Cancer  8, 10-6.   https://doi.org/10.3816/CGC.2010.n.002|9. Madan RA, Gulley JL, Fojo T, Dahut WL (2010). Therapeutic cancer vaccines in prostate cancer: the paradox of improved survival without changes in time to progression. Oncologist  15, 969-75.   https://doi.org/10.1634/theoncologist.2010-0129|10. Madan RA, Mohebtash M, Schlom J, Gulley JL (2010). Therapeutic vaccines in metastatic castration-resistant prostate cancer: principles in clinical trial design. Expert Opin Biol Ther  10, 19-28.   https://doi.org/10.1517/14712590903321421",https://intramural.nih.gov/search/searchview.taf?ipid=68342
224,BC010668-07,"October 01, 2010 -  September 30, 2011",Instrumentation for microSPECT and microPET imaging,Peter L Choyke; MD|IRP Faculty Profile,NULL,"Molecular Imaging Program, NCI",Stephen Scott Adler|Michael  Green|Jurgen  Seidel; PhD,NULL,NULL,Thomas J Pohida; MS (CIT),"1. Kakareka JW, McCann TE, Kosaka N, Mitsunaga M, Morgan NY, Pohida TJ, Choyke PL, Kobayashi H (2011). A portable fluorescence camera for testing surgical specimens in the operating room: description and early evaluation. Mol Imaging Biol  13, 862-7.   https://doi.org/10.1007/s11307-010-0438-2|2. Kobayashi H, Longmire MR, Ogawa M, Choyke PL (2011). Rational chemical design of the next generation of molecular imaging probes based on physics and biology: mixing modalities, colors and signals. Chem Soc Rev  40, 4626-48.   https://doi.org/10.1039/c1cs15077d|3. Xi W, Seidel J, Kakareka JW, Pohida TJ, Milenic DE, Proffitt J, Majewski S, Weisenberger AG, Green MV, Choyke PL (2010). MONICA: a compact, portable dual gamma camera system for mouse whole-body imaging. Nucl Med Biol  37, 245-53.   https://doi.org/10.1016/j.nucmedbio.2009.12.003",https://intramural.nih.gov/search/searchview.taf?ipid=68324
225,BC010670-07,"October 01, 2010 -  September 30, 2011",Molecular-Targeted Radiation Therapy,Norman Norman Coleman; MD|IRP Faculty Profile,NULL,"Radiation Research Program, NCI",Molykutty J Aryankalayil|Adeola Yetunde Makinde|Sanjeewani T Palayoor,Lance  Liotta (George Mason University)|Emanuel  Petricoin (George Mason University),James B Mitchell; PhD (Radiation Biology Branch)|Sunghan  Yoo (Molecular Radiation Therapeutics Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68312
226,BC010671-07,"October 01, 2010 -  September 30, 2011",Genetic Analysis of T-cell Differentiation,"Remy J Bosselut; MD, PhD|IRP Faculty Profile",NULL,"Laboratory of Immune Cell Biology, NCI",Andrea Christine Bohrer|Jong Kyong  Kim|Sugata  Manna|Melanie S Vacchio; PhD|Yumei  Xiong; PhD,NULL,Lionel  Feigenbaum (Office Of The Director)|Lino  Tessarollo (Neural Development Section)|Alfred  Singer; MD (Experimental Immunology Branch),"William E Paul; MD (NIAID) |Paul E Love; MD, PhD (NICHD) |Yasmine  Belkaid; PhD (NIAID) |Wanjun  Chen; PhD (NIDCR)","1. Carpenter AC, Bosselut R (2010). Decision checkpoints in the thymus. Nat Immunol  11, 666-73.   https://doi.org/10.1038/ni.1887|2. Wang L, Carr T, Xiong Y, Wildt KF, Zhu J, Feigenbaum L, Bendelac A, Bosselut R (2010). The sequential activity of Gata3 and Thpok is required for the differentiation of CD1d-restricted CD4+ NKT cells. Eur J Immunol  40, 2385-90.   https://doi.org/10.1002/eji.201040534|3. Wang L, Xiong Y, Bosselut R (2010). Tenuous paths in unexplored territory: From T cell receptor signaling to effector gene expression during thymocyte selection. Semin Immunol  22, 294-302.   https://doi.org/10.1016/j.smim.2010.04.013",https://intramural.nih.gov/search/searchview.taf?ipid=68311
227,BC010675-07,"October 01, 2010 -  September 30, 2011",Development of a Carbohydrate Microarray,Jeffrey  Gildersleeve|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",David W Farnsworth|Saddam Musleh Muthana; PhD|Joseph John Barchi|Yalong  Zhang,NULL,John T. Simpson; PhD (Office Of The Director)|Luis G Rodriguez (Office Of The Director),NULL,"1. Campbell C, Zhang Y, Gildersleeve J (2010) Construction and Use of Glycan Microarrays. Curr. Protocols. Chem. Biol. 2:37-53.|2. Ludek OR, Gu W, Gildersleeve JC (2010). Activation of glycosyl trichloroacetimidates with perchloric acid on silica (HClO(4)-SiO(2)) provides enhanced alpha-selectivity. Carbohydr Res  345, 2074-8.   https://doi.org/10.1016/j.carres.2010.07.030|3. Zhang Y, Campbell C, Li Q, Gildersleeve JC (2010). Multidimensional glycan arrays for enhanced antibody profiling. Mol Biosyst  6, 1583-91.   https://doi.org/10.1039/c002259d|4. Zhang Y, Li Q, Rodriguez LG, Gildersleeve JC (2010). An array-based method to identify multivalent inhibitors. J Am Chem Soc  132, 9653-62.   https://doi.org/10.1021/ja100608w",https://intramural.nih.gov/search/searchview.taf?ipid=68330
228,BC010677-07,"October 01, 2010 -  September 30, 2011",NADPH Oxidase 1: A Novel Target for Colon Cancer Therapy,James Halpern Doroshow|IRP Faculty Profile,NULL,"Office of the Director, NCI","Guojian  Jiang; MD|Joseph E Tomaszewski|Agnes  Juhasz|Jiamo  Lu; MD, MPH, MHS",NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68329
229,BC010678-07,"October 01, 2010 -  September 30, 2011",Keratinocyte Growth Factor (KGF): Clinical Applications,"Jeffrey S Rubin; MD, PhD",NULL,"Laboratory of Cellular and Molecular Biology, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68344
230,BC010680-07,"October 01, 2010 -  September 30, 2011",Characterization of the hCenexin-Plk1 interaction at the centrosomes,Kyung  Lee; PhD|IRP Faculty Profile,NULL,"Chemistry Section, NCI",Kyung Ho  Lee,NULL,Timothy D Veenstra (Office Of The Director),NULL,"1. Huong PT, Moon DO, Kim SO, Kim KE, Jeong SJ, Lee KW, Lee KS, Jang JH, Erikson RL, Ahn JS, Kim BY (2011). Proteasome inhibitor-I enhances tunicamycin-induced chemosensitization of prostate cancer cells through regulation of NF-κB and CHOP expression. Cell Signal  23, 857-65.   https://doi.org/10.1016/j.cellsig.2011.01.010|2. Park JE, Erikson RL, Lee KS (2011). Feed-forward mechanism of converting biochemical cooperativity to mitotic processes at the kinetochore plate. Proc Natl Acad Sci U S A  108, 8200-5.   https://doi.org/10.1073/pnas.1102020108|3. Park JE, Soung NK, Johmura Y, Kang YH, Liao C, Lee KH, Park CH, Nicklaus MC, Lee KS (2010). Polo-box domain: a versatile mediator of polo-like kinase function. Cell Mol Life Sci  67, 1957-70.   https://doi.org/10.1007/s00018-010-0279-9",https://intramural.nih.gov/search/searchview.taf?ipid=68336
231,BC010681-07,"October 01, 2010 -  September 30, 2011",Development of anti-polo-box therapeutic agents,Kyung  Lee; PhD|IRP Faculty Profile,NULL,"Chemistry Section, NCI",Jung Eun  Park,Bo  Kim (Korea Research Institute of Bioscience and Biotechnology)|Michael  Yaffe (Massachusetts Institute of Technology),James  McMahon; PhD (Molecular Targets Laboratory)|Marc C Nicklaus (Chemical Biology Laboratory)|Alexander  Wlodawer; PhD (Macromolecular Crystallography Laboratory)|Stuart H Yuspa; MD (Laboratory of Cancer Biology and Genetics),NULL,"1. Liao C, Park JE, Bang JK, Nicklaus MC, Lee KS (2010). Exploring Potential Binding Modes of Small Drug-like Molecules to the Polo-Box Domain of Human Polo-like Kinase 1. ACS Med Chem Lett  1, 110-114.   https://doi.org/10.1021/ml100020e|2. Liu F, Park J, Qian W, Lim D, Yaffe M, Lee K, Burke T (2011) Serendipitous alkylation of a Plk-1 ligand uncovers a new binding channel. Nat Chem Biol, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=68337
232,BC010683-07,"October 01, 2010 -  September 30, 2011",Role of FH loss in development of HLRCC heriditary kidney cancer,Leonard  Neckers; PhD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI","Kristin  Eckfeld|William Marston Linehan; MD|Naoto  Miyajima; MD, PhD|Mehdi  Mollapour|Thomas L Prince|Bradley T Scroggins|Show all 9",YunJin  Jung (Pusan National University)|Sunil  Sudarshan,NULL,NULL,"1. Kong HS, Lee S, Beebe K, Scroggins B, Gupta G, Lee MJ, Jung YJ, Trepel J, Neckers L (2010). Emetine promotes von Hippel-Lindau-independent degradation of hypoxia-inducible factor-2α in clear cell renal carcinoma. Mol Pharmacol  78, 1072-8.   https://doi.org/10.1124/mol.110.066514|2. Linehan WM, Bratslavsky G, Pinto PA, Schmidt LS, Neckers L, Bottaro DP, Srinivasan R (2010). Molecular diagnosis and therapy of kidney cancer. Annu Rev Med  61, 329-43.   https://doi.org/10.1146/annurev.med.042808.171650|3. Sourbier C, Valera-Romero V, Giubellino A, Yang Y, Sudarshan S, Neckers L, Linehan WM (2010). Increasing reactive oxygen species as a therapeutic approach to treat hereditary leiomyomatosis and renal cell carcinoma. Cell Cycle  9, 4183-9.   https://doi.org/10.4161/cc.9.20.13458|4. Yang Y, Valera VA, Padilla-Nash HM, Sourbier C, Vocke CD, Vira MA, Abu-Asab MS, Bratslavsky G, Tsokos M, Merino MJ, Pinto PA, Srinivasan R, Ried T, Neckers L, Linehan WM (2010). UOK 262 cell line, fumarate hydratase deficient (FH-/FH-) hereditary leiomyomatosis renal cell carcinoma: in vitro and in vivo model of an aberrant energy metabolic pathway in human cancer. Cancer Genet Cytogenet  196, 45-55.   https://doi.org/10.1016/j.cancergencyto.2009.08.018",https://intramural.nih.gov/search/searchview.taf?ipid=68339
233,BC010692-07,"October 01, 2010 -  September 30, 2011",Significance of Marrow Karyotypes in Inherited Bone Marrow Failure Syndromes,Diane Carol Arthur; MD,John Carl Oberholtzer,"Laboratory of Pathology, NCI",Shannon I Skarshaug|Valerie M Zgonc,NULL,Blanche P Alter (Clinical Genetics Branch)|Neelam K Giri; MD (Clinical Genetics Branch)|Sharon Ann Savage (Clinical Genetics Branch),Irina  Maric; MD (CC),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68315
234,BC010696-07,"October 01, 2010 -  September 30, 2011",Study of Hereditary Renal and Other Familial Syndromes,Maria  Merino; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Linda S Wrathall|David D Roberts; PhD|Beatriz  Walter-rodriguez; MD|Maria  Tsokos; MD,NULL,William Marston Linehan; MD (Urologic Oncology Branch)|Peter A Pinto; MD (Urologic Oncology Branch),NULL,"1. Moore LE, Boffetta P, Karami S, Brennan P, Stewart PS, Hung R, Zaridze D, Matveev V, Janout V, Kollarova H, Bencko V, Navratilova M, Szeszenia-Dabrowska N, Mates D, Gromiec J, Holcatova I, Merino M, Chanock S, Chow WH, Rothman N (2010). Occupational trichloroethylene exposure and renal carcinoma risk: evidence of genetic susceptibility by reductive metabolism gene variants. Cancer Res  70, 6527-36.   https://doi.org/10.1158/0008-5472.CAN-09-4167|2. Valera VA, Li-Ning-T E, Walter BA, Roberts DD, Linehan WM, Merino MJ (2010). Protein expression profiling in the spectrum of renal cell carcinomas. J Cancer  1, 184-96.   https://doi.org/10.7150/jca.1.184|3. Wagner M, Browne HN, Marston Linehan W, Merino M, Babar N, Stratton P (2010). Lipid cell tumors in two women with von Hippel-Lindau syndrome. Obstet Gynecol  116 Suppl 2, 535-9.   https://doi.org/10.1097/AOG.0b013e3181e25458|4. Yang Y, Valera VA, Padilla-Nash HM, Sourbier C, Vocke CD, Vira MA, Abu-Asab MS, Bratslavsky G, Tsokos M, Merino MJ, Pinto PA, Srinivasan R, Ried T, Neckers L, Linehan WM (2010). UOK 262 cell line, fumarate hydratase deficient (FH-/FH-) hereditary leiomyomatosis renal cell carcinoma: in vitro and in vivo model of an aberrant energy metabolic pathway in human cancer. Cancer Genet Cytogenet  196, 45-55.   https://doi.org/10.1016/j.cancergencyto.2009.08.018",https://intramural.nih.gov/search/searchview.taf?ipid=68338
235,BC010698-07,"October 01, 2010 -  September 30, 2011",Developing Immunoablative Regimens for the Engraftment of Allogeneic HSCT,Michael R Bishop; MD,NULL,"Experimental Transplantation and Immunology Branch, NCI","Daniel H Fowler|Ronald E Gress; MD|Frances  Hakim; PhD|Christoph  Rader; PhD|Steven  Pavletic; MD, MS|Sivasubramanian  Baskar","Thea  Friedman (Hackensack University Medical Center)|Robert  Korngold (Cancer Center, Hackensack University)",Crystal L. Mackall; MD (Pediatric Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68317
236,BC010701-06,"October 01, 2010 -  September 30, 2011",Human Monoclonal Antibodies Against Cancer,Dimiter Stanchev Dimitrov; PhD,NULL,"Membrane Structure and Function Section, NCI",Weizao  Chen|Yang  Feng|John  Owens|Tianlei  Ying|Zhongyu  Zhu,NULL,Robert  Blumenthal; PhD (Center for Cancer Research Nanobiology Program)|Ira H Pastan; MD (Molecular Biology Section),NULL,"1. Chen W, Zhu Z, Feng Y, Dimitrov DS (2010). A large human domain antibody library combining heavy and light chain CDR3 diversity. Mol Immunol  47, 912-21.   https://doi.org/10.1016/j.molimm.2009.09.039|2. Dimitrov DS (2010). Therapeutic antibodies, vaccines and antibodyomes. MAbs  2, 347-56.   https://doi.org/10.4161/mabs.2.3.11779|3. Feng Y, Xiao X, Zhu Z, Dimitrov DS (2010). Identification and characterization of a novel agonistic anti-DR4 human monoclonal antibody. MAbs  2, 565-70.   https://doi.org/10.4161/mabs.2.5.12570|4. Loomis K, Smith B, Feng Y, Garg H, Yavlovich A, Campbell-Massa R, Dimitrov DS, Blumenthal R, Xiao X, Puri A (2010). Specific targeting to B cells by lipid-based nanoparticles conjugated with a novel CD22-ScFv. Exp Mol Pathol  88, 238-49.   https://doi.org/10.1016/j.yexmp.2010.01.006",https://intramural.nih.gov/search/searchview.taf?ipid=68350
237,BC010707-06,"October 01, 2010 -  September 30, 2011",Role of T regulatory suppression in autoimmunity and cancer,Joost J Oppenheim; MD|IRP Faculty Profile,NULL,"Laboratory of Molecular Immunoregulation, NCI",Xin  Chen|Ola Mae Zack Howard|Anna Lee  Trivett,"Robert  Goldman (Peprotech)|Daniela  Maennel (Immunology, University of Regensburg)",Yinling  Hu (Laboratory of Experimental Immunology),NULL,"1. Chen X, Oppenheim JJ (2011). Contrasting effects of TNF and anti-TNF on the activation of effector T cells and regulatory T cells in autoimmunity. FEBS Lett  585, 3611-8.   https://doi.org/10.1016/j.febslet.2011.04.025|2. Chen X, Oppenheim JJ (2011). Resolving the identity myth: key markers of functional CD4+FoxP3+ regulatory T cells. Int Immunopharmacol  11, 1489-96.   https://doi.org/10.1016/j.intimp.2011.05.018|3. Chen X, Oppenheim JJ (2011). The phenotypic and functional consequences of tumour necrosis factor receptor type 2 expression on CD4(+) FoxP3(+) regulatory T cells. Immunology  133, 426-33.   https://doi.org/10.1111/j.1365-2567.2011.03460.x|4. Hamano R, Huang J, Yoshimura T, Oppenheim JJ, Chen X (2011). TNF optimally activatives regulatory T cells by inducing TNF receptor superfamily members TNFR2, 4-1BB and OX40. Eur J Immunol  41, 2010-20.   https://doi.org/10.1002/eji.201041205",https://intramural.nih.gov/search/searchview.taf?ipid=68354
238,BC010708-06,"October 01, 2010 -  September 30, 2011",Consequences of receptor cross talk on inflammation and algesia,Joost J Oppenheim; MD|IRP Faculty Profile,NULL,"Laboratory of Molecular Immunoregulation, NCI",Ola Mae Zack Howard|Anna Lee  Trivett|Feng  Wei,NULL,"Dennis M Klinman; MD, PhD (Laboratory of Experimental Immunology)",Jeffrey  Cohen; MD (NIAID),"1. Qi J, Buzas K, Fan H, Cohen JI, Wang K, Mont E, Klinman D, Oppenheim JJ, Howard OM (2011). Painful pathways induced by TLR stimulation of dorsal root ganglion neurons. J Immunol  186, 6417-26.   https://doi.org/10.4049/jimmunol.1001241|2. Song C, Rahim RT, Davey PC, Bednar F, Bardi G, Zhang L, Zhang N, Oppenheim JJ, Rogers TJ (2011). Protein kinase Czeta mediates micro-opioid receptor-induced cross-desensitization of chemokine receptor CCR5. J Biol Chem  286, 20354-65.   https://doi.org/10.1074/jbc.M110.177303",https://intramural.nih.gov/search/searchview.taf?ipid=68355
239,BC010709-06,"October 01, 2010 -  September 30, 2011",An Exploratory Study of Biologic and Pathophysiologic Efects of Radiation Therap,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Robyn S Bent|Pamela  Wolters|Sean Joseph Hipp,NULL,Kevin A Camphausen; MD (Radiation Oncology Branch)|Deborah E Citrin (Radiation Oncology Branch)|Aradhana  Kaushal (Radiation Oncology Branch),"Carlo  Pierpaoli; MD, PhD (NICHD)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68383
240,BC010714-06,"October 01, 2010 -  September 30, 2011",Angiogenesis imaging,Peter L Choyke; MD|IRP Faculty Profile,NULL,"Molecular Imaging Program, NCI",Stephen Scott Adler|Harsh Kumar Agarwal|Marcelino  Bernardo|Dagane  Daar|Philip Charles Eclarinal|Elaine Marie Jagoda; MS|Show all 20,Frederick  Giesel (University of Heidelberg)|Michael  Knopp (Ohio State University)|Anwar  Padhani (Mt Vernon Hospital)|Jeff  Winick (GE Healthcare),William Marston Linehan; MD (Urologic Oncology Branch)|William Laurence Dahut; MD (Medical Oncology Branch)|Peter A Pinto; MD (Urologic Oncology Branch)|Giuseppe  Giaccone; MD (Medical Oncology Branch)|Shivaani  Kummar; PhD (Office of the Director)|Ola Anders Landgren (Medical Oncology Branch),"David M Thomasson; PhD (NIAID) |Thomas J Pohida; MS (CIT) |Gary Leonard Griffiths; BSc, PhD (NHLBI) |Chang Hum  Paik; PhD (CC)","1. Annunziata CM, Walker AJ, Minasian L, Yu M, Kotz H, Wood BJ, Calvo K, Choyke P, Kimm D, Steinberg SM, Kohn EC (2010). Vandetanib, designed to inhibit VEGFR2 and EGFR signaling, had no clinical activity as monotherapy for recurrent ovarian cancer and no detectable modulation of VEGFR2. Clin Cancer Res  16, 664-72.   https://doi.org/10.1158/1078-0432.CCR-09-2308|2. Choyke PL (2011). Pilot study of FPPRGD2 for imaging α(v)β(3) integrin--how integral are integrins? Radiology  260, 1-2.   https://doi.org/10.1148/radiol.11110740|3. Choyke PL (2011). Science to practice: angiogenic marker expression during tumor growth--can targeted US microbubbles help monitor molecular changes in the microvasculature? Radiology  258, 655-6.   https://doi.org/10.1148/radiol.102314|4. Kelly RJ, Rajan A, Force J, Lopez-Chavez A, Keen C, Cao L, Yu Y, Choyke P, Turkbey B, Raffeld M, Xi L, Steinberg SM, Wright JJ, Kummar S, Gutierrez M, Giaccone G (2011). Evaluation of KRAS mutations, angiogenic biomarkers, and DCE-MRI in patients with advanced non-small-cell lung cancer receiving sorafenib. Clin Cancer Res  17, 1190-9.   https://doi.org/10.1158/1078-0432.CCR-10-2331|5. Kojima C, Turkbey B, Ogawa M, Bernardo M, Regino CA, Bryant LH, Choyke PL, Kono K, Kobayashi H (2011). Dendrimer-based MRI contrast agents: the effects of PEGylation on relaxivity and pharmacokinetics. Nanomedicine  7, 1001-8.   https://doi.org/10.1016/j.nano.2011.03.007|6. Kummar S, Gutierrez ME, Chen A, Turkbey IB, Allen D, Horneffer YR, Juwara L, Cao L, Yu Y, Kim YS, Trepel J, Chen H, Choyke P, Melillo G, Murgo AJ, Collins J, Doroshow JH (2011). Phase I trial of vandetanib and bevacizumab evaluating the VEGF and EGF signal transduction pathways in adults with solid tumours and lymphomas. Eur J Cancer  47, 997-1005.   https://doi.org/10.1016/j.ejca.2010.12.016|7. Mena E, Choyke P, Tan E, Landgren O, Kurdziel K (2011). Molecular imaging in myeloma precursor disease. Semin Hematol  48, 22-31.   https://doi.org/10.1053/j.seminhematol.2010.11.006|8. Ogawa M, Regino CA, Marcelino B, Williams M, Kosaka N, Bryant LH, Choyke PL, Kobayashi H (2010). New nanosized biocompatible MR contrast agents based on lysine-dendri-graft macromolecules. Bioconjug Chem  21, 955-60.   https://doi.org/10.1021/bc9005442|9. Tan E, Weiss BM, Mena E, Korde N, Choyke PL, Landgren O (2011). Current and future imaging modalities for multiple myeloma and its precursor states. Leuk Lymphoma  52, 1630-40.   https://doi.org/10.3109/10428194.2011.573036|10. Turkbey B, Pinto PA, Mani H, Bernardo M, Pang Y, McKinney YL, Khurana K, Ravizzini GC, Albert PS, Merino MJ, Choyke PL (2010). Prostate cancer: value of multiparametric MR imaging at 3 T for detection--histopathologic correlation. Radiology  255, 89-99.   https://doi.org/10.1148/radiol.09090475",https://intramural.nih.gov/search/searchview.taf?ipid=68365
241,BC010715-06,"October 01, 2010 -  September 30, 2011",Phase II study of flavopiridol in mantle cell lymphoma and DLBCL,"Wyndham H Wilson; MD, PhD|IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",NULL,NULL,Elaine S Jaffe; MD (Laboratory of Pathology)|Stefania  Pittaluga (Laboratory of Pathology),"Adrian U Wiestner; MD, PhD (NHLBI)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68384
242,BC010716-06,"October 01, 2010 -  September 30, 2011",Phase I and II Study of BCL Family Inhibitors in Lymphoma,"Wyndham H Wilson; MD, PhD|IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",Louis  Staudt; MD,NULL,Elaine S Jaffe; MD (Laboratory of Pathology)|Stefania  Pittaluga (Laboratory of Pathology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68385
243,BC010717-06,"October 01, 2010 -  September 30, 2011",Phase I study of bortezomib and DA-EPOCH-R with microarray in DLBCL,"Wyndham H Wilson; MD, PhD|IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",NULL,NULL,Louis  Staudt; MD (Lymphoid Malignancies Branch)|Elaine S Jaffe; MD (Laboratory of Pathology)|Stefania  Pittaluga (Laboratory of Pathology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68386
244,BC010719-06,"October 01, 2010 -  September 30, 2011",Randomized Phase II study of borteozmibEPOCH-R in Mantle cell lymphoma,"Wyndham H Wilson; MD, PhD|IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",NULL,NULL,Elaine S Jaffe; MD (Laboratory of Pathology)|Stefania  Pittaluga (Laboratory of Pathology),"Adrian U Wiestner; MD, PhD (NHLBI)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68387
245,BC010720-06,"October 01, 2010 -  September 30, 2011","Isolation, Characterization, and Behavior of Melanocyte Stem Cells",Thomas J Hornyak,NULL,"Dermatology Branch, NCI",Jennifer Marian Huang|Sandeep Sudhakar Joshi; PhD,NULL,Glenn  Merlino; PhD (Laboratory of Cancer Biology and Genetics),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68369
246,BC010725-06,"October 01, 2010 -  September 30, 2011",Role of Formylpeptide Receptors in Host Defense,"Ji Ming  Wang; MD, PhD|IRP Faculty Profile",NULL,"Laboratory of Molecular Immunoregulation, NCI",Keqiang  Chen|Wang Hua  Gong|Ying  Liu|Ming Yong  Liu; MD,"Xiuwu  Bian (Southwest Hospital, Institute of Pathology)|Yingying  Le (Immunology, Institute for Nutritional Sciences)|Thomas  Rogers (Temple University)|Gert  Schmid-Schonbein (Whitaker Institute, UC San Diego)|Chunfu  Wu (Medicinal Chemistry, Shenyang Pharmaceutical University)",NULL,Philip M Murphy; MD (NIAID),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68361
247,BC010727-06,"October 01, 2010 -  September 30, 2011",Molecular Imaging and Targeted Therapy of HER2-Positive Breast Cancers,Jacek  Capala; PhD,NULL,"Radiation Oncology Branch, NCI",Alejandra  Garcia-Glaessner|Alesia J Holly|Gabriela  Kramer-Marek|Monika Agnieszka Kuban|Rafal Jerzy Zielinski,NULL,Robert  Blumenthal; PhD (Center for Cancer Research Nanobiology Program)|Peter L Choyke; MD (Molecular Imaging Program),"Dale Oscar Kiesewetter; BS, PhD (NIBIB) |Amir Hossein Gandjbakhche; PhD (NICHD) |Gary Leonard Griffiths; BSc, PhD (NHLBI)","1. Bouchelouche K, Capala J (2010). 'Image and treat': an individualized approach to urological tumors. Curr Opin Oncol  22, 274-80.   https://doi.org/10.1097/CCO.0b013e3283373d5c|2. Bouchelouche K, Choyke PL, Capala J (2010). Prostate specific membrane antigen- a target for imaging and therapy with radionuclides. Discov Med  9, 55-61.|3. Bouchelouche K, Tagawa ST, Goldsmith SJ, Turkbey B, Capala J, Choyke P (2011). PET/CT Imaging and Radioimmunotherapy of Prostate Cancer. Semin Nucl Med  41, 29-44.   https://doi.org/10.1053/j.semnuclmed.2010.08.005|4. Bouchelouche K, Turkbey B, Choyke P, Capala J (2010). Imaging prostate cancer: an update on positron emission tomography and magnetic resonance imaging. Curr Urol Rep  11, 180-90.   https://doi.org/10.1007/s11934-010-0105-9|5. Capala J, Bouchelouche K (2010). Molecular imaging of HER2-positive breast cancer: a step toward an individualized 'image and treat' strategy. Curr Opin Oncol  22, 559-66.   https://doi.org/10.1097/CCO.0b013e32833f8c3a|6. Chernomordik V, Hassan M, Lee SB, Zielinski R, Gandjbakhche A, Capala J (2010). Quantitative analysis of Her2 receptor expression in vivo by near-infrared optical imaging. Mol Imaging  9, 192-200.|7. Dahl M, Bouchelouche P, Kramer-Marek G, Capala J, Nordling J, Bouchelouche K (2011). Sarcosine induces increase in HER2/neu expression in androgen-dependent prostate cancer cells. Mol Biol Rep  38, 4237-43.   https://doi.org/10.1007/s11033-010-0442-2|8. Kramer-Marek G, Shenoy N, Seidel J, Griffiths GL, Choyke P, Capala J (2011). 68Ga-DOTA-affibody molecule for in vivo assessment of HER2/neu expression with PET. Eur J Nucl Med Mol Imaging  38, 1967-76.   https://doi.org/10.1007/s00259-011-1810-4|9. Lyakhov I, Zielinski R, Kuban M, Kramer-Marek G, Fisher R, Chertov O, Bindu L, Capala J (2010). HER2- and EGFR-specific affiprobes: novel recombinant optical probes for cell imaging. Chembiochem  11, 345-50.   https://doi.org/10.1002/cbic.200900532|10. Zheng J, Zhang D, Przytycki PF, Zielinski R, Capala J, Przytycka TM (2010). SimBoolNet--a Cytoscape plugin for dynamic simulation of signaling networks. Bioinformatics  26, 141-2.   https://doi.org/10.1093/bioinformatics/btp617|11. Zielinski R, Lyakhov I, Hassan M, Kuban M, Shafer-Weaver K, Gandjbakhche A, Capala J (2011). HER2-affitoxin: a potent therapeutic agent for the treatment of HER2-overexpressing tumors. Clin Cancer Res  17, 5071-81.   https://doi.org/10.1158/1078-0432.CCR-10-2887|12. Zielinski RJ, Smedley JV, Perera PY, Silvera PM, Waldmann TA, Capala J, Perera LP (2010). Smallpox vaccine with integrated IL-15 demonstrates enhanced in vivo viral clearance in immunodeficient mice and confers long term protection against a lethal monkeypox challenge in cynomolgus monkeys. Vaccine  28, 7081-91.   https://doi.org/10.1016/j.vaccine.2010.08.008",https://intramural.nih.gov/search/searchview.taf?ipid=68364
248,BC010728-06,"October 01, 2010 -  September 30, 2011",Phase III Study of R-CHOP v DA-EPOCH-R with microarray,"Wyndham H Wilson; MD, PhD|IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",NULL,"Bruce Allan Chabner|Bruce  Cheson (NCI)|Myron  Czuczman (Oncology, Roswell Park Cancer Institute)|Andrew  Zelenetz (Medicine, MSKCC)",Louis  Staudt; MD (Lymphoid Malignancies Branch)|Elaine S Jaffe; MD (Laboratory of Pathology)|Stefania  Pittaluga (Laboratory of Pathology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68388
249,BC010729-06,"October 01, 2010 -  September 30, 2011",Technology Development,"Michael R Emmert-Buck; MD, PhD",NULL,"Laboratory of Pathology, NCI",Jeffrey C Hanson|Jaime Andres Rodriguez Canales,"Benjamin  Shapiro (Engineering, University of Maryland)|Elisabeth  Smela (Engineering, University of Maryland)",NULL,Robert F Bonner; PhD (NICHD),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68351
250,BC010733-06,"October 01, 2010 -  September 30, 2011",Dermatoscopy in the Evaluation of Pigmented Lesions,Thomas J Hornyak,NULL,"Dermatology Branch, NCI",Kenneth H Kraemer; MD|Neera R Nathan|John  Digiovanna,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68370
251,BC010734-06,"October 01, 2010 -  September 30, 2011",Cutaneous Lesions in Neurofibromatosis Type I and Other Pre-cancerous Syndromes,Thomas J Hornyak,NULL,"Dermatology Branch, NCI",NULL,NULL,"Brigitte  Widemann; MD (Pediatric Oncology Branch)|Chyi-Chia Richard Lee (Laboratory of Pathology)|Phillip A Dennis; MD, PhD (Medical Oncology Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68371
252,BC010735-06,"October 01, 2010 -  September 30, 2011",Structural studies of fimbriae of enterotoxigenic E. coli (ETEC),"Di S Xia; PhD, MS, BS|IRP Faculty Profile",NULL,"Crystallography Section, NCI",Rui  Bao,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68363
253,BC010736-06,"October 01, 2010 -  September 30, 2011",Using mouse knockouts to unravel endothelial gene function,Bradley D St Croix,NULL,"Mouse Cancer Genetics Program, NCI",Mary B Hilton|Steven  Seaman|Mi Young  Yang|Christopher William Larrimore,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68382
254,BC010738-06,"October 01, 2010 -  September 30, 2011","Molecular Genetic Study of Stem Cells, Cancer Stem Cells, and Stem Cell Aging",Steven X Hou|IRP Faculty Profile,NULL,"Mouse Cancer Genetics Program, NCI",Chhavi  Chauhan; PhD|Ying  Liu|Hyunhee  Shin|Shree Ram  Singh|Xiankun  Zeng,Neal  Copeland (Institute of Molecular and Cell Biology)|Nancy  Jenkins (Institute of Molecular and Cell Biology)|Xinhua  Lin (Children's Hospital Medical Center),Lino  Tessarollo (Neural Development Section)|Jonathan  Keller; PhD (Laboratory of Cancer Prevention),NULL,"1. Zeng X, Chauhan C, Hou SX (2010). Characterization of midgut stem cell- and enteroblast-specific Gal4 lines in drosophila. Genesis  48, 607-11.   https://doi.org/10.1002/dvg.20661",https://intramural.nih.gov/search/searchview.taf?ipid=68372
255,BC010740-06,"October 01, 2010 -  September 30, 2011",Carbohydrate Microarray Profiling of Glycan-Binding Antibodies and Lectins,Jeffrey  Gildersleeve|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Sean Rogers Llewellyn|Saddam Musleh Muthana; PhD|Yalong  Zhang,"Lara  Mahal (Chemistry, University of Texas at Austin)|Mohamed  Shoreibah (Abeome Corp.)|Cristina  Voss (Department of Chemistry, German Cancer Research Center)|Mai  Xu; PhD|Matthew  Zimmt (Brown University)",Miriam R Anver (Office Of The Director),NULL,"1. Wang Y, Gildersleeve JC, Basu A, Zimmt MB (2010). Photo- and biophysical studies of lectin-conjugated fluorescent nanoparticles: reduced sensitivity in high density assays. J Phys Chem B  114, 14487-94.   https://doi.org/10.1021/jp101854m|2. Xu M, Wang F, Gildersleeve JC, Achilefu S (2010). MAb L9E10 to blood group H2 antigen binds to colon cancer stem cells and inhibits tumor cell migration and invasion. Hybridoma (Larchmt)  29, 355-9.   https://doi.org/10.1089/hyb.2010.0020",https://intramural.nih.gov/search/searchview.taf?ipid=68366
256,BC010742-06,"October 01, 2010 -  September 30, 2011",Utilizing Glycosyltransferases for Bioconjugation,Pradman  Qasba; PhD,NULL,"Structural Glycobiology Section, NCI",Natalia  Mercer|Boopathy  Ramakrishna,NULL,NULL,"Gary Leonard Griffiths; BSc, PhD (NHLBI)","1. Pasek M, Boeggeman E, Ramakrishnan B, Qasba PK (2010). Galectin-1 as a fusion partner for the production of soluble and folded human beta-1,4-galactosyltransferase-T7 in E. coli. Biochem Biophys Res Commun  394, 679-84.   https://doi.org/10.1016/j.bbrc.2010.03.051|2. Pasek M, Ramakrishnan B, Boeggeman E, Mercer N, Dulcey A, Griffiths G, Qasba P (2011) The N-acetyl binding pocket of N-acetylglucosaminyltransferases also accommodates a sugar analogue with chemical handle at C-2. Glycobiology [Epubaheadofprint].",https://intramural.nih.gov/search/searchview.taf?ipid=68380
257,BC010743-06,"October 01, 2010 -  September 30, 2011",Metabolic Mechanisms for Programmed Cell Death,James Ming Phang; MD|IRP Faculty Profile,NULL,"Laboratory of Comparative Carcinogenesis, NCI",Gregory L Borchert|Kyle  Christian|Chad Nathaniel Hancock; PhD|Yih-horng  Shiao|Wei  Liu,"Ellen  Heber-Katz (Wistar Institute)|Chien-An  Hu (Biochemistry & Molecular Biology, U. New Mexico School of Medicine)|David  Valle (Johns Hopkins University School of Medicine)",Alan O Perantoni; PhD (Cancer and Developmental Biology Laboratory),NULL,"1. Hong SY, Borchert GL, Maciag AE, Nandurdikar RS, Saavedra JE, Keefer LK, Phang JM, Chakrapani H (2010). The Nitric Oxide Prodrug V-PROLI/NO Inhibits Cellular Uptake of Proline. ACS Med Chem Lett  1, 386-389.   https://doi.org/10.1021/ml1000905|2. Tokar EJ, Qu W, Liu J, Liu W, Webber MM, Phang JM, Waalkes MP (2010). Arsenic-specific stem cell selection during malignant transformation. J Natl Cancer Inst  102, 638-49.   https://doi.org/10.1093/jnci/djq093|3. Zabirnyk O, Liu W, Khalil S, Sharma A, Phang JM (2010). Oxidized low-density lipoproteins upregulate proline oxidase to initiate ROS-dependent autophagy. Carcinogenesis  31, 446-54.   https://doi.org/10.1093/carcin/bgp299",https://intramural.nih.gov/search/searchview.taf?ipid=68358
258,BC010744-06,"October 01, 2010 -  September 30, 2011",Regulation of Proline Oxidase for Bioenergetics during Nutrient Stress,James Ming Phang; MD|IRP Faculty Profile,NULL,"Laboratory of Comparative Carcinogenesis, NCI",Kyle  Christian|Larry K Keefer; PhD|James C Gould|Chad Nathaniel Hancock; PhD|John Jeon Lee|Wei  Liu,"Chi V Dang|Chien-An  Hu (Biochemistry & Molecular Biology, U. New Mexico School of Medicine)|David  Valle (Johns Hopkins University School of Medicine)",NULL,NULL,"1. Liu W, Zabirnyk O, Wang H, Shiao YH, Nickerson ML, Khalil S, Anderson LM, Perantoni AO, Phang JM (2010). miR-23b targets proline oxidase, a novel tumor suppressor protein in renal cancer. Oncogene  29, 4914-24.   https://doi.org/10.1038/onc.2010.237|2. Zabirnyk O, Liu W, Khalil S, Sharma A, Phang JM (2010). Oxidized low-density lipoproteins upregulate proline oxidase to initiate ROS-dependent autophagy. Carcinogenesis  31, 446-54.   https://doi.org/10.1093/carcin/bgp299",https://intramural.nih.gov/search/searchview.taf?ipid=68359
259,BC010746-06,"October 01, 2010 -  September 30, 2011",Extracellular Matrix and Stress Substrates: the Role of Prolidase,James Ming Phang; MD|IRP Faculty Profile,NULL,"Laboratory of Comparative Carcinogenesis, NCI",Gregory L Borchert|Larry K Keefer; PhD,Antonella  Forlino (University of Pavia)|Teresa  Gunn (McLaughlin Research Institute)|Ellen  Heber-Katz (Wistar Institute),NULL,NULL,"1. Hong SY, Borchert GL, Maciag AE, Nandurdikar RS, Saavedra JE, Keefer LK, Phang JM, Chakrapani H (2010). The Nitric Oxide Prodrug V-PROLI/NO Inhibits Cellular Uptake of Proline. ACS Med Chem Lett  1, 386-389.   https://doi.org/10.1021/ml1000905|2. Tokar EJ, Qu W, Liu J, Liu W, Webber MM, Phang JM, Waalkes MP (2010). Arsenic-specific stem cell selection during malignant transformation. J Natl Cancer Inst  102, 638-49.   https://doi.org/10.1093/jnci/djq093",https://intramural.nih.gov/search/searchview.taf?ipid=68360
260,BC010747-06,"October 01, 2010 -  September 30, 2011",Charaterization of the Expression and Ligands of KIR3DS1,Daniel  McVicar; PhD|IRP Faculty Profile,NULL,"Laboratory of Experimental Immunology, NCI","Mary  Carrington; MS, PhD|Geraldine Martina O'Connor|Stephen K Anderson; PhD|Laura Ann R Quigley","Marcus  Altfeld (Infectious Disease Unit, Partners AIDS Research Center)|Andrew  Brooks (University of Melbourne)|Bernardo  Galvao-Castro (Goncalo Moniz Research Center)|Jamie  Rossjohn (Dept. of Biochemistry & Molecular Biology, Monash University)",James Jerome Goedert; MD (Infection & Immunoepidemiology Branch),"Suk See De Ravin; MD, PhD (NIAID)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68353
261,BC010748-06,"October 01, 2010 -  September 30, 2011",Clinical Investigation of Signal Transduction Inhibitors,"Phillip A Dennis; MD, PhD",NULL,"Medical Oncology Branch, NCI",Roopa  Dechowdhury|William D Figg; PharmD|Takefumi  Komiya|Giuseppe  Giaccone; MD,NULL,"Ilona  Linnoila; MD (Laboratory Of Genitourinary Cancer Pathogenesis)|Stephen M Hewitt; MD, PhD (Laboratory of Pathology)|Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Joanna H Shih (Biometrics Research Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68349
262,BC010749-06,"October 01, 2010 -  September 30, 2011",DNA Vaccines,"George N Pavlakis; MD, PhD|IRP Faculty Profile",NULL,"Vaccine Branch, NCI",Rachel Elizabeth Kelly Beach|Marjorie  Robert-Guroff; PhD|Bhabadeb S Chowdhury; PhD|Barbara K Felber|Genoveffa  Franchini; MD|Adriana Paola  Martin Morales; MD|Show all 11,"J. Thomas  August (Molecular Biology and Genetics Department, Johns Hopkins University School of Medicine)|Christian  Brander (AIDS Research Center, Massachusetts General Hospital)|David  Heckerman (Microsoft Research)|Richard  Heller (Old Dominion University)|R. Paul  Johnson (New England Primate Research Center)|Amitinder  Kaur (New England Primate Research Center)|Show all 24",Claes  Ohlen (Office Of The Director)|Jeffrey D Lifson; MD (Office Of The Director)|Giorgio  Trinchieri (Cancer Inflammation Program),Konstantinos  Petrovas (NIAID) |Richard A Koup; MD (NIAID),"1. Kulkarni V, Jalah R, Ganneru B, Bergamaschi C, Alicea C, von Gegerfelt A, Patel V, Zhang GM, Chowdhury B, Broderick KE, Sardesai NY, Valentin A, Rosati M, Felber BK, Pavlakis GN (2011). Comparison of immune responses generated by optimized DNA vaccination against SIV antigens in mice and macaques. Vaccine  29, 6742-54.   https://doi.org/10.1016/j.vaccine.2010.12.056|2. Legiewicz M, Zolotukhin AS, Pilkington GR, Purzycka KJ, Mitchell M, Uranishi H, Bear J, Pavlakis GN, Le Grice SF, Felber BK (2010). The RNA transport element of the murine musD retrotransposon requires long-range intramolecular interactions for function. J Biol Chem  285, 42097-104.   https://doi.org/10.1074/jbc.M110.182840|3. Minang JT, Trivett MT, Bolton DL, Trubey CM, Estes JD, Li Y, Smedley J, Pung R, Rosati M, Jalah R, Pavlakis GN, Felber BK, Piatak M, Roederer M, Lifson JD, Ott DE, Ohlen C (2010). Distribution, persistence, and efficacy of adoptively transferred central and effector memory-derived autologous simian immunodeficiency virus-specific CD8+ T cell clones in rhesus macaques during acute infection. J Immunol  184, 315-26.   https://doi.org/10.4049/jimmunol.0902410|4. Patel V, Valentin A, Kulkarni V, Rosati M, Bergamaschi C, Jalah R, Alicea C, Minang JT, Trivett MT, Ohlen C, Zhao J, Robert-Guroff M, Khan AS, Draghia-Akli R, Felber BK, Pavlakis GN (2010). Long-lasting humoral and cellular immune responses and mucosal dissemination after intramuscular DNA immunization. Vaccine  28, 4827-36.   https://doi.org/10.1016/j.vaccine.2010.04.064|5. Santra S, Liao HX, Zhang R, Muldoon M, Watson S, Fischer W, Theiler J, Szinger J, Balachandran H, Buzby A, Quinn D, Parks RJ, Tsao CY, Carville A, Mansfield KG, Pavlakis GN, Felber BK, Haynes BF, Korber BT, Letvin NL (2010). Mosaic vaccines elicit CD8+ T lymphocyte responses that confer enhanced immune coverage of diverse HIV strains in monkeys. Nat Med  16, 324-8.   https://doi.org/10.1038/nm.2108|6. Valentin A, Morrow M, Poirier RH, Aleman K, Little R, Yarchoan R, Pavlakis GN (2010). Identification of a potential pharmacological sanctuary for HIV type 1 in a fraction of CD4(+) primary cells. AIDS Res Hum Retroviruses  26, 79-88.   https://doi.org/10.1089/aid.2009.0044|7. Valentin A, von Gegerfelt A, Rosati M, Miteloudis G, Alicea C, Bergamaschi C, Jalah R, Patel V, Khan AS, Draghia-Akli R, Pavlakis GN, Felber BK (2010). Repeated DNA therapeutic vaccination of chronically SIV-infected macaques provides additional virological benefit. Vaccine  28, 1962-74.   https://doi.org/10.1016/j.vaccine.2009.10.099|8. Vercruysse T, Pawar S, De Borggraeve W, Pardon E, Pavlakis GN, Pannecouque C, Steyaert J, Balzarini J, Daelemans D (2011). Measuring cooperative Rev protein-protein interactions on Rev responsive RNA by fluorescence resonance energy transfer. RNA Biol  8, 316-24.   https://doi.org/10.4161/rna.8.2.13782|9. Witko SE, Johnson JE, Kalyan NK, Felber BK, Pavlakis GN, Sidhu MK, Hendry RM, Udem SA, Parks CL (2010). Refined methods for propagating vesicular stomatitis virus vectors that are defective for G protein expression. J Virol Methods  164, 43-50.   https://doi.org/10.1016/j.jviromet.2009.11.023",https://intramural.nih.gov/search/searchview.taf?ipid=68356
263,BC010750-06,"October 01, 2010 -  September 30, 2011",Cytokines in AIDS and Cancer,"George N Pavlakis; MD, PhD|IRP Faculty Profile",NULL,"Vaccine Branch, NCI",Barbara K Felber|Rachel Elizabeth Kelly Beach|Cristina  Bergamaschi|Bhabadeb S Chowdhury; PhD|Jinyao  Li; PhD|Ashish  Singh; PhD|Show all 8,Richard  Heller (Old Dominion University)|Amir  Khan (VGX Pharmaceuticals)|Maninder  Sidhu (Wyeth Vaccines Research)|David  Weiner (University of Pennsylvania),Claes  Ohlen (Office Of The Director)|Jeffrey D Lifson; MD (Office Of The Director)|Giorgio  Trinchieri (Cancer Inflammation Program)|Howard A Young; PhD (Laboratory of Experimental Immunology),NULL,"1. Legiewicz M, Zolotukhin AS, Pilkington GR, Purzycka KJ, Mitchell M, Uranishi H, Bear J, Pavlakis GN, Le Grice SF, Felber BK (2010). The RNA transport element of the murine musD retrotransposon requires long-range intramolecular interactions for function. J Biol Chem  285, 42097-104.   https://doi.org/10.1074/jbc.M110.182840|2. Majerciak V, Uranishi H, Kruhlak M, Pilkington GR, Massimelli MJ, Bear J, Pavlakis GN, Felber BK, Zheng ZM (2011). Kaposi's sarcoma-associated herpesvirus ORF57 interacts with cellular RNA export cofactors RBM15 and OTT3 to promote expression of viral ORF59. J Virol  85, 1528-40.   https://doi.org/10.1128/JVI.01709-10|3. Valentin A, von Gegerfelt A, Rosati M, Miteloudis G, Alicea C, Bergamaschi C, Jalah R, Patel V, Khan AS, Draghia-Akli R, Pavlakis GN, Felber BK (2010). Repeated DNA therapeutic vaccination of chronically SIV-infected macaques provides additional virological benefit. Vaccine  28, 1962-74.   https://doi.org/10.1016/j.vaccine.2009.10.099|4. Vercruysse T, Pawar S, De Borggraeve W, Pardon E, Pavlakis GN, Pannecouque C, Steyaert J, Balzarini J, Daelemans D (2011). Measuring cooperative Rev protein-protein interactions on Rev responsive RNA by fluorescence resonance energy transfer. RNA Biol  8, 316-24.   https://doi.org/10.4161/rna.8.2.13782|5. Winstone N, Wilson AJ, Morrow G, Boggiano C, Chiuchiolo MJ, Lopez M, Kemelman M, Ginsberg AA, Mullen K, Coleman JW, Wu CD, Narpala S, Ouellette I, Dean HJ, Lin F, Sardesai NY, Cassamasa H, McBride D, Felber BK, Pavlakis GN, Schultz A, Hudgens MG, King CR, Zamb TJ, Parks CL, et al. [1 more author] (2011). Enhanced control of pathogenic Simian immunodeficiency virus SIVmac239 replication in macaques immunized with an interleukin-12 plasmid and a DNA prime-viral vector boost vaccine regimen. J Virol  85, 9578-87.   https://doi.org/10.1128/JVI.05060-11",https://intramural.nih.gov/search/searchview.taf?ipid=68357
264,BC010752-06,"October 01, 2010 -  September 30, 2011",Anti-angiogenesis targeted vaccine therapy,Samir N. Khleif; MD,NULL,"Vaccine Branch, NCI",Tanbir  Najrana; PhD,"Yousef  Rustun (Roswell Park Cancer Institute)|Anil  Sood (Gynecologic Oncology, MDACC)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68373
265,BC010755-06,"October 01, 2010 -  September 30, 2011",Enhancing immune response strategies:,Samir N. Khleif; MD,NULL,"Vaccine Branch, NCI",Zhisong  Chen; PhD|Namju  Chong|Geoffrey  Guittard; PhD|Mikayel  Mkrtichyan; PhD|Laurent L Ozbun|Masaki  Terabe|Show all 7,Vincent  Herrin; MD|emanuelle  Petricoin (George Mason University),John  Schiller; PhD (Laboratory of Cellular Oncology)|Yuk Ying S Pang (Laboratory of Cellular Oncology)|Barry  Gause; PhD (Office Of The Director)|Franklin R Grollman (Medical Oncology Branch)|David J Venzon; PhD (Biostatistics and Data Management Section),Francesco M. Marincola; MD (CC),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68374
266,BC010757-06,"October 01, 2010 -  September 30, 2011",Clinical trial development in cancer vaccines,Samir N. Khleif; MD,NULL,"Vaccine Branch, NCI","Jay Arthur Berzofsky; MD, PhD|Omar  Dakheel; MD|Osama Entoun Rahma; MD","Vincent  Herrin; MD|Joe  Lucci (Gynecologic Oncology, University of Florida)|Therresa  Whiteside (Immuunoligy, University of Pittsburg)",Barry  Gause; PhD (Office Of The Director)|Franklin R Grollman (Medical Oncology Branch)|David J Venzon; PhD (Biostatistics and Data Management Section),NULL,"1. Rahma OE, Ashtar E, Ibrahim R, Toubaji A, Gause B, Herrin VE, Linehan WM, Steinberg SM, Grollman F, Grimes G, Bernstein SA, Berzofsky JA, Khleif SN (2010). A pilot clinical trial testing mutant von Hippel-Lindau peptide as a novel immune therapy in metastatic renal cell carcinoma. J Transl Med  8, 8.   https://doi.org/10.1186/1479-5876-8-8",https://intramural.nih.gov/search/searchview.taf?ipid=68376
267,BC010759-06,"October 01, 2010 -  September 30, 2011",Functional Genomics of Sarcoma,"Paul S Meltzer; MD, PhD|IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI","Ogan D Abaan|Sean Richard Davis; MD, PhD|Princy  Francis|Yevgeniy  Gindin|Arthur A Glatfelter; MS|Yuan  Jiang; MD|Show all 12",Charles  Keller (University of Texas)|Michael  Kelley (Duke University)|Heinrich  Kovar (St. Anna's Children's Hospital)|Jeffrey  Trent (TGen),Chand  Khanna; MD (Pediatric Oncology Branch)|Sharon Ann Savage (Clinical Genetics Branch),NULL,"1. Aryee DN, Niedan S, Kauer M, Schwentner R, Bennani-Baiti IM, Ban J, Muehlbacher K, Kreppel M, Walker RL, Meltzer P, Poremba C, Kofler R, Kovar H (2010). Hypoxia modulates EWS-FLI1 transcriptional signature and enhances the malignant properties of Ewing's sarcoma cells in vitro. Cancer Res  70, 4015-23.   https://doi.org/10.1158/0008-5472.CAN-09-4333|2. Brüderlein S, Sommer JB, Meltzer PS, Li S, Osada T, Ng D, Möller P, Alcorta DA, Kelley MJ (2010). Molecular characterization of putative chordoma cell lines. Sarcoma  2010, 630129.   https://doi.org/10.1155/2010/630129|3. Cao L, Yu Y, Bilke S, Walker RL, Mayeenuddin LH, Azorsa DO, Yang F, Pineda M, Helman LJ, Meltzer PS (2010). Genome-wide identification of PAX3-FKHR binding sites in rhabdomyosarcoma reveals candidate target genes important for development and cancer. Cancer Res  70, 6497-508.   https://doi.org/10.1158/0008-5472.CAN-10-0582",https://intramural.nih.gov/search/searchview.taf?ipid=68378
268,BC010761-06,"October 01, 2010 -  September 30, 2011",Studies of Proteins with Important Roles in Immunology andor Cancer Biology,Jacek Tadeusz Lubkowski,NULL,"Macromolecular Crystallography Laboratory, NCI",NULL,"Roy  Duhe (University of Mississippi, Medical Center)|Mei  Hong (Iowa State University,)|Jan  Konvalinka (Institute of Organic Chemistry and Biochemistry, Academy of Sciences of Czech Republic)|Wuyuan  Lu (Institute of Virology, University of Maryland)|Martin G Pomper|Scott  Sieg (Department of Biological Sciences, Case Western Reserve University)|Show all 8",Joost J Oppenheim; MD (Laboratory of Molecular Immunoregulation)|Daniel  McVicar; PhD (Laboratory of Experimental Immunology)|Shioko  Kimura; PhD (Endocrinology Section),John J O'Shea; MD (NIAMS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68377
269,BC010763-06,"October 01, 2010 -  September 30, 2011",Building on the success of the adoptive immunotherapy of cancer,Nicholas Phillip Restifo; MD|IRP Faculty Profile,NULL,"Surgery Branch, NCI","Zulmarie  Franco; MSc|Richard A Morgan; PhD|Luca  Gattinoni|Steven Aaron Rosenberg; MD, PhD|Yun  Ji|Paul  Robbins|Show all 14",Paul  Antony (Univeristy of Maryland)|Vincenzo  Bronte|Carl  June (Univesity of Pennsylvania)|Ton  Schumacher (Netherlands Cancer Institute)|Christopher  Touloukian (Indianna University),Giorgio  Trinchieri (Cancer Inflammation Program),Robert L Danner; MD (CC) |Mario  Roederer; PhD (NIAID),"1. Bolinger B, Engeler D, Krebs P, Miller S, Firner S, Hoffmann M, Palmer DC, Restifo NP, Tian Y, Clavien PA, Ludewig B (2010). IFN-gamma-receptor signaling ameliorates transplant vasculopathy through attenuation of CD8+ T-cell-mediated injury of vascular endothelial cells. Eur J Immunol  40, 733-43.   https://doi.org/10.1002/eji.200939706|2. Chinnasamy D, Yu Z, Theoret MR, Zhao Y, Shrimali RK, Morgan RA, Feldman SA, Restifo NP, Rosenberg SA (2010). Gene therapy using genetically modified lymphocytes targeting VEGFR-2 inhibits the growth of vascularized syngenic tumors in mice. J Clin Invest  120, 3953-68.   https://doi.org/10.1172/JCI43490|3. Dudley ME, Gross CA, Langhan MM, Garcia MR, Sherry RM, Yang JC, Phan GQ, Kammula US, Hughes MS, Citrin DE, Restifo NP, Wunderlich JR, Prieto PA, Hong JJ, Langan RC, Zlott DA, Morton KE, White DE, Laurencot CM, Rosenberg SA (2010). CD8+ enriched ""young"" tumor infiltrating lymphocytes can mediate regression of metastatic melanoma. Clin Cancer Res  16, 6122-31.   https://doi.org/10.1158/1078-0432.CCR-10-1297|4. Flatz L, Hegazy AN, Bergthaler A, Verschoor A, Claus C, Fernandez M, Gattinoni L, Johnson S, Kreppel F, Kochanek S, Broek Mv, Radbruch A, Lévy F, Lambert PH, Siegrist CA, Restifo NP, Löhning M, Ochsenbein AF, Nabel GJ, Pinschewer DD (2010). Development of replication-defective lymphocytic choriomeningitis virus vectors for the induction of potent CD8+ T cell immunity. Nat Med  16, 339-45.   https://doi.org/10.1038/nm.2104|5. Frankel TL, Burns WR, Peng PD, Yu Z, Chinnasamy D, Wargo JA, Zheng Z, Restifo NP, Rosenberg SA, Morgan RA (2010). Both CD4 and CD8 T cells mediate equally effective in vivo tumor treatment when engineered with a highly avid TCR targeting tyrosinase. J Immunol  184, 5988-98.   https://doi.org/10.4049/jimmunol.1000189|6. Gattinoni L, Ji Y, Restifo NP (2010). Wnt/beta-catenin signaling in T-cell immunity and cancer immunotherapy. Clin Cancer Res  16, 4695-701.   https://doi.org/10.1158/1078-0432.CCR-10-0356|7. Ha SP, Klemen ND, Kinnebrew GH, Brandmaier AG, Marsh J, Hangoc G, Palmer DC, Restifo NP, Cornetta K, Broxmeyer HE, Touloukian CE (2010). Transplantation of mouse HSCs genetically modified to express a CD4-restricted TCR results in long-term immunity that destroys tumors and initiates spontaneous autoimmunity. J Clin Invest  120, 4273-88.   https://doi.org/10.1172/JCI43274|8. Kerkar SP, Muranski P, Kaiser A, Boni A, Sanchez-Perez L, Yu Z, Palmer DC, Reger RN, Borman ZA, Zhang L, Morgan RA, Gattinoni L, Rosenberg SA, Trinchieri G, Restifo NP (2010). Tumor-specific CD8+ T cells expressing interleukin-12 eradicate established cancers in lymphodepleted hosts. Cancer Res  70, 6725-34.   https://doi.org/10.1158/0008-5472.CAN-10-0735|9. Kochenderfer JN, Yu Z, Frasheri D, Restifo NP, Rosenberg SA (2010). Adoptive transfer of syngeneic T cells transduced with a chimeric antigen receptor that recognizes murine CD19 can eradicate lymphoma and normal B cells. Blood  116, 3875-86.   https://doi.org/10.1182/blood-2010-01-265041|10. Quezada SA, Simpson TR, Peggs KS, Merghoub T, Vider J, Fan X, Blasberg R, Yagita H, Muranski P, Antony PA, Restifo NP, Allison JP (2010). Tumor-reactive CD4(+) T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts. J Exp Med  207, 637-50.   https://doi.org/10.1084/jem.20091918|11. Rausch MP, Irvine KR, Antony PA, Restifo NP, Cresswell P, Hastings KT (2010). GILT accelerates autoimmunity to the melanoma antigen tyrosinase-related protein 1. J Immunol  185, 2828-35.   https://doi.org/10.4049/jimmunol.1000945|12. Restifo NP (2010). Can antitumor immunity help to explain ""oncogene addiction""? Cancer Cell  18, 403-5.   https://doi.org/10.1016/j.ccr.2010.11.002|13. Rosenberg SA, Yang JC, Kammula US, Hughes MS, Restifo NP, Schwarz SL, Morton KE, Laurencot CM, Sherry RM (2010). Different adjuvanticity of incomplete freund's adjuvant derived from beef or vegetable components in melanoma patients immunized with a peptide vaccine. J Immunother  33, 626-9.   https://doi.org/10.1097/CJI.0b013e3181dac9de|14. Shrimali RK, Yu Z, Theoret MR, Chinnasamy D, Restifo NP, Rosenberg SA (2010). Antiangiogenic agents can increase lymphocyte infiltration into tumor and enhance the effectiveness of adoptive immunotherapy of cancer. Cancer Res  70, 6171-80.   https://doi.org/10.1158/0008-5472.CAN-10-0153|15. Wrzesinski C, Paulos CM, Kaiser A, Muranski P, Palmer DC, Gattinoni L, Yu Z, Rosenberg SA, Restifo NP (2010). Increased intensity lymphodepletion enhances tumor treatment efficacy of adoptively transferred tumor-specific T cells. J Immunother  33, 1-7.   https://doi.org/10.1097/CJI.0b013e3181b88ffc|16. Xie Y, Akpinarli A, Maris C, Hipkiss EL, Lane M, Kwon EK, Muranski P, Restifo NP, Antony PA (2010). Naive tumor-specific CD4(+) T cells differentiated in vivo eradicate established melanoma. J Exp Med  207, 651-67.   https://doi.org/10.1084/jem.20091921|17. Zou W, Restifo NP (2010). T(H)17 cells in tumour immunity and immunotherapy. Nat Rev Immunol  10, 248-56.   https://doi.org/10.1038/nri2742",https://intramural.nih.gov/search/searchview.taf?ipid=68381
270,BC010766-05,"October 01, 2010 -  September 30, 2011",High Throughput Isolation of Antigen Specific T-cells for Cancer Therapy,Udai S Kammula,NULL,"Surgery Branch, NCI",Tamara A Aghamolla|Melissa Marie Alvarez Downing; MD|Yu Matthew Chiu|Tejaswi Venkata Mudigonda|Biman  Paria|Vishant Aswin Ramadorai|Show all 7,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68459
271,BC010767-05,"October 01, 2010 -  September 30, 2011",Biosynthesis of Selenocysteine and Its Incorporation into Protein,Dolph Lee Hatfield; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Prevention, NCI",Bradley A Carlson|Fang  Chen|Ryuta  Tobe,"Vadim  Gladyshev (Brigham and Womenâs Hospital and Harvard Medical School)|Michael  Howard (University of Utah)|Byeong Jae  Lee (Seoul National University)|Ulrich  Schweizer (Neuroscience Research Center and, Charit-Universittsmedizin Berlin)",NULL,NULL,"1. XXu , Turanov A, Carlson B, Yoo M, Gladyshev V, Hatfield D (2011) Selenocysteine biosynthesis and the replacement of selenocysteine with cysteine in the pathway, in Selenium: Its molecular biology and role in human health., in press.|2. Lobanov AV, Turanov AA, Hatfield DL, Gladyshev VN (2010). Dual functions of codons in the genetic code. Crit Rev Biochem Mol Biol  45, 257-65.   https://doi.org/10.3109/10409231003786094|3. Xu XM, Turanov AA, Carlson BA, Yoo MH, Everley RA, Nandakumar R, Sorokina I, Gygi SP, Gladyshev VN, Hatfield DL (2010). Targeted insertion of cysteine by decoding UGA codons with mammalian selenocysteine machinery. Proc Natl Acad Sci U S A  107, 21430-4.   https://doi.org/10.1073/pnas.1009947107",https://intramural.nih.gov/search/searchview.taf?ipid=68460
272,BC010770-05,"October 01, 2010 -  September 30, 2011",Genotoxicity and mitochondrial toxicity of antiretroviral NRTI and PI drugs,Miriam Christine Poirier; PhD,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Yongmin  Liu|Dariya  Momot|Phuonggiang T Nguyen|Ofelia  Olivero; PhD,"Kris  Oursler (Veterans Administration Hospital)|Maria  Rugeles (Immunovirology, Unversidad de Antioquia)|Dale  Walker (BioMosaics, Inc.)|Vernon  Walker (University of Vermont)",Ettore  Appella; MD (Chemical Immunology Section),NULL,"1. Torres S, Walker D, Divi R, Poirier M, Walker V (2011) Comprehensive Toxicology, 2nd Edition. Elsevier, LTD (London).|2. Divi RL, Einem TL, Fletcher SL, Shockley ME, Kuo MM, St Claire MC, Cook A, Nagashima K, Harbaugh SW, Harbaugh JW, Poirier MC (2010). Progressive mitochondrial compromise in brains and livers of primates exposed in utero to nucleoside reverse transcriptase inhibitors (NRTIs). Toxicol Sci  118, 191-201.   https://doi.org/10.1093/toxsci/kfq235|3. Dutra A, Pak E, Wincovitch S, John K, Poirier MC, Olivero OA (2010). Nuclear bud formation: a novel manifestation of Zidovudine genotoxicity. Cytogenet Genome Res  128, 105-10.   https://doi.org/10.1159/000298794|4. Olivero OA, Vazquez IL, Cooch CC, Ming J, Keller E, Yu M, Borojerdi JP, Braun HM, McKee E, Poirier MC (2010). Long-term AZT exposure alters the metabolic capacity of cultured human lymphoblastoid cells. Toxicol Sci  115, 109-17.   https://doi.org/10.1093/toxsci/kfq023|5. Torres SM, Divi RL, Walker DM, McCash CL, Carter MM, Campen MJ, Einem TL, Chu Y, Seilkop SK, Kang H, Poirier MC, Walker VE (2010). In utero exposure of female CD-1 mice to AZT and/or 3TC: II. Persistence of functional alterations in cardiac tissue. Cardiovasc Toxicol  10, 87-99.   https://doi.org/10.1007/s12012-010-9065-z|6. Torres SM, March TH, Carter MM, McCash CL, Seilkop SK, Poirier MC, Walker DM, Walker VE (2010). In utero exposure of female CD-1 Mice to AZT and/or 3TC: I. Persistence of microscopic lesions in cardiac tissue. Cardiovasc Toxicol  10, 37-50.   https://doi.org/10.1007/s12012-010-9061-3",https://intramural.nih.gov/search/searchview.taf?ipid=68465
273,BC010773-05,"October 01, 2010 -  September 30, 2011",Interactions of APOBEC3 Proteins with Murine Leukemia Viruses,Alan  Rein; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Amanda  Aloia|Demetria P Harvin|Jane  Mirro|Silvia  Sanchez Martinez|Smita  Nair; PhD,John  Coffin (Tufts University)|Patric  Jern (Tufts University)|Karen  Sfanos (Johns Hopkins School of Medicine),NULL,NULL,"1. Rein A, Datta SA, Jones CP, Musier-Forsyth K (2011). Diverse interactions of retroviral Gag proteins with RNAs. Trends Biochem Sci  36, 373-80.   https://doi.org/10.1016/j.tibs.2011.04.001",https://intramural.nih.gov/search/searchview.taf?ipid=68464
274,BC010774-05,"October 01, 2010 -  September 30, 2011",T Cell Alternative p38 Activation Pathway,Jonathan D Ashwell; MD|IRP Faculty Profile,NULL,"Laboratory of Immune Cell Biology, NCI",Muhammad Shamsul Alam|Bei  Dong|Maria Letizia  Giardino Torchia|Paul  Mittelstadt; PhD,Al  Fornace (Georgetown University)|Oded  Livnah (Hebrew University of Jerusalem),Ettore  Appella; MD (Chemical Immunology Section),Dragana  Jankovic; PhD (NIAID),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68389
275,BC010775-05,"October 01, 2010 -  September 30, 2011","Retroviral Gag Trafficking, Env Incorporation, and Virus Assembly",Eric O Freed; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Sherimay  Ablan|Muthukumar  Balasubramaniam|Mary Ann  Checkley|Darren Edwin D'Souza|Vineet Narain KewalRamani; PhD|Sagar Bhalchandra Kudchodkar|Show all 13,"Angela Maria Gronenborn; PhD (Department of Structural Biology, University of Pittsburgh)|Scott  Morham (Myriad Pharmaceuticals)|Tsutomu  Murakami (National Institute of Infectious Diseases)|Akira  Ono (University of Michigan)|Tatyana  Polenova; PhD (University of Delaware)|Jamil  Saad (University of Alabama)|Show all 7",Robert J Fisher (Office Of The Director)|Sriram  Subramaniam; PhD (Laboratory of Cell Biology),Judith Goldstein Levin; PhD (NICHD) |Jennifer A Lippincott Schwartz; PhD (NICHD),"1. Fledderman EL, Fujii K, Ghanam RH, Waki K, Prevelige PE, Freed EO, Saad JS (2010). Myristate exposure in the human immunodeficiency virus type 1 matrix protein is modulated by pH. Biochemistry  49, 9551-62.   https://doi.org/10.1021/bi101245j|2. Freed E, Simon A (2010) Review of EMBO World Lecture Course 'Virus-host: partners in pathogenesis'. Future Virol 5:379-383.|3. Waheed A, Freed E (2011) HIV-1 Gag as a target for antiviral therapy. AIDS Res. Hum. Retroviruses, in press.|4. Waki K, Freed EO (2010). Macrophages and Cell-Cell Spread of HIV-1. Viruses  2, 1603-1620.   https://doi.org/10.3390/v2081603",https://intramural.nih.gov/search/searchview.taf?ipid=68403
276,BC010776-05,"October 01, 2010 -  September 30, 2011",Retrovirus Budding and Endosomal Sorting,Eric O Freed; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Sherimay  Ablan|Muthukumar  Balasubramaniam|Mary Ann  Checkley|Darren Edwin D'Souza|Sagar Bhalchandra Kudchodkar|Lillian Susanna Kuo; PhD|Show all 11,"Scott  Morham (Myriad Pharmaceuticals)|Jamil  Saad (University of Alabama)|Michael  Summers (University of Maryland, Baltimore County)",Robert J Fisher (Office Of The Director)|Terrence R Burke; PhD (Chemical Biology Laboratory)|Sriram  Subramaniam; PhD (Laboratory of Cell Biology),James H Hurley; PhD (NIDDK) |Anton  Simeonov (NHGRI),"1. Freed E, Simon A (2010) Review of EMBO World Lecture Course 'Virus-host: partners in pathogenesis'. Future Virol 5:379-383.|2. Im YJ, Kuo L, Ren X, Burgos PV, Zhao XZ, Liu F, Burke TR, Bonifacino JS, Freed EO, Hurley JH (2010). Crystallographic and functional analysis of the ESCRT-I /HIV-1 Gag PTAP interaction. Structure  18, 1536-47.   https://doi.org/10.1016/j.str.2010.08.010|3. Waheed A, Freed E (2011) HIV-1 Gag as a target for antiviral therapy. AIDS Res. Hum. Retroviruses, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=68404
277,BC010777-05,"October 01, 2010 -  September 30, 2011",Lipid Microdomains and HIV-1 Replication,Eric O Freed; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Sherimay  Ablan|Angelica Nascimento Martins; PhD|Abdul Latheef Abdul Waheed|Kayoko  Waki,NULL,Elena  Chertova (Office Of The Director)|Sriram  Subramaniam; PhD (Laboratory of Cell Biology),NULL,"1. Freed E, Simon A (2010) Review of EMBO World Lecture Course 'Virus-host: partners in pathogenesis'. Future Virol 5:379-383.|2. Waheed A, Freed E (2011) HIV-1 Gag as a target for antiviral therapy. AIDS Res. Hum. Retroviruses, in press.|3. Waheed AA, Freed EO (2010). The Role of Lipids in Retrovirus Replication. Viruses  2, 1146-1180.   https://doi.org/10.3390/v2051146",https://intramural.nih.gov/search/searchview.taf?ipid=68401
278,BC010778-05,"October 01, 2010 -  September 30, 2011",Inhibition of HIV-1 Maturation,Eric O Freed; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Sherimay  Ablan|Guangjin  Hou; PhD|Sagar Bhalchandra Kudchodkar|Alan  Rein; PhD|Angelica Nascimento Martins; PhD|Philip Richard Tedbury|Show all 8,"Asim  Debnath (Lindsley F. Kimball Research Institute of the New York Blood Center)|Angela Maria Gronenborn; PhD (Department of Structural Biology, University of Pittsburgh)|Tsutomu  Murakami (National Institute of Infectious Diseases)|Tatyana  Polenova; PhD (University of Delaware)|Michael  Summers (University of Maryland, Baltimore County)",Elena  Chertova (Office Of The Director),Alasdair C Steven; PhD (NIAMS),"1. Freed E, Simon A (2010) Review of EMBO World Lecture Course 'Virus-host: partners in pathogenesis'. Future Virol 5:379-383.|2. Waheed A, Freed E (2011) HIV-1 Gag as a target for antiviral therapy. AIDS Res. Hum. Retroviruses, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=68402
279,BC010779-05,"October 01, 2010 -  September 30, 2011",Regulation and Consequences of Ubiquitination,Jonathan D Ashwell; MD|IRP Faculty Profile,NULL,"Laboratory of Immune Cell Biology, NCI",Bei  Dong|Netra Pal Meena|Ivana  Munitic,NULL,NULL,Dragana  Jankovic; PhD (NIAID),"1. Conze DB, Zhao Y, Ashwell JD (2010). Non-canonical NF-κB activation and abnormal B cell accumulation in mice expressing ubiquitin protein ligase-inactive c-IAP2. PLoS Biol  8, e1000518.   https://doi.org/10.1371/journal.pbio.1000518",https://intramural.nih.gov/search/searchview.taf?ipid=68390
280,BC010780-05,"October 01, 2010 -  September 30, 2011",Structural studies of molecular cancer targets and drug development,David S Waugh; PhD|IRP Faculty Profile,NULL,"Protein Engineering Section, NCI",George T Lountos|Danielle  Needle,NULL,Terrence R Burke; PhD (Chemical Biology Laboratory)|Yves  Pommier; PhD (Developmental Therapeutics Branch)|Robert  Shoemaker (Screening Technologies Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68409
281,BC010782-05,"October 01, 2010 -  September 30, 2011",Study of the Roles of SDF1 and CXCR4 in Hematopoiesis,Giovanna  Tosato; PhD|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI",Inn-Inn  Chen|Georgina  Espigol Frigole|Kan  Jiang|Hidetaka  Ohnuki|Shuhei  Sakakibara; PhD|Ombretta  Salvucci|Show all 7,Anna C Berardi|Catherine  Porcher (Oxford Univ)|Shushang  Wang (Univ. Texas Southwestern Med Center),Elaine S Jaffe; MD (Laboratory of Pathology)|Stefania  Pittaluga (Laboratory of Pathology)|David  Levens; PhD (Laboratory of Pathology)|Douglas  Lowy; MD (Office Of The Director),Dragan  Maric; PhD (NINDS) |William E Paul; MD (NIAID) |Jinfang  Zhu; PhD (NIAID),"1. de la Luz Sierra M, Sakakibara S, Gasperini P, Salvucci O, Jiang K, McCormick PJ, Segarra M, Stone J, Maric D, Zhu J, Qian X, Lowy DR, Tosato G (2010). The transcription factor Gfi1 regulates G-CSF signaling and neutrophil development through the Ras activator RasGRP1. Blood  115, 3970-9.   https://doi.org/10.1182/blood-2009-10-246967",https://intramural.nih.gov/search/searchview.taf?ipid=68410
282,BC010783-05,"October 01, 2010 -  September 30, 2011",The Molecular Mechanism of TNF-induced Necrotic Cell Death,Zhenggang  Liu; PhD|IRP Faculty Profile,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Kun  Chen|Ilona  Linnoila; MD|Swati Suresh Choksi|Siriporn  Jitkaew|Elena  Pobezinskaya|Yan  Zhang,NULL,NULL,NULL,"1. Li T, Morgan MJ, Choksi S, Zhang Y, Kim YS, Liu ZG (2010). MicroRNAs modulate the noncanonical transcription factor NF-kappaB pathway by regulating expression of the kinase IKKalpha during macrophage differentiation. Nat Immunol  11, 799-805.   https://doi.org/10.1038/ni.1918|2. Morgan MJ, Liu ZG (2010). Reactive oxygen species in TNFalpha-induced signaling and cell death. Mol Cells  30, 1-12.   https://doi.org/10.1007/s10059-010-0105-0|3. Morgan MJ, Liu ZG (2011). Crosstalk of reactive oxygen species and NF-κB signaling. Cell Res  21, 103-15.   https://doi.org/10.1038/cr.2010.178",https://intramural.nih.gov/search/searchview.taf?ipid=68411
283,BC010784-05,"October 01, 2010 -  September 30, 2011",Biochemistry of Melanins and Photoprotection of the Skin,Vincent J. Hearing; PhD,NULL,"Pigment Cell Biology Section, NCI",Won Seon  Choi|Sergio  Coelho|Lanlan  Yin,"Janusz  Beer (Center for Devices & Radiological Health, Food & Drug Administration)|Shosuke  Ito (Department of Chemistry, Fujita Health University)|Ludger  Kolbe (Beiersdorf AG)|Yuji  Yamaguchi",NULL,NULL,"1. Choi W, Miyamura Y, Wolber R, Smuda C, Reinhold W, Liu H, Kolbe L, Hearing VJ (2010). Regulation of human skin pigmentation in situ by repetitive UV exposure: molecular characterization of responses to UVA and/or UVB. J Invest Dermatol  130, 1685-96.   https://doi.org/10.1038/jid.2010.5|2. Coelho SG, Hearing VJ (2010). UVA tanning is involved in the increased incidence of skin cancers in fair-skinned young women. Pigment Cell Melanoma Res  23, 57-63.   https://doi.org/10.1111/j.1755-148X.2009.00656.x|3. Kornhauser A, Coelho SG, Hearing VJ (2010). Applications of hydroxy acids: classification, mechanisms, and photoactivity. Clin Cosmet Investig Dermatol  3, 135-42.   https://doi.org/10.2147/CCID.S9042|4. Yamaguchi Y, Hearing VJ, Maeda A, Morita A (2010). NADPH:quinone oxidoreductase-1 as a new regulatory enzyme that increases melanin synthesis. J Invest Dermatol  130, 645-7.   https://doi.org/10.1038/jid.2009.378",https://intramural.nih.gov/search/searchview.taf?ipid=68412
284,BC010785-05,"October 01, 2010 -  September 30, 2011",Characterization of Pigmentary Disorders and Melanoma Targeting,Vincent J. Hearing; PhD,NULL,"Pigment Cell Biology Section, NCI",Masakazu  Kawaguchi|Taisuke  Kondo|Julio C Valencia; MD|Lanlan  Yin|Won Seon  Choi|Dominik David Ebsen; PhD,"Takeshi  Namiki|Thierry  Passeron|Michael  Pickart (Department of Biology, University of Wisconsin)|Yuji  Yamaguchi",Sriram  Subramaniam; PhD (Laboratory of Cell Biology)|Suresh V Ambudkar; PhD (Transport Biochemistry Section),"Michael Marc Gottesman; MD (OD) |Kevin G Chen; MD (NINDS) |David R Adams (NHGRI) |Joseph A Mindell; BS, MD, PhD (NINDS)","1. Hoashi T, Sato S, Yamaguchi Y, Passeron T, Tamaki K, Hearing VJ (2010). Glycoprotein nonmetastatic melanoma protein b, a melanocytic cell marker, is a melanosome-specific and proteolytically released protein. FASEB J  24, 1616-29.   https://doi.org/10.1096/fj.09-151019|2. Hoashi T, Tamaki K, Hearing VJ (2010). The secreted form of a melanocyte membrane-bound glycoprotein (Pmel17/gp100) is released by ectodomain shedding. FASEB J  24, 916-30.   https://doi.org/10.1096/fj.09-140921|3. Kondo T, Hearing VJ (2011). Update on the regulation of mammalian melanocyte function and skin pigmentation. Expert Rev Dermatol  6, 97-108.   https://doi.org/10.1586/edm.10.70",https://intramural.nih.gov/search/searchview.taf?ipid=68413
285,BC010786-05,"October 01, 2010 -  September 30, 2011",The Regulation of Mammalian Pigmentation,Vincent J. Hearing; PhD,NULL,"Pigment Cell Biology Section, NCI",Won Seon  Choi|Dominik David Ebsen; PhD|Masakazu  Kawaguchi|Taisuke  Kondo|Julio C Valencia; MD|Lanlan  Yin,"Ludger  Kolbe (Beiersdorf AG)|Takeshi  Namiki|Thierry  Passeron|Michael  Pickart (Department of Biology, University of Wisconsin)|Yuji  Yamaguchi",Sriram  Subramaniam; PhD (Laboratory of Cell Biology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68414
286,BC010787-05,"October 01, 2010 -  September 30, 2011",Redox Imaging using Nitroxides and MRI,James B Mitchell; PhD|IRP Faculty Profile,NULL,"Radiation Biology Branch, NCI",John Andrew Cook; PhD|Murali  Krishna; PhD|Ryan Miller Davis|Anastasia L Sowers,NULL,NULL,NULL,"1. Citrin D, Cotrim AP, Hyodo F, Baum BJ, Krishna MC, Mitchell JB (2010). Radioprotectors and mitigators of radiation-induced normal tissue injury. Oncologist  15, 360-71.   https://doi.org/10.1634/theoncologist.2009-S104|2. Day SE, Kettunen MI, Cherukuri MK, Mitchell JB, Lizak MJ, Morris HD, Matsumoto S, Koretsky AP, Brindle KM (2011). Detecting response of rat C6 glioma tumors to radiotherapy using hyperpolarized [1- 13C]pyruvate and 13C magnetic resonance spectroscopic imaging. Magn Reson Med  65, 557-63.   https://doi.org/10.1002/mrm.22698",https://intramural.nih.gov/search/searchview.taf?ipid=68415
287,BC010788-05,"October 01, 2010 -  September 30, 2011",Regulation of Differentiation of Pediatric Embryonal Tumors- Neuroblastoma,Carol J Thiele|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Shiwei  He|Javed  Khan; MD|Chand  Khanna; MD|Zhihui  Liu|Lauren  Marks|Doo-Yi  Oh|Show all 9,"David  Kaplan (Hospital for Sick Kids)|Jinhua  Zhang (Hematology, 2nd China Medical School)",Ira H Pastan; MD (Molecular Biology Section)|Lino  Tessarollo (Neural Development Section),Kai  Ge; PhD (NIDDK),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68416
288,BC010789-05,"October 01, 2010 -  September 30, 2011",Pathophysiologic Consequences of Neurotrophin Activation of Trk in Neuroblastoma,Carol J Thiele|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Zhi-Jie  Li|Lauren  Marks|Javed  Khan; MD|Luke Allister Wylie|Chand  Khanna; MD|Shuang  Yan|Show all 8,"David  Kaplan (Hospital for Sick Kids)|Jinhua  Zhang (Hematology, 2nd China Medical School)",Susan  Bates; MD (Medical Oncology Branch)|Giovanni  Melillo (Screening Technologies Branch)|Seth M Steinberg; PhD (Biostatistics and Data Management Section)|David J Liewehr (Biostatistics and Data Management Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68417
289,BC010791-05,"October 01, 2010 -  September 30, 2011","Effects of genetic polymorphism in MHC, KIR, and related loci on human disease","Mary  Carrington; MS, PhD",NULL,"Laboratory of Experimental Immunology, NCI",Richard  Apps; PhD|Arman A Bashirova|Fuh-Mei  Duh|Luz Maria Fuentes|Xiaojiang  Gao|Smita V Kulkarni; PhD|Show all 11,"Marcus  Altfeld (Infectious Disease Unit, Partners AIDS Research Center)|William  Carr (University of KwaZulu Natal)|Steven  Deeks (San Francisco General Hospital, University of California, San Francisco)|Carey  Farquhar (Epidemiology and Medicine, University of Washington)|David  Goldstein (Duke University)|Michael  Knowles (Cystic Fibrosis Pulmonary Research and Treatment Center, University of North Carolina at Chapel Hill)|Show all 16",Allan  Hildesheim; PhD (Infection & Immunoepidemiology Branch)|James Jerome Goedert; MD (Infection & Immunoepidemiology Branch),Barbara  Rehermann; MD (NIDDK),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68395
290,BC010792-05,"October 01, 2010 -  September 30, 2011",Molecular genetics and population studies of the KIR and HLA gene complexes,"Mary  Carrington; MS, PhD",NULL,"Laboratory of Experimental Immunology, NCI",Richard  Apps; PhD|Daniel  McVicar; PhD|Stephen K Anderson; PhD|Arman A Bashirova|Benjamin W Brittain|Fuh-Mei  Duh|Show all 13,"Marcus  Altfeld (Infectious Disease Unit, Partners AIDS Research Center)|Judith  Kidd (Yale University)|Kenneth  Kidd (Yale University)|Diogo  Meyer (Genetics and evolutionary biology, University of Sao Paulo)|Richard  Single (University of Vermont)|Judith  Torimiro (Johns Hopkins School of Public Health)|Show all 8",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68394
291,BC010793-05,"October 01, 2010 -  September 30, 2011","Role of inflammation, innate resistance, and immunity in carcinogenesis.",Giorgio  Trinchieri|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI","Ali Sajjad Aziz|Ren Ming  Dai|Amiran  Dzutsev; PhD|Silvana Romina Goldszmid|Noriho  Iida; MD, PhD|Rosalba  Salcedo|Show all 10","Mario  Colombo (Experimental Oncology, National Institute of Surgery and Cure of Tumors)|Franca  Gerosa (Pathology/Immunology, University of Verona)|Uzma  Hasan (Infections and Cancer Biology, International Agency for Research on Cancer (IARC-WHO))|Dominique  Kaiserlian (U404, INSERM)|Xiaojing  Ma (Microbiology and Immunology, Weill Medical College)|Sergei A. Nedospasov; PhD, DSc","Nancy H Colburn; PhD (Laboratory of Cancer Prevention)|Barbara K Felber (Vaccine Branch)|George N Pavlakis; MD, PhD (Vaccine Branch)|Glenn  Merlino; PhD (Laboratory of Cancer Biology and Genetics)|Stuart H Yuspa; MD (Laboratory of Cancer Biology and Genetics)|Francis W Ruscetti; PhD (Laboratory of Experimental Immunology)",Alan  Sher; PhD (NIAID) |Francesco M. Marincola; MD (CC),"1. Demaria S, Pikarsky E, Karin M, Coussens LM, Chen YC, El-Omar EM, Trinchieri G, Dubinett SM, Mao JT, Szabo E, Krieg A, Weiner GJ, Fox BA, Coukos G, Wang E, Abraham RT, Carbone M, Lotze MT (2010). Cancer and inflammation: promise for biologic therapy. J Immunother  33, 335-51.   https://doi.org/10.1097/CJI.0b013e3181d32e74|2. Kerkar SP, Muranski P, Kaiser A, Boni A, Sanchez-Perez L, Yu Z, Palmer DC, Reger RN, Borman ZA, Zhang L, Morgan RA, Gattinoni L, Rosenberg SA, Trinchieri G, Restifo NP (2010). Tumor-specific CD8+ T cells expressing interleukin-12 eradicate established cancers in lymphodepleted hosts. Cancer Res  70, 6725-34.   https://doi.org/10.1158/0008-5472.CAN-10-0735|3. Salcedo R, Worschech A, Cardone M, Jones Y, Gyulai Z, Dai RM, Wang E, Ma W, Haines D, O'hUigin C, Marincola FM, Trinchieri G (2010). MyD88-mediated signaling prevents development of adenocarcinomas of the colon: role of interleukin 18. J Exp Med  207, 1625-36.   https://doi.org/10.1084/jem.20100199|4. Saleh M, Trinchieri G (2010) Innate mechanisms of colitis and colon cancer. Nat Rev Immunol, in press.|5. Sangaletti S, Tripodo C, Ratti C, Piconese S, Porcasi R, Salcedo R, Trinchieri G, Colombo M, Chiodoni C (2010) TNF deficiency in leukocytes eliminate pericyts and Tie-2 expressing macrophages hampering tumor progression. Cancer Res, in press.|6. Trinchieri G (2010) Type I Interferon: Friend or Foe? J. Exp. Med, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=68418
292,BC010794-05,"October 01, 2010 -  September 30, 2011",Characterization of Cancer Stem Cells,William  Farrar,NULL,"Laboratory of Cancer Prevention, NCI",Stephanie Marie Cabarcas|Lei  Sun|Xiaohu  Zhang|Ji  Zheng; PhD,NULL,Nadya I Tarasova; PhD (Cancer Inflammation Program)|Timothy D Veenstra (Office Of The Director),NULL,"1. Cabarcas SM, Hurt EM, Farrar WL (2010). Defining the molecular nexus of cancer, type 2 diabetes and cardiovascular disease. Curr Mol Med  10, 744-55.   https://doi.org/10.2174/156652410793384187|2. Crea F, Duhagon Serrat MA, Hurt EM, Thomas SB, Danesi R, Farrar WL (2011). BMI1 silencing enhances docetaxel activity and impairs antioxidant response in prostate cancer. Int J Cancer  128, 1946-54.   https://doi.org/10.1002/ijc.25522|3. Crea F, Hurt EM, Farrar WL (2010). Clinical significance of Polycomb gene expression in brain tumors. Mol Cancer  9, 265.   https://doi.org/10.1186/1476-4598-9-265|4. Duhagon MA, Hurt EM, Sotelo-Silveira JR, Zhang X, Farrar WL (2010). Genomic profiling of tumor initiating prostatospheres. BMC Genomics  11, 324.   https://doi.org/10.1186/1471-2164-11-324|5. Hurt EM, Chan K, Serrat MA, Thomas SB, Veenstra TD, Farrar WL (2010). Identification of vitronectin as an extrinsic inducer of cancer stem cell differentiation and tumor formation. Stem Cells  28, 390-8.   https://doi.org/10.1002/stem.271|6. Mathews LA, Hurt EM, Zhang X, Farrar WL (2010). Epigenetic regulation of CpG promoter methylation in invasive prostate cancer cells. Mol Cancer  9, 267.   https://doi.org/10.1186/1476-4598-9-267|7. Volate SR, Kawasaki BT, Hurt EM, Milner JA, Kim YS, White J, Farrar WL (2010). Gossypol induces apoptosis by activating p53 in prostate cancer cells and prostate tumor-initiating cells. Mol Cancer Ther  9, 461-70.   https://doi.org/10.1158/1535-7163.MCT-09-0507",https://intramural.nih.gov/search/searchview.taf?ipid=68397
293,BC010795-05,"October 01, 2010 -  September 30, 2011",Mechanisms of transcription fidelity in prokaryotes and eukaryotes,Mikhail V Kashlev|IRP Faculty Profile,NULL,"Molecular Mechanisms of Transcription Section, NCI",Masahiko  Imashimizu|Maria L Kireeva|Lucyna E Lubkowska|Celine Marguerite Paulette Walmacq,"Zachary  Burton (Department of Biochemistry and Molecular Biology, Michigan State University)|Benoit  Coulombe (Institut de recherches cliniques de Montreal)|Jianhua  Fu (Cornell University)|Max  Gottesman (Institute of Cancer Research, Columbia University)|Leonard C Lutter; PhD (Molecular Biology Research Program, Henry Ford Hospital)|Charles  Turnbough (Unversity of Alabama)",Jeffrey N Strathern (Gene Regulation and Chromosome Biology Laboratory)|Ding Jun Jin (Gene Regulation and Chromosome Biology Laboratory)|Donald L Court; PhD (Molecular Control and Genetics Section),NULL,"1. Kireeva M, Kashlev M, Burton ZF (2010). Translocation by multi-subunit RNA polymerases. Biochim Biophys Acta  1799, 389-401.   https://doi.org/10.1016/j.bbagrm.2010.01.007|2. Seibold SA, Singh BN, Zhang C, Kireeva M, Domecq C, Bouchard A, Nazione AM, Feig M, Cukier RI, Coulombe B, Kashlev M, Hampsey M, Burton ZF (2010). Conformational coupling, bridge helix dynamics and active site dehydration in catalysis by RNA polymerase. Biochim Biophys Acta  1799, 575-87.   https://doi.org/10.1016/j.bbagrm.2010.05.002",https://intramural.nih.gov/search/searchview.taf?ipid=68419
294,BC010796-05,"October 01, 2010 -  September 30, 2011",Differentiation of tissue- and devlopment of tumor stem cells,John Edward Niederhuber,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",NULL,NULL,"Lalage  Wakefield; PhD (Laboratory of Cancer Biology and Genetics)|Robert  Shoemaker (Screening Technologies Branch)|Susan  Mertins (Screening Technologies Branch)|Vladimir L Larionov; PhD, DSc (Developmental Therapeutics Branch)|Jeffrey E Green; MD (Laboratory of Cancer Biology and Genetics)|Thomas A Misteli; PhD (Hormone Action and Oncogenesis Section)",Ronald  McKay; PhD (NINDS),"1. Stuelten CH, Busch JI, Tang B, Flanders KC, Oshima A, Sutton E, Karpova TS, Roberts AB, Wakefield LM, Niederhuber JE (2010). Transient tumor-fibroblast interactions increase tumor cell malignancy by a TGF-Beta mediated mechanism in a mouse xenograft model of breast cancer. PLoS One  5, e9832.   https://doi.org/10.1371/journal.pone.0009832",https://intramural.nih.gov/search/searchview.taf?ipid=68408
295,BC010797-05,"October 01, 2010 -  September 30, 2011",Mechanisms of Stromal Cell Activation by the Developing Tumor,John Edward Niederhuber,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",NULL,"Amir  Jazaeri (Obstetrics & Gynecology, University of Virginia)|John I Risinger; PhD (NCI)","Jeffrey S Rubin; MD, PhD (Laboratory of Cellular and Molecular Biology)|Bih-Rong  Wei (Laboratory of Cancer Biology and Genetics)|Robert Mark Simpson; DVM, PhD (Laboratory of Cancer Biology and Genetics)",NULL,"1. Aprelikova O, Yu X, Palla J, Wei BR, John S, Yi M, Stephens R, Simpson RM, Risinger JI, Jazaeri A, Niederhuber J (2010). The role of miR-31 and its target gene SATB2 in cancer-associated fibroblasts. Cell Cycle  9, 4387-98.   https://doi.org/10.4161/cc.9.21.13674",https://intramural.nih.gov/search/searchview.taf?ipid=68420
296,BC010800-05,"October 01, 2010 -  September 30, 2011",Convection enhanced delivery of  agents into the brainstem of patients with diff,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Robyn S Bent,NULL,NULL,"Russell R Lonser; MD (NINDS) |Ashok R Asthagiri; MD (NINDS) |Carlo  Pierpaoli; MD, PhD (NICHD) |Joelle  Sarlls; PhD (NINDS)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68421
297,BC010801-05,"October 01, 2010 -  September 30, 2011",Development of Therapies for Neurofibromatosis Type 1 Related Tumors and other G,Brigitte  Widemann; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Alberta A Aikin|Srivandana  Akshintala|Andrea Maria Baldwin|Katherine Elizabeth Warren; MD|Diane  Cole|Eva  Dombi|Show all 16,"Dusica  Babovic-Vuksanovich (Genetics, Mayo-Clinic)|Larry  Baker (SARC)|Jean  Belasco (Neurooncology, Children's Hospital of Philadelphia)|Jaishri  Blakeley (Johns Hopkins)|Susan  Blaney (Texas Children's Cancer Center)|Karen  Cichowski (Brigham and Women's Hospital)|Show all 22","Douglas Russell Stewart; BA, MD (Clinical Genetics Branch)|Thomas J Hornyak (Dermatology Branch)|Karlyne M Reilly; BS, PhD (Mouse Cancer Genetics Program)|Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)","Ann M Cohen-Berger; MD (CC) |Nicholas  Patronas; MD (CC) |Constantine Argyrios Stratakis; MD, DSc (NICHD) |Jeffrey M Solomon; BS, MS, PhD (CC) |Scott Mitchell Paul; MD (CC) |Edmond Joseph Fitzgibbon; MD (NEI)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68422
298,BC010802-05,"October 01, 2010 -  September 30, 2011",Tumor stem cells and metastatic outcomes in mouse models of prostate cancer,Kathleen  Kelly; PhD|IRP Faculty Profile,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Wassim Gergy  Abou-Kheir|Paul Gerard Hynes|Yen Nien  Liu|Victoria  Seng|Heather  Sheppard,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68423
299,BC010803-05,"October 01, 2010 -  September 30, 2011",Characterizing a novel tumor recognition mechanism,"James Chung-Yin Yang; MD, PhD|IRP Faculty Profile",NULL,"Surgery Branch, NCI",Qiong J Wang,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68424
300,BC010804-05,"October 01, 2010 -  September 30, 2011",Using Glycosyltransferases for the Development of Targeted Drug Delivery System,Pradman  Qasba; PhD,NULL,"Structural Glycobiology Section, NCI",Natalia  Mercer|Boopathy  Ramakrishna,NULL,NULL,NULL,"1. Mercer N, Ramakrishnan B, Boeggeman E, Qasba P (2011) Applications of site-specific labelling to study HAMLET, a tumoricidal complex of a-lactalbumin and oleic acid. PLoS ONE, in press.|2. Ramakrishnan B, Boeggeman E, Pasek M, Qasba PK (2011). Bioconjugation using mutant glycosyltransferases for the site-specific labeling of biomolecules with sugars carrying chemical handles. Methods Mol Biol  751, 281-96.   https://doi.org/10.1007/978-1-61779-151-2_17",https://intramural.nih.gov/search/searchview.taf?ipid=68425
301,BC010806-05,"October 01, 2010 -  September 30, 2011",Targeting High-risk Neuroblastoma using high through put siRNA screening,Javed  Khan; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",James  Badgett|Carol J Thiele|Dominik  Bogen|Jianbin Na He|Lee Jay Helman; MD|Laura Beth Hurd|Show all 16,"David  Azorsa (NHGRI)|John  Maris (Pharmacology, Children's Hospital of Philadelphia)",Malcolm A Smith (Clinical Investigations Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68427
302,BC010808-05,"October 01, 2010 -  September 30, 2011",Nucleosome Dynamics,Yawen  Bai; PhD|IRP Faculty Profile,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",Hanqiao  Feng|Carl  Wu; PhD|Jingjun  Hong|Hidenori  Kato|Bing-Rui  Zhou|Zheng  Zhou,NULL,Michael  Bustin; PhD (Protein Section),NULL,"1. Kato H, van Ingen H, Zhou BR, Feng H, Bustin M, Kay LE, Bai Y (2011). Architecture of the high mobility group nucleosomal protein 2-nucleosome complex as revealed by methyl-based NMR. Proc Natl Acad Sci U S A  108, 12283-8.   https://doi.org/10.1073/pnas.1105848108|2. Zhou Z, Feng H, Zhou BR, Ghirlando R, Hu K, Zwolak A, Miller Jenkins LM, Xiao H, Tjandra N, Wu C, Bai Y (2011). Structural basis for recognition of centromere histone variant CenH3 by the chaperone Scm3. Nature  472, 234-7.   https://doi.org/10.1038/nature09854",https://intramural.nih.gov/search/searchview.taf?ipid=68391
303,BC010814-05,"October 01, 2010 -  September 30, 2011",Mechanisms of Retroviral RNA Trafficking and Packaging,Wei-Shau  Hu; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Jianbo  Chen|Vinay K Pathak; PhD|Kari Ann Dilley|Alan  Rein; PhD|John Miller Coffin; PhD|Steven Carter Hatch|Show all 12,"William W Fu|Marie-Louise  Hammarskjold (University of Virginia)|Roger  Ptak (Southern Research Institute)|David  Rekosh (Myles Thayler AIDS Institute, University of Virginia)|Andrew  Wright (Tufts University)",Stephen J Lockett; PhD (Office Of The Director)|Sriram  Subramaniam; PhD (Laboratory of Cell Biology),George  Patterson; PhD (NIBIB),"1. Dilley K, Ni N, Nikolaitchik O, Chen J, Galli A, Hu W (2011) Determining the frequency and mechanisms of HIV-1 and HIV-2 RNA copackaging by single virion analysis. J Virol, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=68428
304,BC010815-05,"October 01, 2010 -  September 30, 2011",Regulation of Hypoxia-Inducible Factors in Pluripotent Cancer Cells.,John Edward Niederhuber,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",NULL,NULL,"Jeffrey S Rubin; MD, PhD (Laboratory of Cellular and Molecular Biology)|Yoshimi Endo Greer (Laboratory of Cellular and Molecular Biology)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68429
305,BC010816-05,"October 01, 2010 -  September 30, 2011",Immunotherapy for Malignant Mesothelioma,Raffit  Hassan|IRP Faculty Profile,NULL,"Laboratory of Molecular Biology, NCI",Ali Awais Ashai|Neetu  Kalra|Yvonne D Mallory|Barbara S Schuler|Jingli  Zhang|Sonya C Duke|Show all 9,NULL,Ira H Pastan; MD (Molecular Biology Section)|Peter L Choyke; MD (Molecular Imaging Program)|Daniel H Fowler (Experimental Transplantation and Immunology Branch)|Maria  Merino; PhD (Laboratory of Pathology),NULL,"1. Hassan R, Cohen SJ, Phillips M, Pastan I, Sharon E, Kelly RJ, Schweizer C, Weil S, Laheru D (2010). Phase I clinical trial of the chimeric anti-mesothelin monoclonal antibody MORAb-009 in patients with mesothelin-expressing cancers. Clin Cancer Res  16, 6132-8.   https://doi.org/10.1158/1078-0432.CCR-10-2275|2. Hassan R, Schweizer C, Lu KF, Schuler B, Remaley AT, Weil SC, Pastan I (2010). Inhibition of mesothelin-CA-125 interaction in patients with mesothelioma by the anti-mesothelin monoclonal antibody MORAb-009: Implications for cancer therapy. Lung Cancer  68, 455-9.   https://doi.org/10.1016/j.lungcan.2009.07.016|3. Zhang Y, Hansen JK, Xiang L, Kawa S, Onda M, Ho M, Hassan R, Pastan I (2010). A flow cytometry method to quantitate internalized immunotoxins shows that taxol synergistically increases cellular immunotoxins uptake. Cancer Res  70, 1082-9.   https://doi.org/10.1158/0008-5472.CAN-09-2405",https://intramural.nih.gov/search/searchview.taf?ipid=68430
306,BC010817-05,"October 01, 2010 -  September 30, 2011",Role of normal cervical stem cells in HPV induced initiation of cervical cancer,John Edward Niederhuber,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",NULL,NULL,John  Schiller; PhD (Laboratory of Cellular Oncology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68431
307,BC010818-05,"October 01, 2010 -  September 30, 2011",Replication Dynamics in Patients on Suppressive Antiretroviral Therapy,Frank  Maldarelli,Stephen H Hughes; PhD,"Host Virus Interaction Branch, NCI",Tiffany Noel Tanzosh|Eleanor Mckenna Pitt Wilson,"Zandrea  Ambrose (University of Pittsburgh)|Jintanat  Ananworanich; MD, PhD (HIV Netherlands Australia Thailand Research Collaboration (HIV/NAT))|Thomas  Benfield (University of Copenhagen)|Scott  Brun (-, Abbott Laboratories)|Nancy  Crum-Clanfione (Naval Medical Center)|Lisa  Demeter (University of Washington)|Show all 27",Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch),"Henry  Masur; MD (CC) |Richard T Davey; MD (NIAID) |Shyamasundaran  Kottilil; MD, PhD (NIAID) |Michael  Polis; MD (NIAID) |Anthony  Fauci; MD (NIAID) |Mark  Connors; MD (NIAID)","1. Mens H, Kearney M, Wiegand A, Shao W, Schønning K, Gerstoft J, Obel N, Maldarelli F, Mellors JW, Benfield T, Coffin JM (2010). HIV-1 continues to replicate and evolve in patients with natural control of HIV infection. J Virol  84, 12971-81.   https://doi.org/10.1128/JVI.00387-10|2. Mens H, Kearney M, Wiegand A, Spindler J, Maldarelli F, Mellors J, Coffin J (2011) Quantifying HIV-1 plasma RNA and sequencing single genomes in HIV infected individuals with viral loads below the limit of detection by standard clinical assays. J Visual Exp, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=68432
308,BC010819-05,"October 01, 2010 -  September 30, 2011",HIV-1 Genetic Variation in Infected Individuals,Frank  Maldarelli,Stephen H Hughes; PhD,"Host Virus Interaction Branch, NCI",Tiffany Noel Tanzosh|Eleanor Mckenna Pitt Wilson,"Guilliaume  Achaz (University of Paris)|Zandrea  Ambrose (University of Pittsburgh)|Sunil  Arora (PGIMER)|Thomas  Benfield (University of Copenhagen)|James Coston Brooks|Eric  Daar (Infectious Diseases, Harbor-UCL Medical Center)|Show all 20","Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch)|Eric O Freed; PhD (Retroviral Replication Laboratory)|Mary  Carrington; MS, PhD (Laboratory of Experimental Immunology)|Vineet Narain KewalRamani; PhD (Retroviral Replication Laboratory)|Wei-Shau  Hu; PhD (Retroviral Replication Laboratory)|Vinay K Pathak; PhD (Retroviral Replication Laboratory)","Henry  Masur; MD (CC) |Shyamasundaran  Kottilil; MD, PhD (NIAID) |Michael  Polis; MD (NIAID) |Caryn G Morse; MD (CC) |H. Clifford  Lane; MD (NIAID) |Joseph A Kovacs; MD (CC)","1. Batorsky R, Kearney MF, Palmer SE, Maldarelli F, Rouzine IM, Coffin JM (2011). Estimate of effective recombination rate and average selection coefficient for HIV in chronic infection. Proc Natl Acad Sci U S A  108, 5661-6.   https://doi.org/10.1073/pnas.1102036108|2. Kearney M, Spindler J, Shao W, Maldarelli F, Palmer S, Hu SL, Lifson JD, KewalRamani VN, Mellors JW, Coffin JM, Ambrose Z (2011). Genetic diversity of simian immunodeficiency virus encoding HIV-1 reverse transcriptase persists in macaques despite antiretroviral therapy. J Virol  85, 1067-76.   https://doi.org/10.1128/JVI.01701-10|3. Mens H, Kearney M, Wiegand A, Shao W, Schønning K, Gerstoft J, Obel N, Maldarelli F, Mellors JW, Benfield T, Coffin JM (2010). HIV-1 continues to replicate and evolve in patients with natural control of HIV infection. J Virol  84, 12971-81.   https://doi.org/10.1128/JVI.00387-10|4. Mens H, Kearney M, Wiegand A, Spindler J, Maldarelli F, Mellors J, Coffin J (2011) Quantifying HIV-1 plasma RNA and sequencing single genomes in HIV infected individuals with viral loads below the limit of detection by standard clinical assays. J Visual Exp, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=68433
309,BC010820-05,"October 01, 2010 -  September 30, 2011",Appearance and Disappearance of Drug Resistance Mutations,Frank  Maldarelli,Stephen H Hughes; PhD,"Host Virus Interaction Branch, NCI",Tiffany Noel Tanzosh,"Zandrea  Ambrose (University of Pittsburgh)|John W Mellors|Lynn  Morris (National Institute for Communicable Diseases)|Douglas  Richman|Pat  Robertson (-, Boehringer Ingelheim)",Eric O Freed; PhD (Retroviral Replication Laboratory)|Vineet Narain KewalRamani; PhD (Retroviral Replication Laboratory),Henry  Masur; MD (CC) |Richard T Davey; MD (NIAID) |H. Clifford  Lane; MD (NIAID),"1. Boyd SD, Maldarelli F, Sereti I, Ouedraogo GL, Rehm CA, Boltz V, Shoemaker D, Pau AK (2011). Transmitted raltegravir resistance in an HIV-1 CRF_AG-infected patient. Antivir Ther  16, 257-61.   https://doi.org/10.3851/IMP1749|2. Cortez K, Maldarelli F (2011) Clinical management of HIV drug resistance. Viruses, in press.|3. Dlamini JN, Hu Z, Ledwaba J, Morris L, Maldarelli FM, Dewar RL, Highbarger HC, Somaroo H, Sangweni P, Follmann DA, Pau AK, Phidisa II Study Team (2011). Genotypic resistance at viral rebound among patients who received lopinavir/ritonavir-based or efavirenz-based first antiretroviral therapy in South Africa. J Acquir Immune Defic Syndr  58, 304-8.   https://doi.org/10.1097/QAI.0b013e3182278c29|4. Ganesan A, Crum-Cianflone N, Higgins J, Qin J, Rehm C, Metcalf J, Brandt C, Vita J, Decker CF, Sklar P, Bavaro M, Tasker S, Follmann D, Maldarelli F (2011). High dose atorvastatin decreases cellular markers of immune activation without affecting HIV-1 RNA levels: results of a double-blind randomized placebo controlled clinical trial. J Infect Dis  203, 756-64.   https://doi.org/10.1093/infdis/jiq115|5. Palmer S, Boltz V, Chow J, Martinson N, McIntyre J, Gray G, Hopley M, Mayers D, Robinson P, Hall D, Maldarelli F, Coffin J, Mellors J, 1100.1413 T (2011) Short-course combivir after single dose nevirapine reduces but does not eliminate the emergence of nevirapine resistance in women. Antiviral Ther, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=68434
310,BC010821-05,"October 01, 2010 -  September 30, 2011",Role of Specific Drugs and Mutations in Partial Suppression of Viremia,Frank  Maldarelli,Stephen H Hughes; PhD,"Host Virus Interaction Branch, NCI",NULL,Nancy  Crum-Clanfione (Naval Medical Center)|Anuradha  Ganesan (Henry M. Jackson Foundation),"Eric O Freed; PhD (Retroviral Replication Laboratory)|Mary  Carrington; MS, PhD (Laboratory of Experimental Immunology)|Vinay K Pathak; PhD (Retroviral Replication Laboratory)|Paul L Boyer (Retroviral Replication Laboratory)",Henry  Masur; MD (CC) |Richard T Davey; MD (NIAID) |Rohan  Hazra (NICHD) |H. Clifford  Lane; MD (NIAID) |Joann  Mican; MD (NIAID) |Irini  Sereti; MD (NIAID),"1. Dlamini JN, Hu Z, Ledwaba J, Morris L, Maldarelli FM, Dewar RL, Highbarger HC, Somaroo H, Sangweni P, Follmann DA, Pau AK, Phidisa II Study Team (2011). Genotypic resistance at viral rebound among patients who received lopinavir/ritonavir-based or efavirenz-based first antiretroviral therapy in South Africa. J Acquir Immune Defic Syndr  58, 304-8.   https://doi.org/10.1097/QAI.0b013e3182278c29",https://intramural.nih.gov/search/searchview.taf?ipid=68435
311,BC010822-05,"October 01, 2010 -  September 30, 2011",Molecular Determinants of Chromosome Transmission and Cell Cycle Regulation,Munira A Basrai; PhD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Wei-Chun  Au|Natasha  Caplen|Lars  Bockmann|Anna V Roschke|John S Choy|Karl Thomas Ried; MD|Show all 11,"Richard  Baker (Univ. of Massachusetts, Amherst)|Kenneth  Belanger (Biology, Colgate University)|Maitreya  Dunham (Genome Sciences, Univ of Washington,)|Grant  Hartzog (MCD Biology, Univ. of California, Santa Cruz)|Oliver J. Rando (Stanford University)",NULL,NULL,"1. Guo Y, Au WC, Shakoury-Elizeh M, Protchenko O, Basrai M, Prinz WA, Philpott CC (2010). Phosphatidylserine is involved in the ferrichrome-induced plasma membrane trafficking of Arn1 in Saccharomyces cerevisiae. J Biol Chem  285, 39564-73.   https://doi.org/10.1074/jbc.M110.177055",https://intramural.nih.gov/search/searchview.taf?ipid=68392
312,BC010824-05,"October 01, 2010 -  September 30, 2011",Molecular structure of the bacterial chemotaxis apparatus,Sriram  Subramaniam; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI","Lisa M. Hartnell|Martin  Kessel; BSc, PhD|Joel Reuben Meyerson|Rachna C Nandwani","Jerry  Hazelbauer (Biochemistry, University of Missouri)|Victor  Sourjik (University of Heidelberg)|Yuhai  Tu (IBM)",NULL,Bernard R Brooks; PhD (NHLBI),"1. Fenton AK, Hobley L, Butan C, Subramaniam S, Sockett RE (2010). A coiled-coil-repeat protein 'Ccrp' in Bdellovibrio bacteriovorus prevents cellular indentation, but is not essential for vibroid cell morphology. FEMS Microbiol Lett  313, 89-95.   https://doi.org/10.1111/j.1574-6968.2010.02125.x",https://intramural.nih.gov/search/searchview.taf?ipid=68436
313,BC010825-05,"October 01, 2010 -  September 30, 2011",HIV neutralization and mechanisms of cellular entry,Sriram  Subramaniam; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",Siddhant  Bhatia|Udaysankar  Chockanathan|Moez M Dawood|Gabriel Abraham Frank|Laurent A Gaudreault|Gould  Patrick|Show all 17,"Sina  Bavari (-, USAMRIID)|Thomas  Hope (University of Illinois-Chicago)|John  Moore (Cornell University)|William  Olson (Progenics Inc.)",Jeffrey D Lifson; MD (Office Of The Director)|Robert  Blumenthal; PhD (Center for Cancer Research Nanobiology Program)|Dimiter Stanchev Dimitrov; PhD (Membrane Structure and Function Section)|Eric O Freed; PhD (Retroviral Replication Laboratory),NULL,"1. Felts RL, Narayan K, Estes JD, Shi D, Trubey CM, Fu J, Hartnell LM, Ruthel GT, Schneider DK, Nagashima K, Bess JW, Bavari S, Lowekamp BC, Bliss D, Lifson JD, Subramaniam S (2010). 3D visualization of HIV transfer at the virological synapse between dendritic cells and T cells. Proc Natl Acad Sci U S A  107, 13336-41.   https://doi.org/10.1073/pnas.1003040107|2. White TA, Bartesaghi A, Borgnia MJ, Meyerson JR, de la Cruz MJ, Bess JW, Nandwani R, Hoxie JA, Lifson JD, Milne JL, Subramaniam S (2010). Molecular architectures of trimeric SIV and HIV-1 envelope glycoproteins on intact viruses: strain-dependent variation in quaternary structure. PLoS Pathog  6, e1001249.   https://doi.org/10.1371/journal.ppat.1001249",https://intramural.nih.gov/search/searchview.taf?ipid=68437
314,BC010826-05,"October 01, 2010 -  September 30, 2011",Technology Development for 3D Electron Microscopy,Sriram  Subramaniam; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",Alberto  Bartesaghi|Michael Jason de la Cruz|Gabriel Abraham Frank|Rachna C Nandwani|Kedar  Narayan|David Michael Schauder,"Guillermo  Sapiro (Electrical Engineering, Uinversity of Minnesota)|John Henry  Scott (NIST)|Chris  Szakal (NIST)",NULL,Bernard R Brooks; PhD (NHLBI) |Terry S Yoo; PhD (NLM),"1. Felts RL, Narayan K, Estes JD, Shi D, Trubey CM, Fu J, Hartnell LM, Ruthel GT, Schneider DK, Nagashima K, Bess JW, Bavari S, Lowekamp BC, Bliss D, Lifson JD, Subramaniam S (2010). 3D visualization of HIV transfer at the virological synapse between dendritic cells and T cells. Proc Natl Acad Sci U S A  107, 13336-41.   https://doi.org/10.1073/pnas.1003040107|2. Murphy GE, Lowekamp BC, Zerfas PM, Chandler RJ, Narasimha R, Venditti CP, Subramaniam S (2010). Ion-abrasion scanning electron microscopy reveals distorted liver mitochondrial morphology in murine methylmalonic acidemia. J Struct Biol  171, 125-32.   https://doi.org/10.1016/j.jsb.2010.04.005|3. White TA, Bartesaghi A, Borgnia MJ, Meyerson JR, de la Cruz MJ, Bess JW, Nandwani R, Hoxie JA, Lifson JD, Milne JL, Subramaniam S (2010). Molecular architectures of trimeric SIV and HIV-1 envelope glycoproteins on intact viruses: strain-dependent variation in quaternary structure. PLoS Pathog  6, e1001249.   https://doi.org/10.1371/journal.ppat.1001249",https://intramural.nih.gov/search/searchview.taf?ipid=68438
315,BC010827-05,"October 01, 2010 -  September 30, 2011",Structural Studies of Bacterial Architecture Using Electron Tomography,Jacqueline L Milne,NULL,"Laboratory of Cell Biology, NCI",Mario J Borgnia; PhD|Sriram  Subramaniam; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68439
316,BC010830-05,"October 01, 2010 -  September 30, 2011",Mechanisms of non-classical multidrug resistance in cancer,Michael Marc Gottesman; MD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",NULL,"Ben  Davidson (Norwegian Radium Hospital)|Ram  Ganapathy (Cleveland Clinic)|Jacob  Hochman (Hebrew University)|Robert  Hollingsworth (MedImmune)|Bo  Rueda (Massachusetts General Hospital)|Michael  Seiden (Hematology Oncology, Dana-Farber/Partners Cancer Care Program)",Suresh V Ambudkar; PhD (Transport Biochemistry Section)|Vincent J. Hearing; PhD (Pigment Cell Biology Section),"Chandan  Das (OD) |Jean-Pierre  Gillet (OD) |Kevin G Chen; MD (NINDS) |Orit  Lavi; PhD (OD) |Radhakrishnan  Padmanabhan (OD) |Joshua  Zimmerberg; PhD, MD (NICHD)","1. Calcagno AM, Salcido CD, Gillet JP, Wu CP, Fostel JM, Mumau MD, Gottesman MM, Varticovski L, Ambudkar SV (2010). Prolonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristics. J Natl Cancer Inst  102, 1637-52.   https://doi.org/10.1093/jnci/djq361|2. Gillet JP, Gottesman MM (2010). Mechanisms of multidrug resistance in cancer. Methods Mol Biol  596, 47-76.   https://doi.org/10.1007/978-1-60761-416-6_4|3. Gillet JP, Gottesman MM (2011). Advances in the molecular detection of ABC transporters involved in multidrug resistance in cancer. Curr Pharm Biotechnol  12, 686-92.   https://doi.org/10.2174/138920111795163931|4. Liang XJ, Meng H, Wang Y, He H, Meng J, Lu J, Wang PC, Zhao Y, Gao X, Sun B, Chen C, Xing G, Shen D, Gottesman MM, Wu Y, Yin JJ, Jia L (2010). Metallofullerene nanoparticles circumvent tumor resistance to cisplatin by reactivating endocytosis. Proc Natl Acad Sci U S A  107, 7449-54.   https://doi.org/10.1073/pnas.0909707107|5. Shen DW, Ma J, Okabe M, Zhang G, Xia D, Gottesman MM (2010). Elevated expression of TMEM205, a hypothetical membrane protein, is associated with cisplatin resistance. J Cell Physiol  225, 822-8.   https://doi.org/10.1002/jcp.22287|6. Shukla S, Skoumbourdis AP, Walsh MJ, Hartz AM, Fung KL, Wu CP, Gottesman MM, Bauer B, Thomas CJ, Ambudkar SV (2011). Synthesis and characterization of a BODIPY conjugate of the BCR-ABL kinase inhibitor Tasigna (nilotinib): evidence for transport of Tasigna and its fluorescent derivative by ABC drug transporters. Mol Pharm  8, 1292-302.   https://doi.org/10.1021/mp2001022",https://intramural.nih.gov/search/searchview.taf?ipid=68440
317,BC010832-05,"October 01, 2010 -  September 30, 2011",Fundamentals of Ligand-Protein Interactions,Marc C Nicklaus|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Igor V Filippov|Chenzhong  Liao|Megan L Peach|Angelo  Pugliese; PhD|Markus  Sitzmann|Iwona Elzbieta Weidlich,NULL,Raul Eduardo Cachau (Office Of The Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68441
318,BC010833-05,"October 01, 2010 -  September 30, 2011",Identification and functional characterization of colorectal cancer genes,Karl Thomas Ried; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Markus Alexander Brown|Natasha  Caplen|Jordi  Camps Polo|Chanelle Monet Case Borden|Chi Chung  Cheng|Timo  Gaiser|Show all 14,NULL,NULL,NULL,"1. Gaedcke J, Grade M, Jung K, Camps J, Jo P, Emons G, Gehoff A, Sax U, Schirmer M, Becker H, Beissbarth T, Ried T, Ghadimi BM (2010). Mutated KRAS results in overexpression of DUSP4, a MAP-kinase phosphatase, and SMYD3, a histone methyltransferase, in rectal carcinomas. Genes Chromosomes Cancer  49, 1024-34.   https://doi.org/10.1002/gcc.20811|2. Grade M, Hummon AB, Camps J, Emons G, Spitzner M, Gaedcke J, Hoermann P, Ebner R, Becker H, Difilippantonio MJ, Ghadimi BM, Beissbarth T, Caplen NJ, Ried T (2011). A genomic strategy for the functional validation of colorectal cancer genes identifies potential therapeutic targets. Int J Cancer  128, 1069-79.   https://doi.org/10.1002/ijc.25453",https://intramural.nih.gov/search/searchview.taf?ipid=68442
319,BC010834-05,"October 01, 2010 -  September 30, 2011","Identifying Diagnostic Markers for Cervical, Breast, and Prostate Cancer",Karl Thomas Ried; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Amanda Iris Bradley|Bernard N Chen|Chi Chung  Cheng|Timo  Gaiser|Kerstin  Heselmeyer|Yue  Hu|Show all 11,Gert  Auer|Elisabeth  Unger,NULL,NULL,"1. Gaiser T, Berroa-Garcia L, Kemmerling R, Dutta A, Ried T, Heselmeyer-Haddad K (2010). Automated analysis of protein expression and gene amplification within the same cells of paraffin-embedded tumour tissue. Anal Cell Pathol (Amst)  33, 105-12.   https://doi.org/10.3233/ACP-CLO-2010-0532|2. Mettu RK, Wan YW, Habermann JK, Ried T, Guo NL (2010). A 12-gene genomic instability signature predicts clinical outcomes in multiple cancer types. Int J Biol Markers  25, 219-28.   https://doi.org/10.5301/jbm.2010.6079|3. Prindiville SA, Ried T (2010). Interphase cytogenetics of sputum cells for the early detection of lung carcinogenesis. Cancer Prev Res (Phila)  3, 416-9.   https://doi.org/10.1158/1940-6207.CAPR-10-0045",https://intramural.nih.gov/search/searchview.taf?ipid=68443
320,BC010835-05,"October 01, 2010 -  September 30, 2011",Consequences of Genomic Instability and Aneuploidy on the Colorectal Cancer Tran,Karl Thomas Ried; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Markus Alexander Brown|Jordi  Camps Polo|Eric  Cardin|Chanelle Monet Case Borden|Bernard N Chen|Chi Chung  Cheng|Show all 14,Thomas  Cremer (University of Munich)|Yuri  Lazebnik (Cold Spring Harbor Laboratories),Andre A Nussenzweig; PhD (Experimental Immunology Branch)|Thomas A Misteli; PhD (Hormone Action and Oncogenesis Section)|Yamini Praful Dalal (Hormone Action and Oncogenesis Section),Danny L Sackett; PhD (NICHD),"1. Gaiser T, Camps J, Meinhardt S, Wangsa D, Nguyen QT, Varma S, Dittfeld C, Kunz-Schughart LA, Kemmerling R, Becker MR, Heselmeyer-Haddad K, Ried T (2011). Genome and transcriptome profiles of CD133-positive colorectal cancer cells. Am J Pathol  178, 1478-88.   https://doi.org/10.1016/j.ajpath.2010.12.036|2. Gemoll T, Roblick UJ, Szymczak S, Braunschweig T, Becker S, Igl BW, Bruch HP, Ziegler A, Hellman U, Difilippantonio MJ, Ried T, Jörnvall H, Auer G, Habermann JK (2011). HDAC2 and TXNL1 distinguish aneuploid from diploid colorectal cancers. Cell Mol Life Sci  68, 3261-74.   https://doi.org/10.1007/s00018-011-0628-3",https://intramural.nih.gov/search/searchview.taf?ipid=68444
321,BC010836-05,"October 01, 2010 -  September 30, 2011",Cancer Genomics,Karl Thomas Ried; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Jordi  Camps Polo|Chanelle Monet Case Borden|Bernard N Chen|Chi Chung  Cheng|Timo  Gaiser|Marian  Grade|Show all 13,"Gert  Auer|Michael  Ghadimi (Surgery, U. of Goettingen)",NULL,NULL,"1. Cheng L, Zhou Z, Flesken-Nikitin A, Toshkov IA, Wang W, Camps J, Ried T, Nikitin AY (2010). Rb inactivation accelerates neoplastic growth and substitutes for recurrent amplification of cIAP1, cIAP2 and Yap1 in sporadic mammary carcinoma associated with p53 deficiency. Oncogene  29, 5700-11.   https://doi.org/10.1038/onc.2010.300|2. Gaiser T, Camps J, Meinhardt S, Wangsa D, Nguyen QT, Varma S, Dittfeld C, Kunz-Schughart LA, Kemmerling R, Becker MR, Heselmeyer-Haddad K, Ried T (2011). Genome and transcriptome profiles of CD133-positive colorectal cancer cells. Am J Pathol  178, 1478-88.   https://doi.org/10.1016/j.ajpath.2010.12.036|3. Goldenberg DM, Zagzag D, Heselmeyer-Haddad KM, Berroa Garcia LY, Ried T, Loo M, Chang CH, Gold DV (2012). Horizontal transmission and retention of malignancy, as well as functional human genes, after spontaneous fusion of human glioblastoma and hamster host cells in vivo. Int J Cancer  131, 49-58.   https://doi.org/10.1002/ijc.26327|4. Grade M, Hummon AB, Camps J, Emons G, Spitzner M, Gaedcke J, Hoermann P, Ebner R, Becker H, Difilippantonio MJ, Ghadimi BM, Beissbarth T, Caplen NJ, Ried T (2011). A genomic strategy for the functional validation of colorectal cancer genes identifies potential therapeutic targets. Int J Cancer  128, 1069-79.   https://doi.org/10.1002/ijc.25453|5. Liu Z, Yang X, Li Z, McMahon C, Sizer C, Barenboim-Stapleton L, Bliskovsky V, Mock B, Ried T, London WB, Maris J, Khan J, Thiele CJ (2011). CASZ1, a candidate tumor-suppressor gene, suppresses neuroblastoma tumor growth through reprogramming gene expression. Cell Death Differ  18, 1174-83.   https://doi.org/10.1038/cdd.2010.187|6. Takizawa M, Kim JS, Tessarollo L, McNeil N, Waldschmidt TJ, Casellas R, Ried T, Janz S (2010). Genetic reporter system for oncogenic Igh-Myc translocations in mice. Oncogene  29, 4113-20.   https://doi.org/10.1038/onc.2010.150|7. Yang Y, Valera VA, Padilla-Nash HM, Sourbier C, Vocke CD, Vira MA, Abu-Asab MS, Bratslavsky G, Tsokos M, Merino MJ, Pinto PA, Srinivasan R, Ried T, Neckers L, Linehan WM (2010). UOK 262 cell line, fumarate hydratase deficient (FH-/FH-) hereditary leiomyomatosis renal cell carcinoma: in vitro and in vivo model of an aberrant energy metabolic pathway in human cancer. Cancer Genet Cytogenet  196, 45-55.   https://doi.org/10.1016/j.cancergencyto.2009.08.018",https://intramural.nih.gov/search/searchview.taf?ipid=68445
322,BC010837-05,"October 01, 2010 -  September 30, 2011",Prediction of Therapy Response in Colorectal Cancer,Karl Thomas Ried; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Jordi  Camps Polo|Natasha  Caplen|Bernard N Chen|Chi Chung  Cheng|Marian  Grade|Yue  Hu|Show all 9,NULL,NULL,NULL,"1. Gaedcke J, Grade M, Jung K, Camps J, Jo P, Emons G, Gehoff A, Sax U, Schirmer M, Becker H, Beissbarth T, Ried T, Ghadimi BM (2010). Mutated KRAS results in overexpression of DUSP4, a MAP-kinase phosphatase, and SMYD3, a histone methyltransferase, in rectal carcinomas. Genes Chromosomes Cancer  49, 1024-34.   https://doi.org/10.1002/gcc.20811|2. Grade M, Hummon AB, Camps J, Emons G, Spitzner M, Gaedcke J, Hoermann P, Ebner R, Becker H, Difilippantonio MJ, Ghadimi BM, Beissbarth T, Caplen NJ, Ried T (2011). A genomic strategy for the functional validation of colorectal cancer genes identifies potential therapeutic targets. Int J Cancer  128, 1069-79.   https://doi.org/10.1002/ijc.25453",https://intramural.nih.gov/search/searchview.taf?ipid=68447
323,BC010839-05,"October 01, 2010 -  September 30, 2011",Exploring the Therapeutic Potential of Stem Cell Biology in Gliomas,"Howard A Fine; MD, PhD",NULL,"Neuro-Oncology Branch, NCI",Baltazar D Aguda|Susie  Ahn|Peter  Bauer; PhD|Mehmet  Baysan|Margaret  Cam; PhD|Emely  Castro-Rivera|Show all 18,NULL,NULL,NULL,"1. Bozdag S, Li A, Wuchty S, Fine HA (2010). FastMEDUSA: a parallelized tool to infer gene regulatory networks. Bioinformatics  26, 1792-3.   https://doi.org/10.1093/bioinformatics/btq275|2. Edwards LA, Woolard K, Son MJ, Li A, Lee J, Ene C, Mantey SA, Maric D, Song H, Belova G, Jensen RT, Zhang W, Fine HA (2011). Effect of brain- and tumor-derived connective tissue growth factor on glioma invasion. J Natl Cancer Inst  103, 1162-78.   https://doi.org/10.1093/jnci/djr224|3. Fraum TJ, Kreisl TN, Sul J, Fine HA, Iwamoto FM (2011). Ischemic stroke and intracranial hemorrhage in glioma patients on antiangiogenic therapy. J Neurooncol  105, 281-9.   https://doi.org/10.1007/s11060-011-0579-4|4. Kotliarov Y, Bozdag S, Cheng H, Wuchty S, Zenklusen JC, Fine HA (2010). CNAReporter: a GenePattern pipeline for the generation of clinical reports of genomic alterations. BMC Med Genomics  3, 11.   https://doi.org/10.1186/1755-8794-3-11|5. Li A, Bozdag S, Kotliarov Y, Fine HA (2010). GliomaPredict: a clinically useful tool for assigning glioma patients to specific molecular subtypes. BMC Med Inform Decis Mak  10, 38.   https://doi.org/10.1186/1472-6947-10-38|6. Park JK, Hodges T, Arko L, Shen M, Dello Iacono D, McNabb A, Olsen Bailey N, Kreisl TN, Iwamoto FM, Sul J, Auh S, Park GE, Fine HA, Black PM (2010). Scale to predict survival after surgery for recurrent glioblastoma multiforme. J Clin Oncol  28, 3838-43.   https://doi.org/10.1200/JCO.2010.30.0582|7. Riddick G, Song H, Ahn S, Walling J, Borges-Rivera D, Zhang W, Fine HA (2011). Predicting in vitro drug sensitivity using Random Forests. Bioinformatics  27, 220-4.   https://doi.org/10.1093/bioinformatics/btq628|8. Sul J, Fine HA (2010). Malignant gliomas: new translational therapies. Mt Sinai J Med  77, 655-66.   https://doi.org/10.1002/msj.20223|9. Wuchty S, Arjona D, Li A, Kotliarov Y, Walling J, Ahn S, Zhang A, Maric D, Anolik R, Zenklusen JC, Fine HA (2011). Prediction of Associations between microRNAs and Gene Expression in Glioma Biology. PLoS One  6, e14681.   https://doi.org/10.1371/journal.pone.0014681",https://intramural.nih.gov/search/searchview.taf?ipid=68398
324,BC010840-05,"October 01, 2010 -  September 30, 2011",Elucidation and Exploitation of GSK3 as a Novel Glioma Therapeutic Target,"Howard A Fine; MD, PhD",NULL,"Neuro-Oncology Branch, NCI",Baltazar D Aguda|Susie  Ahn|Peter  Bauer; PhD|Mehmet  Baysan|Margaret  Cam; PhD|Emely  Castro-Rivera|Show all 18,NULL,NULL,NULL,"1. Bozdag S, Li A, Wuchty S, Fine HA (2010). FastMEDUSA: a parallelized tool to infer gene regulatory networks. Bioinformatics  26, 1792-3.   https://doi.org/10.1093/bioinformatics/btq275|2. Edwards LA, Woolard K, Son MJ, Li A, Lee J, Ene C, Mantey SA, Maric D, Song H, Belova G, Jensen RT, Zhang W, Fine HA (2011). Effect of brain- and tumor-derived connective tissue growth factor on glioma invasion. J Natl Cancer Inst  103, 1162-78.   https://doi.org/10.1093/jnci/djr224|3. Fraum TJ, Kreisl TN, Sul J, Fine HA, Iwamoto FM (2011). Ischemic stroke and intracranial hemorrhage in glioma patients on antiangiogenic therapy. J Neurooncol  105, 281-9.   https://doi.org/10.1007/s11060-011-0579-4|4. Kotliarov Y, Bozdag S, Cheng H, Wuchty S, Zenklusen JC, Fine HA (2010). CNAReporter: a GenePattern pipeline for the generation of clinical reports of genomic alterations. BMC Med Genomics  3, 11.   https://doi.org/10.1186/1755-8794-3-11|5. Li A, Bozdag S, Kotliarov Y, Fine HA (2010). GliomaPredict: a clinically useful tool for assigning glioma patients to specific molecular subtypes. BMC Med Inform Decis Mak  10, 38.   https://doi.org/10.1186/1472-6947-10-38|6. Riddick G, Song H, Ahn S, Walling J, Borges-Rivera D, Zhang W, Fine HA (2011). Predicting in vitro drug sensitivity using Random Forests. Bioinformatics  27, 220-4.   https://doi.org/10.1093/bioinformatics/btq628|7. Sul J, Fine HA (2010). Malignant gliomas: new translational therapies. Mt Sinai J Med  77, 655-66.   https://doi.org/10.1002/msj.20223|8. Wuchty S, Arjona D, Li A, Kotliarov Y, Walling J, Ahn S, Zhang A, Maric D, Anolik R, Zenklusen JC, Fine HA (2011). Prediction of Associations between microRNAs and Gene Expression in Glioma Biology. PLoS One  6, e14681.   https://doi.org/10.1371/journal.pone.0014681",https://intramural.nih.gov/search/searchview.taf?ipid=68399
325,BC010844-05,"October 01, 2010 -  September 30, 2011",DNA Folding in Chromatin and Interaction with Transcription Factors,Victor  Zhurkin; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",Feng  Cui|Tatiana Vladimirovna Nikitina|Difei  Wang,"Sergei  Grigoryev (Pennsylvania State University College of Medicine)|Wilma  Olson (Wright-Rieman Laboratories, Rutgers University)",Sankar  Adhya; PhD (Developmental Genetics Section),David Johannes Clark; PhD (NICHD),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68450
326,BC010845-05,"October 01, 2010 -  September 30, 2011",p53-induced Regulation of Transcription in the Chromatin Context,Victor  Zhurkin; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",Feng  Cui|Difei  Wang,NULL,Curtis  Harris; MD (Laboratory of Human Carcinogenesis)|Ettore  Appella; MD (Chemical Immunology Section),Ronald D Neumann; MD (CC),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68407
327,BC010846-05,"October 01, 2010 -  September 30, 2011",Mechanisms of Transcriptional Control by p300,"Kevin  Gardner; MD, PhD",NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Jung Shin  Byun|Temesgen D Fufa|Gordon Lee Hager; PhD|Cynthia  Haggerty|Jesse F Quintero|Clay Torao Wakano; PhD|Show all 7,NULL,"William D Figg; PharmD (Medical Oncology Branch)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",Dan L Longo; MD (NIA),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68405
328,BC010847-05,"October 01, 2010 -  September 30, 2011",Gene-specific Mechanisms of BRCA1 transcriptional Control,"Kevin  Gardner; MD, PhD",NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Jung Shin  Byun|Lijun  Di|Cynthia  Haggerty|Jesse F Quintero|Tara  Taylor|Clay Torao Wakano; PhD,NULL,"Kent W Hunter; PhD (Laboratory of Cancer Biology and Genetics)|Kevin A Camphausen; MD (Radiation Oncology Branch)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",Dan L Longo; MD (NIA),"1. De Siervi A, De Luca P, Byun JS, Di LJ, Fufa T, Haggerty CM, Vazquez E, Moiola C, Longo DL, Gardner K (2010). Transcriptional autoregulation by BRCA1. Cancer Res  70, 532-42.   https://doi.org/10.1158/0008-5472.CAN-09-1477|2. Di LJ, Fernandez AG, De Siervi A, Longo DL, Gardner K (2010). Transcriptional regulation of BRCA1 expression by a metabolic switch. Nat Struct Mol Biol  17, 1406-13.   https://doi.org/10.1038/nsmb.1941|3. Moiola C, De Luca P, Gardner K, Vazquez E, De Siervi A (2010). Cyclin T1 overexpression induces malignant  transformation and tumor growth. Cell Cycle  9, 3119-26.   https://doi.org/10.4161/cc.9.15.12526",https://intramural.nih.gov/search/searchview.taf?ipid=68406
329,BC010849-05,"October 01, 2010 -  September 30, 2011",Evaluation of Novel Radiation Modifiers,Deborah E Citrin|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Eunjoo Serena Chung|Ayla Oksuz White|Luz Marina Giordano,NULL,James B Mitchell; PhD (Radiation Biology Branch),NULL,"1. Citrin D, Camphausen K, Wood BJ, Quezado M, Denobile J, Pingpank JF, Royal RE, Alexander HR, Seidel G, Steinberg SM, Shuttack Y, Libutti SK (2010). A pilot feasibility study of TNFerade™ biologic with capecitabine and radiation therapy followed by surgical resection for the treatment of rectal cancer. Oncology  79, 382-8.   https://doi.org/10.1159/000323488|2. Mitchell JB, Choudhuri R, Fabre K, Sowers AL, Citrin D, Zabludoff SD, Cook JA (2010). In vitro and in vivo radiation sensitization of human tumor cells by a novel checkpoint kinase inhibitor, AZD7762. Clin Cancer Res  16, 2076-84.   https://doi.org/10.1158/1078-0432.CCR-09-3277",https://intramural.nih.gov/search/searchview.taf?ipid=68451
330,BC010850-05,"October 01, 2010 -  September 30, 2011",Mechanisms of Normal Tissue Toxicity,Deborah E Citrin|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Eunjoo Serena Chung|Luz Marina Giordano|Jason Andrew Horton; PhD|Ayla Oksuz White,David  Gaffney (University of Utah)|Radaition  Oncology (Unniversity of Pennsylvania),James B Mitchell; PhD (Radiation Biology Branch),Pamela Gehron Robey; PhD (NIDCR),"1. Brown AP, Chung EJ, Urick ME, Shield WP, Sowers AL, Thetford A, Shankavaram UT, Mitchell JB, Citrin DE (2010). Evaluation of the fullerene compound DF-1 as a radiation protector. Radiat Oncol  5, 34.   https://doi.org/10.1186/1748-717X-5-34|2. Citrin D, Cotrim AP, Hyodo F, Baum BJ, Krishna MC, Mitchell JB (2010). Radioprotectors and mitigators of radiation-induced normal tissue injury. Oncologist  15, 360-71.   https://doi.org/10.1634/theoncologist.2009-S104",https://intramural.nih.gov/search/searchview.taf?ipid=68452
331,BC010852-05,"October 01, 2010 -  September 30, 2011",Mechanism of action and therapeutic utility of immunostimulatory CpG oligonucleo,"Dennis M Klinman; MD, PhD|IRP Faculty Profile",NULL,"Laboratory of Experimental Immunology, NCI","Christian Hans Bode; MD|Howard A Young; PhD|Hiroyasu  Ito|Takeshi  Kinjo|Nobuaki  Kobayashi; MD, PhD|Adelle P McFarland|Show all 12","Ihsan  Gursel|Jay  Hooper (USAMRIID)|Yoshiaki  Ishigatsubo; MD, PhD (Yokohama City Univ Medical School)|Sven  Klaschik","Joost J Oppenheim; MD (Laboratory of Molecular Immunoregulation)|Giorgio  Trinchieri (Cancer Inflammation Program)|Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)",Igal  Gery; PhD (NEI),"1. Klaschik S, Tross D, Shirota H, Klinman DM (2010). Short- and long-term changes in gene expression mediated by the activation of TLR9. Mol Immunol  47, 1317-24.   https://doi.org/10.1016/j.molimm.2009.11.014|2. Klinman DM, Klaschik S, Tomaru K, Shirota H, Tross D, Ikeuchi H (2010). Immunostimulatory CpG oligonucleotides: Effect on gene expression and utility as vaccine adjuvants. Vaccine  28, 1919-23.   https://doi.org/10.1016/j.vaccine.2009.10.094|3. Sato T, Yamamoto M, Shimosato T, Klinman DM (2010). Accelerated wound healing mediated by activation of Toll-like receptor 9. Wound Repair Regen  18, 586-93.   https://doi.org/10.1111/j.1524-475X.2010.00632.x|4. Sui Y, Zhu Q, Gagnon S, Dzutsev A, Terabe M, Vaccari M, Venzon D, Klinman D, Strober W, Kelsall B, Franchini G, Belyakov IM, Berzofsky JA (2010). Innate and adaptive immune correlates of vaccine and adjuvant-induced control of mucosal transmission of SIV in macaques. Proc Natl Acad Sci U S A  107, 9843-8.   https://doi.org/10.1073/pnas.0911932107|5. Wang HB, Kondo A, Yoshida A, Yoshizaki S, Abe S, Bao LL, Mizuki N, Ichino M, Klinman D, Okuda K, Shimada M (2010). Partial protection against SIV challenge by vaccination of adenovirus and MVA vectors in rhesus monkeys. Gene Ther  17, 4-13.   https://doi.org/10.1038/gt.2009.122|6. Zhu Q, Egelston C, Gagnon S, Sui Y, Belyakov IM, Klinman DM, Berzofsky JA (2010). Using 3 TLR ligands as a combination adjuvant induces qualitative changes in T cell responses needed for antiviral protection in mice. J Clin Invest  120, 607-16.   https://doi.org/10.1172/JCI39293",https://intramural.nih.gov/search/searchview.taf?ipid=68457
332,BC010853-05,"October 01, 2010 -  September 30, 2011",Mechanism of action and therapeutic utility of immunosuppressive oligonucleotide,"Dennis M Klinman; MD, PhD|IRP Faculty Profile",NULL,"Laboratory of Experimental Immunology, NCI","Christian Hans Bode; MD|Hiroyasu  Ito|Takeshi  Kinjo|Nobuaki  Kobayashi; MD, PhD|Allison Marie Scire|Hidekazu  Shirota|Show all 10",NULL,Joost J Oppenheim; MD (Laboratory of Molecular Immunoregulation)|Giorgio  Trinchieri (Cancer Inflammation Program),Igal  Gery; PhD (NEI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68458
333,BC010870-04,"October 01, 2010 -  September 30, 2011",Hematopoietic Stem Cell Transplant for Immunodeficiency with MDS,Dennis D Hickstein|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",NULL,NULL,NULL,Steven M Holland; MD (NIAID),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68530
334,BC010871-04,"October 01, 2010 -  September 30, 2011",Use of Mouse Models of Human Rhabdomyosarcoma to Study Progression to Metastasis,Glenn  Merlino; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Yanlin  Yu,"Lynda  Chin (Harvard Medical School)|Ron  DePinho (Dana Farber, Harvard)","Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Javed  Khan; MD (Pediatric Oncology Branch)|Miriam R Anver (Office Of The Director)|Melinda  Hollingshead (Biological Testing Branch)",NULL,"1. Yu Y, Zeng P, Xiong J, Liu Z, Berger SL, Merlino G (2010). Epigenetic drugs can stimulate metastasis through enhanced expression of the pro-metastatic Ezrin gene. PLoS One  5, e12710.   https://doi.org/10.1371/journal.pone.0012710",https://intramural.nih.gov/search/searchview.taf?ipid=68649
335,BC010872-04,"October 01, 2010 -  September 30, 2011",High troughput screen for small molecule inhibitors of Ran regulated functions,Petr  Kalab; PhD,NULL,"Laboratory of Cellular and Molecular Biology, NCI",NULL,NULL,NULL,Min  Shen (NHGRI) |Cordelle D Tanega (NHGRI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68611
336,BC010873-04,"October 01, 2010 -  September 30, 2011",Underlying Cause of Radiation-induced Fibrosis,Nicole L Simone; MD,NULL,"Radiation Oncology Branch, NCI",NULL,NULL,James B Mitchell; PhD (Radiation Biology Branch),Benjamin  Soule (NIAID),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68552
337,BC010874-04,"October 01, 2010 -  September 30, 2011",Biomarkers of Human Lung Cancer,Curtis  Harris; MD|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Nadine N Bewry|Elise Dawn Bowman|Majda  Haznadar|Dickran Garo Kazandjian; MD|Mohammed A. Khan; PhD|Abdul Matin Mondal|Show all 14,Carlo  Croce (Ohio State University)|Aage  Haugen (National Institute of Occupational Health)|Roger  Reddel (Children's Medical Research Institute)|Jun  Yokota (National Cancer Center Research Institute),"Stephen J Chanock; MD, PhD (Laboratory Translational Genomics)",NULL,"1. Olivo-Marston SE, Mechanic LE, Mollerup S, Bowman ED, Remaley AT, Forman MR, Skaug V, Zheng YL, Haugen A, Harris CC (2010). Serum estrogen and tumor-positive estrogen receptor-alpha are strong prognostic classifiers of non-small-cell lung cancer survival in both men and women. Carcinogenesis  31, 1778-86.   https://doi.org/10.1093/carcin/bgq156|2. Sander M, Slaga TJ, Harris CC (2010). The 24th Aspen Cancer Conference: Mechanisms of toxicity, carcinogenesis, cancer prevention and cancer therapy 2009. Mol Carcinog  49, 410-28.   https://doi.org/10.1002/mc.20608|3. Voortman J, Goto A, Mendiboure J, Sohn JJ, Schetter AJ, Saito M, Dunant A, Pham TC, Petrini I, Lee A, Khan MA, Hainaut P, Pignon JP, Brambilla E, Popper HH, Filipits M, Harris CC, Giaccone G (2010). MicroRNA expression and clinical outcomes in patients treated with adjuvant chemotherapy after complete resection of non-small cell lung carcinoma. Cancer Res  70, 8288-98.   https://doi.org/10.1158/0008-5472.CAN-10-1348",https://intramural.nih.gov/search/searchview.taf?ipid=68525
338,BC010875-04,"October 01, 2010 -  September 30, 2011",Inhibitor of Normal Growth (ING),Curtis  Harris; MD|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Elise Dawn Bowman|Elisa A Spillare|Judith A Welsh,NULL,NULL,NULL,"1. Saito M, Kumamoto K, Robles AI, Horikawa I, Furusato B, Okamura S, Goto A, Yamashita T, Nagashima M, Lee TL, Baxendale VJ, Rennert OM, Takenoshita S, Yokota J, Sesterhenn IA, Trivers GE, Hussain SP, Harris CC (2010). Targeted disruption of Ing2 results in defective spermatogenesis and development of soft-tissue sarcomas. PLoS One  5, e15541.   https://doi.org/10.1371/journal.pone.0015541",https://intramural.nih.gov/search/searchview.taf?ipid=68526
339,BC010876-04,"October 01, 2010 -  September 30, 2011",The role of cancer stem cells in liver cancer heterogeneity and subtypes,Xin Wei Wang; PhD|IRP Faculty Profile,NULL,"Molecular Genetics and Carcinogenesis Section, NCI",Anuradha Samantha Budhu|Marshonna J Forgues|Junfang  Ji|Naoki  Oishi|Sonya Teresa Parpart|Stephanie  Roessler|Show all 8,Yidong  Chen; PhD|Carlo  Croce (Ohio State University)|Lun-Xiu  Qin (Liver Cancer Institute)|Hui-Chuan  Sun (Liver Cancer Institute)|Zhao-You  Tang (Liver Cancer Institute)|Takahiro  Uenishi (Osaka City University)|Show all 7,"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Snorri S. Thorgeirsson; MD, PhD (Laboratory of Experimental Carcinogenesis)|Robert  Wiltrout; PhD (Laboratory of Experimental Immunology)|Howard A Young; PhD (Laboratory of Experimental Immunology)|Mitchell  Ho (Laboratory of Molecular Biology)",NULL,"1. Cairo S, Wang Y, de Reyniès A, Duroure K, Dahan J, Redon MJ, Fabre M, McClelland M, Wang XW, Croce CM, Buendia MA (2010). Stem cell-like micro-RNA signature driven by Myc in aggressive liver cancer. Proc Natl Acad Sci U S A  107, 20471-6.   https://doi.org/10.1073/pnas.1009009107|2. Woo HG, Wang XW, Budhu A, Kim YH, Kwon SM, Tang ZY, Sun Z, Harris CC, Thorgeirsson SS (2011). Association of TP53 mutations with stem cell-like gene expression and survival of patients with hepatocellular carcinoma. Gastroenterology  140, 1063-70.   https://doi.org/10.1053/j.gastro.2010.11.034",https://intramural.nih.gov/search/searchview.taf?ipid=68588
340,BC010877-04,"October 01, 2010 -  September 30, 2011",The identification of human hepatocellular carcinoma metastasis genes,Xin Wei Wang; PhD|IRP Faculty Profile,NULL,"Molecular Genetics and Carcinogenesis Section, NCI",Anuradha Samantha Budhu|Marshonna J Forgues|Sonya Teresa Parpart|Zhipeng  Yu,Yidong  Chen; PhD|Carlo  Croce (Ohio State University)|Lun-Xiu  Qin (Liver Cancer Institute)|Hui-Chuan  Sun (Liver Cancer Institute)|Zhao-You  Tang (Liver Cancer Institute)|Qinghai  Ye (Liver Cancer Insitute),Paul  Goldsmith; PhD (Office of the Director),NULL,"1. Ji J, Wang XW (2010). A Yin-Yang balancing act of the lin28/let-7 link in tumorigenesis. J Hepatol  53, 974-5.   https://doi.org/10.1016/j.jhep.2010.07.001|2. Ji J, Zhao L, Budhu A, Forgues M, Jia HL, Qin LX, Ye QH, Yu J, Shi X, Tang ZY, Wang XW (2010). Let-7g targets collagen type I alpha2 and inhibits cell migration in hepatocellular carcinoma. J Hepatol  52, 690-7.   https://doi.org/10.1016/j.jhep.2009.12.025|3. Roessler S, Jia HL, Budhu A, Forgues M, Ye QH, Lee JS, Thorgeirsson SS, Sun Z, Tang ZY, Qin LX, Wang XW (2010). A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients. Cancer Res  70, 10202-12.   https://doi.org/10.1158/0008-5472.CAN-10-2607|4. Roessler S, Long EL, Budhu A, Chen Y, Zhao X, Ji J, Walker R, Jia HL, Ye QH, Qin LX, Tang ZY, He P, Hunter KW, Thorgeirsson SS, Meltzer PS, Wang XW (2012). Integrative genomic identification of genes on 8p associated with hepatocellular carcinoma progression and patient survival. Gastroenterology  142, 957-966.e12.   https://doi.org/10.1053/j.gastro.2011.12.039",https://intramural.nih.gov/search/searchview.taf?ipid=68587
341,BC010878-04,"October 01, 2010 -  September 30, 2011",Human Colon Cancer,Curtis  Harris; MD|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Elise Dawn Bowman|Mohammed A. Khan; PhD|Derek  Kong|Abdul Matin Mondal|Aaron Joseph Schetter|Jane J Sohn|Show all 9,Carlo  Croce (Ohio State University)|Suet  Leung (Hong Kong University),NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68527
342,BC010879-04,"October 01, 2010 -  September 30, 2011",Role of Toll-like receptors in the generation of acquired immunity,David M Segal; PhD,NULL,"Immune Targeting Section, NCI",Kevin Neal Brown|Yan  Wang,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68546
343,BC010880-04,"October 01, 2010 -  September 30, 2011",Mechanisms of Prostate Tumorigenesis Using Genetically Engineered Mouse Models,Terry Anne Van Dyke,NULL,"Mouse Cancer Genetics Program, NCI",Linda S Cleveland|Debra J Gilbert|Theresa N O'Sullivan|Yurong  Song; PhD|Chunhui  Wang|Stephanie L Henderson,Cory  Abate-shen|Paul  Dayton (University of North Carolina at Chapel Hill)|Michael J Shen,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68582
344,BC010881-04,"October 01, 2010 -  September 30, 2011",Development of TGF-beta antagonists for cancer therapy,Lalage  Wakefield; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Samuel Lee Dengler|Kathleen C Flanders; PhD|Dror  Luger; PhD|Jia  Weng|Yu-an  Yang,"Scott  Lonning (Gene Therapy, Genzyme Corp.)|John  McPherson (Genzyme Corp.)","Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68585
345,BC010885-04,"October 01, 2010 -  September 30, 2011",Study of Tumor Pathogenesis and Development of Therapies for AIDS Malignancies,Robert  Yarchoan; MD|IRP Faculty Profile,NULL,"HIV and AIDS Malignancy Branch, NCI","David A Davis; MD|Zhi Ming  Zheng; MD, PhD|Duosha  Hu; MD, PhD|Nicole  Naiman|Ravindra P Veeranna|Victoria Y Wang|Show all 8",NULL,Giovanna  Tosato; PhD (Laboratory of Cellular Oncology)|Denise  Whitby (Office Of The Director)|Stefania  Pittaluga (Laboratory of Pathology),Joseph A Kovacs; MD (CC) |Peter  Burbelo; PhD (NIDCR),"1. Burbelo PD, Issa AT, Ching KH, Wyvill KM, Little RF, Iadarola MJ, Kovacs JA, Yarchoan R (2010). Distinct profiles of antibodies to Kaposi sarcoma-associated herpesvirus antigens in patients with Kaposi sarcoma, multicentric Castleman disease, and primary effusion lymphoma. J Infect Dis  201, 1919-22.   https://doi.org/10.1086/652869|2. Kang J, Majerciak V, Uldrick T, Wang X, Kruhlak M, Yarchoan R, Zheng Z (2011) Kaposi sarcoma-associated herperviral IL6 and human IL6 open reading frames contain miRNA binding sites that are subject to cellular miRNA regulation. J. Pathology, in press.|3. Wang V, Davis DA, Veeranna RP, Haque M, Yarchoan R (2010). Characterization of the activation of protein tyrosine phosphatase, receptor-type, Z polypeptide 1 (PTPRZ1) by hypoxia inducible factor-2 alpha. PLoS One  5, e9641.   https://doi.org/10.1371/journal.pone.0009641",https://intramural.nih.gov/search/searchview.taf?ipid=68602
346,BC010886-04,"October 01, 2010 -  September 30, 2011",Non-coding RNAs as Prognostic and Diagnostic Markers in Prostate Cancer,Stefan  Ambs|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Tiffany Marie Howe|Robert Scott Hudson|Adrienne Michelle Starks,NULL,Arthur A Hurwitz (Laboratory of Molecular Immunoregulation)|Liudmila  Prokunina-Olsson; PhD (Laboratory Translational Genomics),NULL,"1. Volinia S, Galasso M, Costinean S, Tagliavini L, Gamberoni G, Drusco A, Marchesini J, Mascellani N, Sana ME, Abu Jarour R, Desponts C, Teitell M, Baffa R, Aqeilan R, Iorio MV, Taccioli C, Garzon R, Di Leva G, Fabbri M, Catozzi M, Previati M, Ambs S, Palumbo T, Garofalo M, Veronese A, et al. [26 more authors] (2010). Reprogramming of miRNA networks in cancer and leukemia. Genome Res  20, 589-99.   https://doi.org/10.1101/gr.098046.109",https://intramural.nih.gov/search/searchview.taf?ipid=68466
347,BC010887-04,"October 01, 2010 -  September 30, 2011",Novel Markers for Disease Outcome in Breast Cancer,Stefan  Ambs|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Tiffany Marie Howe|Adrienne Michelle Starks,"Chris  Loffredo (Cancer Genetics and Epidemiology Program, Georgetown University)|Arun  Sreekumar (Baylor College of Medicine)|Feng  Wang-Johanning (University of Texas MD Anderson Cancer Center)",David Anderson Wink (Radiation Biology Branch),NULL,"1. Ambs S (2010). Prognostic significance of subtype classification for short- and long-term survival in breast cancer: survival time holds the key. PLoS Med  7, e1000281.   https://doi.org/10.1371/journal.pmed.1000281|2. Fu YP, Edvardsen H, Kaushiva A, Arhancet JP, Howe TM, Kohaar I, Porter-Gill P, Shah A, Landmark-Høyvik H, Fosså SD, Ambs S, Naume B, Børresen-Dale AL, Kristensen VN, Prokunina-Olsson L (2010). NOTCH2 in breast cancer: association of SNP rs11249433 with gene expression in ER-positive breast tumors without TP53 mutations. Mol Cancer  9, 113.   https://doi.org/10.1186/1476-4598-9-113|3. Glynn SA, Boersma BJ, Dorsey TH, Yi M, Yfantis HG, Ridnour LA, Martin DN, Switzer CH, Hudson RS, Wink DA, Lee DH, Stephens RM, Ambs S (2010). Increased NOS2 predicts poor survival in estrogen receptor-negative breast cancer patients. J Clin Invest  120, 3843-54.   https://doi.org/10.1172/JCI42059|4. Glynn SA, Prueitt RL, Ridnour LA, Boersma BJ, Dorsey TM, Wink DA, Goodman JE, Yfantis HG, Lee DH, Ambs S (2010). COX-2 activation is associated with Akt phosphorylation and poor survival in ER-negative, HER2-positive breast cancer. BMC Cancer  10, 626.   https://doi.org/10.1186/1471-2407-10-626",https://intramural.nih.gov/search/searchview.taf?ipid=68467
348,BC010888-04,"October 01, 2010 -  September 30, 2011",Clinical Trials of Patients with AIDS-Related Malignancies,Robert  Yarchoan; MD|IRP Faculty Profile,NULL,"HIV and AIDS Malignancy Branch, NCI","Karen O Aleman|Zhi Ming  Zheng; MD, PhD|Armenak A Martirosov|Florentino  Merced-Galindez|Mark Niccolo Polizzotto; MD|Thomas S Uldrick|Show all 9",NULL,"Giovanna  Tosato; PhD (Laboratory of Cellular Oncology)|Wyndham H Wilson; MD, PhD (Lymphoid Malignancies Branch)|Denise  Whitby (Office Of The Director)|Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Stefania  Pittaluga (Laboratory of Pathology)|Frank  Maldarelli (Host Virus Interaction Branch)",Joseph A Kovacs; MD (CC) |Amir Hossein Gandjbakhche; PhD (NICHD) |Moinuddin  Hassan; PhD (NICHD) |H. Clifford  Lane; MD (NIAID) |Peter  Burbelo; PhD (NIDCR) |Irina  Maric; MD (CC),"1. Yarchoan R, Uldrick T, Little R (2010) AIDS-Related Malignancies, in Principals and Practice of Oncology, 9th Edition. Lippincott, WIlliams, and WIlkins (Philadelphia), in press.|2. Burbelo PD, Issa AT, Ching KH, Wyvill KM, Little RF, Iadarola MJ, Kovacs JA, Yarchoan R (2010). Distinct profiles of antibodies to Kaposi sarcoma-associated herpesvirus antigens in patients with Kaposi sarcoma, multicentric Castleman disease, and primary effusion lymphoma. J Infect Dis  201, 1919-22.   https://doi.org/10.1086/652869|3. Delviks-Frankenberry K, Chaipan C, Bagni R, Wyvill K, Yarchoan R, Pathak V (2011) Lack of detection of xenotropic murine leukemia virus in HIV-1 lymphoma patients. Advances In Virology, in press.|4. Dunleavy K, Little RF, Pittaluga S, Grant N, Wayne AS, Carrasquillo JA, Steinberg SM, Yarchoan R, Jaffe ES, Wilson WH (2010). The role of tumor histogenesis, FDG-PET, and short-course EPOCH with dose-dense rituximab (SC-EPOCH-RR) in HIV-associated diffuse large B-cell lymphoma. Blood  115, 3017-24.   https://doi.org/10.1182/blood-2009-11-253039|5. Jain L, Sissung TM, Danesi R, Kohn EC, Dahut WL, Kummar S, Venzon D, Liewehr D, English BC, Baum CE, Yarchoan R, Giaccone G, Venitz J, Price DK, Figg WD (2010). Hypertension and hand-foot skin reactions related to VEGFR2 genotype and improved clinical outcome following bevacizumab and sorafenib. J Exp Clin Cancer Res  29, 95.   https://doi.org/10.1186/1756-9966-29-95|6. Kang J, Majerciak V, Uldrick T, Wang X, Kruhlak M, Yarchoan R, Zheng Z (2011) Kaposi sarcoma-associated herperviral IL6 and human IL6 open reading frames contain miRNA binding sites that are subject to cellular miRNA regulation. J. Pathology, in press.|7. Mbisa GL, Miley W, Gamache CJ, Gillette WK, Esposito D, Hopkins R, Busch MP, Schreiber GB, Little RF, Yarchoan R, Ortiz-Conde BA, Labò N, Whitby D (2010). Detection of antibodies to Kaposi's sarcoma-associated herpesvirus: a new approach using K8.1 ELISA and a newly developed recombinant LANA ELISA. J Immunol Methods  356, 39-46.   https://doi.org/10.1016/j.jim.2010.02.015|8. Tang S, Zhao J, Wang A, Viswanath R, Harma H, Little RF, Yarchoan R, Stramer SL, Nyambi PN, Lee S, Wood O, Wong EY, Wang X, Hewlett IK (2010). Characterization of immune responses to capsid protein p24 of human immunodeficiency virus type 1 and implications for detection. Clin Vaccine Immunol  17, 1244-51.   https://doi.org/10.1128/CVI.00066-10|9. Uldrick TS, Wang V, O'Mahony D, Aleman K, Wyvill KM, Marshall V, Steinberg SM, Pittaluga S, Maric I, Whitby D, Tosato G, Little RF, Yarchoan R (2010). An interleukin-6-related systemic inflammatory syndrome in patients co-infected with Kaposi sarcoma-associated herpesvirus and HIV but without Multicentric Castleman disease. Clin Infect Dis  51, 350-8.   https://doi.org/10.1086/654798|10. Valentin A, Morrow M, Poirier RH, Aleman K, Little R, Yarchoan R, Pavlakis GN (2010). Identification of a potential pharmacological sanctuary for HIV type 1 in a fraction of CD4(+) primary cells. AIDS Res Hum Retroviruses  26, 79-88.   https://doi.org/10.1089/aid.2009.0044|11. Yu H, Tawab-Amiri A, Dzutsev A, Sabatino M, Aleman K, Yarchoan R, Terabe M, Sui Y, Berzofsky JA (2011). IL-15 ex vivo overcomes CD4+ T cell deficiency for the induction of human antigen-specific CD8+ T cell responses. J Leukoc Biol  90, 205-14.   https://doi.org/10.1189/jlb.1010579",https://intramural.nih.gov/search/searchview.taf?ipid=68601
349,BC010889-04,"October 01, 2010 -  September 30, 2011",Role of Selenium-containing Proteins in Cancer,Dolph Lee Hatfield; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Prevention, NCI",Bradley A Carlson|Salvador  Naranjo Suarez; PhD|Ryuta  Tobe|Petra Akiko Tsuji|Min-Hyuk  Yoo,NULL,Cindy D Davis (Nutritional Science Research Group),NULL,"1. Hatfield D (2011) Selenium: Its molecular biology and role in human health. Springer Science+Business Media, LLC (New York), in press.|2. Carlson B, Yoo M, Tsuji P, Tobe R, Naranjo-Suarez S, Chen F, Feigenbaum L, Tessarollo L, Lee B, Gladyshev V, Hatfield D (2011) Mouse models that target removal or over-expression of the selenocysteine tRNA[Ser]Sec gene to elucidate the role of selenoproteins in health and development, in Selenium: Its molecular biology and role in human health., in press.|3. Irons R, Tsuji PA, Carlson BA, Ouyang P, Yoo MH, Xu XM, Hatfield DL, Gladyshev VN, Davis CD (2010). Deficiency in the 15-kDa selenoprotein inhibits tumorigenicity and metastasis of colon cancer cells. Cancer Prev Res (Phila)  3, 630-9.   https://doi.org/10.1158/1940-6207.CAPR-10-0003|4. Yoo MH, Carlson BA, Tsuji P, Irons R, Gladyshev VN, Hatfield DL (2010). Alteration of thioredoxin reductase 1 levels in elucidating cancer etiology. Methods Enzymol  474, 255-75.   https://doi.org/10.1016/S0076-6879(10)74015-5",https://intramural.nih.gov/search/searchview.taf?ipid=68528
350,BC010891-04,"October 01, 2010 -  September 30, 2011",Antibody Therapy of Cancer,Mitchell  Ho|IRP Faculty Profile,NULL,"Laboratory of Molecular Biology, NCI",Mingqian  Feng|Wei  Gao|Yen T Phung|Raffit  Hassan|Zhewei  Tang|Ruoqi  Wang,V. Courtney  Broaddus (UCSF)|Gregory  Gore (Mayo Clinic)|Manish  Patankar (University of Wisconsin-Madison)|Min  Qian (East China Normal University)|Shuichi  Takayama (University of Michigan),Ira H Pastan; MD (Molecular Biology Section)|David J Fitzgerald; PhD (Biotherapy Section)|Dimiter Stanchev Dimitrov; PhD (Membrane Structure and Function Section)|Xin Wei Wang; PhD (Molecular Genetics and Carcinogenesis Section),NULL,"1. Gao W, Ho M (2011) The Role of Glypican-3 in Regulating Wnt in Hepatocellular Carcinomas. Cancer Reports 1:14-19.|2. Ho M (2011) Advances in liver cancer antibody therapies: a focus on glypican-3 and mesothelin. BioDrugs, in press.|3. Torisawa YS, Mosadegh B, Cavnar SP, Ho M, Takayama S (2011). Transwells with microstamped membranes produce micropatterned two-dimensional and three-dimensional co-cultures. Tissue Eng Part C Methods  17, 61-7.   https://doi.org/10.1089/ten.TEC.2010.0305|4. Yu L, Feng M, Kim H, Phung Y, Kleiner DE, Gores GJ, Qian M, Wang XW, Ho M (2010). Mesothelin as a potential therapeutic target in human cholangiocarcinoma. J Cancer  1, 141-9.   https://doi.org/10.7150/jca.1.141",https://intramural.nih.gov/search/searchview.taf?ipid=68531
351,BC010892-04,"October 01, 2010 -  September 30, 2011",Characterization of the interaction between inflammation and cancer progression,Robert  Wiltrout; PhD,NULL,"Laboratory of Experimental Immunology, NCI",Timothy  Back|Tim  Chan|Howard A Young; PhD|John R Ortaldo; PhD|Thomas Joseph Sayers; PhD|Anthony J Scarzello|Show all 9,"Bruce  Blazar (University of Minnesota)|Bill  Murphy (Clinical Research, University of Nevada at Reno)|Jon Marc Wigginton; MD (NCI)",David Anderson Wink (Radiation Biology Branch)|Larry K Keefer; PhD (Laboratory of Comparative Carcinogenesis)|Syed Perwez  Hussain (Molecular Genetics and Carcinogenesis Section),NULL,"1. Chen X, Subleski JJ, Hamano R, Howard OM, Wiltrout RH, Oppenheim JJ (2010). Co-expression of TNFR2 and CD25 identifies more of the functional CD4+FOXP3+ regulatory T cells in human peripheral blood. Eur J Immunol  40, 1099-106.   https://doi.org/10.1002/eji.200940022|2. Weiss JM, Ridnour LA, Back T, Hussain SP, He P, Maciag AE, Keefer LK, Murphy WJ, Harris CC, Wink DA, Wiltrout RH (2010). Macrophage-dependent nitric oxide expression regulates tumor cell detachment and metastasis after IL-2/anti-CD40 immunotherapy. J Exp Med  207, 2455-67.   https://doi.org/10.1084/jem.20100670",https://intramural.nih.gov/search/searchview.taf?ipid=68593
352,BC010893-04,"October 01, 2010 -  September 30, 2011",Tumor models for the study of inflammation and oncogenesis,Robert  Wiltrout; PhD,NULL,"Laboratory of Experimental Immunology, NCI",Timothy  Back|Tim  Chan|Howard A Young; PhD|John R Ortaldo; PhD|Anthony J Scarzello|Jimmy  Stauffer|Show all 8,NULL,"Curtis  Harris; MD (Laboratory of Human Carcinogenesis)|Snorri S. Thorgeirsson; MD, PhD (Laboratory of Experimental Carcinogenesis)|William Marston Linehan; MD (Urologic Oncology Branch)|Xin Wei Wang; PhD (Molecular Genetics and Carcinogenesis Section)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68594
353,BC010898-04,"October 01, 2010 -  September 30, 2011",Redox Mechanism Process of Angiogenesis and Wound Healing,David Anderson Wink|IRP Faculty Profile,NULL,"Radiation Biology Branch, NCI",Aminah  Asghar|Yuk Sing Robert Cheng|Lisa Ann Ridnour|Murali  Krishna; PhD|Christopher H Switzer,NULL,Curtis  Harris; MD (Laboratory of Human Carcinogenesis)|Stefan  Ambs (Laboratory of Human Carcinogenesis)|David D Roberts; PhD (Laboratory of Pathology)|Robert  Wiltrout; PhD (Laboratory of Experimental Immunology)|Howard A Young; PhD (Laboratory of Experimental Immunology),NULL,"1. Weiss JM, Ridnour LA, Back T, Hussain SP, He P, Maciag AE, Keefer LK, Murphy WJ, Harris CC, Wink DA, Wiltrout RH (2010). Macrophage-dependent nitric oxide expression regulates tumor cell detachment and metastasis after IL-2/anti-CD40 immunotherapy. J Exp Med  207, 2455-67.   https://doi.org/10.1084/jem.20100670|2. Wink DA, Hines HB, Cheng RY, Switzer CH, Flores-Santana W, Vitek MP, Ridnour LA, Colton CA (2011). Nitric oxide and redox mechanisms in the immune response. J Leukoc Biol  89, 873-91.   https://doi.org/10.1189/jlb.1010550",https://intramural.nih.gov/search/searchview.taf?ipid=68595
354,BC010899-04,"October 01, 2010 -  September 30, 2011",Properties of redox modified NSAIDs in cancer prevention and treatment,David Anderson Wink|IRP Faculty Profile,NULL,"Radiation Biology Branch, NCI",Yuk Sing Robert Cheng|Wilmarie  Flores-santana|James B Mitchell; PhD|Lisa Ann Ridnour|Christopher H Switzer|Murali  Krishna; PhD,"Piero  del Soldato (Pharma, CTG Pharma)|Bruce  King (Department of Chemistry, Wake Forest University)",Larry K Keefer; PhD (Laboratory of Comparative Carcinogenesis)|Grace  Yeh; PhD (Office of the Director)|David D Roberts; PhD (Laboratory of Pathology),NULL,"1. Flores-Santana W, Salmon DJ, Donzelli S, Switzer CH, Basudhar D, Ridnour L, Cheng R, Glynn SA, Paolocci N, Fukuto JM, Miranda KM, Wink DA (2011). The specificity of nitroxyl chemistry is unique among nitrogen oxides in biological systems. Antioxid Redox Signal  14, 1659-74.   https://doi.org/10.1089/ars.2010.3841|2. Jia Y, Wu SL, Isenberg JS, Dai S, Sipes JM, Field L, Zeng B, Bandle RW, Ridnour LA, Wink DA, Ramchandran R, Karger BL, Roberts DD (2010). Thiolutin inhibits endothelial cell adhesion by perturbing Hsp27 interactions with components of the actin and intermediate filament cytoskeleton. Cell Stress Chaperones  15, 165-81.   https://doi.org/10.1007/s12192-009-0130-0|3. Moody TW, Switzer C, Santana-Flores W, Ridnour LA, Berna M, Thill M, Jensen RT, Sparatore A, Del Soldato P, Yeh GC, Roberts DD, Giaccone G, Wink DA (2010). Dithiolethione modified valproate and diclofenac increase E-cadherin expression and decrease proliferation of non-small cell lung cancer cells. Lung Cancer  68, 154-60.   https://doi.org/10.1016/j.lungcan.2009.06.012|4. Rajesh M, Mukhopadhyay P, Bátkai S, Patel V, Saito K, Matsumoto S, Kashiwaya Y, Horváth B, Mukhopadhyay B, Becker L, Haskó G, Liaudet L, Wink DA, Veves A, Mechoulam R, Pacher P (2010). Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy. J Am Coll Cardiol  56, 2115-25.   https://doi.org/10.1016/j.jacc.2010.07.033",https://intramural.nih.gov/search/searchview.taf?ipid=68596
355,BC010907-04,"October 01, 2010 -  September 30, 2011",Papillomavirus Infectious Entry,Christopher  Buck|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI",Diana  Pastrana|Rachel  Schowalter; PhD,NULL,NULL,David Eric Anderson; PhD (NIDDK) |Alasdair C Steven; PhD (NIAMS) |Benes L Trus; PhD (CIT),"1. Buck CB, Lowy DR (2011). Immune readouts may have prognostic value for the course of merkel cell carcinoma, a virally associated disease. J Clin Oncol  29, 1506-8.   https://doi.org/10.1200/JCO.2010.34.0745|2. Graham BS, Kines RC, Corbett KS, Nicewonger J, Johnson TR, Chen M, LaVigne D, Roberts JN, Cuburu N, Schiller JT, Buck CB (2010). Mucosal delivery of human papillomavirus pseudovirus-encapsidated plasmids improves the potency of DNA vaccination. Mucosal Immunol  3, 475-86.   https://doi.org/10.1038/mi.2010.31|3. Huang HS, Buck CB, Lambert PF (2010). Inhibition of gamma secretase blocks HPV infection. Virology  407, 391-6.   https://doi.org/10.1016/j.virol.2010.09.002|4. Karanam B, Peng S, Li T, Buck C, Day PM, Roden RB (2010). Papillomavirus infection requires gamma secretase. J Virol  84, 10661-70.   https://doi.org/10.1128/JVI.01081-10|5. Schiller JT, Buck CB (2011). Cutaneous squamous cell carcinoma: a smoking gun but still no suspects. J Invest Dermatol  131, 1595-6.   https://doi.org/10.1038/jid.2011.151|6. Senger T, Schädlich L, Textor S, Klein C, Michael KM, Buck CB, Gissmann L (2010). Virus-like particles and capsomeres are potent vaccines against cutaneous alpha HPVs. Vaccine  28, 1583-93.   https://doi.org/10.1016/j.vaccine.2009.11.048",https://intramural.nih.gov/search/searchview.taf?ipid=68480
356,BC010910-04,"October 01, 2010 -  September 30, 2011",Genomic Rearrangements in Multiple Myeloma,"Walter M Kuehl; MD, PhD",NULL,"Cancer Genetics Branch, NCI",Leslie Ann Brents|Wei-Dong  Chen|Oleg K Glebov|Gina Young Kim|Anna V Roschke,"Bart  Barlogie (Univ. of Arkansas for Medical Sciences)|P.  Bergsagel (Divison of Hematology, Mayo Clinic)|Rafael  Fonseca (Division of Hematology, Mayo Clinic)|Jeffrey  Sawyer (University of Arkansas for Medical Sciences)|John  Shaughnessy (Universiy of Arkansas for Medical Sciences)",Louis  Staudt; MD (Lymphoid Malignancies Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68626
357,BC010914-04,"October 01, 2010 -  September 30, 2011",Gene Expression Profiling and Clinical Characterization of Phototoxicity,Heidi H Kong|IRP Faculty Profile,NULL,"Dermatology Branch, NCI","Effie Y Nomicos; BS, BSN",NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68620
358,BC010925-04,"October 01, 2010 -  September 30, 2011",Phase I Study of Topical Romidepsin in Early Stage Cutaneous T-cell Lymphoma,Heidi H Kong|IRP Faculty Profile,NULL,"Dermatology Branch, NCI","Effie Y Nomicos; BS, BSN",NULL,Susan  Bates; MD (Medical Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68621
359,BC010929-04,"October 01, 2010 -  September 30, 2011",Tumor Stroma Interactions:  Wound Promoted Tumor Growth,John Edward Niederhuber,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",NULL,NULL,Lalage  Wakefield; PhD (Laboratory of Cancer Biology and Genetics)|Kent W Hunter; PhD (Laboratory of Cancer Biology and Genetics),NULL,"1. Stuelten CH, Busch JI, Tang B, Flanders KC, Oshima A, Sutton E, Karpova TS, Roberts AB, Wakefield LM, Niederhuber JE (2010). Transient tumor-fibroblast interactions increase tumor cell malignancy by a TGF-Beta mediated mechanism in a mouse xenograft model of breast cancer. PLoS One  5, e9832.   https://doi.org/10.1371/journal.pone.0009832",https://intramural.nih.gov/search/searchview.taf?ipid=68657
360,BC010932-04,"October 01, 2010 -  September 30, 2011",T Cell Memory,Jonathan D Ashwell; MD|IRP Faculty Profile,NULL,"Laboratory of Immune Cell Biology, NCI",Bei  Dong|Mirela  Kuka|Ivana  Munitic,NULL,NULL,Dragana  Jankovic; PhD (NIAID),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68471
361,BC010935-04,"October 01, 2010 -  September 30, 2011",Regulation of Metastasis and Angiogenesis by Autotaxin and its Products,Mary  Stracke,John Carl Oberholtzer,"Laboratory of Pathology, NCI",Russell William Bandle|Elliott  Schiffmann|Michael L Pendrak,"Demetrios T Braddock; MD, PhD|Neerja  Kaushik-Basu (UMDNJ-New Jersey Med School)",NULL,NULL,"1. Im E, Motiejunaite R, Aranda J, Park EY, Federico L, Kim TI, Clair T, Stracke ML, Smyth S, Kazlauskas A (2010). Phospholipase Cgamma activation drives increased production of autotaxin in endothelial cells and lysophosphatidic acid-dependent regression. Mol Cell Biol  30, 2401-10.   https://doi.org/10.1128/MCB.01275-09|2. Ptaszynska MM, Pendrak ML, Stracke ML, Roberts DD (2010). Autotaxin signaling via lysophosphatidic acid receptors contributes to vascular endothelial growth factor-induced endothelial cell migration. Mol Cancer Res  8, 309-21.   https://doi.org/10.1158/1541-7786.MCR-09-0288",https://intramural.nih.gov/search/searchview.taf?ipid=68571
362,BC010938-04,"October 01, 2010 -  September 30, 2011",Studies of Skin Microflora in Healthy Individuals and Atopic Dermatitis Patients,Heidi H Kong|IRP Faculty Profile,NULL,"Dermatology Branch, NCI","Effie Y Nomicos; BS, BSN|Deborah  Truman",NULL,NULL,Julia A Segre; PhD (NHGRI) |Hirsh David Komarow; MD (NIAID) |Patrick R. Murray; PhD (CC) |Robert A Sokolic (NHGRI) |Alexandra  Freeman (NIAID),"1. Kong HH, Segre JA (2010). Bridging the translational research gap: a successful partnership involving a physician and a basic scientist. J Invest Dermatol  130, 1478-80.   https://doi.org/10.1038/jid.2010.65",https://intramural.nih.gov/search/searchview.taf?ipid=68622
363,BC010939-04,"October 01, 2010 -  September 30, 2011",RNAi Analysis and Screening for Study of Genes and Anti-Cancer Treatments,Natasha  Caplen|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Magdalena Grandin Grandin|Tamara L Jones|Joshua Nazeer Omade|Lihui  Ou; PhD|Jason James Pitt,Philip L Lorenzi|Shigeki  Miyamoto (University of Wisconsin)|John  Weinstein (MD Anderson),"Stanley  Lipkowitz; MD, PhD (Laboratory of Cellular and Molecular Biology)|Yves  Pommier; PhD (Developmental Therapeutics Branch)|Lee Jay Helman; MD (Pediatric Oncology Branch)|Beverly  Mock; PhD (Office of the Director)",Scott E Martin (NHGRI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68492
364,BC010940-04,"October 01, 2010 -  September 30, 2011",Cutaneous Adverse Drug Reactions,Heidi H Kong|IRP Faculty Profile,NULL,"Dermatology Branch, NCI","Effie Y Nomicos; BS, BSN",NULL,"William Marston Linehan; MD (Urologic Oncology Branch)|Ramaprasad  Srinivasan; MD, PhD (Urologic Oncology Branch)",NULL,"1. Jain L, Gardner ER, Figg WD, Chernick MS, Kong HH (2010). Lack of association between excretion of sorafenib in sweat and hand-foot skin reaction. Pharmacotherapy  30, 52-6.   https://doi.org/10.1592/phco.30.1.52",https://intramural.nih.gov/search/searchview.taf?ipid=68619
365,BC010944-04,"October 01, 2010 -  September 30, 2011",Control of the immune response for cancer vaccine development,Jeffrey  Schlom; PhD|IRP Faculty Profile,NULL,"Laboratory of Tumor Immunology and Biology, NCI",Lajuan  Chase|Kwong Yok Tsang|Joseph Raymond Cohen; PhD|Claudia Mercedes Palena|Renee Nicole Donahue|James W Hodge; PhD|Show all 16,NULL,Lalage  Wakefield; PhD (Laboratory of Cancer Biology and Genetics),NULL,"1. Boehm AL, Higgins J, Franzusoff A, Schlom J, Hodge JW (2010). Concurrent vaccination with two distinct vaccine platforms targeting the same antigen generates phenotypically and functionally distinct T-cell populations. Cancer Immunol Immunother  59, 397-408.   https://doi.org/10.1007/s00262-009-0759-7|2. Farsaci B, Sabzevari H, Higgins JP, Di Bari MG, Takai S, Schlom J, Hodge JW (2010). Effect of a small molecule BCL-2 inhibitor on immune function and use with a recombinant vaccine. Int J Cancer  127, 1603-13.   https://doi.org/10.1002/ijc.25177|3. Masuelli L, Marzocchella L, Focaccetti C, Lista F, Nardi A, Scardino A, Mattei M, Turriziani M, Modesti M, Forni G, Schlom J, Modesti A, Bei R (2010). Local delivery of recombinant vaccinia virus encoding for neu counteracts growth of mammary tumors more efficiently than systemic delivery in neu transgenic mice. Cancer Immunol Immunother  59, 1247-58.   https://doi.org/10.1007/s00262-010-0850-0|4. Vergati M, Cereda V, Madan RA, Gulley JL, Huen NY, Rogers CJ, Hance KW, Arlen PM, Schlom J, Tsang KY (2011). Analysis of circulating regulatory T cells in patients with metastatic prostate cancer pre- versus post-vaccination. Cancer Immunol Immunother  60, 197-206.   https://doi.org/10.1007/s00262-010-0927-9|5. Vergati M, Schlom J, Tsang KY (2011). The consequence of immune suppressive cells in the use of therapeutic cancer vaccines and their importance in immune monitoring. J Biomed Biotechnol  2011, 182413.   https://doi.org/10.1155/2011/182413|6. Schlom J, Huang J (submitted in 2011) Soluble Cd27 (scd27) And Use Thereof. Patent issued: 9,725,494 (US in 2017).",https://intramural.nih.gov/search/searchview.taf?ipid=68543
366,BC010945-04,"October 01, 2010 -  September 30, 2011",Clinical trials employing cancer vaccine combination therapies,"James L Gulley; MD, PhD|IRP Faculty Profile",NULL,"Laboratory of Tumor Immunology and Biology, NCI",Marijo  Bilusic|Bonnie L Casey|Christopher Ryan Heery; MD|Jennifer L Marte|Sheri A Mcmahon|Jeffrey  Schlom; PhD|Show all 11,"William  Carson (Molecular Virology, Immunology and Medical Genetics, Ohio State University)|Robert  DiPaola (The Cancer Institute of New Jersey)|Nuhad  Ibrahim (MD Anderson Cancer Center)|Douglas  McNeel (University of Wisconsin)|Walter  Stadler (University of Chicago)",William Marston Linehan; MD (Urologic Oncology Branch)|William Laurence Dahut; MD (Medical Oncology Branch)|Kevin A Camphausen; MD (Radiation Oncology Branch)|William D Figg; PharmD (Medical Oncology Branch)|Aradhana  Kaushal (Radiation Oncology Branch)|Ravi  Madan (Medical Oncology Branch),NULL,"1. Gulley J, Arlen P, Hodge J, Schlom J (2010) Vaccines and Immunostimulants  Chapter 57, in Cancer Medicine 8., pp. 725-736.|2. Madan R, Gulley J, Celestin J, Arlen P, Schlom J (2010) Cancer immunology, immunotherapeutics and vaccine approaches, in Drug Management of Prostate Cancer., pp. 305-319.|3. Zhu W, Chau C, Gulley J, Dahut W, Figg W (2011) Immunomodulating Drugs for the Treatment of Prostate Cancer, in Immunomodulating Drugs for the Treatment of Cancer., pp. 239-252.|4. Gulley JL, Drake CG (2011). Immunotherapy for prostate cancer: recent advances, lessons learned, and areas for further research. Clin Cancer Res  17, 3884-91.   https://doi.org/10.1158/1078-0432.CCR-10-2656|5. Gulley JL, Madan RA, Schlom J (2011). Impact of tumour volume on the potential efficacy of therapeutic vaccines. Curr Oncol  18, e150-7.   https://doi.org/10.3747/co.v18i3.783|6. Madan RA, Aragon-Ching JB, Gulley JL, Dahut WL (2011). From clinical trials to clinical practice: therapeutic cancer vaccines for the treatment of prostate cancer. Expert Rev Vaccines  10, 743-53.   https://doi.org/10.1586/erv.11.70|7. Madan RA, Gulley JL (2010). The current and emerging role of immunotherapy in prostate cancer. Clin Genitourin Cancer  8, 10-6.   https://doi.org/10.3816/CGC.2010.n.002|8. Madan RA, Gulley JL (2011). Therapeutic cancer vaccine fulfills the promise of immunotherapy in prostate cancer. Immunotherapy  3, 27-31.   https://doi.org/10.2217/imt.10.77|9. Madan RA, Gulley JL, Fojo T, Dahut WL (2010). Therapeutic cancer vaccines in prostate cancer: the paradox of improved survival without changes in time to progression. Oncologist  15, 969-75.   https://doi.org/10.1634/theoncologist.2010-0129|10. Madan RA, Mohebtash M, Schlom J, Gulley JL (2010). Therapeutic vaccines in metastatic castration-resistant prostate cancer: principles in clinical trial design. Expert Opin Biol Ther  10, 19-28.   https://doi.org/10.1517/14712590903321421|11. May KF, Gulley JL, Drake CG, Dranoff G, Kantoff PW (2011). Prostate cancer immunotherapy. Clin Cancer Res  17, 5233-8.   https://doi.org/10.1158/1078-0432.CCR-10-3402|12. Nesslinger NJ, Ng A, Tsang KY, Ferrara T, Schlom J, Gulley JL, Nelson BH (2010). A viral vaccine encoding prostate-specific antigen induces antigen spreading to a common set of self-proteins in prostate cancer patients. Clin Cancer Res  16, 4046-56.   https://doi.org/10.1158/1078-0432.CCR-10-0948|13. Rotow J, Gameiro SR, Madan RA, Gulley JL, Schlom J, Hodge JW (2010). Vaccines as monotherapy and in combination therapy for prostate cancer. Clin Transl Sci  3, 116-22.   https://doi.org/10.1111/j.1752-8062.2010.00186.x|14. Sharifi N, Gulley JL, Dahut WL (2010). An update on androgen deprivation therapy for prostate cancer. Endocr Relat Cancer  17, R305-15.   https://doi.org/10.1677/ERC-10-0187|15. Stein WD, Gulley JL, Schlom J, Madan RA, Dahut W, Figg WD, Ning YM, Arlen PM, Price D, Bates SE, Fojo T (2011). Tumor regression and growth rates determined in five intramural NCI prostate cancer trials: the growth rate constant as an indicator of therapeutic efficacy. Clin Cancer Res  17, 907-17.   https://doi.org/10.1158/1078-0432.CCR-10-1762|16. Vergati M, Cereda V, Madan RA, Gulley JL, Huen NY, Rogers CJ, Hance KW, Arlen PM, Schlom J, Tsang KY (2011). Analysis of circulating regulatory T cells in patients with metastatic prostate cancer pre- versus post-vaccination. Cancer Immunol Immunother  60, 197-206.   https://doi.org/10.1007/s00262-010-0927-9|17. Whiteside TL, Gulley JL, Clay TM, Tsang KY (2011). Immunologic monitoring of cellular immune responses in cancer vaccine therapy. J Biomed Biotechnol  2011, 370374.   https://doi.org/10.1155/2011/370374|18. Sclom J, Madan R, Bilusic M, Heery C, Hodge J, Gulley J (2011) Immune Targeting of Prostate Cancer. ASCO.",https://intramural.nih.gov/search/searchview.taf?ipid=68522
367,BC010946-04,"October 01, 2010 -  September 30, 2011",Protection against Radiation-Induced Carcinogenesis,James B Mitchell; PhD|IRP Faculty Profile,NULL,"Radiation Biology Branch, NCI",John Andrew Cook; PhD|William  Degraff|Kristin  Askin|Maria E Figueroa|Janet W Gamson|Anastasia L Sowers,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68650
368,BC010954-04,"October 01, 2010 -  September 30, 2011",Tumor Growth and Microenvironment Influence T Cell Tolerance to Tumor Antigens,Arthur A Hurwitz,NULL,"Laboratory of Molecular Immunoregulation, NCI",Bonnie Brown Douglas|Scott K Durum; PhD|Joost J Oppenheim; MD|Katherine  Stagliano|Stephanie K Watkins|Ziqiang  Zhu,NULL,Stefan  Ambs (Laboratory of Human Carcinogenesis)|Giorgio  Trinchieri (Cancer Inflammation Program)|Daniel  McVicar; PhD (Laboratory of Experimental Immunology),Alasdair M Gilfillan; PhD (NIAID),"1. Chen X, Hamano R, Subleski JJ, Hurwitz AA, Howard OM, Oppenheim JJ (2010). Expression of costimulatory TNFR2 induces resistance of CD4+FoxP3- conventional T cells to suppression by CD4+FoxP3+ regulatory T cells. J Immunol  185, 174-82.   https://doi.org/10.4049/jimmunol.0903548",https://intramural.nih.gov/search/searchview.taf?ipid=68608
369,BC010955-04,"October 01, 2010 -  September 30, 2011",The Role of T Cell Avidity in Determining Tumor Immunity and Autoimmunity,Arthur A Hurwitz,NULL,"Laboratory of Molecular Immunoregulation, NCI",Bonnie Brown Douglas|Katherine  Stagliano|Stephanie K Watkins|Ziqiang  Zhu,NULL,Lionel  Feigenbaum (Office Of The Director)|Lino  Tessarollo (Neural Development Section)|Nicholas Phillip Restifo; MD (Surgery Branch),NULL,"1. Chen X, Hamano R, Subleski JJ, Hurwitz AA, Howard OM, Oppenheim JJ (2010). Expression of costimulatory TNFR2 induces resistance of CD4+FoxP3- conventional T cells to suppression by CD4+FoxP3+ regulatory T cells. J Immunol  185, 174-82.   https://doi.org/10.4049/jimmunol.0903548",https://intramural.nih.gov/search/searchview.taf?ipid=68607
370,BC010956-04,"October 01, 2010 -  September 30, 2011",EpCAM (CD326) Function in Epithelial Cell Biology and Immunophysiology,Mark  Udey; MD,NULL,"Dermatology Branch, NCI",Joshua Zachary Drago|Xu  Feng; PhD|Michael C Lu|Yoichi  Ogawa|Takeshi  Ouchi; MD|Chuanjin  Wu,Daniel M Kaplan|Asma  Nusrat (Emory University School of Medicine),"Susan  Mackem; MD (Cancer and Developmental Biology Laboratory)|Lino  Tessarollo (Neural Development Section)|Robert Mark Simpson; DVM, PhD (Laboratory of Cancer Biology and Genetics)","Maria Irene Morasso; PhD (NIAMS) |Ronald N Germain; MD, PhD (NIAID)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68580
371,BC010957-04,"October 01, 2010 -  September 30, 2011",Transplant Models,Ronald E Gress; MD|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Catherine Virginia Bare|Anthony David Foster; PhD|Philip J Lucas; PhD|Aditya Samir Mazmudar|Eric Fletcher Moss|Ruifeng  Teng|Show all 7,NULL,Alfred  Singer; MD (Experimental Immunology Branch),Richard J Hodes; MD (NIA) |Arya  Biragyn; PhD (NIA),"1. Lee DK, Hakim FT, Gress RE (2010). The thymus and the immune system: layered levels of control. J Thorac Oncol  5, S273-6.   https://doi.org/10.1097/JTO.0b013e3181f20474|2. Olkhanud PB, Damdinsuren B, Bodogai M, Gress RE, Sen R, Wejksza K, Malchinkhuu E, Wersto RP, Biragyn A (2011). Tumor-evoked regulatory B cells promote breast cancer metastasis by converting resting CD4⁺ T cells to T-regulatory cells. Cancer Res  71, 3505-15.   https://doi.org/10.1158/0008-5472.CAN-10-4316|3. Olkhanud PB, Rochman Y, Bodogai M, Malchinkhuu E, Wejksza K, Xu M, Gress RE, Hesdorffer C, Leonard WJ, Biragyn A (2011). Thymic stromal lymphopoietin is a key mediator of breast cancer progression. J Immunol  186, 5656-62.   https://doi.org/10.4049/jimmunol.1100463",https://intramural.nih.gov/search/searchview.taf?ipid=68520
372,BC010958-04,"October 01, 2010 -  September 30, 2011","Signaling Mechanisms of EphrinB1 in Cell Adhesion, Migration and Invasion",Ira  Daar; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell and Developmental Signaling, NCI",Hee Jun  Cho; PhD|Nicolas Qiang Homble|Yoo-Seok  Hwang|Yon Ju  Ji|Arvinder J Singh|Kathleen T Soria,"Ken  Cho (University of California, Irvine)|Christof  Niehrs; PhD (DKFZ Heidelberg)|Herbert  Steinbeisser (University of Heidelberg)|Colin  Stewart (Institute of medical biology)|Aykut  Uren (Georgetown University Medical Center)","Paul A Randazzo; MD, PhD (Laboratory of Cellular and Molecular Biology)",NULL,"1. Bulut G, Hong SH, Chen K, Beauchamp EM, Rahim S, Kosturko GW, Glasgow E, Dakshanamurthy S, Lee HS, Daar I, Toretsky JA, Khanna C, Uren A (2012). Small molecule inhibitors of ezrin inhibit the invasive phenotype of osteosarcoma cells. Oncogene  31, 269-81.   https://doi.org/10.1038/onc.2011.245|2. Hernandez L, Roux KJ, Wong ES, Mounkes LC, Mutalif R, Navasankari R, Rai B, Cool S, Jeong JW, Wang H, Lee HS, Kozlov S, Grunert M, Keeble T, Jones CM, Meta MD, Young SG, Daar IO, Burke B, Perantoni AO, Stewart CL (2010). Functional coupling between the extracellular matrix and nuclear lamina by Wnt signaling in progeria. Dev Cell  19, 413-25.   https://doi.org/10.1016/j.devcel.2010.08.013",https://intramural.nih.gov/search/searchview.taf?ipid=68494
373,BC010959-04,"October 01, 2010 -  September 30, 2011",Relationship between DNA damage detection and signaling,Andre A Nussenzweig; PhD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",NULL,NULL,NULL,NULL,"1. Blagosklonny MV, Campisi J, Sinclair DA, Bartke A, Blasco MA, Bonner WM, Bohr VA, Brosh RM, Brunet A, Depinho RA, Donehower LA, Finch CE, Finkel T, Gorospe M, Gudkov AV, Hall MN, Hekimi S, Helfand SL, Karlseder J, Kenyon C, Kroemer G, Longo V, Nussenzweig A, Osiewacz HD, Peeper DS, et al. [10 more authors] (2010). Impact papers on aging in 2009. Aging (Albany NY)  2, 111-21.   https://doi.org/10.18632/aging.100132|2. Boboila C, Jankovic M, Yan CT, Wang JH, Wesemann DR, Zhang T, Fazeli A, Feldman L, Nussenzweig A, Nussenzweig M, Alt FW (2010). Alternative end-joining catalyzes robust IgH locus deletions and translocations in the combined absence of ligase 4 and Ku70. Proc Natl Acad Sci U S A  107, 3034-9.   https://doi.org/10.1073/pnas.0915067107|3. Boboila C, Yan C, Wesemann DR, Jankovic M, Wang JH, Manis J, Nussenzweig A, Nussenzweig M, Alt FW (2010). Alternative end-joining catalyzes class switch recombination in the absence of both Ku70 and DNA ligase 4. J Exp Med  207, 417-27.   https://doi.org/10.1084/jem.20092449|4. Bothmer A, Robbiani DF, Feldhahn N, Gazumyan A, Nussenzweig A, Nussenzweig MC (2010). 53BP1 regulates DNA resection and the choice between classical and alternative end joining during class switch recombination. J Exp Med  207, 855-65.   https://doi.org/10.1084/jem.20100244|5. Bunting SF, Callén E, Wong N, Chen HT, Polato F, Gunn A, Bothmer A, Feldhahn N, Fernandez-Capetillo O, Cao L, Xu X, Deng CX, Finkel T, Nussenzweig M, Stark JM, Nussenzweig A (2010). 53BP1 inhibits homologous recombination in Brca1-deficient cells by blocking resection of DNA breaks. Cell  141, 243-54.   https://doi.org/10.1016/j.cell.2010.03.012|6. Bunting SF, Nussenzweig A (2010). Dangerous liaisons: Fanconi anemia and toxic nonhomologous end joining in DNA crosslink repair. Mol Cell  39, 164-6.   https://doi.org/10.1016/j.molcel.2010.07.016|7. Daniel JA, Santos MA, Wang Z, Zang C, Schwab KR, Jankovic M, Filsuf D, Chen HT, Gazumyan A, Yamane A, Cho YW, Sun HW, Ge K, Peng W, Nussenzweig MC, Casellas R, Dressler GR, Zhao K, Nussenzweig A (2010). PTIP promotes chromatin changes critical for immunoglobulin class switch recombination. Science  329, 917-23.   https://doi.org/10.1126/science.1187942|8. Jankovic M, Robbiani DF, Dorsett Y, Eisenreich T, Xu Y, Tarakhovsky A, Nussenzweig A, Nussenzweig MC (2010). Role of the translocation partner in protection against AID-dependent chromosomal translocations. Proc Natl Acad Sci U S A  107, 187-92.   https://doi.org/10.1073/pnas.0908946107|9. Nussenzweig A, Nussenzweig MC (2010). Origin of chromosomal translocations in lymphoid cancer. Cell  141, 27-38.   https://doi.org/10.1016/j.cell.2010.03.016|10. Santos MA, Huen MS, Jankovic M, Chen HT, López-Contreras AJ, Klein IA, Wong N, Barbancho JL, Fernandez-Capetillo O, Nussenzweig MC, Chen J, Nussenzweig A (2010). Class switching and meiotic defects in mice lacking the E3 ubiquitin ligase RNF8. J Exp Med  207, 973-81.   https://doi.org/10.1084/jem.20092308",https://intramural.nih.gov/search/searchview.taf?ipid=68658
374,BC010960-04,"October 01, 2010 -  September 30, 2011",ETIB Clinical Trials,Ronald E Gress; MD|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Sarfraz A Memon|Claude  Sportes,"Robert  Korngold (Cancer Center, Hackensack University)|Andrew  Pecora (Cancer Center, Hackensack University)","Crystal L. Mackall; MD (Pediatric Oncology Branch)|Steven Aaron Rosenberg; MD, PhD (Surgery Branch)",NULL,"1. ElKassar N, Gress RE (2010). An overview of IL-7 biology and its use in immunotherapy. J Immunotoxicol  7, 1-7.   https://doi.org/10.3109/15476910903453296|2. Lee DK, Hakim FT, Gress RE (2010). The thymus and the immune system: layered levels of control. J Thorac Oncol  5, S273-6.   https://doi.org/10.1097/JTO.0b013e3181f20474|3. Sportès C, Babb RR, Krumlauf MC, Hakim FT, Steinberg SM, Chow CK, Brown MR, Fleisher TA, Noel P, Maric I, Stetler-Stevenson M, Engel J, Buffet R, Morre M, Amato RJ, Pecora A, Mackall CL, Gress RE (2010). Phase I study of recombinant human interleukin-7 administration in subjects with refractory malignancy. Clin Cancer Res  16, 727-35.   https://doi.org/10.1158/1078-0432.CCR-09-1303",https://intramural.nih.gov/search/searchview.taf?ipid=68521
375,BC010969-04,"October 01, 2010 -  September 30, 2011",The use of chitosan for cancer vaccine delivery,John  Greiner; PhD,Jeffrey  Schlom; PhD,"Laboratory of Tumor Immunology and Biology, NCI",Garland M Davis|Jonathan Kroemer Fallon; PhD|Shinji  Takai,Connie  Rogers (Penn State University)|David A Zaharoff,William Marston Linehan; MD (Urologic Oncology Branch)|Peter A Pinto; MD (Urologic Oncology Branch),NULL,"1. Zaharoff DA, Hance KW, Rogers CJ, Schlom J, Greiner JW (2010). Intratumoral immunotherapy of established solid tumors with chitosan/IL-12. J Immunother  33, 697-705.   https://doi.org/10.1097/CJI.0b013e3181eb826d",https://intramural.nih.gov/search/searchview.taf?ipid=68517
376,BC010970-04,"October 01, 2010 -  September 30, 2011",The connection of innate and adaptive anti-cancer immunity,John  Greiner; PhD,Jeffrey  Schlom; PhD,"Laboratory of Tumor Immunology and Biology, NCI",Garland M Davis|Jonathan Kroemer Fallon; PhD|Shinji  Takai,NULL,NULL,NULL,"1. Bonmassar L, Fossile E, Scoppola A, Graziani G, Prete SP, Formica V, Cappelletti D, De Vecchis L, Cardillo A, Concolino F, D'Atri S, Balduzzi A, Torino F, Caporaso P, Greiner JW, Bonmassar E, Roselli M, Aquino A (2010). Detection of circulating tumor cells is improved by drug-induced antigen up-regulation: preclinical and clinical studies. Anticancer Res  30, 4721-30.",https://intramural.nih.gov/search/searchview.taf?ipid=68518
377,BC010972-04,"October 01, 2010 -  September 30, 2011",Identification of human tumor-associated antigens,Kwong Yok Tsang,Jeffrey  Schlom; PhD,"Laboratory of Tumor Immunology and Biology, NCI","Caroline Mikaela Maria Jochems; PhD|Jo Anne Tucker; PhD|Claudia Mercedes Palena|James L Gulley; MD, PhD",NULL,Ira H Pastan; MD (Molecular Biology Section)|Tapan K Bera (Molecular Biology Section),NULL,"1. Cereda V, Poole DJ, Palena C, Das S, Bera TK, Remondo C, Gulley JL, Arlen PM, Yokokawa J, Pastan I, Schlom J, Tsang KY (2010). New gene expressed in prostate: a potential target for T cell-mediated prostate cancer immunotherapy. Cancer Immunol Immunother  59, 63-71.   https://doi.org/10.1007/s00262-009-0723-6|2. Vergati M, Intrivici C, Huen NY, Schlom J, Tsang KY (2010). Strategies for cancer vaccine development. J Biomed Biotechnol  2010.   https://doi.org/10.1155/2010/596432",https://intramural.nih.gov/search/searchview.taf?ipid=68578
378,BC010973-04,"October 01, 2010 -  September 30, 2011",Analyses of human T regulatory cells,Kwong Yok Tsang,Jeffrey  Schlom; PhD,"Laboratory of Tumor Immunology and Biology, NCI","James L Gulley; MD, PhD|Caroline Mikaela Maria Jochems; PhD|Jo Anne Tucker; PhD","David  Apelian (GlobeImmune, Inc.)|Pierpaolo  Correale (NCI)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68579
379,BC010974-04,"October 01, 2010 -  September 30, 2011",The development of Saccharomyces (yeast) vaccines for cancer therapy,James W Hodge; PhD|IRP Faculty Profile,NULL,"Laboratory of Tumor Immunology and Biology, NCI",Andressa  Ardiani|Jeffrey  Schlom; PhD|John  Greiner; PhD|Anna Ruth Kwilas; PhD|Marion G Taylor,NULL,NULL,NULL,"1. Boehm AL, Higgins J, Franzusoff A, Schlom J, Hodge JW (2010). Concurrent vaccination with two distinct vaccine platforms targeting the same antigen generates phenotypically and functionally distinct T-cell populations. Cancer Immunol Immunother  59, 397-408.   https://doi.org/10.1007/s00262-009-0759-7",https://intramural.nih.gov/search/searchview.taf?ipid=68604
380,BC010975-04,"October 01, 2010 -  September 30, 2011",Vaccine and radiation for the therapy of human cancers,James W Hodge; PhD|IRP Faculty Profile,NULL,"Laboratory of Tumor Immunology and Biology, NCI",Andressa  Ardiani|Anna Ruth Kwilas; PhD|Jeffrey  Schlom; PhD|Marion G Taylor,"Alex  Franzusoff (Research and Development, GlobeImmune)|Eric  Reits (Netherlands Cancer Institute)",Kevin A Camphausen; MD (Radiation Oncology Branch),Bradford J Wood; MD (CC),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68605
381,BC010976-04,"October 01, 2010 -  September 30, 2011",Role of MFG-E8 in Tumor Biology and Immunophysiology,Mark  Udey; MD,NULL,"Dermatology Branch, NCI",Joshua Zachary Drago|Michael C Lu,NULL,NULL,Jeffrey Burnett Kopp; MD (NIDDK),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68581
382,BC010977-04,"October 01, 2010 -  September 30, 2011",Cbl Proteins as Regulators of Tyrosine Kinase Signaling,"Stanley  Lipkowitz; MD, PhD|IRP Faculty Profile",NULL,"Laboratory of Cellular and Molecular Biology, NCI","Stephen Charles Kales|Ke  Ma|Marion M Nau|Paul A Randazzo; MD, PhD|Philip  Ryan",NULL,"Allan M Weissman; MD (Laboratory of Protein Dynamics and Signaling)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Jeffrey E Green; MD (Laboratory of Cancer Biology and Genetics)",NULL,"1. Kales SC, Ryan PE, Nau MM, Lipkowitz S (2010). Cbl and human myeloid neoplasms: the Cbl oncogene comes of age. Cancer Res  70, 4789-94.   https://doi.org/10.1158/0008-5472.CAN-10-0610|2. Ryan PE, Sivadasan-Nair N, Nau MM, Nicholas S, Lipkowitz S (2010). The N terminus of Cbl-c regulates ubiquitin ligase activity by modulating affinity for the ubiquitin-conjugating enzyme. J Biol Chem  285, 23687-98.   https://doi.org/10.1074/jbc.M109.091157|3. Tan YH, Krishnaswamy S, Nandi S, Kanteti R, Vora S, Onel K, Hasina R, Lo FY, El-Hashani E, Cervantes G, Robinson M, Hsu HS, Kales SC, Lipkowitz S, Karrison T, Sattler M, Vokes EE, Wang YC, Salgia R (2010). CBL is frequently altered in lung cancers: its relationship to mutations in MET and EGFR tyrosine kinases. PLoS One  5, e8972.   https://doi.org/10.1371/journal.pone.0008972",https://intramural.nih.gov/search/searchview.taf?ipid=68637
383,BC010982-04,"October 01, 2010 -  September 30, 2011",Collaborative Pathways that Lead to Leukemia,Peter D Aplan; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI","Sarah H Beachy; PhD|Rachel  Novak|Paul S Meltzer; MD, PhD|Masahiro  Onozawa|Hyun Kyung Kyun Kim|Sheryl Maxine Gough",Steven  Nimer (MSKCC)|Donald  Small (Johns Hopkins University School of Medicine),Lino  Tessarollo (Neural Development Section)|Linda  Wolff; PhD (Laboratory of Cellular Oncology),NULL,"1. Caudell D, Harper DP, Novak RL, Pierce RM, Slape C, Wolff L, Aplan PD (2010). Retroviral insertional mutagenesis identifies Zeb2 activation as a novel leukemogenic collaborating event in CALM-AF10 transgenic mice. Blood  115, 1194-203.   https://doi.org/10.1182/blood-2009-04-216184|2. Estécio MR, Gallegos J, Vallot C, Castoro RJ, Chung W, Maegawa S, Oki Y, Kondo Y, Jelinek J, Shen L, Hartung H, Aplan PD, Czerniak BA, Liang S, Issa JP (2010). Genome architecture marked by retrotransposons modulates predisposition to DNA methylation in cancer. Genome Res  20, 1369-82.   https://doi.org/10.1101/gr.107318.110|3. Tremblay M, Tremblay CS, Herblot S, Aplan PD, Hébert J, Perreault C, Hoang T (2010). Modeling T-cell acute lymphoblastic leukemia induced by the SCL and LMO1 oncogenes. Genes Dev  24, 1093-105.   https://doi.org/10.1101/gad.1897910",https://intramural.nih.gov/search/searchview.taf?ipid=68469
384,BC010983-04,"October 01, 2010 -  September 30, 2011",Pre-clinical Studies of Therapy for Myelodysplastic Syndrome,Peter D Aplan; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Sarah H Beachy; PhD|Yang-Jo  Chung|Sheryl Maxine Gough,JP  Issa (MD Anderson)|Steven  Nimer (MSKCC)|Chris  Slape (Monash University),Terry J Fry (Pediatric Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68470
385,BC010984-04,"October 01, 2010 -  September 30, 2011",Adoptive Cell Transfer Immunotherapy of Cancer,"Steven Aaron Rosenberg; MD, PhD|IRP Faculty Profile",NULL,"Surgery Branch, NCI",Ellen E Douglas|Richard  Sherry; MD|Alena - Gros; PhD|Marybeth S Hughes|Udai S Kammula|Joyce G Landry|Show all 21,NULL,NULL,Yardena Rachel Samuels; PhD (NHGRI),"1. Chinnasamy N, Wargo JA, Yu Z, Rao M, Frankel TL, Riley JP, Hong JJ, Parkhurst MR, Feldman SA, Schrump DS, Restifo NP, Robbins PF, Rosenberg SA, Morgan RA (2011). A TCR targeting the HLA-A*0201-restricted epitope of MAGE-A3 recognizes multiple epitopes of the MAGE-A antigen superfamily in several types of cancer. J Immunol  186, 685-96.   https://doi.org/10.4049/jimmunol.1001775|2. Davis JL, Ripley RT, Frankel TL, Maric I, Lozier JN, Rosenberg SA (2010). Paraneoplastic granulocytosis in metastatic melanoma. Melanoma Res  20, 326-9.   https://doi.org/10.1097/CMR.0b013e328339da1e|3. Frankel TL, Burns W, Riley J, Morgan RA, Davis JL, Hanada K, Quezado M, Rosenberg SA, Royal RE (2010). Identification and characterization of a tumor infiltrating CD56(+)/CD16 (-) NK cell subset with specificity for pancreatic and prostate cancer cell lines. Cancer Immunol Immunother  59, 1757-69.   https://doi.org/10.1007/s00262-010-0897-y|4. Goff SL, Johnson LA, Black MA, Xu H, Zheng Z, Cohen CJ, Morgan RA, Rosenberg SA, Feldman SA (2010). Enhanced receptor expression and in vitro effector function of a murine-human hybrid MART-1-reactive T cell receptor following a rapid expansion. Cancer Immunol Immunother  59, 1551-60.   https://doi.org/10.1007/s00262-010-0882-5|5. Goff SL, Smith FO, Klapper JA, Sherry R, Wunderlich JR, Steinberg SM, White D, Rosenberg SA, Dudley ME, Yang JC (2010). Tumor infiltrating lymphocyte therapy for metastatic melanoma: analysis of tumors resected for TIL. J Immunother  33, 840-7.   https://doi.org/10.1097/CJI.0b013e3181f05b91|6. Hong JJ, Rosenberg SA, Dudley ME, Yang JC, White DE, Butman JA, Sherry RM (2010). Successful treatment of melanoma brain metastases with adoptive cell therapy. Clin Cancer Res  16, 4892-8.   https://doi.org/10.1158/1078-0432.CCR-10-1507|7. Inozume T, Hanada K, Wang QJ, Ahmadzadeh M, Wunderlich JR, Rosenberg SA, Yang JC (2010). Selection of CD8+PD-1+ lymphocytes in fresh human melanomas enriches for tumor-reactive T cells. J Immunother  33, 956-64.   https://doi.org/10.1097/CJI.0b013e3181fad2b0|8. Kerkar SP, Sanchez-Perez L, Yang S, Borman ZA, Muranski P, Ji Y, Chinnasamy D, Kaiser AD, Hinrichs CS, Klebanoff CA, Scott CD, Gattinoni L, Morgan RA, Rosenberg SA, Restifo NP (2011). Genetic engineering of murine CD8+ and CD4+ T cells for preclinical adoptive immunotherapy studies. J Immunother  34, 343-52.   https://doi.org/10.1097/CJI.0b013e3182187600|9. Kochenderfer JN, Rosenberg SA (2011). Chimeric antigen receptor-modified T cells in CLL. N Engl J Med  365, 1937-8; author reply 1938.   https://doi.org/10.1056/NEJMc1111004|10. Prieto PA, Durflinger KH, Wunderlich JR, Rosenberg SA, Dudley ME (2010). Enrichment of CD8+ cells from melanoma tumor-infiltrating lymphocyte cultures reveals tumor reactivity for use in adoptive cell therapy. J Immunother  33, 547-56.   https://doi.org/10.1097/CJI.0b013e3181d367bd|11. Ray S, Chhabra A, Chakraborty NG, Hegde U, Dorsky DI, Chodon T, von Euw E, Comin-Anduix B, Koya RC, Ribas A, Economou JS, Rosenberg SA, Mukherji B, UCLA-CALTECH-CHLA-USC-UCONN Consortium on Translational Program in Engineered Immunity (2010). MHC-I-restricted melanoma antigen specific TCR-engineered human CD4+ T cells exhibit multifunctional effector and helper responses, in vitro. Clin Immunol  136, 338-47.   https://doi.org/10.1016/j.clim.2010.04.013|12. Ripley RT, Davis JL, Klapper JA, Mathur A, Kammula U, Royal RE, Yang JC, Sherry RM, Hughes MS, Libutti SK, White DE, Steinberg SM, Dudley ME, Rosenberg SA, Avital I (2010). Liver resection for metastatic melanoma with postoperative tumor-infiltrating lymphocyte therapy. Ann Surg Oncol  17, 163-70.   https://doi.org/10.1245/s10434-009-0677-0|13. Rosenberg SA, Yang JC, Kammula US, Hughes MS, Restifo NP, Schwarz SL, Morton KE, Laurencot CM, Sherry RM (2010). Different adjuvanticity of incomplete freund's adjuvant derived from beef or vegetable components in melanoma patients immunized with a peptide vaccine. J Immunother  33, 626-9.   https://doi.org/10.1097/CJI.0b013e3181dac9de|14. Shrimali RK, Yu Z, Theoret MR, Chinnasamy D, Restifo NP, Rosenberg SA (2010). Antiangiogenic agents can increase lymphocyte infiltration into tumor and enhance the effectiveness of adoptive immunotherapy of cancer. Cancer Res  70, 6171-80.   https://doi.org/10.1158/0008-5472.CAN-10-0153|15. Wrzesinski C, Paulos CM, Kaiser A, Muranski P, Palmer DC, Gattinoni L, Yu Z, Rosenberg SA, Restifo NP (2010). Increased intensity lymphodepletion enhances tumor treatment efficacy of adoptively transferred tumor-specific T cells. J Immunother  33, 1-7.   https://doi.org/10.1097/CJI.0b013e3181b88ffc",https://intramural.nih.gov/search/searchview.taf?ipid=68541
386,BC010985-04,"October 01, 2010 -  September 30, 2011",Gene therapy of cancer,"Steven Aaron Rosenberg; MD, PhD|IRP Faculty Profile",NULL,"Surgery Branch, NCI",Dhana  Chinnasamy; PhD|Richard  Sherry; MD|Ellen E Douglas|Marybeth S Hughes|Mark E Dudley|Udai S Kammula|Show all 24,NULL,NULL,NULL,"1. Burns WR, Zhao Y, Frankel TL, Hinrichs CS, Zheng Z, Xu H, Feldman SA, Ferrone S, Rosenberg SA, Morgan RA (2010). A high molecular weight melanoma-associated antigen-specific chimeric antigen receptor redirects lymphocytes to target human melanomas. Cancer Res  70, 3027-33.   https://doi.org/10.1158/0008-5472.CAN-09-2824|2. Chinnasamy D, Yu Z, Theoret MR, Zhao Y, Shrimali RK, Morgan RA, Feldman SA, Restifo NP, Rosenberg SA (2010). Gene therapy using genetically modified lymphocytes targeting VEGFR-2 inhibits the growth of vascularized syngenic tumors in mice. J Clin Invest  120, 3953-68.   https://doi.org/10.1172/JCI43490|3. Davis JL, Theoret MR, Zheng Z, Lamers CH, Rosenberg SA, Morgan RA (2010). Development of human anti-murine T-cell receptor antibodies in both responding and nonresponding patients enrolled in TCR gene therapy trials. Clin Cancer Res  16, 5852-61.   https://doi.org/10.1158/1078-0432.CCR-10-1280|4. Frankel TL, Burns WR, Peng PD, Yu Z, Chinnasamy D, Wargo JA, Zheng Z, Restifo NP, Rosenberg SA, Morgan RA (2010). Both CD4 and CD8 T cells mediate equally effective in vivo tumor treatment when engineered with a highly avid TCR targeting tyrosinase. J Immunol  184, 5988-98.   https://doi.org/10.4049/jimmunol.1000189|5. Kalbasi A, Shrimali RK, Chinnasamy D, Rosenberg SA (2010). Prevention of interleukin-2 withdrawal-induced apoptosis in lymphocytes retrovirally cotransduced with genes encoding an antitumor T-cell receptor and an antiapoptotic protein. J Immunother  33, 672-83.   https://doi.org/10.1097/CJI.0b013e3181e475cd|6. Kerkar SP, Muranski P, Kaiser A, Boni A, Sanchez-Perez L, Yu Z, Palmer DC, Reger RN, Borman ZA, Zhang L, Morgan RA, Gattinoni L, Rosenberg SA, Trinchieri G, Restifo NP (2010). Tumor-specific CD8+ T cells expressing interleukin-12 eradicate established cancers in lymphodepleted hosts. Cancer Res  70, 6725-34.   https://doi.org/10.1158/0008-5472.CAN-10-0735|7. Kochenderfer JN, Yu Z, Frasheri D, Restifo NP, Rosenberg SA (2010). Adoptive transfer of syngeneic T cells transduced with a chimeric antigen receptor that recognizes murine CD19 can eradicate lymphoma and normal B cells. Blood  116, 3875-86.   https://doi.org/10.1182/blood-2010-01-265041|8. Morgan RA, Dudley ME, Rosenberg SA (2010). Adoptive cell therapy: genetic modification to redirect effector cell specificity. Cancer J  16, 336-41.   https://doi.org/10.1097/PPO.0b013e3181eb3879|9. Morgan RA, Yang JC, Kitano M, Dudley ME, Laurencot CM, Rosenberg SA (2010). Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2. Mol Ther  18, 843-51.   https://doi.org/10.1038/mt.2010.24|10. Rosenberg SA (2010). Of mice, not men: no evidence for graft-versus-host disease in humans receiving T-cell receptor-transduced autologous T cells. Mol Ther  18, 1744-5.   https://doi.org/10.1038/mt.2010.195",https://intramural.nih.gov/search/searchview.taf?ipid=68540
387,BC010986-04,"October 01, 2010 -  September 30, 2011",Allele-specific gene expression and epigenetic information,Maxwell P Lee; PhD,NULL,"Laboratory of Population Genetics, NCI",Kenneth  Buetow; PhD|Sheryl A Gere|Mitsutaka  Kadota|Howard H Yang,NULL,"Philip  Taylor; MD, ScD (Genetic Epidemiology Branch)|Alisa  Goldstein; PhD (Genetic Epidemiology Branch)|Lalage  Wakefield; PhD (Laboratory of Cancer Biology and Genetics)|Jiuping  Ji (Office of the Director)",NULL,"1. Kadota M, Yang HH, Gomez B, Sato M, Clifford RJ, Meerzaman D, Dunn BK, Wakefield LM, Lee MP (2010). Delineating genetic alterations for tumor progression in the MCF10A series of breast cancer cell lines. PLoS One  5, e9201.   https://doi.org/10.1371/journal.pone.0009201|2. Yang HH, Hu N, Wang C, Ding T, Dunn BK, Goldstein AM, Taylor PR, Lee MP (2010). Influence of genetic background and tissue types on global DNA methylation patterns. PLoS One  5, e9355.   https://doi.org/10.1371/journal.pone.0009355",https://intramural.nih.gov/search/searchview.taf?ipid=68629
388,BC010992-04,"October 01, 2010 -  September 30, 2011",Fidelity of Transcription,Jeffrey N Strathern,NULL,"Gene Regulation and Chromosome Biology Laboratory, NCI",Ashley Suzanne Denney|Mary K Ernst|Deanna R Gotte|Ding Jun Jin|Dwight V Nissley|Alison J Rattray|Show all 7,NULL,Stephen H Hughes; PhD (HIV Drug Resistance Program)|Mikhail V Kashlev (Molecular Mechanisms of Transcription Section)|Donald L Court; PhD (Molecular Control and Genetics Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68572
389,BC010993-04,"October 01, 2010 -  September 30, 2011",Molecular architecture of lymphocyte cortex,James Stephen Shaw; PhD|IRP Faculty Profile,NULL,"Human Immunology Section, NCI",Khadija  Ben-aissa|Genaro  Patino Lopez,"Matthew  Krummel; PhD|(UCSF)|E. Michael  Ostap (Pennsylvania Muscle Institute, University of Pennsylvania)|Matthew  Tyska (Vanderbilt University School of Medicine)",Michael John Kruhlak; PhD (Experimental Immunology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68551
390,BC010994-04,"October 01, 2010 -  September 30, 2011",Lymphocyte membrane-proximal basophilic kinases,James Stephen Shaw; PhD|IRP Faculty Profile,NULL,"Human Immunology Section, NCI",Natalya  Belkina,"Luc  Sabourin; PhD (Ottawa Hospital Research Institute, Canada)|Siu-Pok  Yee (University of Connecticut Health Center)",James L Hartley (Office Of The Director)|Dominic  Esposito; PhD (Office Of The Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68548
391,BC010995-04,"October 01, 2010 -  September 30, 2011",ERM phosphorylation in lymphocytes,James Stephen Shaw; PhD|IRP Faculty Profile,NULL,"Human Immunology Section, NCI",Natalya  Belkina|Khadija  Ben-aissa|Genaro  Patino Lopez,"Hajime  Karasuyama (Department of Immunology, Tokyo Metropolitan Institute of Medical Science)|Ulrich  Von Andrian (Harvard University)",Jung-Hyun  Park (Experimental Immunology Branch),John H Kehrl; MD (NIAID) |Chung  Park (NIAID),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68549
392,BC010996-04,"October 01, 2010 -  September 30, 2011",Molecular mechanisms of ERM regulation,James Stephen Shaw; PhD|IRP Faculty Profile,NULL,"Human Immunology Section, NCI",Natalya  Belkina|Khadija  Ben-aissa|Genaro  Patino Lopez,NULL,Michael John Kruhlak; PhD (Experimental Immunology Branch),Tilman J Rosales (NHLBI) |Jay Robert Knutson; PhD (NHLBI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68550
393,BC010997-04,"October 01, 2010 -  September 30, 2011",Purification of a Novel Antibody Against Solid Organ Cancer Stem Cells,Itzhak  Avital,NULL,"Surgery Branch, NCI",NULL,NULL,"Paul  Goldsmith; PhD (Office of the Director)|Snorri S. Thorgeirsson; MD, PhD (Laboratory of Experimental Carcinogenesis)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68473
394,BC010998-04,"October 01, 2010 -  September 30, 2011",Identification of Novel Mutations In Pediatric Cancers,Javed  Khan; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",James  Badgett|Chand  Khanna; MD|Dominik  Bogen|Tai Chi  Cheuk|Lee Jay Helman; MD|Jianbin Na He|Show all 18,"David  Azorsa (NHGRI)|Daniel  Catchpoole, (The Children's Hospital at Westmead)|Douglas  Hawkins (Pediatric Oncology, Children's Hosp. of Seattle)|John  Maris (Pharmacology, Children's Hospital of Philadelphia)|Robert  Seeger (Division of Pediatric Hematology-Oncology, Children's Hospital of Los Angeles)|Jason  Shohet (Baylor College of Medicine)|Show all 8","Malcolm A Smith (Clinical Investigations Branch)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Stephen J Chanock; MD, PhD (Laboratory Translational Genomics)|Christoph  Rader; PhD (Experimental Transplantation and Immunology Branch)",James G Taylor; MD (NHLBI) |Steven M Holland; MD (NIAID),"1. Chen QR, Yu LR, Tsang P, Wei JS, Song YK, Cheuk A, Chung JY, Hewitt SM, Veenstra TD, Khan J (2011). Systematic proteome analysis identifies transcription factor YY1 as a direct target of miR-34a. J Proteome Res  10, 479-87.   https://doi.org/10.1021/pr1006697|2. Gheeya J, Johansson P, Chen QR, Dexheimer T, Metaferia B, Song YK, Wei JS, He J, Pommier Y, Khan J (2010). Expression profiling identifies epoxy anthraquinone derivative as a DNA topoisomerase inhibitor. Cancer Lett  293, 124-31.   https://doi.org/10.1016/j.canlet.2010.01.004|3. Grohar PJ, Woldemichael GM, Griffin LB, Mendoza A, Chen QR, Yeung C, Currier DG, Davis S, Khanna C, Khan J, McMahon JB, Helman LJ (2011). Identification of an inhibitor of the EWS-FLI1 oncogenic transcription factor by high-throughput screening. J Natl Cancer Inst  103, 962-78.   https://doi.org/10.1093/jnci/djr156|4. Guo X, Chen QR, Song YK, Wei JS, Khan J (2011). Exon array analysis reveals neuroblastoma tumors have distinct alternative splicing patterns according to stage and MYCN amplification status. BMC Med Genomics  4, 35.   https://doi.org/10.1186/1755-8794-4-35",https://intramural.nih.gov/search/searchview.taf?ipid=68615
395,BC010999-04,"October 01, 2010 -  September 30, 2011",Characterization of FGFR4 mutations in Rhabdomyosarcoma,Javed  Khan; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",James  Badgett|Chand  Khanna; MD|Tai Chi  Cheuk|Laura Beth Hurd|John Frederick Shern|Jun S Wei,NULL,"Stephen J Chanock; MD, PhD (Laboratory Translational Genomics)|Glenn  Merlino; PhD (Laboratory of Cancer Biology and Genetics)",James G Taylor; MD (NHLBI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68616
396,BC011001-04,"October 01, 2010 -  September 30, 2011",Micro RNA  Profiling in Pediatric Cancers,Javed  Khan; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",James  Badgett|Tai Chi  Cheuk|Jianbin Na He|Laura Beth Hurd|Peter  Johansson|Hongling  Liao|Show all 14,NULL,Malcolm A Smith (Clinical Investigations Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68617
397,BC011002-04,"October 01, 2010 -  September 30, 2011",BIOINFORMATICS: SYSTEMS BIOLOGY OF NEUROBLASTOMA,Javed  Khan; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Tai Chi  Cheuk|Jianbin Na He|Laura Beth Hurd|Peter  Johansson|Rajesh  Patidar|John Frederick Shern|Show all 10,"John  Maris (Pharmacology, Children's Hospital of Philadelphia)|Jason  Shohet (Baylor College of Medicine)","Timothy D Veenstra (Office Of The Director)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",NULL,"1. Gheeya J, Johansson P, Chen QR, Dexheimer T, Metaferia B, Song YK, Wei JS, He J, Pommier Y, Khan J (2010). Expression profiling identifies epoxy anthraquinone derivative as a DNA topoisomerase inhibitor. Cancer Lett  293, 124-31.   https://doi.org/10.1016/j.canlet.2010.01.004",https://intramural.nih.gov/search/searchview.taf?ipid=68613
398,BC011003-04,"October 01, 2010 -  September 30, 2011",Asymmetric Division and Self Renewal of Cancer Stem Cells,Itzhak  Avital,NULL,"Surgery Branch, NCI",John Ellis Mullinax|Satyajit  Ray; PhD|Hongwu  Xin,NULL,"Paul  Goldsmith; PhD (Office of the Director)|Snorri S. Thorgeirsson; MD, PhD (Laboratory of Experimental Carcinogenesis)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68474
399,BC011004-04,"October 01, 2010 -  September 30, 2011",Bone Marrow Stem Cells Participation in Solid Organ Cancers Carcinogenesis,Itzhak  Avital,NULL,"Surgery Branch, NCI",John Ellis Mullinax|Satyajit  Ray; PhD|Udo  Rudloff|Hongwu  Xin|Udai S Kammula,NULL,"Snorri S. Thorgeirsson; MD, PhD (Laboratory of Experimental Carcinogenesis)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Deborah E Citrin (Radiation Oncology Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68475
400,BC011005-04,"October 01, 2010 -  September 30, 2011",Isolation and Purification of Cancer Stem Cells Based on Functional Appraoch,Itzhak  Avital,NULL,"Surgery Branch, NCI",NULL,NULL,"Snorri S. Thorgeirsson; MD, PhD (Laboratory of Experimental Carcinogenesis)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68472
401,BC011006-04,"October 01, 2010 -  September 30, 2011",Molecular diagnosis and outcome prediction in lymphoma,Louis  Staudt; MD|IRP Faculty Profile,NULL,"Lymphoid Malignancies Branch, NCI","Sameer Gokuldas Jhavar|Wyndham H Wilson; MD, PhD|Weihong  Xu",Elias  Campo (University of Barcelona)|John  Chan (Univ. of Nebraska Medical Center)|Joseph  Connors (British Columbia Cancer Agency)|Richard  Fisher (University of Rochester School of Medicine)|Randy  Gascoyne (British Columbia Cancer Center)|T. Andrew  Lister (St. Bartholomew Hospital)|Show all 9,Elaine S Jaffe; MD (Laboratory of Pathology)|George W Wright (Biometrics Research Branch),John I Powell (CIT) |Wenming  Xiao; PhD (CIT),"1. Steidl C, Lee T, Shah SP, Farinha P, Han G, Nayar T, Delaney A, Jones SJ, Iqbal J, Weisenburger DD, Bast MA, Rosenwald A, Muller-Hermelink HK, Rimsza LM, Campo E, Delabie J, Braziel RM, Cook JR, Tubbs RR, Jaffe ES, Lenz G, Connors JM, Staudt LM, Chan WC, Gascoyne RD (2010). Tumor-associated macrophages and survival in classic Hodgkin's lymphoma. N Engl J Med  362, 875-85.   https://doi.org/10.1056/NEJMoa0905680",https://intramural.nih.gov/search/searchview.taf?ipid=68564
402,BC011007-04,"October 01, 2010 -  September 30, 2011",RNA interference-based screens for molecular targets in cancer,Louis  Staudt; MD|IRP Faculty Profile,NULL,"Lymphoid Malignancies Branch, NCI",Yandan  Yang; PhD,NULL,George W Wright (Biometrics Research Branch),John I Powell (CIT) |Wenming  Xiao; PhD (CIT),"1. Davis RE, Ngo VN, Lenz G, Tolar P, Young RM, Romesser PB, Kohlhammer H, Lamy L, Zhao H, Yang Y, Xu W, Shaffer AL, Wright G, Xiao W, Powell J, Jiang JK, Thomas CJ, Rosenwald A, Ott G, Muller-Hermelink HK, Gascoyne RD, Connors JM, Johnson NA, Rimsza LM, Campo E, et al. [12 more authors] (2010). Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma. Nature  463, 88-92.   https://doi.org/10.1038/nature08638",https://intramural.nih.gov/search/searchview.taf?ipid=68565
403,BC011008-04,"October 01, 2010 -  September 30, 2011",Oncogenic mechanisms and molecular targets in lymphoma,Louis  Staudt; MD|IRP Faculty Profile,NULL,"Lymphoid Malignancies Branch, NCI","Michele  Ceribelli; PhD|Wyndham H Wilson; MD, PhD|Daniel James Hodson|Sameer Gokuldas Jhavar|Priscilla Ninette Kelly; PhD|Lim Huat Kian; MD|Show all 16",Elias  Campo (University of Barcelona)|John  Chan (Univ. of Nebraska Medical Center)|Joseph  Connors (British Columbia Cancer Agency)|Richard  Fisher (University of Rochester School of Medicine)|Randy  Gascoyne (British Columbia Cancer Center)|T. Andrew  Lister (St. Bartholomew Hospital)|Show all 9,Elaine S Jaffe; MD (Laboratory of Pathology),John I Powell (CIT) |Wenming  Xiao; PhD (CIT),"1. Davis RE, Ngo VN, Lenz G, Tolar P, Young RM, Romesser PB, Kohlhammer H, Lamy L, Zhao H, Yang Y, Xu W, Shaffer AL, Wright G, Xiao W, Powell J, Jiang JK, Thomas CJ, Rosenwald A, Ott G, Muller-Hermelink HK, Gascoyne RD, Connors JM, Johnson NA, Rimsza LM, Campo E, et al. [12 more authors] (2010). Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma. Nature  463, 88-92.   https://doi.org/10.1038/nature08638|2. Hartmann EM, Campo E, Wright G, Lenz G, Salaverria I, Jares P, Xiao W, Braziel RM, Rimsza LM, Chan WC, Weisenburger DD, Delabie J, Jaffe ES, Gascoyne RD, Dave SS, Mueller-Hermelink HK, Staudt LM, Ott G, Beà S, Rosenwald A (2010). Pathway discovery in mantle cell lymphoma by integrated analysis of high-resolution gene expression and copy number profiling. Blood  116, 953-61.   https://doi.org/10.1182/blood-2010-01-263806|3. Pérez-Galán P, Mora-Jensen H, Weniger MA, Shaffer AL, Rizzatti EG, Chapman CM, Mo CC, Stennett LS, Rader C, Liu P, Raghavachari N, Stetler-Stevenson M, Yuan C, Pittaluga S, Maric I, Dunleavy KM, Wilson WH, Staudt LM, Wiestner A (2011). Bortezomib resistance in mantle cell lymphoma is associated with plasmacytic differentiation. Blood  117, 542-52.   https://doi.org/10.1182/blood-2010-02-269514|4. Staudt LM (2010). Oncogenic activation of NF-kappaB. Cold Spring Harb Perspect Biol  2, a000109.   https://doi.org/10.1101/cshperspect.a000109",https://intramural.nih.gov/search/searchview.taf?ipid=68562
404,BC011010-04,"October 01, 2010 -  September 30, 2011",Oncogenic mechanisms and molecular targets in myeloma,Louis  Staudt; MD|IRP Faculty Profile,NULL,"Lymphoid Malignancies Branch, NCI",Laurence  Lamy|Hong  Zhao,Bart  Barlogie (Univ. of Arkansas for Medical Sciences)|John  Shaughnessy (Univ. of Arkansas for Medical Sciences),"Walter M Kuehl; MD, PhD (Cancer Genetics Branch)|Ola Anders Landgren (Medical Oncology Branch)|Christina M Annunziata (Medical Oncology Branch)",NULL,"1. Staudt LM (2010). Oncogenic activation of NF-kappaB. Cold Spring Harb Perspect Biol  2, a000109.   https://doi.org/10.1101/cshperspect.a000109",https://intramural.nih.gov/search/searchview.taf?ipid=68563
405,BC011011-04,"October 01, 2010 -  September 30, 2011",The genome-wide function of supercoiling and alternative DNA conformations,David  Levens; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Laura  Baranello|Ashutosh  Gupta|Yeung  Ho|Hsin-Hao Timothy Hsiao|Fedor Edmundovich Kouzine|Zuqin  Nie; PhD|Show all 8,NULL,"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Yves  Pommier; PhD (Developmental Therapeutics Branch)",Keji  Zhao; PhD (NHLBI) |Rafael Cristian Casellas; PhD (NIAMS) |Teresa M Przytycka (NLM),"1. Liu J, Chung HJ, Vogt M, Jin Y, Malide D, He L, Dundr M, Levens D (2011). JTV1 co-activates FBP to induce USP29 transcription and stabilize p53 in response to oxidative stress. EMBO J  30, 846-58.   https://doi.org/10.1038/emboj.2011.11",https://intramural.nih.gov/search/searchview.taf?ipid=68631
406,BC011012-04,"October 01, 2010 -  September 30, 2011",Study of Hepatic Arterial Infusion of Melphalan for Malignancy in the liver,Marybeth S Hughes,"Steven Aaron Rosenberg; MD, PhD","Surgery Branch, NCI",NULL,"Sanjiv  Agarwla (St. Luke's Hospital and Health System)|H. Denis Alexander; PhD (Department of Hematology, Belfast City Hospital)|Mark  Faries (John Wayne Cancer Institute)|Charles  Nutting (Sweedish Medical Center)|James F Pingpank (NCI)|Gary  Siskin (Albany Medical Center)|Show all 8",William D Figg; PharmD (Medical Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68606
407,BC011017-04,"October 01, 2010 -  September 30, 2011",The study of underlying mechanism of EGFR-Ras signaling in glioblastoma,Terry Anne Van Dyke,NULL,"Mouse Cancer Genetics Program, NCI",Linda S Cleveland|Debra J Gilbert|Xiuyun  Lu|Theresa N O'Sullivan|Yurong  Song; PhD|Teresa L Sullivan|Show all 9,Leroy E Hood|Patrick  Paddison (University of Seattle),Nadya I Tarasova; PhD (Cancer Inflammation Program),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68583
408,BC011018-04,"October 01, 2010 -  September 30, 2011",Differential Gene Expression and Targeting of Gliomas Using Radiation,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Ryan J Hanson,NULL,Kevin A Camphausen; MD (Radiation Oncology Branch)|Ira  Gordon (Radiation Oncology Branch),Russell R Lonser; MD (NINDS) |Marsha J Merrill; PhD (NINDS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68591
409,BC011019-04,"October 01, 2010 -  September 30, 2011",Diffuse Intrinsic Pontine Glioma Genomic Study,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Robyn S Bent|Laurie  Steffen,NULL,"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Martha Maria Nicacio Quezado; MD (Laboratory of Pathology)|Jonathan Keith Killian (Cancer Genetics Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68590
410,BC011024-04,"October 01, 2010 -  September 30, 2011",Tumor and Metastasis Therapy,Chand  Khanna; MD,NULL,"Pediatric Oncology Branch, NCI",Anita C Epps|Lee Jay Helman; MD|Radhika Vishwanath Gharpure|Ling  Ren,"Timothy  Fan (Veterinary Clinical Medicine, University of Illinois)|Richard  Gorlick (Laboratory of Cellular Carcinogenesis and Tumor Promotion, Albert Einstein College of Medicine)|Timothy  Green (AstraZeneca)|Stephen  Lesnick (Huntsman Cancer Center)|Aykut  Uren (Georgetown University Medical Center)","Timothy D Veenstra (Office Of The Director)|Stephen M Hewitt; MD, PhD (Laboratory of Pathology)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Allan M Weissman; MD (Laboratory of Protein Dynamics and Signaling)",NULL,"1. Mendoza A, Hong SH, Osborne T, Khan MA, Campbell K, Briggs J, Eleswarapu A, Buquo L, Ren L, Hewitt SM, Dakir el H, Dakir el-H, Garfield S, Walker R, Merlino G, Green JE, Hunter KW, Wakefield LM, Khanna C (2010). Modeling metastasis biology and therapy in real time in the mouse lung. J Clin Invest  120, 2979-88.   https://doi.org/10.1172/JCI40252",https://intramural.nih.gov/search/searchview.taf?ipid=68618
411,BC011025-04,"October 01, 2010 -  September 30, 2011",Regulation of RANTES expression in T lymphocytes,Alan M Krensky,NULL,"Laboratory of Cellular and Molecular Biology, NCI",Carol  Clayberger|Juan Manuel Crespo-Barreto; PhD|Dong Seok  Kim; PhD|Seok Joo  Kwon; PhD|Wei  Zhang; PhD,NULL,NULL,Keji  Zhao; PhD (NHLBI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68623
412,BC011026-04,"October 01, 2010 -  September 30, 2011",Function of granulysin,Alan M Krensky,NULL,"Laboratory of Cellular and Molecular Biology, NCI","Carol  Clayberger|Tianhong  Wang|Carole A Parent; PhD|Paul A Randazzo; MD, PhD",NULL,Joost J Oppenheim; MD (Laboratory of Molecular Immunoregulation)|Jeffrey D Lifson; MD (Office Of The Director),David F Stroncek; MD (CC) |Francesco M. Marincola; MD (CC),"1. Tewary P, Yang D, de la Rosa G, Li Y, Finn MW, Krensky AM, Clayberger C, Oppenheim JJ (2010). Granulysin activates antigen-presenting cells through TLR4 and acts as an immune alarmin. Blood  116, 3465-74.   https://doi.org/10.1182/blood-2010-03-273953|2. Xing J, Wu F, Wang S, Krensky AM, Mody CH, Zheng C (2010). Granulysin production and anticryptococcal activity is dependent upon a far upstream enhancer that binds STAT5 in human peripheral blood CD4+ T cells. J Immunol  185, 5074-81.   https://doi.org/10.4049/jimmunol.1001725",https://intramural.nih.gov/search/searchview.taf?ipid=68624
413,BC011027-04,"October 01, 2010 -  September 30, 2011",Animal models to study the role of INK4b loss in human acute myeloid leukemia,Linda  Wolff; PhD|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI",Joanna  Fares|Rita  Humeniuk|Richard P Koller|Juraj  Bies,NULL,NULL,NULL,"1. Bies J, Sramko M, Fares J, Rosu-Myles M, Zhang S, Koller R, Wolff L (2010). Myeloid-specific inactivation of p15Ink4b results in monocytosis and predisposition to myeloid leukemia. Blood  116, 979-87.   https://doi.org/10.1182/blood-2009-08-238360",https://intramural.nih.gov/search/searchview.taf?ipid=68598
414,BC011028-04,"October 01, 2010 -  September 30, 2011",Clinical Studies of the Molecular Genetic Basis of Kidney Cancer,William Marston Linehan; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Kevin Patrick Asher; MD|Leonard  Neckers; PhD|Masaya  Baba|Donald P Bottaro; PhD|Gennady  Bratslavsky|Celene  Chua|Show all 35,NULL,"Maria  Merino; PhD (Laboratory of Pathology)|Michael R Emmert-Buck; MD, PhD (Laboratory of Pathology)|Peter L Choyke; MD (Molecular Imaging Program)","Emily Y Chew; MD (NEI) |Karel  Pacak; MD, PhD (NICHD) |Richard  Childs; MD (NHLBI) |Pamela  Stratton; MD (NICHD) |Bradford J Wood; MD (CC) |Russell R Lonser; MD (NINDS)","1. Benhammou JN, Boris RS, Pacak K, Pinto PA, Linehan WM, Bratslavsky G (2010). Functional and oncologic outcomes of partial adrenalectomy for pheochromocytoma in patients with von Hippel-Lindau syndrome after at least 5 years of followup. J Urol  184, 1855-9.   https://doi.org/10.1016/j.juro.2010.06.102|2. Bratslavsky G, Linehan WM (2010). Long-term management of bilateral, multifocal, recurrent renal carcinoma. Nat Rev Urol  7, 267-75.   https://doi.org/10.1038/nrurol.2010.44|3. Gupta GN, Peterson J, Thakore KN, Pinto PA, Linehan WM, Bratslavsky G (2010). Oncological outcomes of partial nephrectomy for multifocal renal cell carcinoma greater than 4 cm. J Urol  184, 59-63.   https://doi.org/10.1016/j.juro.2010.03.035|4. Johann DJ, Wei BR, Prieto DA, Chan KC, Ye X, Valera VA, Simpson RM, Rudnick PA, Xiao Z, Issaq HJ, Linehan WM, Stein SE, Veenstra TD, Blonder J (2010). Combined blood/tissue analysis for cancer biomarker discovery: application to renal cell carcinoma. Anal Chem  82, 1584-8.   https://doi.org/10.1021/ac902204k|5. Kaye DR, Storey BB, Pacak K, Pinto PA, Linehan WM, Bratslavsky G (2010). Partial adrenalectomy: underused first line therapy for small adrenal tumors. J Urol  184, 18-25.   https://doi.org/10.1016/j.juro.2010.03.052|6. Linehan WM, Bratslavsky G, Pinto PA, Schmidt LS, Neckers L, Bottaro DP, Srinivasan R (2010). Molecular diagnosis and therapy of kidney cancer. Annu Rev Med  61, 329-43.   https://doi.org/10.1146/annurev.med.042808.171650|7. Linehan WM, Srinivasan R, Schmidt LS (2010). The genetic basis of kidney cancer: a metabolic disease. Nat Rev Urol  7, 277-85.   https://doi.org/10.1038/nrurol.2010.47|8. Liu NW, Khurana K, Sudarshan S, Pinto PA, Linehan WM, Bratslavsky G (2010). Repeat partial nephrectomy on the solitary kidney: surgical, functional and oncological outcomes. J Urol  183, 1719-24.   https://doi.org/10.1016/j.juro.2010.01.010|9. Matts RL, Brandt GE, Lu Y, Dixit A, Mollapour M, Wang S, Donnelly AC, Neckers L, Verkhivker G, Blagg BS (2011). A systematic protocol for the characterization of Hsp90 modulators. Bioorg Med Chem  19, 684-92.   https://doi.org/10.1016/j.bmc.2010.10.029|10. Miller DC, Ruterbusch J, Colt JS, Davis FG, Linehan WM, Chow WH, Schwartz K (2010). Contemporary clinical epidemiology of renal cell carcinoma: insight from a population based case-control study. J Urol  184, 2254-8.   https://doi.org/10.1016/j.juro.2010.08.018|11. Rahma OE, Ashtar E, Ibrahim R, Toubaji A, Gause B, Herrin VE, Linehan WM, Steinberg SM, Grollman F, Grimes G, Bernstein SA, Berzofsky JA, Khleif SN (2010). A pilot clinical trial testing mutant von Hippel-Lindau peptide as a novel immune therapy in metastatic renal cell carcinoma. J Transl Med  8, 8.   https://doi.org/10.1186/1479-5876-8-8|12. Singer EA, Bratslavsky G, Linehan WM, Srinivasan R (2010). Targeted therapies for non-clear renal cell carcinoma. Target Oncol  5, 119-29.   https://doi.org/10.1007/s11523-010-0148-3|13. Singer EA, Gupta GN, Srinivasan R (2011) Update on targeted therapies for clear cell renal cell carcinoma. Curr Opin Oncol 23:283-9.|14. Sourbier C, Valera-Romero V, Giubellino A, Yang Y, Sudarshan S, Neckers L, Linehan WM (2010). Increasing reactive oxygen species as a therapeutic approach to treat hereditary leiomyomatosis and renal cell carcinoma. Cell Cycle  9, 4183-9.   https://doi.org/10.4161/cc.9.20.13458|15. Yang Y, Valera VA, Padilla-Nash HM, Sourbier C, Vocke CD, Vira MA, Abu-Asab MS, Bratslavsky G, Tsokos M, Merino MJ, Pinto PA, Srinivasan R, Ried T, Neckers L, Linehan WM (2010). UOK 262 cell line, fumarate hydratase deficient (FH-/FH-) hereditary leiomyomatosis renal cell carcinoma: in vitro and in vivo model of an aberrant energy metabolic pathway in human cancer. Cancer Genet Cytogenet  196, 45-55.   https://doi.org/10.1016/j.cancergencyto.2009.08.018|16. Young LR, Vandyke R, Gulleman PM, Inoue Y, Brown KK, Schmidt LS, Linehan WM, Hajjar F, Kinder BW, Trapnell BC, Bissler JJ, Franz DN, McCormack FX (2010). Serum vascular endothelial growth factor-D prospectively distinguishes lymphangioleiomyomatosis from other diseases. Chest  138, 674-81.   https://doi.org/10.1378/chest.10-0573",https://intramural.nih.gov/search/searchview.taf?ipid=68635
415,BC011031-04,"October 01, 2010 -  September 30, 2011",Cancer stem cells and human liver cancer,"Snorri S. Thorgeirsson; MD, PhD",NULL,"Laboratory of Experimental Carcinogenesis, NCI",Hirofumi  Akita|Jesper B Andersen; PhD|Marian E Durkin|Valentina  Factor|Matthew C Gillen|Agnes  Holczbauer|Show all 10,"Ju-Seog  Lee; PhD (NCI)|Tania  Roskams (Dpt. Pathology, K.U.Leuven University)","Xin Wei Wang; PhD (Molecular Genetics and Carcinogenesis Section)|Steven Aaron Rosenberg; MD, PhD (Surgery Branch)|Itzhak  Avital (Surgery Branch)",NULL,"1. Andersen JB, Loi R, Perra A, Factor VM, Ledda-Columbano GM, Columbano A, Thorgeirsson SS (2010). Progenitor-derived hepatocellular carcinoma model in the rat. Hepatology  51, 1401-9.   https://doi.org/10.1002/hep.23488|2. Marquardt JU, Factor VM, Thorgeirsson SS (2010). Epigenetic regulation of cancer stem cells in liver cancer: current concepts and clinical implications. J Hepatol  53, 568-77.   https://doi.org/10.1016/j.jhep.2010.05.003",https://intramural.nih.gov/search/searchview.taf?ipid=68576
416,BC011032-04,"October 01, 2010 -  September 30, 2011",Post-translational modifications of Hsp90 that impact drug efficacy,Leonard  Neckers; PhD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI","Kristin  Eckfeld|Naoto  Miyajima; MD, PhD|Mehdi  Mollapour|Thomas L Prince|Bradley T Scroggins|Daniel Jaaron Selig|Show all 9","Brian  Blagg (Chemistry, University of Kansas)|Gabriela X Chiosis|Robert  Cotter (Johns Hopkins University)|Marc  Cox (University of Texas at El Paso)|Timothy  Haystead (Duke University)|Larry  Karnitz (Mayo Clinic)|Show all 11",James G McNally; PhD (Laboratory of Receptor Biology and Gene Expression)|Jane Beth Trepel (Medical Oncology Branch),NULL,"1. Mollapour M, Tsutsumi S, Donnelly AC, Beebe K, Tokita MJ, Lee MJ, Lee S, Morra G, Bourboulia D, Scroggins BT, Colombo G, Blagg BS, Panaretou B, Stetler-Stevenson WG, Trepel JB, Piper PW, Prodromou C, Pearl LH, Neckers L (2010). Swe1Wee1-dependent tyrosine phosphorylation of Hsp90 regulates distinct facets of chaperone function. Mol Cell  37, 333-43.   https://doi.org/10.1016/j.molcel.2010.01.005|2. Trepel J, Mollapour M, Giaccone G, Neckers L (2010). Targeting the dynamic HSP90 complex in cancer. Nat Rev Cancer  10, 537-49.   https://doi.org/10.1038/nrc2887",https://intramural.nih.gov/search/searchview.taf?ipid=68656
417,BC011033-04,"October 01, 2010 -  September 30, 2011",Mechanisms of MHC Class II Association with Plasma Membrane Microdomains,Paul A Roche; PhD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Berta  Bosch Pages|Karis  Faust|Sanjay  Khandelwal,James  Drake (NCI)|Satoshi  Ishido (Riken Center for Allergy and Immunology)|Laura  Santambrogio (Memorial Sloan Kettering),Lionel  Feigenbaum (Office Of The Director),NULL,"1. Khandelwal S, Roche PA (2010). Distinct MHC class II molecules are associated on the dendritic cell surface in cholesterol-dependent membrane microdomains. J Biol Chem  285, 35303-10.   https://doi.org/10.1074/jbc.M110.147793",https://intramural.nih.gov/search/searchview.taf?ipid=68538
418,BC011035-04,"October 01, 2010 -  September 30, 2011",Regulation of Exocytosis from Immune Cells,Paul A Roche; PhD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Karis  Faust|Sunil  Kaul,Laura  Santambrogio (Memorial Sloan Kettering)|Sidney  Whiteheart (Univ. of Kentucky),Lionel  Feigenbaum (Office Of The Director),Katherine Walton Roche; PhD (NINDS),"1. Suh YH, Terashima A, Petralia RS, Wenthold RJ, Isaac JT, Roche KW, Roche PA (2010). A neuronal role for SNAP-23 in postsynaptic glutamate receptor trafficking. Nat Neurosci  13, 338-43.   https://doi.org/10.1038/nn.2488",https://intramural.nih.gov/search/searchview.taf?ipid=68537
419,BC011037-04,"October 01, 2010 -  September 30, 2011",Developing new immunotherapies based of CD4 T cells,Nicholas Phillip Restifo; MD|IRP Faculty Profile,NULL,"Surgery Branch, NCI",Anthony J Leonardi|Pawel J Muranski,NULL,NULL,Robert L Danner; MD (CC),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68532
420,BC011038-04,"October 01, 2010 -  September 30, 2011",Molecular Therapeutics of Kidney Cancer: VHL Gene and Fumarate Hydratase Gene,William Marston Linehan; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Kevin Patrick Asher; MD|Leonard  Neckers; PhD|Donald P Bottaro; PhD|Gennady  Bratslavsky|Celene  Chua|Donna  Drake|Show all 31,NULL,Maria  Merino; PhD (Laboratory of Pathology)|Peter L Choyke; MD (Molecular Imaging Program)|James  McMahon; PhD (Molecular Targets Laboratory),"Emily Y Chew; MD (NEI) |Karel  Pacak; MD, PhD (NICHD) |Pamela  Stratton; MD (NICHD) |Bradford J Wood; MD (CC)","1. Benhammou JN, Boris RS, Pacak K, Pinto PA, Linehan WM, Bratslavsky G (2010). Functional and oncologic outcomes of partial adrenalectomy for pheochromocytoma in patients with von Hippel-Lindau syndrome after at least 5 years of followup. J Urol  184, 1855-9.   https://doi.org/10.1016/j.juro.2010.06.102|2. Bratslavsky G, Linehan WM (2010). Long-term management of bilateral, multifocal, recurrent renal carcinoma. Nat Rev Urol  7, 267-75.   https://doi.org/10.1038/nrurol.2010.44|3. Gupta GN, Boris R, Chung P, Marston Linehan W, Pinto PA, Bratslavsky G (2013) Robot-assisted laparoscopic partial nephrectomy for tumors greater than 4 cm and high nephrometry score: feasibility, renal functional, and oncological outcomes with minimum 1 year follow-up. Urol Oncol 31:51-6|4. Gupta GN, Peterson J, Thakore KN, Pinto PA, Linehan WM, Bratslavsky G (2010). Oncological outcomes of partial nephrectomy for multifocal renal cell carcinoma greater than 4 cm. J Urol  184, 59-63.   https://doi.org/10.1016/j.juro.2010.03.035|5. Johann DJ, Wei BR, Prieto DA, Chan KC, Ye X, Valera VA, Simpson RM, Rudnick PA, Xiao Z, Issaq HJ, Linehan WM, Stein SE, Veenstra TD, Blonder J (2010). Combined blood/tissue analysis for cancer biomarker discovery: application to renal cell carcinoma. Anal Chem  82, 1584-8.   https://doi.org/10.1021/ac902204k|6. Kaye DR, Storey BB, Pacak K, Pinto PA, Linehan WM, Bratslavsky G (2010). Partial adrenalectomy: underused first line therapy for small adrenal tumors. J Urol  184, 18-25.   https://doi.org/10.1016/j.juro.2010.03.052|7. Linehan WM, Bratslavsky G, Pinto PA, Schmidt LS, Neckers L, Bottaro DP, Srinivasan R (2010). Molecular diagnosis and therapy of kidney cancer. Annu Rev Med  61, 329-43.   https://doi.org/10.1146/annurev.med.042808.171650|8. Linehan WM, Srinivasan R, Schmidt LS (2010). The genetic basis of kidney cancer: a metabolic disease. Nat Rev Urol  7, 277-85.   https://doi.org/10.1038/nrurol.2010.47|9. Rahma OE, Ashtar E, Ibrahim R, Toubaji A, Gause B, Herrin VE, Linehan WM, Steinberg SM, Grollman F, Grimes G, Bernstein SA, Berzofsky JA, Khleif SN (2010). A pilot clinical trial testing mutant von Hippel-Lindau peptide as a novel immune therapy in metastatic renal cell carcinoma. J Transl Med  8, 8.   https://doi.org/10.1186/1479-5876-8-8|10. Singer EA, Bratslavsky G, Linehan WM, Srinivasan R (2010). Targeted therapies for non-clear renal cell carcinoma. Target Oncol  5, 119-29.   https://doi.org/10.1007/s11523-010-0148-3|11. Singer EA, Gupta GN, Srinivasan R (2011) Update on targeted therapies for clear cell renal cell carcinoma. Curr Opin Oncol 23:283-9.|12. Sourbier C, Valera-Romero V, Giubellino A, Yang Y, Sudarshan S, Neckers L, Linehan WM (2010). Increasing reactive oxygen species as a therapeutic approach to treat hereditary leiomyomatosis and renal cell carcinoma. Cell Cycle  9, 4183-9.   https://doi.org/10.4161/cc.9.20.13458|13. Yang Y, Valera VA, Padilla-Nash HM, Sourbier C, Vocke CD, Vira MA, Abu-Asab MS, Bratslavsky G, Tsokos M, Merino MJ, Pinto PA, Srinivasan R, Ried T, Neckers L, Linehan WM (2010). UOK 262 cell line, fumarate hydratase deficient (FH-/FH-) hereditary leiomyomatosis renal cell carcinoma: in vitro and in vivo model of an aberrant energy metabolic pathway in human cancer. Cancer Genet Cytogenet  196, 45-55.   https://doi.org/10.1016/j.cancergencyto.2009.08.018",https://intramural.nih.gov/search/searchview.taf?ipid=68636
421,BC011039-04,"October 01, 2010 -  September 30, 2011",Long distant regulation of c-myb in normal cells and acute myeloid leukemia,Linda  Wolff; PhD|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI",Richard P Koller|Junfang  Zhang,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68597
422,BC011043-04,"October 01, 2010 -  September 30, 2011",Molecular Therapeutics of Kidney Cancer:  MET Gene and BHD Gene,William Marston Linehan; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Kevin Patrick Asher; MD|Leonard  Neckers; PhD|Masaya  Baba|Donald P Bottaro; PhD|Gennady  Bratslavsky|Celene  Chua|Show all 33,"Mutsuo  Furihata|Yoshihiko  Kakinuma (Kochi Medical School)|Eric  Miska (Gurdon Institute)|Alessio  Nencioni (University of Genoa)|Junichi  Sadoshima (UMDNJ)|Masahiro  Yao, M.D. (Urologic Surgery, Yokohama City University Medical School)",Maria  Merino; PhD (Laboratory of Pathology)|Peter L Choyke; MD (Molecular Imaging Program)|Jonathan  Keller; PhD (Laboratory of Cancer Prevention)|Lino  Tessarollo (Neural Development Section)|Deborah K Morrison (Laboratory of Cell and Developmental Signaling)|Terence P Yamaguchi; PhD (Cell Signaling in Vertebrate Development Section),David R Davies; PhD (NIDDK),"1. Gupta GN, Boris R, Chung P, Marston Linehan W, Pinto PA, Bratslavsky G (2013) Robot-assisted laparoscopic partial nephrectomy for tumors greater than 4 cm and high nephrometry score: feasibility, renal functional, and oncological outcomes with minimum 1 year follow-up. Urol Oncol 31:51-6|2. Gupta GN, Peterson J, Thakore KN, Pinto PA, Linehan WM, Bratslavsky G (2010). Oncological outcomes of partial nephrectomy for multifocal renal cell carcinoma greater than 4 cm. J Urol  184, 59-63.   https://doi.org/10.1016/j.juro.2010.03.035|3. Linehan WM, Bratslavsky G, Pinto PA, Schmidt LS, Neckers L, Bottaro DP, Srinivasan R (2010). Molecular diagnosis and therapy of kidney cancer. Annu Rev Med  61, 329-43.   https://doi.org/10.1146/annurev.med.042808.171650|4. Linehan WM, Srinivasan R, Schmidt LS (2010). The genetic basis of kidney cancer: a metabolic disease. Nat Rev Urol  7, 277-85.   https://doi.org/10.1038/nrurol.2010.47|5. Singer EA, Gupta GN, Srinivasan R (2011) Update on targeted therapies for clear cell renal cell carcinoma. Curr Opin Oncol 23:283-9.|6. Young LR, Vandyke R, Gulleman PM, Inoue Y, Brown KK, Schmidt LS, Linehan WM, Hajjar F, Kinder BW, Trapnell BC, Bissler JJ, Franz DN, McCormack FX (2010). Serum vascular endothelial growth factor-D prospectively distinguishes lymphangioleiomyomatosis from other diseases. Chest  138, 674-81.   https://doi.org/10.1378/chest.10-0573",https://intramural.nih.gov/search/searchview.taf?ipid=68632
423,BC011046-04,"October 01, 2010 -  September 30, 2011",Mechanisms of apoptosis regulation which impede cancer cell death in lung cancer,King F Kwong,NULL,"Surgery Branch, NCI",Keytam Salem Awad; PhD|Lisa Ann Tobin|Yili  Xie,NULL,Karl Thomas Ried; MD (Cancer Genetics Branch)|Jordi  Camps Polo (Cancer Genetics Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68627
424,BC011049-04,"October 01, 2010 -  September 30, 2011",Development and evaluation of apoptosis targeted therapies in lung cancer,King F Kwong,NULL,"Surgery Branch, NCI",Keytam Salem Awad; PhD|Nora  Eccles|Lisa Ann Tobin|Yili  Xie,Matthias  Epple (University of Duisburg-Essen)|Kazunori  Kataoka (Univ of Tokyo)|Kanjiro  Miyata (Univ of Tokyo)|Viktoriya  Sokolova (University of Duisburg-Essen),Deb  Chatterjee (Office Of The Director)|Stanislaw J Kaczmarczyk (Office Of The Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68628
425,BC011053-04,"October 01, 2010 -  September 30, 2011",TMPRSS2-ERG chromosomal translocations and prostate cancer,Kathleen  Kelly; PhD|IRP Faculty Profile,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Wassim Gergy  Abou-Kheir|Orla Majella Casey|Paul Gerard Hynes|Heather  Sheppard,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68612
426,BC011054-04,"October 01, 2010 -  September 30, 2011",Nuclear Factor-kappaB in Ovarian Cancer,Christina M Annunziata|IRP Faculty Profile,NULL,"Medical Oncology Branch, NCI",Anna Maartje Aalbers|Marianne K-H Kim|Elise C Kohn; MD,NULL,Louis  Staudt; MD (Lymphoid Malignancies Branch),NULL,"1. Annunziata CM, Stavnes HT, Kleinberg L, Berner A, Hernandez LF, Birrer MJ, Steinberg SM, Davidson B, Kohn EC (2010). Nuclear factor kappaB transcription factors are coexpressed and convey a poor outcome in ovarian cancer. Cancer  116, 3276-84.   https://doi.org/10.1002/cncr.25190|2. Hernandez L, Hsu SC, Davidson B, Birrer MJ, Kohn EC, Annunziata CM (2010). Activation of NF-kappaB signaling by inhibitor of NF-kappaB kinase beta increases aggressiveness of ovarian cancer. Cancer Res  70, 4005-14.   https://doi.org/10.1158/0008-5472.CAN-09-3912",https://intramural.nih.gov/search/searchview.taf?ipid=68468
427,BC011055-04,"October 01, 2010 -  September 30, 2011",Serum Antibody Profiling with a Carbohydrate Microarray,Jeffrey  Gildersleeve|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI","Christopher Thomas Campbell; MD, PhD|Sudipa  Chowdhury|Sean Rogers Llewellyn|Saddam Musleh Muthana; PhD|Yalong  Zhang",NULL,"Lisa  Mcshane (Biometrics Research Branch)|Jeffrey  Schlom; PhD (Laboratory of Tumor Immunology and Biology)|Marjorie  Robert-Guroff; PhD (Vaccine Branch)|Mark E Sherman; MD (Hormonal and Reproductive Epidemiology Branch)|James L Gulley; MD, PhD (Laboratory of Tumor Immunology and Biology)|James W Hodge; PhD (Laboratory of Tumor Immunology and Biology)",NULL,"1. Oyelaran O, Gildersleeve JC (2010). Evaluation of human antibody responses to keyhole limpet hemocyanin on a carbohydrate microarray. Proteomics Clin Appl  4, 285-94.   https://doi.org/10.1002/prca.200900130",https://intramural.nih.gov/search/searchview.taf?ipid=68516
428,BC011056-04,"October 01, 2010 -  September 30, 2011",Promoting tumor cell apoptosis by death ligands,Thomas Joseph Sayers; PhD,NULL,"Laboratory of Experimental Immunology, NCI",Alan  Brooks,"Avi  Ashkenazi (Genentech, Inc.)|William  Murphy (University of Nevada)|Noako  Seki (Kurume University)|Hideo  Yagita (Immunology, Juntendo University)","Stanley  Lipkowitz; MD, PhD (Laboratory of Cellular and Molecular Biology)|Natasha  Caplen (Cancer Genetics Branch)|James  McMahon; PhD (Molecular Targets Laboratory)|Kirk R Gustafson; PhD (Molecular Targets Laboratory)|Curtis  Henrich (Molecular Targets Laboratory)|William  Farrar (Laboratory of Cancer Prevention)",NULL,"1. Brooks AD, Jacobsen KM, Li W, Shanker A, Sayers TJ (2010). Bortezomib sensitizes human renal cell carcinomas to TRAIL apoptosis through increased activation of caspase-8 in the death-inducing signaling complex. Mol Cancer Res  8, 729-38.   https://doi.org/10.1158/1541-7786.MCR-10-0022|2. Seki N, Toh U, Sayers TJ, Fujii T, Miyagi M, Akagi Y, Kusukawa J, Kage M, Shirouzu K, Yamana H (2010). Bortezomib sensitizes human esophageal squamous cell carcinoma cells to TRAIL-mediated apoptosis via activation of both extrinsic and intrinsic apoptosis pathways. Mol Cancer Ther  9, 1842-51.   https://doi.org/10.1158/1535-7163.MCT-09-0918",https://intramural.nih.gov/search/searchview.taf?ipid=68542
429,BC011058-04,"October 01, 2010 -  September 30, 2011",Development of a Vaccine for HIVAIDS: Humoral Immunity,Marjorie  Robert-Guroff; PhD|IRP Faculty Profile,NULL,"Vaccine Branch, NCI","Egidio  Brocca-Cofano|George N Pavlakis; MD, PhD|Thorsten  Demberg|Genoveffa  Franchini; MD|Janet M Dipasquale|Barbara K Felber|Show all 12","Susan  Barnett (Chiron Corporation)|Satya  Dandekar (University of California, Davis)|Barbara  Ensoli (Istituto Superiore di Sanita)|Timothy  Fouts (Profectus BioSciences, Inc.)|Robert  Gallo; MD (Institute of Human Virology, Maryland University)|Jonathan  Heeney (University of Cambridge)|Show all 12",David J Venzon; PhD (Biostatistics and Data Management Section),NULL,"1. Brocca-Cofano E, Xiao P, Robert-Guroff M (2011) Envelope specific antibodies and HIV vaccine efficacy, in AIDS, Book 1. Intech Open Access publisher, in press.|2. Patel V, Valentin A, Kulkarni V, Rosati M, Bergamaschi C, Jalah R, Alicea C, Minang JT, Trivett MT, Ohlen C, Zhao J, Robert-Guroff M, Khan AS, Draghia-Akli R, Felber BK, Pavlakis GN (2010). Long-lasting humoral and cellular immune responses and mucosal dissemination after intramuscular DNA immunization. Vaccine  28, 4827-36.   https://doi.org/10.1016/j.vaccine.2010.04.064|3. Vargas-Inchaustegui D, Demberg t, Robert-Guroff M (2011) A CD8a- subpopulation of macaque circulatory natural killer cells can mediate both antibody-dependent and antibody-independent cytotoxic activities. Immunology Inpress.|4. Xiao P, Zhao J, Patterson LJ, Brocca-Cofano E, Venzon D, Kozlowski PA, Hidajat R, Demberg T, Robert-Guroff M (2010). Multiple vaccine-elicited nonneutralizing antienvelope antibody activities contribute to protective efficacy by reducing both acute and chronic viremia following simian/human immunodeficiency virus SHIV89.6P challenge in rhesus macaques. J Virol  84, 7161-73.   https://doi.org/10.1128/JVI.00410-10",https://intramural.nih.gov/search/searchview.taf?ipid=68535
430,BC011059-04,"October 01, 2010 -  September 30, 2011",Biologic Pathway Analysis,Kenneth  Buetow; PhD,NULL,"Laboratory of Population Genetics, NCI",Sol  Efroni|Ying  Hu; PhD|Cu  Nguyen|Hongen  Zhang,NULL,NULL,NULL,"1. Greenblum SI, Efroni S, Schaefer CF, Buetow KH (2011). The PathOlogist: an automated tool for pathway-centric analysis. BMC Bioinformatics  12, 133.   https://doi.org/10.1186/1471-2105-12-133",https://intramural.nih.gov/search/searchview.taf?ipid=68482
431,BC011061-04,"October 01, 2010 -  September 30, 2011",Computational RNA Nanodesign,Bruce Allen Shapiro; PhD|IRP Faculty Profile,NULL,"Image Processing Section, NCI",Kirill Andreevich Afonin|Eckart  Bindewald|Kazimierz Wojcieck Kasprzak|Tae Jin  Kim|Shu Yun  Le|Bartholomeus Johannes Machielse|Show all 10,"Juan  Arroyo (Developmental Biology, Mitre Corporation)|Luc  Jaeger (University of California Santa Barbara)|Robert L Jernigan; PhD (NCI)|Hugo  Martinez (Consultant, SAIC)|Roderick  Melnik (M2Net Laboratory, Wilfrid Laurier University)|Hanan  Samet (University of Maryland)",Yun Xing M Wang (Structural Biophysics Laboratory)|Robert J Fisher (Office Of The Director)|Howard A Young; PhD (Laboratory of Experimental Immunology)|Joseph John Barchi (Chemical Biology Laboratory)|Javed  Khan; MD (Pediatric Oncology Branch)|Marina A Dobrovolskaia (Office Cancer Nanotechnology Research),NULL,"1. Afonin K, Grabow W, Walker F, Bindewald E, Dobrovolskaia M, Shapiro B, Jaeger L (2011) Design and self-assembly of siRNA functionalized RNA nanoparticles for use in automated nanomedicine. Nature Protocols, in press.|2. Afonin KA, Bindewald E, Yaghoubian AJ, Voss N, Jacovetty E, Shapiro BA, Jaeger L (2010). In vitro assembly of cubic RNA-based scaffolds designed in silico. Nat Nanotechnol  5, 676-82.   https://doi.org/10.1038/nnano.2010.160|3. Paliy M, Melnik R, Shapiro BA (2010). Coarse-graining RNA nanostructures for molecular dynamics simulations. Phys Biol  7, 036001.   https://doi.org/10.1088/1478-3975/7/3/036001",https://intramural.nih.gov/search/searchview.taf?ipid=68547
432,BC011062-04,"October 01, 2010 -  September 30, 2011",Development of a Vaccine for HIVAIDS: Cellular Immunity,Marjorie  Robert-Guroff; PhD|IRP Faculty Profile,NULL,"Vaccine Branch, NCI","Thorsten  Demberg|George N Pavlakis; MD, PhD|Janet M Dipasquale|Barbara K Felber|Lois Jean Patterson|Iskra  Tuero; PhD|Show all 8","Susan  Barnett (Chiron Corporation)|Satya  Dandekar (University of California, Davis)|Barbara  Ensoli (Istituto Superiore di Sanita)|Ashley  Haase (University of Minnesota)|Welkin  Johnson; PhD (Dept of Microbiology and Mol Genetics, Harvard Medical School)|Michael G. Katze; PhD (University of Washington)|Show all 10",David J Venzon; PhD (Biostatistics and Data Management Section),Vanessa  Hirsch (NIAID) |Robert Alan Seder; MD (NIAID),"1. Cafaro A, Bellino S, Titti F, Maggiorella MT, Sernicola L, Wiseman RW, Venzon D, Karl JA, O'Connor D, Monini P, Robert-Guroff M, Ensoli B (2010). Impact of viral dose and major histocompatibility complex class IB haplotype on viral outcome in mauritian cynomolgus monkeys vaccinated with Tat upon challenge with simian/human immunodeficiency virus SHIV89.6P. J Virol  84, 8953-8.   https://doi.org/10.1128/JVI.00377-10|2. Patel V, Valentin A, Kulkarni V, Rosati M, Bergamaschi C, Jalah R, Alicea C, Minang JT, Trivett MT, Ohlen C, Zhao J, Robert-Guroff M, Khan AS, Draghia-Akli R, Felber BK, Pavlakis GN (2010). Long-lasting humoral and cellular immune responses and mucosal dissemination after intramuscular DNA immunization. Vaccine  28, 4827-36.   https://doi.org/10.1016/j.vaccine.2010.04.064|3. Vargas-Inchaustegui D, Demberg t, Robert-Guroff M (2011) A CD8a- subpopulation of macaque circulatory natural killer cells can mediate both antibody-dependent and antibody-independent cytotoxic activities. Immunology Inpress.",https://intramural.nih.gov/search/searchview.taf?ipid=68536
433,BC011063-04,"October 01, 2010 -  September 30, 2011",Development of a Vaccine for HIVAIDS: Translation to the Clinic,Marjorie  Robert-Guroff; PhD|IRP Faculty Profile,NULL,"Vaccine Branch, NCI","Egidio  Brocca-Cofano|George N Pavlakis; MD, PhD|Jay Arthur Berzofsky; MD, PhD|Thorsten  Demberg|Janet M Dipasquale|Barbara K Felber|Show all 10","Susan  Barnett (Chiron Corporation)|Timothy  Fouts (Profectus BioSciences, Inc.)|Robert  Gallo; MD (Institute of Human Virology, Maryland University)|Ashley  Haase (University of Minnesota)|Jonathan  Heeney (University of Cambridge)|Christopher  Miller (University of California, Davis)",NULL,NULL,"1. Hidajat R, Kuate S, Venzon D, Kalyanaraman V, Kalisz I, Treece J, Lian Y, Barnett SW, Robert-Guroff M (2010). Construction and immunogenicity of replication-competent adenovirus 5 host range mutant recombinants expressing HIV-1 gp160 of SF162 and TV1 strains. Vaccine  28, 3963-71.   https://doi.org/10.1016/j.vaccine.2010.03.046",https://intramural.nih.gov/search/searchview.taf?ipid=68534
434,BC011064-04,"October 01, 2010 -  September 30, 2011",A Modifier of Plasmacytoma Susceptibility Maps to Mouse Chr 1,Beverly  Mock; PhD|IRP Faculty Profile,NULL,"Office of the Director, NCI",Kaori  Sakakibara|John K Simmons|Ke  Zhang,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68653
435,BC011065-04,"October 01, 2010 -  September 30, 2011",Preclinical Testing of HDAC and mTOR Inhibitors,Beverly  Mock; PhD|IRP Faculty Profile,NULL,"Office of the Director, NCI","Richard C Robinson|Kaori  Sakakibara|John K Simmons|Shuling  Zhang; MD, PhD|Ke  Zhang",NULL,"Ola Anders Landgren (Medical Oncology Branch)|Robert Mark Simpson; DVM, PhD (Laboratory of Cancer Biology and Genetics)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68654
436,BC011066-04,"October 01, 2010 -  September 30, 2011",Genetic Pathways Altered by MMTV in Mouse Mammary Tumors,Robert  Callahan; PhD,NULL,"Mammary Biology and Tumorigenesis Laboratory, NCI",Karim M Lashin|David M Mccurdy|Ahmed M Raafat|Gilbert  Smith; PhD,NULL,David  Munroe (Office Of The Director)|Robert H Stephens (Business Operations Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68487
437,BC011069-04,"October 01, 2010 -  September 30, 2011",Biology and Therapy of Lymphopenia,Crystal L. Mackall; MD,NULL,"Pediatric Oncology Branch, NCI",Natasha Marie Fewkes|Wangko Pieter Henning Lundstrom,NULL,Ronald E Gress; MD (Experimental Transplantation and Immunology Branch)|Claude  Sportes (Experimental Transplantation and Immunology Branch),NULL,"1. Fewkes NM, Krauss AC, Guimond M, Meadors JL, Dobre S, Mackall CL (2010). Pharmacologic modulation of niche accessibility via tyrosine kinase inhibition enhances marrow and thymic engraftment after hematopoietic stem cell transplantation. Blood  115, 4120-9.   https://doi.org/10.1182/blood-2009-10-248898|2. Fewkes NM, Mackall CL (2010). Novel gamma-chain cytokines as candidate immune modulators in immune therapies for cancer. Cancer J  16, 392-8.   https://doi.org/10.1097/PPO.0b013e3181eacbc4|3. Guimond M, Freud AG, Mao HC, Yu J, Blaser BW, Leong JW, Vandeusen JB, Dorrance A, Zhang J, Mackall CL, Caligiuri MA (2010). In vivo role of Flt3 ligand and dendritic cells in NK cell homeostasis. J Immunol  184, 2769-75.   https://doi.org/10.4049/jimmunol.0900685|4. Sportès C, Babb RR, Krumlauf MC, Hakim FT, Steinberg SM, Chow CK, Brown MR, Fleisher TA, Noel P, Maric I, Stetler-Stevenson M, Engel J, Buffet R, Morre M, Amato RJ, Pecora A, Mackall CL, Gress RE (2010). Phase I study of recombinant human interleukin-7 administration in subjects with refractory malignancy. Clin Cancer Res  16, 727-35.   https://doi.org/10.1158/1078-0432.CCR-09-1303",https://intramural.nih.gov/search/searchview.taf?ipid=68641
438,BC011070-04,"October 01, 2010 -  September 30, 2011",Hematopathology Diagnosis,Elaine S Jaffe; MD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI","Theresa M Davies Hill|Alison Rozmus Huppmann; MD|Qingyan  Liu|Stefania  Pittaluga|Joo Joo Song|Ewa Beata Bajor-Dattilo; MD, PhD|Show all 11","Elias  Campo (University of Barcelona)|Wing  Chan (Pathology, University of Nebraska)|Andreas  Chott (Pathology, University of Vienna)|Falko  Fend|Nancy  Harris|Leticia  Quintanilla-Martinez (Pathology, Technical University of Munich)|Show all 8","Wyndham H Wilson; MD, PhD (Lymphoid Malignancies Branch)|Louis  Staudt; MD (Lymphoid Malignancies Branch)|Kieron Michael Dunleavy (Lymphoid Malignancies Branch)|Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch)|Richard  Little; MD, PhD (Clinical Investigations Branch)|Susan  Bates; MD (Medical Oncology Branch)","Adrian U Wiestner; MD, PhD (NHLBI) |Katherine Rainsford Calvo (CC) |Vemulkonda Koneti Rao; MD, FRCPA (NIAID) |Jeffrey  Cohen; MD (NIAID)","1. Campo E, Swerdlow SH, Harris NL, Pileri S, Stein H, Jaffe ES (2011). The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood  117, 5019-32.   https://doi.org/10.1182/blood-2011-01-293050|2. Cohen JI, Jaffe ES, Dale JK, Pittaluga S, Heslop HE, Rooney CM, Gottschalk S, Bollard CM, Rao VK, Marques A, Burbelo PD, Turk SP, Fulton R, Wayne AS, Little RF, Cairo MS, El-Mallawany NK, Fowler D, Sportes C, Bishop MR, Wilson W, Straus SE (2011). Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States. Blood  117, 5835-49.   https://doi.org/10.1182/blood-2010-11-316745|3. da Silva SP, Resnick E, Lucas M, Lortan J, Patel S, Cunningham-Rundles C, Gatter K, Liu Q, Jaffe ES, Chapel H (2011). Lymphoid proliferations of indeterminate malignant potential arising in adults with common variable immunodeficiency disorders: unusual case studies and immunohistological review in the light of possible causative events. J Clin Immunol  31, 784-91.   https://doi.org/10.1007/s10875-011-9565-z|4. Dojcinov SD, Venkataraman G, Pittaluga S, Wlodarska I, Schrager JA, Raffeld M, Hills RK, Jaffe ES (2011). Age-related EBV-associated lymphoproliferative disorders in the Western population: a spectrum of reactive lymphoid hyperplasia and lymphoma. Blood  117, 4726-35.   https://doi.org/10.1182/blood-2010-12-323238|5. Dojcinov SD, Venkataraman G, Raffeld M, Pittaluga S, Jaffe ES (2010). EBV positive mucocutaneous ulcer--a study of 26 cases associated with various sources of immunosuppression. Am J Surg Pathol  34, 405-17.   https://doi.org/10.1097/PAS.0b013e3181cf8622|6. Garcia-Herrera A, Song JY, Chuang SS, Villamor N, Colomo L, Pittaluga S, Alvaro T, Rozman M, de Anda Gonzalez J, Arrunategui AM, Fernandez E, Gonzalvo E, Estrach T, Colomer D, Raffeld M, Gaulard P, Campo E, Jaffe ES, Martinez A (2011). Nonhepatosplenic γδ T-cell lymphomas represent a spectrum of aggressive cytotoxic T-cell lymphomas with a mainly extranodal presentation. Am J Surg Pathol  35, 1214-25.   https://doi.org/10.1097/PAS.0b013e31822067d1|7. Grant C, Dunleavy K, Eberle FC, Pittaluga S, Wilson WH, Jaffe ES (2011). Primary mediastinal large B-cell lymphoma, classic Hodgkin lymphoma presenting in the mediastinum, and mediastinal gray zone lymphoma: what is the oncologist to do? Curr Hematol Malig Rep  6, 157-63.   https://doi.org/10.1007/s11899-011-0090-1|8. Herrinton LJ, Liu L, Abramson O, Jaffe ES (2012). The incidence of hepatosplenic T-cell lymphoma in a large managed care organization, with reference to anti-tumor necrosis factor therapy, Northern California, 2000-2006. Pharmacoepidemiol Drug Saf  21, 49-52.   https://doi.org/10.1002/pds.2216|9. Jaffe ES (2011). Centralized review offers promise for the clinician, the pathologist, and the patient with newly diagnosed lymphoma. J Clin Oncol  29, 1398-9.   https://doi.org/10.1200/JCO.2010.34.2741|10. Jaffe ES, Pittaluga S (2011). Aggressive B-cell lymphomas: a review of new and old entities in the WHO classification. Hematology Am Soc Hematol Educ Program  2011, 506-14.   https://doi.org/10.1182/asheducation-2011.1.506|11. Maldonado NI, Cabanillas F, Jaffe ES, Raffeld M, Lozada L (2011). Successful treatment of a patient with Epstein-Barr virus-positive B-cell lymphoproliferative disorder resembling post-transplant lymphoproliferative disorder using single-agent rituximab. J Clin Oncol  29, e658-60.   https://doi.org/10.1200/JCO.2011.34.8656|12. Marti GE, Stetler-Stevenson M, Grant ND, White T, Figg WD, Tohnya T, Jaffe ES, Dunleavy K, Janik JE, Steinberg SM, Wilson WH (2011). Phase I trial of 7-hydroxystaurosporine and fludararbine phosphate: in vivo evidence of 7-hydroxystaurosporine induced apoptosis in chronic lymphocytic leukemia. Leuk Lymphoma  52, 2284-92.   https://doi.org/10.3109/10428194.2011.589547|13. Piekarz RL, Frye R, Prince HM, Kirschbaum MH, Zain J, Allen SL, Jaffe ES, Ling A, Turner M, Peer CJ, Figg WD, Steinberg SM, Smith S, Joske D, Lewis I, Hutchins L, Craig M, Fojo AT, Wright JJ, Bates SE (2011). Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma. Blood  117, 5827-34.   https://doi.org/10.1182/blood-2010-10-312603|14. Pittaluga S, Jaffe ES (2010). T-cell/histiocyte-rich large B-cell lymphoma. Haematologica  95, 352-6.   https://doi.org/10.3324/haematol.2009.016931|15. Rizzo KA, Streubel B, Pittaluga S, Chott A, Xi L, Raffeld M, Jaffe ES (2010). Marginal zone lymphomas in children and the young adult population; characterization of genetic aberrations by FISH and RT-PCR. Mod Pathol  23, 866-73.   https://doi.org/10.1038/modpathol.2010.63|16. Rodriguez-Canales J, Eberle FC, Jaffe ES, Emmert-Buck MR (2011). Why is it crucial to reintegrate pathology into cancer research? Bioessays  33, 490-8.   https://doi.org/10.1002/bies.201100017|17. Schuster SJ, Neelapu SS, Gause BL, Janik JE, Muggia FM, Gockerman JP, Winter JN, Flowers CR, Nikcevich DA, Sotomayor EM, McGaughey DS, Jaffe ES, Chong EA, Reynolds CW, Berry DA, Santos CF, Popa MA, McCord AM, Kwak LW (2011). Vaccination with patient-specific tumor-derived antigen in first remission improves disease-free survival in follicular lymphoma. J Clin Oncol  29, 2787-94.   https://doi.org/10.1200/JCO.2010.33.3005|18. Shao H, Xi L, Raffeld M, Feldman AL, Ketterling RP, Knudson R, Rodriguez-Canales J, Hanson J, Pittaluga S, Jaffe ES (2011). Clonally related histiocytic/dendritic cell sarcoma and chronic lymphocytic leukemia/small lymphocytic lymphoma: a study of seven cases. Mod Pathol  24, 1421-32.   https://doi.org/10.1038/modpathol.2011.102|19. Song JY, Eberle FC, Xi L, Raffeld M, Rahma O, Wilson WH, Dunleavy K, Pittaluga S, Jaffe ES (2011). Coexisting and clonally identical classic hodgkin lymphoma and nodular lymphocyte predominant hodgkin lymphoma. Am J Surg Pathol  35, 767-72.   https://doi.org/10.1097/PAS.0b013e3182147f91|20. Steidl C, Lee T, Shah SP, Farinha P, Han G, Nayar T, Delaney A, Jones SJ, Iqbal J, Weisenburger DD, Bast MA, Rosenwald A, Muller-Hermelink HK, Rimsza LM, Campo E, Delabie J, Braziel RM, Cook JR, Tubbs RR, Jaffe ES, Lenz G, Connors JM, Staudt LM, Chan WC, Gascoyne RD (2010). Tumor-associated macrophages and survival in classic Hodgkin's lymphoma. N Engl J Med  362, 875-85.   https://doi.org/10.1056/NEJMoa0905680|21. Summers TA, Jaffe ES (2011). Hairy cell leukemia diagnostic criteria and differential diagnosis. Leuk Lymphoma  52 Suppl 2, 6-10.   https://doi.org/10.3109/10428194.2011.565435|22. Taddesse-Heath L, Meloni-Ehrig A, Scheerle J, Kelly JC, Jaffe ES (2010). Plasmablastic lymphoma with MYC translocation: evidence for a common pathway in the generation of plasmablastic features. Mod Pathol  23, 991-9.   https://doi.org/10.1038/modpathol.2010.72|23. Vela-Chávez T, Adam P, Kremer M, Bink K, Bacon CM, Menon G, Ferry JA, Fend F, Jaffe ES, Quintanilla-Martínez L (2011). Cyclin D1 positive diffuse large B-cell lymphoma is a post-germinal center-type lymphoma without alterations in the CCND1 gene locus. Leuk Lymphoma  52, 458-66.   https://doi.org/10.3109/10428194.2010.540361|24. Venkataraman G, McClain KL, Pittaluga S, Rao VK, Jaffe ES (2010). Development of disseminated histiocytic sarcoma in a patient with autoimmune lymphoproliferative syndrome and associated Rosai-Dorfman disease. Am J Surg Pathol  34, 589-94.   https://doi.org/10.1097/PAS.0b013e3181d5ddf8|25. Venkataraman G, Raffeld M, Pittaluga S, Jaffe ES (2011). CD15-expressing nodular lymphocyte-predominant Hodgkin lymphoma. Histopathology  58, 803-5.   https://doi.org/10.1111/j.1365-2559.2011.03829.x",https://intramural.nih.gov/search/searchview.taf?ipid=68609
439,BC011073-04,"October 01, 2010 -  September 30, 2011",Immunobiology and Immunotherapy of Pediatric Tumors,Crystal L. Mackall; MD,NULL,"Pediatric Oncology Branch, NCI",Yongzhi  Cui; MD|Javed  Khan; MD|Steven Lorenz Highfill|Chand  Khanna; MD|Daniel W Lee|Joanna L Meadors|Show all 10,Malcolm  Brenner (Baylor College of Medicine)|Laurence  Cooper (MD Anderson Cancer Center)|Carl  June (University of Pennsylvania)|Michel  Sadelain (Memorial Sloan-Kettering Cancer Institute)|Delores  Schendel (Max-Delbruck-Center for Molecular Medicine),"Maria  Tsokos; MD (Laboratory of Pathology)|Peter D Aplan; MD (Cancer Genetics Branch)|Ira H Pastan; MD (Molecular Biology Section)|Christoph  Rader; PhD (Experimental Transplantation and Immunology Branch)|Steven Aaron Rosenberg; MD, PhD (Surgery Branch)|Alfred  Singer; MD (Experimental Immunology Branch)",NULL,"1. Ahmed N, Heslop HE, Mackall CL (2010). T-cell-based therapies for malignancy and infection in childhood. Pediatr Clin North Am  57, 83-96.   https://doi.org/10.1016/j.pcl.2009.11.002|2. Cairo MS, Jordan CT, Maley CC, Chao C, Melnick A, Armstrong SA, Shlomchik W, Molldrem J, Ferrone S, Mackall C, Zitvogel L, Bishop MR, Giralt SA, June CH (2010). NCI first International Workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation: report from the committee on the biological considerations of hematological relapse following allogeneic stem cell transplantation unrelated to graft-versus-tumor effects: state of the science. Biol Blood Marrow Transplant  16, 709-28.   https://doi.org/10.1016/j.bbmt.2010.03.002|3. Capitini CM, Mackall CL, Wayne AS (2010). Immune-based therapeutics for pediatric cancer. Expert Opin Biol Ther  10, 163-78.   https://doi.org/10.1517/14712590903431022|4. Fewkes NM, Mackall CL (2010). Novel gamma-chain cytokines as candidate immune modulators in immune therapies for cancer. Cancer J  16, 392-8.   https://doi.org/10.1097/PPO.0b013e3181eacbc4|5. Wayne AS, Capitini CM, Mackall CL (2010). Immunotherapy of childhood cancer: from biologic understanding to clinical application. Curr Opin Pediatr  22, 2-11.   https://doi.org/10.1097/MOP.0b013e3283350d3e|6. Zhang H, Cui Y, Voong N, Sabatino M, Stroncek DF, Morisot S, Civin CI, Wayne AS, Levine BL, Mackall CL (2011). Activating signals dominate inhibitory signals in CD137L/IL-15 activated natural killer cells. J Immunother  34, 187-95.   https://doi.org/10.1097/CJI.0b013e31820d2a21",https://intramural.nih.gov/search/searchview.taf?ipid=68639
440,BC011074-04,"October 01, 2010 -  September 30, 2011",Clinical Program in Pediatric Sarcomas,Crystal L. Mackall; MD,NULL,"Pediatric Oncology Branch, NCI",Lee Jay Helman; MD,"Nai-Kong  Cheung (Memorial Sloan Kettering Cancer Center)|Carl  June (University of Pennsylvania)|Bruce  Levine (Abramson Family Cancer Research Center, University of Pennsylvania)","Maria  Tsokos; MD (Laboratory of Pathology)|Steven Aaron Rosenberg; MD, PhD (Surgery Branch)",NULL,"1. Capitini CM, Mackall CL, Wayne AS (2010). Immune-based therapeutics for pediatric cancer. Expert Opin Biol Ther  10, 163-78.   https://doi.org/10.1517/14712590903431022|2. Fewkes NM, Mackall CL (2010). Novel gamma-chain cytokines as candidate immune modulators in immune therapies for cancer. Cancer J  16, 392-8.   https://doi.org/10.1097/PPO.0b013e3181eacbc4|3. Mackall C (2011) In Search of Targeted Therapies for Pediatric Cancer. Frontiers in Pediatric Oncology 1:1-5.|4. Wayne AS, Capitini CM, Mackall CL (2010). Immunotherapy of childhood cancer: from biologic understanding to clinical application. Curr Opin Pediatr  22, 2-11.   https://doi.org/10.1097/MOP.0b013e3283350d3e|5. Zhang H, Cui Y, Voong N, Sabatino M, Stroncek DF, Morisot S, Civin CI, Wayne AS, Levine BL, Mackall CL (2011). Activating signals dominate inhibitory signals in CD137L/IL-15 activated natural killer cells. J Immunother  34, 187-95.   https://doi.org/10.1097/CJI.0b013e31820d2a21",https://intramural.nih.gov/search/searchview.taf?ipid=68640
441,BC011076-04,"October 01, 2010 -  September 30, 2011",Roles of NADPH Oxidase 5 and Dual Oxidase 2 in Cancer,James Halpern Doroshow|IRP Faculty Profile,NULL,"Office of the Director, NCI",Smitha  Antony|Yongzhong  Wu,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68495
442,BC011078-04,"October 01, 2010 -  September 30, 2011",Phase 01 Clinical Trials,James Halpern Doroshow|IRP Faculty Profile,NULL,"Office of the Director, NCI",Agnes  Juhasz|Joseph E Tomaszewski,NULL,Yves  Pommier; PhD (Developmental Therapeutics Branch)|William M Bonner; PhD (Developmental Therapeutics Branch)|Ralph  Parchment (Toxicology and Pharmacology Branch),NULL,"1. Holbeck SL, Collins JM, Doroshow JH (2010). Analysis of Food and Drug Administration-approved anticancer agents in the NCI60 panel of human tumor cell lines. Mol Cancer Ther  9, 1451-60.   https://doi.org/10.1158/1535-7163.MCT-10-0106|2. Kinders RJ, Hollingshead M, Lawrence S, Ji J, Tabb B, Bonner WM, Pommier Y, Rubinstein L, Evrard YA, Parchment RE, Tomaszewski J, Doroshow JH, National Cancer Institute Phase 0 Clinical Trials Team (2010). Development of a validated immunofluorescence assay for γH2AX as a pharmacodynamic marker of topoisomerase I inhibitor activity. Clin Cancer Res  16, 5447-57.   https://doi.org/10.1158/1078-0432.CCR-09-3076|3. Kummar S, Gutierrez ME, Gardner ER, Chen X, Figg WD, Zajac-Kaye M, Chen M, Steinberg SM, Muir CA, Yancey MA, Horneffer YR, Juwara L, Melillo G, Ivy SP, Merino M, Neckers L, Steeg PS, Conley BA, Giaccone G, Doroshow JH, Murgo AJ (2010). Phase I trial of 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG), a heat shock protein inhibitor, administered twice weekly in patients with advanced malignancies. Eur J Cancer  46, 340-7.   https://doi.org/10.1016/j.ejca.2009.10.026|4. Kummar S, Gutierrez ME, Gardner ER, Figg WD, Melillo G, Dancey J, Sausville EA, Conley BA, Murgo AJ, Doroshow JH (2010). A phase I trial of UCN-01 and prednisone in patients with refractory solid tumors and lymphomas. Cancer Chemother Pharmacol  65, 383-9.   https://doi.org/10.1007/s00280-009-1154-y|5. Redon CE, Nakamura AJ, Zhang YW, Ji JJ, Bonner WM, Kinders RJ, Parchment RE, Doroshow JH, Pommier Y (2010). Histone gammaH2AX and poly(ADP-ribose) as clinical pharmacodynamic biomarkers. Clin Cancer Res  16, 4532-42.   https://doi.org/10.1158/1078-0432.CCR-10-0523|6. Reinhold WC, Mergny JL, Liu H, Ryan M, Pfister TD, Kinders R, Parchment R, Doroshow J, Weinstein JN, Pommier Y (2010). Exon array analyses across the NCI-60 reveal potential regulation of TOP1 by transcription pausing at guanosine quartets in the first intron. Cancer Res  70, 2191-203.   https://doi.org/10.1158/0008-5472.CAN-09-3528|7. Rubinstein LV, Steinberg SM, Kummar S, Kinders R, Parchment RE, Murgo AJ, Tomaszewski JE, Doroshow JH (2010). The statistics of phase 0 trials. Stat Med  29, 1072-6.   https://doi.org/10.1002/sim.3840|8. Wang LH, Pfister TD, Parchment RE, Kummar S, Rubinstein L, Evrard YA, Gutierrez ME, Murgo AJ, Tomaszewski JE, Doroshow JH, Kinders RJ (2010). Monitoring drug-induced gammaH2AX as a pharmacodynamic biomarker in individual circulating tumor cells. Clin Cancer Res  16, 1073-84.   https://doi.org/10.1158/1078-0432.CCR-09-2799",https://intramural.nih.gov/search/searchview.taf?ipid=68496
443,BC011081-04,"October 01, 2010 -  September 30, 2011",Prostate Section,Peter A Pinto; MD,William Marston Linehan; MD,"Urologic Oncology Branch, NCI",Saurin Akshay Chokshi|Gopal N Gupta|Donald P Bottaro; PhD|Leonard  Neckers; PhD,NULL,"Peter L Choyke; MD (Molecular Imaging Program)|Maria  Merino; PhD (Laboratory of Pathology)|Michael R Emmert-Buck; MD, PhD (Laboratory of Pathology)|Stefan  Ambs (Laboratory of Human Carcinogenesis)|James L Gulley; MD, PhD (Laboratory of Tumor Immunology and Biology)|William Laurence Dahut; MD (Medical Oncology Branch)",Bradford J Wood; MD (CC),"1. Erickson HS, Josephson JW, Vira M, Albert PS, Gillespie JW, Rodriguez-Canales J, Pinto PA, Chuaqui RF, Emmert-Buck MR, Coleman JA (2010). Influence of hypoxia induced by minimally invasive prostatectomy on gene expression: implications for biomarker analysis. Am J Transl Res  2, 210-22.|2. Rastinehad AR, Baccala AA, Chung PH, Proano JM, Kruecker J, Xu S, Locklin JK, Turkbey B, Shih J, Bratslavsky G, Linehan WM, Glossop ND, Yan P, Kadoury S, Choyke PL, Wood BJ, Pinto PA (2011). D'Amico risk stratification correlates with degree of suspicion of prostate cancer on multiparametric magnetic resonance imaging. J Urol  185, 815-20.   https://doi.org/10.1016/j.juro.2010.10.076|3. Turkbey B, Mani H, Shah V, Rastinehad AR, Bernardo M, Pohida T, Pang Y, Daar D, Benjamin C, McKinney YL, Trivedi H, Chua C, Bratslavsky G, Shih JH, Linehan WM, Merino MJ, Choyke PL, Pinto PA (2011). Multiparametric 3T prostate magnetic resonance imaging to detect cancer: histopathological correlation using prostatectomy specimens processed in customized magnetic resonance imaging based molds. J Urol  186, 1818-24.   https://doi.org/10.1016/j.juro.2011.07.013|4. Turkbey B, Pinto PA, Mani H, Bernardo M, Pang Y, McKinney YL, Khurana K, Ravizzini GC, Albert PS, Merino MJ, Choyke PL (2010). Prostate cancer: value of multiparametric MR imaging at 3 T for detection--histopathologic correlation. Radiology  255, 89-99.   https://doi.org/10.1148/radiol.09090475|5. Turkbey B, Xu S, Kruecker J, Locklin J, Pang Y, Bernardo M, Merino MJ, Wood BJ, Choyke PL, Pinto PA (2011). Documenting the location of prostate biopsies with image fusion. BJU Int  107, 53-7.   https://doi.org/10.1111/j.1464-410X.2010.09483.x",https://intramural.nih.gov/search/searchview.taf?ipid=68662
444,BC011084-04,"October 01, 2010 -  September 30, 2011",Cellular functions of Ran GTPase,Petr  Kalab; PhD,NULL,"Laboratory of Cellular and Molecular Biology, NCI",Keisuke  Hasegawa|Sung Jin  Ryu|Yilan  Shi,Rebecca  Heald (University of California at Berkeley)|John  Yates (The Scripps Research Institute),NULL,NULL,"1. Lowe AR, Siegel JJ, Kalab P, Siu M, Weis K, Liphardt JT (2010). Selectivity mechanism of the nuclear pore complex characterized by single cargo tracking. Nature  467, 600-3.   https://doi.org/10.1038/nature09285",https://intramural.nih.gov/search/searchview.taf?ipid=68610
445,BC011088-04,"October 01, 2010 -  September 30, 2011",Functional genomics of breast cancer,"Paul S Meltzer; MD, PhD|IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI","Sean Richard Davis; MD, PhD|Yuan  Jiang; MD|John E Lueders|Mark  Mackiewicz|Robert L Walker; BS|Joshua James Waterfall|Show all 8",NULL,Mark E Sherman; MD (Hormonal and Reproductive Epidemiology Branch)|Jonine Danya Figueroa (Hormonal and Reproductive Epidemiology Branch),NULL,"1. Bolton KL, Garcia-Closas M, Pfeiffer RM, Duggan MA, Howat WJ, Hewitt SM, Yang XR, Cornelison R, Anzick SL, Meltzer P, Davis S, Lenz P, Figueroa JD, Pharoah PD, Sherman ME (2010). Assessment of automated image analysis of breast cancer tissue microarrays for epidemiologic studies. Cancer Epidemiol Biomarkers Prev  19, 992-9.   https://doi.org/10.1158/1055-9965.EPI-09-1023",https://intramural.nih.gov/search/searchview.taf?ipid=68647
446,BC011090-04,"October 01, 2010 -  September 30, 2011",Merkel Cell Carcinoma Polyomavirus,Christopher  Buck|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI",Diana  Pastrana|Jesse Elijah Reeves; MS|Rachel  Schowalter; PhD,"Yuan  Chang (Cancer Institute, University of Pittsburgh)|Patrick  Moore (Cancer Institute, University of Pittsburgh)|Herbert  Pfister (University of Cologne)",Ola Anders Landgren (Medical Oncology Branch)|Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch),"Adrian U Wiestner; MD, PhD (NHLBI)","1. Johne R, Buck CB, Allander T, Atwood WJ, Garcea RL, Imperiale MJ, Major EO, Ramqvist T, Norkin LC (2011). Taxonomical developments in the family Polyomaviridae. Arch Virol  156, 1627-34.   https://doi.org/10.1007/s00705-011-1008-x|2. Pastrana DV, Pumphrey KA, Cuburu N, Schowalter RM, Buck CB (2010). Characterization of monoclonal antibodies specific for the Merkel cell polyomavirus capsid. Virology  405, 20-5.   https://doi.org/10.1016/j.virol.2010.06.022|3. Schowalter RM, Pastrana DV, Pumphrey KA, Moyer AL, Buck CB (2010). Merkel cell polyomavirus and two previously unknown polyomaviruses are chronically shed from human skin. Cell Host Microbe  7, 509-15.   https://doi.org/10.1016/j.chom.2010.05.006",https://intramural.nih.gov/search/searchview.taf?ipid=68481
447,BC011091-04,"October 01, 2010 -  September 30, 2011",Cancer Genomics Technology Development,"Paul S Meltzer; MD, PhD|IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI","Sean Richard Davis; MD, PhD|Yevgeniy  Gindin|Arthur A Glatfelter; MS|Yuan  Jiang; MD|John E Lueders|Robert L Walker; BS|Show all 11",NULL,Gordon Lee Hager; PhD (Laboratory of Receptor Biology and Gene Expression)|Glenn  Merlino; PhD (Laboratory of Cancer Biology and Genetics)|Sharon Ann Savage (Clinical Genetics Branch)|Xin Wei Wang; PhD (Molecular Genetics and Carcinogenesis Section)|Elaine S Jaffe; MD (Laboratory of Pathology)|Kenneth H Kraemer; MD (Dermatology Branch),Jeffery L Miller; MD (NIDDK),"1. Anzick SL, Chen WD, Park Y, Meltzer P, Bell D, El-Naggar AK, Kaye FJ (2010). Unfavorable prognosis of CRTC1-MAML2 positive mucoepidermoid tumors with CDKN2A deletions. Genes Chromosomes Cancer  49, 59-69.   https://doi.org/10.1002/gcc.20719|2. Killian JK, Bilke S, Davis S, Walker RL, Jaeger E, Killian MS, Waterfall JJ, Bibikova M, Fan JB, Smith WI, Meltzer PS (2011). A methyl-deviator epigenotype of estrogen receptor-positive breast carcinoma is associated with malignant biology. Am J Pathol  179, 55-65.   https://doi.org/10.1016/j.ajpath.2011.03.022|3. Killian JK, Walker RL, Suuriniemi M, Jones L, Scurci S, Singh P, Cornelison R, Harmon S, Boisvert N, Zhu J, Wang Y, Bilke S, Davis S, Giaccone G, Smith WI, Meltzer PS (2010). Archival fine-needle aspiration cytopathology (FNAC) samples: untapped resource for clinical molecular profiling. J Mol Diagn  12, 739-45.   https://doi.org/10.2353/jmoldx.2010.090238|4. Liu F, Killian JK, Yang M, Walker RL, Hong JA, Zhang M, Davis S, Zhang Y, Hussain M, Xi S, Rao M, Meltzer PA, Schrump DS (2010). Epigenomic alterations and gene expression profiles in respiratory epithelia exposed to cigarette smoke condensate. Oncogene  29, 3650-64.   https://doi.org/10.1038/onc.2010.129|5. Morisot S, Wayne AS, Bohana-Kashtan O, Kaplan IM, Gocke CD, Hildreth R, Stetler-Stevenson M, Walker RL, Davis S, Meltzer PS, Wheelan SJ, Brown P, Jones RJ, Shultz LD, Civin CI (2010). High frequencies of leukemia stem cells in poor-outcome childhood precursor-B acute lymphoblastic leukemias. Leukemia  24, 1859-66.   https://doi.org/10.1038/leu.2010.184|6. Voortman J, Lee JH, Killian JK, Suuriniemi M, Wang Y, Lucchi M, Smith WI, Meltzer P, Wang Y, Giaccone G (2010). Array comparative genomic hybridization-based characterization of genetic alterations in pulmonary neuroendocrine tumors. Proc Natl Acad Sci U S A  107, 13040-5.   https://doi.org/10.1073/pnas.1008132107",https://intramural.nih.gov/search/searchview.taf?ipid=68648
448,BC011095-04,"October 01, 2010 -  September 30, 2011",Identification of HIF-Regulated Oncogenic Mediators in Renal Cell Carcinoma,Donald P Bottaro; PhD,William Marston Linehan; MD,"Urologic Oncology Branch, NCI","Daniel Christopher Rabe|Ramaprasad  Srinivasan; MD, PhD|Kristen Elizabeth Raffensperger|Leonard  Neckers; PhD|Peter A Pinto; MD",NULL,"Tawnya Carlene McKee; BA, PhD (Molecular Targets Laboratory)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68477
449,BC011099-04,"October 01, 2010 -  September 30, 2011",Canine Glioma and Embryonic Neural Stem Cell Project,"Howard A Fine; MD, PhD",NULL,"Neuro-Oncology Branch, NCI",Kevin D Woolard,NULL,NULL,NULL,"1. Bozdag S, Li A, Wuchty S, Fine HA (2010). FastMEDUSA: a parallelized tool to infer gene regulatory networks. Bioinformatics  26, 1792-3.   https://doi.org/10.1093/bioinformatics/btq275|2. Edwards LA, Woolard K, Son MJ, Li A, Lee J, Ene C, Mantey SA, Maric D, Song H, Belova G, Jensen RT, Zhang W, Fine HA (2011). Effect of brain- and tumor-derived connective tissue growth factor on glioma invasion. J Natl Cancer Inst  103, 1162-78.   https://doi.org/10.1093/jnci/djr224|3. Kotliarov Y, Bozdag S, Cheng H, Wuchty S, Zenklusen JC, Fine HA (2010). CNAReporter: a GenePattern pipeline for the generation of clinical reports of genomic alterations. BMC Med Genomics  3, 11.   https://doi.org/10.1186/1755-8794-3-11|4. Li A, Bozdag S, Kotliarov Y, Fine HA (2010). GliomaPredict: a clinically useful tool for assigning glioma patients to specific molecular subtypes. BMC Med Inform Decis Mak  10, 38.   https://doi.org/10.1186/1472-6947-10-38|5. Riddick G, Song H, Ahn S, Walling J, Borges-Rivera D, Zhang W, Fine HA (2011). Predicting in vitro drug sensitivity using Random Forests. Bioinformatics  27, 220-4.   https://doi.org/10.1093/bioinformatics/btq628|6. Wuchty S, Arjona D, Li A, Kotliarov Y, Walling J, Ahn S, Zhang A, Maric D, Anolik R, Zenklusen JC, Fine HA (2011). Prediction of Associations between microRNAs and Gene Expression in Glioma Biology. PLoS One  6, e14681.   https://doi.org/10.1371/journal.pone.0014681",https://intramural.nih.gov/search/searchview.taf?ipid=68512
450,BC011100-04,"October 01, 2010 -  September 30, 2011",SCF as a Novel CNS and Glioma-Derived Angiogenic Factor and SC Chemotaxic Factor,"Howard A Fine; MD, PhD",NULL,"Neuro-Oncology Branch, NCI",Susie  Ahn|Peter  Bauer; PhD|Margaret  Cam; PhD|Emely  Castro-Rivera|Chibawanye Isidore Ene|Hong Sug Kim|Show all 14,NULL,NULL,NULL,"1. Bozdag S, Li A, Wuchty S, Fine HA (2010). FastMEDUSA: a parallelized tool to infer gene regulatory networks. Bioinformatics  26, 1792-3.   https://doi.org/10.1093/bioinformatics/btq275|2. Edwards LA, Woolard K, Son MJ, Li A, Lee J, Ene C, Mantey SA, Maric D, Song H, Belova G, Jensen RT, Zhang W, Fine HA (2011). Effect of brain- and tumor-derived connective tissue growth factor on glioma invasion. J Natl Cancer Inst  103, 1162-78.   https://doi.org/10.1093/jnci/djr224|3. Kotliarov Y, Bozdag S, Cheng H, Wuchty S, Zenklusen JC, Fine HA (2010). CNAReporter: a GenePattern pipeline for the generation of clinical reports of genomic alterations. BMC Med Genomics  3, 11.   https://doi.org/10.1186/1755-8794-3-11|4. Li A, Bozdag S, Kotliarov Y, Fine HA (2010). GliomaPredict: a clinically useful tool for assigning glioma patients to specific molecular subtypes. BMC Med Inform Decis Mak  10, 38.   https://doi.org/10.1186/1472-6947-10-38|5. Riddick G, Song H, Ahn S, Walling J, Borges-Rivera D, Zhang W, Fine HA (2011). Predicting in vitro drug sensitivity using Random Forests. Bioinformatics  27, 220-4.   https://doi.org/10.1093/bioinformatics/btq628|6. Wuchty S, Arjona D, Li A, Kotliarov Y, Walling J, Ahn S, Zhang A, Maric D, Anolik R, Zenklusen JC, Fine HA (2011). Prediction of Associations between microRNAs and Gene Expression in Glioma Biology. PLoS One  6, e14681.   https://doi.org/10.1371/journal.pone.0014681",https://intramural.nih.gov/search/searchview.taf?ipid=68507
451,BC011101-04,"October 01, 2010 -  September 30, 2011",Identifying New Glioma-Associated Tumor Suppressors and Oncogenes,"Howard A Fine; MD, PhD",NULL,"Neuro-Oncology Branch, NCI",Baltazar D Aguda|Susie  Ahn|Peter  Bauer; PhD|Mehmet  Baysan|Margaret  Cam; PhD|Emely  Castro-Rivera|Show all 19,NULL,NULL,NULL,"1. Bozdag S, Li A, Wuchty S, Fine HA (2010). FastMEDUSA: a parallelized tool to infer gene regulatory networks. Bioinformatics  26, 1792-3.   https://doi.org/10.1093/bioinformatics/btq275|2. Edwards LA, Woolard K, Son MJ, Li A, Lee J, Ene C, Mantey SA, Maric D, Song H, Belova G, Jensen RT, Zhang W, Fine HA (2011). Effect of brain- and tumor-derived connective tissue growth factor on glioma invasion. J Natl Cancer Inst  103, 1162-78.   https://doi.org/10.1093/jnci/djr224|3. Fraum TJ, Kreisl TN, Sul J, Fine HA, Iwamoto FM (2011). Ischemic stroke and intracranial hemorrhage in glioma patients on antiangiogenic therapy. J Neurooncol  105, 281-9.   https://doi.org/10.1007/s11060-011-0579-4|4. Kotliarov Y, Bozdag S, Cheng H, Wuchty S, Zenklusen JC, Fine HA (2010). CNAReporter: a GenePattern pipeline for the generation of clinical reports of genomic alterations. BMC Med Genomics  3, 11.   https://doi.org/10.1186/1755-8794-3-11|5. Li A, Bozdag S, Kotliarov Y, Fine HA (2010). GliomaPredict: a clinically useful tool for assigning glioma patients to specific molecular subtypes. BMC Med Inform Decis Mak  10, 38.   https://doi.org/10.1186/1472-6947-10-38|6. Riddick G, Song H, Ahn S, Walling J, Borges-Rivera D, Zhang W, Fine HA (2011). Predicting in vitro drug sensitivity using Random Forests. Bioinformatics  27, 220-4.   https://doi.org/10.1093/bioinformatics/btq628|7. Wuchty S, Arjona D, Li A, Kotliarov Y, Walling J, Ahn S, Zhang A, Maric D, Anolik R, Zenklusen JC, Fine HA (2011). Prediction of Associations between microRNAs and Gene Expression in Glioma Biology. PLoS One  6, e14681.   https://doi.org/10.1371/journal.pone.0014681",https://intramural.nih.gov/search/searchview.taf?ipid=68508
452,BC011102-04,"October 01, 2010 -  September 30, 2011",The Role of miRNAs in Glioma Stem Cell and Glioma Biology,"Howard A Fine; MD, PhD",NULL,"Neuro-Oncology Branch, NCI",Baltazar D Aguda|Susie  Ahn|Peter  Bauer; PhD|Mehmet  Baysan|Margaret  Cam; PhD|Emely  Castro-Rivera|Show all 19,NULL,NULL,NULL,"1. Bozdag S, Li A, Wuchty S, Fine HA (2010). FastMEDUSA: a parallelized tool to infer gene regulatory networks. Bioinformatics  26, 1792-3.   https://doi.org/10.1093/bioinformatics/btq275|2. Edwards LA, Woolard K, Son MJ, Li A, Lee J, Ene C, Mantey SA, Maric D, Song H, Belova G, Jensen RT, Zhang W, Fine HA (2011). Effect of brain- and tumor-derived connective tissue growth factor on glioma invasion. J Natl Cancer Inst  103, 1162-78.   https://doi.org/10.1093/jnci/djr224|3. Kotliarov Y, Bozdag S, Cheng H, Wuchty S, Zenklusen JC, Fine HA (2010). CNAReporter: a GenePattern pipeline for the generation of clinical reports of genomic alterations. BMC Med Genomics  3, 11.   https://doi.org/10.1186/1755-8794-3-11|4. Li A, Bozdag S, Kotliarov Y, Fine HA (2010). GliomaPredict: a clinically useful tool for assigning glioma patients to specific molecular subtypes. BMC Med Inform Decis Mak  10, 38.   https://doi.org/10.1186/1472-6947-10-38|5. Riddick G, Song H, Ahn S, Walling J, Borges-Rivera D, Zhang W, Fine HA (2011). Predicting in vitro drug sensitivity using Random Forests. Bioinformatics  27, 220-4.   https://doi.org/10.1093/bioinformatics/btq628|6. Wuchty S, Arjona D, Li A, Kotliarov Y, Walling J, Ahn S, Zhang A, Maric D, Anolik R, Zenklusen JC, Fine HA (2011). Prediction of Associations between microRNAs and Gene Expression in Glioma Biology. PLoS One  6, e14681.   https://doi.org/10.1371/journal.pone.0014681",https://intramural.nih.gov/search/searchview.taf?ipid=68509
453,BC011105-04,"October 01, 2010 -  September 30, 2011",Study of HIV Protease Dimerization (PD) and Identification of PD Inhibitors,Hiroaki  Mitsuya,NULL,"HIV and AIDS Malignancy Branch, NCI",Debananda  Das; PhD|David A Davis; MD|Darshan  Desai; BS|Robert  Yarchoan; MD|Kenji  Maeda|Hirotomo  Nakata|Show all 7,"Masayuki  Amano (Kumamoto University School of Medicine)|Arun  Ghosh|Yasuhiro  Koh (Kumamoto University School of Medicine)|Hiromi  Ogata-Aoki (Kumamoto University School of Medicine)|Irene  Weber (Department of Biology, Georgia State University)",NULL,NULL,"1. Ghosh A, Chapsal B, Mitsuya H (2010) Darunavir, a new PI with dual mechanism: from a novel drug design concept to new hope against drug-resistant HIV, in Aspartic Acid Proteases as Therapeutic Targets., in press.|2. Maeda K, Mitsuya H (2010) Development of antiviral therapeutics for HIV-1 infection and AIDS, in AIDS in the 21st Century., in press.|3. Mitsuya H, Ghosh A (2010) Development of HIV-1 protease inhibitors, antiretroviral resistance and current challenges of HIV/AIDS management, in Aspartic Acid Proteases as Therapeutic Targets., in press.|4. Ghosh AK, Gemma S, Simoni E, Baldridge A, Walters DE, Ide K, Tojo Y, Koh Y, Amano M, Mitsuya H (2010). Synthesis and biological evaluation of novel allophenylnorstatine-based HIV-1 protease inhibitors incorporating high affinity P2-ligands. Bioorg Med Chem Lett  20, 1241-6.   https://doi.org/10.1016/j.bmcl.2009.11.123|5. Koh Y, Amano M, Towata T, Danish M, Leshchenko-Yashchuk S, Das D, Nakayama M, Tojo Y, Ghosh AK, Mitsuya H (2010). In vitro selection of highly darunavir-resistant and replication-competent HIV-1 variants by using a mixture of clinical HIV-1 isolates resistant to multiple conventional protease inhibitors. J Virol  84, 11961-9.   https://doi.org/10.1128/JVI.00967-10",https://intramural.nih.gov/search/searchview.taf?ipid=68651
454,BC011106-04,"October 01, 2010 -  September 30, 2011",Specification of T cell function during development,Alfred  Singer; MD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Tejas Bharat Kadakia|Thomas  McCaughtry,"Wilfried  Ellmeier (Immunology, University of Vienna)|Batu M Erman|Sophia D Sarafova (NCI)","Remy J Bosselut; MD, PhD (Laboratory of Immune Cell Biology)|Lionel  Feigenbaum (Office Of The Director)","Paul E Love; MD, PhD (NICHD)","1. Park J, Adoro S, Singer A (2010) Coreceptor tuning: A cytokine-mediated homestatic mechanism that maximizes CD8 T cell reactivity while maintaining peripheral tolerance, in The life and death of T lymphocytes - The influence of cytokines under physiological and pathological conditions., pp. 1-14.|2. Park JH, Adoro S, Guinter T, Erman B, Alag AS, Catalfamo M, Kimura MY, Cui Y, Lucas PJ, Gress RE, Kubo M, Hennighausen L, Feigenbaum L, Singer A (2010). Signaling by intrathymic cytokines, not T cell antigen receptors, specifies CD8 lineage choice and promotes the differentiation of cytotoxic-lineage T cells. Nat Immunol  11, 257-64.   https://doi.org/10.1038/ni.1840|3. Singer A (2010). Molecular and cellular basis of T cell lineage commitment: An overview. Semin Immunol  22, 253.   https://doi.org/10.1016/j.smim.2010.06.001",https://intramural.nih.gov/search/searchview.taf?ipid=68560
455,BC011107-04,"October 01, 2010 -  September 30, 2011",Analysis of the Function and Regulation of Protein Scaffolds and Signal Modulato,Deborah K Morrison|IRP Faculty Profile,NULL,"Laboratory of Cell and Developmental Signaling, NCI",Prashanth Thirupopuliyur Bhaskar|Ira  Daar; PhD|Junghwa  Lim|Melissa M Mckay|Natasha Rose Schuh,Robert  Lewis (Univeristy of Nebraska Medical Center)|Rebecca  Page (Brown Medical School)|John  Scott (Oregon Health and Science University)|Kate  Storey (University of Dundee)|Matthias  TschÃ¶p (University of Cincinnati),Timothy D Veenstra (Office Of The Director),NULL,"1. Lim J, Zhou M, Veenstra TD, Morrison DK (2010). The CNK1 scaffold binds cytohesins and promotes insulin pathway signaling. Genes Dev  24, 1496-506.   https://doi.org/10.1101/gad.1904610|2. McKay MM, Morrison DK (2010). Proteomic analysis of scaffold proteins in the ERK cascade. Methods Mol Biol  661, 323-34.   https://doi.org/10.1007/978-1-60761-795-2_19|3. Smith FD, Langeberg LK, Cellurale C, Pawson T, Morrison DK, Davis RJ, Scott JD (2010). AKAP-Lbc enhances cyclic AMP control of the ERK1/2 cascade. Nat Cell Biol  12, 1242-9.   https://doi.org/10.1038/ncb2130",https://intramural.nih.gov/search/searchview.taf?ipid=68655
456,BC011108-04,"October 01, 2010 -  September 30, 2011",MAP Kinase signal transduction disruption in cancer,Jonathan S Wiest; PhD,NULL,"Office of the Director, NCI",Kathleen L Decicco|Monika  Deshpande|Sarah Anderson Jung|Zhihong  Shan,NULL,"Phillip A Dennis; MD, PhD (Medical Oncology Branch)|Giorgio  Trinchieri (Cancer Inflammation Program)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68592
457,BC011109-04,"October 01, 2010 -  September 30, 2011",Study of Structures of CCR5 and Its Interactions with CCR5 Inhibitors,Hiroaki  Mitsuya,NULL,"HIV and AIDS Malignancy Branch, NCI",Debananda  Das; PhD|Kenji  Maeda|Hirotomo  Nakata,Arun  Ghosh|Hiromi  Ogata-Aoki (Kumamoto University School of Medicine)|Yoshikazu  Takaoka (Ono Pharmaceutical Co. Ltd.),Seth M Steinberg; PhD (Biostatistics and Data Management Section),NULL,"1. Nakata H, Kruhlak M, Kamata W, Ogata-Aoki H, Li J, Maeda K, Ghosh AK, Mitsuya H (2010). Effects of CC chemokine receptor 5 (CCR5) inhibitors on the dynamics of CCR5 and CC-chemokine-CCR5 interactions. Antivir Ther  15, 321-31.   https://doi.org/10.3851/IMP1529",https://intramural.nih.gov/search/searchview.taf?ipid=68652
458,BC011111-04,"October 01, 2010 -  September 30, 2011",Cytokine signaling in developing thymocytes and T cells,Alfred  Singer; MD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Gil  Katz,NULL,Lionel  Feigenbaum (Office Of The Director),Lothar  Hennighausen; PhD (NIDDK),"1. Park J, Adoro S, Singer A (2010) Coreceptor tuning: A cytokine-mediated homestatic mechanism that maximizes CD8 T cell reactivity while maintaining peripheral tolerance, in The life and death of T lymphocytes - The influence of cytokines under physiological and pathological conditions., pp. 1-14.|2. Park JH, Adoro S, Guinter T, Erman B, Alag AS, Catalfamo M, Kimura MY, Cui Y, Lucas PJ, Gress RE, Kubo M, Hennighausen L, Feigenbaum L, Singer A (2010). Signaling by intrathymic cytokines, not T cell antigen receptors, specifies CD8 lineage choice and promotes the differentiation of cytotoxic-lineage T cells. Nat Immunol  11, 257-64.   https://doi.org/10.1038/ni.1840|3. Singer A (2010). Molecular and cellular basis of T cell lineage commitment: An overview. Semin Immunol  22, 253.   https://doi.org/10.1016/j.smim.2010.06.001",https://intramural.nih.gov/search/searchview.taf?ipid=68561
459,BC011112-04,"October 01, 2010 -  September 30, 2011",Development and function of regulatory T cells,Alfred  Singer; MD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Xuguang C Tai,NULL,Lionel  Feigenbaum (Office Of The Director)|Dinah  Singer; PhD (Office of the Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68557
460,BC011113-04,"October 01, 2010 -  September 30, 2011",T cell survival,Alfred  Singer; MD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Motoko  Kimura|Jung-Hyun  Park,NULL,NULL,NULL,"1. Park J, Adoro S, Singer A (2010) Coreceptor tuning: A cytokine-mediated homestatic mechanism that maximizes CD8 T cell reactivity while maintaining peripheral tolerance, in The life and death of T lymphocytes - The influence of cytokines under physiological and pathological conditions., pp. 1-14.",https://intramural.nih.gov/search/searchview.taf?ipid=68558
461,BC011114-04,"October 01, 2010 -  September 30, 2011",Role of microRNAs in T cell development,Alfred  Singer; MD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Susanna  Jeurling|Leonid  Popezinsky,NULL,Lionel  Feigenbaum (Office Of The Director),"Paul E Love; MD, PhD (NICHD)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68559
462,BC011115-04,"October 01, 2010 -  September 30, 2011",Epigenetic Mechanisms of Gene Expression in Lung Cancer Cells,David  Schrump; MD|IRP Faculty Profile,NULL,"Surgery Branch, NCI",Scott M Atay; MD|Mahadev  Rao|Trevor Christopher Upham; MD|Julie A Hong|Mary R Zhang|Yuwei  Zhang,NULL,Victor  Marquez; PhD (Chemical Biology Laboratory),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68544
463,BC011116-04,"October 01, 2010 -  September 30, 2011",MHC-independent T cells,Alfred  Singer; MD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Leonid  Popezinsky|Jung-Hyun  Park|Anastassia  Tikhonova,NULL,Lionel  Feigenbaum (Office Of The Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68555
464,BC011117-04,"October 01, 2010 -  September 30, 2011",T cell receptor regulation of cytokine signaling,Alfred  Singer; MD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68556
465,BC011118-04,"October 01, 2010 -  September 30, 2011",Role of Shh in developmental patterning and proliferation of digit skeleton,Susan  Mackem; MD|IRP Faculty Profile,NULL,"Cancer and Developmental Biology Laboratory, NCI",Xiaozhong  Bao|Christopher Alan Burnette; PhD|Victoria E Elliott|Jianjian  Zhu,Gerard  Evan (UCSF)|Licia  Selleri (Cornell Univ Weill Medical College),Stephen J Lockett; PhD (Office Of The Director),Yosuke  Mukoyama; PhD (NHLBI) |Sohyun  Ahn; PhD (NICHD),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68644
466,BC011119-04,"October 01, 2010 -  September 30, 2011",Hoxd gene functions in digit morphogenesis and role of Gli3-Hoxd interaction,Susan  Mackem; MD|IRP Faculty Profile,NULL,"Cancer and Developmental Biology Laboratory, NCI",Xiaozhong  Bao|Bau Lin Huang|Rebecca A Moriarty,"Benoit  Bruneau (UCSF)|Denis  Duboule (Zoology and Animal Biology, Univ. of Geneva)|Masahiro  Iwamoto; DDS, PhD (Thomas Jefferson University)|Maurizio  Pacifici (Univ. Pennsylvania School of Medicine)|John  Rasweiler (SUNY Downstate)|Makoto  Taketo (Orthopedics, Kyoto University)",David  Levens; PhD (Laboratory of Pathology)|Alexandra L Joyner  (Office Of The Director),"Yingzi  Yang; PhD (NHGRI) |Richa  Agarwala; BTech, MS, PhD (NLM) |Ivan  Ovcharenko; PhD (NLM)","1. Galli A, Robay D, Osterwalder M, Bao X, Bénazet JD, Tariq M, Paro R, Mackem S, Zeller R (2010). Distinct roles of Hand2 in initiating polarity and posterior Shh expression during the onset of mouse limb bud development. PLoS Genet  6, e1000901.   https://doi.org/10.1371/journal.pgen.1000901|2. Maes C, Kobayashi T, Selig MK, Torrekens S, Roth SI, Mackem S, Carmeliet G, Kronenberg HM (2010). Osteoblast precursors, but not mature osteoblasts, move into developing and fractured bones along with invading blood vessels. Dev Cell  19, 329-44.   https://doi.org/10.1016/j.devcel.2010.07.010",https://intramural.nih.gov/search/searchview.taf?ipid=68645
467,BC011120-04,"October 01, 2010 -  September 30, 2011",Genome-wide identification of target promoters of developmental regulators,Susan  Mackem; MD|IRP Faculty Profile,NULL,"Cancer and Developmental Biology Laboratory, NCI",Xiaozhong  Bao|Bau Lin Huang,"Benoit  Bruneau (UCSF)|Steve  Vokes (U. Texas, Austin)",NULL,"Ivan  Ovcharenko; PhD (NLM) |Richa  Agarwala; BTech, MS, PhD (NLM)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68642
468,BC011121-04,"October 01, 2010 -  September 30, 2011",RNA interference approach to dissect roles of notochord regulators,Susan  Mackem; MD|IRP Faculty Profile,NULL,"Cancer and Developmental Biology Laboratory, NCI",Xiaozhong  Bao|Victoria E Elliott|Jianjian  Zhu,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68643
469,BC011122-04,"October 01, 2010 -  September 30, 2011",Epigenetic Alterations Induced by Tobacco Smoke,David  Schrump; MD|IRP Faculty Profile,NULL,"Surgery Branch, NCI",Scott M Atay; MD|Julie A Hong|Fang  Liu|Mahadev  Rao|Trevor Christopher Upham; MD|Mary R Zhang|Show all 7,NULL,"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",NULL,"1. Liu F, Killian JK, Yang M, Walker RL, Hong JA, Zhang M, Davis S, Zhang Y, Hussain M, Xi S, Rao M, Meltzer PA, Schrump DS (2010). Epigenomic alterations and gene expression profiles in respiratory epithelia exposed to cigarette smoke condensate. Oncogene  29, 3650-64.   https://doi.org/10.1038/onc.2010.129",https://intramural.nih.gov/search/searchview.taf?ipid=68545
470,BC011123-04,"October 01, 2010 -  September 30, 2011",Development of Grb2 SH2 Domain Antagonists as Anti-Cancer Therapeutics,Donald P Bottaro; PhD,William Marston Linehan; MD,"Urologic Oncology Branch, NCI",Young Hwan Lee|Joseph V Reilly|Peter A Pinto; MD,NULL,Jane Beth Trepel (Medical Oncology Branch)|Terrence R Burke; PhD (Chemical Biology Laboratory)|Ettore  Appella; MD (Chemical Immunology Section)|Melinda  Hollingshead (Biological Testing Branch)|Lawrence R Phillips (Molecular Pharmocology Branch)|Robert J Fisher (Office Of The Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68478
471,BC011124-04,"October 01, 2010 -  September 30, 2011",Oncogenic Met Signaling in Urologic Malignancies,Donald P Bottaro; PhD,William Marston Linehan; MD,"Urologic Oncology Branch, NCI","Fabiola  Cecchi|Cathy  Vocke; PhD|Young Hwan Lee|Ramaprasad  Srinivasan; MD, PhD|Kristen Elizabeth Raffensperger|Joseph V Reilly|Show all 7","Stuart  Aaronson (Research, Mount Sinai Medical Center)|Teresa  Burgess (Preclinical Development, Amgen)|Ascoli  Carl (Clinical Development Oncology, Rockland Immunologicals, Inc)|James  Christensen (Oncology Research, Pfizer)|Angela  Coxon (Amgen)|Regina  Day (NCI)|Show all 24","Maria  Merino; PhD (Laboratory of Pathology)|Patricia  Steeg; PhD (Developmental Therapeutics Branch)|Kevin A Camphausen; MD (Radiation Oncology Branch)|Jeffrey S Rubin; MD, PhD (Laboratory of Cellular and Molecular Biology)|Peter L Choyke; MD (Molecular Imaging Program)|Terrence R Burke; PhD (Chemical Biology Laboratory)",NULL,"1. Cecchi F, Rabe DC, Bottaro DP (2010). Targeting the HGF/Met signalling pathway in cancer. Eur J Cancer  46, 1260-70.   https://doi.org/10.1016/j.ejca.2010.02.028|2. Cecchi F, Rabe DC, Bottaro DP (2011) The Hepatocyte Growth Factor Receptor: Structure, Function and Pharmacological Targeting in Cancer. Curr Signal Transduct Ther 6:146-151|3. Felici A, Giubellino A, Bottaro DP (2010). Gab1 mediates hepatocyte growth factor-stimulated mitogenicity and morphogenesis in multipotent myeloid cells. J Cell Biochem  111, 310-21.   https://doi.org/10.1002/jcb.22695|4. Linehan WM, Bratslavsky G, Pinto PA, Schmidt LS, Neckers L, Bottaro DP, Srinivasan R (2010). Molecular diagnosis and therapy of kidney cancer. Annu Rev Med  61, 329-43.   https://doi.org/10.1146/annurev.med.042808.171650|5. Mungunsukh O, Lee YH, Marquez AP, Cecchi F, Bottaro DP, Day RM (2010). A tandem repeat of a fragment of Listeria monocytogenes internalin B protein induces cell survival and proliferation. Am J Physiol Lung Cell Mol Physiol  299, L905-14.   https://doi.org/10.1152/ajplung.00094.2010",https://intramural.nih.gov/search/searchview.taf?ipid=68479
472,BC011126-04,"October 01, 2010 -  September 30, 2011",Preventive Vaccines for HIV,Genoveffa  Franchini; MD|IRP Faculty Profile,NULL,"Vaccine Branch, NCI",Shari  Gordon; PhD|Marjorie  Robert-Guroff; PhD|Namal Prasanna Malimbada-Liyanage|Poonam  Poonam|Monica  Vaccari|Melvin Nelson Doster,"Guido  Ferrari (Duke University)|Donald  Forthal (School of Medicine, Univ of CA)|Chris  Miller; MS|David C Montefiori; PhD (Department of Surgery, NIAID)|Eckhard  Podack (Department of Microbiology, University of Miami)",John  Schiller; PhD (Laboratory of Cellular Oncology)|Jeffrey  Roberts (Laboratory of Cellular Oncology)|Christopher  Buck (Laboratory of Cellular Oncology),Nancy R Miller (NIAID) |Vanessa  Hirsch (NIAID),"1. Gordon SN, Cecchinato V, Andresen V, Heraud JM, Hryniewicz A, Parks RW, Venzon D, Chung HK, Karpova T, McNally J, Silvera P, Reimann KA, Matsui H, Kanehara T, Shinmura Y, Yokote H, Franchini G (2011). Smallpox vaccine safety is dependent on T cells and not B cells. J Infect Dis  203, 1043-53.   https://doi.org/10.1093/infdis/jiq162|2. Gordon SN, Kines RC, Kutsyna G, Ma ZM, Hryniewicz A, Roberts JN, Fenizia C, Hidajat R, Brocca-Cofano E, Cuburu N, Buck CB, Bernardo ML, Robert-Guroff M, Miller CJ, Graham BS, Lowy DR, Schiller JT, Franchini G (2012). Targeting the vaginal mucosa with human papillomavirus pseudovirion vaccines delivering simian immunodeficiency virus DNA. J Immunol  188, 714-23.   https://doi.org/10.4049/jimmunol.1101404|3. Gordon SN, Weissman AR, Cecchinato V, Fenizia C, Ma ZM, Lee TH, Zaffiri L, Andresen V, Parks RW, Jones KS, Heraud JM, Ferrari MG, Chung HK, Venzon D, Mahieux R, Murphy EL, Jacobson S, Miller CJ, Ruscetti FW, Franchini G (2010). Preexisting infection with human T-cell lymphotropic virus type 2 neither exacerbates nor attenuates simian immunodeficiency virus SIVmac251 infection in macaques. J Virol  84, 3043-58.   https://doi.org/10.1128/JVI.01655-09|4. Moutaftsi M, Tscharke DC, Vaughan K, Koelle DM, Stern L, Calvo-Calle M, Ennis F, Terajima M, Sutter G, Crotty S, Drexler I, Franchini G, Yewdell JW, Head SR, Blum J, Peters B, Sette A (2010). Uncovering the interplay between CD8, CD4 and antibody responses to complex pathogens. Future Microbiol  5, 221-39.   https://doi.org/10.2217/fmb.09.110",https://intramural.nih.gov/search/searchview.taf?ipid=68513
473,BC011130-04,"October 01, 2010 -  September 30, 2011",Investigation of the Hepatocyte Growth FactorMet Pathway,Robert Andrew Byrd|IRP Faculty Profile,NULL,"Structural Biophysics Laboratory, NCI",NULL,NULL,Donald P Bottaro; PhD (Urologic Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68484
474,BC011131-04,"October 01, 2010 -  September 30, 2011",Investigation of Protein-Protein Interactions in the ERAD Ubiquitylation Pathway,Robert Andrew Byrd|IRP Faculty Profile,NULL,"Structural Biophysics Laboratory, NCI",Yinghua  Chen|Ranabir  Das|Tao  Huang|Aaren  Gonzales|Jess R Li,NULL,Allan M Weissman; MD (Laboratory of Protein Dynamics and Signaling)|Xinhua  Ji; PhD (Biomolecular Structure Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68485
475,BC011132-04,"October 01, 2010 -  September 30, 2011",Methods Development,Robert Andrew Byrd|IRP Faculty Profile,NULL,"Structural Biophysics Laboratory, NCI",Yinghua  Chen|Yun Xing M Wang|Ranabir  Das|Aaren  Gonzales|Jess R Li|Shangjin  Sun,NULL,NULL,Charles  Schwieters; PhD (CIT),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68483
476,BC011149-03,"October 01, 2010 -  September 30, 2011",Role of microRNAs in Regulating Gene Expression,Howard A Young; PhD|IRP Faculty Profile,NULL,"Laboratory of Experimental Immunology, NCI","Michael E Sanford|Ram  Savan|Mary  Carrington; MS, PhD",NULL,Stuart F J Le Grice; PhD (Retroviral Replication Laboratory)|Bruce Allen Shapiro; PhD (Image Processing Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68745
477,BC011150-03,"October 01, 2010 -  September 30, 2011",Chronic Inflammation and Carcinogenesis,Scott K Durum; PhD|IRP Faculty Profile,NULL,"Laboratory of Molecular Immunoregulation, NCI",Miranda L Hanson|Katherine Emily Hardey|Julie  Hixon|Wenqing  Li|Wei  Shen,NULL,Howard A Young; PhD (Laboratory of Experimental Immunology)|Giorgio  Trinchieri (Cancer Inflammation Program),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68683
478,BC011152-03,"October 01, 2010 -  September 30, 2011",Regulation of human dendritic cell activation,Giorgio  Trinchieri|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",Earl W Bere|Marco  Cardone|Aastha  Kaul|Lyudmila A Lyakh|Robin T Winkler Pickett,"Franca  Gerosa (Pathology/Immunology, University of Verona)|Uzma  Hasan (Infections and Cancer Biology, International Agency for Research on Cancer (IARC-WHO))|Xiaojing  Ma (Microbiology and Immunology, Weill Medical College)","Barbara K Felber (Vaccine Branch)|George N Pavlakis; MD, PhD (Vaccine Branch)|Francis W Ruscetti; PhD (Laboratory of Experimental Immunology)",NULL,"1. Stewart C, Trinchieri G (2011) Turning on and off the immunological switch:  Immune response polarization and its control by IL-10 and STAT3, in Immunologic Signature of Rejection. .  Volume VII,  pp. 27-56.|2. Nussenblatt RB, Bielekova B, Childs R, Krensky A, Strober W, Trinchieri G, Center for Human Immunology, Autoimmunity and Inflammation, National Institutes of Health (2010). National Institutes of Health Center for Human Immunology Conference, September 2009. Ann N Y Acad Sci  1200 Suppl 1, E1-23.   https://doi.org/10.1111/j.1749-6632.2010.05682.x|3. Perrot I, Deauvieau F, Massacrier C, Hughes N, Garrone P, Durand I, Demaria O, Viaud N, Gauthier L, Blery M, Bonnefoy-Berard N, Morel Y, Tschopp J, Alexopoulou L, Trinchieri G, Paturel C, Caux C (2010). TLR3 and Rig-like receptor on myeloid dendritic cells and Rig-like receptor on human NK cells are both mandatory for production of IFN-gamma in response to double-stranded RNA. J Immunol  185, 2080-8.   https://doi.org/10.4049/jimmunol.1000532|4. Trinchieri G (2010) Type I Interferon: Friend or Foe? J. Exp. Med, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=68736
479,BC011153-03,"October 01, 2010 -  September 30, 2011",Role of mouse microbiome in acancer and inflammation,Giorgio  Trinchieri|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI","Amiran  Dzutsev; PhD|Silvana Romina Goldszmid|Noriho  Iida; MD, PhD|Rosalba  Salcedo|Loretta R Smith|Robin T Winkler Pickett",NULL,NULL,Francesco M. Marincola; MD (CC),"1. Demaria S, Pikarsky E, Karin M, Coussens LM, Chen YC, El-Omar EM, Trinchieri G, Dubinett SM, Mao JT, Szabo E, Krieg A, Weiner GJ, Fox BA, Coukos G, Wang E, Abraham RT, Carbone M, Lotze MT (2010). Cancer and inflammation: promise for biologic therapy. J Immunother  33, 335-51.   https://doi.org/10.1097/CJI.0b013e3181d32e74|2. Salcedo R, Worschech A, Cardone M, Jones Y, Gyulai Z, Dai RM, Wang E, Ma W, Haines D, O'hUigin C, Marincola FM, Trinchieri G (2010). MyD88-mediated signaling prevents development of adenocarcinomas of the colon: role of interleukin 18. J Exp Med  207, 1625-36.   https://doi.org/10.1084/jem.20100199|3. Saleh M, Trinchieri G (2010) Innate mechanisms of colitis and colon cancer. Nat Rev Immunol, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=68735
480,BC011154-03,"October 01, 2010 -  September 30, 2011",Biological Functions of Chromosomal Proteins,Michael  Bustin; PhD|IRP Faculty Profile,NULL,"Protein Section, NCI",Liron  Abuhatzira; PhD|Tao  Deng|Takashi  Furusawa|Tamar Klara Kleinberger|Jamie Elyse Kugler|Cedric  Malicet|Show all 8,"Melinda K Duncan; PhD (Biological Sciences, The University of Delaware)|Stavros  Lomvardas (University of California, San Francisco)|Eran  Meshorer (Hebrew University)|Leon  Mullenders (Radiation Genetics, University of Leiden)|Joseph  Orly (Hebrew University)",Kenneth H Kraemer; MD (Dermatology Branch)|Joost J Oppenheim; MD (Laboratory of Molecular Immunoregulation),NULL,"1. Bustin M (2010). High mobility group proteins. Biochim Biophys Acta  1799, 1-2.   https://doi.org/10.1016/j.bbagrm.2010.01.006|2. Gerlitz G, Bustin M (2011). The role of chromatin structure in cell migration. Trends Cell Biol  21, 6-11.   https://doi.org/10.1016/j.tcb.2010.09.002|3. Kurahashi T, Furusawa T, Ueda T, Bustin M (2010). The nucleosome binding protein HMGN3 is expressed in pancreatic alpha-cells and affects plasma glucagon levels in mice. J Cell Biochem  109, 49-57.   https://doi.org/10.1002/jcb.22377",https://intramural.nih.gov/search/searchview.taf?ipid=68673
481,BC011155-03,"October 01, 2010 -  September 30, 2011",Antibody-based therapeutics and vaccines against AIDS,Dimiter Stanchev Dimitrov; PhD,NULL,"Membrane Structure and Function Section, NCI",Weizao  Chen|Yang  Feng|Rui  Gong; PhD|John  Owens|Haiyan  Qin|Emily D Streaker|Show all 10,"Christopher  Broder (Uniformed Services University of the Health Sciences)|Barton  Haynes (Duke University)|Shibo  Jiang (Virology, New York Blood Center)|David C Montefiori; PhD (Department of Surgery, NIAID)|Gerald  Quinnan (Uniformed Services University of the Health Sciences)|Ruth  Ruprecht (Harvard Medical School)",Robert  Blumenthal; PhD (Center for Cancer Research Nanobiology Program),Peter D Kwong; PhD (NIAID),"1. Chen W, Xiao X, Wang Y, Zhu Z, Dimitrov DS (2010). Bifunctional fusion proteins of the human engineered antibody domain m36 with human soluble CD4 are potent inhibitors of diverse HIV-1 isolates. Antiviral Res  88, 107-15.   https://doi.org/10.1016/j.antiviral.2010.08.004|2. Chen W, Zhu Z, Feng Y, Dimitrov DS (2010). A large human domain antibody library combining heavy and light chain CDR3 diversity. Mol Immunol  47, 912-21.   https://doi.org/10.1016/j.molimm.2009.09.039|3. Dimitrov DS (2010). Therapeutic antibodies, vaccines and antibodyomes. MAbs  2, 347-56.   https://doi.org/10.4161/mabs.2.3.11779|4. Zhang MY, Borges AR, Ptak RG, Wang Y, Dimitrov AS, Alam SM, Wieczorek L, Bouma P, Fouts T, Jiang S, Polonis VR, Haynes BF, Quinnan GV, Montefiori DC, Dimitrov DS (2010). Potent and broad neutralizing activity of a single chain antibody fragment against cell-free and cell-associated HIV-1. MAbs  2, 266-74.   https://doi.org/10.4161/mabs.2.3.11416",https://intramural.nih.gov/search/searchview.taf?ipid=68682
482,BC011156-03,"October 01, 2010 -  September 30, 2011",Antibody therapeutics against biodefense-related diseases,Dimiter Stanchev Dimitrov; PhD,NULL,"Membrane Structure and Function Section, NCI",Weizao  Chen|Yang  Feng|John  Owens|Vinita  Puri|Tianlei  Ying|Zhongyu  Zhu,Kei  Amemiya; PhD (NINDS)|Christopher  Broder (Uniformed Services University of the Health Sciences),NULL,NULL,"1. Xiao X, Zhu Z, Dankmeyer JL, Wormald MM, Fast RL, Worsham PL, Cote CK, Amemiya K, Dimitrov DS (2010). Human anti-plague monoclonal antibodies protect mice from Yersinia pestis in a bubonic plague model. PLoS One  5, e13047.   https://doi.org/10.1371/journal.pone.0013047",https://intramural.nih.gov/search/searchview.taf?ipid=68681
483,BC011158-03,"October 01, 2010 -  September 30, 2011",Study the role(s) of p53 in embryonic stem cells,Jing  Huang|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Yunlong  He|Mangmang  Li,NULL,Jianxin  Shi (Biostatistics Branch),NULL,"1. Lee KH, Li M, Michalowski AM, Zhang X, Liao H, Chen L, Xu Y, Wu X, Huang J (2010). A genomewide study identifies the Wnt signaling pathway as a major target of p53 in murine embryonic stem cells. Proc Natl Acad Sci U S A  107, 69-74.   https://doi.org/10.1073/pnas.0909734107|2. Li M, Huang J (2010). A new puzzling role of p53 in mouse embryonic stem cells. Cell Cycle  9, 1669-70.   https://doi.org/10.4161/cc.9.9.11596|3. Zhang X, Huang J (2010). Integrative genome-wide approaches in embryonic stem cell research. Integr Biol (Camb)  2, 510-6.   https://doi.org/10.1039/c0ib00068j",https://intramural.nih.gov/search/searchview.taf?ipid=68696
484,BC011159-03,"October 01, 2010 -  September 30, 2011",Identification of Biomarkers for Response to Chemoprevention of Colon Cancer,Nancy H Colburn; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Prevention, NCI",Glenn  Hegamyer|Shakir M Saud|Matthew R Young; PhD,Gerd  Bobe|Robert  Chapkin (Texas A&M)|Terry  Hartman (Penn State Univ),Amanda  Cross (Nutritional Epidemiology Branch)|John A Milner (Nutritional Science Research Group),NULL,"1. Bobe G, Albert PS, Sansbury LB, Lanza E, Schatzkin A, Colburn NH, Cross AJ (2010). Interleukin-6 as a potential indicator for prevention of high-risk adenoma recurrence by dietary flavonols in the polyp prevention trial. Cancer Prev Res (Phila)  3, 764-75.   https://doi.org/10.1158/1940-6207.CAPR-09-0161|2. Bobe G, Murphy G, Albert PS, Sansbury LB, Lanza E, Schatzkin A, Colburn NH, Cross AJ (2010). Serum cytokine concentrations, flavonol intake and colorectal adenoma recurrence in the Polyp Prevention Trial. Br J Cancer  103, 1453-61.   https://doi.org/10.1038/sj.bjc.6605915|3. Bobe G, Murphy G, Albert PS, Sansbury LB, Young MR, Lanza E, Schatzkin A, Colburn NH, Cross AJ (2011). Do interleukin polymorphisms play a role in the prevention of colorectal adenoma recurrence by dietary flavonols? Eur J Cancer Prev  20, 86-95.   https://doi.org/10.1097/CEJ.0b013e3283429e45|4. Hartman TJ, Albert PS, Zhang Z, Bagshaw D, Kris-Etherton PM, Ulbrecht J, Miller CK, Bobe G, Colburn NH, Lanza E (2010). Consumption of a legume-enriched, low-glycemic index diet is associated with biomarkers of insulin resistance and inflammation among men at risk for colorectal cancer. J Nutr  140, 60-7.   https://doi.org/10.3945/jn.109.114249|5. Zhang Z, Lanza E, Kris-Etherton PM, Colburn NH, Bagshaw D, Rovine MJ, Ulbrecht JS, Bobe G, Chapkin RS, Hartman TJ (2010). A high legume low glycemic index diet improves serum lipid profiles in men. Lipids  45, 765-75.   https://doi.org/10.1007/s11745-010-3463-7|6. Zhang Z, Lanza E, Ross AC, Albert PS, Colburn NH, Rovine MJ, Bagshaw D, Ulbrecht JS, Hartman TJ (2011). A high-legume low-glycemic index diet reduces fasting plasma leptin in middle-aged insulin-resistant and -sensitive men. Eur J Clin Nutr  65, 415-8.   https://doi.org/10.1038/ejcn.2010.273",https://intramural.nih.gov/search/searchview.taf?ipid=68677
485,BC011160-03,"October 01, 2010 -  September 30, 2011",Mechanisms in development & regulation of metastasis in lung cancer,King F Kwong,NULL,"Surgery Branch, NCI",Keytam Salem Awad; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68714
486,BC011162-03,"October 01, 2010 -  September 30, 2011",Molecular Profiling of Pancreatic Cancer,Syed Perwez  Hussain|IRP Faculty Profile,NULL,"Molecular Genetics and Carcinogenesis Section, NCI","Naotake  Funamizu; MD, PhD|Peijun  He|Curtis Ray Lacy|Geng  Zhang",Jochen  Gaedcke|Anirban  Maitra (Johns Hopkins University School of Medicine),Karl Thomas Ried; MD (Cancer Genetics Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68698
487,BC011163-03,"October 01, 2010 -  September 30, 2011",Host immature myeloid cells in tumor suppressor or promoter roles of TGFbeta,Li  Yang; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Bhagelu Ram  Achyut|Sudheer Kumar Gara|Yanli  Pang|Hangyi  Yan,NULL,Giorgio  Trinchieri (Cancer Inflammation Program)|Robert  Wiltrout; PhD (Laboratory of Experimental Immunology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68741
488,BC011165-03,"October 01, 2010 -  September 30, 2011",Role of immature myeloid cells in premetastatic lung,Li  Yang; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Bhagelu Ram  Achyut|Sudheer Kumar Gara|Hangyi  Yan,NULL,Pengnian Charles Lin; PhD (Mouse Cancer Genetics Program),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68742
489,BC011167-03,"October 01, 2010 -  September 30, 2011",A novel preclinical model of spontaneous metastasis,Glenn  Merlino; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Chi-Ping  Day|Jennifer D Rieker,NULL,"Melinda  Hollingshead (Biological Testing Branch)|Dominic  Esposito; PhD (Office Of The Director)|Phillip A Dennis; MD, PhD (Medical Oncology Branch)|Nicholas Phillip Restifo; MD (Surgery Branch)|Terry Anne Van Dyke (Mouse Cancer Genetics Program)",NULL,"1. Mendoza A, Hong SH, Osborne T, Khan MA, Campbell K, Briggs J, Eleswarapu A, Buquo L, Ren L, Hewitt SM, Dakir el H, Dakir el-H, Garfield S, Walker R, Merlino G, Green JE, Hunter KW, Wakefield LM, Khanna C (2010). Modeling metastasis biology and therapy in real time in the mouse lung. J Clin Invest  120, 2979-88.   https://doi.org/10.1172/JCI40252",https://intramural.nih.gov/search/searchview.taf?ipid=68719
490,BC011168-03,"October 01, 2010 -  September 30, 2011",Physiological and pathological functions of E3 ubiquitin ligases Smurfs,Ying  Zhang|IRP Faculty Profile,NULL,"Laboratory of Cellular and Molecular Biology, NCI",Michael  Blank|Mary E Heller|Yi  Tang,"Beth  Levine; MD (UT Southwestern Medical Center)|Lianping  Xing (Department of Pathology, University of Rochester)",Miriam R Anver (Office Of The Director),Chuxia  Deng; PhD (NIDDK),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68746
491,BC011169-03,"October 01, 2010 -  September 30, 2011",Inflammation and Prostate Carcinogenesis,Arthur A Hurwitz,NULL,"Laboratory of Molecular Immunoregulation, NCI",Bonnie Brown Douglas|Katherine  Stagliano,NULL,William  Farrar (Laboratory of Cancer Prevention)|Lionel  Feigenbaum (Office Of The Director)|Stefan  Ambs (Laboratory of Human Carcinogenesis),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68697
492,BC011170-03,"October 01, 2010 -  September 30, 2011",Comparative Functional Genomics,"Snorri S. Thorgeirsson; MD, PhD",NULL,"Laboratory of Experimental Carcinogenesis, NCI","Jesper B Andersen; PhD|Valentina  Factor|Phuongnga  Ton|Daekwan  Seo; PhD, MS, BA|Tanya N Hoang","Hanne  Bisgaard (Medical Biochemistry and Genetics, University of Copenhagen)|Diego F Calvisi (NCI)",Glenn  Merlino; PhD (Laboratory of Cancer Biology and Genetics)|Robert  Wiltrout; PhD (Laboratory of Experimental Immunology)|Douglas  Lowy; MD (Office Of The Director)|Nicolae C Popescu; PhD (Molecular Cytogenetics Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68734
493,BC011173-03,"October 01, 2010 -  September 30, 2011",Genomic Classification of Human Liver Cancer,"Snorri S. Thorgeirsson; MD, PhD",NULL,"Laboratory of Experimental Carcinogenesis, NCI","Jesper B Andersen; PhD|Marian E Durkin|Valentina  Factor|Matthew C Gillen|Jens Uwe Marquardt|Daekwan  Seo; PhD, MS, BA|Show all 8","Peter  Galle|Ju-Seog  Lee; PhD (NCI)|Tania  Roskams (Dpt. Pathology, K.U.Leuven University)",Xin Wei Wang; PhD (Molecular Genetics and Carcinogenesis Section)|Curtis  Harris; MD (Laboratory of Human Carcinogenesis)|Laufey Thora Amundadottir (Laboratory Translational Genomics),NULL,"1. Roessler S, Jia HL, Budhu A, Forgues M, Ye QH, Lee JS, Thorgeirsson SS, Sun Z, Tang ZY, Qin LX, Wang XW (2010). A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients. Cancer Res  70, 10202-12.   https://doi.org/10.1158/0008-5472.CAN-10-2607|2. Thorgeirsson SS (2011). The almighty MYC: orchestrating the micro-RNA universe to generate aggressive liver cancer. J Hepatol  55, 486-7.   https://doi.org/10.1016/j.jhep.2011.01.042|3. Woo HG, Lee JH, Yoon JH, Kim CY, Lee HS, Jang JJ, Yi NJ, Suh KS, Lee KU, Park ES, Thorgeirsson SS, Kim YJ (2010). Identification of a cholangiocarcinoma-like gene expression trait in hepatocellular carcinoma. Cancer Res  70, 3034-41.   https://doi.org/10.1158/0008-5472.CAN-09-2823",https://intramural.nih.gov/search/searchview.taf?ipid=68732
494,BC011175-03,"October 01, 2010 -  September 30, 2011",Validation of Therapeutic Target Genes in Human Liver Cancer,"Snorri S. Thorgeirsson; MD, PhD",NULL,"Laboratory of Experimental Carcinogenesis, NCI","Marian E Durkin|Valentina  Factor|Yun Han Lee|Phuongnga  Ton|Daekwan  Seo; PhD, MS, BA|Tanya N Hoang",NULL,"Udai S Kammula (Surgery Branch)|Steven Aaron Rosenberg; MD, PhD (Surgery Branch)|Itzhak  Avital (Surgery Branch)",NULL,"1. Lee YH, Andersen JB, Song HT, Judge AD, Seo D, Ishikawa T, Marquardt JU, Kitade M, Durkin ME, Raggi C, Woo HG, Conner EA, Avital I, Maclachlan I, Factor VM, Thorgeirsson SS (2010). Definition of ubiquitination modulator COP1 as a novel therapeutic target in human hepatocellular carcinoma. Cancer Res  70, 8264-9.   https://doi.org/10.1158/0008-5472.CAN-10-0749",https://intramural.nih.gov/search/searchview.taf?ipid=68733
495,BC011176-03,"October 01, 2010 -  September 30, 2011",Functions of KSHV microRNAs,Joseph M Ziegelbauer|IRP Faculty Profile,NULL,"HIV and AIDS Malignancy Branch, NCI",Thomas S Uldrick,NULL,NULL,NULL,"1. Abend JR, Uldrick T, Ziegelbauer JM (2010). Regulation of tumor necrosis factor-like weak inducer of apoptosis receptor protein (TWEAKR) expression by Kaposi's sarcoma-associated herpesvirus microRNA prevents TWEAK-induced apoptosis and inflammatory cytokine expression. J Virol  84, 12139-51.   https://doi.org/10.1128/JVI.00884-10",https://intramural.nih.gov/search/searchview.taf?ipid=68747
496,BC011177-03,"October 01, 2010 -  September 30, 2011",Botulinum Toxin for Painful Cutaneous Leiomyomas,Heidi H Kong|IRP Faculty Profile,NULL,"Dermatology Branch, NCI","Edward W Cowen|Effie Y Nomicos; BS, BSN",NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68713
497,BC011179-03,"October 01, 2010 -  September 30, 2011",Biomarkers of Human Esophageal Cancer,Curtis  Harris; MD|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI","Akagi  Ichiro; MD, PhD|Elise Dawn Bowman|Mohammed A. Khan; PhD|Aaron Joseph Schetter|Elisa A Spillare|Judith A Welsh|Show all 7",NULL,NULL,NULL,"1. Nguyen GH, Schetter AJ, Chou DB, Bowman ED, Zhao R, Hawkes JE, Mathé EA, Kumamoto K, Zhao Y, Budhu A, Hagiwara N, Wang XW, Miyashita M, Casson AG, Harris CC (2010). Inflammatory and microRNA gene expression as prognostic classifier of Barrett's-associated esophageal adenocarcinoma. Clin Cancer Res  16, 5824-34.   https://doi.org/10.1158/1078-0432.CCR-10-1110|2. Wang X, Tian X, Liu F, Zhao Y, Sun M, Chen D, Lu C, Wang Z, Shi X, Zhang Q, Zhang D, Shen Z, Li F, Harris CC, Cai H, Ke Y (2010). Detection of HPV DNA in esophageal cancer specimens from different regions and ethnic groups: a descriptive study. BMC Cancer  10, 19.   https://doi.org/10.1186/1471-2407-10-19",https://intramural.nih.gov/search/searchview.taf?ipid=68693
498,BC011181-03,"October 01, 2010 -  September 30, 2011",Functional Analysis of Variants Identified in Human Breast Cancer Susceptibility,Shyam K Sharan|IRP Faculty Profile,NULL,"Genetics of Cancer Susceptibility Section, NCI",Suhwan  Chang|Rajani Kant Chittela|Alok  Mishra|Susan L North|Stacey S Stauffer|Thirthagiri  Eswary,"Stephen  Byers (Georgetown University)|William  Foulkes (McGill University)|Debananda  Pati (Texas Children's Cancer Center, Baylor College of Medicine)",Andre A Nussenzweig; PhD (Experimental Immunology Branch)|Robert Andrew Byrd (Structural Biophysics Laboratory)|Mark H Greene; MD (Clinical Genetics Branch),Chuxia  Deng; PhD (NIDDK),"1. Chang S, Wang R, a K, Kim K, Martin B, Cavallone L, Haines D, Basik M, Mai P, Poggi E, Issacs C, Looi L, Mun K, Greene M, Byers S, Teo S, Deng C, Sharan S (2011) Tumor Suppressor BRCA1 epigenetically controls oncogenic miRNA-155. Nature Medicine, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=68727
499,BC011184-03,"October 01, 2010 -  September 30, 2011",Mechanism of Radiation Affects on microRNA,Nicole L Simone; MD,NULL,"Radiation Oncology Branch, NCI",NULL,NULL,James B Mitchell; PhD (Radiation Biology Branch),Benjamin  Soule (NIAID),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68729
500,BC011185-03,"October 01, 2010 -  September 30, 2011",Role of Inflammation in the Development and Progression of Pancreatic Cancer,Syed Perwez  Hussain|IRP Faculty Profile,NULL,"Molecular Genetics and Carcinogenesis Section, NCI","Naotake  Funamizu; MD, PhD|Peijun  He|Curtis Ray Lacy|Geng  Zhang",Carlo  Croce (Ohio State University Cancer Center)|Jochen  Gaedcke|Anirban  Maitra (Johns Hopkins University School of Medicine),David Anderson Wink (Radiation Biology Branch)|Karl Thomas Ried; MD (Cancer Genetics Branch)|Robert  Wiltrout; PhD (Laboratory of Experimental Immunology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68699
501,BC011186-03,"October 01, 2010 -  September 30, 2011",Animal model of Pancreatic Cancer,Syed Perwez  Hussain|IRP Faculty Profile,NULL,"Molecular Genetics and Carcinogenesis Section, NCI","Naotake  Funamizu; MD, PhD|Peijun  He|Geng  Zhang",NULL,Robert  Wiltrout; PhD (Laboratory of Experimental Immunology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68700
502,BC011187-03,"October 01, 2010 -  September 30, 2011",Sphingolipid Signaling in Mammals,"Jairaj K Acharya; MBBS, PhD|IRP Faculty Profile",NULL,"Laboratory of Cell and Developmental Signaling, NCI",Diwash  Acharya|Zachary Thomas Daar|Teresa  Kosakowska Cholo|Jing  Lin|Shelby Ashton Payne|Razi  Raziuddin|Show all 9,Usha  Acharya (University of Mass. Medical School)|joost  holthuis (University of Utrecht),Lino  Tessarollo (Neural Development Section)|Shyam K Sharan (Genetics of Cancer Susceptibility Section)|Sarangan  Ravichandran (Office Of The Director),NULL,"1. Masood MA, Yuan C, Acharya JK, Veenstra TD, Blonder J (2010). Quantitation of ceramide phosphorylethanolamines containing saturated and unsaturated sphingoid base cores. Anal Biochem  400, 259-69.   https://doi.org/10.1016/j.ab.2010.01.033|2. Yonamine I, Bamba T, Nirala NK, Jesmin N, Kosakowska-Cholody T, Nagashima K, Fukusaki E, Acharya JK, Acharya U (2011). Sphingosine kinases and their metabolites modulate endolysosomal trafficking in photoreceptors. J Cell Biol  192, 557-67.   https://doi.org/10.1083/jcb.201004098|3. Yuan C, Rao RP, Jesmin N, Bamba T, Nagashima K, Pascual A, Preat T, Fukusaki E, Acharya U, Acharya JK (2011). CDase is a pan-ceramidase in Drosophila. Mol Biol Cell  22, 33-43.   https://doi.org/10.1091/mbc.E10-05-0453",https://intramural.nih.gov/search/searchview.taf?ipid=68668
503,BC011188-03,"October 01, 2010 -  September 30, 2011",Diazeniumdiolates as Broad-Spectrum Anticancer Agents,Larry K Keefer; PhD,NULL,"Laboratory of Comparative Carcinogenesis, NCI",Zhao  Cao|Kenyatta Meticeo Cosby; MD|Laura  Fornwald|James Ming Phang; MD|Ryan John Holland; PhD|Joseph  Saavedra|Show all 7,"Khosrow  Kashfi (CUNY Med School)|Robert  Prud'homme (Princeton University)|Paul  Shami (Medical Oncology, U of Utah)|Ana  Tari (Department of Experimental Therapeutics, M.D. Anderson Cancer Center)|Astrid  Weyerbrock (UNIVERSITÃTSKLINIKUM FREIBURG)",Xinhua  Ji; PhD (Biomolecular Structure Section)|Jonathan  Weiss (Laboratory of Experimental Immunology),NULL,"1. Keefer L (2010) Broad-spectrum anti-cancer activity of Osup2sup-arylated diazeniumdiolates. Forum on Immunopathol. Dis. Ther 1:205-218.|2. Kiziltepe T, Anderson K, Kutok J, Jia L, Boucher K, Saavedra J, Keefer L, Shami P (2010) JS-K has potent anti-angiogenic activity iin vitroI and inhibits tumour angiogenesis in a multiple myeloma model iin vivoI. J. Pharm. Pharmacol 62:145-51.|3. Kumar V, Hong SY, Maciag AE, Saavedra JE, Adamson DH, Prud'homme RK, Keefer LK, Chakrapani H (2010). Stabilization of the nitric oxide (NO) prodrugs and anticancer leads, PABA/NO and Double JS-K, through incorporation into PEG-protected nanoparticles. Mol Pharm  7, 291-8.   https://doi.org/10.1021/mp900245h|4. Nath N, Chattopadhyay M, Pospishil L, Cieciura LZ, Goswami S, Kodela R, Saavedra JE, Keefer LK, Kashfi K (2010). JS-K, a nitric oxide-releasing prodrug, modulates ß-catenin/TCF signaling in leukemic Jurkat cells: evidence of an S-nitrosylated mechanism. Biochem Pharmacol  80, 1641-9.   https://doi.org/10.1016/j.bcp.2010.08.011|5. Weiss JM, Ridnour LA, Back T, Hussain SP, He P, Maciag AE, Keefer LK, Murphy WJ, Harris CC, Wink DA, Wiltrout RH (2010). Macrophage-dependent nitric oxide expression regulates tumor cell detachment and metastasis after IL-2/anti-CD40 immunotherapy. J Exp Med  207, 2455-67.   https://doi.org/10.1084/jem.20100670",https://intramural.nih.gov/search/searchview.taf?ipid=68708
504,BC011189-03,"October 01, 2010 -  September 30, 2011",Molecular Pathogenic Mechanism of Rhabdomyosarcoma,Liang  Cao,"Paul S Meltzer; MD, PhD","Cancer Genetics Branch, NCI",Yunkai  Yu|Zhigang  Kang,NULL,Lee Jay Helman; MD (Pediatric Oncology Branch),NULL,"1. Cao L, Yu Y, Bilke S, Walker RL, Mayeenuddin LH, Azorsa DO, Yang F, Pineda M, Helman LJ, Meltzer PS (2010). Genome-wide identification of PAX3-FKHR binding sites in rhabdomyosarcoma reveals candidate target genes important for development and cancer. Cancer Res  70, 6497-508.   https://doi.org/10.1158/0008-5472.CAN-10-0582",https://intramural.nih.gov/search/searchview.taf?ipid=68674
505,BC011190-03,"October 01, 2010 -  September 30, 2011",CHemical Biology of Nitroxyl (HNO),David Anderson Wink|IRP Faculty Profile,NULL,"Radiation Biology Branch, NCI",Yuk Sing Robert Cheng|Wilmarie  Flores-santana|James B Mitchell; PhD|Murali  Krishna; PhD|Lisa Ann Ridnour|Christopher H Switzer,"Jon  Fukuto (UCLA)|Bruce  King (Department of Chemistry, Wake Forest University)|Nazerano  Paolocci (Department of Cardiology, Johns Hopkins University Medical School)",Larry K Keefer; PhD (Laboratory of Comparative Carcinogenesis),NULL,"1. Andrei D, Salmon DJ, Donzelli S, Wahab A, Klose JR, Citro ML, Saavedra JE, Wink DA, Miranda KM, Keefer LK (2010). Dual mechanisms of HNO generation by a nitroxyl prodrug of the diazeniumdiolate (NONOate) class. J Am Chem Soc  132, 16526-32.   https://doi.org/10.1021/ja106552p",https://intramural.nih.gov/search/searchview.taf?ipid=68740
506,BC011191-03,"October 01, 2010 -  September 30, 2011",Preclinical Mouse Model of Thyroid Carcinogenesis,Sheueyann  Cheng; PhD|IRP Faculty Profile,NULL,"Gene Regulation Section, NCI",Laura  Fozzatti|Dong Wook  Kim; PhD|Won Gu  Kim|Changxue  Lu|Jeong-Won  Park|Li  Zhao|Show all 7,"Frances  Carr (University of Vermont College of Medicine)|Young  Jo (Chungnam national University Hospital)|THOMAS  KLONISCH (University of Manitoba)|Matthew D Ringel; MD (Lab. of Molec. Endocrinol., Washington Hospital Center)|Mark  Willingham (Wake Forest University School of Medicine)|GZ  Zhu (Marshall University)",Electron  Kebebew; MD (Surgery Branch)|Kathleen  Kelly; PhD (Laboratory Of Genitourinary Cancer Pathogenesis),NULL,"1. Guigon CJ, Fozzatti L, Lu C, Willingham MC, Cheng SY (2010). Inhibition of mTORC1 signaling reduces tumor growth but does not prevent cancer progression in a mouse model of thyroid cancer. Carcinogenesis  31, 1284-91.   https://doi.org/10.1093/carcin/bgq059|2. Guigon CJ, Kim DW, Zhu X, Zhao L, Cheng SY (2010). Tumor suppressor action of liganded thyroid hormone receptor beta by direct repression of beta-catenin gene expression. Endocrinology  151, 5528-36.   https://doi.org/10.1210/en.2010-0475|3. Huang Y, Guigon CJ, Fan J, Cheng SY, Zhu GZ (2010). Pituitary homeobox 2 (PITX2) promotes thyroid  carcinogenesis by activation of cyclin D2. Cell Cycle  9, 1333-41.   https://doi.org/10.4161/cc.9.7.11126|4. Lu C, Zhao L, Ying H, Willingham MC, Cheng SY (2010). Growth activation alone is not sufficient to cause metastatic thyroid cancer in a mouse model of follicular thyroid carcinoma. Endocrinology  151, 1929-39.   https://doi.org/10.1210/en.2009-1017|5. Zhu XG, Zhao L, Willingham MC, Cheng SY (2010). Thyroid hormone receptors are tumor suppressors in a mouse model of metastatic follicular thyroid carcinoma. Oncogene  29, 1909-19.   https://doi.org/10.1038/onc.2009.476",https://intramural.nih.gov/search/searchview.taf?ipid=68676
507,BC011192-03,"October 01, 2010 -  September 30, 2011",The Mechanism of Thymic Lymphomagenesis in Genetically Engineered Mouse Model,Terry Anne Van Dyke,NULL,"Mouse Cancer Genetics Program, NCI",Linda S Cleveland|Debra J Gilbert|Xiuyun  Lu|Theresa N O'Sullivan|Yurong  Song; PhD|Teresa L Sullivan|Show all 8,NULL,Jonathan  Keller; PhD (Laboratory of Cancer Prevention),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68739
508,BC011194-03,"October 01, 2010 -  September 30, 2011",Modeling the MET Oncogene in Osteosarcoma,Su-Young  Kim,NULL,"Pediatric Oncology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68710
509,BC011195-03,"October 01, 2010 -  September 30, 2011",Sequencing the Osteosarcoma Kinome,Su-Young  Kim,NULL,"Pediatric Oncology Branch, NCI",NULL,NULL,"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68711
510,BC011196-03,"October 01, 2010 -  September 30, 2011",The NIH Pediatric and wildtype GIST Clinic,Su-Young  Kim,NULL,"Pediatric Oncology Branch, NCI",Carly Jean Smith,NULL,NULL,"Constantine Argyrios Stratakis; MD, DSc (NICHD)","1. Janeway KA, Kim SY, Lodish M, Nosé V, Rustin P, Gaal J, Dahia PL, Liegl B, Ball ER, Raygada M, Lai AH, Kelly L, Hornick JL, NIH Pediatric and Wild-Type GIST Clinic, O'Sullivan M, de Krijger RR, Dinjens WN, Demetri GD, Antonescu CR, Fletcher JA, Helman L, Stratakis CA (2011). Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations. Proc Natl Acad Sci U S A  108, 314-8.   https://doi.org/10.1073/pnas.1009199108|2. Kim SY, Janeway K, Pappo A (2010). Pediatric and wild-type gastrointestinal stromal tumor: new therapeutic approaches. Curr Opin Oncol  22, 347-50.   https://doi.org/10.1097/CCO.0b013e32833aaae7",https://intramural.nih.gov/search/searchview.taf?ipid=68712
511,BC011197-03,"October 01, 2010 -  September 30, 2011",Regulation and Function of WIP1 Phosphatase and its Role in Tumor Cells,Ettore  Appella; MD|IRP Faculty Profile,NULL,"Chemical Immunology Section, NCI",Hidetsugu  Fujigaki|Ryo  Hayashi|Lisa Marie Jenkins|Sharlyn  Mazur; PhD|Michael Zeev Stern|Kan  Tanoue,NULL,Stewart  Durell (Laboratory of Cell Biology),Daniel  Appella; PhD (NIDDK),"1. Hayashi R, Tanoue K, Durell SR, Chatterjee DK, Jenkins LM, Appella DH, Appella E (2011). Optimization of a cyclic peptide inhibitor of Ser/Thr phosphatase PPM1D (Wip1). Biochemistry  50, 4537-49.   https://doi.org/10.1021/bi101949t|2. Oh KS, Bustin M, Mazur SJ, Appella E, Kraemer KH (2011). UV-induced histone H2AX phosphorylation and DNA damage related proteins accumulate and persist in nucleotide excision repair-deficient XP-B cells. DNA Repair (Amst)  10, 5-15.   https://doi.org/10.1016/j.dnarep.2010.09.004",https://intramural.nih.gov/search/searchview.taf?ipid=68669
512,BC011199-03,"October 01, 2010 -  September 30, 2011",Embryonic Transcription Factor Function in Human Colorectal Cancer Stem Cells,John M Jessup,NULL,"Diagnostics Evaluation Branch, NCI",Jingyu  Zhang,NULL,"Snorri S. Thorgeirsson; MD, PhD (Laboratory of Experimental Carcinogenesis)|Gordon Lee Hager; PhD (Laboratory of Receptor Biology and Gene Expression)|Robert  Kinders (Toxicology and Pharmacology Branch)|Timothy D Veenstra (Office Of The Director)",NULL,"1. Jessup JM, Zhang JM (submitted in 2010) Pharmaceutical Composition Comprising Nanog Shrna, And Method Of Using Nanog Shrna To Treat Cancer. Patent issued: 9,163,236 (US in 2016). Patent pending: PCT/US2011/063451 (PC application).",https://intramural.nih.gov/search/searchview.taf?ipid=68702
513,BC011200-03,"October 01, 2010 -  September 30, 2011",Shape change and Nitric Oxide (NO) Modulation of Core Pluripotent TF Expression,John M Jessup,NULL,"Diagnostics Evaluation Branch, NCI",Jingyu  Zhang,NULL,"Snorri S. Thorgeirsson; MD, PhD (Laboratory of Experimental Carcinogenesis)|Gordon Lee Hager; PhD (Laboratory of Receptor Biology and Gene Expression)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68703
514,BC011202-03,"October 01, 2010 -  September 30, 2011",Mechanism of the initial steps in transcription-coupled DNA repair (TCR),Mikhail V Kashlev|IRP Faculty Profile,NULL,"Molecular Mechanisms of Transcription Section, NCI",Lucyna E Lubkowska|Celine Marguerite Paulette Walmacq,Patrick  Cramer (LM University)|Michelle  Wang (Cornell University),NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68707
515,BC011203-03,"October 01, 2010 -  September 30, 2011",Proteolysis and Regulation of Bacterial Cell Growth Control,Susan  Gottesman; PhD|IRP Faculty Profile,NULL,"Biochemical Genetics Section, NCI",Aurelia  Battesti|Nadim  Majdalani|David G Packer|Song  Tong,NULL,Sue H Wickner; PhD (DNA Molecular Biology Section)|Yan Ning H Zhou (Gene Regulation and Chromosome Biology Laboratory)|Xinhua  Ji; PhD (Biomolecular Structure Section)|Michael  Maurizi; PhD (Biochemistry of Proteins Section)|Yawen  Bai; PhD (Laboratory Of Biochemistry & Molecular Biology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68688
516,BC011204-03,"October 01, 2010 -  September 30, 2011",Preclinical development of AlaTIMP-2 as an cancer therapeutic,"William G Stetler-Stevenson; MD, PhD|IRP Faculty Profile",NULL,"Radiation Oncology Branch, NCI",Dimitra  Bourmpoulia; PhD|Frank  Cuttitta; PhD|Liliana  Guedez; PhD|Hui  Han|Sandra  Jensen-Taubman|Laurie Ann  Shuman Moss|Show all 7,NULL,"Maryalice  Stetler-Stevenson; MD, PhD (Laboratory of Pathology)|Peter L Choyke; MD (Molecular Imaging Program)",NULL,"1. Bourboulia D, Stetler-Stevenson WG (2010). Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesion. Semin Cancer Biol  20, 161-8.   https://doi.org/10.1016/j.semcancer.2010.05.002|2. Guedez L, Stetler-Stevenson WG (2010). The prognostic value of TIMP-1 in multiple myeloma. Leuk Res  34, 576-7.   https://doi.org/10.1016/j.leukres.2009.10.005|3. Lee SJ, Tsang PS, Diaz TM, Wei BY, Stetler-Stevenson WG (2010). TIMP-2 modulates VEGFR-2 phosphorylation and enhances phosphodiesterase activity in endothelial cells. Lab Invest  90, 374-82.   https://doi.org/10.1038/labinvest.2009.136",https://intramural.nih.gov/search/searchview.taf?ipid=68731
517,BC011205-03,"October 01, 2010 -  September 30, 2011",Population based studies,Ola Anders Landgren,NULL,"Medical Oncology Branch, NCI",Rene A Costello; MT|Mary Ann M Yancey|Adriana  Zingone; MD,Magnus  Bjorkholm (Karolinska)|Sigurdur  Kristinsson (Karolinska)|Robert  Kyle (Mayo Clinic)|Vincent  Rajkumar (Mayo Clinic),"Neil Edward Caporaso; MS, MD (Genetic Epidemiology Branch)|Martha S Linet; PhD (Radiation Epidemiology Branch)|Eric Andrew Engels; PhD (Infection & Immunoepidemiology Branch)",NULL,"1. Andersson TM, Lambert PC, Derolf AR, Kristinsson SY, Eloranta S, Landgren O, Björkholm M, Dickman PW (2010). Temporal trends in the proportion cured among adults diagnosed with acute myeloid leukaemia in Sweden 1973-2001, a population-based study. Br J Haematol  148, 918-24.   https://doi.org/10.1111/j.1365-2141.2009.08026.x|2. Kristinsson SY, Tang M, Pfeiffer RM, Björkholm M, Blimark C, Mellqvist UH, Wahlin A, Turesson I, Landgren O (2010). Monoclonal gammopathy of undetermined significance and risk of skeletal fractures: a population-based study. Blood  116, 2651-5.   https://doi.org/10.1182/blood-2010-04-282848|3. Landgren O, Pfeiffer RM, Kristinsson SY, Bjorkholm M (2010) Survival patterns in patients with Hodgkins lymphoma with a pre-existing hospital discharge diagnosis of autoimmune disease. J Clin Oncol 28:5081-7.|4. Landgren O, Rajkumar SV, Pfeiffer RM, Kyle RA, Katzmann JA, Dispenzieri A, Cai Q, Goldin LR, Caporaso NE, Fraumeni JF, Blot WJ, Signorello LB (2010). Obesity is associated with an increased risk of monoclonal gammopathy of undetermined significance among black and white women. Blood  116, 1056-9.   https://doi.org/10.1182/blood-2010-01-262394|5. Mailankody S, Pfeiffer RM, Kristinsson SY, Korde N, Bjorkholm M, Goldin LR, Turesson I, Landgren O (2011). Risk of acute myeloid leukemia and myelodysplastic syndromes after multiple myeloma and its precursor disease (MGUS). Blood  118, 4086-92.   https://doi.org/10.1182/blood-2011-05-355743|6. Waxman AJ, Mink PJ, Devesa SS, Anderson WF, Weiss BM, Kristinsson SY, McGlynn KA, Landgren O (2010). Racial disparities in incidence and outcome in multiple myeloma: a population-based study. Blood  116, 5501-6.   https://doi.org/10.1182/blood-2010-07-298760",https://intramural.nih.gov/search/searchview.taf?ipid=68715
518,BC011206-03,"October 01, 2010 -  September 30, 2011",Genome wide profiling of histone variants in colorectal cancer cells,Yamini Praful Dalal|IRP Faculty Profile,NULL,"Hormone Action and Oncogenesis Section, NCI",Song  Fu|Rajbir K Gill|Marcin Piotr Walkiewicz,NULL,Karl Thomas Ried; MD (Cancer Genetics Branch),Emilios K Dimitriadis; PhD (NIBIB),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68678
519,BC011207-03,"October 01, 2010 -  September 30, 2011",Analysis of centromere identity and structure in human cells,Yamini Praful Dalal|IRP Faculty Profile,NULL,"Hormone Action and Oncogenesis Section, NCI",Minh  Bui|Rajbir K Gill|Delphine Chantal Anne Marie Quenet; PhD,"Amander  Clark (University of California, LA)|Stephan  Diekmann (Leibniz Institute for Aging/Fritz Lippman Institute)",NULL,Emilios K Dimitriadis; PhD (NIBIB),"1. Ambartsumyan G, Gill RK, Perez SD, Conway D, Vincent J, Dalal Y, Clark AT (2010). Centromere protein A dynamics in human pluripotent stem cell self-renewal, differentiation and DNA damage. Hum Mol Genet  19, 3970-82.   https://doi.org/10.1093/hmg/ddq312|2. Dalal Y, Bui M (2010). Down the rabbit hole of centromere assembly and dynamics. Curr Opin Cell Biol  22, 392-402.   https://doi.org/10.1016/j.ceb.2010.02.005|3. Dimitriadis EK, Weber C, Gill RK, Diekmann S, Dalal Y (2010). Tetrameric organization of vertebrate centromeric nucleosomes. Proc Natl Acad Sci U S A  107, 20317-22.   https://doi.org/10.1073/pnas.1009563107",https://intramural.nih.gov/search/searchview.taf?ipid=68679
520,BC011208-03,"October 01, 2010 -  September 30, 2011",Roles of Chromatin-modifying Factors in Epigenetic Control of the Genome,Shivinder Singh Grewal|IRP Faculty Profile,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",Ozan  Aygun|Vanivilasini  Balachandran|Natalia  Komissarova; PhD|Emiko  Matsuda|Sameet Satish Mehta; PhD|Takeshi  Mizuguchi|Show all 8,NULL,Peter C Fitzgerald (Office of the Director),Jun  Zhu; PhD (NHLBI),"1. Aygün O, Grewal SI (2010). Assembly and functions of heterochromatin in the fission yeast genome. Cold Spring Harb Symp Quant Biol  75, 259-67.   https://doi.org/10.1101/sqb.2010.75.055|2. Iwasaki O, Tanaka A, Tanizawa H, Grewal SI, Noma K (2010). Centromeric localization of dispersed Pol III genes in fission yeast. Mol Biol Cell  21, 254-65.   https://doi.org/10.1091/mbc.e09-09-0790|3. Ni T, Tu K, Wang Z, Song S, Wu H, Xie B, Scott KC, Grewal SI, Gao Y, Zhu J (2010). The prevalence and regulation of antisense transcripts in Schizosaccharomyces pombe. PLoS One  5, e15271.   https://doi.org/10.1371/journal.pone.0015271|4. Reyes-Turcu FE, Zhang K, Zofall M, Chen E, Grewal SI (2011). Defects in RNA quality control factors reveal RNAi-independent nucleation of heterochromatin. Nat Struct Mol Biol  18, 1132-8.   https://doi.org/10.1038/nsmb.2122|5. Zhang K, Fischer T, Porter RL, Dhakshnamoorthy J, Zofall M, Zhou M, Veenstra T, Grewal SI (2011). Clr4/Suv39 and RNA quality control factors cooperate to trigger RNAi and suppress antisense RNA. Science  331, 1624-7.   https://doi.org/10.1126/science.1198712",https://intramural.nih.gov/search/searchview.taf?ipid=68691
521,BC011209-03,"October 01, 2010 -  September 30, 2011",Kinetochore Interaction with Centromere Chromatin in human cells,Yamini Praful Dalal|IRP Faculty Profile,NULL,"Hormone Action and Oncogenesis Section, NCI",Rajbir K Gill|Marcin Piotr Walkiewicz|Delphine Chantal Anne Marie Quenet; PhD|Minh  Bui|Song  Fu,"Amander  Clark (University of California, LA)|Stephan  Diekmann (Leibniz Institute for Aging/Fritz Lippman Institute)",NULL,Aleksandra Urszula Nita-Lazar; PhD (NIAID) |Emilios K Dimitriadis; PhD (NIBIB),"1. Dalal Y (2010) Alternative Nucleosomal states, in McGraw-Hill Science and Technology Research Updates 2010. McGraw-Hill Science and Technology (New York), pp. 11-12.|2. Ambartsumyan G, Gill RK, Perez SD, Conway D, Vincent J, Dalal Y, Clark AT (2010). Centromere protein A dynamics in human pluripotent stem cell self-renewal, differentiation and DNA damage. Hum Mol Genet  19, 3970-82.   https://doi.org/10.1093/hmg/ddq312|3. Dalal Y, Bui M (2010). Down the rabbit hole of centromere assembly and dynamics. Curr Opin Cell Biol  22, 392-402.   https://doi.org/10.1016/j.ceb.2010.02.005|4. Dimitriadis EK, Weber C, Gill RK, Diekmann S, Dalal Y (2010). Tetrameric organization of vertebrate centromeric nucleosomes. Proc Natl Acad Sci U S A  107, 20317-22.   https://doi.org/10.1073/pnas.1009563107",https://intramural.nih.gov/search/searchview.taf?ipid=68680
522,BC011210-03,"October 01, 2010 -  September 30, 2011",Magnetic Drug Delivery for Cancer,"Michael R Emmert-Buck; MD, PhD",NULL,"Laboratory of Pathology, NCI",Michael D Armani|Michael  Tangrea,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68684
523,BC011211-03,"October 01, 2010 -  September 30, 2011",Subcellular protein localization in B. subtilis,Kumaran S Ramamurthi|IRP Faculty Profile,NULL,"Laboratory of Molecular Biology, NCI",Jean-Philippe  Castaing|Sarah Elaine Ebmeier|Prahathees  Eswara Moorthy,"Joseph  Pogliano (University of California, San Diego)|Douglas  Weibel (University of Wisconsin-Madison)",NULL,Aravind L Iyer; PhD (NLM) |Hari  Shroff; PhD (NIBIB),"1. Huang KC, Ramamurthi KS (2010). Macromolecules that prefer their membranes curvy. Mol Microbiol  76, 822-32.   https://doi.org/10.1111/j.1365-2958.2010.07168.x|2. Ramamurthi KS (2010). Protein localization by recognition of membrane curvature. Curr Opin Microbiol  13, 753-7.   https://doi.org/10.1016/j.mib.2010.09.014|3. Ramamurthi KS (2010). Signal transduction: bacterial thermometer works by measuring membrane thickness. Curr Biol  20, R707-9.   https://doi.org/10.1016/j.cub.2010.07.010|4. Subramaniam AB, Lecuyer S, Ramamurthi KS, Losick R, Stone HA (2010). Particle/Fluid interface replication as a means of producing topographically patterned polydimethylsiloxane surfaces for deposition of lipid bilayers. Adv Mater  22, 2142-7.   https://doi.org/10.1002/adma.200903625",https://intramural.nih.gov/search/searchview.taf?ipid=68725
524,BC011212-03,"October 01, 2010 -  September 30, 2011",Functions of IKK&945; in Skin Homeostasis and Skin Tumorigenesis,Yinling  Hu|IRP Faculty Profile,NULL,"Laboratory of Experimental Immunology, NCI",Howard A Young; PhD|Robert  Wiltrout; PhD,NULL,"Ji Ming  Wang; MD, PhD (Laboratory of Molecular Immunoregulation)",NULL,"1. Xia X, Park E, Liu B, Willette-Brown J, Gong W, Wang J, Mitchell D, Fischer SM, Hu Y (2010). Reduction of IKKalpha expression promotes chronic ultraviolet B exposure-induced skin inflammation and carcinogenesis. Am J Pathol  176, 2500-8.   https://doi.org/10.2353/ajpath.2010.091041",https://intramural.nih.gov/search/searchview.taf?ipid=68695
525,BC011213-03,"October 01, 2010 -  September 30, 2011",Application of Gold Nanoparticles to Increase the Efficacy of Radiation Therapy,Jacek  Capala; PhD,NULL,"Radiation Oncology Branch, NCI",Simeon Kolawole Adesina|Alesia J Holly|Rafal Jerzy Zielinski,NULL,Robert  Blumenthal; PhD (Center for Cancer Research Nanobiology Program),"Gary Leonard Griffiths; BSc, PhD (NHLBI)","1. Smith B, Lyakhov I, Loomis K, Needle D, Baxa U, Yavlovich A, Capala J, Blumenthal R, Puri A (2011). Hyperthermia-triggered intracellular delivery of anticancer agent to HER2(+) cells by HER2-specific affibody (ZHER2-GS-Cys)-conjugated thermosensitive liposomes (HER2(+) affisomes). J Control Release  153, 187-94.   https://doi.org/10.1016/j.jconrel.2011.04.005",https://intramural.nih.gov/search/searchview.taf?ipid=68675
526,BC011214-03,"October 01, 2010 -  September 30, 2011",Post-Transcriptional Regulation of Interleukin-7 Receptor Expression,Jung-Hyun  Park|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Changwan  Hong|Grace Yoonhee Kim|Davinna Lachelle Ligons|Megan A Luckey|Saho  Maruyama; PhD,Thomas  Hunig (University of Wuerzburg)|Scott  Walsh (University of Maryland),NULL,Marta Liliana Catalfamo; PhD (NIAID) |Bibiana  Bielekova; MD (NINDS),"1. Park JH, Adoro S, Guinter T, Erman B, Alag AS, Catalfamo M, Kimura MY, Cui Y, Lucas PJ, Gress RE, Kubo M, Hennighausen L, Feigenbaum L, Singer A (2010). Signaling by intrathymic cytokines, not T cell antigen receptors, specifies CD8 lineage choice and promotes the differentiation of cytotoxic-lineage T cells. Nat Immunol  11, 257-64.   https://doi.org/10.1038/ni.1840",https://intramural.nih.gov/search/searchview.taf?ipid=68723
527,BC011215-03,"October 01, 2010 -  September 30, 2011",Immune Regulatory Roles of Suppressor Of Cytokine Signaling (SOCS) Molecules,Jung-Hyun  Park|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Changwan  Hong|Alfred  Singer; MD|Davinna Lachelle Ligons|Megan A Luckey,NULL,James Stephen Shaw; PhD (Human Immunology Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68724
528,BC011216-03,"October 01, 2010 -  September 30, 2011",CHEMOTACTIC SIGNALS REGULATING HUMAN NEUTROPHIL AND BREAST METASTATIC MIGRATION,Carole A Parent; PhD,NULL,"Laboratory of Cellular and Molecular Biology, NCI",Philippe  Afonso|Satarupa  Das|Paul W Kriebel|Lunhua  Liu|Wolfgang  Losert; PhD|Christina  Stuelten|Show all 9,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68722
529,BC011217-03,"October 01, 2010 -  September 30, 2011",Preclinical Characterization of Drugs in Mouse Model of Lung Cancer,Terry Anne Van Dyke,NULL,"Mouse Cancer Genetics Program, NCI",Simone  Difilippantonio|Serguei V Kozlov|Zoe W Ohler,"David  Gandara (University of Califormia at Davis)|Neal  Goodwin (Jackson Laboratory, West)|Colin  Hill (GNS Healthcare, Inc.)|Kwok-Kin  Wong (Harvard University)",Giuseppe  Giaccone; MD (Medical Oncology Branch),NULL,"1. Walrath JC, Hawes JJ, Van Dyke T, Reilly KM (2010). Genetically engineered mouse models in cancer research. Adv Cancer Res  106, 113-64.   https://doi.org/10.1016/S0065-230X(10)06004-5",https://intramural.nih.gov/search/searchview.taf?ipid=68737
530,BC011219-03,"October 01, 2010 -  September 30, 2011",Combination Gene Therapy and Th1Th2 Therapy,Daniel H Fowler,NULL,"Experimental Transplantation and Immunology Branch, NCI",Shoba M Amarnath|Tania Cristina Felizardo|J  Foley|Miriam E Mossoba,"Carl  June (University of Penn)|Bruce  Levine (Abramson Family Cancer Research Center, University of Pennsylvania)|Jeffrey A. Medin; PhD (University of Toronto)",NULL,David F Stroncek; MD (CC),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68685
531,BC011220-03,"October 01, 2010 -  September 30, 2011",Understanding T Cell Rapamycin Resistance,Daniel H Fowler,NULL,"Experimental Transplantation and Immunology Branch, NCI",Shoba M Amarnath|Tania Cristina Felizardo|J  Foley|Miriam E Mossoba,"Carl  June (University of Penn)|Bruce  Levine (Abramson Family Cancer Research Center, University of Pennsylvania)",NULL,David F Stroncek; MD (CC),"1. Amarnath S, Chen H, Foley JE, Costanzo CM, Sennesh JD, Solomon MA, Fowler DH (2011). Host-based Th2 cell therapy for prolongation of cardiac allograft viability. PLoS One  6, e18885.   https://doi.org/10.1371/journal.pone.0018885|2. Amarnath S, Costanzo CM, Mariotti J, Ullman JL, Telford WG, Kapoor V, Riley JL, Levine BL, June CH, Fong T, Warner NL, Fowler DH (2010). Regulatory T cells and human myeloid dendritic cells promote tolerance via programmed death ligand-1. PLoS Biol  8, e1000302.   https://doi.org/10.1371/journal.pbio.1000302|3. Mossoba ME, Onda M, Taylor J, Massey PR, Treadwell S, Sharon E, Hassan R, Pastan I, Fowler DH (2011). Pentostatin plus cyclophosphamide safely and effectively prevents immunotoxin immunogenicity in murine hosts. Clin Cancer Res  17, 3697-705.   https://doi.org/10.1158/1078-0432.CCR-11-0493",https://intramural.nih.gov/search/searchview.taf?ipid=68686
532,BC011222-03,"October 01, 2010 -  September 30, 2011",CNS sirtuins in radiation-induced vascular permeability and neurodegeneration,Deedee Kay Smart|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Alexandra  Lin|Sadhanshu  Shukla; PhD,NULL,Jane Beth Trepel (Medical Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68730
533,BC011223-03,"October 01, 2010 -  September 30, 2011",Function of O-GlcNAc-modified Human RNA Polymerase II in Transcription,Brian  Lewis,NULL,"Lymphoid Malignancies Branch, NCI","Jason Alexander Piotrowski; BA, MS",NULL,NULL,John Allan Hanover; PhD (NIDDK),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68718
534,BC011224-03,"October 01, 2010 -  September 30, 2011",Wnt-Dependent Neurite Outgrowth in Ewing Tumor Cells,"Jeffrey S Rubin; MD, PhD",NULL,"Laboratory of Cellular and Molecular Biology, NCI",Bolormaa  Baljinnyam|Yoshimi Endo Greer,NULL,Christopher John Westlake; PhD (Laboratory of Cell and Developmental Signaling),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68726
535,BC011225-03,"October 01, 2010 -  September 30, 2011",Identification of Molecular Factors Associated with Response to Interleukin-2,"James Chung-Yin Yang; MD, PhD|IRP Faculty Profile",NULL,"Surgery Branch, NCI",Qiong J Wang,NULL,NULL,Francesco M. Marincola; MD (CC) |Ena  Wang (CC) |Marianna  Sabatino (CC),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68744
536,BC011226-03,"October 01, 2010 -  September 30, 2011",Optimization of tissue depletion for LCM-MS coupling,Donald J Johann,NULL,"Medical Oncology Branch, NCI",Sumana  Mukherjee,NULL,"Michael R Emmert-Buck; MD, PhD (Laboratory of Pathology)",NULL,"1. Johann D, Mukherjee S, Prieto D, Veenstra T, Blonder J (2010) Profiling solid tumor heterogeneity by LCM and biological MS of fresh frozen tissue sections. Methods Mol Biol, in press.|2. Johann DJ, Wei BR, Prieto DA, Chan KC, Ye X, Valera VA, Simpson RM, Rudnick PA, Xiao Z, Issaq HJ, Linehan WM, Stein SE, Veenstra TD, Blonder J (2010). Combined blood/tissue analysis for cancer biomarker discovery: application to renal cell carcinoma. Anal Chem  82, 1584-8.   https://doi.org/10.1021/ac902204k|3. Ye X, Luke B, Johann D, Chan C, Prieto D, Ono A, Veenstra T, Blonder J (2010) Post-digestion 18O exchangelabeling for quantitative shotgun proteomics of membrane proteins. Methods Mol Biol, in press.|4. Ye X, Luke BT, Johann DJ, Ono A, Prieto DA, Chan KC, Issaq HJ, Veenstra TD, Blonder J (2010). Optimized method for computing (18)O/(16)O ratios of differentially stable-isotope labeled peptides in the context of postdigestion (18)O exchange/labeling. Anal Chem  82, 5878-86.   https://doi.org/10.1021/ac101284c",https://intramural.nih.gov/search/searchview.taf?ipid=68705
537,BC011227-03,"October 01, 2010 -  September 30, 2011",Estrogen metabolite profiling of thin tissue sections,Donald J Johann,NULL,"Medical Oncology Branch, NCI",NULL,NULL,"Michael R Emmert-Buck; MD, PhD (Laboratory of Pathology)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68706
538,BC011228-03,"October 01, 2010 -  September 30, 2011",Tumor-Reactive Immune Cells Generated from Drosphila Antigen Presenting Cells,"James Chung-Yin Yang; MD, PhD|IRP Faculty Profile",NULL,"Surgery Branch, NCI",NULL,Mann-Cheong  Fung (Johnson and Johnson)|Didier  Leturcq (Johnson and Johnson),NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68743
539,BC011229-03,"October 01, 2010 -  September 30, 2011",Mechanisms of Tumor Cell Dormancy and Tumor Recurrence,Jeffrey E Green; MD,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Lara Helmi el Touny|Aleksandra M Michalowska|Ziyao M Liu,Dalit  Barkan (Haifa University)|Pepper  Schedin (University of Colorado),"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",NULL,"1. Barkan D, El Touny LH, Michalowski AM, Smith JA, Chu I, Davis AS, Webster JD, Hoover S, Simpson RM, Gauldie J, Green JE (2010). Metastatic growth from dormant cells induced by a col-I-enriched fibrotic environment. Cancer Res  70, 5706-16.   https://doi.org/10.1158/0008-5472.CAN-09-2356|2. Barkan D, Green JE, Chambers AF (2010). Extracellular matrix: a gatekeeper in the transition from dormancy to metastatic growth. Eur J Cancer  46, 1181-8.   https://doi.org/10.1016/j.ejca.2010.02.027|3. Mendoza A, Hong SH, Osborne T, Khan MA, Campbell K, Briggs J, Eleswarapu A, Buquo L, Ren L, Hewitt SM, Dakir el H, Dakir el-H, Garfield S, Walker R, Merlino G, Green JE, Hunter KW, Wakefield LM, Khanna C (2010). Modeling metastasis biology and therapy in real time in the mouse lung. J Clin Invest  120, 2979-88.   https://doi.org/10.1172/JCI40252|4. O'Brien J, Hansen K, Barkan D, Green J, Schedin P (2011) NSAIDs target pro-tumorigenic extracellular matrix of the postpartum mammary gland. International Journal of Developmental Biology, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=68689
540,BC011231-03,"October 01, 2010 -  September 30, 2011",Clinical Trial of AZD0530 in Recurrent Osteosarcoma,Su-Young  Kim,NULL,"Pediatric Oncology Branch, NCI",NULL,NULL,"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68709
541,BC011232-03,"October 01, 2010 -  September 30, 2011",A Glycopeptide from Interstitial Cystitis Patients as a Novel Anticancer Lead,Joseph John Barchi|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Kristie M Adams|M A Siddiqui,Frank  Delaglio; PhD|Susan  Keay|Alex  Mackerell Jr (University of Maryland),NULL,Daron  Freedberg (OD),"1. Kaczmarek P, Tocci G, Keay S, Adams K, Zhang C, Koch K, Grkovic D, Guo L, Michejda C, Barchi J (2010) Structure#8722;Activity Studies on Antiproliferative Factor (APF) Glycooctapeptide Derivatives. ACS Medicinal Chemistry Letters 1:390-394.|2. Koch K, Zhang C, Kaczmarek P, Barchi J, Guo L, Shahjee H, Keay S (2011) The effect of a novel frizzled 8-related antiproliferative factor on in vitro carcinoma and melanoma cell proliferation and invasion. Investigational New Drugs, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=68671
542,BC011233-03,"October 01, 2010 -  September 30, 2011",Structural Bioinformatics,Byungkook  Lee; PhD|IRP Faculty Profile,NULL,"Molecular Modeling Section, NCI",Dukka Bahadur Kc|Bangalore K Sathyanarayana|Chin-Hsien  Tai|Todd J Taylor,NULL,NULL,NULL,"1. Kim C, Basner J, Lee B (2010). Detecting internally symmetric protein structures. BMC Bioinformatics  11, 303.   https://doi.org/10.1186/1471-2105-11-303",https://intramural.nih.gov/search/searchview.taf?ipid=68717
543,BC011238-03,"October 01, 2010 -  September 30, 2011",Computational Biology,Byungkook  Lee; PhD|IRP Faculty Profile,NULL,"Molecular Modeling Section, NCI",NULL,NULL,Ira H Pastan; MD (Molecular Biology Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68716
544,BC011239-03,"October 01, 2010 -  September 30, 2011",Relapse after Allogeneic Hematopoietic Stem Cell Transplantation,Michael R Bishop; MD,NULL,"Experimental Transplantation and Immunology Branch, NCI",Ronald E Gress; MD|Frances  Hakim; PhD|Nancy M Hardy,Sergio  Giralt (M.D. ANDERSON CANCER CENTER)|Carl  June (University of Pennsylvania),Crystal L. Mackall; MD (Pediatric Oncology Branch)|Terry J Fry (Pediatric Oncology Branch)|Alan S Wayne; MD (Pediatric Oncology Branch),NULL,"1. Bishop MR, Alyea EP, Cairo MS, Falkenburg JH, June CH, Kröger N, Little RF, Miller JS, Pavletic SZ, Porter D, Riddell SR, van Besien K, Wayne AS, Weisdorf DJ, Wu R, Giralt S (2010). Introduction to the reports from the National Cancer Institute First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant  16, 563-4.   https://doi.org/10.1016/j.bbmt.2010.02.025|2. Cairo MS, Jordan CT, Maley CC, Chao C, Melnick A, Armstrong SA, Shlomchik W, Molldrem J, Ferrone S, Mackall C, Zitvogel L, Bishop MR, Giralt SA, June CH (2010). NCI first International Workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation: report from the committee on the biological considerations of hematological relapse following allogeneic stem cell transplantation unrelated to graft-versus-tumor effects: state of the science. Biol Blood Marrow Transplant  16, 709-28.   https://doi.org/10.1016/j.bbmt.2010.03.002|3. Miller JS, Warren EH, van den Brink MR, Ritz J, Shlomchik WD, Murphy WJ, Barrett AJ, Kolb HJ, Giralt S, Bishop MR, Blazar BR, Falkenburg JH (2010). NCI First International Workshop on The Biology, Prevention, and Treatment of Relapse After Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on the Biology Underlying Recurrence of Malignant Disease following Allogeneic HSCT: Graft-versus-Tumor/Leukemia Reaction. Biol Blood Marrow Transplant  16, 565-86.   https://doi.org/10.1016/j.bbmt.2010.02.005|4. Pavletic SZ, Kumar S, Mohty M, de Lima M, Foran JM, Pasquini M, Zhang MJ, Giralt S, Bishop MR, Weisdorf D (2010). NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on the Epidemiology and Natural History of Relapse following Allogeneic Cell Transplantation. Biol Blood Marrow Transplant  16, 871-90.   https://doi.org/10.1016/j.bbmt.2010.04.004|5. van den Brink MR, Porter DL, Giralt S, Lu SX, Jenq RR, Hanash A, Bishop MR (2010). Relapse after allogeneic hematopoietic cell therapy. Biol Blood Marrow Transplant  16, S138-45.   https://doi.org/10.1016/j.bbmt.2009.10.023",https://intramural.nih.gov/search/searchview.taf?ipid=68672
545,BC011240-03,"October 01, 2010 -  September 30, 2011",Pathway Analysis in Mouse Model for Astrocytoma via Systems Biology Approach,Terry Anne Van Dyke,NULL,"Mouse Cancer Genetics Program, NCI","Simone  Difilippantonio|Karlyne M Reilly; BS, PhD|Deborah B Householder|Zoe W Ohler",NULL,"Howard A Fine; MD, PhD (Neuro-Oncology Branch)",NULL,"1. Van Dyke T (2010). Finding the tumor copycat: approximating a human cancer. Nat Med  16, 976-7.   https://doi.org/10.1038/nm0910-976|2. Walrath JC, Hawes JJ, Van Dyke T, Reilly KM (2010). Genetically engineered mouse models in cancer research. Adv Cancer Res  106, 113-64.   https://doi.org/10.1016/S0065-230X(10)06004-5",https://intramural.nih.gov/search/searchview.taf?ipid=68738
546,BC011250-02,"October 01, 2010 -  September 30, 2011",Informatics Solutions to Biomedical Research,Maxwell P Lee; PhD,NULL,"Laboratory of Population Genetics, NCI",Kenneth  Buetow; PhD|Howard H Yang,NULL,"Philip  Taylor; MD, ScD (Genetic Epidemiology Branch)|Alisa  Goldstein; PhD (Genetic Epidemiology Branch)|Dinah  Singer; PhD (Office of the Director)|Kent W Hunter; PhD (Laboratory of Cancer Biology and Genetics)|Lalage  Wakefield; PhD (Laboratory of Cancer Biology and Genetics)",NULL,"1. Devaiah BN, Lu H, Gegonne A, Sercan Z, Zhang H, Clifford RJ, Lee MP, Singer DS (2010). Novel functions for TAF7, a regulator of TAF1-independent transcription. J Biol Chem  285, 38772-80.   https://doi.org/10.1074/jbc.M110.173864|2. Hu N, Clifford RJ, Yang HH, Wang C, Goldstein AM, Ding T, Taylor PR, Lee MP (2010). Genome wide analysis of DNA copy number neutral loss of heterozygosity (CNNLOH) and its relation to gene expression in esophageal squamous cell carcinoma. BMC Genomics  11, 576.   https://doi.org/10.1186/1471-2164-11-576|3. Yang HH, Hu N, Wang C, Ding T, Dunn BK, Goldstein AM, Taylor PR, Lee MP (2010). Influence of genetic background and tissue types on global DNA methylation patterns. PLoS One  5, e9355.   https://doi.org/10.1371/journal.pone.0009355",https://intramural.nih.gov/search/searchview.taf?ipid=68749
547,BC011251-02,"October 01, 2010 -  September 30, 2011",Molecular Genetic Epidemiology of Primary Hepatocellular Carcinoma,Kenneth  Buetow; PhD,NULL,"Laboratory of Population Genetics, NCI",Constance M Cultraro|Li  Dong|Sol  Efroni|Michael N Edmonson|Richard Phillip Finney|Sharon I Greenblum|Show all 12,NULL,Dinah  Singer; PhD (Office of the Director)|Katherine Ann McGlynn; PhD (Hormonal and Reproductive Epidemiology Branch),NULL,"1. Edmonson MN, Zhang J, Yan C, Finney RP, Meerzaman DM, Buetow KH (2011). Bambino: a variant detector and alignment viewer for next-generation sequencing data in the SAM/BAM format. Bioinformatics  27, 865-6.   https://doi.org/10.1093/bioinformatics/btr032",https://intramural.nih.gov/search/searchview.taf?ipid=68750
548,BC011252-02,"October 01, 2010 -  September 30, 2011",The Cancer Genome Anatomy Projects Genetic Annotation Initiative,Kenneth  Buetow; PhD,NULL,"Laboratory of Population Genetics, NCI",Jenny M Kelley|Maxwell P Lee; PhD|Cu  Nguyen|Hongen  Zhang,NULL,"Philip  Taylor; MD, ScD (Genetic Epidemiology Branch)|Dinah  Singer; PhD (Office of the Director)|Lalage  Wakefield; PhD (Laboratory of Cancer Biology and Genetics)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68751
549,BC011253-02,"October 01, 2010 -  September 30, 2011",Genetics and Epigenetics of Cancer,Maxwell P Lee; PhD,NULL,"Laboratory of Population Genetics, NCI",Kenneth  Buetow; PhD|Beverly W Duncan|Sheryl A Gere|Mitsutaka  Kadota|Hailong  Wu|Howard H Yang,Charles  Adisa (Abia State University Teaching Hospital)|Junya  Fukuoka (Toyama University),"Philip  Taylor; MD, ScD (Genetic Epidemiology Branch)|Alisa  Goldstein; PhD (Genetic Epidemiology Branch)|Dinah  Singer; PhD (Office of the Director)|Kent W Hunter; PhD (Laboratory of Cancer Biology and Genetics)|Lalage  Wakefield; PhD (Laboratory of Cancer Biology and Genetics)|Jiuping  Ji (Office of the Director)",NULL,"1. Abnet CC, Freedman ND, Hu N, Wang Z, Yu K, Shu XO, Yuan JM, Zheng W, Dawsey SM, Dong LM, Lee MP, Ding T, Qiao YL, Gao YT, Koh WP, Xiang YB, Tang ZZ, Fan JH, Wang C, Wheeler W, Gail MH, Yeager M, Yuenger J, Hutchinson A, Jacobs KB, et al. [8 more authors] (2010). A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma. Nat Genet  42, 764-7.   https://doi.org/10.1038/ng.649|2. Hu N, Clifford RJ, Yang HH, Wang C, Goldstein AM, Ding T, Taylor PR, Lee MP (2010). Genome wide analysis of DNA copy number neutral loss of heterozygosity (CNNLOH) and its relation to gene expression in esophageal squamous cell carcinoma. BMC Genomics  11, 576.   https://doi.org/10.1186/1471-2164-11-576|3. Kadota M, Yang HH, Gomez B, Sato M, Clifford RJ, Meerzaman D, Dunn BK, Wakefield LM, Lee MP (2010). Delineating genetic alterations for tumor progression in the MCF10A series of breast cancer cell lines. PLoS One  5, e9201.   https://doi.org/10.1371/journal.pone.0009201|4. Yang HH, Hu N, Wang C, Ding T, Dunn BK, Goldstein AM, Taylor PR, Lee MP (2010). Influence of genetic background and tissue types on global DNA methylation patterns. PLoS One  5, e9355.   https://doi.org/10.1371/journal.pone.0009355",https://intramural.nih.gov/search/searchview.taf?ipid=68752
550,BC011255-02,"October 01, 2010 -  September 30, 2011",Genetic Modifiers of Intitiation and Progression of Mammary Cancer,Kent W Hunter; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Jude  Alsarraj|Ling  Bai|Lalage  Wakefield; PhD|Farhoud  Faraji|Thomas Rudolf Geiger|Natalie E Goldberger; PhD|Show all 10,"Pier Paolo  Pandolfi (Harvard University)|Fernando  Pardo-Manuel de la Villena (UNC)|Daniel  Pomp (UNC)|David  Threadgill; PhD (Department of Genetics, University of North Carolina School of Medicine)",Giorgio  Trinchieri (Cancer Inflammation Program),Keiko  Ozato; PhD (NICHD),"1. Gordon RR, La Merrill M, Hunter KW, Sørensen P, Threadgill DW, Pomp D (2010). Dietary fat-dependent transcriptional architecture and copy number alterations associated with modifiers of mammary cancer metastasis. Clin Exp Metastasis  27, 279-93.   https://doi.org/10.1007/s10585-010-9326-z|2. He M, Mangiameli DP, Kachala S, Hunter K, Gillespie J, Bian X, Shen HC, Libutti SK (2010). Expression signature developed from a complex series of mouse models accurately predicts human breast cancer survival. Clin Cancer Res  16, 249-59.   https://doi.org/10.1158/1078-0432.CCR-09-1602|3. Korde LA, Lusa L, McShane L, Lebowitz PF, Lukes L, Camphausen K, Parker JS, Swain SM, Hunter K, Zujewski JA (2010). Gene expression pathway analysis to predict response   to neoadjuvant docetaxel and capecitabine for breast cancer. Breast Cancer Res Treat  119, 685-99.   https://doi.org/10.1007/s10549-009-0651-3|4. La Merrill M, Gordon RR, Hunter KW, Threadgill DW, Pomp D (2010). Dietary fat alters pulmonary metastasis of mammary cancers through cancer autonomous and non-autonomous changes in gene expression. Clin Exp Metastasis  27, 107-16.   https://doi.org/10.1007/s10585-009-9302-7|5. Mendoza A, Hong SH, Osborne T, Khan MA, Campbell K, Briggs J, Eleswarapu A, Buquo L, Ren L, Hewitt SM, Dakir el H, Dakir el-H, Garfield S, Walker R, Merlino G, Green JE, Hunter KW, Wakefield LM, Khanna C (2010). Modeling metastasis biology and therapy in real time in the mouse lung. J Clin Invest  120, 2979-88.   https://doi.org/10.1172/JCI40252",https://intramural.nih.gov/search/searchview.taf?ipid=68754
551,BC011258-02,"October 01, 2010 -  September 30, 2011",Analysis of tumor cell death on antigen-specific immune responses,Tim Friedrich Greten|IRP Faculty Profile,NULL,"Medical Oncology Branch, NCI",Jaba  Gamrekelashvili|Eugene  Kim,"Lothar  JÃ¤ntsch (Helmholtz Centre for Infection Research)|Michael Peter Manns; MD (epartment of Gastroenterology and Hepatology, edizinische Hochschule Hannover)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68757
552,BC011259-02,"October 01, 2010 -  September 30, 2011",Effect of the Ras oncogene on genomic stability,Ji  Luo|IRP Faculty Profile,NULL,"Medical Oncology Branch, NCI",Meng-Tzu  Weng,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68758
553,BC011260-02,"October 01, 2010 -  September 30, 2011",Study the chromatin binding proteins in embryonic stem cells,Jing  Huang|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Mangmang  Li|Zhang  Xinyue,NULL,Jianxin  Shi (Biostatistics Branch),NULL,"1. Huang J, Dorsey J, Chuikov S, Pérez-Burgos L, Zhang X, Jenuwein T, Reinberg D, Berger SL (2010). G9a and Glp methylate lysine 373 in the tumor suppressor p53. J Biol Chem  285, 9636-41.   https://doi.org/10.1074/jbc.M109.062588|2. Lee KH, Li M, Michalowski AM, Zhang X, Liao H, Chen L, Xu Y, Wu X, Huang J (2010). A genomewide study identifies the Wnt signaling pathway as a major target of p53 in murine embryonic stem cells. Proc Natl Acad Sci U S A  107, 69-74.   https://doi.org/10.1073/pnas.0909734107|3. Li M, Huang J (2010). A new puzzling role of p53 in mouse embryonic stem cells. Cell Cycle  9, 1669-70.   https://doi.org/10.4161/cc.9.9.11596|4. Liu F, Barsyte-Lovejoy D, Allali-Hassani A, He Y, Herold JM, Chen X, Yates CM, Frye SV, Brown PJ, Huang J, Vedadi M, Arrowsmith CH, Jin J (2011). Optimization of cellular activity of G9a inhibitors 7-aminoalkoxy-quinazolines. J Med Chem  54, 6139-50.   https://doi.org/10.1021/jm200903z|5. Yang J, Huang J, Dasgupta M, Sears N, Miyagi M, Wang B, Chance MR, Chen X, Du Y, Wang Y, An L, Wang Q, Lu T, Zhang X, Wang Z, Stark GR (2010). Reversible methylation of promoter-bound STAT3 by histone-modifying enzymes. Proc Natl Acad Sci U S A  107, 21499-504.   https://doi.org/10.1073/pnas.1016147107|6. Zhang X, Huang J (2010). Integrative genome-wide approaches in embryonic stem cell research. Integr Biol (Camb)  2, 510-6.   https://doi.org/10.1039/c0ib00068j",https://intramural.nih.gov/search/searchview.taf?ipid=68759
554,BC011261-02,"October 01, 2010 -  September 30, 2011",Molecule-Guided Investigations into p53 Biology,Federico  Bernal|IRP Faculty Profile,NULL,"Lymphoid Malignancies Branch, NCI",Bethanie Lynn Morrison; PhD|Elisabeth Avery Russell,Jean-Christophe  Marine (KU Leuven)|Charles  Stiles (Dana-Farber Cancer Institute)|Geoffrey  Wahl (The Salk Institute for Biological Studies)|Loren  Walensky (Dana-Farber Cancer Institute),NULL,NULL,"1. Bernal F, Wade M, Godes M, Davis T, Whitehead D, Kung A, Wahl G, Walensky L (2010) A Stapled p53 Helix Overcomes HDMX-Mediated Suppression of p53. Cancer Cell, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=68760
555,BC011262-02,"October 01, 2010 -  September 30, 2011",Optimization of the Chemistry of Hydrocarbon-Stabilized Peptides,Federico  Bernal|IRP Faculty Profile,NULL,"Lymphoid Malignancies Branch, NCI",Joseph J Mitala,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68761
556,BC011264-02,"October 01, 2010 -  September 30, 2011",Glucocorticoids and T cell development and function,Jonathan D Ashwell; MD|IRP Faculty Profile,NULL,"Laboratory of Immune Cell Biology, NCI",Bei  Dong|Paul  Mittelstadt; PhD,NULL,NULL,Dragana  Jankovic; PhD (NIAID) |Daniel C Douek; MD (NIAID),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68763
557,BC011267-02,"October 01, 2010 -  September 30, 2011",Preclinical drug development in pancreas cancer,Udo  Rudloff|IRP Faculty Profile,NULL,"Surgery Branch, NCI",Lindy Lockwood Davis; MD|Anne Michele Miermont-Eltejaye|Pflicke  Holger|Yaroslav  Teper,Umesh  Bhanot (Memorial Sloan-Kettering Cancer Center)|Duncan  Jodrell (CRUK Cambridge Research Institute),"Paul  Goldsmith; PhD (Office of the Director)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",Scott E Martin (NHGRI) |Yardena Rachel Samuels; PhD (NHGRI) |Craig Joseph Thomas (NHGRI),"1. Rudloff U, Samuels Y (2010). A growing family: adding mutated Erbb4 as a novel cancer target. Cell Cycle  9, 1487-503.   https://doi.org/10.4161/cc.9.8.11239|2. Rudloff U, Samuels Y (2010). TYRO3-mediated regulation of MITF: a novel target in melanoma? Pigment Cell Melanoma Res  23, 9-11.   https://doi.org/10.1111/j.1755-148X.2009.00649.x",https://intramural.nih.gov/search/searchview.taf?ipid=68766
558,BC011268-02,"October 01, 2010 -  September 30, 2011",Lung Cancer Stem Cell Program,Giuseppe  Giaccone; MD,NULL,"Medical Oncology Branch, NCI","Phillip A Dennis; MD, PhD",NULL,Curtis  Harris; MD (Laboratory of Human Carcinogenesis)|Ilona  Linnoila; MD (Laboratory Of Genitourinary Cancer Pathogenesis)|David  Schrump; MD (Surgery Branch),NULL,"1. Chen M, Voeller D, Marquez VE, Kaye FJ, Steeg PS, Giaccone G, Zajac-Kaye M (2010). Enhanced growth inhibition by combined DNA methylation/HDAC inhibitors in lung tumor cells with silenced CDKN2A. Int J Oncol  37, 963-71.   https://doi.org/10.3892/ijo_00000747|2. Voortman J, Goto A, Mendiboure J, Sohn JJ, Schetter AJ, Saito M, Dunant A, Pham TC, Petrini I, Lee A, Khan MA, Hainaut P, Pignon JP, Brambilla E, Popper HH, Filipits M, Harris CC, Giaccone G (2010). MicroRNA expression and clinical outcomes in patients treated with adjuvant chemotherapy after complete resection of non-small cell lung carcinoma. Cancer Res  70, 8288-98.   https://doi.org/10.1158/0008-5472.CAN-10-1348",https://intramural.nih.gov/search/searchview.taf?ipid=68767
559,BC011269-02,"October 01, 2010 -  September 30, 2011",Thoracic Cancer Research Laboratory,Giuseppe  Giaccone; MD,NULL,"Medical Oncology Branch, NCI",Arlene Wendy Berman|Guinevere Joy Ng Chun|Corrine Marie Keen|Yongwha  Moon|Iacopo  Petrini|Trung C Pham|Show all 20,NULL,"Terry  Moody; PhD (Office of the Director)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Curtis  Harris; MD (Laboratory of Human Carcinogenesis)",NULL,"1. Giaccone G, Wang Y (2011). Strategies for overcoming resistance to EGFR family tyrosine kinase inhibitors. Cancer Treat Rev  37, 456-64.   https://doi.org/10.1016/j.ctrv.2011.01.003|2. Harada T, Yatabe Y, Takeshita M, Koga T, Yano T, Wang Y, Giaccone G (2011). Role and relevance of TrkB mutations and expression in non-small cell lung cancer. Clin Cancer Res  17, 2638-45.   https://doi.org/10.1158/1078-0432.CCR-10-3034|3. Killian JK, Walker RL, Suuriniemi M, Jones L, Scurci S, Singh P, Cornelison R, Harmon S, Boisvert N, Zhu J, Wang Y, Bilke S, Davis S, Giaccone G, Smith WI, Meltzer PS (2010). Archival fine-needle aspiration cytopathology (FNAC) samples: untapped resource for clinical molecular profiling. J Mol Diagn  12, 739-45.   https://doi.org/10.2353/jmoldx.2010.090238|4. Voortman J, Lee JH, Killian JK, Suuriniemi M, Wang Y, Lucchi M, Smith WI, Meltzer P, Wang Y, Giaccone G (2010). Array comparative genomic hybridization-based characterization of genetic alterations in pulmonary neuroendocrine tumors. Proc Natl Acad Sci U S A  107, 13040-5.   https://doi.org/10.1073/pnas.1008132107",https://intramural.nih.gov/search/searchview.taf?ipid=68768
560,BC011275-02,"October 01, 2010 -  September 30, 2011",Gene expression and regulation in endocrine cancers,Electron  Kebebew; MD|IRP Faculty Profile,NULL,"Surgery Branch, NCI",Swaroop Reddi Bommareddi|Krisana  Gesuwan|Mei  He|Meenu  Jain|Naris  Nilubol; MD|Erin Elizabeth Patterson|Show all 11,"Frank  Rauscher (The Wistar Institute)|Martha  Zeiger (Surgery, Johns Hopkins)","Antonio  Fojo; MD, PhD (Medical Oncology Branch)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)","Karel  Pacak; MD, PhD (NICHD) |Constantine Argyrios Stratakis; MD, DSc (NICHD)","1. Mathur A, Weng J, Moses W, Steinberg SM, Rahbari R, Rahabari R, Kitano M, Khanafshar E, Ljung BM, Duh QY, Clark OH, Kebebew E (2010). A prospective study evaluating the accuracy of using combined clinical factors and candidate diagnostic markers to refine the accuracy of thyroid fine needle aspiration biopsy. Surgery  148, 1170-6; discussion 1176-7.   https://doi.org/10.1016/j.surg.2010.09.025|2. Moses W, Weng J, Khanafshar E, Duh QY, Clark OH, Kebebew E (2010). Multiple genetic alterations in papillary thyroid cancer are associated with younger age at presentation. J Surg Res  160, 179-83.   https://doi.org/10.1016/j.jss.2009.05.031|3. Nilubol N, Kebebew E (2011). Personalizing thyroid cancer care: are we there yet? Ann Surg Oncol  18, 1819-20.   https://doi.org/10.1245/s10434-011-1735-y|4. Rahbari R, Holloway AK, He M, Khanafshar E, Clark OH, Kebebew E (2011). Identification of differentially expressed microRNA in parathyroid tumors. Ann Surg Oncol  18, 1158-65.   https://doi.org/10.1245/s10434-010-1359-7|5. Suh I, Kebebew E (2010). The biology of thyroid oncogenesis. Cancer Treat Res  153, 3-21.   https://doi.org/10.1007/978-1-4419-0857-5_1|6. Suh I, Vriens MR, Guerrero MA, Griffin A, Shen WT, Duh QY, Clark OH, Kebebew E (2010). Serum thyroglobulin is a poor diagnostic biomarker of malignancy in follicular and Hurthle-cell neoplasms of the thyroid. Am J Surg  200, 41-6.   https://doi.org/10.1016/j.amjsurg.2009.08.030|7. Wang CC, Friedman L, Kennedy GC, Wang H, Kebebew E, Steward DL, Zeiger MA, Westra WH, Wang Y, Khanafshar E, Fellegara G, Rosai J, Livolsi V, Lanman RB (2011). A large multicenter correlation study of thyroid nodule cytopathology and histopathology. Thyroid  21, 243-51.   https://doi.org/10.1089/thy.2010.0243|8. Yip L, Kebebew E, Milas M, Carty SE, Fahey TJ, Parangi S, Zeiger MA, Nikiforov YE (2010). Summary statement: utility of molecular marker testing in thyroid cancer. Surgery  148, 1313-5.   https://doi.org/10.1016/j.surg.2010.09.023",https://intramural.nih.gov/search/searchview.taf?ipid=68772
561,BC011277-02,"October 01, 2010 -  September 30, 2011",Procaspase 3 activator compounds combined with X-ray irradiation,Karl Erick Haglund,NULL,"Radiation Oncology Branch, NCI",Kheem Singh Bisht,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68774
562,BC011278-02,"October 01, 2010 -  September 30, 2011",Mechanisms of Early Stage Mammary Tumorigenesis,Terry Anne Van Dyke,NULL,"Mouse Cancer Genetics Program, NCI",Linda S Cleveland|Sanaz Arkani Jansen|Xiuyun  Lu|Zhenye  Yang; PhD|Stephanie L Henderson,NULL,Peter L Choyke; MD (Molecular Imaging Program)|Joseph D Kalen (Office Of The Director),"Roberto  Weigert; MSc Chemistry, PhD (NIDCR)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68775
563,BC011280-02,"October 01, 2010 -  September 30, 2011",Cancer Therapy Trials using novel vaccine platforms,Ravi  Madan|IRP Faculty Profile,NULL,"Medical Oncology Branch, NCI","Philip M Arlen; MD|William Laurence Dahut; MD|William D Figg; PharmD|Antonio  Fojo; MD, PhD",NULL,"James L Gulley; MD, PhD (Laboratory of Tumor Immunology and Biology)|Jeffrey  Schlom; PhD (Laboratory of Tumor Immunology and Biology)",NULL,"1. Gulley JL, Arlen PM, Madan RA, Tsang KY, Pazdur MP, Skarupa L, Jones JL, Poole DJ, Higgins JP, Hodge JW, Cereda V, Vergati M, Steinberg SM, Halabi S, Jones E, Chen C, Parnes H, Wright JJ, Dahut WL, Schlom J (2010). Immunologic and prognostic factors associated with overall survival employing a poxviral-based PSA vaccine in metastatic castrate-resistant prostate cancer. Cancer Immunol Immunother  59, 663-74.   https://doi.org/10.1007/s00262-009-0782-8|2. Madan RA, Aragon-Ching JB, Gulley JL, Dahut WL (2011). From clinical trials to clinical practice: therapeutic cancer vaccines for the treatment of prostate cancer. Expert Rev Vaccines  10, 743-53.   https://doi.org/10.1586/erv.11.70|3. Madan RA, Gulley JL, Fojo T, Dahut WL (2010). Therapeutic cancer vaccines in prostate cancer: the paradox of improved survival without changes in time to progression. Oncologist  15, 969-75.   https://doi.org/10.1634/theoncologist.2010-0129|4. Rotow J, Gameiro SR, Madan RA, Gulley JL, Schlom J, Hodge JW (2010). Vaccines as monotherapy and in combination therapy for prostate cancer. Clin Transl Sci  3, 116-22.   https://doi.org/10.1111/j.1752-8062.2010.00186.x",https://intramural.nih.gov/search/searchview.taf?ipid=68776
564,BC011281-02,"October 01, 2010 -  September 30, 2011",Combination therapies involving novel cancer vaccines,Ravi  Madan|IRP Faculty Profile,NULL,"Medical Oncology Branch, NCI",Philip M Arlen; MD|William Laurence Dahut; MD|William D Figg; PharmD|Andrea Borghese Apolo,NULL,"James L Gulley; MD, PhD (Laboratory of Tumor Immunology and Biology)|Jeffrey  Schlom; PhD (Laboratory of Tumor Immunology and Biology)|Aradhana  Kaushal (Radiation Oncology Branch)",NULL,"1. Bilusic M, Heery C, Madan RA (2011). Immunotherapy in prostate cancer: emerging strategies against a formidable foe. Vaccine  29, 6485-97.   https://doi.org/10.1016/j.vaccine.2011.06.088|2. Bilusic M, Madan RA (2012). Therapeutic cancer vaccines:  the latest advancement in targeted therapy. Am J Ther  19, e172-81.   https://doi.org/10.1097/MJT.0b013e3182068cdb|3. Madan RA, Gulley JL (2010). The current and emerging role of immunotherapy in prostate cancer. Clin Genitourin Cancer  8, 10-6.   https://doi.org/10.3816/CGC.2010.n.002",https://intramural.nih.gov/search/searchview.taf?ipid=68777
565,BC011282-02,"October 01, 2010 -  September 30, 2011",RNAi screen for chromatin modifiers in DNA repair and aging,Philipp  Oberdoerffer|IRP Faculty Profile,NULL,"Mouse Cancer Genetics Program, NCI",Sandra  Burkett|Katherine M Nyswaner|Satyendra Kumar Singh|Carrie Antoinette Williams,NULL,Gordon Lee Hager; PhD (Laboratory of Receptor Biology and Gene Expression)|Ofir  Hakim (Hormone Action and Oncogenesis Section)|Prabhakar R Gudla; PhD (Office Of The Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68778
566,BC011283-02,"October 01, 2010 -  September 30, 2011",Investigating the role of DNA breaks in mammalian aging,Philipp  Oberdoerffer|IRP Faculty Profile,NULL,"Mouse Cancer Genetics Program, NCI",Katherine M Nyswaner|Satyendra Kumar Singh|Carrie Antoinette Williams,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68779
567,BC011286-02,"October 01, 2010 -  September 30, 2011",Therapeutic targets and novel anticancer agents for endocrine cancers,Electron  Kebebew; MD|IRP Faculty Profile,NULL,"Surgery Branch, NCI",Swaroop Reddi Bommareddi|Krisana  Gesuwan|Mei  He|Meenu  Jain|Naris  Nilubol; MD|Erin Elizabeth Patterson|Show all 11,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68782
568,BC011287-02,"October 01, 2010 -  September 30, 2011",Clinical and genetic studies in familial nonmedullary thyroid cancer (FNMTC),Electron  Kebebew; MD|IRP Faculty Profile,NULL,"Surgery Branch, NCI",Brent Lin Bian|Mei  He|Krisana  Gesuwan,NULL,NULL,NULL,"1. Vriens MR, Moses W, Weng J, Peng M, Griffin A, Bleyer A, Pollock BH, Indelicato DJ, Hwang J, Kebebew E (2011) Clinical and molecular features of papillary thyroid cancer in adolescents and young adults. Cancer 117:259-67.",https://intramural.nih.gov/search/searchview.taf?ipid=68783
569,BC011293-02,"October 01, 2010 -  September 30, 2011",Impact of chromatin structure on alternative splicing of CD45 pre-mRNA,Shalini  Oberdoerffer|IRP Faculty Profile,NULL,"Mouse Cancer Genetics Program, NCI",Melissa K Gregory|Philipp  Oberdoerffer|Sanjeev  Shukla,NULL,Mikhail V Kashlev (Molecular Mechanisms of Transcription Section),NULL,"1. Shukla S, Kavak E, Gregory M, Imashimizu M, Shutinoski B, Kashlev M, Oberdoerffer S, Sandberg R, Oberdoerffer S (2011) CTCF-promoted RNA polymerase II pausing links DNA methylation to splicing. Nature, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=68786
570,BC011294-02,"October 01, 2010 -  September 30, 2011",Conditional manipulation of hnRNPLL expression in murine models,Shalini  Oberdoerffer|IRP Faculty Profile,NULL,"Mouse Cancer Genetics Program, NCI",Maria Fernanda Prigge,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68787
571,BC011295-02,"October 01, 2010 -  September 30, 2011",Optimizing the graft versus leukemia effect for pediatric ALL,Terry J Fry|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Crystal L. Mackall; MD|Nicole M Nasholm|Haiying  Qin|Jessica Carolyn Shand,NULL,NULL,NULL,"1. Fry TJ, Lankester AC (2010). Cancer immunotherapy: will expanding knowledge lead to success in pediatric oncology? Hematol Oncol Clin North Am  24, 109-27.   https://doi.org/10.1016/j.hoc.2009.11.010|2. Fry TJ, Willasch A, Bader P (2010). The graft-versus-tumor effect in pediatric malignancy. Pediatr Clin North Am  57, 67-81.   https://doi.org/10.1016/j.pcl.2009.12.002",https://intramural.nih.gov/search/searchview.taf?ipid=68788
572,BC011296-02,"October 01, 2010 -  September 30, 2011",Development of dipeptidyl peptidase inhibitors as novel immune adjuvants,Terry J Fry|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Najat  Bouchkouj; MD|Brynn  Duncan,NULL,Giorgio  Trinchieri (Cancer Inflammation Program)|James W Hodge; PhD (Laboratory of Tumor Immunology and Biology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68789
573,BC011298-02,"October 01, 2010 -  September 30, 2011",Ph I Radiation and Lenalidomide in pediatric malignant glioma,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Robyn S Bent|Sean Joseph Hipp,NULL,Kevin A Camphausen; MD (Radiation Oncology Branch)|Deborah E Citrin (Radiation Oncology Branch),Joelle  Sarlls; PhD (NINDS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68790
574,BC011299-02,"October 01, 2010 -  September 30, 2011",Noninvasive Evaluation of Pediatric CNS Tumors,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Laurie  Steffen,NULL,Peter L Choyke; MD (Molecular Imaging Program)|Karen A Kurdziel; MD (Molecular Imaging Program),Dima Ali Hammoud; MD (CC),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68791
575,BC011300-02,"October 01, 2010 -  September 30, 2011",CANCER AND INFLAMMATION GENETICS,Michael  Dean; PhD|IRP Faculty Profile,NULL,"Laboratory of Experimental Immunology, NCI",Albert M Gold|Stephen K Anderson; PhD|Kate M McGee|Silvia  Jimenez-Morales|Lisa  Maslan|Kevin  Misner|Show all 10,"Federico  Antillon (UNOP)|Walter  Guerra (Instituto Cancerologia)|Ken  Offitt (Medicine, Sloan Kettering Cancer Center)|Taras K Oleksyk|Lorena  Orozco (INMEGEN)|Ana  Ortiz (University of Puerto Rico Comprehensive Cancer Center)|Show all 7","Nadya I Tarasova; PhD (Cancer Inflammation Program)|Meredith  Yeager (Office of the Director)|Lee Elizabeth Moore; PhD, MD (Occupational and Environmental Epidemiology Branch)",NULL,"1. Nickerson ML, Kostiha BN, Brandt W, Fredericks W, Xu KP, Yu FS, Gold B, Chodosh J, Goldberg M, Lu DW, Yamada M, Tervo TM, Grutzmacher R, Croasdale C, Hoeltzenbein M, Sutphin J, Malkowicz SB, Wessjohann L, Kruth HS, Dean M, Weiss JS (2010). UBIAD1 mutation alters a mitochondrial prenyltransferase to cause Schnyder corneal dystrophy. PLoS One  5, e10760.   https://doi.org/10.1371/journal.pone.0010760",https://intramural.nih.gov/search/searchview.taf?ipid=68792
576,BC011301-02,"October 01, 2010 -  September 30, 2011",Cancer and Inflammation: Function and Therapy,Michael  Dean; PhD|IRP Faculty Profile,NULL,"Laboratory of Experimental Immunology, NCI",Alexander Stanley Borsa|Albert M Gold|Kate M McGee|Silvia  Jimenez-Morales|Stephen K Anderson; PhD|Lisa  Maslan|Show all 11,"Rando  Allikmets (Columbia University)|Ken  Offitt (Medicine, Sloan Kettering Cancer Center)","Antonio  Fojo; MD, PhD (Medical Oncology Branch)|Nadya I Tarasova; PhD (Cancer Inflammation Program)|Susan  Bates; MD (Medical Oncology Branch)|Meredith  Yeager (Office of the Director)",Daniel R. Weinberger; MD (NIMH),"1. Baas DC, Despriet DD, Gorgels TG, Bergeron-Sawitzke J, Uitterlinden AG, Hofman A, van Duijn CM, Merriam JE, Smith RT, Barile GR, ten Brink JB, Vingerling JR, Klaver CC, Allikmets R, Dean M, Bergen AA (2010). The ERCC6 gene and age-related macular degeneration. PLoS One  5, e13786.   https://doi.org/10.1371/journal.pone.0013786|2. Tan W, Dean M, Law AJ (2010). Molecular cloning and characterization of the human ErbB4 gene: identification of novel splice isoforms in the developing and adult brain. PLoS One  5, e12924.   https://doi.org/10.1371/journal.pone.0012924",https://intramural.nih.gov/search/searchview.taf?ipid=68793
577,BC011302-02,"October 01, 2010 -  September 30, 2011",Screen for Ras inhibitors,Ji  Luo|IRP Faculty Profile,NULL,"Medical Oncology Branch, NCI",Meng-Tzu  Weng,NULL,NULL,Anton  Simeonov (NHGRI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68794
578,BC011303-02,"October 01, 2010 -  September 30, 2011",Ras oncogene induced protein SUMOylation changes,Ji  Luo|IRP Faculty Profile,NULL,"Medical Oncology Branch, NCI",Bing  Yu,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68795
579,BC011304-02,"October 01, 2010 -  September 30, 2011",New shRNA vectors for mammalian genetic analysis,Ji  Luo|IRP Faculty Profile,NULL,"Medical Oncology Branch, NCI",Bing  Yu,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68796
580,BC011306-02,"October 01, 2010 -  September 30, 2011",Inhibitors of protein-protein interactions,Nadya I Tarasova; PhD,Giorgio  Trinchieri,"Cancer Inflammation Program, NCI",Mateusz J Gabryszuk|Liv H Johannessen|Lyuba Aleksandrovna Khavrutskii|Jarrett R Remsberg,Vadim  Gaponenko|Alla  Ivanova|Joseph R Kates|Olga  Timofeeva (Georgetown University),Michael  Dean; PhD (Laboratory of Experimental Immunology)|Alan O Perantoni; PhD (Cancer and Developmental Biology Laboratory)|Francis W Ruscetti; PhD (Laboratory of Experimental Immunology)|Arthur A Hurwitz (Laboratory of Molecular Immunoregulation)|Joseph John Barchi (Chemical Biology Laboratory)|Joost J Oppenheim; MD (Laboratory of Molecular Immunoregulation),NULL,"1. Wang H, Yang Y, Sharma N, Tarasova NI, Timofeeva OA, Winkler-Pickett RT, Tanigawa S, Perantoni AO (2010). STAT1 activation regulates proliferation and differentiation of renal progenitors. Cell Signal  22, 1717-26.   https://doi.org/10.1016/j.cellsig.2010.06.012",https://intramural.nih.gov/search/searchview.taf?ipid=68798
581,BC011307-02,"October 01, 2010 -  September 30, 2011",Self-assembling protoviral nanoparticles,Nadya I Tarasova; PhD,Giorgio  Trinchieri,"Cancer Inflammation Program, NCI",Yuhong  Chen; PhD,Vadim  Gaponenko|Joseph R Kates,Sriram  Subramaniam; PhD (Laboratory of Cell Biology)|Joost J Oppenheim; MD (Laboratory of Molecular Immunoregulation)|Ola Mae Zack Howard (Laboratory of Molecular Immunoregulation)|Sergey G Tarasov (Structural Biophysics Laboratory),NULL,"1. Polgar O, Ierano C, Tamaki A, Stanley B, Ward Y, Xia D, Tarasova N, Robey RW, Bates SE (2010). Mutational analysis of threonine 402 adjacent to the GXXXG dimerization motif in transmembrane segment 1 of ABCG2. Biochemistry  49, 2235-45.   https://doi.org/10.1021/bi902085q",https://intramural.nih.gov/search/searchview.taf?ipid=68799
582,BC011311-02,"October 01, 2010 -  September 30, 2011",Identification of genetic interactors of Brca2,Shyam K Sharan|IRP Faculty Profile,NULL,"Genetics of Cancer Susceptibility Section, NCI",Suhwan  Chang|Xia  Ding,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68803
583,BC011312-02,"October 01, 2010 -  September 30, 2011",Protein regulation in multiple myeloma,Christina M Annunziata|IRP Faculty Profile,NULL,"Medical Oncology Branch, NCI",James J Driscoll; MD|Ji  Luo|Ola Anders Landgren,NULL,NULL,NULL,"1. Driscoll JJ, Burris J, Annunziata CM (2012). Targeting the proteasome with bortezomib in multiple myeloma:  update on therapeutic benefit as an upfront single agent, induction regimen for stem-cell transplantation and as maintenance therapy. Am J Ther  19, 133-44.   https://doi.org/10.1097/MJT.0b013e3181ff7a9e|2. Driscoll JJ, Pelluru D, Lefkimmiatis K, Fulciniti M, Prabhala RH, Greipp PR, Barlogie B, Tai YT, Anderson KC, Shaughnessy JD, Annunziata CM, Munshi NC (2010). The sumoylation pathway is dysregulated in multiple myeloma and is associated with adverse patient outcome. Blood  115, 2827-34.   https://doi.org/10.1182/blood-2009-03-211045",https://intramural.nih.gov/search/searchview.taf?ipid=68804
584,BC011313-02,"October 01, 2010 -  September 30, 2011",Design and Utility of Novel Protienaceous Biomaterials,Joel Patrick Schneider; PhD|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Monica Cristina Branco|Iris Maria Geisler|Michael Christopher Giano|Katelyn Jean Nagy|Chomdao  Sinthuvanich|Daniel James Smith|Show all 8,Eric  Furst (University of Delaware)|Darrin  Pochan (University of Delaware)|Mehmet  Sarikaya (University of Washington)|Norm  Wagner (University of Delaware),Robert  Blumenthal; PhD (Center for Cancer Research Nanobiology Program)|Ruth  Nussinov; PhD (Center for Cancer Research Nanobiology Program),NULL,"1. Altunbas A, Sharma N, Lamm MS, Yan C, Nagarkar RP, Schneider JP, Pochan DJ (2010). Peptide--silica hybrid networks: biomimetic control of network mechanical behavior. ACS Nano  4, 181-8.   https://doi.org/10.1021/nn901226h|2. Branco MC, Pochan DJ, Wagner NJ, Schneider JP (2010). The effect of protein structure on their controlled release from an injectable peptide hydrogel. Biomaterials  31, 9527-34.   https://doi.org/10.1016/j.biomaterials.2010.08.047|3. Gungormus M, Branco M, Fong H, Schneider JP, Tamerler C, Sarikaya M (2010). Self assembled bi-functional peptide hydrogels with biomineralization-directing peptides. Biomaterials  31, 7266-74.   https://doi.org/10.1016/j.biomaterials.2010.06.010|4. Nagarkar RP, Hule RA, Pochan DJ, Schneider JP (2010). Domain swapping in materials design. Biopolymers  94, 141-55.   https://doi.org/10.1002/bip.21332|5. Rughani R, Branco M, Pochan D, Schneider J (2010) De Novo Design of a Shear Thin Recoverable Peptide-based Hydrogel Capable of Intrafibrillar Photopolymerization. Macromolecules inpress.|6. Yan C, Altunbas A, Yucel T, Nagarkar RP, Schneider JP, Pochan DJ (2010). Injectable solid hydrogel: mechanism of shear-thinning and immediate recovery of injectable β-hairpin peptide hydrogels. Soft Matter  6, 5143-5156.   https://doi.org/10.1039/C0SM00642D",https://intramural.nih.gov/search/searchview.taf?ipid=68805
585,BC011314-02,"October 01, 2010 -  September 30, 2011",Development of antibacterial agents and materials,Joel Patrick Schneider; PhD|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Ana Salome Rocha Do Nascimento Veiga,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68806
586,BC011315-02,"October 01, 2010 -  September 30, 2011",Molecular characterization of endometrial cancer,Christina M Annunziata|IRP Faculty Profile,NULL,"Medical Oncology Branch, NCI",Elise C Kohn; MD|Anne Mary Noonan; MD|Larry  Maxwell,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68807
587,BC011316-02,"October 01, 2010 -  September 30, 2011",Role of the human transcription factor T in chordoma growth,Karl Erick Haglund,NULL,"Radiation Oncology Branch, NCI",Kheem Singh Bisht,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68808
588,BC011318-02,"October 01, 2010 -  September 30, 2011",Detection and Analysis of Mouse Retroviruses in Humans,Frank  Maldarelli,Stephen H Hughes; PhD,"Host Virus Interaction Branch, NCI",Eleanor Mckenna Pitt Wilson,NULL,Vinay K Pathak; PhD (Retroviral Replication Laboratory)|Francis W Ruscetti; PhD (Laboratory of Experimental Immunology)|Kathryn  Jones; PhD (Laboratory of Experimental Immunology)|William Marston Linehan; MD (Urologic Oncology Branch)|Peter A Pinto; MD (Urologic Oncology Branch),NULL,"1. Aloia AL, Sfanos KS, Isaacs WB, Zheng Q, Maldarelli F, De Marzo AM, Rein A (2010). XMRV: a new virus in prostate cancer? Cancer Res  70, 10028-33.   https://doi.org/10.1158/0008-5472.CAN-10-2837|2. Kearney M, Lee K, Bagni R, Wiegand A, Spindler J, Maldarelli F, Pinto P, Linehan W, Vocke C, Delviks-Frankenberry K, deVere White R, Del Prete G, Mellors J, Lifson J, KewalRamani V, Pathak V, Coffin J, Le Grice S (2011) Nucleic acid, antibody, and virus culture methods to detect xenotropic MLV-related virus (XMRV) in macaque and human blood samples. Adv Virol, in press.|3. Kearney M, Maldarelli F (2010). Current status of xenotropic murine leukemia virus-related retrovirus in chronic fatigue syndrome and prostate cancer: reach for a scorecard, not a prescription pad. J Infect Dis  202, 1463-6.   https://doi.org/10.1086/657169",https://intramural.nih.gov/search/searchview.taf?ipid=68810
589,BC011319-02,"October 01, 2010 -  September 30, 2011",Role of FIR in limb morphogenesis,Susan  Mackem; MD|IRP Faculty Profile,NULL,"Cancer and Developmental Biology Laboratory, NCI",Xiaozhong  Bao|Bau Lin Huang,NULL,David  Levens; PhD (Laboratory of Pathology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68811
590,BC011320-02,"October 01, 2010 -  September 30, 2011",Targeting dendritic cells for selective modulation of GVHD,Terry J Fry|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Christian  Capitini|Crystal L. Mackall; MD|Nicole M Nasholm,NULL,Giorgio  Trinchieri (Cancer Inflammation Program),Lothar  Hennighausen; PhD (NIDDK),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68812
591,BC011321-02,"October 01, 2010 -  September 30, 2011",Identification and characterization of FGF target genes,Mark B Lewandoski|IRP Faculty Profile,NULL,"Genetics of Vertebrate Development Section, NCI",Cynthia M Elder|Ying  Zhang,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68813
592,BC011322-02,"October 01, 2010 -  September 30, 2011",Molecular profiling of  tumor tissue using targeted clinical proteomics,Donald J Johann,NULL,"Medical Oncology Branch, NCI",Sumana  Mukherjee,NULL,"Michael R Emmert-Buck; MD, PhD (Laboratory of Pathology)",NULL,"1. Johann D, Mukherjee S, Prieto D, Veenstra T, Blonder J (2010) Profiling solid tumor heterogeneity by LCM and biological MS of fresh frozen tissue sections. Methods Mol Biol, in press.|2. Johann DJ, Wei BR, Prieto DA, Chan KC, Ye X, Valera VA, Simpson RM, Rudnick PA, Xiao Z, Issaq HJ, Linehan WM, Stein SE, Veenstra TD, Blonder J (2010). Combined blood/tissue analysis for cancer biomarker discovery: application to renal cell carcinoma. Anal Chem  82, 1584-8.   https://doi.org/10.1021/ac902204k|3. Ye X, Luke B, Johann D, Chan C, Prieto D, Ono A, Veenstra T, Blonder J (2010) Post-digestion 18O exchangelabeling for quantitative shotgun proteomics of membrane proteins. Methods Mol Biol, in press.|4. Ye X, Luke BT, Johann DJ, Ono A, Prieto DA, Chan KC, Issaq HJ, Veenstra TD, Blonder J (2010). Optimized method for computing (18)O/(16)O ratios of differentially stable-isotope labeled peptides in the context of postdigestion (18)O exchange/labeling. Anal Chem  82, 5878-86.   https://doi.org/10.1021/ac101284c",https://intramural.nih.gov/search/searchview.taf?ipid=68814
593,BC011324-02,"October 01, 2010 -  September 30, 2011",Centrosomal proteins in the regulation of spindle bipolarity and ciliogenesis,Kyung  Lee; PhD|IRP Faculty Profile,NULL,"Chemistry Section, NCI",Tae Sung  Kim,Raymond L Erikson|Kunsoo  Rhee (Seoul National University),Timothy D Veenstra (Office Of The Director),NULL,"1. Johmura Y, Soung N, Park J, Yu L, Zhou M, Bang J, Kim B, Erikson R, Veenstra T, Lee K (2011) A Bifurcated Spindle Assembly Pathway Regulated by Mammalian Polo-like Kinase 1. Proc Natl Acad Sci USA, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=68816
594,BC011325-02,"October 01, 2010 -  September 30, 2011",Search for XMRV,Alan  Rein; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Amanda  Aloia|Demetria P Harvin|Jane  Mirro,NULL,Frank  Maldarelli (Host Virus Interaction Branch),NULL,"1. Aloia AL, Sfanos KS, Isaacs WB, Zheng Q, Maldarelli F, De Marzo AM, Rein A (2010). XMRV: a new virus in prostate cancer? Cancer Res  70, 10028-33.   https://doi.org/10.1158/0008-5472.CAN-10-2837",https://intramural.nih.gov/search/searchview.taf?ipid=68817
595,BC011326-02,"October 01, 2010 -  September 30, 2011",Sensitization of chordoma cell lines to ionizing radiation,Karl Erick Haglund,NULL,"Radiation Oncology Branch, NCI",Kheem Singh Bisht,NULL,NULL,"Menghang  Xia (NHGRI) |Christopher P Austin; AB, MD (NHGRI) |Ruili  Huang (NHGRI)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68818
596,BC011328-02,"October 01, 2010 -  September 30, 2011",Characterization of the Osteosarcoma Genome,"Paul S Meltzer; MD, PhD|IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI","Ogan D Abaan|Sean Richard Davis; MD, PhD|Princy  Francis|Arthur A Glatfelter; MS|Yuan  Jiang; MD|John E Lueders|Show all 12",NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68820
597,BC011330-02,"October 01, 2010 -  September 30, 2011",Tumor heterogeneity in breast cancer brain metastasis after brain radiation,Deedee Kay Smart|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Alexandra  Lin,NULL,Patricia  Steeg; PhD (Developmental Therapeutics Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68821
598,BC011332-02,"October 01, 2010 -  September 30, 2011",Tumor Microenvironment in Cancer Progression,Rosandra N Kaplan|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Amber Jin Giles|Javed  Khan; MD|Miki B Kasai|Carol J Thiele|Chand  Khanna; MD|Christianne  Persenaire|Show all 9,"Jackie  Bromberg (Memorial Sloan Kettering Cancer Center)|David  Lyden (Weill Cornell Medical Center)|Shakeel  Modak (Memorial Sloan Kettering Cancer Center)|Shahin  Rafii (Weill Cornell Medical Center)|Tanya  Trippett (Pediatrics, Memorial Sloan Kettering)|Leonard  Wexler (Memorial Sloan Kettering Cancer Center)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68823
599,BC011333-02,"October 01, 2010 -  September 30, 2011",Neuropsychological outcome measures in patients receiving whole brain radiation,Deedee Kay Smart|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68824
600,BC011334-02,"October 01, 2010 -  September 30, 2011",Biomarkers and Therapeutic Targets in Angiogenesis and Metastasis,Rosandra N Kaplan|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Miki B Kasai|Javed  Khan; MD|Chand  Khanna; MD|Christianne  Persenaire|Crystal L. Mackall; MD|Lee Jay Helman; MD|Show all 8,"Jackie  Bromberg (Memorial Sloan Kettering Cancer Center)|Ira  Dunkel (Memorial Sloan Kettering Cancer Center)|Paul  Meyers (Memorial Sloan Kettering Cancer Center)|Shakeel  Modak (Memorial Sloan Kettering Cancer Center)|Peter  Steinherz (Memorial Sloan Kettering Cancer Center)|Tanya  Trippett (Pediatrics, Memorial Sloan Kettering)|Show all 7",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68825
601,BC011336-02,"October 01, 2010 -  September 30, 2011",Tools for Prediction of Drug Metabolism and Metabolites,Marc C Nicklaus|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Angelo  Pugliese; PhD,NULL,Demetrius  Albanes; MD (Nutritional Epidemiology Branch),"Christopher P Austin; AB, MD (NHGRI)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68827
602,BC011337-02,"October 01, 2010 -  September 30, 2011",Generation of T-cell receptors recognizing antigens on non-melanoma tumors,"James Chung-Yin Yang; MD, PhD|IRP Faculty Profile",NULL,"Surgery Branch, NCI",Kenichi  Hanada|Qiong J Wang,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68828
603,BC011338-02,"October 01, 2010 -  September 30, 2011",Functional Analysis of the REL Transcription Factors in B-Cells,Brian  Lewis,NULL,"Lymphoid Malignancies Branch, NCI","Alfonso  Fernandez; PhD|Louis  Staudt; MD|Jason Alexander Piotrowski; BA, MS|Stella Maris  Ranuncolo",NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68829
604,BC011339-02,"October 01, 2010 -  September 30, 2011",Replication and Pathogenic Potential of XMRV in Humans,Vinay K Pathak; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Ryan C Burdick|Chawaree  Chaipan|Krista A Delviks-Frankenberry|Tobias  Paprotka|Narasimhan Jayanth  Venkatachari; PhD,"Ralph  deVere White (University of California, Davis)|Hsing-Jien  Kung (Department of Biological Chemistry, University of California, Davis)|Cliffort  Pepper (University of California, Davis)",NULL,NULL,"1. Chaipan C, Dilley KA, Paprotka T, Delviks-Frankenberry KA, Venkatachari NJ, Hu WS, Pathak VK (2011). Severe restriction of xenotropic murine leukemia virus-related virus replication and spread in cultured human peripheral blood mononuclear cells. J Virol  85, 4888-97.   https://doi.org/10.1128/JVI.00046-11|2. Delviks-Frankenberry K, Chaipan C, Bagni R, Wyvill K, Yarchoan R, Pathak V (2011) Lack of detection of xenotropic murine leukemia virus-related virus in HIV-1 lymphoma patients. Adv Virol, in press.|3. Kearney M, Lee K, Bagni R, Wiegand A, Spindler J, Maldarelli F, Pinto P, Linehan W, Vocke C, Delviks-Frankenberry K, deVere White R, Del Prete G, Mellors J, Lifson J, KewalRamani V, Pathak V, Coffin J, Le Grice S (2011) Nucleic acid, antibody, and virus culture methods to detect xenotropic MLV-related virus (XMRV) in macaque and human blood samples. Adv Virol, in press.|4. Ndongwe T, Adedeji A, Michailidis E, Ong Y, Hachiya A, Marchand B, Ryan E, Rai D, Kirby K, Liu S, Whatley A, Burke D, Johnson M, Kodama E, Delviks-Frankenberry K, Pathak V, Mitsuya H, Parniak M, Singh K, Sarafianos S (2011) Biochemical, inhibition, and resistance studies of xenotropic murine leukemia virus-related virus reverse transcriptase. Nucleic Acids Res, in press.|5. Paprotka T, Delviks-Frankenberry KA, Cingöz O, Martinez A, Kung HJ, Tepper CG, Hu WS, Fivash MJ, Coffin JM, Pathak VK (2011). Recombinant origin of the retrovirus XMRV. Science  333, 97-101.   https://doi.org/10.1126/science.1205292",https://intramural.nih.gov/search/searchview.taf?ipid=68830
605,BC011340-02,"October 01, 2010 -  September 30, 2011",Preclinical development of new therapeutics for children with CNS Tumors,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Devang  Pastakia|Brigitte  Widemann; MD|Laurie  Steffen|Nalini M Jayaprakash,Vinay  Jain (Arog Pharmaceuticals LLC)|Sil  Lutkewitte (Targepeutics)|Clinton  Stewart (St Jude Children's Research Hospital),Kevin A Camphausen; MD (Radiation Oncology Branch),Russell R Lonser; MD (NINDS) |Marsha J Merrill; PhD (NINDS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68831
606,BC011341-02,"October 01, 2010 -  September 30, 2011","Familial Gastric Cancer: Diagnosis, DNA Sequencing, Early detection",Itzhak  Avital,NULL,"Surgery Branch, NCI",Satyajit  Ray; PhD,NULL,"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",Theo  Heller; MD (NIDDK),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68832
607,BC011342-02,"October 01, 2010 -  September 30, 2011",Pancreatic perfusion for locally unresectable pancreatic cancer,Itzhak  Avital,NULL,"Surgery Branch, NCI",John Ellis Mullinax|Satyajit  Ray; PhD|Udo  Rudloff|Udai S Kammula,NULL,NULL,Bradford J Wood; MD (CC) |Elliot Brian Levy (CC),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68833
608,BC011343-02,"October 01, 2010 -  September 30, 2011",Clinical protocols for the treatment of GI cancer,Tim Friedrich Greten|IRP Faculty Profile,NULL,"Medical Oncology Branch, NCI",Austin Gerard Duffy|William D Figg; PharmD|Jane Beth Trepel|Douglas K Price,NULL,Peter L Choyke; MD (Molecular Imaging Program)|Liang  Cao (Cancer Genetics Branch),Bradford J Wood; MD (CC) |Aradhana M Venkatesan (CC),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68834
609,BC011344-02,"October 01, 2010 -  September 30, 2011",Analysis of immune suppressor mechanisms in patients with HCC,Tim Friedrich Greten|IRP Faculty Profile,NULL,"Medical Oncology Branch, NCI",Austin Gerard Duffy|Fei  Zhao,NULL,NULL,NULL,"1. Greten TF, Manns MP, Korangy F (2011). Myeloid derived suppressor cells in human diseases. Int Immunopharmacol  11, 802-7.   https://doi.org/10.1016/j.intimp.2011.01.003",https://intramural.nih.gov/search/searchview.taf?ipid=68835
610,BC011345-02,"October 01, 2010 -  September 30, 2011",Analysis of myeloid derived suppressor cells in mice,Tim Friedrich Greten|IRP Faculty Profile,NULL,"Medical Oncology Branch, NCI",Lydia Asrat Haile,"Jan  Buer (University of Essen)|Michael Peter Manns; MD (epartment of Gastroenterology and Hepatology, edizinische Hochschule Hannover)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68836
611,BC011346-02,"October 01, 2010 -  September 30, 2011",Immune suppressor mechanism in a murine model of hepatitis and liver cancer,Tim Friedrich Greten|IRP Faculty Profile,NULL,"Medical Oncology Branch, NCI",Tamar  Kapanadze,NULL,"Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)|Masaki  Terabe (Vaccine Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68837
612,BC011347-02,"October 01, 2010 -  September 30, 2011",Genetic Correlation with Efficacy and Toxicity of Brain Tumor Therapies,Fabio  Iwamoto,NULL,"Neuro-Oncology Branch, NCI",NULL,NULL,"Stephen J Chanock; MD, PhD (Laboratory Translational Genomics)|Preetha  Rajaraman (Radiation Epidemiology Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68838
613,BC011348-02,"October 01, 2010 -  September 30, 2011",Aging and Primary Central Nervous System Tumors,Fabio  Iwamoto,NULL,"Neuro-Oncology Branch, NCI",NULL,Lisa  DeAngelis (MSKCC)|Adilia  Hormigo (MSKCC)|Jacob  Scott (Moffitt Cancer Center),NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68839
614,BC011350-02,"October 01, 2010 -  September 30, 2011",Molecular Discovery Program,Robert Andrew Byrd|IRP Faculty Profile,NULL,"Structural Biophysics Laboratory, NCI",Claudia A Lipschultz|Carla R Hemp,NULL,James  McMahon; PhD (Molecular Targets Laboratory)|Joel Patrick Schneider; PhD (Chemical Biology Laboratory),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68841
615,BC011351-02,"October 01, 2010 -  September 30, 2011",Bladder Cancer Program,Andrea Borghese Apolo|IRP Faculty Profile,NULL,"Medical Oncology Branch, NCI",Ravi  Madan|William D Figg; PharmD|William Laurence Dahut; MD|Jane Beth Trepel,NULL,"James L Gulley; MD, PhD (Laboratory of Tumor Immunology and Biology)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68842
616,BC011352-02,"October 01, 2010 -  September 30, 2011",Molecular and clinical profiling,Ola Anders Landgren,NULL,"Medical Oncology Branch, NCI",Rene A Costello; MT|Mary Ann M Yancey|Adriana  Zingone; MD,Sigurdur  Kristinsson (Karolinska)|Robert  Kyle (Mayo Clinic)|Vincent  Rajkumar (Mayo Clinic),Peter L Choyke; MD (Molecular Imaging Program)|Louis  Staudt; MD (Lymphoid Malignancies Branch),Richard  Childs; MD (NHLBI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68843
617,BC011353-02,"October 01, 2010 -  September 30, 2011",Development and validation of preclinical mouse model for serous ovarian cancer,Terry Anne Van Dyke,NULL,"Mouse Cancer Genetics Program, NCI",Simone  Difilippantonio|Deborah B Householder|Serguei V Kozlov|Zoe W Ohler,"Neal  Goodwin (Jackson Laboratory, West)|Leroy E Hood",Christina M Annunziata (Medical Oncology Branch)|Elise C Kohn; MD (Medical Oncology Branch),NULL,"1. Walrath JC, Hawes JJ, Van Dyke T, Reilly KM (2010). Genetically engineered mouse models in cancer research. Adv Cancer Res  106, 113-64.   https://doi.org/10.1016/S0065-230X(10)06004-5",https://intramural.nih.gov/search/searchview.taf?ipid=68844
618,BC011354-02,"October 01, 2010 -  September 30, 2011",BCR Signaling in ABC DLBCL,"Wyndham H Wilson; MD, PhD|IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",Kieron Michael Dunleavy,NULL,Louis  Staudt; MD (Lymphoid Malignancies Branch)|Elaine S Jaffe; MD (Laboratory of Pathology)|Stefania  Pittaluga (Laboratory of Pathology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68845
619,BC011356-02,"October 01, 2010 -  September 30, 2011",FLSC - Vaccine Branch HIV Vaccine Primate Study,Mary C Custer,Robert  Wiltrout; PhD,"Basic Research Laboratory, NCI",NULL,NULL,"Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)|Barbara K Felber (Vaccine Branch)|George N Pavlakis; MD, PhD (Vaccine Branch)|Marjorie  Robert-Guroff; PhD (Vaccine Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68846
620,BC011367-01,"October 01, 2010 -  September 30, 2011",A Phase II Trial of Sunitinib in the Treatment of Recurrent Malignant Gliomas,Teri Nguyen Kreisl; MD,NULL,"Neuro-Oncology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=72759
621,BC011368-01,"October 01, 2010 -  September 30, 2011",D-Loperamide as a Marker of PgP Function in Gliomas,Teri Nguyen Kreisl; MD,NULL,"Neuro-Oncology Branch, NCI",NULL,NULL,NULL,Peter  Herscovitch; MD (CC) |Robert  Innis; MD (NIMH),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=72761
622,BC011369-01,"October 01, 2010 -  September 30, 2011",Enhancing Immune Reconstitution after HSCT,Kirsten  Williams,NULL,"Experimental Transplantation and Immunology Branch, NCI",Amber Rose Arthur,NULL,Peter L Choyke; MD (Molecular Imaging Program),NULL,"1. Williams K, Chu Y, Gress RE (2010) The Influence of Cytokines on the Life and Death of T Lymphocytes in Physiologic Environment and in Patients with Immune Disorders: Cancer, Viral Infections, or Autoimmunity, in The Life and Death of T Lymphocytes - The Influence of Cytokines under Physiological and Pathological Conditions. Transworld Research Network (Kerala, India), pp. 217-39.|2. Williams K, Gress RE (2010) Immune Reconstitution Following Allogeneic Stem Cell Transplant, in Allogeneic Stem Cell Transplantation. Humana Press (New York), pp. 545-64.",https://intramural.nih.gov/search/searchview.taf?ipid=72763
623,BC011370-01,"October 01, 2010 -  September 30, 2011",The Pathogenesis and Treatment of chronic GVHD,Kirsten  Williams,NULL,"Experimental Transplantation and Immunology Branch, NCI",NULL,Stephanie R Lee|Paul  Martin,NULL,NULL,"1. Chien JW, Duncan S, Williams KM, Pavletic SZ (2010). Bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation-an increasingly recognized manifestation of chronic graft-versus-host disease. Biol Blood Marrow Transplant  16, S106-14.   https://doi.org/10.1016/j.bbmt.2009.11.002|2. Norman BC, Jacobsohn DA, Williams KM, Au BK, Au MA, Lee SJ, Moravec CK, Chien JW (2011). Fluticasone, azithromycin and montelukast therapy in reducing corticosteroid exposure in bronchiolitis obliterans syndrome after allogeneic hematopoietic SCT: a case series of eight patients. Bone Marrow Transplant  46, 1369-73.   https://doi.org/10.1038/bmt.2010.311",https://intramural.nih.gov/search/searchview.taf?ipid=72765
624,BC011372-01,"October 01, 2010 -  September 30, 2011",Microenvironmental regulation of glioblastoma radiosensitivity,Philip Jeffrey Tofilon|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Kevin A Camphausen; MD|Muhammad  Jamal|Barbara Helen Rath|Patricia S Tsang; PhD|Christopher Albert Crutchfield; PhD,NULL,NULL,NULL,"1. Jamal M, Rath BH, Williams ES, Camphausen K, Tofilon PJ (2010). Microenvironmental regulation of glioblastoma radioresponse. Clin Cancer Res  16, 6049-59.   https://doi.org/10.1158/1078-0432.CCR-10-2435",https://intramural.nih.gov/search/searchview.taf?ipid=72767
625,BC011373-01,"October 01, 2010 -  September 30, 2011",Radiation-induced translational control of gene expression,Philip Jeffrey Tofilon|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Heekyong  Bae|Kevin A Camphausen; MD|Christopher Albert Crutchfield; PhD|Thomas John Hayman,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=72769
626,BC011374-01,"October 01, 2010 -  September 30, 2011",Allotransplant for DOCK8 deficiency,Dennis D Hickstein|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=72771
627,BC011375-01,"October 01, 2010 -  September 30, 2011",Investigating the role of SIRT1 in hematopoetic stem cell maintenance,Philipp  Oberdoerffer|IRP Faculty Profile,NULL,"Mouse Cancer Genetics Program, NCI",Katherine M Nyswaner|Satyendra Kumar Singh|Carrie Antoinette Williams,NULL,Jonathan  Keller; PhD (Laboratory of Cancer Prevention),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=72773
628,BC011376-01,"October 01, 2010 -  September 30, 2011",Molecular Interactions that Drive p63 and p73 Function,Federico  Bernal|IRP Faculty Profile,NULL,"Lymphoid Malignancies Branch, NCI",Joseph J Mitala|Bethanie Lynn Morrison; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=72775
629,BC011378-01,"October 01, 2010 -  September 30, 2011",Studies of amplification in rhabdomyosarcoma,Frederic Glenn Barr|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=72777
630,BC011379-01,"October 01, 2010 -  September 30, 2011",Inhibitor Development Against the Wip1 Phosphatase,Stewart  Durell,Michael Marc Gottesman; MD,"Laboratory of Cell Biology, NCI",NULL,NULL,Ettore  Appella; MD (Chemical Immunology Section),Daniel  Appella; PhD (NIDDK),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=72779
631,BC011381-01,"October 01, 2010 -  September 30, 2011",Brd4 is an atypical kinase that regulates transcription,Dinah  Singer; PhD|IRP Faculty Profile,NULL,"Office of the Director, NCI",Devaiah Nanjappa Ballachanda|Jocelyn D Weissman,NULL,Brian  Lewis (Lymphoid Malignancies Branch),Keiko  Ozato; PhD (NICHD) |Pamela Gehron Robey; PhD (NIDCR),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=72783
632,BC011382-01,"October 01, 2010 -  September 30, 2011",Systems-level analysis of the regulation and function of p53 dynamics,Eric  Batchelor; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",NULL,NULL,NULL,NULL,"1. Geva-Zatorsky N, Dekel E, Batchelor E, Lahav G, Alon U (2010). Fourier analysis and systems identification of the p53 feedback loop. Proc Natl Acad Sci U S A  107, 13550-5.   https://doi.org/10.1073/pnas.1001107107|2. Loewer A, Batchelor E, Gaglia G, Lahav G (2010). Basal dynamics of p53 reveal transcriptionally attenuated pulses in cycling cells. Cell  142, 89-100.   https://doi.org/10.1016/j.cell.2010.05.031|3. Toettcher JE, Mock C, Batchelor E, Loewer A, Lahav G (2010). A synthetic-natural hybrid oscillator in human cells. Proc Natl Acad Sci U S A  107, 17047-52.   https://doi.org/10.1073/pnas.1005615107",https://intramural.nih.gov/search/searchview.taf?ipid=72785
633,BC011383-01,"October 01, 2010 -  September 30, 2011",Transcription Dynamics in Single Cells,Daniel Robert Larson; PhD|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Murali  Palangat; PhD,NULL,NULL,"Carson C Chow; BASc, PhD (NIDDK)","1. Larson D (2011) What do expression dynamics tell us about the mechanism of transcription? Curr Opin Genet Dev, in press.|2. Lionnet T, Wu B, Grünwald D, Singer RH, Larson DR (2010). Nuclear physics: quantitative single-cell approaches to nuclear organization and gene expression. Cold Spring Harb Symp Quant Biol  75, 113-26.   https://doi.org/10.1101/sqb.2010.75.057",https://intramural.nih.gov/search/searchview.taf?ipid=72787
634,BC011385-01,"October 01, 2010 -  September 30, 2011",Detection of Specific Glycan Moieties on the Cell Surface,Pradman  Qasba; PhD,NULL,"Structural Glycobiology Section, NCI",Natalia  Mercer|Boopathy  Ramakrishna|Luke Anthony Verdi,NULL,NULL,NULL,"1. Pasek M, Ramakrishnan B, Boeggeman E, Mercer N, Dulcey A, Griffiths G, Qasba P (2011) The N-acetyl binding pocket of N-acetylglucosaminyltransferases also accommodates a sugar analogue with chemical handle at C-2. Glycobiology [Epubaheadofprint].|2. Ramakrishnan B, Boeggeman E, Pasek M, Qasba PK (2011). Bioconjugation using mutant glycosyltransferases for the site-specific labeling of biomolecules with sugars carrying chemical handles. Methods Mol Biol  751, 281-96.   https://doi.org/10.1007/978-1-61779-151-2_17",https://intramural.nih.gov/search/searchview.taf?ipid=72791
635,BC011387-01,"October 01, 2010 -  September 30, 2011",Studies of gene fusions in rhabdomyosarcoma,Frederic Glenn Barr|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=72793
636,BC011388-01,"October 01, 2010 -  September 30, 2011",molecular analysis of medullary thyroid carcinoma tissues,Samuel A Wells,Giuseppe  Giaccone; MD,"Medical Oncology Branch, NCI","Antonio  Fojo; MD, PhD|Paola A Salerno|Anna  Tamburrino",rebecca  chernock (washington university)|jeffrey  moley (Washington University)|Massimo  Santoro,"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=72795
637,BC011389-01,"October 01, 2010 -  September 30, 2011",small molecule therapy for thyroid cancer,Samuel A Wells,Giuseppe  Giaccone; MD,"Medical Oncology Branch, NCI","Antonio  Fojo; MD, PhD|Ann Wild Gramza|Jean L Ward",NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=72797
638,BC011390-01,"October 01, 2010 -  September 30, 2011",Vascular Biology in Cancer,Pengnian Charles Lin; PhD|IRP Faculty Profile,NULL,"Mouse Cancer Genetics Program, NCI",Yongfen  Min,Carlos  Arteaga (Vanderbilt University)|Tim  Blackwell (Vanderbilt University)|Matthew  Bogyoi (Stanford University)|Xiaolin  He (Northwestern University)|Sebastian  Joyce (Vanderbilt University)|Deyu  Li (Vanderbilt University)|Show all 7,Peter F Johnson; PhD (Laboratory of Cancer Prevention)|Jonathan  Keller; PhD (Laboratory of Cancer Prevention)|Shyam K Sharan (Genetics of Cancer Susceptibility Section)|Li  Yang; PhD (Laboratory of Cancer Biology and Genetics),NULL,"1. DeBusk LM, Boelte K, Min Y, Lin PC (2010). Heterozygous deficiency of delta-catenin impairs pathological angiogenesis. J Exp Med  207, 77-84.   https://doi.org/10.1084/jem.20091097|2. Jiang M, Min Y, Debusk L, Fernandez S, Strand DW, Hayward SW, Lin PC (2010). Spontaneous immortalization of human dermal microvascular endothelial cells. World J Stem Cells  2, 114-20.   https://doi.org/10.4252/wjsc.v2.i5.114|3. Kobayashi H, Huang J, Ye F, Shyr Y, Blackwell TS, Lin PC (2010). Interleukin-32beta propagates vascular inflammation and exacerbates sepsis in a mouse model. PLoS One  5, e9458.   https://doi.org/10.1371/journal.pone.0009458|4. Min Y, Ren X, Vaught DB, Chen J, Donnelly E, Lynch CC, Lin PC (2010). Tie2 signaling regulates osteoclastogenesis and osteolytic bone invasion of breast cancer. Cancer Res  70, 2819-28.   https://doi.org/10.1158/0008-5472.CAN-09-1915|5. Shaifer CA, Huang J, Lin PC (2010). Glioblastoma cells incorporate into tumor vasculature and contribute to vascular radioresistance. Int J Cancer  127, 2063-75.   https://doi.org/10.1002/ijc.25249|6. Shim AH, Liu H, Focia PJ, Chen X, Lin PC, He X (2010). Structures of a platelet-derived growth factor/propeptide complex and a platelet-derived growth factor/receptor complex. Proc Natl Acad Sci U S A  107, 11307-12.   https://doi.org/10.1073/pnas.1000806107|7. Wang SE, Yu Y, Criswell TL, Debusk LM, Lin PC, Zent R, Johnson DH, Ren X, Arteaga CL (2010). Oncogenic mutations regulate tumor microenvironment through induction of growth factors and angiogenic mediators. Oncogene  29, 3335-48.   https://doi.org/10.1038/onc.2010.112",https://intramural.nih.gov/search/searchview.taf?ipid=72799
639,BC011391-01,"October 01, 2010 -  September 30, 2011",Role of IKKa in lung squamous cell carcinoma development,Yinling  Hu|IRP Faculty Profile,NULL,"Laboratory of Experimental Immunology, NCI",Maheshvarma Rvs Datla|Aifu  Lin|Robert  Wiltrout; PhD|Jami D Willette brown|Howard A Young; PhD|Zuoxiang  Xiao|Show all 7,NULL,"Ji Ming  Wang; MD, PhD (Laboratory of Molecular Immunoregulation)",NULL,"1. Liu B, Willette-Brown J, Liu S, Chen X, Fischer SM, Hu Y (2011). IKKα represses a network of inflammation and proliferation pathways and elevates c-Myc antagonists and differentiation in a dose-dependent manner in the skin. Cell Death Differ  18, 1854-64.   https://doi.org/10.1038/cdd.2011.56|2. Xia X, Park E, Liu B, Willette-Brown J, Gong W, Wang J, Mitchell D, Fischer SM, Hu Y (2010). Reduction of IKKalpha expression promotes chronic ultraviolet B exposure-induced skin inflammation and carcinogenesis. Am J Pathol  176, 2500-8.   https://doi.org/10.2353/ajpath.2010.091041",https://intramural.nih.gov/search/searchview.taf?ipid=72801
640,BC011393-01,"October 01, 2010 -  September 30, 2011",Development and regulation of stem cell lineages in skin,"Isaac Franklin Brownell; MD, PhD|IRP Faculty Profile",NULL,"Dermatology Branch, NCI",Amy B Coxon|Mark  Udey; MD|James Francis Perna|Ying  Xiao,NULL,NULL,NULL,"1. Brownell I, Guevara E, Bai CB, Loomis CA, Joyner AL (2011). Nerve-derived sonic hedgehog defines a niche for hair follicle stem cells capable of becoming epidermal stem cells. Cell Stem Cell  8, 552-65.   https://doi.org/10.1016/j.stem.2011.02.021",https://intramural.nih.gov/search/searchview.taf?ipid=72805
641,BC011394-01,"October 01, 2010 -  September 30, 2011",Molecular pathogenesis of Merkel cell carcinoma,"Isaac Franklin Brownell; MD, PhD|IRP Faculty Profile",NULL,"Dermatology Branch, NCI",Amy B Coxon|Kenneth Michael Daily|James Francis Perna,Boris  Bastian (UCSF)|Klaus  Busam (Memorial Sloan-Kettering)|Daniel  Coit (Memorial Sloan-Kettering)|Jedd  Wolchok (Memorial Sloan-Kettering),Eric Alan Stahlberg (Biostatistics and Data Management Section),Scott E Martin (NHGRI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=72807
642,BC011397-01,"October 01, 2010 -  September 30, 2011",Alternative splicing in Ras transformed cells,Ji  Luo|IRP Faculty Profile,NULL,"Medical Oncology Branch, NCI",Valentin  Giroux,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=72809
643,BC011398-01,"October 01, 2010 -  September 30, 2011",Membrane trafficking function in primary cilium assembly and signaling,Christopher John Westlake; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell and Developmental Signaling, NCI",Jeffrey Tate Gray|Quanlong  Lu; PhD,NULL,"Jeffrey S Rubin; MD, PhD (Laboratory of Cellular and Molecular Biology)",NULL,"1. Westlake CJ, Baye LM, Nachury MV, Wright KJ, Ervin KE, Phu L, Chalouni C, Beck JS, Kirkpatrick DS, Slusarski DC, Sheffield VC, Scheller RH, Jackson PK (2011). Primary cilia membrane assembly is initiated by Rab11 and transport protein particle II (TRAPPII) complex-dependent trafficking of Rabin8 to the centrosome. Proc Natl Acad Sci U S A  108, 2759-64.   https://doi.org/10.1073/pnas.1018823108",https://intramural.nih.gov/search/searchview.taf?ipid=72811
644,BC011399-01,"October 01, 2010 -  September 30, 2011",Regulation of microRNA expression by Mutant p53,Ashish Kumar Lal|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI","Sven  Bilke|Sapna  Gopalasubramanian|Princy  Francis|Toshifumi  Hara|Xiao Ling  Li|Paul S Meltzer; MD, PhD|Show all 7",NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=72813
645,BC011400-01,"October 01, 2010 -  September 30, 2011",Function of Mutant p53-regulated microRNAs in cancer cells,Ashish Kumar Lal|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI","Sven  Bilke|Toshifumi  Hara|Princy  Francis|Matthew Fletcher Jones|Xiao Ling  Li|Paul S Meltzer; MD, PhD|Show all 7",NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=72815
646,BC011401-01,"October 01, 2010 -  September 30, 2011",Mechanisms regulating the context-dependant function of microRNAs,Ashish Kumar Lal|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI","Sven  Bilke|Toshifumi  Hara|Princy  Francis|Xiao Ling  Li|Paul S Meltzer; MD, PhD|Murugan  Subramanian",NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=72817
647,BC011402-01,"October 01, 2010 -  September 30, 2011",MicroRNA phenotypic screening for the discovery of novel anti-cancer microRNAs,Ashish Kumar Lal|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Natasha  Caplen|Toshifumi  Hara|Xiao Ling  Li|Murugan  Subramanian,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=72819
648,BC011403-01,"October 01, 2010 -  September 30, 2011",Mechanistic investigation of the RTK cooperation paradigm in vitro and in vivo,Jayne M Stommel|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI",Andrew L Smith|Brice Alexander Pitt Wilson,NULL,NULL,NULL,"1. Yang S, Wang X, Contino G, Liesa M, Sahin E, Ying H, Bause A, Li Y, Stommel JM, Dell'antonio G, Mautner J, Tonon G, Haigis M, Shirihai OS, Doglioni C, Bardeesy N, Kimmelman AC (2011). Pancreatic cancers require autophagy for tumor growth. Genes Dev  25, 717-29.   https://doi.org/10.1101/gad.2016111|2. Ying H, Zheng H, Scott K, Wiedemeyer R, Yan H, Lim C, Huang J, Dhakal S, Ivanova E, Xiao Y, Zhang H, Hu J, Stommel JM, Lee MA, Chen AJ, Paik JH, Segatto O, Brennan C, Elferink LA, Wang YA, Chin L, DePinho RA (2010). Mig-6 controls EGFR trafficking and suppresses gliomagenesis. Proc Natl Acad Sci U S A  107, 6912-7.   https://doi.org/10.1073/pnas.0914930107",https://intramural.nih.gov/search/searchview.taf?ipid=72821
649,BC011404-01,"October 01, 2010 -  September 30, 2011",RTK effector gene discovery.,Jayne M Stommel|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI",Andrew L Smith|Brice Alexander Pitt Wilson,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=72823
650,BC011405-01,"October 01, 2010 -  September 30, 2011",microRNA Profiling in the Spectrum of Kidney Tumors,Maria  Merino; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Linda S Wrathall|David D Roberts; PhD|Beatriz  Walter-rodriguez; MD,NULL,William Marston Linehan; MD (Urologic Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=72825
651,BC011406-01,"October 01, 2010 -  September 30, 2011",miRNA profiling  of prostate cancer.,Maria  Merino; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Linda S Wrathall|Beatriz  Walter-rodriguez; MD,NULL,William Marston Linehan; MD (Urologic Oncology Branch)|Peter A Pinto; MD (Urologic Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=72827
652,BC011407-01,"October 01, 2010 -  September 30, 2011",Establishment of an International DIPG Registry,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",NULL,Suzanne  Baker (St. Jude Children's Research Hospital)|Ute  Bartels (Hospital for Sick Children)|Eric  Bouffet (Hospital for Sick Children)|Maryam  Fouladi (Cincinnati Children's Hospital Center)|Jacques  Grill (Gustave Roussy Institute)|Darren  Hargrave (Great ormond Street Hospital for Children)|Show all 12,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=72829
653,BC011408-01,"October 01, 2010 -  September 30, 2011",Compare substrate specificities of wild type and mutant EGFR kinases.,Udayan  Guha|IRP Faculty Profile,NULL,"Medical Oncology Branch, NCI",Tapan Kumar Maity|Sahib  Singh|Xu  Zhang,Ileana  Cristea (Princeton University)|Heng  Zhu (Johns Hopkins Medical Institute),NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=72831
654,BC011409-01,"October 01, 2010 -  September 30, 2011",Gene Expression Profiling and RNA visualization with Single-Molecule FISH,Daniel Robert Larson; PhD|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Murali  Palangat; PhD,NULL,David  Levens; PhD (Laboratory of Pathology),NULL,"1. Larson D (2011) What do expression dynamics tell us about the mechanism of transcription? Curr Opin Genet Dev, in press.|2. Larson DR (2010). The economy of photons. Nat Methods  7, 357-9.   https://doi.org/10.1038/nmeth0510-357|3. Silverman SJ, Petti AA, Slavov N, Parsons L, Briehof R, Thiberge SY, Zenklusen D, Gandhi SJ, Larson DR, Singer RH, Botstein D (2010). Metabolic cycling in single yeast cells from unsynchronized steady-state populations limited on glucose or phosphate. Proc Natl Acad Sci U S A  107, 6946-51.   https://doi.org/10.1073/pnas.1002422107",https://intramural.nih.gov/search/searchview.taf?ipid=72833
655,BC011410-01,"October 01, 2010 -  September 30, 2011",Protein phosphorylation downstream of mutant EGFR kinases,Udayan  Guha|IRP Faculty Profile,NULL,"Medical Oncology Branch, NCI",Muneeb  Ahmed|Tapan Kumar Maity|Sahib  Singh|Abhilash  Venugopalan|Xu  Zhang,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=72835
656,BC011411-01,"October 01, 2010 -  September 30, 2011",Development of ESiPSC approach for non-germline GEM modelling,Terry Anne Van Dyke,NULL,"Mouse Cancer Genetics Program, NCI",N Keith Collins|Serguei V Kozlov,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=72837
657,BC011412-01,"October 01, 2010 -  September 30, 2011",Role of ERRFI1 in mutant EGFR-driven lung tumorigenesis,Udayan  Guha|IRP Faculty Profile,NULL,"Medical Oncology Branch, NCI",Tapan Kumar Maity|Abhilash  Venugopalan|Xu  Zhang,NULL,"Michael R Emmert-Buck; MD, PhD (Laboratory of Pathology)|Ilona  Linnoila; MD (Laboratory Of Genitourinary Cancer Pathogenesis)|Harold  Varmus; MD (Office Of The Director)",Xiaoyuan  Chen; PhD (NIBIB),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=72839
658,BC011413-01,"October 01, 2010 -  September 30, 2011",Autologous T cells Transduced with an Anti-CD19 Chimeric Antigen Receptor,James N Kochenderfer|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Robert Olds Carpenter; PhD,NULL,"Mark E Dudley (Surgery Branch)|Steven Aaron Rosenberg; MD, PhD (Surgery Branch)",NULL,"1. Kochenderfer JN, Wilson WH, Janik JE, Dudley ME, Stetler-Stevenson M, Feldman SA, Maric I, Raffeld M, Nathan DA, Lanier BJ, Morgan RA, Rosenberg SA (2010). Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19. Blood  116, 4099-102.   https://doi.org/10.1182/blood-2010-04-281931",https://intramural.nih.gov/search/searchview.taf?ipid=72841
659,BC011414-01,"October 01, 2010 -  September 30, 2011",Identification of potentially active tyrosine kinases in lung cancer,Udayan  Guha|IRP Faculty Profile,NULL,"Medical Oncology Branch, NCI",Tapan Kumar Maity|Abhilash  Venugopalan|Xu  Zhang,Todd  Golub (Broad Institute of MIT and Harvard)|Marc  Ladanyi (Memorial Sloan-Kettering Cancer Center),"Stephen M Hewitt; MD, PhD (Laboratory of Pathology)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=72843
660,BC011415-01,"October 01, 2010 -  September 30, 2011",Allogeneic T cells Transduced with an Anti-CD19 Chimeric Antigen Receptor,James N Kochenderfer|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Robert Olds Carpenter; PhD|Ronald E Gress; MD|Frances  Hakim; PhD,NULL,"Mark E Dudley (Surgery Branch)|Steven Aaron Rosenberg; MD, PhD (Surgery Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=72845
661,BC011416-01,"October 01, 2010 -  September 30, 2011",Investigation of Rabs and trafficking regulators roles in tumorigenesis,Christopher John Westlake; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell and Developmental Signaling, NCI",Akiko  Chiba,NULL,Laufey Thora Amundadottir (Laboratory Translational Genomics),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=72847
662,BC011417-01,"October 01, 2010 -  September 30, 2011",New Chimeric Antigen Receptors for Treating Hematologic Malignancies,James N Kochenderfer|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Robert Olds Carpenter; PhD|Ronald E Gress; MD,NULL,Richard A Morgan; PhD (Surgery Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=72849
663,BC011418-01,"October 01, 2010 -  September 30, 2011",Modulating Cancer Stem Cell Signaling in Thoracic Malignancies,David  Schrump; MD|IRP Faculty Profile,NULL,"Surgery Branch, NCI",Suzanne M Inchauste|Sichuan  Xi|Mary R Zhang,NULL,NULL,NULL,"1. Xi S, Yang M, Tao Y, Xu H, Shan J, Inchauste S, Zhang M, Mercedes L, Hong JA, Rao M, Schrump DS (2010). Cigarette smoke induces C/EBP-β-mediated activation of miR-31 in normal human respiratory epithelia and lung cancer cells. PLoS One  5, e13764.   https://doi.org/10.1371/journal.pone.0013764",https://intramural.nih.gov/search/searchview.taf?ipid=72851
664,BC011419-01,"October 01, 2010 -  September 30, 2011",Structural Biology of GTPase Activating Proteins,Robert Andrew Byrd|IRP Faculty Profile,NULL,"Structural Biophysics Laboratory, NCI",Shangjin  Sun,NULL,"Paul A Randazzo; MD, PhD (Laboratory of Cellular and Molecular Biology)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=72853
665,CO020003-03,"October 01, 2010 -  September 30, 2011",Office of Cancer Genomics,Douglas  Lowy; MD|IRP Faculty Profile,NULL,"National Cancer Institute, NCI",Daniela S Gerhard,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68849
666,CP000101-07,"October 01, 2010 -  September 30, 2011",Human Studies of Diet and Nutrition,"Philip  Taylor; MD, ScD",NULL,"Genetic Epidemiology Branch, NCI",NULL,"David  Baer (BHNRC, USDA)|Jerry  Combs (USDA)|Joanne  Dorgan; PhD (NCI)|Terryl  Hartman (Penn State University)|Meryl  Wastney (Metabolic Modeling Services)",Ruth  Pfeiffer; PhD (Biostatistics Branch)|Somdat  Mahabir (Analytic Epidemiology Research Branch)|Blossom  Patterson (Biometry Research Group),NULL,"1. Wastney ME, Combs GF, Canfield WK, Taylor PR, Patterson KY, Hill AD, Moler JE, Patterson BH (2011). A human model of selenium that integrates metabolism from selenite and selenomethionine. J Nutr  141, 708-17.   https://doi.org/10.3945/jn.110.129049",https://intramural.nih.gov/search/searchview.taf?ipid=68892
667,CP000112-07,"October 01, 2010 -  September 30, 2011",Nutrition Intervention Trials in Linxian China,"Christian Cormac Abnet; PhD, MPH|IRP Faculty Profile  | |Sanford Martin Dawsey; MD|IRP Faculty Profile  |Philip  Taylor; MD, ScD",NULL,"Nutritional Epidemiology Branch, NCI

Genetic Epidemiology Branch, NCI",Farin  Kamangar|Nan  Hu,"You-Lin  Qiao (Cancer Institute of the Chinese Academy of Science)|Guo-Qing  Wang (CICAMS)|Wen-Qiang  Wei (Cancer Institute, Chinese Academy of Medical Sciences)",Mark J Roth (Laboratory of Pathology),NULL,"1. Murphy G, Fan JH, Mark SD, Dawsey SM, Selhub J, Wang J, Taylor PR, Qiao YL, Abnet CC (2011). Prospective study of serum cysteine levels and oesophageal and gastric cancers in China. Gut  60, 618-23.   https://doi.org/10.1136/gut.2010.225854",https://intramural.nih.gov/search/searchview.taf?ipid=68890
668,CP000150-07,"October 01, 2010 -  September 30, 2011",Biologic Specimen Bank for Early Lung Cancer Markers in Chinese Tin Miners,"Philip  Taylor; MD, ScD",NULL,"Genetic Epidemiology Branch, NCI",Nan  Hu|Chaoyu C Wang|Alisa  Goldstein; PhD|Asieh  Golozar|Ying  Gao,"Brooks  Cash (NNMC)|You-Lin  Qiao (Cancer Institute of the Chinese Academy of Science)|Xia-Ou  Shu (Vanderbilt University Medical Center)|Jian-Min  Yuan; MD, PhD (Epidemiology and Community Health, University of Minnesota, School of Public Health)|Wei  Zheng (Venderbilt University)|Yun-Ling  Zheng","Maxwell P Lee; PhD (Laboratory of Population Genetics)|Michael R Emmert-Buck; MD, PhD (Laboratory of Pathology)|Christian Cormac Abnet; PhD, MPH (Nutritional Epidemiology Branch)|Stephen M Hewitt; MD, PhD (Laboratory of Pathology)|Ruth  Pfeiffer; PhD (Biostatistics Branch)|Mark J Roth (Laboratory of Pathology)",NULL,"1. Su H, Hu N, Yang HH, Wang C, Takikita M, Wang QH, Giffen C, Clifford R, Hewitt SM, Shou JZ, Goldstein AM, Lee MP, Taylor PR (2011). Global gene expression profiling and validation in esophageal squamous cell carcinoma and its association with clinical phenotypes. Clin Cancer Res  17, 2955-66.   https://doi.org/10.1158/1078-0432.CCR-10-2724|2. Takikita M, Hu N, Shou JZ, Giffen C, Wang QH, Wang C, Hewitt SM, Taylor PR (2011). Fascin and CK4 as biomarkers for esophageal squamous cell carcinoma. Anticancer Res  31, 945-52.",https://intramural.nih.gov/search/searchview.taf?ipid=68891
669,CP000176-07,"October 01, 2010 -  September 30, 2011",Biologic Specimen Bank for Early Lung Cancer Markers in Chinese Tin Miners,"Philip  Taylor; MD, ScD",NULL,"Genetic Epidemiology Branch, NCI",NULL,You-Lin  Qiao (Cancer Institute of the Chinese Academy of Science)|Wendy  Wang (NCI/DCP),Ping  Hu; MS (Biometry Research Group),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68893
670,CP000185-07,"October 01, 2010 -  September 30, 2011",Upper Gastrointestinal Cancer Studies,"Christian Cormac Abnet; PhD, MPH|IRP Faculty Profile  |Philip  Taylor; MD, ScD| | |Sanford Martin Dawsey; MD|IRP Faculty Profile",NULL,"Nutritional Epidemiology Branch, NCI

Genetic Epidemiology Branch, NCI",Gwen  Murphy|Arash  Etemadi|Nan  Hu|Neal David Freedman,"Paolo  Boffetta (International Agency for Research on Cancer)|Paul  Brennan (International Agency for Research on Cancer, Lyon, France)|Renato  Fagundes|David  Fleischer (Mayo Clinic (Scottsdale))|Reza  Malekzadeh (Digestive Disease Research Center, Tehran University of Medical Sciences)|You-Lin  Qiao (Cancer Institute of the Chinese Academy of Science)|Show all 10",Edward L Korn (Clinical Trials Section),NULL,"1. Chris C, Abnet C, Cantwell M, Murray L (2010) Exposure to oral bisphosphonates and risk of esophageal cancer. JAMA 6:657-63.|2. Mukherjee S, Roth MJ, Dawsey SM, Yan W, Rodriguez-Canales J, Erickson HS, Hu N, Goldstein AM, Taylor PR, Richardson AM, Tangrea MA, Chuaqui RF, Emmert-Buck MR (2010). Increased matrix metalloproteinase activation in esophageal squamous cell carcinoma. J Transl Med  8, 91.   https://doi.org/10.1186/1479-5876-8-91|3. Robert P, Abnet C, Dawsey S, White R (2010) Frequent occurrence of esophageal cancer in young people in western Kenya. Dis Esophagus 23:128-35.|4. Yue-Ming Z, Bergman J, Dawsey S, Fleischer D, He S, Lu N, Wang G, Weusten B (2010) Radiofrequency ablation for early esophageal squamous cell neoplasia. Endoscopy 42:327-33.",https://intramural.nih.gov/search/searchview.taf?ipid=68894
671,CP004410-35,"October 01, 2010 -  September 30, 2011",Family Studies,"Neil Edward Caporaso; MS, MD|IRP Faculty Profile  |Lynn Rachel Goldin; PhD| | |Alisa  Goldstein; PhD|IRP Faculty Profile  | |Maria Teresa Pia Landi; MD, PhD|IRP Faculty Profile  | |Xiaohong Rose Yang; PhD|IRP Faculty Profile  | |Margaret Anne Tucker|IRP Faculty Profile",NULL,"Genetic Epidemiology Branch, NCI

Human Genetics Program, NCI","Gladys M. Glenn; MD, PhD|Mary Louise McMaster; MD","Janis  Beach (Information Management Systems)|Giovanna  Bianchi-Scarra (University of Genova)|Tim  Bishop (Institute for Cancer Research)|Donato  Calista (Bufalini Hospital)|Florence  Demenais (Institut National de la Sante et de la Recherche Medicale)|David  Elder (University of Pennsylvania School of Medicine, Philadelphia, PA)|Show all 11",June  Peters (Clinical Genetics Branch)|Kenneth H Kraemer; MD (Dermatology Branch),"Jeffery P Struewing; MS, MD (NHGRI)","1. Bradford PT, Goldstein AM, Tamura D, Khan SG, Ueda T, Boyle J, Oh KS, Imoto K, Inui H, Moriwaki S, Emmert S, Pike KM, Raziuddin A, Plona TM, DiGiovanna JJ, Tucker MA, Kraemer KH (2011). Cancer and neurologic degeneration in xeroderma pigmentosum: long term follow-up characterises the role of DNA repair. J Med Genet  48, 168-76.   https://doi.org/10.1136/jmg.2010.083022|2. Goldin L, Caporaso N, Slager S (2010) Familial Chronic Lymphocytic Leukemia. Current Opinion in Hematology 17:350-5.|3. Goldin LR, Kristinsson SY, Liang XS, Derolf AR, Landgren O, Björkholm M (2012). Familial aggregation of acute myeloid leukemia and myelodysplastic syndromes. J Clin Oncol  30, 179-83.   https://doi.org/10.1200/JCO.2011.37.1203|4. Goldstein AM (2011). Germline BAP1 mutations and tumor susceptibility. Nat Genet  43, 925-6.   https://doi.org/10.1038/ng.956|5. Han SS, Yeager M, Moore LE, Wei MH, Pfeiffer R, Toure O, Purdue MP, Johansson M, Scelo G, Chung CC, Gaborieau V, Zaridze D, Schwartz K, Szeszenia-Dabrowska N, Davis F, Bencko V, Colt JS, Janout V, Matveev V, Foretova L, Mates D, Navratilova M, Boffetta P, Berg CD, Grubb RL, et al. [19 more authors] (2012). The chromosome 2p21 region harbors a complex genetic architecture for association with risk for renal cell carcinoma. Hum Mol Genet  21, 1190-200.   https://doi.org/10.1093/hmg/ddr551|6. Kristinsson SY, Björkholm M, Hultcrantz M, Derolf ÅR, Landgren O, Goldin LR (2011). Chronic immune stimulation might act as a trigger for the development of acute myeloid leukemia or myelodysplastic syndromes. J Clin Oncol  29, 2897-903.   https://doi.org/10.1200/JCO.2011.34.8540|7. Kristinsson SY, Tang M, Pfeiffer RM, Björkholm M, Goldin LR, Blimark C, Mellqvist UH, Wahlin A, Turesson I, Landgren O (2012). Monoclonal gammopathy of undetermined significance and risk of infections: a population-based study. Haematologica  97, 854-8.   https://doi.org/10.3324/haematol.2011.054015|8. Lanasa MC, Allgood SD, Slager SL, Dave SS, Love C, Marti GE, Kay NE, Hanson CA, Rabe KG, Achenbach SJ, Goldin LR, Camp NJ, Goodman BK, Vachon CM, Spector LG, Rassenti LZ, Leis JF, Gockerman JP, Strom SS, Call TG, Glenn M, Cerhan JR, Levesque MC, Weinberg JB, Caporaso NE (2011). Immunophenotypic and gene expression analysis of monoclonal B-cell lymphocytosis shows biologic characteristics associated with good prognosis CLL. Leukemia  25, 1459-66.   https://doi.org/10.1038/leu.2011.117|9. Lindqvist EK, Goldin LR, Landgren O, Blimark C, Mellqvist UH, Turesson I, Wahlin A, Björkholm M, Kristinsson SY (2011). Personal and family history of immune-related conditions increase the risk of plasma cell disorders: a population-based study. Blood  118, 6284-91.   https://doi.org/10.1182/blood-2011-04-347559|10. Mcmaster M, Goldstein A, Parry D (2011) Clinical features distinguish chordoma associated with tuberous sclerosis complex (TSC) from chordoma in the general pediatric population. J Med Genet 48:444-9.|11. McMaster ML, Goldstein AM, Parry DM (2011). Clinical features distinguish childhood chordoma associated with tuberous sclerosis complex (TSC) from chordoma in the general paediatric population. J Med Genet  48, 444-9.   https://doi.org/10.1136/jmg.2010.085092|12. Yang X, Amundadottir L, Burdett L, Chanock S, Goldstein A, Jessop L, Myers T, Pfeiffer R, Tucker M, Wheeler W, Yeager S, Yuenger J (2011) Lack of germline PALB2 mutations in melanoma-prone families with CDKN2A mutations and pancreatic cancer. Familial Cancer 2011:2011.|13. Yang XR, Jessop L, Myers T, Amundadottir L, Pfeiffer RM, Wheeler W, Pike KM, Yuenger J, Burdett L, Yeager M, Chanock SJ, Tucker MA, Goldstein AM (2011). Lack of germline PALB2 mutations in melanoma-prone families with CDKN2A mutations and pancreatic cancer. Fam Cancer  10, 545-8.   https://doi.org/10.1007/s10689-011-9447-9",https://intramural.nih.gov/search/searchview.taf?ipid=68865
672,CP005782-17,"October 01, 2010 -  September 30, 2011",Epidemiology of Oncogenic Viruses,"Thomas R O'Brien; BA, MPH, MD|IRP Faculty Profile",NULL,"Infection & Immunoepidemiology Branch, NCI",NULL,NULL,"Mary  Carrington; MS, PhD (Laboratory of Experimental Immunology)|Stephen J Chanock; MD, PhD (Laboratory Translational Genomics)|Ruth  Pfeiffer; PhD (Biostatistics Branch)|Kai  Yu (Biostatistics Branch)|Jeff  Yuenger (Office of the Director)|Liudmila  Prokunina-Olsson; PhD (Laboratory Translational Genomics)",NULL,"1. Donnelly RP, Dickensheets H, O'Brien TR (2011). Interferon-lambda and therapy for chronic hepatitis C virus infection. Trends Immunol  32, 443-50.   https://doi.org/10.1016/j.it.2011.07.002|2. O'Brien T, Kohaar I, Maeder D, Pfeiffer R, Prokunina-Olsson L, Schadt E, Yeager S (2010) Human Genetic Variants Linked to Chronic Hepatitis B Are Associated with Expression of HLA-DPA1 and HLA-DPB1. JOURNAL OF HEPATOLOGY 52:1.",https://intramural.nih.gov/search/searchview.taf?ipid=68864
673,CP005803-17,"October 01, 2010 -  September 30, 2011",Genetic Epidemiology,"Lynn Rachel Goldin; PhD| | |Maria Teresa Pia Landi; MD, PhD|IRP Faculty Profile  | |Margaret Anne Tucker|IRP Faculty Profile  | |Xiaohong Rose Yang; PhD|IRP Faculty Profile  | |Alisa  Goldstein; PhD|IRP Faculty Profile",NULL,"Genetic Epidemiology Branch, NCI

Human Genetics Program, NCI","Neil Edward Caporaso; MS, MD|Gladys M. Glenn; MD, PhD|Mary Louise McMaster; MD|Dilys  Parry; PhD|Thomas  Fears; PhD|Jorge R Toro","Tim  Bishop (Institute for Cancer Research)|Donato  Calista (Bufalini Hospital)|Florence  Demenais (Institut National de la Sante et de la Recherche Medicale)|Kari  Hemminki; PhD (Department of Biosciences, Karolinska Institute)|Lene  Mellemkjaer (Danish Cancer Society)|Jorgen  Olsen (Danish Cancer Society)","Naoko  Ishibe; ScD (Clinical & Translational Epidemiology Branch)|Martha S Linet; PhD (Radiation Epidemiology Branch)|Roni T Falk (Hormonal and Reproductive Epidemiology Branch)|Mitchell Henry Gail; PhD, MD (Biostatistics Branch)|Ruth  Pfeiffer; PhD (Biostatistics Branch)|Sholom  Wacholder; PhD (Biostatistics Branch)","David  Ng; AB, MD (NHGRI)","1. Fears T, Halpern H, Elder E, Guerry G, Holly H, Sagebiel S, Tucker M (2011) Sunbeds and sunlamps: who used them and their risk for melanoma. Pigment cell melanoma research 24:574-81.|2. Fears TR, Sagebiel RW, Halpern A, Elder DE, Holly EA, Guerry D, Tucker MA (2011). Sunbeds and sunlamps: who used them and their risk for melanoma. Pigment Cell Melanoma Res  24, 574-81.   https://doi.org/10.1111/j.1755-148X.2011.00842.x|3. Goldin L, Bjorkholm M, Kristinsson S, Landgren C, Paltiel O (2011) Infection in Infancy and Subsequent Risk of Developing Lymphoma in Children and Young Adults. Blood 117:1670-1672.|4. Goldin LR, Landgren O, Kristinsson SY, Björkholm M, Paltiel O (2011). Infection in infancy and subsequent risk of developing lymphoma in children and young adults. Blood  117, 1670-2.   https://doi.org/10.1182/blood-2010-09-306274|5. Kristinsson SY, Björkholm M, Hultcrantz M, Derolf ÅR, Landgren O, Goldin LR (2011). Chronic immune stimulation might act as a trigger for the development of acute myeloid leukemia or myelodysplastic syndromes. J Clin Oncol  29, 2897-903.   https://doi.org/10.1200/JCO.2011.34.8540|6. Lindqvist E, Goldin L, Landgren O, Blimark C, Mellqvist U, Turesson I, Wahlin A, Bjorkholm M, Kristinsson S (2011) Personal and family history of immune-related conditions increase the risk of plasma cell disorders: a population-based study. Blood 118:6284-6291|7. Sigurdur K, Bjorkholm M, Goldin L, Gridley G, Koshiol J, Landgren C, McMaster M, Turesson I (2010) Immune-related and inflammatory conditions and risk of lymphoplasmacytic lymphoma or Waldenstrom macroglobulinemia. J Natl Cancer Inst 102:557-67.|8. Yang XR, Chang-Claude J, Goode EL, Couch FJ, Nevanlinna H, Milne RL, Gaudet M, Schmidt MK, Broeks A, Cox A, Fasching PA, Hein R, Spurdle AB, Blows F, Driver K, Flesch-Janys D, Heinz J, Sinn P, Vrieling A, Heikkinen T, Aittomäki K, Heikkilä P, Blomqvist C, Lissowska J, Peplonska B, et al. [149 more authors] (2011). Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst  103, 250-63.   https://doi.org/10.1093/jnci/djq526",https://intramural.nih.gov/search/searchview.taf?ipid=68863
674,CP005804-17,"October 01, 2010 -  September 30, 2011",Pharmacogenetic Studies,"Maria Teresa Pia Landi; MD, PhD|IRP Faculty Profile  | |Neil Edward Caporaso; MS, MD|IRP Faculty Profile",NULL,"Genetic Epidemiology Branch, NCI",Andrea  Baccarelli|Alisa  Goldstein; PhD|Lynn Rachel Goldin; PhD,Janis  Beach (Information Management Systems)|Maria  Landi (DCEG),Andrew Wells Bergen (Office of the Director)|Margaret Anne Tucker (Human Genetics Program),NULL,"1. Dario C, Bertazzi P, Caporaso N, De S, Landi M, Lubin J, Pesatori A, Tucker M, Wacholder S (2010) Lung cancer and occupation in a population-based case-control study. Am J Epidemiology 171:323-33.|2. Rotunno M, Hu N, Su H, Wang C, Goldstein AM, Bergen AW, Consonni D, Pesatori AC, Bertazzi PA, Wacholder S, Shih J, Caporaso NE, Taylor PR, Landi MT (2011). A gene expression signature from peripheral whole blood for stage I lung adenocarcinoma. Cancer Prev Res (Phila)  4, 1599-608.   https://doi.org/10.1158/1940-6207.CAPR-10-0170",https://intramural.nih.gov/search/searchview.taf?ipid=68862
675,CP010119-16,"October 01, 2010 -  September 30, 2011",Studies of Occupational Cancer (Pesticides),"Laura Elizabeth Beane Freeman|IRP Faculty Profile  |Jay  Lubin; PhD| | |Mary Helen Ward; MS, PhD|IRP Faculty Profile  |Shelia K Zahm; ScM, ScD| |Michael  Alavanja; PhD",NULL,"Occupational and Environmental Epidemiology Branch, NCI

Biostatistics Branch, NCI

Office of the Director, NCI","Stella  Koutros|Jonathan Nicholas Hofmann|Debra  Silverman; ScD, ScM|Nathaniel C Rothman; MD|Dalsu  Baris|Joanne S Colt|Show all 7",Jane  Hoppin; ScD|Lisbeth  Lopez-Carrillo (Mexican National Institute of Public Health)|Andrew  Olshan (University of North Carolina)|Sandra  Petralia (Roche Laboratories)|Dale  Sandler; PhD (NIEHS)|Dennis  Weisenburger (University of Nebraska Medical Center),"Ola Anders Landgren (Medical Oncology Branch)|Neil Edward Caporaso; MS, MD (Genetic Epidemiology Branch)|Sharon Ann Savage (Clinical Genetics Branch)|Patricia  Hartge; ScD (Epidemiology and Biostatistics Program)",NULL,"1. Blair A, Marrett L, Beane Freeman L (2011). Occupational cancer in developed countries. Environ Health  10 Suppl 1, S9.   https://doi.org/10.1186/1476-069X-10-S1-S9|2. Carol C, Alavanja M, Andreotti G, Blair A, Hoppin J, Koutros S, Lynch C, Platz E, Sandler D (2010) Coumaphos Exposure and Incident Cancer among Male Participants in the Agricultural Health Study (AHS). Environ Health Perspect 118:92-6.|3. Davis MF, Kamel F, Hoppin JA, Alavanja MC, Freeman LB, Gray GC, Nelson K, Silbergeld E (2011). Neurologic symptoms associated with raising poultry and swine among participants in the Agricultural Health Study. J Occup Environ Med  53, 190-5.   https://doi.org/10.1097/JOM.0b013e31820805d5|4. Freeman LE, Rusiecki JA, Hoppin JA, Lubin JH, Koutros S, Andreotti G, Zahm SH, Hines CJ, Coble JB, Barone-Adesi F, Sloan J, Sandler DP, Blair A, Alavanja MC (2011). Atrazine and cancer incidence among pesticide applicators in the agricultural health study (1994-2007). Environ Health Perspect  119, 1253-9.   https://doi.org/10.1289/ehp.1103561|5. Hines CJ, Deddens JA, Coble J, Kamel F, Alavanja MC (2011). Determinants of captan air and dermal exposures among orchard pesticide applicators in the Agricultural Health Study. Ann Occup Hyg  55, 620-33.   https://doi.org/10.1093/annhyg/mer008|6. Jane H, Alavanja M, Beane L, Coble J, Henneberger P, Kullman G, London S, Sandler D, Umbach D (2010) Pesticide use and adult-onset asthma among male farmers in the Agricultural Health Study. American Journal of Respiratory and Critical Care Medicine 34:1296-303.|7. Koutros S, Alavanja M, Beane L, Blair A, Hoppin J, Knott C, Lubin J, Lynch C, Sandler D (2010) An Update of Cancer Incidence in the Agricultural Health Study. J Occup Environ Med 52:1098-105.|8. Leslie D, Alavanja M, Lynch C, Sandler D (2010) Pesticide use and cutaneous melanoma in pesticide applicators in the agricultural heath study. Environ Health Perspect 118:812-7.|9. Matthew B, Alavanja M, Beane L, Blair A, Dosemeci M, Hoppin J, Lubin J, Rusiecki J, Sandler D, Williams B (2010) Occupational Exposure to Terbufos and the Incidence of Cancer in the Agricultural Health Study. Cancer Causes Control 21:871-7.|10. Starks SE, Gerr F, Kamel F, Lynch CF, Alavanja MC, Sandler DP, Hoppin JA (2012). High pesticide exposure events and central nervous system function among pesticide applicators in the Agricultural Health Study. Int Arch Occup Environ Health  85, 505-15.   https://doi.org/10.1007/s00420-011-0694-8|11. Waggoner JK, Kullman GJ, Henneberger PK, Umbach DM, Blair A, Alavanja MC, Kamel F, Lynch CF, Knott C, London SJ, Hines CJ, Thomas KW, Sandler DP, Lubin JH, Beane Freeman LE, Hoppin JA (2011). Mortality in the agricultural health study, 1993-2007. Am J Epidemiol  173, 71-83.   https://doi.org/10.1093/aje/kwq323",https://intramural.nih.gov/search/searchview.taf?ipid=68857
676,CP010120-16,"October 01, 2010 -  September 30, 2011",Studies of Occupational Cancer,"Michael  Alavanja; PhD| |Wong H Chow| | |Nathaniel C Rothman; MD|IRP Faculty Profile  | |Debra  Silverman; ScD, ScM|IRP Faculty Profile  | |Qing  Lan|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI","Dalsu  Baris|Joanne S Colt|Bu Tian  Ji|Mary Helen Ward; MS, PhD|Aaron E Blair; PhD, MPH|Patricia S Stewart; PhD|Show all 13","Paolo  Boffetta (International Agency for Research on Cancer)|Paul  Brennan (International Agency for Research on Cancer, Lyon, France)|Leon  Burmeister (University of Iowa)|Brian  Chiu (Northwestern University)|Pierluigi  Cocco (University of Cagliari)|Larwence  Figgs (St. Louis University)|Show all 21","Jay  Lubin; PhD (Biostatistics Branch)|Louise  Brinton; PhD (Hormonal and Reproductive Epidemiology Branch)|Montserrat  Garcia-Closas; MD, PhD (Hormonal and Reproductive Epidemiology Branch)","Dale  Sandler; PhD (NIEHS) |Jane  Hoppin; ScD (NIEHS) |Freya  Kamel; PhD, MPH (NIEHS)","1. Amaral AF, Porta M, Silverman DT, Milne RL, Kogevinas M, Rothman N, Cantor KP, Jackson BP, Pumarega JA, López T, Carrato A, Guarner L, Real FX, Malats N (2012). Pancreatic cancer risk and levels of trace elements. Gut  61, 1583-8.   https://doi.org/10.1136/gutjnl-2011-301086|2. Andreotti G, Boffetta P, Rosenberg PS, Berndt SI, Karami S, Menashe I, Yeager M, Chanock SJ, Zaridze D, Matteev V, Janout V, Kollarova H, Bencko V, Navratilova M, Szeszenia-Dabrowska N, Mates D, Rothman N, Brennan P, Chow WH, Moore LE (2010). Variants in blood pressure genes and the risk of renal cell carcinoma. Carcinogenesis  31, 614-20.   https://doi.org/10.1093/carcin/bgp321|3. Bhatti P, Blair A, Bell EM, Rothman N, Lan Q, Barr DB, Needham LL, Portengen L, Figgs LW, Vermeulen R (2010). Predictors of 2,4-dichlorophenoxyacetic acid exposure among herbicide applicators. J Expo Sci Environ Epidemiol  20, 160-8.   https://doi.org/10.1038/jes.2009.14|4. Chang CM, Schroeder JC, Huang WY, Dunphy CH, Baric RS, Olshan AF, Dorsey KC, Dent GA, Cerhan JR, Lynch CF, Rothman N, Cantor KP, Blair A (2010). Non-Hodgkin lymphoma (NHL) subtypes defined by common translocations: utility of fluorescence in situ hybridization (FISH) in a case-control study. Leuk Res  34, 190-5.   https://doi.org/10.1016/j.leukres.2009.05.007|5. Coble JB, Stewart PA, Vermeulen R, Yereb D, Stanevich R, Blair A, Silverman DT, Attfield M (2010). The Diesel Exhaust in Miners Study: II. Exposure monitoring surveys and development of exposure groups. Ann Occup Hyg  54, 747-61.   https://doi.org/10.1093/annhyg/meq024|6. Heck JE, Charbotel B, Moore LE, Karami S, Zaridze DG, Matveev V, Janout V, Kollárová H, Foretova L, Bencko V, Szeszenia-Dabrowska N, Lissowska J, Mates D, Ferro G, Chow WH, Rothman N, Stewart P, Brennan P, Boffetta P (2010). Occupation and renal cell cancer in Central and Eastern Europe. Occup Environ Med  67, 47-53.   https://doi.org/10.1136/oem.2009.046250|7. Julia H, Bencko V, Boffetta P, Brennan P, Charbotel B, Chow W, Ferro G, Foretova L, Janout V, Karami S, Kollarova H, Lissowska J, Mates D, Matveev V, Moore-Robert L, Rothman N, Stewart P, Szeszenia-Dabrowska N, Zaridze D (2010) Occupation and risk of renal cell cancer in Central and Eastern Europe. Occup Environ Med 67:47-53.|8. K. S, Bencko V, Boffetta P, Brennan P, Chow W, Foretova L, Hainaut P, Holcatova I, Jaeger E, Janout V, Kollarova H, Le F, Mates D, Matveev V, Moore-Robert L, Navratilova M, Pawlita M, Rothman N, Szeszenia-Dabrowska N, Villar S, Waldman F, Waterboer T, Zaridze D (2010) TP53, EGFR, and KRAS mutations in relation to VHL inactivation and lifestyle risk factors in renal-cell carcinoma from central and eastern Europe. Cancer Lett 293:92-8.|9. Karami S, Boffetta P, Brennan P, Stewart PA, Zaridze D, Matveev V, Janout V, Kollarova H, Bencko V, Navratilova M, Szeszenia-Dabrowska N, Mates D, Gromiec JP, Sobotka R, Chow WH, Rothman N, Moore LE (2011). Renal cancer risk and occupational exposure to polycyclic aromatic hydrocarbons and plastics. J Occup Environ Med  53, 218-23.   https://doi.org/10.1097/JOM.0b013e31820a40a3|10. Karami S, Boffetta P, Stewart P, Rothman N, Hunting KL, Dosemeci M, Berndt SI, Brennan P, Chow WH, Moore LE (2010). Occupational sunlight exposure and risk of renal cell carcinoma. Cancer  116, 2001-10.   https://doi.org/10.1002/cncr.24939|11. Liao LM, Brennan P, van Bemmel DM, Zaridze D, Matveev V, Janout V, Kollarova H, Bencko V, Navratilova M, Szeszenia-Dabrowska N, Mates D, Rothman N, Boffetta P, Chow WH, Moore LE (2011). LINE-1 methylation levels in leukocyte DNA and risk of renal cell cancer. PLoS One  6, e27361.   https://doi.org/10.1371/journal.pone.0027361|12. Moore LE, Boffetta P, Karami S, Brennan P, Stewart PS, Hung R, Zaridze D, Matveev V, Janout V, Kollarova H, Bencko V, Navratilova M, Szeszenia-Dabrowska N, Mates D, Gromiec J, Holcatova I, Merino M, Chanock S, Chow WH, Rothman N (2010). Occupational trichloroethylene exposure and renal carcinoma risk: evidence of genetic susceptibility by reductive metabolism gene variants. Cancer Res  70, 6527-36.   https://doi.org/10.1158/0008-5472.CAN-09-4167|13. Parveen B, Barr D, Bell E, Blair A, Figgs L, Lan Q, Needham L, Portengen L, Rothman N, Vermeulen R (2010) Predictors of 2,4-dichlorophenoxyacetic acid exposure among herbicide applicators. J Expo Sci Environ Epidemiol 20:160-8.|14. Stenzel P, Blair A, Hein M, Ruder A, Stenzel M, Waters M (2010) Statistical modeling of occupational chlorinated solvent exposures for case-control studies using a literature-based database. Annals of Occupational Hygiene 54:459-72.|15. Vermeulen R, Coble JB, Yereb D, Lubin JH, Blair A, Portengen L, Stewart PA, Attfield M, Silverman DT (2010). The Diesel Exhaust in Miners Study: III. Interrelations between respirable elemental carbon and gaseous and particulate components of diesel exhaust derived from area sampling in underground non-metal mining facilities. Ann Occup Hyg  54, 762-73.   https://doi.org/10.1093/annhyg/meq023",https://intramural.nih.gov/search/searchview.taf?ipid=68859
677,CP010121-16,"October 01, 2010 -  September 30, 2011",Molecular Epidemiology Studies of Occupational and Environmental Exposures,Nathaniel C Rothman; MD|IRP Faculty Profile,NULL,"Occupational and Environmental Epidemiology Branch, NCI","Dalsu  Baris|Mary Helen Ward; MS, PhD|Mustafa  Dosemeci; PhD|Michael  Alavanja; PhD|Laura Elizabeth Beane Freeman|Kenneth  Cantor; PhD|Show all 15","Robert  Branch (University of Pittsburgh)|Paul  Brennan (International Agency for Research on Cancer, Lyon, France)|David  DeMarini (United States Environmental Protection Agency)|Manolis  Kogevinas|Nria  Malats (Institut Municipal dInvestigaci Mdica)|Stephen  Rappaport (School of Public Health, University of California)|Show all 13","Shelia K Zahm; ScM, ScD (Office of the Director)|Patricia  Hartge; ScD (Epidemiology and Biostatistics Program)",NULL,"1. Cantor K, Carrato A, Castano-Vinyals G, Chanock S, Dosemeci M, Garcia-Closas M, Garcia-Closas R, Kogevinas M, Malats N, Real F, Rothman N, Samanic C, Serra C, Silverman D, Tardon A, Villanueva C, Welch R, Yeager S (2010) Polymorphisms in GSTT1, GSTZ1, and CYP2E1, disinfection by-products, and risk of bladder cancer in Spain. Environ Health Perspect 118:1545-50.|2. Cantor KP, Villanueva CM, Silverman DT, Figueroa JD, Real FX, Garcia-Closas M, Malats N, Chanock S, Yeager M, Tardon A, Garcia-Closas R, Serra C, Carrato A, Castaño-Vinyals G, Samanic C, Rothman N, Kogevinas M (2010). Polymorphisms in GSTT1, GSTZ1, and CYP2E1, disinfection by-products, and risk of bladder cancer in Spain. Environ Health Perspect  118, 1545-50.   https://doi.org/10.1289/ehp.1002206|3. Guey LT, García-Closas M, Murta-Nascimento C, Lloreta J, Palencia L, Kogevinas M, Rothman N, Vellalta G, Calle ML, Marenne G, Tardón A, Carrato A, García-Closas R, Serra C, Silverman DT, Chanock S, Real FX, Malats N, EPICURO/Spanish Bladder Cancer Study investigators (2010). Genetic susceptibility to distinct bladder cancer subphenotypes. Eur Urol  57, 283-92.   https://doi.org/10.1016/j.eururo.2009.08.001|4. Jelle V, Kromhout H, Lan Q, Portengen L, Rothman N, Vermeulen R (2010) Flexible meta-regression to assess the shape of the benzene-leukemia exposure-response curve. Environ Health Perspect 118:526-32.|5. Jelle V, Kromhout H, Lan Q, Rothman N, Vermeulen R (2011) Occupational benzene exposure and the risk of lymphoma subtypes: a meta-analysis of cohort studies incorporating three study quality dimensions. Environmental Health Perspectives 119:159-67.|6. Lan Q, Wang SS, Menashe I, Armstrong B, Zhang Y, Hartge P, Purdue MP, Holford TR, Morton LM, Kricker A, Cerhan JR, Grulich A, Cozen W, Zahm SH, Yeager M, Vajdic CM, Schenk M, Leaderer B, Yuenger J, Severson RK, Chatterjee N, Chanock SJ, Zheng T, Rothman N (2011). Genetic variation in Th1/Th2 pathway genes and risk of non-Hodgkin lymphoma: a pooled analysis of three population-based case-control studies. Br J Haematol  153, 341-50.   https://doi.org/10.1111/j.1365-2141.2010.08424.x|7. Li Y, Zheng T, Kilfoy BA, Lan Q, Holford T, Han X, Zhao P, Dai M, Leaderer B, Rothman N, Zhang Y (2010). Genetic polymorphisms in cytochrome P450s, GSTs, NATs, alcohol consumption and risk of non-Hodgkin lymphoma. Am J Hematol  85, 213-5.   https://doi.org/10.1002/ajh.21608|8. Marenne G, Rodríguez-Santiago B, Closas MG, Pérez-Jurado L, Rothman N, Rico D, Pita G, Pisano DG, Kogevinas M, Silverman DT, Valencia A, Real FX, Chanock SJ, Génin E, Malats N (2011). Assessment of copy number variation using the Illumina Infinium 1M SNP-array: a comparison of methodological approaches in the Spanish Bladder Cancer/EPICURO study. Hum Mutat  32, 240-8.   https://doi.org/10.1002/humu.21398|9. Shen M, Armstrong B, Cerhan J, Chanock S, Chatterjee N, Cozen W, Davis S, Grulich A, Hartge P, Holford T, Kricker A, Lan Q, Leaderer B, Menashe I, Morton L, Purdue M, Rothman N, Severson R, Vajdic C, Wang S, Yeager M, Zahm S, Zhang Y, Zheng T (2010) Polymorphisms in DNA repair genes and risk of non-Hodgkin lymphoma in a pooled analysis of three studies. British J of Haemortology 151:239-44.|10. Shen M, Zhang L, Lee KM, Vermeulen R, Hosgood HD, Li G, Yin S, Rothman N, Chanock S, Smith MT, Lan Q (2011). Polymorphisms in genes involved in innate immunity and susceptibility to benzene-induced hematotoxicity. Exp Mol Med  43, 374-8.   https://doi.org/10.3858/emm.2011.43.6.041|11. Shen M, Zheng T, Lan Q, Zhang Y, Hosgood HD, Zahm SH, Holford TR, Leaderer B, Yeager M, Yuenger J, Chanock S, Rothman N (2011). Polymorphisms in integrin genes and lymphoma risk. Leuk Res  35, 968-70.   https://doi.org/10.1016/j.leukres.2010.12.012|12. Vlaanderen J, Lan Q, Kromhout H, Rothman N, Vermeulen R (2011). Occupational benzene exposure and the risk of lymphoma subtypes: a meta-analysis of cohort studies incorporating three study quality dimensions. Environ Health Perspect  119, 159-67.   https://doi.org/10.1289/ehp.1002318|13. Vlaanderen J, Portengen L, Rothman N, Lan Q, Kromhout H, Vermeulen R (2010). Flexible meta-regression to assess the shape of the benzene-leukemia exposure-response curve. Environ Health Perspect  118, 526-32.   https://doi.org/10.1289/ehp.0901127|14. Zhang L, Lan Q, Guo W, Hubbard AE, Li G, Rappaport SM, McHale CM, Shen M, Ji Z, Vermeulen R, Yin S, Rothman N, Smith MT (2011). Chromosome-wide aneuploidy study (CWAS) in workers exposed to an established leukemogen, benzene. Carcinogenesis  32, 605-12.   https://doi.org/10.1093/carcin/bgq286|15. Zhang L, McHale CM, Rothman N, Li G, Ji Z, Vermeulen R, Hubbard AE, Ren X, Shen M, Rappaport SM, North M, Skibola CF, Yin S, Vulpe C, Chanock SJ, Smith MT, Lan Q (2010). Systems biology of human benzene exposure. Chem Biol Interact  184, 86-93.   https://doi.org/10.1016/j.cbi.2009.12.011|16. Zhang L, Tang X, Rothman N, Vermeulen R, Ji Z, Shen M, Qiu C, Guo W, Liu S, Reiss B, Freeman LB, Ge Y, Hubbard AE, Hua M, Blair A, Galvan N, Ruan X, Alter BP, Xin KX, Li S, Moore LE, Kim S, Xie Y, Hayes RB, Azuma M, et al. [9 more authors] (2010). Occupational exposure to formaldehyde, hematotoxicity, and leukemia-specific chromosome changes in cultured myeloid progenitor cells. Cancer Epidemiol Biomarkers Prev  19, 80-8.   https://doi.org/10.1158/1055-9965.EPI-09-0762",https://intramural.nih.gov/search/searchview.taf?ipid=68860
678,CP010122-16,"October 01, 2010 -  September 30, 2011",Occupational Exposure Assessment,Melissa Charmaine Friesen|IRP Faculty Profile,NULL,"Occupational and Environmental Epidemiology Branch, NCI","Michael  Alavanja; PhD|Dalsu  Baris|Aaron E Blair; PhD, MPH|Kenneth  Cantor; PhD|Wong H Chow|Joanne S Colt|Show all 21","Olufemi  Adegoke (Meharry Medical College, Nashville, TN)|Wolfgang  Ahrens (University of Bremen)|Ruth  Allen (Environmental Protection Agency, Washington, DC)|Tye  Arbuckle (Health Canada)|Michael  Attfield (National Institute for Occupational Safety and Health, Morgantown, WV)|Berit  Bakke (National Institute of Occupational Health)|Show all 58",Nilanjan  Chatterjee (Biostatistics Branch)|Allan  Hildesheim; PhD (Infection & Immunoepidemiology Branch)|Peter D Inskip; ScD (Radiation Epidemiology Branch)|Martha S Linet; PhD (Radiation Epidemiology Branch)|Jay  Lubin; PhD (Biostatistics Branch)|Preetha  Rajaraman (Radiation Epidemiology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68858
679,CP010123-16,"October 01, 2010 -  September 30, 2011",Occupational and Environmental Determinants of Cancer among Women and Minorities,"Michael  Alavanja; PhD| | |Laura Elizabeth Beane Freeman|IRP Faculty Profile  | |Melissa Charmaine Friesen|IRP Faculty Profile  | |Qing  Lan|IRP Faculty Profile  |Jay  Lubin; PhD| |Lee Elizabeth Moore; PhD, MD| | |Mark  Purdue|IRP Faculty Profile  | |Nathaniel C Rothman; MD|IRP Faculty Profile  | |Debra  Silverman; ScD, ScM|IRP Faculty Profile  | |Mary Helen Ward; MS, PhD|IRP Faculty Profile  |Wong H Chow",NULL,"Occupational and Environmental Epidemiology Branch, NCI

Biostatistics Branch, NCI","Dalsu  Baris|Aaron E Blair; PhD, MPH|Bu Tian  Ji|Patricia S Stewart; PhD",NULL,"Patricia  Hartge; ScD (Epidemiology and Biostatistics Program)|Robert  Hoover; MD, ScD (Epidemiology and Biostatistics Program)|Shelia K Zahm; ScM, ScD (Office of the Director)|Martha S Linet; PhD (Radiation Epidemiology Branch)",NULL,"1. Jianfeng L, Cai H, Cai Q, Chow W, Dai Q, Franke A, Gao Y, Li H, Rothman N, Shrubsole M, Shu X, Yang G, Zheng W (2010) Urinary polyphenols and breast cancer risk: results from the Shanghai Women's Health Study. Breast Cancer Res Treat 120:693-702.|2. Lan Q, Wang SS, Menashe I, Armstrong B, Zhang Y, Hartge P, Purdue MP, Holford TR, Morton LM, Kricker A, Cerhan JR, Grulich A, Cozen W, Zahm SH, Yeager M, Vajdic CM, Schenk M, Leaderer B, Yuenger J, Severson RK, Chatterjee N, Chanock SJ, Zheng T, Rothman N (2011). Genetic variation in Th1/Th2 pathway genes and risk of non-Hodgkin lymphoma: a pooled analysis of three population-based case-control studies. Br J Haematol  153, 341-50.   https://doi.org/10.1111/j.1365-2141.2010.08424.x|3. Liao LM, Baccarelli A, Shu XO, Gao YT, Ji BT, Yang G, Li HL, Hoxha M, Dioni L, Rothman N, Zheng W, Chow WH (2011). Mitochondrial DNA copy number and risk of gastric cancer: a report from the Shanghai Women's Health Study. Cancer Epidemiol Biomarkers Prev  20, 1944-9.   https://doi.org/10.1158/1055-9965.EPI-11-0379|4. Luo J, Gao YT, Chow WH, Shu XO, Li H, Yang G, Cai Q, Li G, Rothman N, Cai H, Shrubsole MJ, Franke AA, Zheng W, Dai Q (2012). Urinary polyphenols, glutathione S-transferases copy number variation, and breast cancer risk: results from the Shanghai women's health study. Mol Carcinog  51, 379-88.   https://doi.org/10.1002/mc.20799|5. Purdue M, Baris D, Chanock S, Lan Q, Menashe I, Rothman N, Yeager M, Zahm S, Zhang Y, Zheng T (2011) Variation in innate immunity genes and risk of multiple myeloma. BRITISH JOURNAL OF HAEMATOLOGY 29:42-6.|6. Purdue MP, Lan Q, Menashe I, Zheng T, Zhang Y, Yeager M, Hosgood HD, Zahm SH, Chanock SJ, Rothman N, Baris D (2011). Variation in innate immunity genes and risk of multiple myeloma. Hematol Oncol  29, 42-6.   https://doi.org/10.1002/hon.954|7. Tsogzolmaa D, Cai H, Cai Q, Chow W, Dai Q, Deng X, Gao Y, Li H, Milne G, Murff H, Rothman N, Shrubsole M, Shu X, Yang G, Zheng W (2011) Obesity, age, and oxidative stress in middle-aged and older women. Antioxidants redox signaling 14:2453-60.|8. Turner PC, Ji BT, Shu XO, Zheng W, Chow WH, Gao YT, Hardie LJ (2011). A biomarker survey of urinary deoxynivalenol in China: the Shanghai Women's Health Study. Food Addit Contam Part A Chem Anal Control Expo Risk Assess  28, 1220-3.   https://doi.org/10.1080/19440049.2011.584070|9. Zhang L, Lan Q, Guo W, Hubbard AE, Li G, Rappaport SM, McHale CM, Shen M, Ji Z, Vermeulen R, Yin S, Rothman N, Smith MT (2011). Chromosome-wide aneuploidy study (CWAS) in workers exposed to an established leukemogen, benzene. Carcinogenesis  32, 605-12.   https://doi.org/10.1093/carcin/bgq286",https://intramural.nih.gov/search/searchview.taf?ipid=68861
680,CP010124-16,"October 01, 2010 -  September 30, 2011",Cervical cancer and human papillomavirus (HPV) infection,Nicolas Albert Hermann Wentzensen|IRP Faculty Profile,NULL,"Hormonal and Reproductive Epidemiology Branch, NCI",Mark E Sherman; MD|Lauren  Wilson; PhD|Vikrant Vasant Sahasrabuddhe|Hannah  Yang,"Marc  Arbyn (Scientific Institute of Public Health)|Robert  Burk (Albert Einstein College of Medicine)|G  Clifford (IARC)|J.Thomas  Cox (University of California, Santa Barbara)|Jack  Cuzick (Wolfson Institute of Preventive Medicine and Queen Mary University of Londo)|Maire A Duggan|Show all 27",Sholom  Wacholder; PhD (Biostatistics Branch)|Julia  Gage (Clinical Genetics Branch)|Hormuzdiar Aspandiar Katki; MS (Biostatistics Branch)|Douglas  Lowy; MD (Office Of The Director)|Mark  Schiffman; MD (Clinical Genetics Branch)|John  Schiller; PhD (Laboratory of Cellular Oncology),NULL,"1. Burks HR, Smith KM, Wentzensen N, Tenney M, Tuller E, Moxley K, Mathews C, Dunn ST, Wang SS, Gold MA (2011). Risk of cervical intraepithelial neoplasia 2+ among women with a history of previous treatment for cervical intraepithelial neoplasia: ASCUS and LSIL Pap smears after treatment. J Low Genit Tract Dis  15, 11-4.   https://doi.org/10.1097/LGT.0b013e3181ed3d6d|2. Castle PE, Bulten J, Confortini M, Klinkhamer P, Pellegrini A, Siebers AG, Ronco G, Arbyn M (2010). Age-specific patterns of unsatisfactory results for conventional Pap smears and liquid-based cytology: data from two randomised clinical trials. BJOG  117, 1067-73.   https://doi.org/10.1111/j.1471-0528.2010.02650.x|3. Castle PE, Schiffman M, Wheeler CM, Wentzensen N, Gravitt PE (2010). Human papillomavirus genotypes in cervical intraepithelial neoplasia grade 3. Cancer Epidemiol Biomarkers Prev  19, 1675-81.   https://doi.org/10.1158/1055-9965.EPI-10-0251|4. Castle PE, Schiffman M, Wheeler CM, Wentzensen N, Gravitt PE (2010). Impact of improved classification on the association of human papillomavirus with cervical precancer. Am J Epidemiol  171, 155-63.   https://doi.org/10.1093/aje/kwp390|5. Gage JC, Castle PE (2010). Preventing cervical cancer globally by acting locally: if not now, when? J Natl Cancer Inst  102, 1524-7.   https://doi.org/10.1093/jnci/djq382|6. Gage JC, Duggan MA, Nation JG, Gao S, Castle PE (2010). Detection of cervical cancer and its precursors by endocervical curettage in 13,115 colposcopically guided biopsy examinations. Am J Obstet Gynecol  203, 481.e1-9.   https://doi.org/10.1016/j.ajog.2010.06.048|7. Gage JC, Ghosh A, Borgonovo S, Follansbee S, Wentzensen N, Gravitt PE, Grabe N, Lahrmann B, Castle PE (2011). A comparison of dacron versus Flocked nylon swabs for anal cytology specimen collection. Acta Cytol  55, 364-7.   https://doi.org/10.1159/000329488|8. Gage JC, Schiffman M, Solomon D, Wheeler CM, Castle PE (2010). Comparison of measurements of human papillomavirus persistence for postcolposcopic surveillance for cervical precancerous lesions. Cancer Epidemiol Biomarkers Prev  19, 1668-74.   https://doi.org/10.1158/1055-9965.EPI-09-1286|9. Marc A, Martin-Hirsch P, Wentzensen N (2010) Human papillomavirus-based triage of women showing a cervical cytology result of borderline or mild dyskaryosis. British Journal of Obstetrics and Gynecology 117:641-4.|10. Niels G, Lahrmann B, Pommerencke T, Reuschenbach M, Wentzensen N, von M (2010) A virtual microscopy system to scan, evaluate and archive biomarker enhanced cervical cytology slides. Cellular Oncology 32:109-119.|11. Wentzensen N, Carreon J, Castle P, Gravitt P, Schiffman M, Wheeler C, Wilson L (2010) Hierarchical clustering of human papilloma virus genotype patterns in the ASCUS-LSIL triage study. Cancer Research 70:8578-8586.|12. Wentzensen N, Wilson LE, Wheeler CM, Carreon JD, Gravitt PE, Schiffman M, Castle PE (2010). Hierarchical clustering of human papilloma virus genotype patterns in the ASCUS-LSIL triage study. Cancer Res  70, 8578-86.   https://doi.org/10.1158/0008-5472.CAN-10-1188|13. Yang HP, Walmer DK, Merisier D, Gage JC, Bell L, Rangwala S, Shrestha N, Kobayashi L, Eder PS, Castle PE (2011). A pilot analytic study of a research-level, lower-cost human papillomavirus 16, 18, and 45 test. J Virol Methods  176, 112-4.   https://doi.org/10.1016/j.jviromet.2011.05.024",https://intramural.nih.gov/search/searchview.taf?ipid=68853
681,CP010125-16,"October 01, 2010 -  September 30, 2011",Cancer Risk and Environmental Exposures,"Mary Helen Ward; MS, PhD|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI","Dalsu  Baris|Joanne S Colt|Debra  Silverman; ScD, ScM|Michael  Alavanja; PhD|Nathaniel C Rothman; MD|Aaron E Blair; PhD, MPH|Show all 12",Lorraine  Backer (Centers for Disease Control)|Benjamin  Blount (CDC)|Robert  Branch (University of Pittsburgh)|John W Brock (CDC)|Patricia  Buffler (Univerity of California at Berkeley)|James  Cerhan (Mayo Clinic)|Show all 27,"Shelia K Zahm; ScM, ScD (Office of the Director)|Jay  Lubin; PhD (Biostatistics Branch)",NULL,"1. Baris D, Andrew A, Cantor K, Cherala S, Colt J, Fraumeni J, Hoover R, Johnson A, Karagas M, Kelsey K, Lubin J, Marsit C, Rothman N, Samanic C, Schned A, Schwenn M, Silverman D, Verill C, Wadell R (2010) A case-control study of smoking and bladder cancer risk: emergent patterns over time. J Natl Cancer Inst 101:1553-61.|2. Colt JS, Karagas MR, Schwenn M, Baris D, Johnson A, Stewart P, Verrill C, Moore LE, Lubin J, Ward MH, Samanic C, Rothman N, Cantor KP, Beane Freeman LE, Schned A, Cherala S, Silverman DT (2011). Occupation and bladder cancer in a population-based case-control study in Northern New England. Occup Environ Med  68, 239-49.   https://doi.org/10.1136/oem.2009.052571|3. Ward MH, Cross AJ, Abnet CC, Sinha R, Markin RS, Weisenburger DD (2012). Heme iron from meat and risk of adenocarcinoma of the esophagus and stomach. Eur J Cancer Prev  21, 134-8.   https://doi.org/10.1097/CEJ.0b013e32834c9b6c",https://intramural.nih.gov/search/searchview.taf?ipid=68866
682,CP010126-16,"October 01, 2010 -  September 30, 2011",Hormone-Related Cancers,Michael Blaise Cook|IRP Faculty Profile  |Jonine Danya Figueroa| | |Gretchen L Gierach|IRP Faculty Profile  | |Katherine Ann McGlynn; PhD|IRP Faculty Profile  | |Nicolas Albert Hermann Wentzensen|IRP Faculty Profile  |Louise  Brinton; PhD,NULL,"Hormonal and Reproductive Epidemiology Branch, NCI",Patricia  Madigan|Mark E Sherman; MD|Roni T Falk|Britton Lindsay Trabert|Hannah  Yang|Barbara J Fuhrman|Show all 7,David  Alberts (University of Arizona Cancer Center)|Douglas  Bauer (University of California at San Francisco)|Ralph  Coates (Centers for Disease Control and Prevention)|Joanne  Dorgan; PhD (NCI)|Kathleen  Egan (Harvard University)|Loren  Erickson (Department of Defense)|Show all 11,"Barry Ira Graubard; PhD (Biostatistics Branch)|William Frederick Anderson (Biostatistics Branch)|Stephen J Chanock; MD, PhD (Laboratory Translational Genomics)|Aaron E Blair; PhD, MPH (Occupational and Environmental Epidemiology Branch)","Jeffery P Struewing; MS, MD (NHGRI) |Matthew P. Longnecker; MD, ScD (NIEHS)","1. Amankwah EK, Kelemen LE, Wang Q, Song H, Chenevix-Trench G, Australian Ovarian Cancer Study Group, Beesley J, Webb PM, Australian Cancer Study (Ovarian Cancer), Pearce CL, Wu AH, Pike MC, Stram DO, Chang-Claude J, Wang-Gohrke S, Ness RB, Goode EL, Cunningham JM, Fridley BL, Vierkant RA, Tworoger SS, Whittemore AS, McGuire V, Sieh W, Gayther SA, Gentry-Maharaj A, Menon U, Ovarian Cancer Association Consortium, et al. [18 more authors] (2011). Prostate cancer susceptibility polymorphism rs2660753 is not associated with invasive ovarian cancer. Cancer Epidemiol Biomarkers Prev  20, 1028-31.   https://doi.org/10.1158/1055-9965.EPI-11-0053|2. Andreas S, Cook M, McGlynn K, Rusner C (2011) Impact of classification of mixed germ-cell tumours on incidence trends of nonseminoma. Int J Androl 34:e274-e277.|3. Andrew G, Brinton L, Dorgan J, Egleston B, Kahle L, Spittle C (2011) Serum antimllerian hormone in healthy premenopausal women. Fertility and sterility 95:2718-21.|4. Atchison EA, Gridley G, Carreon JD, Leitzmann MF, McGlynn KA (2011). Risk of cancer in a large cohort of U.S. veterans with diabetes. Int J Cancer  128, 635-43.   https://doi.org/10.1002/ijc.25362|5. Benson G, Brinton L, Sherman M (2010) Lobular Involution, Mammographic Density and Breast Cancer Risk: Visualizing the Future? J Natl Cancer Inst 102:1685-7.|6. Broeks A, Schmidt MK, Sherman ME, Couch FJ, Hopper JL, Dite GS, Apicella C, Smith LD, Hammet F, Southey MC, Van 't Veer LJ, de Groot R, Smit VT, Fasching PA, Beckmann MW, Jud S, Ekici AB, Hartmann A, Hein A, Schulz-Wendtland R, Burwinkel B, Marme F, Schneeweiss A, Sinn HP, Sohn C, Genica Network, kConFab, AOCS, et al. [127 more authors] (2011). Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium. Hum Mol Genet  20, 3289-303.   https://doi.org/10.1093/hmg/ddr228|7. Catherine L, Cook M, McGlynn K (2010) A systematic review and meta-analysis of the relationship between body size and testicular cancer. Br J Cancer 103:1467-74.|8. Chia VM, Quraishi SM, Devesa SS, Purdue MP, Cook MB, McGlynn KA (2010). International trends in the incidence of testicular cancer, 1973-2002. Cancer Epidemiol Biomarkers Prev  19, 1151-9.   https://doi.org/10.1158/1055-9965.EPI-10-0031|9. Cook M, Akre O, Forman D, Madigan P, McGlynn K, Richiardi L (2010) A systematic review and meta-analysis of perinatal variables in relation to the risk of testicular cancer--experiences of the son. Int J Epidemiol 39:1605-1618.|10. Cook MB, Akre O, Forman D, Madigan MP, Richiardi L, McGlynn KA (2010). A systematic review and meta-analysis of perinatal variables in relation to the risk of testicular cancer--experiences of the son. Int J Epidemiol  39, 1605-18.   https://doi.org/10.1093/ije/dyq120|11. Cook MB, McGlynn KA, Devesa SS, Freedman ND, Anderson WF (2011). Sex disparities in cancer mortality and survival. Cancer Epidemiol Biomarkers Prev  20, 1629-37.   https://doi.org/10.1158/1055-9965.EPI-11-0246|12. Cook MB, Trabert B, McGlynn KA (2011). Organochlorine compounds and testicular dysgenesis syndrome: human data. Int J Androl  34, e68-84; discussion e84-5.   https://doi.org/10.1111/j.1365-2605.2011.01171.x|13. Dorgan JF, Stanczyk FZ, Kahle LL, Brinton LA (2010). Prospective case-control study of premenopausal serum estradiol and testosterone levels and breast cancer risk. Breast Cancer Res  12, R98.   https://doi.org/10.1186/bcr2779|14. Endogenous Hormones and Breast Cancer Collaborative Group, Key TJ, Appleby PN, Reeves GK, Roddam AW, Helzlsouer KJ, Alberg AJ, Rollison DE, Dorgan JF, Brinton LA, Overvad K, Kaaks R, Trichopoulou A, Clavel-Chapelon F, Panico S, Duell EJ, Peeters PH, Rinaldi S, Fentiman IS, Dowsett M, Manjer J, Lenner P, Hallmans G, Baglietto L, English DR, Giles GG, et al. [26 more authors] (2011). Circulating sex hormones and breast cancer risk factors in postmenopausal women: reanalysis of 13 studies. Br J Cancer  105, 709-22.   https://doi.org/10.1038/bjc.2011.254|15. Falk RT, Gentzschein E, Stanczyk FZ, Garcia-Closas M, Figueroa JD, Ioffe OB, Lissowska J, Brinton LA, Sherman ME (2012). Sex steroid hormone levels in breast adipose tissue and serum in postmenopausal women. Breast Cancer Res Treat  131, 287-94.   https://doi.org/10.1007/s10549-011-1734-5|16. Figueroa J, Ahn S, AittomÃ¤ki K, Andrulis I, Anton-Culver H, Antonenkova N, Apicella C, Arias J, Arndt V, Ashworth A, Baglietto L, Barile M, Beckmann M, Beesley J, BenÃ­tez J, Bermisheva M, Blomqvist C, Bogdanova N, Bojesen S, Brauch H, Bremer M, Brennan P, Brenner H, Brinton L, Brock I, et al. [75 more authors] (2011) Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: Findings from the Breast Cancer Association Consortium. Human molecular genetics 2011:2011.|17. Figueroa J, Anderson W, Benson G, Brinton L, Cornelison R, Duggan M, Flanders K, Garcia-Closas M, Lissowska J, Matsuno R, Ooshima A, Peplonska B, Pfeiffer R, Sherman M, Wakefield L, Yang X (2010) Expression of TGF-beta signaling factors in invasive breast cancers: relationships with age at diagnosis and tumor characteristics. Breast Cancer Res Treat 121:727-35.|18. Figueroa JD, Flanders KC, Garcia-Closas M, Anderson WF, Yang XR, Matsuno RK, Duggan MA, Pfeiffer RM, Ooshima A, Cornelison R, Gierach GL, Brinton LA, Lissowska J, Peplonska B, Wakefield LM, Sherman ME (2010). Expression of TGF-beta signaling factors in invasive breast cancers: relationships with age at diagnosis and tumor characteristics. Breast Cancer Res Treat  121, 727-35.   https://doi.org/10.1007/s10549-009-0590-z|19. Figueroa JD, Garcia-Closas M, Humphreys M, Platte R, Hopper JL, Southey MC, Apicella C, Hammet F, Schmidt MK, Broeks A, Tollenaar RA, Van't Veer LJ, Fasching PA, Beckmann MW, Ekici AB, Strick R, Peto J, dos Santos Silva I, Fletcher O, Johnson N, Sawyer E, Tomlinson I, Kerin M, Burwinkel B, Marme F, GENICA Network, kConFab AOCS Management Group, et al. [120 more authors] (2011). Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium. Hum Mol Genet  20, 4693-706.   https://doi.org/10.1093/hmg/ddr368|20. Frank S, Brinton L, Falk R, Figueroa J, Sherman M (2011) Sex steroid hormone levels in breast adipose tissue and serum in postmenopausal women. Breast cancer research and treatment 2011:2011.|21. Galina L, Akbari M, Brinton L, Carney M, Chen C, De I, Doherty J, Endometrial E, Endometrial A, Garcia-Closas M, Gaudet M, Goodman M, Henderson B, Kolonel L, Le L, Levine D, Liang X, Lissowska J, Matsuno R, Narod S, OMara T, Olson S, Orlow I, Prescott J, Rebbeck T, et al. [8 more authors] (2011) The obesity-associated polymorphisms FTO rs9939609 and MC4R rs17782313 and endometrial cancer risk in non-Hispanic white women. PLoS Genet 6:e16756.|22. Gaudet MM, Falk RT, Gierach GL, Lacey JV, Graubard BI, Dorgan JF, Brinton LA (2010). Do adipokines underlie the association between known risk factors and breast cancer among a cohort of United States women? Cancer Epidemiol  34, 580-6.   https://doi.org/10.1016/j.canep.2010.05.014|23. Gaudet MM, Yang HP, Bosquet JG, Healey CS, Ahmed S, Dunning AM, Easton DF, Spurdle AB, Ferguson K, O'Mara T, Lambrechts D, Despierre E, Vergote I, Amant F, Lacey JV, Lissowska J, Peplonska B, Brinton LA, Chanock S, Garcia-Closas M (2010). No association between FTO or HHEX and endometrial cancer risk. Cancer Epidemiol Biomarkers Prev  19, 2106-9.   https://doi.org/10.1158/1055-9965.EPI-10-0515|24. Gierach GL, Brinton LA, Sherman ME (2010). Lobular involution, mammographic density, and breast cancer risk: visualizing the future? J Natl Cancer Inst  102, 1685-7.   https://doi.org/10.1093/jnci/djq433|25. Joanne D, Brinton L, Egleston B, Kahle L, Shaw C, Spittle C (2010) Assay reproducibility and within-person variation of Mllerian inhibiting substance. Fertil Steril 94:301-304.|26. Joanne D, Brinton L, Kahle L, Stanczyk F (2010) Prospective Case-Control Study of Premenopausal Serum Estradiol and Testosterone Levels and Breast Cancer Risk. Breast Cancer Research 12:R98.|27. Kim C, McGlynn KA, McCorkle R, Erickson RL, Niebuhr DW, Ma S, Graubard B, Aschebrook-Kilfoy B, Barry KH, Zhang Y (2011). Quality of life among testicular cancer survivors: a case-control study in the United States. Qual Life Res  20, 1629-37.   https://doi.org/10.1007/s11136-011-9907-6|28. Lacey JV, Yang H, Gaudet MM, Dunning A, Lissowska J, Sherman ME, Peplonska B, Brinton LA, Healey CS, Ahmed S, Pharoah P, Easton D, Chanock S, Garcia-Closas M (2011). Endometrial cancer and genetic variation in PTEN, PIK3CA, AKT1, MLH1, and MSH2 within a population-based case-control study. Gynecol Oncol  120, 167-73.   https://doi.org/10.1016/j.ygyno.2010.10.016|29. Lerro CC, McGlynn KA, Cook MB (2010). A systematic review and meta-analysis of the relationship between body size and testicular cancer. Br J Cancer  103, 1467-74.   https://doi.org/10.1038/sj.bjc.6605934|30. Lin WY, Camp NJ, Cannon-Albright LA, Allen-Brady K, Balasubramanian S, Reed MW, Hopper JL, Apicella C, Giles GG, Southey MC, Milne RL, Arias-Pérez JI, Menéndez-Rodríguez P, Benítez J, Grundmann M, Dubrowinskaja N, Park-Simon TW, Dörk T, Garcia-Closas M, Figueroa J, Sherman M, Lissowska J, Easton DF, Dunning AM, Rajaraman P, et al. [6 more authors] (2011). A role for XRCC2 gene polymorphisms in breast cancer risk and survival. J Med Genet  48, 477-84.   https://doi.org/10.1136/jmedgenet-2011-100018|31. Lurie G, Gaudet MM, Spurdle AB, Carney ME, Wilkens LR, Yang HP, Weiss NS, Webb PM, Thompson PJ, Terada K, Setiawan VW, Rebbeck TR, Prescott J, Orlow I, O'Mara T, Olson SH, Narod SA, Matsuno RK, Lissowska J, Liang X, Levine DA, Le Marchand L, Kolonel LN, Henderson BE, Garcia-Closas M, Australian National Endometrial Cancer Study Group, Epidemiology of Endometrial Cancer Consortium (E2C2), et al. [6 more authors] (2011). The obesity-associated polymorphisms FTO rs9939609 and MC4R rs17782313 and endometrial cancer risk in non-Hispanic white women. PLoS One  6, e16756.   https://doi.org/10.1371/journal.pone.0016756|32. Lurie G, Wilkens LR, Thompson PJ, Shvetsov YB, Matsuno RK, Carney ME, Palmieri RT, Wu AH, Pike MC, Pearce CL, Menon U, Gentry-Maharaj A, Gayther SA, Ramus SJ, Whittemore AS, McGuire V, Sieh W, Pharoah PD, Song H, Gronwald J, Jakubowska A, Cybulski C, Lubinski J, Schildkraut JM, Berchuck A, et al. [13 more authors] (2011) Estrogen receptor beta rs1271572 polymorphism and invasive ovarian carcinoma risk: pooled analysis within the Ovarian Cancer Association Consortium. PLoS One 6:e20703|33. Mia G, Ahmed S, Amant F, Brinton L, Chanock S, Despierre E, Dunning A, Easton D, Ferguson K, Garcia-Closas M, Gonzalez J, Healey C, Lacey J, Lambrechts D, Lissowska J, OMara T, Peplonska B, Spurdle A, Vergote I, Yang H (2010) No association between FTO or HHEX and endometrial cancer risk. Cancer Epidemiol Biomarkers Prev 19:2106-9.|34. Milne RL, Gaudet MM, Spurdle AB, Fasching PA, Couch FJ, Benítez J, Arias Pérez JI, Zamora MP, Malats N, Dos Santos Silva I, Gibson LJ, Fletcher O, Johnson N, Anton-Culver H, Ziogas A, Figueroa J, Brinton L, Sherman ME, Lissowska J, Hopper JL, Dite GS, Apicella C, Southey MC, Sigurdson AJ, Linet MS, GENICA Network, kConFab, AOCS, et al. [57 more authors] (2010). Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study. Breast Cancer Res  12, R110.   https://doi.org/10.1186/bcr2797|35. Olivia F, Ashworth A, Brinton L, Chanock S, Garcia-Closas M, Heikkinen T, Johnson N, Nevanlinna H, Silva I (2010) Missense Variants in ATM in 26,101 Breast Cancer Cases and 29,842 Controls. Cancer Epidemiol Biomarkers Prev 9:2143-2151.|36. Permuth-Wey J, Chen Z, Tsai YY, Lin HY, Chen YA, Barnholtz-Sloan J, Birrer MJ, Chanock SJ, Cramer DW, Cunningham JM, Fenstermacher D, Fridley BL, Garcia-Closas M, Gayther SA, Gentry-Maharaj A, Gonzalez-Bosquet J, Iversen E, Jim H, McLaughlin J, Menon U, Narod SA, Phelan CM, Ramus SJ, Risch H, Song H, Ovarian Cancer Association Consortium (OCAC), et al. [12 more authors] (2011). MicroRNA processing and binding site polymorphisms are not replicated in the Ovarian Cancer Association Consortium. Cancer Epidemiol Biomarkers Prev  20, 1793-7.   https://doi.org/10.1158/1055-9965.EPI-11-0397|37. Permuth-Wey J, Kim D, Tsai YY, Lin HY, Chen YA, Barnholtz-Sloan J, Birrer MJ, Bloom G, Chanock SJ, Chen Z, Cramer DW, Cunningham JM, Dagne G, Ebbert-Syfrett J, Fenstermacher D, Fridley BL, Garcia-Closas M, Gayther SA, Ge W, Gentry-Maharaj A, Gonzalez-Bosquet J, Goode EL, Iversen E, Jim H, Kong W, Ovarian Cancer Association Consortium, et al. [20 more authors] (2011). LIN28B polymorphisms influence susceptibility to epithelial ovarian cancer. Cancer Res  71, 3896-903.   https://doi.org/10.1158/0008-5472.CAN-10-4167|38. Roger M, AOCS A, kConFab k, Ahmed S, Andrulis I, Anton-Culver H, Apicella C, Arias J, Auvinen P, Baglietto L, Beckmann M, Benitez J, Bojesen S, Brauch H, Brinton L, Bruning T, Chang-Claude J, Chenevix-Trench G, Couch F, Cox A, Cross S, Czene K, Dite G, Dunning A, Easton D, et al. [60 more authors] (2010) Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the Breast Cancer Association Consortium: a combined case-control study. Breast Cancer Res 12:R110.|39. Shama A, Cantwell M, Cardwell C, Cook M, Murray L (2010) Maternal body mass index and risk of testicular cancer in male offspring: A systematic review and meta-analysis. Cancer Epidemiol 2010:na.|40. Shaw CM, Stanczyk FZ, Egleston BL, Kahle LL, Spittle CS, Godwin AK, Brinton LA, Dorgan JF (2011). Serum antimüllerian hormone in healthy premenopausal women. Fertil Steril  95, 2718-21.   https://doi.org/10.1016/j.fertnstert.2011.05.051|41. Sherman M, Blows F, Garcia-Closas M, Hewitt S, Howatt W, Pharoah P (2010) Molecular pathology in epidemiologic studies: a primer on key considerations. Cancer Epidemiol Biomarkers Prev 19:966-72.|42. Sherman ME, Howatt W, Blows FM, Pharoah P, Hewitt SM, Garcia-Closas M (2010). Molecular pathology in epidemiologic studies: a primer on key considerations. Cancer Epidemiol Biomarkers Prev  19, 966-72.   https://doi.org/10.1158/1055-9965.EPI-10-0056|43. Spurdle AB, Thompson DJ, Ahmed S, Ferguson K, Healey CS, O'Mara T, Walker LC, Montgomery SB, Dermitzakis ET, Australian National Endometrial Cancer Study Group, Fahey P, Montgomery GW, Webb PM, Fasching PA, Beckmann MW, Ekici AB, Hein A, Lambrechts D, Coenegrachts L, Vergote I, Amant F, Salvesen HB, Trovik J, Njolstad TS, Helland H, Scott RJ, National Study of Endometrial Cancer Genetics Group, et al. [25 more authors] (2011). Genome-wide association study identifies a common variant associated with risk of endometrial cancer. Nat Genet  43, 451-4.   https://doi.org/10.1038/ng.812|44. Trabert B, Graubard B, Klebanoff M, Longnecker M, McGlynn K, Stanczyk F (2011) Placental characteristics as a proxy measure of serum hormone and protein levels during pregnancy with a male fetus. Cancer Causes Control 22:689-695.|45. Trabert B, Longnecker MP, Graubard BI, Klebanoff MA, Stanczyk FZ, McGlynn KA (2011). Placental characteristics as a proxy measure of serum hormone and protein levels during pregnancy with a male fetus. Cancer Causes Control  22, 689-95.   https://doi.org/10.1007/s10552-011-9741-8|46. Trabert B, McGlynn K, Sigurdson A, Strom S, Sweeney A (2011) Marijuana use and testicular germ cell tumors. Cancer 117:848-53.|47. Trabert B, Sigurdson AJ, Sweeney AM, Strom SS, McGlynn KA (2011). Marijuana use and testicular germ cell tumors. Cancer  117, 848-53.   https://doi.org/10.1002/cncr.25499|48. Trabert B, Stang A, Cook MB, Rusner C, McGlynn KA (2011). Impact of classification of mixed germ-cell tumours on incidence trends of non-seminoma. Int J Androl  34, e274-7.   https://doi.org/10.1111/j.1365-2605.2011.01187.x|49. Victoria C, Cook M, Devesa S, McGlynn K, Purdue M, Quraishi S (2010) International trends in the incidence of testicular cancer, 1973-2002. Cancer Epidemiol Biomarkers Prev 19:1151-9.|50. Yang H, Black A, Brinton L, Falk R, Faupel-Badger J, Potischman N, Sherman M, Wentzensen N (2011) Association of serum sex steroid hormone hemodilution and body mass index among healthy postmenopausal women. Ann Epidemiol 21:466-71.|51. Yang H, Brinton L, Burdett L, Chanock S, Ciampa J, Figueroa J, Garcia-Closas M, Gaudet M, Gonzalez J, Lacey J, Li Q, Lissowska J, Peplonska B, Platz E, Sherman M (2010) Common genetic variation in the sex hormone metabolic pathway and endometrial cancer risk: pathway-based evaluation of candidate genes. Carcinogenesis 31:827-833.|52. Yang H, Brinton L, Garcia-Closas M, Lacey J, Lissowska J, Peplonska B, Platz E, Sherman M (2010) Active and passive cigarette smoking and the risk of endometrial cancer in Poland. Eur J Cancer 46:690-6.|53. Yang HP, Black A, Falk RT, Brinton LA, Potischman N, Wentzensen N, Faupel-Badger JM, Sherman ME (2011). Association of serum sex steroid hormone hemodilution and body mass index among healthy postmenopausal women. Ann Epidemiol  21, 466-71.   https://doi.org/10.1016/j.annepidem.2011.01.003|54. Yang HP, Brinton LA, Platz EA, Lissowska J, Lacey JV, Sherman ME, Peplonska B, Garcia-Closas M (2010). Active and passive cigarette smoking and the risk of endometrial cancer in Poland. Eur J Cancer  46, 690-6.   https://doi.org/10.1016/j.ejca.2009.11.015|55. Yang HP, Gonzalez Bosquet J, Li Q, Platz EA, Brinton LA, Sherman ME, Lacey JV, Gaudet MM, Burdette LA, Figueroa JD, Ciampa JG, Lissowska J, Peplonska B, Chanock SJ, Garcia-Closas M (2010). Common genetic variation in the sex hormone metabolic pathway and endometrial cancer risk: pathway-based evaluation of candidate genes. Carcinogenesis  31, 827-33.   https://doi.org/10.1093/carcin/bgp328",https://intramural.nih.gov/search/searchview.taf?ipid=68867
683,CP010127-16,"October 01, 2010 -  September 30, 2011",Etiologic Studies of Diet and Cancer,Eric Andrew Engels; PhD|IRP Faculty Profile  | |Rashmi P Sinha; PhD|IRP Faculty Profile  | |Katherine Ann McGlynn; PhD|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI

Nutritional Epidemiology Branch, NCI

Hormonal and Reproductive Epidemiology Branch, NCI",Neal David Freedman,NULL,NULL,NULL,"1. Mathew A, Daniel CR, Ferrucci LM, Seth T, Devesa SS, George PS, Shetty H, Devasenapathy N, Yurgalevitch S, Rastogi T, Prabhakaran D, Gupta PC, Chatterjee N, Sinha R (2011). Assessment of follow-up, and the completeness and accuracy of cancer case ascertainment in three areas of India. Cancer Epidemiol  35, 334-41.   https://doi.org/10.1016/j.canep.2011.03.006|2. Nair M, Prabhakaran D, Narayan KM, Sinha R, Lakshmy R, Devasenapathy N, Daniel CR, Gupta R, George PS, Mathew A, Tandon N, Reddy KS (2011). HbA(1c) values for defining diabetes and impaired fasting glucose in Asian Indians. Prim Care Diabetes  5, 95-102.   https://doi.org/10.1016/j.pcd.2011.02.002|3. Sinha R, Daniel CR, Devasenapathy N, Shetty H, Yurgalevitch S, Ferrucci LM, George PS, Morrissey KG, Ramakrishnan L, Graubard BI, Kapur K, Reddy KS, McAdams MJ, Rastogi T, Chatterjee N, Gupta PC, Wacholder S, Prabhakaran D, Mathew AA (2011). Multi-center feasibility study evaluating recruitment, variability in risk factors and biomarkers for a diet and cancer cohort in India. BMC Public Health  11, 405.   https://doi.org/10.1186/1471-2458-11-405|4. Tasevska N, Cross AJ, Dodd KW, Ziegler RG, Caporaso NE, Sinha R (2011). No effect of meat, meat cooking preferences, meat mutagens or heme iron on lung cancer risk in the prostate, lung, colorectal and ovarian cancer screening trial. Int J Cancer  128, 402-11.   https://doi.org/10.1002/ijc.25327",https://intramural.nih.gov/search/searchview.taf?ipid=68885
684,CP010128-16,"October 01, 2010 -  September 30, 2011",Therapeutic and Diagnostic Factors as Related to Cancer Risk,Gretchen L Gierach|IRP Faculty Profile  |Louise  Brinton; PhD,NULL,"Hormonal and Reproductive Epidemiology Branch, NCI",Mark E Sherman; MD,Douglas  Bauer (University of California at San Francisco)|Lenore  Buckley (Virginia Commonwealth University)|Theodore  Colton (Boston University School of Public Health)|Olga  Dvorkina (SUNY Health Sciences Center)|Susanne  Kruger-Kjaer (Danish Cancer Registry)|Emmet  Lamb (Stanford University)|Show all 8,"Allan  Hildesheim; PhD (Infection & Immunoepidemiology Branch)|Robert  Hoover; MD, ScD (Epidemiology and Biostatistics Program)|Catherine G Schairer (Biostatistics Branch)|Arthur  Schatzkin; PhD (Nutritional Epidemiology Branch)|Patricia  Hartge; ScD (Epidemiology and Biostatistics Program)|Jay  Lubin; PhD (Biostatistics Branch)",NULL,"1. Brinton LA, Moghissi KS, Westhoff CL, Lamb EJ, Scoccia B (2010). Cancer risk among infertile women with androgen excess or menstrual disorders (including polycystic ovary syndrome). Fertil Steril  94, 1787-92.   https://doi.org/10.1016/j.fertnstert.2009.10.012",https://intramural.nih.gov/search/searchview.taf?ipid=68868
685,CP010131-16,"October 01, 2010 -  September 30, 2011",Studies of Populations Exposed to Therapeutic Medical Radiation and Other Agents,Peter D Inskip; ScD| | |Amy  de Gonzalez|IRP Faculty Profile,NULL,"Radiation Epidemiology Branch, NCI","Rochelle E Curtis|Ruth Anne Kleinerman; MPH|Michele M Doody; MS|Alice  Sigurdson; PhD|Steven L Simon|Kiyohiko  Mabuchi; MD, DPhil|Show all 14","David  Abramson (New York Presbyterian Hospital)|Michael  Andersson (Danish Cancer Society)|Florent  de-Vathaire (Unit 605, Inserm)|Sophie  Fossa|Mary  Gospodarowicz (Princess Margaret Hospital)|Per  Hall (Karolinska Instituet)|Show all 24",Margaret Anne Tucker (Human Genetics Program)|Jay  Lubin; PhD (Biostatistics Branch),NULL,"1. Berrington A (2010) Sample-size efficiencies via the multiple-primary-cancer study: why fewer cases may not mean less work. Epidemiology 21:373-5.|2. Berrington A, Berg C, Curtis R, Gilbert E, Ron E, Smith S, Stovall M (2010) Second solid cancers after radiotherapy for breast cancer in SEER cancer registries. Br J Cancer 102:220-6.|3. Berrington de Gonzalez A, Curtis RE, Gilbert E, Berg CD, Smith SA, Stovall M, Ron E (2010). Second solid cancers after radiotherapy for breast cancer in SEER cancer registries. Br J Cancer  102, 220-6.   https://doi.org/10.1038/sj.bjc.6605435|4. Berrington de Gonzalez A, Curtis RE, Kry SF, Gilbert E, Lamart S, Berg CD, Stovall M, Ron E (2011). Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registries. Lancet Oncol  12, 353-60.   https://doi.org/10.1016/S1470-2045(11)70061-4|5. Bijwaard H, Brenner A, Dekkers F, van Dillen T, Land CE, Boice JD (2010). Breast cancer risk from different mammography screening practices. Radiat Res  174, 367-76.   https://doi.org/10.1667/RR2067.1|6. Harmen B, Boice J, Brenner A, Dekkers F, Land C, van T (2010) Breast cancer risk from different mammography screening practices. Radiation Research 174:367-76.|7. Kleinerman R, Mabuchi K, Weinstock R (2010) High-dose Abdominal Radiotherapy and Risk of Diabetes Mellitus. Archives of Internal Medicine 170:1506-7.|8. Lönn S, Gilbert ES, Ron E, Smith SA, Stovall M, Curtis RE (2010). Comparison of second cancer risks from brachytherapy and external beam therapy after uterine corpus cancer. Cancer Epidemiol Biomarkers Prev  19, 464-74.   https://doi.org/10.1158/1055-9965.EPI-09-0892|9. Little MP, Kleinerman RA, Stiller CA, Li G, Kroll ME, Murphy MF (2012). Analysis of retinoblastoma age incidence data using a fully stochastic cancer model. Int J Cancer  130, 631-40.   https://doi.org/10.1002/ijc.26039|10. Liu JC, Givi B, Wolden S, Kleinerman RA, Dunkel IJ, Lee N, Shah JP, Abramson DH, Kraus DH (2011). Secondary skull base malignancies in survivors of retinoblastoma: the memorial sloan kettering cancer center experience. Skull Base  21, 103-8.   https://doi.org/10.1055/s-0031-1275256|11. Morton LM, Landgren O (2011). Associations between non-Hodgkin lymphoma and renal cell carcinoma. Leuk Lymphoma  52, 2201-2.   https://doi.org/10.3109/10428194.2011.614711|12. Pooja B, Abramson D, Carlson D, Colanta A, Dunkel I, Kleinerman R, Kraus D (2011) Sinonasal Adenocarcinoma: A rare second malignancy in long term retinoblastoma survivors. Pediatric Cancer and Blood 57:693-5.|13. Stefan L, Curtis R, Gilbert E, Ron E, Smith S, Stovall M (2010) Comparison of second cancer risks from brachytherapy and external beam therapy after uterine corpus cancer. Cancer Epidemiol Biomarkers Prev 19:464-74.",https://intramural.nih.gov/search/searchview.taf?ipid=68869
686,CP010132-16,"October 01, 2010 -  September 30, 2011",Studies of Populations Exposed to Environmental Sources of Radiation,Martha S Linet; PhD|IRP Faculty Profile  |Preetha  Rajaraman,NULL,"Radiation Epidemiology Branch, NCI","Steven L Simon|Alina V Brenner|Maureen Cusack Hatch; MD|Kiyohiko  Mabuchi; MD, DPhil|Daryl  Freedman|Alice  Sigurdson; PhD|Show all 7","Bruce  Alexander (University of Minnesota)|Boris  Gusev (Kazakh Institute for Radiation Medicine and Ecology)|Terry  Hartman (Pennsylvania State University)|Margaret  Karagas (Dartmouth University, Lebanon, NH)|Heather  Nelson (Harvard School of Public Health)|Alex  Romanukha (National Institute for Standards and Technology)|Show all 9",NULL,NULL,"1. Cardis E, Hatch M (2011). The Chernobyl accident--an epidemiological perspective. Clin Oncol (R Coll Radiol)  23, 251-60.   https://doi.org/10.1016/j.clon.2011.01.510|2. Drozdovitch V, Khrouch V, Maceika E, Zvonova I, Vlasov O, Bratilova A, Gavrilin Y, Goulko G, Hoshi M, Kesminiene A, Shinkarev S, Tenet V, Cardis E, Bouville A (2010). Reconstruction of radiation doses in a case-control study of thyroid cancer following the Chernobyl accident. Health Phys  99, 1-16.   https://doi.org/10.1097/HP.0b013e3181c910dd|3. Freedman D, Abnet C, Graubard B, Linet M, Looker A (2010) Serum 25-hydroxyvitamin D and Cancer Mortality in the NHANES III Study (1988-2006). Cancer Research 70:8587-97.|4. Hatch M, Bouville A, Brenner A, Furukawa K, Markov V, McConnell R, Olinjyk v, Ron E, Shpak V, Terekhova G, Tronko M, Zablotska L (2010) Prevalence of hyperthyroidism after exposure during childhood or adolescence to radioiodines from the Chornobyl nuclear accident: dose-response results from the Ukrainian-American Cohort Study. Radiat Res 174:763-72.|5. Liu Y, Melin BS, Rajaraman P, Wang Z, Linet M, Shete S, Amos CI, Lau CC, Scheurer ME, Tsavachidis S, Armstrong GN, Houlston RS, Hosking FJ, Claus EB, Barnholtz-Sloan J, Lai R, Il'yasova D, Schildkraut J, Sadetzki S, Johansen C, Bernstein JL, Olson SH, Jenkins RB, LaChance D, Vick NA, Gliogene Consortium, et al. [7 more authors] (2012). Insight in glioma susceptibility through an analysis of 6p22.3, 12p13.33-12.1, 17q22-23.2 and 18q23 SNP genotypes in familial and non-familial glioma. Hum Genet  131, 1507-17.   https://doi.org/10.1007/s00439-012-1187-x",https://intramural.nih.gov/search/searchview.taf?ipid=68854
687,CP010133-16,"October 01, 2010 -  September 30, 2011",Studies of Populations Exposed to Occupational Sources of Radiation,Preetha  Rajaraman| | |Martha S Linet; PhD|IRP Faculty Profile,NULL,"Radiation Epidemiology Branch, NCI",Michele M Doody; MS|Daryl  Freedman|Maureen Cusack Hatch; MD|Peter D Inskip; ScD|Alice  Sigurdson; PhD|Steven L Simon|Show all 8,"Bruce  Alexander (University of Minnesota)|Anssi P Auvinen|Timo  Hakulinen (Finnish Cancer Registry)|Terry  Hartman (Pennsylvania State University)|Juozas  Kurtinaitis (Lithuanian Cancer Registry)|Lynne  Pinkerton (National Institute of Occupational Safety and Health, Cincinnati, OH)|Show all 17",NULL,NULL,"1. Freedman D, Alexander B, Hoffbeck R, Kimlin M, Linet M (2010) Multiple indicators of ambient and personal sun exposure and risk of non-Hodgkin lymphoma (United States). J Photochem Photobiol B 101:321-5.|2. Freedman DM, Kimlin MG, Hoffbeck RW, Alexander BH, Linet MS (2010). Multiple indicators of ambient and personal ultraviolet radiation exposure and risk of non-Hodgkin lymphoma (United States). J Photochem Photobiol B  101, 321-5.   https://doi.org/10.1016/j.jphotobiol.2010.08.001|3. Kitahara CM, Platz EA, Freeman LE, Hsing AW, Linet MS, Park Y, Schairer C, Schatzkin A, Shikany JM, Berrington de González A (2011). Obesity and thyroid cancer risk among U.S. men and women: a pooled analysis of five prospective studies. Cancer Epidemiol Biomarkers Prev  20, 464-72.   https://doi.org/10.1158/1055-9965.EPI-10-1220|4. Meinhold CL, Ron E, Schonfeld SJ, Alexander BH, Freedman DM, Linet MS, Berrington de González A (2010). Nonradiation risk factors for thyroid cancer in the US Radiologic Technologists Study. Am J Epidemiol  171, 242-52.   https://doi.org/10.1093/aje/kwp354",https://intramural.nih.gov/search/searchview.taf?ipid=68870
688,CP010134-16,"October 01, 2010 -  September 30, 2011",Studies of Atomic Bomb Survivors,"Amy  de Gonzalez|IRP Faculty Profile  | |Kiyohiko  Mabuchi; MD, DPhil|IRP Faculty Profile",NULL,"Radiation Epidemiology Branch, NCI",Alina V Brenner|Mark Peter Little,"Kyoji  Furukawa; PhD|Yuko  Hirai (Genetics, Radiation Effects Research Foundation)|Kazunori  Kodama (Radiation Effects Research Foundation, Japan)|Jun  Nagano (Radiation Effects Research Foundation)|Nori  Nakamwa (Radiation Effects Research Foundation)|Kazuo  Neriishi (Radiation Effects Research Foundation)|Show all 12",NULL,NULL,"1. Christopher L, Davis S, Hayashi M, Kasagi F, Kodama K, Kopecky K, Mabuchi K, McDougall J, Nishi N, Sakata R, Semmens E, Soda M, Sugiyama H, Suyama A (2010) Relationship between radiation exposure and risk of second primary cancers among atomic bomb survivors. Cancer Res 70:7187-98.|2. Hayashi Y, Lagarde F, Tsuda N, Funamoto S, Preston DL, Koyama K, Mabuchi K, Ron E, Kodama K, Tokuoka S (2010). Papillary microcarcinoma of the thyroid among atomic bomb survivors: tumor characteristics and radiation risk. Cancer  116, 1646-55.   https://doi.org/10.1002/cncr.24872|3. Kyoji F, Egawa H, Funamoto S, Kasagi F, Kodama K, Lonn S, Mabuchi K, Matsuo T, Ozasa K, Preston D, Tokuoka S, Yonehara S (2010) Radiation and smoking effects on lung cancer incidence among atomic-bomb survivors. Radiat Res 174:72-82.|4. Sarah D, Boerma M, Constine L, Cuttler D, Fajarado L, Kodama K, Mabuchi K, Marks L, Mettler F, Pierce L, Shore R, Trott K, Yeh E (2010) Radiation-related heart disease: current knowledge and future prospects. Int J Radiat Oncol Biol Phys 76:656-65.|5. Yuzo H, Funamoto S, Kodama K, Koyama K, Legarde F, Mabuchi K, Preston D, Ron E, Tokuoka S, Tsuda N (2010) Papillary Microcarcinoma of the Thyroid among Atomic Bomb Survivors: Tumor Characteristics and Radiation Risk. Cancer 116:1646-55.",https://intramural.nih.gov/search/searchview.taf?ipid=68896
689,CP010135-16,"October 01, 2010 -  September 30, 2011",Studies of Non-Ionizing Radiation-Related Cancer,Martha S Linet; PhD|IRP Faculty Profile  |Peter D Inskip; ScD,NULL,"Radiation Epidemiology Branch, NCI",Alina V Brenner|Preetha  Rajaraman|Daryl  Freedman|Alice  Sigurdson; PhD|Gila I Neta,"Bruce  Alexander (University of Minnesota)|Bryan  Bassig|Peter  Black (Brigham and Women's Hospital & Dana Farber Cancer Center)|W.  Bleyer (Children's Cancer Group)|Mary Brantley Butler|Howard  Fine (Neuro-Oncology Branch, National Cancer Institute)|Show all 12",Nathaniel C Rothman; MD (Occupational and Environmental Epidemiology Branch),NULL,"1. Bhatti P, Stewart PA, Linet MS, Blair A, Inskip PD, Rajaraman P (2011). Comparison of occupational exposure assessment methods in a case-control study of lead, genetic susceptibility and risk of adult brain tumours. Occup Environ Med  68, 4-9.   https://doi.org/10.1136/oem.2009.048132|2. Bridget M, Aldape K, Bondy M, Brannstrom T, Broholm H, Butler M, Davis F, Feychting M, yasova D, Inskip P, Johansen C, Melin B, Rankin K, Ruder A, Scheurer M, Schuz J, Schwartzbaum J, Wrensch M (2011) Risk factors for oligodendroglial tumors: a pooled international study. Neuro-Oncology 13:242-50.|3. Inskip P, Devesa S, Hoover R (2010) Brain cancer incidence trends in relation to cellular telephone use in the United States. Neuro-Oncology 12:1147-51.|4. Inskip PD, Hoover RN, Devesa SS (2010). Brain cancer incidence trends in relation to cellular telephone use in the United States. Neuro Oncol  12, 1147-51.   https://doi.org/10.1093/neuonc/noq077|5. McCarthy BJ, Rankin KM, Aldape K, Bondy ML, Brännström T, Broholm H, Feychting M, Il'yasova D, Inskip PD, Johansen C, Melin BS, Ruder AM, Butler MA, Scheurer ME, Schüz J, Schwartzbaum JA, Wrensch MR, Davis FG (2011). Risk factors for oligodendroglial tumors: a pooled international study. Neuro Oncol  13, 242-50.   https://doi.org/10.1093/neuonc/noq173|6. Rajaraman P, Black P, Fine H, Hutchinson A, Inskip P, Linet M, Loeffler J, Rothman N, Selker R, Shapiro W, Wichner S (2010) DNA repair gene polymorphisms and risk of adult meningioma, glioma, and acoustic neuroma. neuro-oncology 12:37-48.|7. Rajaraman P, Brenner A, Chanock S, Fine H, Inskip P, Linet M, Neta G, Pfeiffer R, Rothman N, Thomas G, Wang S, Yeager M (2010) Risk of meningioma and common variation in genes related to innate immunity. Cancer Epidem Biomark Prev 19:1356-61.|8. Rajaraman P, Brenner AV, Neta G, Pfeiffer R, Wang SS, Yeager M, Thomas G, Fine HA, Linet MS, Rothman N, Chanock SJ, Inskip PD (2010). Risk of meningioma and common variation in genes related to innate immunity. Cancer Epidemiol Biomarkers Prev  19, 1356-61.   https://doi.org/10.1158/1055-9965.EPI-09-1151|9. Sigurdson AJ, Jones IM, Wei Q, Wu X, Spitz MR, Stram DA, Gross MD, Huang WY, Wang LE, Gu J, Thomas CB, Reding DJ, Hayes RB, Caporaso NE (2011). Prospective analysis of DNA damage and repair markers of lung cancer risk from the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Carcinogenesis  32, 69-73.   https://doi.org/10.1093/carcin/bgq204",https://intramural.nih.gov/search/searchview.taf?ipid=68871
690,CP010136-16,"October 01, 2010 -  September 30, 2011",Cancer Risk in Human Populations,"Debra  Silverman; ScD, ScM|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI","Bu Tian  Ji|Dalsu  Baris|Joanne S Colt|Mary Helen Ward; MS, PhD|Joseph B Coble|Claudine M Samanic|Show all 12",NULL,"Linda M Brown; MPH, DPhil (Biostatistics Branch)|Mark  Schiffman; MD (Clinical Genetics Branch)",NULL,"1. Bertuccio P, La Vecchia C, Silverman DT, Petersen GM, Bracci PM, Negri E, Li D, Risch HA, Olson SH, Gallinger S, Miller AB, Bueno-de-Mesquita HB, Talamini R, Polesel J, Ghadirian P, Baghurst PA, Zatonski W, Fontham ET, Bamlet WR, Holly EA, Lucenteforte E, Hassan M, Yu H, Kurtz RC, Cotterchio M, et al. [5 more authors] (2011). Cigar and pipe smoking, smokeless tobacco use and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (PanC4). Ann Oncol  22, 1420-6.   https://doi.org/10.1093/annonc/mdq613|2. Chang CY, Cook MB, Lee YC, Lin JT, Ando T, Bhatia S, Chow WH, El-Omar EM, Goto H, Li YQ, McColl K, Reddy N, Rhee PL, Sharma P, Sung JJ, Ghoshal U, Wong JY, Wu JC, Zhang J, Ho KY, Asian Barrett''s Consortium (2011). Current status of Barrett's esophagus research in Asia. J Gastroenterol Hepatol  26, 240-6.   https://doi.org/10.1111/j.1440-1746.2010.06529.x|3. Colt JS, Schwartz K, Graubard BI, Davis F, Ruterbusch J, Digaetano R, Purdue M, Rothman N, Wacholder S, Chow WH (2011) Hypertension and risk of renal cell carcinoma among white and black Americans. Epidemiology 22:797-804|4. CY C, Ando T, Bhatia S, Chow W, Consortium A, Cook M, El-Omar E, Ghoshal U, Goto H, Ho K, Lee Y, Li Y, Lin J, McColl K, Reddy N, Rhee P, Sharma P, Sung J, Wong J, Wu J, Zhang J (2011) Current status of Barrett's Esophagus Research in Asia. J Gastroenterol Hepatol 26:240-246.|5. Donghui L, Bracci P, Hassan M, Holly E, Silverman D, Tang H (2011) Diabetes and Risk of Pancreatic Cancer: a Pooled Analysis of Three Large Case-Control Studies. Cancer Causes Control 22:189-97.|6. Filson CP, Miller DC, Colt JS, Ruterbusch J, Linehan WM, Chow WH, Schwartz K (2012). Surgical approach and the use of lymphadenectomy and adrenalectomy among patients undergoing radical nephrectomy for renal cell carcinoma. Urol Oncol  30, 856-63.   https://doi.org/10.1016/j.urolonc.2010.08.024|7. Gawron AJ, Fought AJ, Lissowska J, Ye W, Zhang X, Chow WH, Beane Freeman LE, Hou L (2011). Polymorphisms in chemokine and receptor genes and gastric cancer risk and survival in a high risk Polish population. Scand J Gastroenterol  46, 333-40.   https://doi.org/10.3109/00365521.2010.537679|8. Gibson TM, Brennan P, Han S, Karami S, Zaridze D, Janout V, Kollarova H, Bencko V, Navratilova M, Szeszenia-Dabrowska N, Mates D, Slamova A, Pfeiffer RM, Stolzenberg-Solomon RZ, Mayne ST, Yeager M, Chanock S, Rothman N, Chow WH, Rosenberg PS, Boffetta P, Moore LE (2011). Comprehensive evaluation of one-carbon metabolism pathway gene variants and renal cell cancer risk. PLoS One  6, e26165.   https://doi.org/10.1371/journal.pone.0026165|9. Jia Y, Persson C, Hou L, Zheng Z, Yeager M, Lissowska J, Chanock SJ, Chow WH, Ye W (2010). A comprehensive analysis of common genetic variation in MUC1,  MUC5AC, MUC6 genes and risk of stomach cancer. Cancer Causes Control  21, 313-21.   https://doi.org/10.1007/s10552-009-9463-3|10. Karami S, Schwartz K, Purdue MP, Davis FG, Ruterbusch JJ, Munuo SS, Wacholder S, Graubard BI, Colt JS, Chow WH (2010). Family history of cancer and renal cell cancer risk in Caucasians and African Americans. Br J Cancer  102, 1676-80.   https://doi.org/10.1038/sj.bjc.6605680|11. Li D, Tang H, Hassan MM, Holly EA, Bracci PM, Silverman DT (2011). Diabetes and risk of pancreatic cancer: a pooled analysis of three large case-control studies. Cancer Causes Control  22, 189-97.   https://doi.org/10.1007/s10552-010-9686-3|12. Yi-Chia L, Bhatia S, Chow W, Cook M, El-Omar E, Goto H, Ho K, Li Y, Lin J, Rhee P, Sharma P, Sung J, Wong J, Wu J (2010) Interobserver reliability in the endoscopic diagnosis and grading of Barrett's esophagus: an Asian multinational study. Gastrointestinal Endoscopy 9:699-704.",https://intramural.nih.gov/search/searchview.taf?ipid=68872
691,CP010142-13,"October 01, 2010 -  September 30, 2011",Genetic and Pharmacogenetic Modifiers of Cancer Risk and Intervention Outcomes,"Sonja  Berndt|IRP Faculty Profile  | |Stephen J Chanock; MD, PhD|IRP Faculty Profile  | |Barry Ira Graubard; PhD|IRP Faculty Profile  | |Robert  Hoover; MD, ScD|IRP Faculty Profile  | |Hormuzdiar Aspandiar Katki; MS|IRP Faculty Profile  | |Ruth  Pfeiffer; PhD|IRP Faculty Profile  | |Philip Samuel Rosenberg; PhD|IRP Faculty Profile  | |Sharon Ann Savage|IRP Faculty Profile  | |Sholom  Wacholder; PhD|IRP Faculty Profile  | |Mark H Greene; MD|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI

Biostatistics Branch, NCI

Epidemiology and Biostatistics Program, NCI

Laboratory Translational Genomics, NCI

Clinical Genetics Branch, NCI",Lisa  Mirabello|Rebecca  Troisi,Joseph  Constantino (National Surgical Adjuvant Breast & Bowel Project Statistical Center)|Chester  Douglass (Harvard School of Dentistry)|Michael  Pollak (McGill University)|Larry  Wickerham (NSABP Group Headquarters)|Norman  Wolmark (National Surgical Adjuvant Breast and Bowel Project),Kenneth  Buetow; PhD (Laboratory of Population Genetics)|Ying  Gao (Genetic Epidemiology Branch)|Meredith  Yeager (Office of the Director),NULL,"1. Gao Y, Katki H, Graubard B, Pollak M, Martin M, Tao Y, Schoen RE, Church T, Hayes RB, Greene MH, Berndt SI (2012). Serum IGF1, IGF2 and IGFBP3 and risk of advanced colorectal adenoma. Int J Cancer  131, E105-13.   https://doi.org/10.1002/ijc.26438|2. Mirabello L, Berndt S, Burdett L, Cawthon R, Chowdhury S, Douglass C, Duong L, Hayes R, Richards E, Savage S, Teshome K (2011) Telomere length and variation in telomere biology genes in individuals with osteosarcoma. International Journal of Molecular Epidemiology and Genetics 2:19-29.|3. Mirabello L, Berndt S, Burdett L, Chowdhury S, Douglass C, Grotmol T, Hayes R, Hoover R, Hutchinson A, Savage S, Teshome K, Uzoka A, Wang Z, Yu K (2011) A comprehensive candidate gene approach identifies genetic variation associated with osteosarcoma. BMC Cancer 11:209.|4. Mirabello L, Berndt S, Burdett L, Chowdhury S, Douglass C, Hayes R, Hoover R, Savage S, Seratti G, Teshome K, Uzoka A, Yeager S (2010) Genetic variation at chromosome 8q24 in osteosarcoma cases and controls. Carcinogenesis 31:1400-1404.|5. Mirabello L, Craft A, Daw N, Douglass C, Hoover R, Murphy G, PatiÃ±o-Garcia A, Pfeiffer R, Savage S, Schuz J, Troisi R (2011) Height at diagnosis and birth-weight as risk factors for osteosarcoma. Cancer Causes Control 22:899-908.|6. Mirabello L, Pfeiffer R, Murphy G, Daw NC, Patiño-Garcia A, Troisi RJ, Hoover RN, Douglass C, Schüz J, Craft AW, Savage SA (2011). Height at diagnosis and birth-weight as risk factors for osteosarcoma. Cancer Causes Control  22, 899-908.   https://doi.org/10.1007/s10552-011-9763-2|7. Mirabello L, Richards EG, Duong LM, Yu K, Wang Z, Cawthon R, Berndt SI, Burdett L, Chowdhury S, Teshome K, Douglass C, Savage SA, National Osteosarcoma Etiology Study Group (2011). Telomere length and variation in telomere biology genes in individuals with osteosarcoma. Int J Mol Epidemiol Genet  2, 19-29.|8. Mirabello L, Yu K, Berndt SI, Burdett L, Wang Z, Chowdhury S, Teshome K, Uzoka A, Hutchinson A, Grotmol T, Douglass C, Hayes RB, Hoover RN, Savage SA, National Osteosarcoma Etiology Study Group (2011). A comprehensive candidate gene approach identifies genetic variation associated with osteosarcoma. BMC Cancer  11, 209.   https://doi.org/10.1186/1471-2407-11-209|9. Savage S, Mirabello L (2011) Using Epidemiology and Genomics to Understand Osteosarcoma Etiology. Sarcoma 2011:548151.|10. Savage SA, Mirabello L (2011). Using epidemiology and genomics to understand osteosarcoma etiology. Sarcoma  2011, 548151.   https://doi.org/10.1155/2011/548151",https://intramural.nih.gov/search/searchview.taf?ipid=68873
692,CP010144-13,"October 01, 2010 -  September 30, 2011",Clinical Genetic Studies of Familial and Hereditary Cancer Syndromes,"Christian Peter Kratz| | |Philip Samuel Rosenberg; PhD|IRP Faculty Profile  | |Sharon Ann Savage|IRP Faculty Profile  | |Douglas Russell Stewart; BA, MD|IRP Faculty Profile  | |Mark H Greene; MD|IRP Faculty Profile",NULL,"Biostatistics Branch, NCI

Clinical Genetics Branch, NCI","Mitchell Henry Gail; PhD, MD|Sholom  Wacholder; PhD|Alexander  Pemov|Renee C Bremer|Hormuzdiar Aspandiar Katki; MS|Michael E Stefanek|Show all 8",David  Alberts (University of Arizona Cancer Center)|Tim  Bishop (Institute for Cancer Research)|Robert  Brodsky (Johns Hopkins University School of Medicine)|Joseph  Califano (Johns Hopkins University School of Medicine)|George  Dover (Johns Hopkins University School of Medicine)|Peter  Durie (Toronto Hospital for Sick Children)|Show all 58,"Thomas  Fears; PhD (Genetic Epidemiology Branch)|Patricia  Hartge; ScD (Epidemiology and Biostatistics Program)|Robert  Hoover; MD, ScD (Epidemiology and Biostatistics Program)|Katherine Ann McGlynn; PhD (Hormonal and Reproductive Epidemiology Branch)|Mark E Sherman; MD (Hormonal and Reproductive Epidemiology Branch)|Margaret Anne Tucker (Human Genetics Program)","Jeffery P Struewing; MS, MD (NHGRI) |Pamela  Stratton; MD (NICHD)","1. Akiko S, Alter B (2010) Pathophysiology and Management of Inherited Bone Marrow Failure Syndromes. Blood Reviews 24:101-22.|2. Alter B, Carr A, Giri N, Greene M, Leathwood L, Loud J, Peters J, Rosenberg P, Savage S (2010) Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort study. Br J Haematol 0:0-0.|3. Alter B, Olson S (2010) Wilms tumor, AML, and medulloblastoma in a child with cancer prone syndrome of total premature chromatid separation and Fanconi anemia. Pediatric Blood Cancer 54:488-489.|4. Antonis A, Aalfs C, Agnarsson B, Aittomaki K, Allavena A, Andrulis I, Arnold N, Barile M, Basil J, Beesley J, Benitez J, Berthet P, Blanco I, Blank S, Blok M, Boggess J, Bonadona V, Borg A, Buys S, Caldes T, Caligo M, Casella C, Chen X, Chenevix-Trench G, Claes K, et al. [75 more authors] (2010) Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction. Cancer Research 70:9743-9754.|5. Antonis A, Altshuler D, Andrulis I, Arason A, Baglietto L, Beattie M, Beckmann M, Benitez J, Blanco I, Blows F, Bonanni B, Borg A, Brauch H, Buys S, Caldes T, Caligo M, Casella C, Chang-Claude J, Chenevix-Trench G, Couch F, Cox A, Cross S, Daly M, Devilee P, Diasio R, et al. [75 more authors] (2010) A genome-wide association study identifies a 19p13 locus that modifies the risk of breast cancer in BRCA1 mutation carriers and which is associated with estrogen receptor-negative and triple-negative breast cancer in the general population. Nature Genetics 42:1.|6. Chang S, Wang RH, Akagi K, Kim KA, Martin BK, Cavallone L, Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab), Haines DC, Basik M, Mai P, Poggi E, Isaacs C, Looi LM, Mun KS, Greene MH, Byers SW, Teo SH, Deng CX, Sharan SK (2011). Tumor suppressor BRCA1 epigenetically controls oncogenic microRNA-155. Nat Med  17, 1275-82.   https://doi.org/10.1038/nm.2459|7. Chao MM, Todd MA, Kontny U, Neas K, Sullivan MJ, Hunter AG, Picketts DJ, Kratz CP (2010). T-cell acute lymphoblastic leukemia in association with Börjeson-Forssman-Lehmann syndrome due to a mutation in PHF6. Pediatr Blood Cancer  55, 722-4.   https://doi.org/10.1002/pbc.22574|8. Christophe E, Aittomaki K, Andrulis I, Antoniou A, Arnold N, Barjhoux L, Beesley J, Benitez J, Bignon Y, Bignon Y, Brewer C, Caldes T, Chen X, Chenevix-Trench G, Cook M, Couch F, Deissler H, Domchek S, Dreyfus H, Easton D, Eeles R, Ehrencrona H, Evans D, Frenay M, Friedman E, et al. [44 more authors] (2010) Association of the Variants CASP8 D302H and CASP10 V410I with Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers. Cancer Epidemiology Biomarkers Prevention 19:2859-2868.|9. Dührsen U, Kratz CP, Flotho C, Lauenstein T, Bommer M, König E, Brittinger G, Heimpel H (2011). Long-term outcome of hemizygous and heterozygous carriers of a germline GATA1 (G208R) mutation. Ann Hematol  90, 301-6.   https://doi.org/10.1007/s00277-010-1088-9|10. Denayer E, Descheemaeker MJ, Stewart DR, Keymolen K, Plasschaert E, Ruppert SL, Snow J, Thurm AE, Joseph LA, Fryns JP, Legius E (2011). Observations on intelligence and behavior in 15 patients with Legius syndrome. Am J Med Genet C Semin Med Genet  157C, 123-8.   https://doi.org/10.1002/ajmg.c.30297|11. Ekaterina T, Alter B, Giri N, Mueller C, Savage S, Weinstein S (2010) Ocular and orbital manifestations of the inherited bone marrow failure syndromes: Fanconi anemia and dyskeratosis congenita. Ophthalmology 117:615-22.|12. Eliezer S, Baker K, Berger A, Coombes S, Handel D, Mannes A, Stewart D, Zlott D (2011) Oral Ketamine in the Palliative Care Setting: A Review of the Literature and Case Report of a Patient with Neurofibromatosis Type 1 (NF1) and Glomus Tumor-Associated Complex Regional Pain Syndrome (CRPS). American Journal of Hospice and Palliative Medicine 2011:2011.|13. Ellen D, Coombes S, Descheemaeke M, Fryns J, Joseph L, Keymolen K, Legius E, Snow J, Stewart D, Thurm A (2011) Observations on Intelligence and Behavior in 15 Patients with Legius Syndrome. AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS 157:123-8.|14. Ewens KG, Jones MR, Ankener W, Stewart DR, Urbanek M, Dunaif A, Legro RS, Chua A, Azziz R, Spielman RS, Goodarzi MO, Strauss JF (2011). Type 2 diabetes susceptibility single-nucleotide polymorphisms are not associated with polycystic ovary syndrome. Fertil Steril  95, 2538-41.e1-6.   https://doi.org/10.1016/j.fertnstert.2011.02.050|15. Gadalla SM, Lund M, Pfeiffer RM, Gørtz S, Mueller CM, Moxley RT, Kristinsson SY, Björkholm M, Shebl FM, Hilbert JE, Landgren O, Wohlfahrt J, Melbye M, Greene MH (2011) Cancer Risk Among Patients With Myotonic Muscular Dystrophy. JAMA 306:2480-2486|16. Greene M, Bracci J, Bratslavsky G, Choyke P, Korde L, Kratz C, Ling A, Mai P, McMaster M, Mueller C, Peters J, Premkumar A, Watkins R (2010) Familial Testicular Germ Cell Tumors in Adults: 2010 Summary of Genetic Risk Factors and Clinical Phenotype. Endocrine-Related Cancer 17:R109-R121.|17. Greene M, Mai P (2011) Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutations carriers. Human Molecular Genetics 20:3304-3321.|18. Greene M, Mai P (2011) Haplotype Structure in Ashkenazi Jewish BRCA1 and BRCA2 Mutation Carriers. Human Molecular Genetics 2011:2011.|19. Hannah T, Alter B, Atias D, Aviner S, Ben A, Bitan M, Dgany O, Elhasid R, Kapelusnik J, Kaplinsky C, Koren A, Krasnov T, Laor R, Levin C, Nishri D, Rosenberg P, Stepensky P, Vilk-Ravel S, Yacobovich J, Yaniv I, Zilber R (2010) Frequency and Natural History of Inherited Bone Marrow Failure Syndromes: the Israeli Inherited Bone Marrow Failure Registry. Haematologica 95:1300-1307.|20. Im KM, Kirchhoff T, Wang X, Green T, Chow CY, Vijai J, Korn J, Gaudet MM, Fredericksen Z, Shane Pankratz V, Guiducci C, Crenshaw A, McGuffog L, Kartsonaki C, Morrison J, Healey S, Sinilnikova OM, Mai PL, Greene MH, Piedmonte M, Rubinstein WS, HEBON, Hogervorst FB, Rookus MA, Collée JM, Hoogerbrugge N, kConFab, Ontario Cancer Genetics Network, SWE-BRCA, UKFOCR, EMBRACE, et al. [90 more authors] (2011). Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers. Hum Genet  130, 685-99.   https://doi.org/10.1007/s00439-011-1003-z|21. Ion C, Ahmadian M, Carta C, Cirillo M, Dallapiccola B, Dentici M, Digilio C, Gelb B, Gremer L, Horn D, Joshi V, Konig R, Kratz C, Kucherlapati R, Kutsche K, Lepri F, Mazzanti L, Merbitz-Zahradnik T, Mundlos S, Pantaleoni F, Patton M, Pennacchio L, Roberts A, Rossi C, Tartaglia M, et al. [3 more authors] (2010) A restricted spectrum of NRAS mutations causes Noonan syndrome. Nature Genetics 42:27-9.|22. Judith A, Anne T, Dorr H, Dufke A, Gillessen-Kaesbach G, Horn D, Konig R, Kratz C, Kutsche K, Pauli S, Raskin S, Wieczorek D, Zenker M (2010) THE FACE OF NOONAN SYNDROME: DOES PHENOTYPE PREDICT GENOTYPE. American Journal of Medical Genetics A 152:1960-1966.|23. Katharina W, Kratz C (2010) Constitutional Mismatch Repair-Deficiency Syndrome. Haematologica 95:699-701.|24. Kathryn E, Ankener W, Azziz R, Chua A, Dunaif A, Goodarzi M, Jones M, Legro R, Spielman R, Stewart D, Strauss J, Urbanek M (2011) TYPE 2 DIABETES SUSCEPTIBILITY SNPS ARE NOT ASSOCIATED WITH PCOS. Fertility and Sterility 95:2538-41.|25. Korde L, Mueller C, Loud J, Struewing J, Nichols K, Greene M, Mai P (2011) No Evidence of Excess Breast Cancer Risk Among Mutation-Negative Women from BRCA Mutation-Positive Families. Breast Cancer Research and Treatment 125:169-173|26. Kratz C, Berndt S, Burdett L, Greene M, Han S, Mai P, Pfeiffer R, Rosenberg P, Yeager S (2011) Variants in or near KITLG, BAK1, DMRT1 and TERT-CLPTM1L predispose to familial testicular germ cell tumor. Cancer Research 48:473-6.|27. Kratz C, Bratslavsky G, Shi J (2011) The clinical utility of testicular cancer risk loci (invited commentary). Genome Medicine 3:1.|28. Kratz C, Greene M, Mai P (2010) Familial Testicular Germ Cell Tumors. Best Practice Research Clinical Endocrinology Metabolism 24:503-513.|29. Kratz C, Hasle H, Rapisuwon S, Reed H, Rosenberg P (2011) Cancer in Noonan, Costello, Cardio-facio-cutaneous and LEOPARD Syndromes. American Journal of Medical Genetics Part C 157:83-9.|30. Kratz CP, Han SS, Rosenberg PS, Berndt SI, Burdett L, Yeager M, Korde LA, Mai PL, Pfeiffer R, Greene MH (2011). Variants in or near KITLG, BAK1, DMRT1, and TERT-CLPTM1L predispose to familial testicular germ cell tumour. J Med Genet  48, 473-6.   https://doi.org/10.1136/jmedgenet-2011-100001|31. Kratz CP, Rapisuwon S, Reed H, Hasle H, Rosenberg PS (2011). Cancer in Noonan, Costello, cardiofaciocutaneous and LEOPARD syndromes. Am J Med Genet C Semin Med Genet  157C, 83-9.   https://doi.org/10.1002/ajmg.c.30300|32. Lothar G, Ahmadian M, Cirstea I, Dvorsky R, Kratz C, Merbitz-Zahradnik T, Wittinghofer A, Zenker M (2011) Germline KRAS mutations cause distinct mechanistic and structural alterations leading to aberrant biochemical and functional properties. Human Mutation 32:33-43.|33. Lothar G, MerbitzZahradnik T, Dvorsky R, Cirstea I, Kratz C, Zenker M, Wittinghofer A, Ahmadian M (2011) Germline KRAS mutations cause distinct mechanistic and structural alterations leading to aberrant biochemical and functional properties. Human Mutation 32:33-43|34. Loud J (2010) Direct-to-Consumer Genetic and Genomic Testing: Preparing Nurse Practitioners for Genomic Healthcare. Journal for Nurse Practitioners 6:585-594.|35. Mai P, Greene M, Wentzensen N (2011) Challenges Related to Developing Serum-Based Biomarkers for Early Ovarian Cancer Detection. Cancer Prevention Research 4:303-306.|36. Mai P, Wentzensen N, Greene M (2011) Challenges Related to Developing Serum-Based Biomarkers for Early Ovarian Cancer Detection. Cancer Prevention Research 4:303-306|37. Mai PL, Wentzensen N, Greene MH (2011). Challenges related to developing serum-based biomarkers for early ovarian cancer detection. Cancer Prev Res (Phila)  4, 303-6.   https://doi.org/10.1158/1940-6207.CAPR-11-0053|38. Mia G, Greene M, Mai P, Offit K (2010) COMMON GENETIC VARIANTS AND MODIFICATION OF PENETRANCE OF BRCA2-ASSOCIATED BREAST CANCER. PLoS Genetics 6:e1001183.|39. Mwe C, Hunter A, Kratz C, Neas K, Picketts D, Sullivan M (2010) T-cell acute lymphoblastic leukemia in association with Brjeson-Forssman-Lehmann syndrome due to a mutation in PHF6. Pediatric Blood Cancer 55:722-724.|40. Peters JA, Kenen R, Hoskins LM, Koehly LM, Graubard B, Loud JT, Greene MH (2011). Unpacking the blockers: understanding perceptions and social constraints of health communication in hereditary breast ovarian cancer (HBOC) susceptibility families. J Genet Couns  20, 450-64.   https://doi.org/10.1007/s10897-011-9370-0|41. Soto E, Stewart DR, Mannes AJ, Ruppert SL, Baker K, Zlott D, Handel D, Berger AM (2012). Oral ketamine in the palliative care setting: a review of the literature and case report of a patient with neurofibromatosis type 1 and glomus tumor-associated complex regional pain syndrome. Am J Hosp Palliat Care  29, 308-17.   https://doi.org/10.1177/1049909111416345|42. Susan R, Antoniou A, Greene M, Mai P (2010) Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers:implications for risk prediction. Cancer Research 70:9742-54.|43. Ulrich D, Brittinger G, Flotho C, Heimpel H, Konig E, Kratz C, Lauenstein T (2011) Long-term outcome of hemizygous and heterozygous carriers. Annals of Hematology 90:301-306.",https://intramural.nih.gov/search/searchview.taf?ipid=68874
693,CP010145-12,"October 01, 2010 -  September 30, 2011",Intervention Trials in Persons at Increased Genetic Risk of Cancer,"Mitchell Henry Gail; PhD, MD|IRP Faculty Profile  |Mark E Sherman; MD| | |Nicolas Albert Hermann Wentzensen|IRP Faculty Profile  | |Mark H Greene; MD|IRP Faculty Profile",NULL,"Biostatistics Branch, NCI

Hormonal and Reproductive Epidemiology Branch, NCI

Clinical Genetics Branch, NCI",June  Peters|Michael E Stefanek|Jennifer T Loud,"David  Alberts (University of Arizona Cancer Center)|Deborah A. Bell; MD (Department of Laboratory Medicine and Pathology, Mayo Clinic)|Molly  Brewer (Arizona Cancer Center)|Robert  Brodsky (Johns Hopkins University School of Medicine)|Joseph  Califano (Johns Hopkins University School of Medicine)|Catherine K Chow; MD (CC)|Show all 17",Margaret Anne Tucker (Human Genetics Program)|Jennifer  Eng Wong (Medical Oncology Branch)|Paul Kj Han (Healthcare Delivery Research Program)|Richard P Moser (Behavioral Research Program)|Sheila Ann Prindiville (Office Of The Director)|Jeanne Frances Rosenthal  (Infection & Immunoepidemiology Branch),NULL,"1. Greene M, Mai P (2011) Large Prospective Study of Ovarian Cancer Screening in High-risk Women: CA125 Cut-point Defined by Menopausal Status. Cancer Prevention Research 4:1401-8.|2. Greene M, Mai P, Schwartz P (2010) Does Risk-Reducing Bilateral Salpingectomy with Ovarian Retention (BSOR) Warrant Consideration as a Temporary Bridge to Risk-Reducing Bilateral Oophorectomy (RRBO) in BRCA12 Mutation Carriers who are not Currently Ready for RRSO? American Journal of Obstetrics and Gynecology 203:1.|3. Greene MH, Mai PL, Schwartz PE (2011). Does bilateral salpingectomy with ovarian retention warrant consideration as a temporary bridge to risk-reducing bilateral oophorectomy in BRCA1/2 mutation carriers? Am J Obstet Gynecol  204, 19.e1-6.   https://doi.org/10.1016/j.ajog.2010.05.038|4. Melanie F, Badano A, De J, Duyn J, El R, Greene M, Loud J, Myers K (2011) An anthropomorphic phantom for quantitative evaluation of breast MRI. Medical Physics 38:743.|5. Melanie F, De Zwart J, Loud J, El Khouli R, Myers K, Greene M, Duyn J, Badano A (2011) An anthropomorphic phantom for quantitative evaluation of breast MRI. Medical Physics 38:743|6. Peters J, Graubard B, Greene M, Hoskins L, Kenen R, Koehly L, Loud J (2011) Unpacking the Blockers: Understanding perceptions and social constraints of communication in HBOC families. Journal of Genetic Counseling 2011:2011.|7. Peters JA, Kenen R, Hoskins LM, Koehly LM, Graubard B, Loud JT, Greene MH (2011). Unpacking the blockers: understanding perceptions and social constraints of health communication in hereditary breast ovarian cancer (HBOC) susceptibility families. J Genet Couns  20, 450-64.   https://doi.org/10.1007/s10897-011-9370-0|8. Skates SJ, Mai P, Horick NK, Piedmonte M, Drescher CW, Isaacs C, Armstrong DK, Buys SS, Rodriguez GC, Horowitz IR, Berchuck A, Daly MB, Domchek S, Cohn DE, Van Le L, Schorge JO, Newland W, Davidson SA, Barnes M, Brewster W, Azodi M, Nerenstone S, Kauff ND, Fabian CJ, Sluss PM, et al. [5 more authors] (2011). Large prospective study of ovarian cancer screening in high-risk women: CA125 cut-point defined by menopausal status. Cancer Prev Res (Phila)  4, 1401-8.   https://doi.org/10.1158/1940-6207.CAPR-10-0402",https://intramural.nih.gov/search/searchview.taf?ipid=68875
694,CP010150-12,"October 01, 2010 -  September 30, 2011","Infections, immunity, and inflammation in cancer",Eric Andrew Engels; PhD|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI",Meredith Sarah Shiels|Anil Kumar Chaturvedi|Jill Elizabeth Koshiol|James Jerome Goedert; MD,NULL,Ruth  Pfeiffer; PhD (Biostatistics Branch)|Lindsay Mcomber Morton (Radiation Epidemiology Branch)|Patricia  Hartge; ScD (Epidemiology and Biostatistics Program)|Neal David Freedman (Nutritional Epidemiology Branch)|Joseph  Fraumeni; MD (Office of the Director),NULL,"1. Anhang Price R, Koshiol J, Kobrin S, Tiro JA (2011). Knowledge and intention to participate in cervical cancer screening after the human papillomavirus vaccine. Vaccine  29, 4238-43.   https://doi.org/10.1016/j.vaccine.2011.03.076|2. Emilie L, Costagliola D, Engels E (2010) Skin cancers associated with HIV infection and solid-organ transplantation among elderly adults. Int J Cancer 126:1724-31.|3. Engels E, Parsons R, Pfeiffer R, Ricker W, Warren J (2011) Use of SEER-Medicare data to conduct case-control studies of cancer among the U.S. elderly. American Journal of Epidemiology 2011:2011.|4. Engels EA, Pfeiffer RM, Fraumeni JF, Kasiske BL, Israni AK, Snyder JJ, Wolfe RA, Goodrich NP, Bayakly AR, Clarke CA, Copeland G, Finch JL, Fleissner ML, Goodman MT, Kahn A, Koch L, Lynch CF, Madeleine MM, Pawlish K, Rao C, Williams MA, Castenson D, Curry M, Parsons R, Fant G, et al. [1 more author] (2011). Spectrum of cancer risk among US solid organ transplant recipients. JAMA  306, 1891-901.   https://doi.org/10.1001/jama.2011.1592|5. Engels EA, Pfeiffer RM, Landgren O, Moore RD (2010). Immunologic and virologic predictors of AIDS-related non-hodgkin lymphoma in the highly active antiretroviral therapy era. J Acquir Immune Defic Syndr  54, 78-84.   https://doi.org/10.1097/01.qai.0000371677.48743.8d|6. Engels EA, Pfeiffer RM, Ricker W, Wheeler W, Parsons R, Warren JL (2011). Use of surveillance, epidemiology, and end results-medicare data to conduct case-control studies of cancer among the US elderly. Am J Epidemiol  174, 860-70.   https://doi.org/10.1093/aje/kwr146|7. Lesley A, Engels E, Landgren O (2010) Common community acquired infections and subsequent risk of chronic lymphocytic leukaemia. Br J Haematol 147:444-9.|8. Pine SR, Mechanic LE, Enewold L, Chaturvedi AK, Katki HA, Zheng YL, Bowman ED, Engels EA, Caporaso NE, Harris CC (2011). Increased levels of circulating interleukin 6, interleukin 8, C-reactive protein, and risk of lung cancer. J Natl Cancer Inst  103, 1112-22.   https://doi.org/10.1093/jnci/djr216|9. Quinlan SC, Pfeiffer RM, Morton LM, Engels EA (2011). Risk factors for early-onset and late-onset post-transplant lymphoproliferative disorder in kidney recipients in the United States. Am J Hematol  86, 206-9.   https://doi.org/10.1002/ajh.21911|10. Shiels M, Engels E, Goedert J (2010) Recent trends and future directions in HIV-associated cancer. Cancer 0:5507-16.|11. Simard EP, Pfeiffer RM, Engels EA (2011). Cumulative incidence of cancer among individuals with acquired immunodeficiency syndrome in the United States. Cancer  117, 1089-96.   https://doi.org/10.1002/cncr.25547",https://intramural.nih.gov/search/searchview.taf?ipid=68876
695,CP010152-12,"October 01, 2010 -  September 30, 2011",PLCO Trial Etiologic and Early Marker Study,"Robert  Hoover; MD, ScD|IRP Faculty Profile  | |Mark  Purdue|IRP Faculty Profile  |Ann  Hsing; PhD",NULL,"Infection & Immunoepidemiology Branch, NCI

Occupational and Environmental Epidemiology Branch, NCI

Epidemiology and Biostatistics Program, NCI",Wen-Yi  Huang|Amanda  Black,"Gerry  Andriole (Washington University)|Thomas  Beck (Mountain States Tumor Institute)|Saundra  Buys (Hunstman Cancer Institute, University of Utah)|Timothy R. Church; PhD (Environ & Occup Health, University of Minnesota School of Public Health)|David T Crawford|Mona  Fouad (University of Alabama, Birmingham)|Show all 11",Christine Dorothy Berg (Early Detection Research Group)|Prisca N Fall (Biostatistics Branch),NULL,"1. Berndt SI, Sampson J, Yeager M, Jacobs KB, Wang Z, Hutchinson A, Chung C, Orr N, Wacholder S, Chatterjee N, Yu K, Kraft P, Feigelson HS, Thun MJ, Diver WR, Albanes D, Virtamo J, Weinstein S, Schumacher FR, Cancel-Tassin G, Cussenot O, Valeri A, Andriole GL, Crawford ED, Haiman C, et al. [27 more authors] (2011). Large-scale fine mapping of the HNF1B locus and prostate cancer risk. Hum Mol Genet  20, 3322-9.   https://doi.org/10.1093/hmg/ddr213|2. Haiman CA, Chen GK, Blot WJ, Strom SS, Berndt SI, Kittles RA, Rybicki BA, Isaacs WB, Ingles SA, Stanford JL, Diver WR, Witte JS, Hsing AW, Nemesure B, Rebbeck TR, Cooney KA, Xu J, Kibel AS, Hu JJ, John EM, Gueye SM, Watya S, Signorello LB, Hayes RB, Wang Z, et al. [37 more authors] (2011). Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21. Nat Genet  43, 570-3.   https://doi.org/10.1038/ng.839|3. Hofmann JN, Yu K, Bagni RK, Lan Q, Rothman N, Purdue MP (2011). Intra-individual variability over time in serum cytokine levels among participants in the prostate, lung, colorectal, and ovarian cancer screening Trial. Cytokine  56, 145-8.   https://doi.org/10.1016/j.cyto.2011.06.012|4. James S, Flood A, Hsing A, Kitahara C, Meyer T, Redden D, Willcox B, Ziegler R (2011) Dietary carbohydrate, glycemic index, glycemic load, and risk of prostate cancer. Cancer Causes Control 22:995-1002.|5. Jonathan H, Hayes R, Horst R, Purdue M, Yu K (2010) Long-term variation in serum 25-hydroxyvitamin D concentration among participants in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Cancer Epidemiology, Biomarkers Prevention 19:927-31.|6. Nyante SJ, Black A, Kreimer AR, Duggan MA, Carreon JD, Kessel B, Buys SS, Ragard LR, Johnson KA, Dunn BK, Lamerato L, Commins JM, Berg CD, Sherman ME (2011). Pathologic findings following false-positive screening tests for ovarian cancer in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial. Gynecol Oncol  120, 474-9.   https://doi.org/10.1016/j.ygyno.2010.11.015|7. Purdue M, Bagni R, Baris D, Hocking W, Lan Q, Reding D, Rothman N (2011) Prediagnostic serum levels of cytokines and other immune markers and risk of non-hodgkin lymphoma. Cancer research 71:4898-907.|8. Purdue MP, Lan Q, Bagni R, Hocking WG, Baris D, Reding DJ, Rothman N (2011). Prediagnostic serum levels of cytokines and other immune markers and risk of non-hodgkin lymphoma. Cancer Res  71, 4898-907.   https://doi.org/10.1158/0008-5472.CAN-11-0165|9. Shikany JM, Flood AP, Kitahara CM, Hsing AW, Meyer TE, Willcox BJ, Redden DT, Ziegler RG (2011). Dietary carbohydrate, glycemic index, glycemic load, and risk of prostate cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) cohort. Cancer Causes Control  22, 995-1002.   https://doi.org/10.1007/s10552-011-9772-1|10. Zheng J, Liu F, Lin X, Wang X, Ding Q, Jiang H, Chen H, Lu D, Jin G, Hsing AW, Shao Q, Qi J, Ye Y, Wang Z, Gao X, Wang G, Chu LW, Ouyang J, Huang Y, Chen Y, Gao Y, Shi R, Wu Q, Wang M, Zhang Z, et al. [8 more authors] (2012). Predictive performance of prostate cancer risk in Chinese men using 33 reported prostate cancer risk-associated SNPs. Prostate  72, 577-83.   https://doi.org/10.1002/pros.21462",https://intramural.nih.gov/search/searchview.taf?ipid=68877
696,CP010158-11,"October 01, 2010 -  September 30, 2011",Studies of Rare Cancers,Michael Blaise Cook|IRP Faculty Profile  | |Allan  Hildesheim; PhD|IRP Faculty Profile  | |Katherine Ann McGlynn; PhD|IRP Faculty Profile  |Mark E Sherman; MD| | |Nicolas Albert Hermann Wentzensen|IRP Faculty Profile  |Louise  Brinton; PhD,NULL,"Infection & Immunoepidemiology Branch, NCI

Hormonal and Reproductive Epidemiology Branch, NCI",Vikrant Vasant Sahasrabuddhe|Elna Christina Marianne Persson,"Streamson  Chua (Columbia University)|Scott  Davis (Fred Hutchinson Cancer Research Center)|James  Dick (Johns Hopkins Univeristy)|James  Fox (MIT)|Yu-Tang  Gao (Shanghai Cancer Institute)|Evelyene  Lennette (Virolab, Inc.)|Show all 12",Kelly Jen-Yi Yu (Early Detection Research Group),NULL,"1. Altekruse SF, Devesa SS, Dickie LA, McGlynn KA, Kleiner DE (2011). Histological classification of liver and intrahepatic bile duct cancers in SEER registries. J Registry Manag  38, 201-5.|2. Brinton L (2011) Breast Cancer Risk Among Patients with Klinefelter Syndrome. Acta Paediatr 100:814-818.|3. Brinton LA (2011). Breast cancer risk among patients with Klinefelter syndrome. Acta Paediatr  100, 814-8.   https://doi.org/10.1111/j.1651-2227.2010.02131.x|4. Enewold LR, Zhou J, Devesa SS, Berrington de Gonzalez A, Anderson WF, Zahm SH, Stojadinovic A, Peoples GE, Marrogi AJ, Potter JF, McGlynn KA, Zhu K (2011). Thyroid cancer incidence among active duty U.S. military personnel, 1990-2004. Cancer Epidemiol Biomarkers Prev  20, 2369-76.   https://doi.org/10.1158/1055-9965.EPI-11-0596|5. Gage JC, Ghosh A, Borgonovo S, Follansbee S, Wentzensen N, Gravitt PE, Grabe N, Lahrmann B, Castle PE (2011). A comparison of dacron versus Flocked nylon swabs for anal cytology specimen collection. Acta Cytol  55, 364-7.   https://doi.org/10.1159/000329488|6. Jessica D, Du X, El-Serag H, McGlynn K, Morgan R, Richardson P (2010) Use of surveillance for hepatocellular carcinoma among patients with cirrhosis in the United States. Hepatology 52:132-41.|7. Lindsey E, Brinton L, McGlynn K, Potter J, Zahm S, Zhu K (2010) Oral contraceptive use among women in the military and the general U.S. population. J Womens Health (Larchmt) 19:839-45.|8. McGlynn KA, London WT (2012). International liver cancer incidence trends--letter. Cancer Epidemiol Biomarkers Prev  21, 384-5; author reply 386.   https://doi.org/10.1158/1055-9965.EPI-11-1102|9. Wang SS, Menashe I, Cerhan JR, Cozen W, Severson RK, Davis S, Hutchinson A, Rothman N, Chanock SJ, Bernstein L, Hartge P, Morton LM (2011). Variations in chromosomes 9 and 6p21.3 with risk of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev  20, 42-9.   https://doi.org/10.1158/1055-9965.EPI-10-0638|10. Zhou J, Enewold L, Zahm SH, Devesa SS, Anderson WF, Potter JF, McGlynn KA, Zhu K (2011). Melanoma incidence rates among whites in the U.S. Military. Cancer Epidemiol Biomarkers Prev  20, 318-23.   https://doi.org/10.1158/1055-9965.EPI-10-0869",https://intramural.nih.gov/search/searchview.taf?ipid=68878
697,CP010167-11,"October 01, 2010 -  September 30, 2011",General Studies of Epidemiology,"Robert  Hoover; MD, ScD|IRP Faculty Profile",NULL,"Epidemiology and Biostatistics Program, NCI",Rebecca  Troisi|Patricia  Hartge; ScD,NULL,Sharon Ann Savage (Clinical Genetics Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68879
698,CP010168-11,"October 01, 2010 -  September 30, 2011",Early Life Exposures and Subsequent Cancer Risk,"Robert  Hoover; MD, ScD|IRP Faculty Profile",NULL,"Epidemiology and Biostatistics Program, NCI",NULL,Ervin  Adam (Baylor College of Medicine)|Elizabeth  Hatch (Boston University)|Arthur  Herbst (University of Chicago)|Chung  Hsieh (University of Massachuetts)|Michele  Lauria (Dartmouth Hitchcock Medical Center)|Julie  Palmer (Boston University)|Show all 12,NULL,NULL,"1. Faupel-Badger JM, Staff AC, Thadhani R, Powe CE, Potischman N, Hoover RN, Troisi R (2011). Maternal angiogenic profile in pregnancies that remain normotensive. Eur J Obstet Gynecol Reprod Biol  158, 189-93.   https://doi.org/10.1016/j.ejogrb.2011.05.001|2. Faupel-Badger JM, Wang Y, Karumanchi SA, Stanczyk F, Pollak M, McElrath T, Hoover RN, Troisi R (2011). Associations of pregnancy characteristics with maternal and cord steroid hormones, angiogenic factors, and insulin-like growth factor axis. Cancer Causes Control  22, 1587-95.   https://doi.org/10.1007/s10552-011-9835-3|3. Linda T, Adam E, Hatch E, Hoover R, Hyer M, Kaufman R, Noller K, Palmer J, Troisi R (2010) Birth defects in the sons and daughters of women who were exposed in utero to diethylstilbestrol (DES). Int J Androl 33:377-84.|4. Titus-Ernstoff L, Troisi R, Hatch EE, Palmer JR, Hyer M, Kaufman R, Adam E, Noller K, Hoover RN (2010). Birth defects in the sons and daughters of women who were exposed in utero to diethylstilbestrol (DES). Int J Androl  33, 377-84.   https://doi.org/10.1111/j.1365-2605.2009.01010.x",https://intramural.nih.gov/search/searchview.taf?ipid=68880
699,CP010169-10,"October 01, 2010 -  September 30, 2011","Nutrition, Metabolism, and Cancer","Stephen J Chanock; MD, PhD|IRP Faculty Profile  | |Barry Ira Graubard; PhD|IRP Faculty Profile  | |Robert  Hoover; MD, ScD|IRP Faculty Profile  | |Regina Gale Ziegler; PhD, MPH|IRP Faculty Profile",NULL,"Biostatistics Branch, NCI

Epidemiology and Biostatistics Program, NCI

Laboratory Translational Genomics, NCI","Mitchell Henry Gail; PhD, MD|Gloria L Gridley|Patricia  Hartge; ScD|Hormuzdiar Aspandiar Katki; MS|Catherine G Schairer","Ray  Greenberg (University of South Carolina)|Rudolf  Kaaks (International Agency for Research on Cancer)|Lawrence  Kolonel (University of Hawaii)|Abraham  Nomura (School of Public Health, University of Hawaii)|Emanuel  Petricoin (Food and Drug Administration)|Malcolm  Pike (University of Southern California)|Show all 11",Demetrius  Albanes; MD (Nutritional Epidemiology Branch)|Larry K Keefer; PhD (Laboratory of Comparative Carcinogenesis)|Louise  Brinton; PhD (Hormonal and Reproductive Epidemiology Branch)|Roni T Falk (Hormonal and Reproductive Epidemiology Branch)|Richard  Hayes; PhD (Occupational and Environmental Epidemiology Branch)|Peter D Inskip; ScD (Radiation Epidemiology Branch),NULL,"1. Ziegler R, Boyd-Morin J, Falk R, Faupel-Badger J, Fuhrman B, Henderson M, Hoover R, Keefer L, Sue L, Veenstra T, Xu X (2010) A new approach to measuring estrogen exposure and metabolism in epidemiologic studies. J Steroid Biochem Mol Biol 0:0-0.",https://intramural.nih.gov/search/searchview.taf?ipid=68883
700,CP010170-11,"October 01, 2010 -  September 30, 2011",Multidisciplinary Studies of Hematopoietic Malignancies,Patricia  Hartge; ScD| | |Lindsay Mcomber Morton|IRP Faculty Profile,NULL,"Radiation Epidemiology Branch, NCI

Epidemiology and Biostatistics Program, NCI",Martha S Linet; PhD,James  Cerhan (Mayo Clinic)|Wendy  Cozen (Norris Comprehensive Cancer Center)|Scott  Davis (Fred Hutchinson Cancer Research Center)|Anneclaire  De-Roos (Fred Hutchinson Cancer Center)|Maryjean  Schenk (Barbara Karmanos Cancer Institute)|Richard  Severson (Barbara Karmanos Cancer Institute),"Joanne S Colt (Occupational and Environmental Epidemiology Branch)|Shelia K Zahm; ScM, ScD (Office of the Director)|Aaron E Blair; PhD, MPH (Occupational and Environmental Epidemiology Branch)|Mary Helen Ward; MS, PhD (Occupational and Environmental Epidemiology Branch)|Nathaniel C Rothman; MD (Occupational and Environmental Epidemiology Branch)|Sophia S Wang; PhD (Infection & Immunoepidemiology Branch)",NULL,"1. Morton LM, Cerhan JR, Hartge P, Vasef MA, Neppalli VT, Natkunam Y, Dogan A, Dave BJ, Jain S, Levy R, Lossos IS, Cozen W, Davis S, Schenk MJ, Maurer MJ, Lynch CF, Rothman N, Chatterjee N, Yu K, Staudt LM, Weisenburger DD, Wang SS (2011). Immunostaining to identify molecular subtypes of diffuse large B-cell lymphoma in a population-based epidemiologic study in the pre-rituximab era. Int J Mol Epidemiol Genet  2, 245-52.|2. Purdue MP, Bakke B, Stewart P, De Roos AJ, Schenk M, Lynch CF, Bernstein L, Morton LM, Cerhan JR, Severson RK, Cozen W, Davis S, Rothman N, Hartge P, Colt JS (2011). A case-control study of occupational exposure to trichloroethylene and non-Hodgkin lymphoma. Environ Health Perspect  119, 232-8.   https://doi.org/10.1289/ehp.1002106|3. Ross B, Hartge P, Ness R, Samet J (2010) From epidemiology to policy: toward more effective practice. Annals of Epidemiology 20:409-11.|4. Wheeler DC, De Roos AJ, Cerhan JR, Morton LM, Severson R, Cozen W, Ward MH (2011). Spatial-temporal analysis of non-Hodgkin lymphoma in the NCI-SEER NHL case-control study. Environ Health  10, 63.   https://doi.org/10.1186/1476-069X-10-63",https://intramural.nih.gov/search/searchview.taf?ipid=68881
701,CP010176-11,"October 01, 2010 -  September 30, 2011",Epidemiology and Natural History of Cancer-Associated Viruses,"Eric Andrew Engels; PhD|IRP Faculty Profile  |James Jerome Goedert; MD| | |Barry Ira Graubard; PhD|IRP Faculty Profile  | |Thomas R O'Brien; BA, MPH, MD|IRP Faculty Profile  | |Ruth  Pfeiffer; PhD|IRP Faculty Profile  | |Philip Samuel Rosenberg; PhD|IRP Faculty Profile  | |Sam  Mbulaiteye|IRP Faculty Profile",NULL,"Infection & Immunoepidemiology Branch, NCI

Biostatistics Branch, NCI",Charles  Rabkin|Anil Kumar Chaturvedi|Denise  Whitby,"M  Eyster (Pennsylvania State University)|Angelos  Hatzakis (University of Athens Medical School)|Michael  Lederman; MD (Case Western Reserve University)|Nino  Romano (University of Palermo)|Cloe  Thio (Dept of Medicine, Johns Hopkins University School of Medicine)|David  Thomas (Johns Hopkins University)|Show all 7","Stephen J Chanock; MD, PhD (Laboratory Translational Genomics)",NULL,"1. Biryahwaho B, Amin M, Parsons R, Dollard S, Munuo S, Hladik W, Mbulaiteye S, Pfeiffer R, Shebl F (2010) Sex and geographic patterns of human herpesvirus 8 infection in a nationally representative populationbased sample in Uganda. The Journal of infectious diseases 202:1347-53.|2. Biryahwaho B, Dollard SC, Pfeiffer RM, Shebl FM, Munuo S, Amin MM, Hladik W, Parsons R, Mbulaiteye SM (2010). Sex and geographic patterns of human herpesvirus 8 infection in a nationally representative population‐based sample in Uganda. J Infect Dis  202, 1347-53.   https://doi.org/10.1086/656525|3. Guech-ongey M, Yagi M, Palacpac N, Emmanuel B, Stefan C, Talisuna A, Bhatia K, Biggar R, Nkrumah F, Neequaye J, Tougan T, Horii T, Mbulaiteye S (2011) Antibodies reactive to Plasmodium falciparum serine repeat antigen in children with Burkitt lymphoma from Ghana. International Journal of Cancer NA:N/A|4. Shebl FM, Dollard SC, Pfeiffer RM, Biryahwaho B, Amin MM, Munuo SS, Hladik W, Parsons R, Graubard BI, Mbulaiteye SM (2011). Human herpesvirus 8 seropositivity among sexually active adults in Uganda. PLoS One  6, e21286.   https://doi.org/10.1371/journal.pone.0021286",https://intramural.nih.gov/search/searchview.taf?ipid=68882
702,CP010180-10,"October 01, 2010 -  September 30, 2011",Prostate Cancer Studies,Ann  Hsing; PhD,NULL,"Infection & Immunoepidemiology Branch, NCI",NULL,Richard  Biritwum (Univ of Ghana Medical School)|Peter  Carroll (UCSF)|Chawnshang  Chang (University of Rochester)|Chu  Chen (University of Washington)|Streamson  Chua (Columbia University)|Angelo  DeMarzo (Johns Hopkins U)|Show all 15,Richard  Hayes; PhD (Occupational and Environmental Epidemiology Branch)|Sabah  Quraishi (Hormonal and Reproductive Epidemiology Branch)|Lisa Wey-Lan Chu (Hormonal and Reproductive Epidemiology Branch),NULL,"1. Ashraful H, Ambrosone C, Goodman P, Hsing A, Kappil M, Kristal A, Lucia M, Parnes H, Santella R, Tangen C, Thompson I, Till C, Wang Q (2010) Serum oxidized protein and prostate cancer risk within the Prostate Cancer Prevention Trial. Cancer Prev Res 3:478-83.|2. Buadi F, Hsing AW, Katzmann JA, Pfeiffer RM, Waxman A, Yeboah ED, Biritwum RB, Tettey Y, Adjei A, Chu LW, DeMarzo A, Netto GJ, Dispenzieri A, Kyle RA, Rajkumar SV, Landgren O (2011). High prevalence of polyclonal hypergamma-globulinemia in adult males in Ghana, Africa. Am J Hematol  86, 554-8.   https://doi.org/10.1002/ajh.22040|3. Chang BL, Spangler E, Gallagher S, Haiman CA, Henderson B, Isaacs W, Benford ML, Kidd LR, Cooney K, Strom S, Ingles SA, Stern MC, Corral R, Joshi AD, Xu J, Giri VN, Rybicki B, Neslund-Dudas C, Kibel AS, Thompson IM, Leach RJ, Ostrander EA, Stanford JL, Witte J, Casey G, et al. [9 more authors] (2011). Validation of genome-wide prostate cancer associations in men of African descent. Cancer Epidemiol Biomarkers Prev  20, 23-32.   https://doi.org/10.1158/1055-9965.EPI-10-0698|4. Goodman PJ, Tangen CM, Kristal AR, Thompson IM, Lucia MS, Platz EA, Figg WD, Hoque A, Hsing A, Neuhouser ML, Parnes HL, Reichardt JK, Santella RM, Till C, Lippman SM (2010). Transition of a clinical trial into translational research: the prostate cancer prevention trial experience. Cancer Prev Res (Phila)  3, 1523-33.   https://doi.org/10.1158/1940-6207.CAPR-09-0256|5. Hsing A, Chu L, Meyer T, Niwa S, Quraishi S (2010) Measuring Serum Melatonin in Epidemiologic Studies. Cancer Epidemiol Biomarkers Prev 19:932-7.|6. Hsing AW, Meyer TE, Niwa S, Quraishi SM, Chu LW (2010). Measuring serum melatonin in epidemiologic studies. Cancer Epidemiol Biomarkers Prev  19, 932-7.   https://doi.org/10.1158/1055-9965.EPI-10-0004|7. Hulin-Curtis SL, Petit D, Figg WD, Hsing AW, Reichardt JK (2010). Finasteride metabolism and pharmacogenetics: new approaches to personalized prevention of prostate cancer. Future Oncol  6, 1897-913.   https://doi.org/10.2217/fon.10.149|8. Kosti O, Goldman L, Saha DT, Orden RA, Pollock AJ, Madej HL, Hsing AW, Chu LW, Lynch JH, Goldman R (2011). DNA damage phenotype and prostate cancer risk. Mutat Res  719, 41-6.   https://doi.org/10.1016/j.mrgentox.2010.11.005|9. Liu F, Hsing AW, Wang X, Shao Q, Qi J, Ye Y, Wang Z, Chen H, Gao X, Wang G, Chu LW, Ding Q, OuYang J, Gao X, Huang Y, Chen Y, Gao YT, Zhang ZF, Rao J, Shi R, Wu Q, Wang M, Zhang Z, Zhang Y, Jiang H, et al. [12 more authors] (2011). Systematic confirmation study of reported prostate cancer risk-associated single nucleotide polymorphisms in Chinese men. Cancer Sci  102, 1916-20.   https://doi.org/10.1111/j.1349-7006.2011.02036.x|10. Siobhan S, De A, Goodman P, Hoque A, Hsing A, Platz E, Thompson I, Till C, Viscidi R, Zenilman J (2010) Human papillomavirus types 16, 18, and 31 serostatus and prostate cancer risk in the Prostate Cancer Prevention Trial. Cancer Epidemiol Biomarkers Prev 19:614-618.|11. Yao S, Till C, Kristal AR, Goodman PJ, Hsing AW, Tangen CM, Platz EA, Stanczyk FZ, Reichardt JK, Tang L, Neuhouser ML, Santella RM, Figg WD, Price DK, Parnes HL, Lippman SM, Thompson IM, Ambrosone CB, Hoque A (2011). Serum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: a nested case-control study. Cancer Causes Control  22, 1121-31.   https://doi.org/10.1007/s10552-011-9787-7",https://intramural.nih.gov/search/searchview.taf?ipid=68897
703,CP010181-09,"October 01, 2010 -  September 30, 2011",Methods for Epidemiology Studies,"Mitchell Henry Gail; PhD, MD|IRP Faculty Profile  | |Barry Ira Graubard; PhD|IRP Faculty Profile  | |Hormuzdiar Aspandiar Katki; MS|IRP Faculty Profile  |Jay  Lubin; PhD| | |Ruth  Pfeiffer; PhD|IRP Faculty Profile  | |Philip Samuel Rosenberg; PhD|IRP Faculty Profile  | |Joshua Neil Sampson|IRP Faculty Profile  | |Jianxin  Shi|IRP Faculty Profile  | |Sholom  Wacholder; PhD|IRP Faculty Profile  | |Kai  Yu|IRP Faculty Profile  |Nilanjan  Chatterjee",NULL,"Biostatistics Branch, NCI",Junmo  Nam,"Efstathia  Bura (The George Washington University, Washington, DC)|Raymond  Carroll (Texas A&M University)|Laure  El (GW Biostat)|Katherine  Flegal (Centers for Disease Control and Prevention)|Kari  Hemminki; PhD (Department of Biosciences, Karolinska Institute)|Cathy  Kronin (DCCPS, NCI, Rockville, MD)|Show all 13","Patricia  Hartge; ScD (Epidemiology and Biostatistics Program)|Eric Andrew Engels; PhD (Infection & Immunoepidemiology Branch)|Edward L Korn (Clinical Trials Section)|Sam  Mbulaiteye (Infection & Immunoepidemiology Branch)|Stephen J Chanock; MD, PhD (Laboratory Translational Genomics)|Maria Teresa Pia Landi; MD, PhD (Genetic Epidemiology Branch)",NULL,"1. Alexander S, Lang S, Pfeiffer R, Umlauf N (2010) Comparing Penalized Splines and Fractional Polynomials as Smoothing Techniques for Flexible Modeling the Effect of Continuous Predictor Values. COMPUT STAT DATA AN 55:1540-51.|2. Annette M, Bjornson R, Carriero N, Chatterjee N, Hartge P, Rothman N (2011) Power of Data Mining Methods to Detect Genetic Associations and Interactions. HUMAN HERED 72:85-97.|3. Bhattacharjee S, Wang Z, Ciampa J, Kraft P, Chanock S, Yu K, Chatterjee N (2010). Using principal components of genetic variation for robust and powerful detection of gene-gene interactions in case-control and case-only studies. Am J Hum Genet  86, 331-42.   https://doi.org/10.1016/j.ajhg.2010.01.026|4. Chatterjee N, Caporaso N, Gail M, Park J (2011) Predicting the future of genetic risk-prediction. CANCER EPIDEM BIOMAR 20:3-8.|5. Chatterjee N, Feigelson H, Sinha S (2010) Analysis of cohort studies with multivariate and partially observed disease classification data. BIOMETRIKA 3:683-698.|6. Chatterjee N, Park JH, Caporaso N, Gail MH (2011). Predicting the future of genetic risk prediction. Cancer Epidemiol Biomarkers Prev  20, 3-8.   https://doi.org/10.1158/1055-9965.EPI-10-1022|7. Dewei S, Graubard B, Li Y, Li Z, Zhang H (2010) Trend tests for genetic association using population-based cross-sectional complex survey data. Biostatistics 11:48-56.|8. Domenico P, Decarli A, Gail M, Masala G, Pee D, Petracci E, Pfeiffer R, Schairer C (2011) Risk Factor Modification and Projections of Absolute Breast Cancer Risk. J NATL CANCER I 103:1037-48.|9. Freedman AN, Yu B, Gail MH, Costantino JP, Graubard BI, Vogel VG, Anderson GL, McCaskill-Stevens W (2011). Benefit/risk assessment for breast cancer chemoprevention with raloxifene or tamoxifen for women age 50 years or older. J Clin Oncol  29, 2327-33.   https://doi.org/10.1200/JCO.2010.33.0258|10. Gail M (2011) Personalized estimates of breast cancer risk in clinical practice and public health. STAT MED 30:1090-104|11. Gail M (2011) Personalized estimates of breast cancer risk in clinical practice and public health. STAT MED 30:1090-104.|12. Han SS, Chang JT (2010). Reconsidering the asymptotic null distribution of likelihood ratio tests for genetic linkage in multivariate variance components models under complete pleiotropy. Biostatistics  11, 226-41.   https://doi.org/10.1093/biostatistics/kxp054|13. Kant AK, Graubard BI (2011). 20-Year trends in dietary and meal behaviors were similar in U.S. children and adolescents of different race/ethnicity. J Nutr  141, 1880-8.   https://doi.org/10.3945/jn.111.144915|14. Lozier JN, Rosenberg PS, Goedert JJ, Menashe I (2011). A case-control study reveals immunoregulatory gene haplotypes that influence inhibitor risk in severe haemophilia A. Haemophilia  17, 641-9.   https://doi.org/10.1111/j.1365-2516.2010.02473.x|15. Lubin J, Boffetta P, Brennan P, Castellsague X, Chen C, Curado M, Dal L, Daudt A, Fabianova E, Fernandez L, Franceschi S, Gaudet M, Hashibe M, Hayes R, Herrero R, Kelsey K, Koifman S, La C, Lazarus P, Levi F, Lissowska J, Mates D, Matos E, McClean M, Menezes A, et al. [16 more authors] (2011) An examination of male and female odds ratios by BMI, cigarette smoking, and alcohol consumption for cancers of the oral cavity, pharynx, and larynx in pooled data from 15 case-control studies. CANCER CAUSE CONTROL 22:1217-31.|16. Lubin J, Boffetta P, Brennan P, Castellsague X, Chen C, Curado M, Dal L, Daudt A, Fabianova E, Fernandez L, Franceschi S, Gaudet M, Hashibe M, Hayes R, Herrero R, Kelsey K, Koifman S, La C, Lazarus P, Levi F, Lissowska J, Mates I, Matos E, McClean M, Menezes A, et al. [15 more authors] (2010) Body mass index, cigarette smoking, and alcohol consumption and cancers of the oral cavity, pharynx, and larynx: modeling odds ratios in pooled case-control data. Am J Epidemiol 171:1250-61.|17. Lubin JH, Gaudet MM, Olshan AF, Kelsey K, Boffetta P, Brennan P, Castellsague X, Chen C, Curado MP, Dal Maso L, Daudt AW, Fabianova E, Fernandez L, Wünsch-Filho V, Franceschi S, Herrero R, Koifman S, La Vecchia C, Lazarus P, Levi F, Lissowska J, Mates IN, Matos E, McClean M, Menezes A, et al. [15 more authors] (2010). Body mass index, cigarette smoking, and alcohol consumption and cancers of the oral cavity, pharynx, and larynx: modeling odds ratios in pooled case-control data. Am J Epidemiol  171, 1250-61.   https://doi.org/10.1093/aje/kwq088|18. Lubin JH, Muscat J, Gaudet MM, Olshan AF, Curado MP, Dal Maso L, Wünsch-Filho V, Sturgis EM, Szeszenia-Dabrowska N, Castellsague X, Zhang ZF, Smith E, Fernandez L, Matos E, Franceschi S, Fabianova E, Rudnai P, Purdue MP, Mates D, Wei Q, Herrero R, Kelsey K, Morgenstern H, Shangina O, Koifman S, et al. [17 more authors] (2011). An examination of male and female odds ratios by BMI, cigarette smoking, and alcohol consumption for cancers of the oral cavity, pharynx, and larynx in pooled data from 15 case-control studies. Cancer Causes Control  22, 1217-31.   https://doi.org/10.1007/s10552-011-9792-x|19. Molinaro AM, Carriero N, Bjornson R, Hartge P, Rothman N, Chatterjee N (2011). Power of data mining methods to detect genetic associations and interactions. Hum Hered  72, 85-97.   https://doi.org/10.1159/000330579|20. Nam JM (2011). Power and sample size requirements for non-inferiority in studies comparing two matched proportions where the events are correlated. Comput Stat Data Anal  55, 2880-2887.   https://doi.org/10.1016/j.csda.2011.04.020|21. Park JH, Gail MH, Weinberg CR, Carroll RJ, Chung CC, Wang Z, Chanock SJ, Fraumeni JF, Chatterjee N (2011). Distribution of allele frequencies and effect sizes and their interrelationships for common genetic susceptibility variants. Proc Natl Acad Sci U S A  108, 18026-31.   https://doi.org/10.1073/pnas.1114759108|22. Petracci E, Decarli A, Schairer C, Pfeiffer RM, Pee D, Masala G, Palli D, Gail MH (2011). Risk factor modification and projections of absolute breast cancer risk. J Natl Cancer Inst  103, 1037-48.   https://doi.org/10.1093/jnci/djr172|23. Pfeiffer R, Gail M, Pee D (2010) On combining data from genome-wide association studies to discover disease-associated SNPs. Statistical Science 24:547-560.|24. Pfeiffer R, Petracci E (2011) Variance computations for functional of absolute risk estimates. STAT PROBABIL LETT 81:807-12.|25. Pfeiffer RM, Gail MH (2011). Two criteria for evaluating risk prediction models. Biometrics  67, 1057-65.   https://doi.org/10.1111/j.1541-0420.2010.01523.x|26. Pfeiffer RM, Petracci E (2011). Variance computations for functional of absolute risk estimates. Stat Probab Lett  81, 807-812.   https://doi.org/10.1016/j.spl.2011.02.002|27. Rosenberg P, Anderson W (2010) Proportional hazards models and age-period-cohort analysis of cancer rates. Stat Med 29:1228-38.|28. Rosenberg PS, Anderson WF (2010). Proportional hazards models and age-period-cohort analysis of cancer rates. Stat Med  29, 1228-38.   https://doi.org/10.1002/sim.3865|29. Rosenberg PS, Tamary H, Alter BP (2011). How high are carrier frequencies of rare recessive syndromes? Contemporary estimates for Fanconi Anemia in the United States and Israel. Am J Med Genet A  155A, 1877-83.   https://doi.org/10.1002/ajmg.a.34087|30. Sampson J (2011) What are the consequences if i postpone treatment of my PSA-detected prostate cancer? CANCER EPIDEM BIOMAR 20:727-28.|31. Sampson J, Chanock S, Chatterjee N, Jacobs K, Yeager S (2011) Efficient study design for next generation sequencing. GENET EPIDEMIOL 35:269-77.|32. Sampson J, Jacobs K, Yeager M, Chanock S, Chatterjee N (2011). Efficient study design for next generation sequencing. Genet Epidemiol  35, 269-77.   https://doi.org/10.1002/gepi.20575|33. Sampson JN (2011). What are the consequences if i postpone treatment of my PSA-detected prostate cancer? Cancer Epidemiol Biomarkers Prev  20, 727-8.   https://doi.org/10.1158/1055-9965.EPI-11-0057|34. Wacholder S, Chen BE, Wilcox A, Macones G, Gonzalez P, Befano B, Hildesheim A, Rodríguez AC, Solomon D, Herrero R, Schiffman M, CVT group (2010). Risk of miscarriage with bivalent vaccine against human papillomavirus (HPV) types 16 and 18: pooled analysis of two randomised controlled trials. BMJ  340, c712.   https://doi.org/10.1136/bmj.c712|35. Wacholder S, Han SS, Weinberg CR (2011). Inference from a multiplicative model of joint genetic effects for [corrected] ovarian cancer risk. J Natl Cancer Inst  103, 82-3.   https://doi.org/10.1093/jnci/djq510|36. Yu K, Bergen A, Caporaso N, Chatterjee N, Chen J, Li Q, Wheeler B (2010) A partially linear tree-based regression model for multivariate outcomes. Biometrics 66:89-96.|37. Yu K, Liang F, Ciampa J, Chatterjee N (2011). Efficient p-value evaluation for resampling-based tests. Biostatistics  12, 582-93.   https://doi.org/10.1093/biostatistics/kxq078|38. Yu K, Wheeler W, Li Q, Bergen AW, Caporaso N, Chatterjee N, Chen J (2010). A partially linear tree-based regression model for multivariate outcomes. Biometrics  66, 89-96.   https://doi.org/10.1111/j.1541-0420.2009.01235.x|39. Yu KJ, Hsu WL, Pfeiffer RM, Chiang CJ, Wang CP, Lou PJ, Cheng YJ, Gravitt P, Diehl SR, Goldstein AM, Chen CJ, Hildesheim A (2011). Prognostic utility of anti-EBV antibody testing for defining NPC risk among individuals from high-risk NPC families. Clin Cancer Res  17, 1906-14.   https://doi.org/10.1158/1078-0432.CCR-10-1681",https://intramural.nih.gov/search/searchview.taf?ipid=68856
704,CP010182-09,"October 01, 2010 -  September 30, 2011",Epidemiologic Field Studies,"Nilanjan  Chatterjee| | |Barry Ira Graubard; PhD|IRP Faculty Profile  | |Ruth  Pfeiffer; PhD|IRP Faculty Profile  | |Mitchell Henry Gail; PhD, MD|IRP Faculty Profile",NULL,"Biostatistics Branch, NCI",Catherine G Schairer,"Farhat  Ben (Institute Salah Azaiz, Tunis)|Robert  Chamberlain (M.D. Anderson Cancer Center)|Paul  Levine (George Washington U)|Donghui  Li (M.D. Anderson Cancer Center)|Sherif  Omar (National Cancer Institute, Cairo, Egypt)|Amr  Soliman (M.D. Anderson Cancer Center)|Show all 9","Joseph  Fraumeni; MD (Office of the Director)|Robert  Hoover; MD, ScD (Epidemiology and Biostatistics Program)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68886
705,CP010183-09,"October 01, 2010 -  September 30, 2011",Descriptive Studies and Record Linkage,William Frederick Anderson,NULL,"Biostatistics Branch, NCI","Nilanjan  Chatterjee|Mitchell Henry Gail; PhD, MD|Jay  Lubin; PhD|Ruth  Pfeiffer; PhD|Philip Samuel Rosenberg; PhD|Catherine G Schairer|Show all 7","Hans-Olov  Adami (Karolinska Institute)|Johanna  Adami (Karolinska Institute)|Johan  Askling (Karolinska Institute)|Paolo  Boffetta (International Agency for Research on Cancer)|Paige  Bracci (UCSF)|Leslie  Carroll (Information Management Services, Inc)|Show all 28","Dalsu  Baris (Occupational and Environmental Epidemiology Branch)|Louise  Brinton; PhD (Hormonal and Reproductive Epidemiology Branch)|Neil Edward Caporaso; MS, MD (Genetic Epidemiology Branch)|Wong H Chow (Occupational and Environmental Epidemiology Branch)|Rochelle E Curtis (Radiation Epidemiology Branch)|Eric Andrew Engels; PhD (Infection & Immunoepidemiology Branch)",NULL,"1. Alexander S, VHMPP V, Brant L, Concin H, Concin N, Diem G, Goebel G, Gruber-Moesenbache U, Nagel G, Oberaigner W, Offner F, Pfeiffer K, Pfeiffer R, Pompella A, Ruttmann E, Ulmer H (2010) Prospective study of the association of serum gamma-glutamyltransferase with cervical intraepithelial neoplasia III and invasive cervical cancer. CANCER RES 70:3586-93.|2. Anderson W, Rosenberg P (2011) Age-Period-Cohort Models in Cancer Surveillance Research: Ready for Prime Time? CANCER EPIDEM BIOMAR 20:1263-68.|3. Gail M, Mai P (2010) Comparing Breast Cancer Risk Assessment Models. J NATL CANCER INST 102:665-8.|4. Ismail J, Anderson W, Jeong J, Redmond C (2011) Breast Cancer Adjuvant Therapy: Time to Consider its Time-Dependent Effects? J CLIN ONCOL 29:2301-04.|5. Jatoi I, Anderson WF, Jeong JH, Redmond CK (2011). Breast cancer adjuvant therapy: time to consider its time-dependent effects. J Clin Oncol  29, 2301-4.   https://doi.org/10.1200/JCO.2010.32.3550|6. Menashe I, Maeder D, Garcia-Closas M, Figueroa JD, Bhattacharjee S, Rotunno M, Kraft P, Hunter DJ, Chanock SJ, Rosenberg PS, Chatterjee N (2010). Pathway analysis of breast cancer genome-wide association study highlights three pathways and one canonical signaling cascade. Cancer Res  70, 4453-9.   https://doi.org/10.1158/0008-5472.CAN-09-4502|7. Nichols HB, Berrington de González A, Lacey JV, Rosenberg PS, Anderson WF (2011). Declining incidence of contralateral breast cancer in the United States from 1975 to 2006. J Clin Oncol  29, 1564-9.   https://doi.org/10.1200/JCO.2010.32.7395|8. Rosenberg PS, Anderson WF (2011). Age-period-cohort models in cancer surveillance research: ready for prime time? Cancer Epidemiol Biomarkers Prev  20, 1263-8.   https://doi.org/10.1158/1055-9965.EPI-11-0421|9. Rosenberg PS, Tamary H, Alter BP (2011). How high are carrier frequencies of rare recessive syndromes? Contemporary estimates for Fanconi Anemia in the United States and Israel. Am J Med Genet A  155A, 1877-83.   https://doi.org/10.1002/ajmg.a.34087|10. Schairer C, Brown LM, Mai PL (2011). Inflammatory breast cancer: high risk of contralateral breast cancer compared to comparably staged non-inflammatory breast cancer. Breast Cancer Res Treat  129, 117-24.   https://doi.org/10.1007/s10549-010-1324-y",https://intramural.nih.gov/search/searchview.taf?ipid=68855
706,CP010184-09,"October 01, 2010 -  September 30, 2011",Consultation and Collaboration,Sholom  Wacholder; PhD|IRP Faculty Profile  | |Barry Ira Graubard; PhD|IRP Faculty Profile,NULL,"Biostatistics Branch, NCI","Linda M Brown; MPH, DPhil|Nilanjan  Chatterjee|Mitchell Henry Gail; PhD, MD|Gloria L Gridley|Junmo  Nam|Ruth  Pfeiffer; PhD","Paul  Bakaki (Makerere University Medical School and Mulago Hospital, Kampala, Uganda)|A.  Barrett (National Heart, Lung, and Blood Institute)|Eleuterio  Bravo-Otero (University of Puerto Rico)|David  Brenner (Columbia University)|Robert  Burk (Albert Einstein College of Medicine)|Julianne  Byrne (Washington Children's hospital)|Show all 86","Michael  Alavanja; PhD (Occupational and Environmental Epidemiology Branch)|Aaron E Blair; PhD, MPH (Occupational and Environmental Epidemiology Branch)|Philip E Castle; PhD, MPH (Hormonal and Reproductive Epidemiology Branch)|Wong H Chow (Occupational and Environmental Epidemiology Branch)|Joseph B Coble (Occupational and Environmental Epidemiology Branch)|Joanne S Colt (Occupational and Environmental Epidemiology Branch)","Harvey J Alter; MD (CC) |Jane  Hoppin; ScD (NIEHS) |Joni L Rutter (NIDA) |Dale  Sandler; PhD (NIEHS) |Jeffery P Struewing; MS, MD (NHGRI) |Clarice  Weinberg; PhD (NIEHS)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68888
707,CP010185-09,"October 01, 2010 -  September 30, 2011",Biodefense Project,Martha S Linet; PhD|IRP Faculty Profile,NULL,"Radiation Epidemiology Branch, NCI",Alice  Sigurdson; PhD|Vladimir  Drozdovitch|Choonsik  Lee|Amy  de Gonzalez|Steven L Simon,"Harold  Beck (DOE Environmental Measurements Laboratory (retired))|Victor  Kryuchkov (Institute of Biophysics)|Sergey  Shinkarev (Moscow Institute of Biophysics)|Sergey  Sholom (URPI)|Nikolai  Talerko (Scientific Center of Radiation Medicine, Ukraine)|Eduardo  Yukihara (Oklahoma State University)",NULL,NULL,"1. Eduardo Y, McKeever S, Mittani J, Simon S (2010) Optically Stimulated Luminescence (OSL) of dental enamel for retrospective assessment of radiation exposure. Radiation Measurements 98:432-9.|2. Grosche B, Lackland DT, Land CE, Simon SL, Apsalikov KN, Pivina LM, Bauer S, Gusev BI (2011). Mortality from cardiovascular diseases in the Semipalatinsk historical cohort, 1960-1999, and its relationship to radiation exposure. Radiat Res  176, 660-9.   https://doi.org/10.1667/rr2211.1|3. Sholom S, Dewitt R, Simon SL, Bouville A, McKeever SW (2011). Emergency Dose Estimation Using Optically Stimulated Luminescence from Human Tooth Enamel. Radiat Meas  46, 778-782.   https://doi.org/10.1016/j.radmeas.2011.03.008|4. Simon S, Beck H, Bouville A, Land C (2010) Radiation doses and cancer risks in the Marshall Islands associated with exposure to fallout from Bikini and Enewetak nuclear weapons tests: summary. Health Physics 99:105-23.",https://intramural.nih.gov/search/searchview.taf?ipid=68887
708,CP010187-07,"October 01, 2010 -  September 30, 2011",Cancer Genetic Markers of Susceptibility,"Stephen J Chanock; MD, PhD|IRP Faculty Profile  | |Mark  Purdue|IRP Faculty Profile  | |Nathaniel C Rothman; MD|IRP Faculty Profile  | |Margaret Anne Tucker|IRP Faculty Profile  | |Robert  Hoover; MD, ScD|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI

Epidemiology and Biostatistics Program, NCI

Laboratory Translational Genomics, NCI

Human Genetics Program, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68895
709,CP010188-07,"October 01, 2010 -  September 30, 2011",Risk prediction methods,"Barry Ira Graubard; PhD|IRP Faculty Profile  | |Mark H Greene; MD|IRP Faculty Profile  |Patricia  Hartge; ScD| | |Robert  Hoover; MD, ScD|IRP Faculty Profile  | |Hormuzdiar Aspandiar Katki; MS|IRP Faculty Profile  | |Ruth  Pfeiffer; PhD|IRP Faculty Profile  | |Sholom  Wacholder; PhD|IRP Faculty Profile  | |Mitchell Henry Gail; PhD, MD|IRP Faculty Profile",NULL,"Biostatistics Branch, NCI

Epidemiology and Biostatistics Program, NCI

Clinical Genetics Branch, NCI",Nilanjan  Chatterjee|Catherine G Schairer|Ju-Hyun  Park|Arpita  Ghosh,Garnet  Anderson (WHI Clinical Coordinating Center)|Heather  Feigelson (American Cancer Society)|David  Hunter (Harvard School of Public Health)|Ross  Prentice (Fred Hutchinson Cancer Research Center),"Demetrius  Albanes; MD (Nutritional Epidemiology Branch)|Thomas R O'Brien; BA, MPH, MD (Infection & Immunoepidemiology Branch)|Yikyung  Park (Nutritional Epidemiology Branch)|Sara  Schonfeld (Radiation Epidemiology Branch)",NULL,"1. Gail MH (2011). Personalized estimates of breast cancer risk in clinical practice and public health. Stat Med  30, 1090-104.   https://doi.org/10.1002/sim.4187",https://intramural.nih.gov/search/searchview.taf?ipid=68889
710,CP010190-06,"October 01, 2010 -  September 30, 2011",Genetic Epidemiology of Telomere Maintenance and Cancer Etiology,Mark H Greene; MD|IRP Faculty Profile  | |Sharon Ann Savage|IRP Faculty Profile,NULL,"Clinical Genetics Branch, NCI",Shahinaz M Gadalla|Lisa  Mirabello,"Steven  Artandi (Stanford University)|Alison  Bertuch; MD, PhD (Pediatrics, Baylor College of Medicine)|Richard  Cawthon (University of Utah)|Immaculata  DeVivo (Harvard Medical School)|David  Hunter (Harvard School of Public Health)|Davide  Ruggero (University of California San Francisco)|Show all 7",NULL,NULL,"1. Batista LF, Pech MF, Zhong FL, Nguyen HN, Xie KT, Zaug AJ, Crary SM, Choi J, Sebastiano V, Cherry A, Giri N, Wernig M, Alter BP, Cech TR, Savage SA, Reijo Pera RA, Artandi SE (2011). Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cells. Nature  474, 399-402.   https://doi.org/10.1038/nature10084|2. Gadalla S, Alter B, Cawthon R, Giri N, Savage S (2010) Telomere Length in Blood, Buccal Cells, and Fibroblasts from Patients with Inherited Bone Marrow Failure Syndromes. Aging 2:867-74.|3. Gadalla S, Savage S (2011) Telomere Biology in Hematopoiesis and Stem Cell Transplantation. BLOOD REV 2011:2011.|4. Gadalla SM, Cawthon R, Giri N, Alter BP, Savage SA (2010). Telomere length in blood, buccal cells, and fibroblasts from patients with inherited bone marrow failure syndromes. Aging (Albany NY)  2, 867-74.   https://doi.org/10.18632/aging.100235|5. Giri N, Lee R, Faro A, Huddleston CB, White FV, Alter BP, Savage SA (2011). Lung transplantation for pulmonary fibrosis in dyskeratosis congenita: Case Report and systematic literature review. BMC Blood Disord  11, 3.   https://doi.org/10.1186/1471-2326-11-3|6. Jennifer P, DeVivo I, Savage S (2011) Epidemiologic evidence for a role of telomere dysfunction in cancer etiology. Mutation Research 2011:2011.|7. Michael P, Savage S, Tolar J, Young N (2011) Optimization of Therapy for Severe Aplastic Anemia Based on Clinical, Biological and Treatment Response Parameters: Conclusions of an International Working Group on Severe Aplastic Anemia Convened by the Blood and Marrow Transplant Clinical Trials N. Biology of Blood and Bone Marrow Transplantation 17:291-9.|8. Mirabello L, Brinton L, Cawthon R, Garcia-Closas M, Lissowska J, Peplonska B, Savage S, Sherman M (2010) Leukocyte telomere length in a population-based case-control of ovarian cancer: A pilot study. Cancer Causes and Control 21:77-82.|9. Mirabello L, Chatterjee N, DeVivo I, Hayes R, Hunter D, Kraft P, Prescott J, Savage S, Wong J, Yu K (2010) The association of telomere length and genetic variation in telomere biology genes. Human Mutation 31:1050-8.|10. Mirabello L, Garcia-Closas M, Cawthon R, Lissowska J, Brinton LA, Pepłońska B, Sherman ME, Savage SA (2010). Leukocyte telomere length in a population-based case-control study of ovarian cancer: a pilot study. Cancer Causes Control  21, 77-82.   https://doi.org/10.1007/s10552-009-9436-6|11. Mirabello L, Yeager M, Chowdhury S, Qi L, Deng X, Wang Z, Hutchinson A, Savage SA (2012). Worldwide genetic structure in 37 genes important in telomere biology. Heredity (Edinb)  108, 124-33.   https://doi.org/10.1038/hdy.2011.55|12. Mirabello L, Yu K, Kraft P, De Vivo I, Hunter DJ, Prescott J, Wong JY, Chatterjee N, Hayes RB, Savage SA (2010). The association of telomere length and genetic variation in telomere biology genes. Hum Mutat  31, 1050-8.   https://doi.org/10.1002/humu.21314|13. Pulsipher MA, Young NS, Tolar J, Risitano AM, Deeg HJ, Anderlini P, Calado R, Kojima S, Eapen M, Harris R, Scheinberg P, Savage S, Maciejewski JP, Tiu RV, DiFronzo N, Horowitz MM, Antin JH (2011). Optimization of therapy for severe aplastic anemia based on clinical, biologic, and treatment response parameters: conclusions of an international working group on severe aplastic anemia convened by the Blood and Marrow Transplant Clinical Trials Network, March 2010. Biol Blood Marrow Transplant  17, 291-9.   https://doi.org/10.1016/j.bbmt.2010.10.028|14. Savage S, Bertuch A (2010) The Genetics and Clinical Manifestations of Telomere Biology Disorders. Genetics in Medicine 12:753-64.|15. Savage SA, Bertuch AA (2010). The genetics and clinical manifestations of telomere  biology disorders. Genet Med  12, 753-64.   https://doi.org/10.1097/GIM.0b013e3181f415b5|16. Wentzensen IM, Mirabello L, Pfeiffer RM, Savage SA (2011). The association of telomere length and cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev  20, 1238-50.   https://doi.org/10.1158/1055-9965.EPI-11-0005|17. Yuan Y, Bingner RL, Locke MA, Stafford J, Theurer FD (2011) Assessing the long term impact of phosphorus fertilization on phosphorus loadings using AnnAGNPS. Int J Environ Res Public Health 8:2181-99|18. Zhong F, Savage SA, Shkreli M, Giri N, Jessop L, Myers T, Chen R, Alter BP, Artandi SE (2011). Disruption of telomerase trafficking by TCAB1 mutation causes dyskeratosis congenita. Genes Dev  25, 11-6.   https://doi.org/10.1101/gad.2006411",https://intramural.nih.gov/search/searchview.taf?ipid=68898
711,CP010192-04,"October 01, 2010 -  September 30, 2011","Biorepository Processing, Storage, and Research","Shelia K Zahm; ScM, ScD",NULL,"Office of the Director, NCI",Marianne  Henderson,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68905
712,CP010193-05,"October 01, 2010 -  September 30, 2011",Whole Genome Scan for Pancreatic Cancer Risk in the Pancreatic Cancer Cohort Con,"Laufey Thora Amundadottir|IRP Faculty Profile  | |Stephen J Chanock; MD, PhD|IRP Faculty Profile  |Patricia  Hartge; ScD| | |Robert  Hoover; MD, ScD|IRP Faculty Profile  | |Rachael Zoe Solomon|IRP Faculty Profile",NULL,"Nutritional Epidemiology Branch, NCI

Epidemiology and Biostatistics Program, NCI

Laboratory Translational Genomics, NCI",Julie  Mendelsohn,"Alan  Arslan (NYU)|Paige  Bracci (UCSF)|H  Bueno-de-Mesquita (Dept of Chronic Dis Epidemiology, Natl Inst for Pub Health and the Environ)|E  Duell (Dartmouth Medical School, Norris Cotton Cancer Center)|Charles  Fuchs (Harvard)|Steve  Gallinger (MSHRI)|Show all 17",Geoffrey Scott Tobias (Human Genetics Program)|Kai  Yu (Biostatistics Branch)|Amy  Hutchinson (Office of the Director),NULL,"1. Zeng H, Yu H, Lu L, Jain D, Kidd MS, Saif MW, Chanock SJ, Hartge P, PanScan Consortium, Risch HA (2011). Genetic effects and modifiers of radiotherapy and chemotherapy on survival in pancreatic cancer. Pancreas  40, 657-63.   https://doi.org/10.1097/MPA.0b013e31821268d1",https://intramural.nih.gov/search/searchview.taf?ipid=68899
713,CP010194-05,"October 01, 2010 -  September 30, 2011",Diet and Cancer in India,Rashmi P Sinha; PhD|IRP Faculty Profile,NULL,"Nutritional Epidemiology Branch, NCI",NULL,NULL,Barry Ira Graubard; PhD (Biostatistics Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68900
714,CP010195-05,"October 01, 2010 -  September 30, 2011","Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study",Rachael Zoe Solomon|IRP Faculty Profile  | |Demetrius  Albanes; MD|IRP Faculty Profile,NULL,"Nutritional Epidemiology Branch, NCI","Stephanie Joan Weinstein|Arthur  Schatzkin; PhD|Rashmi P Sinha; PhD|Amanda  Cross|Christian Cormac Abnet; PhD, MPH|Neal David Freedman|Show all 9","Paul  Brennan (International Agency for Research on Cancer, Lyon, France)|Kaye  Brock|Federico  Canzian (German Cancer Research Center)|Charles  Fuchs (Harvard)|Susan  Hankinson (Epidemiology Department, Harvard School of Public Health)|Richard  Hayes (NYU Langone Medical Center, NYU Cancer Institute)|Show all 26","Stephen J Chanock; MD, PhD (Laboratory Translational Genomics)|Nathaniel C Rothman; MD (Occupational and Environmental Epidemiology Branch)|Qing  Lan (Occupational and Environmental Epidemiology Branch)|Neil Edward Caporaso; MS, MD (Genetic Epidemiology Branch)|Maria Teresa Pia Landi; MD, PhD (Genetic Epidemiology Branch)|Philip  Taylor; MD, ScD (Genetic Epidemiology Branch)",NULL,"1. Albanes D, Mondul AM, Yu K, Parisi D, Horst RL, Virtamo J, Weinstein SJ (2011). Serum 25-hydroxy vitamin D and prostate cancer risk in a large nested case-control study. Cancer Epidemiol Biomarkers Prev  20, 1850-60.   https://doi.org/10.1158/1055-9965.EPI-11-0403|2. Arem H, Weinstein SJ, Horst RL, Virtamo J, Yu K, Albanes D, Abnet CC (2011). Serum 25-hydroxyvitamin D and risk of oropharynx and larynx cancers in Finnish men. Cancer Epidemiol Biomarkers Prev  20, 1178-84.   https://doi.org/10.1158/1055-9965.EPI-11-0153|3. Douglas JB, Silverman DT, Weinstein SJ, Graubard BI, Pollak MN, Tao Y, Virtamo J, Albanes D, Stolzenberg-Solomon RZ (2011). Serum C-reactive protein and risk of pancreatic cancer in two nested, case-control studies. Cancer Epidemiol Biomarkers Prev  20, 359-69.   https://doi.org/10.1158/1055-9965.EPI-10-1024|4. Gibson TM, Weinstein SJ, Mayne ST, Pfeiffer RM, Selhub J, Taylor PR, Virtamo J, Albanes D, Stolzenberg-Solomon R (2010). A prospective study of one-carbon metabolism biomarkers and risk of renal cell carcinoma. Cancer Causes Control  21, 1061-9.   https://doi.org/10.1007/s10552-010-9534-5|5. Jiao L, Weinstein SJ, Albanes D, Taylor PR, Graubard BI, Virtamo J, Stolzenberg-Solomon RZ (2011). Evidence that serum levels of the soluble receptor for advanced glycation end products are inversely associated with pancreatic cancer risk: a prospective study. Cancer Res  71, 3582-9.   https://doi.org/10.1158/0008-5472.CAN-10-2573|6. Lisa G, Abnet C, Albanes D, Bertrand K, Chow W, Freedman M, Hankinson S, Hartge P, Hartmuller V, Harvey C, Hayes R, Helzlsouer K, Horst R, Koenig K, Kolonel L, Kolonel L, Laden F, McCullough M, Oshinsky S, Parisi D, Purdue M, Shu X, Snyder K, Solomon R, Tworoger S, et al. [7 more authors] (2010) Circulating 25-hydroxyvitamin D and the risk of rarer cancers: Design and methods of the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. American Journal of Epidemiology 172:10-20.|7. Lisa G, Ahn J, Albanes D, Cai Q, Campbell D, Chen Y, Chow W, Hartmuller V, Helzlsouer K, Horst R, Koeing K, Kolonel L, McCullough M, Moore L, Oshinsky S, Purdue M, Setiawan W, Shu X, Snyder K, Stevens V, Xiang Y, Yang G, Yu K, Zeleniuch-Jacquotte A, Zheng W (2010) Circulating 25-hydroxyvitamin D and risk of kidney cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. American Journal of Epidemiology 172:47-57.|8. Margaret W, Albanes D, Genova E, Groshong S, Husgafvel-Pursiainen K, Lucia M, Virtamo J, Wolff H (2010) Effects of beta-carotene supplementation on molecular markers of lung carcinogenesis in male smokers. Cancer Prev Res 3:745-52.|9. Marjorie M, Albanes D, Ashby J, Bertrand K, Cai H, Chen Y, Flanders W, Freedman M, Gallicchio L, Giovannucci E, Hankinson S, Hartge P, Hartmuller V, Harvey C, Hayes R, Helzlsouer K, Horst R, Jacobs E, Koenig K, Kolonel L, Laden F, Marchand L, Oshinsky S, Purdue M, Shu X, et al. [7 more authors] (2010) Correlates of circulating 25-hydroxyvitamin D: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. American Jounal of Epidemiology 172:21-35.|10. McCullough ML, Weinstein SJ, Freedman DM, Helzlsouer K, Flanders WD, Koenig K, Kolonel L, Laden F, Le Marchand L, Purdue M, Snyder K, Stevens VL, Stolzenberg-Solomon R, Virtamo J, Yang G, Yu K, Zheng W, Albanes D, Ashby J, Bertrand K, Cai H, Chen Y, Gallicchio L, Giovannucci E, Jacobs EJ, et al. [7 more authors] (2010). Correlates of circulating 25-hydroxyvitamin D: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol  172, 21-35.   https://doi.org/10.1093/aje/kwq113|11. Mondul AM, Rager HC, Kopp W, Virtamo J, Albanes D (2011). Supplementation with alpha-tocopherol or beta-carotene reduces serum concentrations of vascular endothelial growth factor-D, but Not -A or -C, in male smokers. J Nutr  141, 2030-4.   https://doi.org/10.3945/jn.111.143669|12. Shen M, Cawthon R, Rothman N, Weinstein SJ, Virtamo J, Hosgood HD, Hu W, Lim U, Albanes D, Lan Q (2011). A prospective study of telomere length measured by monochrome multiplex quantitative PCR and risk of lung cancer. Lung Cancer  73, 133-7.   https://doi.org/10.1016/j.lungcan.2010.11.009|13. Stolzenberg-Solomon R, Albanes D, Arslan A, Cai Q, Clipp S, Harvey C, Hayes R, Helzlsouer K, Horst R, Irish L, Jacobs E, Koenig K, Kolonel L, Le L, McCullough M, Oshinsky S, Patel A, Purdue M, Qi D, Shu X, Snyder K, Virtamo J, Wilkins L, Yu K, Zeleniuch-Jacquotte A, et al. [1 more authors] (2010) Circulating 25-hydroxyvitamin D and risk of pancreatic cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers (VDPP). Am J Epidemiol 172:81-93.|14. Stolzenberg-Solomon RZ, Jacobs EJ, Arslan AA, Qi D, Patel AV, Helzlsouer KJ, Weinstein SJ, McCullough ML, Purdue MP, Shu XO, Snyder K, Virtamo J, Wilkins LR, Yu K, Zeleniuch-Jacquotte A, Zheng W, Albanes D, Cai Q, Harvey C, Hayes R, Clipp S, Horst RL, Irish L, Koenig K, Le Marchand L, et al. [1 more author] (2010). Circulating 25-hydroxyvitamin D and risk of pancreatic cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol  172, 81-93.   https://doi.org/10.1093/aje/kwq120|15. Wei Z, Arslan A, Danforth K, Gao Y, Goodman M, Hankinson S, Harvey C, Hayes R, Helzlsouer K, Henderson B, Horst R, Kolonel L, McCullough M, Weinstein S, Patel A, Purdue M, Shu X, Snyder K, Steplowski E, Tworoger S, Visvanathan K, Yu K, Zeleniuch-Jacquotte A (2010) Circulating 25-hydroxyvitamin D and Risk of Epithelial Ovarian Cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. American Journal of Epidemiology 172:70-80.",https://intramural.nih.gov/search/searchview.taf?ipid=68901
715,CP010196-05,"October 01, 2010 -  September 30, 2011",Prospective Studies of Diet and Cancer in the AARP Cohort,Charles E Matthews|IRP Faculty Profile  | |Rashmi P Sinha; PhD|IRP Faculty Profile,NULL,"Nutritional Epidemiology Branch, NCI",Yikyung  Park|Amanda  Cross|Rachael Zoe Solomon|Neal David Freedman|Jacqueline M Major; MS|Steven  Moore,NULL,NULL,NULL,"1. Brinton LA, Gierach GL, Andaya A, Park Y, Schatzkin A, Hollenbeck AR, Spitz MR (2011). Reproductive and hormonal factors and lung cancer risk in the NIH-AARP Diet and Health Study cohort. Cancer Epidemiol Biomarkers Prev  20, 900-11.   https://doi.org/10.1158/1055-9965.EPI-10-1325|2. Cross A, Ferrucci L, Graubard B, Hollenbeck A, Park Y, Risch A, Schatzkin A, Sinha R, Ward M (2010) A large prospective study of meat consumption and colorectal cancer risk: investigating potential mechanisms underlying this association. Cancer Research 70:2406-14.|3. Cross AJ, Ferrucci LM, Risch A, Graubard BI, Ward MH, Park Y, Hollenbeck AR, Schatzkin A, Sinha R (2010). A large prospective study of meat consumption and colorectal cancer risk: an investigation of potential mechanisms underlying this association. Cancer Res  70, 2406-14.   https://doi.org/10.1158/0008-5472.CAN-09-3929|4. Doubeni CA, Schootman M, Major JM, Stone RA, Laiyemo AO, Park Y, Lian M, Messer L, Graubard BI, Sinha R, Hollenbeck AR, Schatzkin A (2012). Health status, neighborhood socioeconomic context, and premature mortality in the United States: The National Institutes of Health-AARP Diet and Health Study. Am J Public Health  102, 680-8.   https://doi.org/10.2105/AJPH.2011.300158|5. Eisenberg ML, Park Y, Hollenbeck AR, Lipshultz LI, Schatzkin A, Pletcher MJ (2011). Fatherhood and the risk of cardiovascular mortality in the NIH-AARP Diet and Health Study. Hum Reprod  26, 3479-85.   https://doi.org/10.1093/humrep/der305|6. Freedman N, Abnet C, Cross A, Everhart J, Hollenbeck A, McGlynn K, Park Y, Schatzkin A, Sinha R (2010) Association of Meat and Fat Intake With Liver Disease and Hepatocellular Carcinoma in the NIH-AARP Cohort. J Natl Cancer Inst 17:1354-65.|7. Freedman N, Abnet C, Hollenbeck A, Lacey J, Leitzmann M, Schatzkin A (2010) The association of menstrual and reproductive factors with upper gastrointestinal tract cancers in the NIH-AARP cohort. Cancer 116:1572-81.|8. Freedman ND, Cross AJ, McGlynn KA, Abnet CC, Park Y, Hollenbeck AR, Schatzkin A, Everhart JE, Sinha R (2010). Association of meat and fat intake with liver disease and hepatocellular carcinoma in the NIH-AARP cohort. J Natl Cancer Inst  102, 1354-65.   https://doi.org/10.1093/jnci/djq301|9. Freedman ND, Lacey JV, Hollenbeck AR, Leitzmann MF, Schatzkin A, Abnet CC (2010). The association of menstrual and reproductive factors with upper gastrointestinal tract cancers in the NIH-AARP cohort. Cancer  116, 1572-81.   https://doi.org/10.1002/cncr.24880|10. Gao J, Huang X, Park Y, Hollenbeck A, Blair A, Schatzkin A, Chen H (2011). Daytime napping, nighttime sleeping, and Parkinson disease. Am J Epidemiol  173, 1032-8.   https://doi.org/10.1093/aje/kwq478|11. Gao J, Huang X, Park Y, Hollenbeck A, Chen H (2011). An exploratory study on CLU, CR1 and PICALM and Parkinson disease. PLoS One  6, e24211.   https://doi.org/10.1371/journal.pone.0024211|12. Gao J, Xu H, Weinberg C, Huang X, Park Y, Hollenbeck A, Blair A, Schatzkin A, Burch L, Chen H (2011). An exploratory study on the CHRNA3-CHRNA5-CHRNB4 cluster, smoking, and Parkinson's disease. Neurodegener Dis  8, 296-9.   https://doi.org/10.1159/000323190|13. George SM, Moore SC, Chow WH, Schatzkin A, Hollenbeck AR, Matthews CE (2011). A prospective analysis of prolonged sitting time and risk of renal cell carcinoma among 300,000 older adults. Ann Epidemiol  21, 787-90.   https://doi.org/10.1016/j.annepidem.2011.04.012|14. Jianjun G, Blair A, Chen H, Hollenbeck A, Huang X, Park Y (2011) Daytime napping is an early symptom of Parkinsons disease. Am J Epidemiol 173:1032-8.|15. Kabat GC, Cross AJ, Park Y, Schatzkin A, Hollenbeck AR, Rohan TE, Sinha R (2010). Intakes of dietary iron and heme-iron and risk of postmenopausal breast cancer in the National Institutes of Health-AARP Diet and Health Study. Am J Clin Nutr  92, 1478-83.   https://doi.org/10.3945/ajcn.2010.29753|16. Leitzmann MF, Brenner A, Moore SC, Koebnick C, Park Y, Hollenbeck A, Schatzkin A, Ron E (2010). Prospective study of body mass index, physical activity and thyroid cancer. Int J Cancer  126, 2947-56.   https://doi.org/10.1002/ijc.24913|17. Lin SW, Freedman ND, Hollenbeck AR, Schatzkin A, Abnet CC (2011). Prospective study of self-reported diabetes and risk of upper gastrointestinal cancers. Cancer Epidemiol Biomarkers Prev  20, 954-61.   https://doi.org/10.1158/1055-9965.EPI-10-1244|18. Reis JP, Loria CM, Sorlie PD, Park Y, Hollenbeck A, Schatzkin A (2011). Lifestyle factors and risk for new-onset diabetes: a population-based cohort study. Ann Intern Med  155, 292-9.   https://doi.org/10.7326/0003-4819-155-5-201109060-00006|19. Schonfeld SJ, Ron E, Kitahara CM, Brenner A, Park Y, Sigurdson AJ, Schatzkin A, de González AB (2011). Hormonal and reproductive factors and risk of postmenopausal thyroid cancer in the NIH-AARP Diet and Health Study. Cancer Epidemiol  35, e85-90.   https://doi.org/10.1016/j.canep.2011.05.009|20. Song Y, Xu Q, Park Y, Hollenbeck A, Schatzkin A, Chen H (2011). Multivitamins, individual vitamin and mineral supplements, and risk of diabetes among older U.S. adults. Diabetes Care  34, 108-14.   https://doi.org/10.2337/dc10-1260|21. Zervoudakis A, Strickler HD, Park Y, Xue X, Hollenbeck A, Schatzkin A, Gunter MJ (2011). Reproductive history and risk of colorectal cancer in postmenopausal women. J Natl Cancer Inst  103, 826-34.   https://doi.org/10.1093/jnci/djr101",https://intramural.nih.gov/search/searchview.taf?ipid=68907
716,CP010197-05,"October 01, 2010 -  September 30, 2011","Physical Activity, Energy Balance, and Cancer",Demetrius  Albanes; MD|IRP Faculty Profile  |Amanda  Cross| | |Charles E Matthews|IRP Faculty Profile  | |Rashmi P Sinha; PhD|IRP Faculty Profile  | |Rachael Zoe Solomon|IRP Faculty Profile,NULL,"Nutritional Epidemiology Branch, NCI",Steven  Moore,NULL,NULL,NULL,"1. Colbert LH, Matthews CE, Havighurst TC, Kim K, Schoeller DA (2011). Comparative validity of physical activity measures in older adults. Med Sci Sports Exerc  43, 867-76.   https://doi.org/10.1249/MSS.0b013e3181fc7162",https://intramural.nih.gov/search/searchview.taf?ipid=68902
717,CP010198-05,"October 01, 2010 -  September 30, 2011",Lower Gastrointestinal Cancer Studies,Amanda  Cross,NULL,"Nutritional Epidemiology Branch, NCI",Arthur  Schatzkin; PhD|Rashmi P Sinha; PhD,Andrew P Flood|Philip  Schoenfeld (University of Michigan School of Medicine),Elaine L Lanza (Laboratory of Cancer Prevention),NULL,"1. Flood A, Mason JB, Liu Z, Cash BD, Schatzkin A, Schoenfeld PS, Cross AJ (2011). Concentration of folate in colorectal tissue biopsies predicts prevalence of adenomatous polyps. Gut  60, 66-72.   https://doi.org/10.1136/gut.2010.208074|2. Gerd B, Albert P, Colburn N, Cross A, Lanza E, Sansbury L, Schatzkin A (2010) Interleukin-6 as a potential indicator for prevention of high-risk adenoma recurrence by dietary flavonols in the polyp prevention trial. CANCER PREV RES 3:764-75.|3. Gerd B, Albert P, Cross A, Hance K, Laiyemo A, Lanza E, Murphy G, Rogers C, Sansbury L, Schatzkin A (2010) Serum adiponectin, leptin, C-peptide, homocysteine, and colorectal adenoma recurrence in the Polyp Prevention Trial. Cancer Epidemiology Biomarkers and Prevention 19:1441-52.",https://intramural.nih.gov/search/searchview.taf?ipid=68903
718,CP010199-05,"October 01, 2010 -  September 30, 2011",Methods for Etiologic Studies of Diet and Cancer,Rashmi P Sinha; PhD|IRP Faculty Profile,NULL,"Nutritional Epidemiology Branch, NCI",Amanda  Cross|Yikyung  Park|Charles E Matthews,NULL,Amy F Subar (Risk Factor Monitoring and Methods Branch)|Victor  Kipnis (Biometry Research Group)|Frances E Thompson (Risk Factor Monitoring and Methods Branch)|Douglas N Midthune (Biometry Research Group)|Laurence  Freedman (Biometry Research Group)|Richard P Troiano (Risk Factor Monitoring and Methods Branch),NULL,"1. Daniel CR, Cross AJ, Graubard BI, Hollenbeck AR, Park Y, Sinha R (2011). Prospective investigation of poultry and fish intake in relation to cancer risk. Cancer Prev Res (Phila)  4, 1903-11.   https://doi.org/10.1158/1940-6207.CAPR-11-0241|2. Kana W, Cho E, Giovannucci E, Holmes M, Sinha R, Willett W (2010) Meat mutagens and breast cancer in postmenopausal women--a cohort analysis. CANCER EPIDEM BIOMAR 19:1301-10.|3. Tasevska N, Midthune D, Potischman N, Subar AF, Cross AJ, Bingham SA, Schatzkin A, Kipnis V (2011). Use of the predictive sugars biomarker to evaluate self-reported total sugars intake in the Observing Protein and Energy Nutrition (OPEN) study. Cancer Epidemiol Biomarkers Prev  20, 490-500.   https://doi.org/10.1158/1055-9965.EPI-10-0820",https://intramural.nih.gov/search/searchview.taf?ipid=68904
719,CP010200-04,"October 01, 2010 -  September 30, 2011",GEI - Genome-Wide Association Studies,"Stephen J Chanock; MD, PhD|IRP Faculty Profile  |Nilanjan  Chatterjee| | |Maria Teresa Pia Landi; MD, PhD|IRP Faculty Profile  | |Margaret Anne Tucker|IRP Faculty Profile  | |Neil Edward Caporaso; MS, MD|IRP Faculty Profile",NULL,"Biostatistics Branch, NCI

Laboratory Translational Genomics, NCI

Genetic Epidemiology Branch, NCI

Human Genetics Program, NCI",NULL,NULL,Mark  Purdue (Occupational and Environmental Epidemiology Branch),NULL,"1. Ciampa J, Yeager M, Amundadottir L, Jacobs K, Kraft P, Chung C, Wacholder S, Yu K, Wheeler W, Thun MJ, Divers WR, Gapstur S, Albanes D, Virtamo J, Weinstein S, Giovannucci E, Willett WC, Cancel-Tassin G, Cussenot O, Valeri A, Hunter D, Hoover R, Thomas G, Chanock S, Chatterjee N (2011). Large-scale exploration of gene-gene interactions in prostate cancer using a multistage genome-wide association study. Cancer Res  71, 3287-95.   https://doi.org/10.1158/0008-5472.CAN-10-2646",https://intramural.nih.gov/search/searchview.taf?ipid=68906
720,CP010201-02,"October 01, 2010 -  September 30, 2011",Laboratory of Translational Genomics,"Stephen J Chanock; MD, PhD|IRP Faculty Profile",NULL,"Laboratory Translational Genomics, NCI",Laufey Thora Amundadottir|Liudmila  Prokunina-Olsson; PhD|Kevin Michael Brown,NULL,NULL,NULL,"1. Ahn J, Kibel AS, Park JY, Rebbeck TR, Rennert H, Stanford JL, Ostrander EA, Chanock S, Wang MH, Mittal RD, Isaacs WB, Platz EA, Hayes RB (2011). Prostate cancer predisposition loci and risk of metastatic disease and prostate cancer recurrence. Clin Cancer Res  17, 1075-81.   https://doi.org/10.1158/1078-0432.CCR-10-0881|2. Beckmann L, Hüsing A, Setiawan VW, Amiano P, Clavel-Chapelon F, Chanock SJ, Cox DG, Diver R, Dossus L, Feigelson HS, Haiman C, Hallmans G, Hayes RB, Henderson BE, Hoover RN, Hunter DJ, Khaw K, Kolonel LN, Kraft P, Lund E, Le Marchand L, Peeters PH, Riboli E, Stram D, Thomas G, BPC3, et al. [9 more authors] (2011). Comprehensive analysis of hormone and genetic variation in 36 genes related to steroid hormone metabolism in pre- and postmenopausal women from the breast and prostate cancer cohort consortium (BPC3). J Clin Endocrinol Metab  96, E360-7.   https://doi.org/10.1210/jc.2010-0912|3. Calado RT, Brudno J, Mehta P, Kovacs JJ, Wu C, Zago MA, Chanock SJ, Boyer TD, Young NS (2011). Constitutional telomerase mutations are genetic risk factors for cirrhosis. Hepatology  53, 1600-7.   https://doi.org/10.1002/hep.24173|4. Campa D, Kaaks R, Le Marchand L, Haiman CA, Travis RC, Berg CD, Buring JE, Chanock SJ, Diver WR, Dostal L, Fournier A, Hankinson SE, Henderson BE, Hoover RN, Isaacs C, Johansson M, Kolonel LN, Kraft P, Lee IM, McCarty CA, Overvad K, Panico S, Peeters PH, Riboli E, Sanchez MJ, et al. [10 more authors] (2011). Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium. J Natl Cancer Inst  103, 1252-63.   https://doi.org/10.1093/jnci/djr265|5. Catalona WJ, Bailey-Wilson JE, Camp NJ, Chanock SJ, Cooney KA, Easton DF, Eeles RA, FitzGerald LM, Freedman ML, Gudmundsson J, Kittles RA, Margulies EH, McGuire BB, Ostrander EA, Rebbeck TR, Stanford JL, Thibodeau SN, Witte JS, Isaacs WB (2011). National Cancer Institute Prostate Cancer Genetics Workshop. Cancer Res  71, 3442-6.   https://doi.org/10.1158/0008-5472.CAN-11-0314|6. Chung CC, Ciampa J, Yeager M, Jacobs KB, Berndt SI, Hayes RB, Gonzalez-Bosquet J, Kraft P, Wacholder S, Orr N, Yu K, Hutchinson A, Boland J, Chen Q, Feigelson HS, Thun MJ, Diver WR, Albanes D, Virtamo J, Weinstein S, Schumacher FR, Cancel-Tassin G, Cussenot O, Valeri A, Andriole GL, et al. [25 more authors] (2011). Fine mapping of a region of chromosome 11q13 reveals multiple independent loci associated with risk of prostate cancer. Hum Mol Genet  20, 2869-78.   https://doi.org/10.1093/hmg/ddr189|7. Elks CE, Perry JR, Sulem P, Chasman DI, Franceschini N, He C, Lunetta KL, Visser JA, Byrne EM, Cousminer DL, Gudbjartsson DF, Esko T, Feenstra B, Hottenga JJ, Koller DL, Kutalik Z, Lin P, Mangino M, Marongiu M, McArdle PF, Smith AV, Stolk L, van Wingerden SH, Zhao JH, Albrecht E, GIANT Consortium, et al. [149 more authors] (2010). Thirty new loci for age at menarche identified by a meta-analysis of genome-wide association studies. Nat Genet  42, 1077-85.   https://doi.org/10.1038/ng.714|8. González JR, Rodríguez-Santiago B, Cáceres A, Pique-Regi R, Rothman N, Chanock SJ, Armengol L, Pérez-Jurado LA (2011). A fast and accurate method to detect allelic genomic imbalances underlying mosaic rearrangements using SNP array data. BMC Bioinformatics  12, 166.   https://doi.org/10.1186/1471-2105-12-166|9. Gonzalez-Bosquet J, Calcei J, Wei JS, Garcia-Closas M, Sherman ME, Hewitt S, Vockley J, Lissowska J, Yang HP, Khan J, Chanock S (2011). Detection of somatic mutations by high-resolution DNA melting (HRM) analysis in multiple cancers. PLoS One  6, e14522.   https://doi.org/10.1371/journal.pone.0014522|10. Hosgood HD, Purdue MP, Wang SS, Zheng T, Morton LM, Lan Q, Menashe I, Zhang Y, Cerhan JR, Grulich A, Cozen W, Yeager M, Holford TR, Vajdic CM, Davis S, Leaderer B, Kricker A, Schenk M, Zahm SH, Chatterjee N, Chanock SJ, Rothman N, Hartge P, Armstrong B (2011). A pooled analysis of three studies evaluating genetic variation in innate immunity genes and non-Hodgkin lymphoma risk. Br J Haematol  152, 721-6.   https://doi.org/10.1111/j.1365-2141.2010.08518.x|11. Kote-Jarai Z, Amin Al Olama A, Leongamornlert D, Tymrakiewicz M, Saunders E, Guy M, Giles GG, Severi G, Southey M, Hopper JL, Sit KC, Harris JM, Batra J, Spurdle AB, Clements JA, Hamdy F, Neal D, Donovan J, Muir K, Pharoah PD, Chanock SJ, Brown N, Benlloch S, Castro E, Mahmud N, et al. [6 more authors] (2011). Identification of a novel prostate cancer susceptibility variant in the KLK3 gene transcript. Hum Genet  129, 687-94.   https://doi.org/10.1007/s00439-011-0981-1|12. Lacey JV, Yang H, Gaudet MM, Dunning A, Lissowska J, Sherman ME, Peplonska B, Brinton LA, Healey CS, Ahmed S, Pharoah P, Easton D, Chanock S, Garcia-Closas M (2011). Endometrial cancer and genetic variation in PTEN, PIK3CA, AKT1, MLH1, and MSH2 within a population-based case-control study. Gynecol Oncol  120, 167-73.   https://doi.org/10.1016/j.ygyno.2010.10.016|13. Lindström S, Vachon CM, Li J, Varghese J, Thompson D, Warren R, Brown J, Leyland J, Audley T, Wareham NJ, Loos RJ, Paterson AD, Rommens J, Waggott D, Martin LJ, Scott CG, Pankratz VS, Hankinson SE, Hazra A, Hunter DJ, Hopper JL, Southey MC, Chanock SJ, Liu J, Eriksson L, et al. [9 more authors] (2011). Common variants in ZNF365 are associated with both mammographic density and breast cancer risk. Nat Genet  43, 185-7.   https://doi.org/10.1038/ng.760|14. Lindstrom S, Schumacher F, Siddiq A, Travis RC, Campa D, Berndt SI, Diver WR, Severi G, Allen N, Andriole G, Bueno-de-Mesquita B, Chanock SJ, Crawford D, Gaziano JM, Giles GG, Giovannucci E, Guo C, Haiman CA, Hayes RB, Halkjaer J, Hunter DJ, Johansson M, Kaaks R, Kolonel LN, Navarro C, et al. [14 more authors] (2011). Characterizing associations and SNP-environment interactions for GWAS-identified prostate cancer risk markers--results from BPC3. PLoS One  6, e17142.   https://doi.org/10.1371/journal.pone.0017142|15. Lu Y, Abdou AM, Cerhan JR, Morton LM, Severson RK, Davis S, Cozen W, Rothman N, Bernstein L, Chanock S, Hartge P, Wang SS (2011). Human leukocyte antigen class I and II alleles and overall survival in diffuse large B-cell lymphoma and follicular lymphoma. ScientificWorldJournal  11, 2062-70.   https://doi.org/10.1100/2011/373876|16. Machado M, Magalhães WC, Sene A, Araújo B, Faria-Campos AC, Chanock SJ, Scott L, Oliveira G, Tarazona-Santos E, Rodrigues MR (2011). Phred-Phrap package to analyses tools: a pipeline to facilitate population genetics re-sequencing studies. Investig Genet  2, 3.   https://doi.org/10.1186/2041-2223-2-3|17. Machiela MJ, Chen CY, Chen C, Chanock SJ, Hunter DJ, Kraft P (2011). Evaluation of polygenic risk scores for predicting breast and prostate cancer risk. Genet Epidemiol  35, 506-514.   https://doi.org/10.1002/gepi.20600|18. Marenne G, Rodríguez-Santiago B, Closas MG, Pérez-Jurado L, Rothman N, Rico D, Pita G, Pisano DG, Kogevinas M, Silverman DT, Valencia A, Real FX, Chanock SJ, Génin E, Malats N (2011). Assessment of copy number variation using the Illumina Infinium 1M SNP-array: a comparison of methodological approaches in the Spanish Bladder Cancer/EPICURO study. Hum Mutat  32, 240-8.   https://doi.org/10.1002/humu.21398|19. Parikh H, Wang Z, Pettigrew KA, Jia J, Daugherty S, Yeager M, Jacobs KB, Hutchinson A, Burdett L, Cullen M, Qi L, Boland J, Collins I, Albert TJ, Vatten LJ, Hveem K, Njølstad I, Cancel-Tassin G, Cussenot O, Valeri A, Virtamo J, Thun MJ, Feigelson HS, Diver WR, Chatterjee N, et al. [9 more authors] (2011). Fine mapping the KLK3 locus on chromosome 19q13.33 associated with prostate cancer susceptibility and PSA levels. Hum Genet  129, 675-85.   https://doi.org/10.1007/s00439-011-0953-5|20. Pasaniuc B, Zaitlen N, Lettre G, Chen GK, Tandon A, Kao WH, Ruczinski I, Fornage M, Siscovick DS, Zhu X, Larkin E, Lange LA, Cupples LA, Yang Q, Akylbekova EL, Musani SK, Divers J, Mychaleckyj J, Li M, Papanicolaou GJ, Millikan RC, Ambrosone CB, John EM, Bernstein L, Zheng W, et al. [20 more authors] (2011). Enhanced statistical tests for GWAS in admixed populations: assessment using African Americans from CARe and a Breast Cancer Consortium. PLoS Genet  7, e1001371.   https://doi.org/10.1371/journal.pgen.1001371|21. Pomerantz MM, Shrestha Y, Flavin RJ, Regan MM, Penney KL, Mucci LA, Stampfer MJ, Hunter DJ, Chanock SJ, Schafer EJ, Chan JA, Tabernero J, Baselga J, Richardson AL, Loda M, Oh WK, Kantoff PW, Hahn WC, Freedman ML (2010). Analysis of the 10q11 cancer risk locus implicates MSMB and NCOA4 in human prostate tumorigenesis. PLoS Genet  6, e1001204.   https://doi.org/10.1371/journal.pgen.1001204|22. Prescott J, Kraft P, Chasman DI, Savage SA, Mirabello L, Berndt SI, Weissfeld JL, Han J, Hayes RB, Chanock SJ, Hunter DJ, De Vivo I (2011). Genome-wide association study of relative telomere length. PLoS One  6, e19635.   https://doi.org/10.1371/journal.pone.0019635|23. Purdue MP, Johansson M, Zelenika D, Toro JR, Scelo G, Moore LE, Prokhortchouk E, Wu X, Kiemeney LA, Gaborieau V, Jacobs KB, Chow WH, Zaridze D, Matveev V, Lubinski J, Trubicka J, Szeszenia-Dabrowska N, Lissowska J, Rudnai P, Fabianova E, Bucur A, Bencko V, Foretova L, Janout V, Boffetta P, et al. [79 more authors] (2011). Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3. Nat Genet  43, 60-5.   https://doi.org/10.1038/ng.723|24. Shen M, Zhang L, Lee KM, Vermeulen R, Hosgood HD, Li G, Yin S, Rothman N, Chanock S, Smith MT, Lan Q (2011). Polymorphisms in genes involved in innate immunity and susceptibility to benzene-induced hematotoxicity. Exp Mol Med  43, 374-8.   https://doi.org/10.3858/emm.2011.43.6.041|25. Shen M, Zheng T, Lan Q, Zhang Y, Hosgood HD, Zahm SH, Holford TR, Leaderer B, Yeager M, Yuenger J, Chanock S, Rothman N (2011). Polymorphisms in integrin genes and lymphoma risk. Leuk Res  35, 968-70.   https://doi.org/10.1016/j.leukres.2010.12.012|26. Strawbridge RJ, Dupuis J, Prokopenko I, Barker A, Ahlqvist E, Rybin D, Petrie JR, Travers ME, Bouatia-Naji N, Dimas AS, Nica A, Wheeler E, Chen H, Voight BF, Taneera J, Kanoni S, Peden JF, Turrini F, Gustafsson S, Zabena C, Almgren P, Barker DJ, Barnes D, Dennison EM, Eriksson JG, DIAGRAM Consortium, GIANT Consortium, MuTHER Consortium, CARDIoGRAM Consortium, C4D Consortium, et al. [78 more authors] (2011). Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes. Diabetes  60, 2624-34.   https://doi.org/10.2337/db11-0415|27. Wang H, Yamamoto JF, Caberto C, Saltzman B, Decker R, Vogt TM, Yokochi L, Chanock S, Wilkens LR, Le Marchand L (2011). Genetic variation in the bioactivation pathway for polycyclic hydrocarbons and heterocyclic amines in relation to risk of colorectal neoplasia. Carcinogenesis  32, 203-9.   https://doi.org/10.1093/carcin/bgq237|28. Wolpin BM, Kraft P, Xu M, Steplowski E, Olsson ML, Arslan AA, Bueno-de-Mesquita HB, Gross M, Helzlsouer K, Jacobs EJ, LaCroix A, Petersen G, Stolzenberg-Solomon RZ, Zheng W, Albanes D, Allen NE, Amundadottir L, Austin MA, Boutron-Ruault MC, Buring JE, Canzian F, Chanock SJ, Gaziano JM, Giovannucci EL, Hallmans G, et al. [25 more authors] (2010). Variant ABO blood group alleles, secretor status, and risk of pancreatic cancer: results from the pancreatic cancer cohort consortium. Cancer Epidemiol Biomarkers Prev  19, 3140-9.   https://doi.org/10.1158/1055-9965.EPI-10-0751|29. Yang XR, Chang-Claude J, Goode EL, Couch FJ, Nevanlinna H, Milne RL, Gaudet M, Schmidt MK, Broeks A, Cox A, Fasching PA, Hein R, Spurdle AB, Blows F, Driver K, Flesch-Janys D, Heinz J, Sinn P, Vrieling A, Heikkinen T, Aittomäki K, Heikkilä P, Blomqvist C, Lissowska J, Peplonska B, et al. [149 more authors] (2011). Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst  103, 250-63.   https://doi.org/10.1093/jnci/djq526|30. Zeng H, Yu H, Lu L, Jain D, Kidd MS, Saif MW, Chanock SJ, Hartge P, PanScan Consortium, Risch HA (2011). Genetic effects and modifiers of radiotherapy and chemotherapy on survival in pancreatic cancer. Pancreas  40, 657-63.   https://doi.org/10.1097/MPA.0b013e31821268d1|31. Zhu G, Pan D, Zheng T, Lan Q, Chen X, Chen Y, Kim C, Bi X, Holford T, Boyle P, Leaderer B, Chanock SJ, Rothman N, Zhang Y (2011). Polymorphisms in Th1/Th2 cytokine genes, hormone replacement therapy, and risk of non-Hodgkin lymphoma. Front Oncol  1.   https://doi.org/10.3389/fonc.2011.00021",https://intramural.nih.gov/search/searchview.taf?ipid=68911
721,CP010202-03,"October 01, 2010 -  September 30, 2011","Biochemical, molecular, and dietary studies for pancreatic cancer within PLCO",Rachael Zoe Solomon|IRP Faculty Profile,NULL,"Nutritional Epidemiology Branch, NCI",NULL,K  Dodd (DCCPS/NCI)|Brietta M Oaks,"Cari Meinhold Kitahara (Radiation Epidemiology Branch)|Debra  Silverman; ScD, ScM (Occupational and Environmental Epidemiology Branch)|Richard  Hayes; PhD (Occupational and Environmental Epidemiology Branch)",NULL,"1. Meinhold CL, Dodd KW, Jiao L, Flood A, Shikany JM, Genkinger JM, Hayes RB, Stolzenberg-Solomon RZ (2010). Available carbohydrates, glycemic load, and pancreatic cancer: is there a link? Am J Epidemiol  171, 1174-82.   https://doi.org/10.1093/aje/kwq061",https://intramural.nih.gov/search/searchview.taf?ipid=68852
722,CP010206-02,"October 01, 2010 -  September 30, 2011","Human Papillomavirus (HPV) Natural History, Genomics and Risk Assessment",Mark  Schiffman; MD|IRP Faculty Profile,NULL,"Clinical Genetics Branch, NCI",Mark H Greene; MD|Julia  Gage|Lisa  Mirabello,Sameer K Antani; PhD|Robert  Burk (Albert Einstein College of Medicine)|S  Goldie (Harvard)|Rodney D Long|Attila  Lorincz (Digene),"Philip E Castle; PhD, MPH (Hormonal and Reproductive Epidemiology Branch)|Douglas  Lowy; MD (Office Of The Director)|Nicolas Albert Hermann Wentzensen (Hormonal and Reproductive Epidemiology Branch)|Sholom  Wacholder; PhD (Biostatistics Branch)|Hormuzdiar Aspandiar Katki; MS (Biostatistics Branch)|Arpita  Ghosh (Biostatistics Branch)",NULL,"1. Castle PE, Rodríguez AC, Burk RD, Herrero R, Wacholder S, Hildesheim A, Morales J, Rydzak G, Schiffman M, Proyecto Epidemiológico Guanacaste Group (2011). Long-term persistence of prevalently detected human papillomavirus infections in the absence of detectable cervical precancer and cancer. J Infect Dis  203, 814-22.   https://doi.org/10.1093/infdis/jiq116|2. Castle PE, Shaber R, LaMere BJ, Kinney W, Fetterma B, Poitras N, Lorey T, Schiffman M, Dunne A, Ostolaza JM, McKinney S, Burk RD (2011). Human papillomavirus (HPV) genotypes in women with cervical precancer and cancer at Kaiser Permanente Northern California. Cancer Epidemiol Biomarkers Prev  20, 946-53.   https://doi.org/10.1158/1055-9965.EPI-10-1267|3. Clarke MA, Gage JC, Ajenifuja KO, Wentzensen NA, Adepiti AC, Wacholder S, Burk RD, Schiffman M (2011). A population-based cross-sectional study of age-specific risk factors for high risk human papillomavirus prevalence in rural Nigeria. Infect Agent Cancer  6, 12.   https://doi.org/10.1186/1750-9378-6-12|4. Gage J, Adepiti A, Ajenifuja K, Burk R, Eklund C, Harford J, Hutchinson M, Reilly M, Schiffman M, Soliman A, Wacholder S, Wentzensen N (2011) The age-specific prevalence of human papillomavirus and risk of cytologic abnormalities in rural Nigeria: Implications for screen-and-treat strategies. International Journal of Cancer 2011:26211.|5. Gage JC, Ajenifuja KO, Wentzensen NA, Adepiti AC, Eklund C, Reilly M, Hutchinson M, Wacholder S, Harford J, Soliman AS, Burk RD, Schiffman M (2012). The age-specific prevalence of human papillomavirus and risk of cytologic abnormalities in rural Nigeria: implications for screen-and-treat strategies. Int J Cancer  130, 2111-7.   https://doi.org/10.1002/ijc.26211|6. Rodríguez AC, Schiffman M, Herrero R, Hildesheim A, Bratti C, Sherman ME, Solomon D, Guillén D, Alfaro M, Morales J, Hutchinson M, Katki H, Cheung L, Wacholder S, Burk RD (2010). Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection. J Natl Cancer Inst  102, 315-24.   https://doi.org/10.1093/jnci/djq001|7. Schiffman M, Alfaro M, Befano B, Burk R, Castle P, Chen Z, Guillen D, Herrero R, Hildesheim A, Hutchinson M, Morales J, Rodriguez A, Safaeian M, Sherman M, Solomon D, Wacholder S, Yu K, deSalle R (2010) A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasia. Cancer Research 70:3159-69.|8. Schiffman M, Rodriguez AC, Chen Z, Wacholder S, Herrero R, Hildesheim A, Desalle R, Befano B, Yu K, Safaeian M, Sherman ME, Morales J, Guillen D, Alfaro M, Hutchinson M, Solomon D, Castle PE, Burk RD (2010). A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasia. Cancer Res  70, 3159-69.   https://doi.org/10.1158/0008-5472.CAN-09-4179|9. Schiffman M, Wentzensen N, Wacholder S, Kinney W, Gage JC, Castle PE (2011). Human papillomavirus testing in the prevention of cervical cancer. J Natl Cancer Inst  103, 368-83.   https://doi.org/10.1093/jnci/djq562|10. Wentzensen N, Rodriguez AC, Viscidi R, Herrero R, Hildesheim A, Ghosh A, Morales J, Wacholder S, Guillen D, Alfaro M, Safaeian M, Burk RD, Schiffman M (2011). A competitive serological assay shows naturally acquired immunity to human papillomavirus infections in the Guanacaste Natural History Study. J Infect Dis  204, 94-102.   https://doi.org/10.1093/infdis/jir209",https://intramural.nih.gov/search/searchview.taf?ipid=68912
723,CP010207-02,"October 01, 2010 -  September 30, 2011",PLCO EEMS and Extended Follow Up,"Robert  Hoover; MD, ScD|IRP Faculty Profile",NULL,"Epidemiology and Biostatistics Program, NCI",Amanda  Black,NULL,Christine Dorothy Berg (Early Detection Research Group)|Philip  Prorok (Biometry Research Group)|Mark  Purdue (Occupational and Environmental Epidemiology Branch)|Ann  Hsing; PhD (Infection & Immunoepidemiology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68913
724,CP010209-02,"October 01, 2010 -  September 30, 2011",HPV and cancer at multiple anatomic sites,Aimee Rebecca Kreimer|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI",NULL,NULL,NULL,NULL,"1. Kreimer A, Bratti C, Burk R, Cheung L, Demuth F, Gonzalez P, Herrero R, Hildesheim A, Rodriguez A, Schiffman M, Sherman M (2011) Long-term risk of recurrent cervical HPV infection and CIN2+ following excisional treatment. Obstetrics Gynecology 2011:2011.|2. Kreimer AR, Chaturvedi AK (2011). HPV-associated Oropharyngeal Cancers--Are They Preventable? Cancer Prev Res (Phila)  4, 1346-9.   https://doi.org/10.1158/1940-6207.CAPR-11-0379|3. Kreimer AR, Schiffman M, Herrero R, Hildesheim A, González P, Burk RD, Porras C, Sherman ME, Demuth F, Cheung L, Bratti C, Cecilia Rodríguez A (2012). Long-term risk of recurrent cervical human papillomavirus infection and precancer and cancer following excisional treatment. Int J Cancer  131, 211-8.   https://doi.org/10.1002/ijc.26349",https://intramural.nih.gov/search/searchview.taf?ipid=68915
725,CP010210-02,"October 01, 2010 -  September 30, 2011","HPV, cervical neoplasia, and vaccination",Ann  Hsing; PhD| | |Mark  Schiffman; MD|IRP Faculty Profile  | |Allan  Hildesheim; PhD|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI

Clinical Genetics Branch, NCI",Mahboobeh  Safaeian|Aimee Rebecca Kreimer,Mary  Carrington (SAIC Frederick)|L  Pinto (SAIC-NCI),"Douglas  Lowy; MD (Office Of The Director)|John  Schiller; PhD (Laboratory of Cellular Oncology)|Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)|Sholom  Wacholder; PhD (Biostatistics Branch)|Hormuzdiar Aspandiar Katki; MS (Biostatistics Branch)",NULL,"1. Hui-Chi C, Chen C, Chou Y, Hsieh C, Hsing A, Liaw K, Lin C, Pan M, Schiffman M, Study C, You S (2011) Prevalence of genotype-specific human papillomavirus infection and cervical neoplasia in Taiwan: a community-based survey of 10,602 women. Int J Cancer 128:1192-1203.",https://intramural.nih.gov/search/searchview.taf?ipid=68916
726,CP010211-02,"October 01, 2010 -  September 30, 2011",Viral and Host Factors Associated with NPC,Alisa  Goldstein; PhD|IRP Faculty Profile  | |Allan  Hildesheim; PhD|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI

Genetic Epidemiology Branch, NCI",Cindy M Chang|Cheng-Ping  Wang,NULL,"Mary  Carrington; MS, PhD (Laboratory of Experimental Immunology)|Ruth  Pfeiffer; PhD (Biostatistics Branch)|Kai  Yu (Biostatistics Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68917
727,CP010212-02,"October 01, 2010 -  September 30, 2011",Molecular mechanisms of infection-related cancer,Charles  Rabkin|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI",NULL,NULL,NULL,NULL,"1. Camargo MC, Anderson WF, King JB, Correa P, Thomas CC, Rosenberg PS, Eheman CR, Rabkin CS (2011). Divergent trends for gastric cancer incidence by anatomical subsite in US adults. Gut  60, 1644-9.   https://doi.org/10.1136/gut.2010.236737|2. Sabunciyan S, Mandelberg N, Rabkin CS, Yolken R, Viscidi R (2011). No difference in antibody titers against xenotropic MLV related virus in prostate cancer cases and cancer-free controls. Mol Cell Probes  25, 134-6.   https://doi.org/10.1016/j.mcp.2011.01.005|3. Sarven S, Mandelberg N, Rabkin C, Viscidi R, Yolken R (2011) No difference in antibody titers against Xenotropic MLV Related Virus in prostate cancer cases and cancer-free controls. International Journal of Cancer 5:134-6.",https://intramural.nih.gov/search/searchview.taf?ipid=68918
728,CP010213-02,"October 01, 2010 -  September 30, 2011",Studies of Head and Neck Cancers,Anil Kumar Chaturvedi|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI",NULL,NULL,NULL,NULL,1. Chaturvedi A (2010) Beyond cervical cancer: burden of other HPV-related cancers among men and women. Journal of adolescent health 46:S20-6.,https://intramural.nih.gov/search/searchview.taf?ipid=68919
729,CP010214-02,"October 01, 2010 -  September 30, 2011",Microbes and Human Malignancies,James Jerome Goedert; MD,NULL,"Infection & Immunoepidemiology Branch, NCI",NULL,"Dominique  Costagliola (INSERM, U943)|Wendy  Cozen (Norris Comprehensive Cancer Center)|Heather  Feigelson (American Cancer Society)|Jeffrey  Gordon (WUSTL)|Carmela  Lauria (Lega Italiana per la lotta contro i tumori-sez)|Mario  Luppi (Departments of Oncology, Hematology and Respiratory Diseases)|Show all 9",Barbara J Fuhrman (Hormonal and Reproductive Epidemiology Branch)|Roberto  Flores (Office Of The Director),NULL,"1. Alison A, Benson C, Bosch R, Collier A, Deeks S, Eron J, Gange S, Gebo K, Goedert J, Harrigan R, Hogg R, Horberg M, Jacobson L, John M, Justice A, Kirk G, Kitahata M, Klein M, Lau B, Martin J, McKaig R, Moore R, Napravnik S, Rachalis A, Rodriguez B, et al. [6 more authors] (2010) Missing Data in the Estimation of the Prevalence of Accumulated HIV Drug Resistance in Antiretroviral-Treated Patients in North America. American Journal of Epidemiology 174:727-735.|2. Althoff KN, Justice AC, Gange SJ, Deeks SG, Saag MS, Silverberg MJ, Gill MJ, Lau B, Napravnik S, Tedaldi E, Klein MB, Gebo KA, North American AIDS Cohorts Collaboration on Research, Design (NA-ACCORD) (2010) Virologic and immunologic response to HAART, by age and regimen class. AIDS 24:2469-79|3. Amodio E, Goedert JJ, Barozzi P, Riva G, Firenze A, Bonura F, Viviano E, Romano N, Luppi M (2011). Differences in Kaposi sarcoma-associated herpesvirus-specific and herpesvirus-non-specific immune responses in classic Kaposi sarcoma cases and matched controls in Sicily. Cancer Sci  102, 1769-73.   https://doi.org/10.1111/j.1349-7006.2011.02032.x|4. An P, Li R, Wang JM, Yoshimura T, Takahashi M, Samudralal R, O'Brien SJ, Phair J, Goedert JJ, Kirk GD, Troyer JL, Sezgin E, Buchbinder SP, Donfield S, Nelson GW, Winkler CA (2011). Role of exonic variation in chemokine receptor genes on AIDS: CCRL2 F167Y association with pneumocystis pneumonia. PLoS Genet  7, e1002328.   https://doi.org/10.1371/journal.pgen.1002328|5. Chinn LW, Tang M, Kessing BD, Lautenberger JA, Troyer JL, Malasky MJ, McIntosh C, Kirk GD, Wolinsky SM, Buchbinder SP, Gomperts ED, Goedert JJ, O'Brien SJ (2010). Genetic associations of variants in genes encoding HIV-dependency factors required for HIV-1 infection. J Infect Dis  202, 1836-45.   https://doi.org/10.1086/657322|6. Emanuele A, Barozzi P, Bonura F, Firenze A, Goedert J, Luppi M, Riva G, Romano N, Viviano E (2011) Differences in KSHV-specific and nonspecific immune responses in classic Kaposi sarcoma and controls. Cancer Science 2011:1349-7006.|7. Gadalla SM, Preiss LR, Eyster ME, Goedert JJ (2011). Correlates of high hepatitis C virus RNA load in a cohort of HIV-negative and HIV-positive individuals with haemophilia. J Viral Hepat  18, 161-9.   https://doi.org/10.1111/j.1365-2893.2010.01289.x|8. Goedert J, Airola M, Anderson L, Calamusa G, Dazzi C, Graubard B, Lauria C, Madsen C, Messina A, Pelser C, Perna A, Preiss L, Romano N (2010) Risk of classic Kaposi sarcoma with exposures to plants and soils in Sicily. Cancer Epidemiol Biomarkers Prevention 5:23.|9. Goedert JJ, Pfeiffer R, Zhu M, Yang XR, Garcia-Closas M, Lissowska J, Kopp WC (2012). Peripheral blood immunologic phenotype of population-based breast cancer cases and matched controls. Eur J Clin Invest  42, 572-4.   https://doi.org/10.1111/j.1365-2362.2011.02610.x|10. Hessol NA, Napolitano LA, Smith D, Lie Y, Levine A, Young M, Cohen M, Minkoff H, Anastos K, D'Souza G, Greenblatt RM, Goedert JJ (2010). HIV tropism and decreased risk of breast cancer. PLoS One  5, e14349.   https://doi.org/10.1371/journal.pone.0014349|11. Joshua H, An P, Buchbinder S, Detels R, Goedert J, Gottlieb G, Jacobson L, Kaslow R, Kessing B, Kirk G, Margolick J, Martinson J, Maust B, Mullins J, Nelson G, O S, Troyer J, Winkler C, Wolinsky S, Wong K (2010) Multistage genomewide association study identifies a locus at 1q41 associated with rate of HIV-1 disease progression to clinical AIDS. Journal of Infectious Diseases 201:618-26.|12. Keri A, Anastos K, Benson C, Bosch R, Collier A, Deeks S, Eron J, Gange S, Gebo K, Gill M, Goedert J, Hogg R, Jacobson L, Justice A, Kirk G, Kitahata M, Klein M, Martin J, Moore R, Rodriguez B, Rouke S, Sagg M, Silverberg M, Sterling T, Tadaldi E (2010) Virologic and immunologic response to highly active antiretroviral therapy, by age and regimen class: An observational prospective study. AIDS 24:2469-79.|13. Keri A, Benson C, Bosch R, Brooks J, Buchacz K, Collier A, Deeks S, Eron J, Gange S, Gebo K, Gill J, Goedert J, Hogg R, Horberg M, Jacobson L, Justice A, Kirk G, Kitahata M, Klein M, Martin J, McKaig R, Moore R, Napravnik S, Rachlis A, Rodriguez B, et al. [5 more authors] (2010) CD4 count at presentation for HIV care in the United States and Canada: Are those over 50 years more likely to have a delayed presentation? AIDS Research and Therapy 15:45.|14. Lederman MM, Alter G, Daskalakis DC, Rodriguez B, Sieg SF, Hardy G, Cho M, Anthony D, Harding C, Weinberg A, Silverman RH, Douek DC, Margolis L, Goldstein DB, Carrington M, Goedert JJ (2010). Determinants of protection among HIV‐exposed seronegative persons: an overview. J Infect Dis  202 Suppl 3, S333-8.   https://doi.org/10.1086/655967|15. Limou S, Coulonges C, Herbeck JT, van Manen D, An P, Le Clerc S, Delaneau O, Diop G, Taing L, Montes M, van't Wout AB, Gottlieb GS, Therwath A, Rouzioux C, Delfraissy JF, Lelièvre JD, Lévy Y, Hercberg S, Dina C, Phair J, Donfield S, Goedert JJ, Buchbinder S, Estaquier J, Schächter F, et al. [6 more authors] (2010). Multiple-cohort genetic association study reveals CXCR6 as a new chemokine receptor involved in long-term nonprogression to AIDS. J Infect Dis  202, 908-15.   https://doi.org/10.1086/655782|16. Lozier JN, Rosenberg PS, Goedert JJ, Menashe I (2011). A case-control study reveals immunoregulatory gene haplotypes that influence inhibitor risk in severe haemophilia A. Haemophilia  17, 641-9.   https://doi.org/10.1111/j.1365-2516.2010.02473.x|17. Maimuna M, Goedert J, Hainaut P, Hall A, Kaye S, Kirk G, Kuniholm M, Lesi O, McConkey S, Rowland-Jones S, Welzel T, Whittle H (2010) Hepatitis B Viral Load and Risk for Liver Cirrhosis and Hepatocellular Carcinoma in the Gambia, West Africa. Journal of Viral Hepatitis 17:115-22.|18. Pelser C, Middeldorp J, Mbulaiteye SM, Lauria C, Messina A, Viviano E, Romano N, Vitale F, Goedert JJ (2010). Risk of classical Kaposi sarcoma by plasma levels of Epstein-Barr virus antibodies, sCD26, sCD23 and sCD30. Infect Agent Cancer  5, 18.   https://doi.org/10.1186/1750-9378-5-18|19. Ping A, Li R, Wang J, Yoshimura T, Takahashi M, Samudralal R, O'Brien S, Phair J, Goedert J, Kirk G, Buchbinder S, Donifield S, Nelson G, Winkler C (2011) Role of exonic variation in chemokine receptor genes on AIDS: CCRL2 F167Y association with Pneumocystis pneumonia. PLoS Genetics 10:e1002328|20. Timothy M, Busch M, Duggal P, Goedert J, Hoots W, Kirk G, Peters M, Rosen H, Thio C, Thomas D, Tobler L (2010) Large-scale candidate gene analysis of spontaneous clearance of hepatitis C virus. J Infect Dis 201:1371-80.|21. Timothy S, Bosch R, Brooks J, Deeks S, Eron J, Freeman A, French A, Gange S, Gebo K, Gill M, Goedert J, Hogg R, Horberg M, Jacobson L, Justice A, Kirk G, Kitahata M, Klein M, Lau B, Martin J, McKaig R, Moore R, Napravnik S, Rodriguez B, Silverberg M, et al. [3 more authors] (2010) Risk Factors for Tuberculosis After Highly Active Antiretroviral Therapy Initiation in theUnited States and Canada: Implications for Tuberculosis Screening Strategies. AIDS 204:893-901.|22. Troyer JL, Nelson GW, Lautenberger JA, Chinn L, McIntosh C, Johnson RC, Sezgin E, Kessing B, Malasky M, Hendrickson SL, Li G, Pontius J, Tang M, An P, Winkler CA, Limou S, Le Clerc S, Delaneau O, Zagury JF, Schuitemaker H, van Manen D, Bream JH, Gomperts ED, Buchbinder S, Goedert JJ, et al. [2 more authors] (2011). Genome-wide association study implicates PARD3B-based AIDS restriction. J Infect Dis  203, 1491-502.   https://doi.org/10.1093/infdis/jir046",https://intramural.nih.gov/search/searchview.taf?ipid=68920
730,CP010215-02,"October 01, 2010 -  September 30, 2011",Human microbiome and cancer,Mahboobeh  Safaeian,NULL,"Infection & Immunoepidemiology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68921
731,CP010216-02,"October 01, 2010 -  September 30, 2011",Immune responses to HPV infection and HPV vaccination,Mahboobeh  Safaeian,NULL,"Infection & Immunoepidemiology Branch, NCI",NULL,NULL,NULL,NULL,"1. Baker R, Dauner JG, Rodriguez AC, Williams MC, Kemp TJ, Hildesheim A, Pinto LA (2011). Increased plasma levels of adipokines and inflammatory markers in older women with persistent HPV infection. Cytokine  53, 282-5.   https://doi.org/10.1016/j.cyto.2010.11.014|2. Coseo SE, Porras C, Dodd LE, Hildesheim A, Rodriguez AC, Schiffman M, Herrero R, Wacholder S, Gonzalez P, Sherman ME, Jimenez S, Solomon D, Bougelet C, van Doorn LJ, Quint W, Safaeian M, Costa Rica HPV Vaccine Trial (CVT) Group (2011). Evaluation of the polyclonal ELISA HPV serology assay as a biomarker for human papillomavirus exposure. Sex Transm Dis  38, 976-82.   https://doi.org/10.1097/OLQ.0b013e31822545c0|3. Kemp TJ, Hildesheim A, Safaeian M, Dauner JG, Pan Y, Porras C, Schiller JT, Lowy DR, Herrero R, Pinto LA (2011). HPV16/18 L1 VLP vaccine induces cross-neutralizing antibodies that may mediate cross-protection. Vaccine  29, 2011-4.   https://doi.org/10.1016/j.vaccine.2011.01.001|4. Safaeian M, Burk R, Herrero R, Hildesheim A, Quint K, Rodriguez A, Schiffman M, Viscidi R, Wacholder S (2010) Chlamydia trachomatis and risk of prevalent and incident cervical premalignancy in a population-based cohort. Journal of Infectious Diseases 102:1794-804.|5. Safaeian M, Quint K, Schiffman M, Rodriguez AC, Wacholder S, Herrero R, Hildesheim A, Viscidi RP, Quint W, Burk RD (2010). Chlamydia trachomatis and risk of prevalent and incident cervical premalignancy in a population-based cohort. J Natl Cancer Inst  102, 1794-804.   https://doi.org/10.1093/jnci/djq436|6. Safaeian M, van Doorslaer K, Schiffman M, Chen Z, Rodriguez AC, Herrero R, Hildesheim A, Burk RD (2010). Lack of heterogeneity of HPV16 E7 sequence compared with HPV31 and HPV73 may be related to its unique carcinogenic properties. Arch Virol  155, 367-70.   https://doi.org/10.1007/s00705-009-0579-2|7. Shebl FM, Pinto LA, García-Piñeres A, Lempicki R, Williams M, Harro C, Hildesheim A (2010). Comparison of mRNA and protein measures of cytokines following vaccination with human papillomavirus-16 L1 virus-like particles. Cancer Epidemiol Biomarkers Prev  19, 978-81.   https://doi.org/10.1158/1055-9965.EPI-10-0064",https://intramural.nih.gov/search/searchview.taf?ipid=68922
732,CP010217-01,"October 01, 2010 -  September 30, 2011",HPV Vaccine Trial,Hormuzdiar Aspandiar Katki; MS|IRP Faculty Profile  | |Aimee Rebecca Kreimer|IRP Faculty Profile  |Mahboobeh  Safaeian| | |Mark  Schiffman; MD|IRP Faculty Profile  | |Sholom  Wacholder; PhD|IRP Faculty Profile  | |Allan  Hildesheim; PhD|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI

Biostatistics Branch, NCI

Clinical Genetics Branch, NCI",Anil Kumar Chaturvedi|Nora  Macklin|Felipe A Castro|Ligia  Pinto,Rolando  Herrero (IARC)|Douglas  Lowy; MD (NCI)|Wim  Quint (Delft Diagnostic Laboratory)|Ana-Cecilia  Rodriguez (Proyecto Epidemiologico Guanacaste)|John  Schiller; PhD (NCI)|Diane  Solomon; PhD (NCI),Mark E Sherman; MD (Hormonal and Reproductive Epidemiology Branch)|Nicolas Albert Hermann Wentzensen (Hormonal and Reproductive Epidemiology Branch),NULL,"1. Herrero Acosta R, Wacholder S, Rodriguez A, Solomon D, Gonzalez P, Kreimer A, Porras C, Schussler J, Jimenez S, Sherman M, Quint W, Schiller J, Lowy D, Schiffman M, Hildesheim A (2011) Prevention of persistent HPV infection by a HPV 16-18 vaccine: a community based randomized clinical trial in Guanacaste, Costa Rica, in Cancer Discovery., pp. 2159-8290.|2. Chaturvedi AK, Katki HA, Hildesheim A, Rodríguez AC, Quint W, Schiffman M, Van Doorn LJ, Porras C, Wacholder S, Gonzalez P, Sherman ME, Herrero R, CVT Group (2011). Human papillomavirus infection with multiple types: pattern of coinfection and risk of cervical disease. J Infect Dis  203, 910-20.   https://doi.org/10.1093/infdis/jiq139",https://intramural.nih.gov/search/searchview.taf?ipid=72877
733,CP010218-01,"October 01, 2010 -  September 30, 2011",Etiology of Biliary Tract Cancer,Jill Elizabeth Koshiol|IRP Faculty Profile  |Ann  Hsing; PhD,NULL,"Infection & Immunoepidemiology Branch, NCI",Felipe A Castro,NULL,Gabriella  Andreotti (Occupational and Environmental Epidemiology Branch),NULL,"1. Andreotti G, Liu E, Gao YT, Safaeian M, Rashid A, Shen MC, Wang BS, Deng J, Han TQ, Zhang BH, Hsing AW (2011). Medical history and the risk of biliary tract cancers in Shanghai, China: implications for a role of inflammation. Cancer Causes Control  22, 1289-96.   https://doi.org/10.1007/s10552-011-9802-z|2. Wang WJ, Xu WH, Liu CZ, Rashid A, Cheng JR, Liao P, Hu H, Chu LW, Gao YT, Yu K, Hsing AW (2010). Identification of Serum Biomarkers for Biliary Tract Cancers by a Proteomic Approach Based on Time-of-Flight Mass Spectrometry. Cancers (Basel)  2, 1602-16.   https://doi.org/10.3390/cancers2031602",https://intramural.nih.gov/search/searchview.taf?ipid=72879
734,CP010219-01,"October 01, 2010 -  September 30, 2011",Studies of other risk factors for radiosensitive tumors,Martha S Linet; PhD|IRP Faculty Profile  | |Amy  de Gonzalez|IRP Faculty Profile,NULL,"Radiation Epidemiology Branch, NCI",NULL,NULL,NULL,NULL,"1. Berrington A, Anton-Culver H, Beane L, Beeson W, Cerhan J, Clipp S, English D, Flint A, Folsom A, Freedman D, Giles G, Hakansson N, Hannan L, Hartge P, Henderson K, Hoffman-Bolton J, Hoppin J, Koenig K, Lee I, Linet M, McInnis R, Moore S, Park Y, Pocobelli G, Schatzkin A, et al. [8 more authors] (2010) Body mass index and mortality: a pooled analysis of 19 prospective studies. N Engl J Med 363:2211-9.|2. Kitahara CM, Berrington de González A, Freedman ND, Huxley R, Mok Y, Jee SH, Samet JM (2011). Total cholesterol and cancer risk in a large prospective study in Korea. J Clin Oncol  29, 1592-8.   https://doi.org/10.1200/JCO.2010.31.5200|3. Kitahara CM, Platz EA, Freeman LE, Hsing AW, Linet MS, Park Y, Schairer C, Schatzkin A, Shikany JM, Berrington de González A (2011). Obesity and thyroid cancer risk among U.S. men and women: a pooled analysis of five prospective studies. Cancer Epidemiol Biomarkers Prev  20, 464-72.   https://doi.org/10.1158/1055-9965.EPI-10-1220|4. Kitahara CM, Platz EA, Park Y, Hollenbeck AR, Schatzkin A, Berrington de González A (2012). Body fat distribution, weight change during adulthood, and thyroid cancer risk in the NIH-AARP Diet and Health Study. Int J Cancer  130, 1411-9.   https://doi.org/10.1002/ijc.26161",https://intramural.nih.gov/search/searchview.taf?ipid=72881
735,CP010220-01,"October 01, 2010 -  September 30, 2011",Barretts Esophagus,"Christian Cormac Abnet; PhD, MPH|IRP Faculty Profile  |Wong H Chow| | |Sanford Martin Dawsey; MD|IRP Faculty Profile  | |Ruth  Pfeiffer; PhD|IRP Faculty Profile  |Philip  Taylor; MD, ScD| | |Michael Blaise Cook|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI

Nutritional Epidemiology Branch, NCI

Biostatistics Branch, NCI

Hormonal and Reproductive Epidemiology Branch, NCI

Genetic Epidemiology Branch, NCI",Neal David Freedman,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=72883
736,CP010221-01,"October 01, 2010 -  September 30, 2011",Etiologic Studies of Prostate Cancer,"Sonja  Berndt|IRP Faculty Profile  | |Stephen J Chanock; MD, PhD|IRP Faculty Profile  |Ann  Hsing; PhD| | |Demetrius  Albanes; MD|IRP Faculty Profile",NULL,"Infection & Immunoepidemiology Branch, NCI

Occupational and Environmental Epidemiology Branch, NCI

Nutritional Epidemiology Branch, NCI

Laboratory Translational Genomics, NCI",Alison Marian Mondul|Jacqueline M Major; MS|Mark  Purdue|Stephanie Joan Weinstein,Susan  Gapstur (American Cancer Society)|Brian  Henderson (University of Southern California)|David  Hunter (Harvard School of Public Health)|Laurence N Kolonel|Peter  Kraft|Sara  Lindstrom (Harvard School of Public Health)|Show all 7,"Kevin  Jacobs (Office of the Director)|Robert  Hoover; MD, ScD (Epidemiology and Biostatistics Program)|Joanne Lee Watters (Clinical & Translational Epidemiology Branch)|Meredith  Yeager (Office of the Director)|Zhaoming  Wang (Office of the Director)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=72885
737,CP010222-01,"October 01, 2010 -  September 30, 2011",Studies of Populations Exposed to Diagnostic Medical Radiation,Peter D Inskip; ScD| | |Amy  de Gonzalez|IRP Faculty Profile,NULL,"Radiation Epidemiology Branch, NCI",Rochelle E Curtis|Donald  Miller|Ruth Anne Kleinerman; MPH|Michele M Doody; MS|Alice  Sigurdson; PhD|Steven L Simon|Show all 14,David  Abramson (New York Presbyterian Hospital)|Gabriel  Chodick|Graca M Dores|Per  Hall (Karolinska Instituet)|Froydis  Langmark (The Norwegian Cancer Registry)|Charles  Lynch (University of Iowa)|Show all 14,Margaret Anne Tucker (Human Genetics Program)|Jay  Lubin; PhD (Biostatistics Branch),NULL,"1. Berrington de González A (2011). Estimates of the potential risk of radiation-related cancer from screening in the UK. J Med Screen  18, 163-4.   https://doi.org/10.1258/jms.2011.011073|2. Berrington de Gonzalez A, Kim KP, Smith-Bindman R, McAreavey D (2010) Myocardial perfusion scans: projected population cancer risks from current levels of use in the United States. Circulation 122:2403-10|3. Hough M, Johnson P, Rajon D, Jokisch D, Lee C, Bolch W (2011). An image-based skeletal dosimetry model for the ICRP reference adult male--internal electron sources. Phys Med Biol  56, 2309-46.   https://doi.org/10.1088/0031-9155/56/8/001|4. Johnson PB, Bahadori AA, Eckerman KF, Lee C, Bolch WE (2011). Response functions for computing absorbed dose to skeletal tissues from photon irradiation--an update. Phys Med Biol  56, 2347-65.   https://doi.org/10.1088/0031-9155/56/8/002|5. Lee C, Bolch W, Bouville A, Fisher R, Kim K, Long D, Simon S (2011) Organ doses for reference adult male and female undergoing computed tomography estimated by Monte Carlo simulations. Medical Physics 38:1196-1206.|6. Lee C, Bolch W, Hurtado J, Lodwick D, Pafundi D, Williams J (2010) The UF family of reference hybrid phantoms for computational radiation dosimetry. Physics in Medicine and Biology 55:339-63.|7. Lee C, Kim K, Long D, Fisher R, Simon S, Bouville A, Bolch W (2011) Organ doses for reference adult male and female undergoing computed tomography estimated by Monte Carlo simulations. Medical Physics 38:1196-1206|8. Lee C, Kim KP, Long D, Fisher R, Tien C, Simon SL, Bouville A, Bolch WE (2011). Organ doses for reference adult male and female undergoing computed tomography estimated by Monte Carlo simulations. Med Phys  38, 1196-206.   https://doi.org/10.1118/1.3544658|9. Lee C, Lodwick D, Hurtado J, Pafundi D, Williams JL, Bolch WE (2010). The UF family of reference hybrid phantoms for computational radiation dosimetry. Phys Med Biol  55, 339-63.   https://doi.org/10.1088/0031-9155/55/2/002|10. Matthew H, Bolch W, Derek J, Didier R, Johnson P, Lee C (2011) An image-based skeletal dosimetry model for the ICRP reference adult male--internal electron sources. Physics in Medicine and Biology 56:2309-46.|11. Rajaraman P, Ansell P, Berrington A, Linet M, Neta G, Roman E, Ron E, Simpson J (2011) Early-life Exposure to Diagnostic Radiation and Ultrasound Scans. British Medical Journal 2011:342-472.|12. Rajaraman P, Simpson J, Neta G, Berrington de Gonzalez A, Ansell P, Linet MS, Ron E, Roman E (2011). Early life exposure to diagnostic radiation and ultrasound scans and risk of childhood cancer: case-control study. BMJ  342, d472.   https://doi.org/10.1136/bmj.d472|13. Ronckers CM, Land CE, Miller JS, Stovall M, Lonstein JE, Doody MM (2010). Cancer mortality among women frequently exposed to radiographic examinations for spinal disorders. Radiat Res  174, 83-90.   https://doi.org/10.1667/RR2022.1|14. Wesley B, Johnson P, Lee C, Wayson M (2010) Hybrid computational phantoms for medical dose reconstruction. Radiation and Environmental Biophysics 49:155-68.",https://intramural.nih.gov/search/searchview.taf?ipid=72887
738,SC000167-20,"October 01, 2010 -  September 30, 2011",Molecular Pathology of Pulmonary Carcinogenesis,Ilona  Linnoila; MD,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Kathleen Mary Tompkins|Yan  Li|Claire  McWhite|Xu  Naizhen|Florent Raphael  Suau|Xiaoyang  Wang|Show all 7,NULL,"Phillip A Dennis; MD, PhD (Medical Oncology Branch)|Shioko  Kimura; PhD (Endocrinology Section)",NULL,"1. Makoto M, Ball D, Linnoila I (2011) Insights into the achaete-scute homolog-1 gene (hASH1) in normal and neoplastic human lung. Lung Cancer, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=68933
739,SC000550-31,"October 01, 2010 -  September 30, 2011",Lymphoma Disease Discovery and Defintion,Elaine S Jaffe; MD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Theresa M Davies Hill|Franziska Carola Eberle|Alison Rozmus Huppmann; MD|Alina Abby Leung|Qingyan  Liu|Mark  Raffeld; MD|Show all 12,"Elias  Campo (University of Barcelona)|Wing  Chan (Pathology, University of Nebraska)|Andreas  Chott (Pathology, University of Vienna)|Stefan D Dojcinov|Falko  Fend|Randy  Gascoyne (British Columbia Cancer Center)|Show all 15","Wyndham H Wilson; MD, PhD (Lymphoid Malignancies Branch)|Louis  Staudt; MD (Lymphoid Malignancies Branch)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Jonathan Keith Killian (Cancer Genetics Branch)|Susan  Bates; MD (Medical Oncology Branch)|Kieron Michael Dunleavy (Lymphoid Malignancies Branch)","Jeffrey  Cohen; MD (NIAID) |Katherine Rainsford Calvo (CC) |Thomas Arthur Fleisher; MD (CC) |Vemulkonda Koneti Rao; MD, FRCPA (NIAID) |Adrian U Wiestner; MD, PhD (NHLBI)","1. Campo E, Swerdlow SH, Harris NL, Pileri S, Stein H, Jaffe ES (2011). The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood  117, 5019-32.   https://doi.org/10.1182/blood-2011-01-293050|2. Dojcinov SD, Venkataraman G, Raffeld M, Pittaluga S, Jaffe ES (2010). EBV positive mucocutaneous ulcer--a study of 26 cases associated with various sources of immunosuppression. Am J Surg Pathol  34, 405-17.   https://doi.org/10.1097/PAS.0b013e3181cf8622|3. Dowdell KC, Niemela JE, Price S, Davis J, Hornung RL, Oliveira JB, Puck JM, Jaffe ES, Pittaluga S, Cohen JI, Fleisher TA, Rao VK (2010). Somatic FAS mutations are common in patients with genetically undefined autoimmune lymphoproliferative syndrome. Blood  115, 5164-9.   https://doi.org/10.1182/blood-2010-01-263145|4. Eberle FC, Hanson JC, Killian JK, Wei L, Ylaya K, Hewitt SM, Jaffe ES, Emmert-Buck MR, Rodriguez-Canales J (2010). Immunoguided laser assisted microdissection techniques for DNA methylation analysis of archival tissue specimens. J Mol Diagn  12, 394-401.   https://doi.org/10.2353/jmoldx.2010.090200|5. Hartmann EM, Campo E, Wright G, Lenz G, Salaverria I, Jares P, Xiao W, Braziel RM, Rimsza LM, Chan WC, Weisenburger DD, Delabie J, Jaffe ES, Gascoyne RD, Dave SS, Mueller-Hermelink HK, Staudt LM, Ott G, Beà S, Rosenwald A (2010). Pathway discovery in mantle cell lymphoma by integrated analysis of high-resolution gene expression and copy number profiling. Blood  116, 953-61.   https://doi.org/10.1182/blood-2010-01-263806|6. Jaffe ES (2011). Centralized review offers promise for the clinician, the pathologist, and the patient with newly diagnosed lymphoma. J Clin Oncol  29, 1398-9.   https://doi.org/10.1200/JCO.2010.34.2741|7. Pittaluga S, Jaffe ES (2010). T-cell/histiocyte-rich large B-cell lymphoma. Haematologica  95, 352-6.   https://doi.org/10.3324/haematol.2009.016931|8. Rizzo KA, Streubel B, Pittaluga S, Chott A, Xi L, Raffeld M, Jaffe ES (2010). Marginal zone lymphomas in children and the young adult population; characterization of genetic aberrations by FISH and RT-PCR. Mod Pathol  23, 866-73.   https://doi.org/10.1038/modpathol.2010.63|9. Rodriguez-Canales J, Eberle FC, Jaffe ES, Emmert-Buck MR (2011). Why is it crucial to reintegrate pathology into cancer research? Bioessays  33, 490-8.   https://doi.org/10.1002/bies.201100017|10. Steidl C, Lee T, Shah SP, Farinha P, Han G, Nayar T, Delaney A, Jones SJ, Iqbal J, Weisenburger DD, Bast MA, Rosenwald A, Muller-Hermelink HK, Rimsza LM, Campo E, Delabie J, Braziel RM, Cook JR, Tubbs RR, Jaffe ES, Lenz G, Connors JM, Staudt LM, Chan WC, Gascoyne RD (2010). Tumor-associated macrophages and survival in classic Hodgkin's lymphoma. N Engl J Med  362, 875-85.   https://doi.org/10.1056/NEJMoa0905680|11. Summers TA, Jaffe ES (2011). Hairy cell leukemia diagnostic criteria and differential diagnosis. Leuk Lymphoma  52 Suppl 2, 6-10.   https://doi.org/10.3109/10428194.2011.565435|12. Taddesse-Heath L, Meloni-Ehrig A, Scheerle J, Kelly JC, Jaffe ES (2010). Plasmablastic lymphoma with MYC translocation: evidence for a common pathway in the generation of plasmablastic features. Mod Pathol  23, 991-9.   https://doi.org/10.1038/modpathol.2010.72|13. Venkataraman G, McClain KL, Pittaluga S, Rao VK, Jaffe ES (2010). Development of disseminated histiocytic sarcoma in a patient with autoimmune lymphoproliferative syndrome and associated Rosai-Dorfman disease. Am J Surg Pathol  34, 589-94.   https://doi.org/10.1097/PAS.0b013e3181d5ddf8",https://intramural.nih.gov/search/searchview.taf?ipid=68934
740,SC000892-28,"October 01, 2010 -  September 30, 2011",Molecular Biology of the Metastatic Phenotype,Patricia  Steeg; PhD|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI",Joshua Wade Collins|Takashi  Hoshino|Natascia  Marino|Jean-Claude A Marshall|Devin  Matthews|Joji  Nakayama,"Kathy  Miller (Indiana University)|Maximillian  Murone (Debio Pharmaceuticals)|George  Sledge, Jr. (Indiana University)|Fernando  Vidal-Vanaclocha",Maria  Merino; PhD (Laboratory of Pathology)|Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Timothy D Veenstra (Office Of The Director)|Cari E Graff-Cherry (Office Of The Director),NULL,"1. Sleeman J, Steeg PS (2010). Cancer metastasis as a therapeutic target. Eur J Cancer  46, 1177-80.   https://doi.org/10.1016/j.ejca.2010.02.039",https://intramural.nih.gov/search/searchview.taf?ipid=68936
741,SC003657-37,"October 01, 2010 -  September 30, 2011",Immunopathologic Mechanisms Involved in Inflammatory Skin Diseases,"Stephen I Katz; PhD, MD",NULL,"Dermatology Branch, NCI",NULL,NULL,Howard A Young; PhD (Laboratory of Experimental Immunology),Jay T Linton (NIAMS) |Naoko  Okiyama (NIAMS) |Keiko  Ozato; PhD (NICHD) |Hong G Zhang; PhD (NIAMS),"1. Chae JJ, Cho YH, Lee GS, Cheng J, Liu PP, Feigenbaum L, Katz SI, Kastner DL (2011). Gain-of-function Pyrin mutations induce NLRP3 protein-independent interleukin-1β activation and severe autoinflammation in mice. Immunity  34, 755-68.   https://doi.org/10.1016/j.immuni.2011.02.020|2. Miyagawa F, Gutermuth J, Zhang H, Katz SI (2010). The use of mouse models to better understand mechanisms of autoimmunity and tolerance. J Autoimmun  35, 192-8.   https://doi.org/10.1016/j.jaut.2010.06.007|3. Paek SY, Steinberg SM, Katz SI (2011). Remission in dermatitis herpetiformis: a cohort study. Arch Dermatol  147, 301-5.   https://doi.org/10.1001/archdermatol.2010.336",https://intramural.nih.gov/search/searchview.taf?ipid=68937
742,SC003669-22,"October 01, 2010 -  September 30, 2011",Regulation of Cutaneous Accessory Cell Activity in Health and Disease,Mark  Udey; MD,NULL,"Dermatology Branch, NCI",Michael C Lu|Yoichi  Ogawa,"Bjorn  Clausen (University of Amsterdam)|Sarah  Millar (University of Pennsylvania)|Esther  von Stebut (Dermatology, University of Mainz)",NULL,"Stephen I Katz; PhD, MD (NIAMS) |Maria Irene Morasso; PhD (NIAMS) |Robert Alan Seder; MD (NIAID)","1. Kastenmüller K, Wille-Reece U, Lindsay RW, Trager LR, Darrah PA, Flynn BJ, Becker MR, Udey MC, Clausen BE, Igyarto BZ, Kaplan DH, Kastenmüller W, Germain RN, Seder RA (2011). Protective T cell immunity in mice following protein-TLR7/8 agonist-conjugate immunization requires aggregation, type I IFN, and multiple DC subsets. J Clin Invest  121, 1782-96.   https://doi.org/10.1172/JCI45416",https://intramural.nih.gov/search/searchview.taf?ipid=68938
743,SC004002-42,"October 01, 2010 -  September 30, 2011",IL-2IL-15 Cytokine Receptor: Implications for Cancer Therapy and Vaccine Design,"Thomas Alexander Waldmann; MD, PhD|IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",Bonita R Bryant|Jing  Chen|Sigrid Priscilla Dubois|Kayhan  Garmestani; PhD|Carolyn  Goldman|Wei  Ju|Show all 12,"Richard  Bamford; PhD|Sandor  Damjanovich, M.D. (Dept of Biophysics and Cell Biology, University of Debrecen)|Bana  Jabri (University of Chicago)|Nicole  Urquhart (Dept of, University of the West Indies)","Martin W Brechbiel; PhD (Radiation Oncology Branch)|Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)",Steven J Jacobson; PhD (NINDS) |Bibiana  Bielekova; MD (NINDS),"1. Chen J, Petrus M, Bryant BR, Nguyen VP, Goldman CK, Bamford R, Morris JC, Janik JE, Waldmann TA (2010). Autocrine/paracrine cytokine stimulation of leukemic cell proliferation in smoldering and chronic adult T-cell leukemia. Blood  116, 5948-56.   https://doi.org/10.1182/blood-2010-04-277418|2. Kolibab K, Yang A, Derrick SC, Waldmann TA, Perera LP, Morris SL (2010). Highly persistent and effective prime/boost regimens against tuberculosis that use a multivalent modified vaccine virus Ankara-based tuberculosis vaccine with interleukin-15 as a molecular adjuvant. Clin Vaccine Immunol  17, 793-801.   https://doi.org/10.1128/CVI.00006-10|3. Merkel TJ, Perera PY, Kelly VK, Verma A, Llewellyn ZN, Waldmann TA, Mosca JD, Perera LP (2010). Development of a highly efficacious vaccinia-based dual vaccine against smallpox and anthrax, two important bioterror entities. Proc Natl Acad Sci U S A  107, 18091-6.   https://doi.org/10.1073/pnas.1013083107|4. Pancewicz J, Taylor JM, Datta A, Baydoun HH, Waldmann TA, Hermine O, Nicot C (2010). Notch signaling contributes to proliferation and tumor formation of human T-cell leukemia virus type 1-associated adult T-cell leukemia. Proc Natl Acad Sci U S A  107, 16619-24.   https://doi.org/10.1073/pnas.1010722107|5. Steel JC, Ramlogan CA, Yu P, Sakai Y, Forni G, Waldmann TA, Morris JC (2010). Interleukin-15 and its receptor augment dendritic cell vaccination against the neu oncogene through the induction of antibodies partially independent of CD4 help. Cancer Res  70, 1072-81.   https://doi.org/10.1158/0008-5472.CAN-09-1301|6. Zielinski RJ, Smedley JV, Perera PY, Silvera PM, Waldmann TA, Capala J, Perera LP (2010). Smallpox vaccine with integrated IL-15 demonstrates enhanced in vivo viral clearance in immunodeficient mice and confers long term protection against a lethal monkeypox challenge in cynomolgus monkeys. Vaccine  28, 7081-91.   https://doi.org/10.1016/j.vaccine.2010.08.008",https://intramural.nih.gov/search/searchview.taf?ipid=68941
744,SC004020-34,"October 01, 2010 -  September 30, 2011","Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AIDS","Jay Arthur Berzofsky; MD, PhD|IRP Faculty Profile",NULL,"Vaccine Branch, NCI",Alison Elizabeth Hogg|Liat  Izhak|Jessica J O'Konek|Genoveffa  Franchini; MD|Stanley Ted Parish|Charles D Pendleton|Show all 16,"Shizuo  Akira (Osaka University)|Gurdyal  Besra (University of Birmingham)|Vincenzo  Bronte|David  Carbone (Vanderbilt University)|Charles  Delisi|Anthony L Devico; PhD (Maryland Biotechnical Center, Institute of Human Virology, University of Maryland)|Show all 35","Lee Jay Helman; MD (Pediatric Oncology Branch)|Thomas Alexander Waldmann; MD, PhD (Lymphoid Malignancies Branch)|Lalage  Wakefield; PhD (Laboratory of Cancer Biology and Genetics)|Allan  Hildesheim; PhD (Infection & Immunoepidemiology Branch)|Claude  Sportes (Experimental Transplantation and Immunology Branch)|William Marston Linehan; MD (Urologic Oncology Branch)","Brian  Kelsall; MD (NIAID) |David Harvey Margulies; MD, PhD (NIAID) |Bernard  Moss; MD, PhD (NIAID) |Gary J Nabel; MD, PhD (NIAID) |Warren  Strober; MD (NIAID) |Patricia  Earl; PhD (NIAID)","1. De Groot A, Cohen T, Ardito M, Moise B, Martin B, Berzofsky J (2010) Use of bioinformatics to predict MHC ligands and T-cell epitopes: application to epitope-driven vaccine design. Methods in Microbiology 37:35-66.|2. Mahajan B, Berzofsky JA, Boykins RA, Majam V, Zheng H, Chattopadhyay R, de la Vega P, Moch JK, Haynes JD, Belyakov IM, Nakhasi HL, Kumar S (2010). Multiple antigen peptide vaccines against Plasmodium falciparum malaria. Infect Immun  78, 4613-24.   https://doi.org/10.1128/IAI.00533-10|3. Rahma OE, Ashtar E, Ibrahim R, Toubaji A, Gause B, Herrin VE, Linehan WM, Steinberg SM, Grollman F, Grimes G, Bernstein SA, Berzofsky JA, Khleif SN (2010). A pilot clinical trial testing mutant von Hippel-Lindau peptide as a novel immune therapy in metastatic renal cell carcinoma. J Transl Med  8, 8.   https://doi.org/10.1186/1479-5876-8-8|4. Sui Y, Zhu Q, Gagnon S, Dzutsev A, Terabe M, Vaccari M, Venzon D, Klinman D, Strober W, Kelsall B, Franchini G, Belyakov IM, Berzofsky JA (2010). Innate and adaptive immune correlates of vaccine and adjuvant-induced control of mucosal transmission of SIV in macaques. Proc Natl Acad Sci U S A  107, 9843-8.   https://doi.org/10.1073/pnas.0911932107|5. Takaku S, Terabe M, Ambrosino E, Peng J, Lonning S, McPherson JM, Berzofsky JA (2010). Blockade of TGF-beta enhances tumor vaccine efficacy mediated by CD8(+) T cells. Int J Cancer  126, 1666-74.   https://doi.org/10.1002/ijc.24961|6. Zhu Q, Egelston C, Gagnon S, Sui Y, Belyakov IM, Klinman DM, Berzofsky JA (2010). Using 3 TLR ligands as a combination adjuvant induces qualitative changes in T cell responses needed for antiviral protection in mice. J Clin Invest  120, 607-16.   https://doi.org/10.1172/JCI39293",https://intramural.nih.gov/search/searchview.taf?ipid=68942
745,SC006321-32,"October 01, 2010 -  September 30, 2011",Modulation of Therapeutic Response,James B Mitchell; PhD|IRP Faculty Profile,NULL,"Radiation Biology Branch, NCI",Rajani  Choudhuri|John Andrew Cook; PhD|William  Degraff|Murali  Krishna; PhD|Kristin  Askin|Janet W Gamson|Show all 8,NULL,Deborah E Citrin (Radiation Oncology Branch),"Carter  Van Waes; MD, PhD (NIDCD) |Bruce J Baum; DMD, PhD (NIDCR)","1. Citrin D, Cotrim AP, Hyodo F, Baum BJ, Krishna MC, Mitchell JB (2010). Radioprotectors and mitigators of radiation-induced normal tissue injury. Oncologist  15, 360-71.   https://doi.org/10.1634/theoncologist.2009-S104|2. Cook JA, Choudhuri R, Degraff W, Gamson J, Mitchell JB (2010). Halofuginone enhances the radiation sensitivity of human tumor cell lines. Cancer Lett  289, 119-26.   https://doi.org/10.1016/j.canlet.2009.08.009|3. Davis RM, Sowers AL, DeGraff W, Bernardo M, Thetford A, Krishna MC, Mitchell JB (2011). A novel nitroxide is an effective brain redox imaging contrast agent and in vivo radioprotector. Free Radic Biol Med  51, 780-90.   https://doi.org/10.1016/j.freeradbiomed.2011.05.019|4. Flores-Santana W, Moody T, Chen W, Gorczynski MJ, Shoman ME, Velázquez C, Thetford A, Mitchell JB, Cherukuri MK, King SB, Wink DA (2012). Nitroxide derivatives of non-steroidal anti-inflammatory drugs exert anti-inflammatory and superoxide dismutase scavenging properties in A459 cells. Br J Pharmacol  165, 1058-67.   https://doi.org/10.1111/j.1476-5381.2011.01527.x|5. Mitchell JB, Choudhuri R, Fabre K, Sowers AL, Citrin D, Zabludoff SD, Cook JA (2010). In vitro and in vivo radiation sensitization of human tumor cells by a novel checkpoint kinase inhibitor, AZD7762. Clin Cancer Res  16, 2076-84.   https://doi.org/10.1158/1078-0432.CCR-09-3277|6. Singh AK, Chen J, Calado R, Sowers A, Mitchell JB, Barrett AJ (2010). TBI with lung dose reduction does not improve hematopoietic cell homing to BM during allogeneic transplantation. Bone Marrow Transplant  45, 25-30.   https://doi.org/10.1038/bmt.2009.121|7. Vissink A, Mitchell JB, Baum BJ, Limesand KH, Jensen SB, Fox PC, Elting LS, Langendijk JA, Coppes RP, Reyland ME (2010). Clinical management of salivary gland hypofunction and xerostomia in head-and-neck cancer patients: successes and barriers. Int J Radiat Oncol Biol Phys  78, 983-91.   https://doi.org/10.1016/j.ijrobp.2010.06.052",https://intramural.nih.gov/search/searchview.taf?ipid=68943
746,SC006330-31,"October 01, 2010 -  September 30, 2011",Radiation Field Modeling and Computerized Treatment Planning,Robert W Miller,Kevin A Camphausen; MD,"Radiation Oncology Branch, NCI",NULL,"Wei  Chen (University of Texas)|Thomas  Fearon (Radiology, Children's National Medical Center)|Chang-Ming  Ma (Radiation Oncology Department, Fox Chase Cancer Center)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68928
747,SC006353-29,"October 01, 2010 -  September 30, 2011",Metal Chelate Conjugated Monoclonal Antibodies for Tumor Diagnosis and Therapy,Martin W Brechbiel; PhD|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Kwamena  Baidoo|Francois  Guerard; PhD|Young-Seung  Kim|Kevin A Camphausen; MD|Diane E Milenic|Deborah E Citrin|Show all 9,"Lynn  Francesconi (Hunter College)|Silvia  Jurisson (University of Missouri, Columbia)|Ruby  Meredith (UAB)|Marty  Pomper (Johns Hopkins)|Tom  Quinn (U. Missouri, Co.)|Andrew  Scott (Ludwig Institute for Cancer Research)|Show all 7","Thomas Alexander Waldmann; MD, PhD (Lymphoid Malignancies Branch)|James B Mitchell; PhD (Radiation Biology Branch)",Peter  Herscovitch; MD (CC),"1. Milenic DE, Brady ED, Garmestani K, Albert PS, Abdulla A, Brechbiel MW (2010). Improved efficacy of alpha-particle-targeted radiation therapy: dual targeting of human epidermal growth factor receptor-2 and tumor-associated glycoprotein 72. Cancer  116, 1059-66.   https://doi.org/10.1002/cncr.24793|2. Milenic DE, Wong KJ, Baidoo KE, Nayak TK, Regino CA, Garmestani K, Brechbiel MW (2010). Targeting HER2: a report on the in vitro and in vivo pre-clinical data supporting trastuzumab as a radioimmunoconjugate for clinical trials. MAbs  2, 550-64.   https://doi.org/10.4161/mabs.2.5.13054|3. Nayak TK, Garmestani K, Baidoo KE, Milenic DE, Brechbiel MW (2010). Preparation, biological evaluation, and pharmacokinetics of the human anti-HER1 monoclonal antibody panitumumab labeled with 86Y for quantitative PET of carcinoma. J Nucl Med  51, 942-50.   https://doi.org/10.2967/jnumed.109.071290|4. Nayak TK, Garmestani K, Baidoo KE, Milenic DE, Brechbiel MW (2011). PET imaging of tumor angiogenesis in mice with VEGF-A-targeted (86)Y-CHX-A″-DTPA-bevacizumab. Int J Cancer  128, 920-6.   https://doi.org/10.1002/ijc.25409|5. Nayak TK, Regino CA, Wong KJ, Milenic DE, Garmestani K, Baidoo KE, Szajek LP, Brechbiel MW (2010). PET imaging of HER1-expressing xenografts in mice with 86Y-CHX-A''-DTPA-cetuximab. Eur J Nucl Med Mol Imaging  37, 1368-76.   https://doi.org/10.1007/s00259-009-1370-z|6. Nwe K, Bernardo M, Regino CA, Williams M, Brechbiel MW (2010). Comparison of MRI properties between derivatized DTPA and DOTA gadolinium-dendrimer conjugates. Bioorg Med Chem  18, 5925-31.   https://doi.org/10.1016/j.bmc.2010.06.086|7. Villaraza AJ, Milenic DE, Brechbiel MW (2010). Improved speciation characteristics of PEGylated indocyanine green-labeled Panitumumab: revisiting the solution and spectroscopic properties of a near-infrared emitting anti-HER1 antibody for optical imaging of cancer. Bioconjug Chem  21, 2305-12.   https://doi.org/10.1021/bc100336b",https://intramural.nih.gov/search/searchview.taf?ipid=68944
748,SC006387-24,"October 01, 2010 -  September 30, 2011",Nitroxides as Protectors Against Oxidative Stress,James B Mitchell; PhD|IRP Faculty Profile,NULL,"Radiation Biology Branch, NCI",Rajani  Choudhuri|Murali  Krishna; PhD|John Andrew Cook; PhD|William  Degraff|Kristin  Askin|Janet W Gamson|Show all 8,"Dr. Kameron  Maxwell (Research, Mitos)|Jacquie  Shukaliak-Quandt (University of British Columbia)",Frank Jess Gonzalez; PhD (Laboratory of Metabolism),Tracey Ann Rouault; MD (NICHD),"1. Fabre K, Saito K, DeGraff W, Sowers A, Thetford A, Cook J, Krishna M, Mitchell J (2011) The Effects of Reseveratrol and Selected Metabolites on the Radiation and Antioxidant Response. Cancer Biol. Therap, in press.|2. Samuni Y, Cook JA, Choudhuri R, Degraff W, Sowers AL, Krishna MC, Mitchell JB (2010). Inhibition of adipogenesis by Tempol in 3T3-L1 cells. Free Radic Biol Med  49, 667-73.   https://doi.org/10.1016/j.freeradbiomed.2010.05.028|3. Samuni Y, Ishii H, Hyodo F, Samuni U, Krishna MC, Goldstein S, Mitchell JB (2010). Reactive oxygen species mediate hepatotoxicity induced by the Hsp90 inhibitor geldanamycin and its analogs. Free Radic Biol Med  48, 1559-63.   https://doi.org/10.1016/j.freeradbiomed.2010.03.001",https://intramural.nih.gov/search/searchview.taf?ipid=68945
749,SC006538-18,"October 01, 2010 -  September 30, 2011",Development of Angiogenesis Inhibitors,William D Figg; PharmD|IRP Faculty Profile,NULL,"Medical Oncology Branch, NCI",Cindy Huong-Bich Chau|William Laurence Dahut; MD|Christian Tyler Kirkland|Stephen T Pisle|Douglas K Price|Kelie M Reece; PhD|Show all 9,Christopher  Schofield (University of Oxford)|Neil  Vargesson; PhD (University of Aberdeen),"James L Gulley; MD, PhD (Laboratory of Tumor Immunology and Biology)|Kevin  Gardner; MD, PhD (Laboratory of Receptor Biology and Gene Expression)|Tawnya Carlene McKee; BA, PhD (Molecular Targets Laboratory)",NULL,"1. Chau C, Figg W (2010) Pharmacology of Cancer Biotherapeutics: Angiogenesis Agents, in Cancer: Principles and Practices of Oncology, 9th Edition., pp. 527-36.|2. Cook KM, Figg WD (2010). Angiogenesis inhibitors: current strategies and future prospects. CA Cancer J Clin  60, 222-43.   https://doi.org/10.3322/caac.20075|3. Gardner ER, Kelly M, Springman E, Lee KJ, Li H, Moore W, Figg WD (2012). Antiangiogenic and antitumor activity of LP-261, a novel oral tubulin binding agent, alone and in combination with bevacizumab. Invest New Drugs  30, 90-7.   https://doi.org/10.1007/s10637-010-9520-5|4. Kluetz PG, Figg WD, Dahut WL (2010). Angiogenesis inhibitors in the treatment of prostate cancer. Expert Opin Pharmacother  11, 233-47.   https://doi.org/10.1517/14656560903451716|5. Ning YM, Gulley JL, Arlen PM, Woo S, Steinberg SM, Wright JJ, Parnes HL, Trepel JB, Lee MJ, Kim YS, Sun H, Madan RA, Latham L, Jones E, Chen CC, Figg WD, Dahut WL (2010). Phase II trial of bevacizumab, thalidomide, docetaxel, and prednisone in patients with metastatic castration-resistant prostate cancer. J Clin Oncol  28, 2070-6.   https://doi.org/10.1200/JCO.2009.25.4524",https://intramural.nih.gov/search/searchview.taf?ipid=68946
750,SC006581-28,"October 01, 2010 -  September 30, 2011",Molecular Pathogenesis of Multiple Myeloma,"Walter M Kuehl; MD, PhD",NULL,"Cancer Genetics Branch, NCI",Leslie Ann Brents|Wei-Dong  Chen|Yulia  Demchenko|Oleg K Glebov,"Bart  Barlogie (Univ. of Arkansas for Medical Sciences)|P.  Bergsagel (Divison of Hematology, Mayo Clinic)|Carlo  Croce (The Ohio State University)|Rafael  Fonseca (Division of Hematology, Mayo Clinic)|John  Shaughnessy (Universiy of Arkansas for Medical Sciences)|Brendan  Weiss",Louis  Staudt; MD (Lymphoid Malignancies Branch)|Ola Anders Landgren (Medical Oncology Branch),NULL,"1. Demchenko YN, Kuehl WM (2010). A critical role for the NFkB pathway in multiple myeloma. Oncotarget  1, 59-68.   https://doi.org/10.18632/oncotarget.109",https://intramural.nih.gov/search/searchview.taf?ipid=68947
751,SC006663-22,"October 01, 2010 -  September 30, 2011",Molecular Characterization of Breast Duct Epithelium at Risk for Breast Cancer,David  Danforth,NULL,"Surgery Branch, NCI",Marybeth S Hughes,NULL,"Armando  Filie (Laboratory of Pathology)|Karl Thomas Ried; MD (Cancer Genetics Branch)|Mark H Greene; MD (Clinical Genetics Branch)|Maria  Merino; PhD (Laboratory of Pathology)|David Erwin Kleiner; MD, PhD (Laboratory of Pathology)|Joanna H Shih (Biometrics Research Branch)",NULL,"1. Pigati L, Yaddanapudi SC, Iyengar R, Kim DJ, Hearn SA, Danforth D, Hastings ML, Duelli DM (2010). Selective release of microRNA species from normal and malignant mammary epithelial cells. PLoS One  5, e13515.   https://doi.org/10.1371/journal.pone.0013515",https://intramural.nih.gov/search/searchview.taf?ipid=68948
752,SC006732-23,"October 01, 2010 -  September 30, 2011",Multidrug Resistance Mediated by P-glycoprotein,"Antonio  Fojo; MD, PhD",NULL,"Medical Oncology Branch, NCI",Susan  Bates; MD|Lyn Ann J Mickley|William D Figg; PharmD|Wilfred D Stein|Julia  Wilkerson|Douglas K Price|Show all 7,NULL,"James L Gulley; MD, PhD (Laboratory of Tumor Immunology and Biology)",Robert  Innis; MD (NIMH),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68949
753,SC006737-20,"October 01, 2010 -  September 30, 2011",Development of Novel Therapies for HIV Infection,Robert  Yarchoan; MD|IRP Faculty Profile,NULL,"HIV and AIDS Malignancy Branch, NCI",David A Davis; MD|Hiroaki  Mitsuya|Nicole  Naiman,Jean  Chmielewski (Purdue University)|Indira  Hewlett (Food and Drug  Administration)|Shixing  Tang (FDA),"Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)|Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Frank  Maldarelli (Host Virus Interaction Branch)|George N Pavlakis; MD, PhD (Vaccine Branch)|Eric O Freed; PhD (Retroviral Replication Laboratory)",Paul T Wingfield; PhD (NIAMS),"1. Daniels SI, Davis DA, Soule EE, Stahl SJ, Tebbs IR, Wingfield P, Yarchoan R (2010). The initial step in human immunodeficiency virus type 1 GagProPol processing can be regulated by reversible oxidation. PLoS One  5, e13595.   https://doi.org/10.1371/journal.pone.0013595|2. Tang S, Zhao J, Wang A, Viswanath R, Harma H, Little RF, Yarchoan R, Stramer SL, Nyambi PN, Lee S, Wood O, Wong EY, Wang X, Hewlett IK (2010). Characterization of immune responses to capsid protein p24 of human immunodeficiency virus type 1 and implications for detection. Clin Vaccine Immunol  17, 1244-51.   https://doi.org/10.1128/CVI.00066-10|3. Valentin A, Morrow M, Poirier RH, Aleman K, Little R, Yarchoan R, Pavlakis GN (2010). Identification of a potential pharmacological sanctuary for HIV type 1 in a fraction of CD4(+) primary cells. AIDS Res Hum Retroviruses  26, 79-88.   https://doi.org/10.1089/aid.2009.0044",https://intramural.nih.gov/search/searchview.taf?ipid=68950
754,SC006738-20,"October 01, 2010 -  September 30, 2011",Development of Antiviral Therapy of HIV-1 Infection,Hiroaki  Mitsuya,NULL,"HIV and AIDS Malignancy Branch, NCI",Debananda  Das; PhD|Darshan  Desai; BS|Kenji  Maeda|Hirotomo  Nakata|Ravikiran S Yedidi,"Masayuki  Amano (Kumamoto University School of Medicine)|Arun  Ghosh|Hiroyuki  Hayakawa (Yamasa Corporation)|Eiichi  Kodama (Kyoto University)|Yasuhiro  Koh (Kumamoto University School of Medicine)|Masao 		  Matsuoka (Institute for Virus Research, Kyoto University)|Show all 9",NULL,NULL,"1. Ghosh A, Chapsal B, Mitsuya H (2010) Darunavir, a new PI with dual mechanism: from a novel drug design concept to new hope against drug-resistant HIV, in Aspartic Acid Proteases as Therapeutic Targets., in press.|2. Maeda K, Mitsuya H (2010) Development of antiviral therapeutics for HIV-1 infection and AIDS, in AIDS in the 21st Century., in press.|3. Mitsuya H, Ghosh A (2010) Development of HIV-1 protease inhibitors, antiretroviral resistance and current challenges of HIV/AIDS management, in Aspartic Acid Proteases as Therapeutic Targets., in press.|4. Ghosh AK, Gemma S, Simoni E, Baldridge A, Walters DE, Ide K, Tojo Y, Koh Y, Amano M, Mitsuya H (2010). Synthesis and biological evaluation of novel allophenylnorstatine-based HIV-1 protease inhibitors incorporating high affinity P2-ligands. Bioorg Med Chem Lett  20, 1241-6.   https://doi.org/10.1016/j.bmcl.2009.11.123|5. Ghosh AK, Xu CX, Rao KV, Baldridge A, Agniswamy J, Wang YF, Weber IT, Aoki M, Miguel SG, Amano M, Mitsuya H (2010). Probing multidrug-resistance and protein-ligand interactions with oxatricyclic designed ligands in HIV-1 protease inhibitors. ChemMedChem  5, 1850-4.   https://doi.org/10.1002/cmdc.201000318|6. Tojo Y, Koh Y, Amano M, Aoki M, Das D, Kulkarni S, Anderson DD, Ghosh AK, Mitsuya H (2010). Novel protease inhibitors (PIs) containing macrocyclic components and 3(R),3a(S),6a(R)-bis-tetrahydrofuranylurethane that are potent against multi-PI-resistant HIV-1 variants in vitro. Antimicrob Agents Chemother  54, 3460-70.   https://doi.org/10.1128/AAC.01766-09",https://intramural.nih.gov/search/searchview.taf?ipid=68929
755,SC006741-19,"October 01, 2010 -  September 30, 2011",Lymphoma Studies,"Wyndham H Wilson; MD, PhD|IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",NULL,NULL,"Louis  Staudt; MD (Lymphoid Malignancies Branch)|Elaine S Jaffe; MD (Laboratory of Pathology)|Maryalice  Stetler-Stevenson; MD, PhD (Laboratory of Pathology)|Stefania  Pittaluga (Laboratory of Pathology)","Adrian U Wiestner; MD, PhD (NHLBI)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68930
756,SC006891-23,"October 01, 2010 -  September 30, 2011",Solid Tumors,Lee Jay Helman; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Fernanda  Arnaldez|Barbara A Dickens|Crystal L. Mackall; MD|Lauren M Long|Su-Young  Kim|Brigitte  Widemann; MD,George  Demetri (Dana Farber Cancer Institute)|Katherine  Janeway (Dana Farber Cancer Institute)|Alberto  Pappo (St Jude Children's Research Hospital),"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Jonathan Keith Killian (Cancer Genetics Branch)","Constantine Argyrios Stratakis; MD, DSc (NICHD)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68951
757,SC006892-23,"October 01, 2010 -  September 30, 2011",Molecular Biology of Pediatric Tumors,Lee Jay Helman; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Fernanda  Arnaldez|Barbara A Dickens|Patrick  Grohar|Crystal L. Mackall; MD|Lauren M Long|Arnulfo G Mendoza|Show all 8,NULL,"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",NULL,"1. Cao L, Yu Y, Bilke S, Walker RL, Mayeenuddin LH, Azorsa DO, Yang F, Pineda M, Helman LJ, Meltzer PS (2010). Genome-wide identification of PAX3-FKHR binding sites in rhabdomyosarcoma reveals candidate target genes important for development and cancer. Cancer Res  70, 6497-508.   https://doi.org/10.1158/0008-5472.CAN-10-0582|2. Kim SY, Helman LJ (2009). Strategies to explore new approaches in the investigation and treatment of osteosarcoma. Cancer Treat Res  152, 517-28.   https://doi.org/10.1007/978-1-4419-0284-9_31|3. Mayeenuddin LH, Yu Y, Kang Z, Helman LJ, Cao L (2010). Insulin-like growth factor 1 receptor antibody induces rhabdomyosarcoma cell death via a process involving AKT and Bcl-x(L). Oncogene  29, 6367-77.   https://doi.org/10.1038/onc.2010.364",https://intramural.nih.gov/search/searchview.taf?ipid=68952
758,SC007263-19,"October 01, 2010 -  September 30, 2011",TRAIL-induced Cell Death in Breast Cancer Cells,"Stanley  Lipkowitz; MD, PhD|IRP Faculty Profile",NULL,"Laboratory of Cellular and Molecular Biology, NCI",Kathryn Jill Chavez|Sireesha  Garimella,Mauricio A Cuello|Sandra M Swain; MD,"Natasha  Caplen (Cancer Genetics Branch)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Jeffrey E Green; MD (Laboratory of Cancer Biology and Genetics)",NULL,"1. Murrow LM, Garimella SV, Jones TL, Caplen NJ, Lipkowitz S (2010). Identification of WEE1 as a potential molecular target in cancer cells by RNAi screening of the human tyrosine kinome. Breast Cancer Res Treat  122, 347-57.   https://doi.org/10.1007/s10549-009-0571-2",https://intramural.nih.gov/search/searchview.taf?ipid=68954
759,SC007281-18,"October 01, 2010 -  September 30, 2011",Nitric Oxide as a Modifier of Oxidative Stress,David Anderson Wink|IRP Faculty Profile,NULL,"Radiation Biology Branch, NCI",Aminah  Asghar|Yuk Sing Robert Cheng|Margaret Carroll Murray|Lisa Ann Ridnour|James B Mitchell; PhD|Christopher H Switzer,"Piero  del Soldato (Pharma, CTG Pharma)|Micheal  Vitek (Neurology, Duke Uniuversity Medical School)",Curtis  Harris; MD (Laboratory of Human Carcinogenesis)|Larry K Keefer; PhD (Laboratory of Comparative Carcinogenesis)|Stefan  Ambs (Laboratory of Human Carcinogenesis)|Terry  Moody; PhD (Office of the Director),NULL,"1. Glynn SA, Boersma BJ, Dorsey TH, Yi M, Yfantis HG, Ridnour LA, Martin DN, Switzer CH, Hudson RS, Wink DA, Lee DH, Stephens RM, Ambs S (2010). Increased NOS2 predicts poor survival in estrogen receptor-negative breast cancer patients. J Clin Invest  120, 3843-54.   https://doi.org/10.1172/JCI42059|2. Glynn SA, Prueitt RL, Ridnour LA, Boersma BJ, Dorsey TM, Wink DA, Goodman JE, Yfantis HG, Lee DH, Ambs S (2010). COX-2 activation is associated with Akt phosphorylation and poor survival in ER-negative, HER2-positive breast cancer. BMC Cancer  10, 626.   https://doi.org/10.1186/1471-2407-10-626|3. Switzer CH, Cheng RY, Vitek TM, Christensen DJ, Wink DA, Vitek MP (2011). Targeting SET/I(2)PP2A oncoprotein functions as a multi-pathway strategy for cancer therapy. Oncogene  30, 2504-13.   https://doi.org/10.1038/onc.2010.622",https://intramural.nih.gov/search/searchview.taf?ipid=68955
760,SC009144-27,"October 01, 2010 -  September 30, 2011",Mechanisms of transcription factor integration at the c-myc promoter,David  Levens; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Yeung  Ho|Hsin-Hao Timothy Hsiao|Zuqin  Nie; PhD|Suzanne Laurie Sanford,"Demetrios T Braddock; MD, PhD|John  Cleveland","Lino  Tessarollo (Neural Development Section)|Gordon Lee Hager; PhD (Laboratory of Receptor Biology and Gene Expression)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Louis  Staudt; MD (Lymphoid Malignancies Branch)|Yves  Pommier; PhD (Developmental Therapeutics Branch)",Keji  Zhao; PhD (NHLBI) |Rafael Cristian Casellas; PhD (NIAMS) |Teresa M Przytycka (NLM),"1. Levens D (2010). You Don't Muck with MYC. Genes Cancer  1, 547-554.   https://doi.org/10.1177/1947601910377492",https://intramural.nih.gov/search/searchview.taf?ipid=68956
761,SC009163-24,"October 01, 2010 -  September 30, 2011",Signal Transduction Therapy--Basic Science,Elise C Kohn; MD,NULL,"Medical Oncology Branch, NCI",Gary  Altwerger|Mathew  Angelos|Giovanna  Casagrande|Marco  Mineo|Christina M Annunziata|Victoria M Virador|Show all 12,Riccardo  Alessandro (U-Palermo)|Ben  Davidson (Norwegian Radium Hospital)|Gordon  Mills (MD Anderson Cancer Center),"David Jay Goldstein (Office of the Director)|Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Stephen M Hewitt; MD, PhD (Laboratory of Pathology)|Robert  Callahan; PhD (Mammary Biology and Tumorigenesis Laboratory)",David John Sandstrom; PhD (NIMH),"1. Annunziata CM, Stavnes HT, Kleinberg L, Berner A, Hernandez LF, Birrer MJ, Steinberg SM, Davidson B, Kohn EC (2010). Nuclear factor kappaB transcription factors are coexpressed and convey a poor outcome in ovarian cancer. Cancer  116, 3276-84.   https://doi.org/10.1002/cncr.25190|2. Han JJ, Yu M, Houston N, Steinberg SM, Kohn EC (2011). Progranulin is a potential prognostic biomarker in advanced epithelial ovarian cancers. Gynecol Oncol  120, 5-10.   https://doi.org/10.1016/j.ygyno.2010.09.006|3. Hays JL, Kim G, Giuroiu I, Kohn EC (2010). Proteomics and ovarian cancer: integrating proteomics information into clinical care. J Proteomics  73, 1864-72.   https://doi.org/10.1016/j.jprot.2010.05.013|4. He Y, Blackford JA, Kohn EC, Simons SS (2010). STAMP alters the growth of transformed and ovarian cancer cells. BMC Cancer  10, 128.   https://doi.org/10.1186/1471-2407-10-128|5. Hernandez L, Hsu SC, Davidson B, Birrer MJ, Kohn EC, Annunziata CM (2010). Activation of NF-kappaB signaling by inhibitor of NF-kappaB kinase beta increases aggressiveness of ovarian cancer. Cancer Res  70, 4005-14.   https://doi.org/10.1158/0008-5472.CAN-09-3912|6. Rasool N, LaRochelle W, Zhong H, Ara G, Cohen J, Kohn EC (2010). Secretory leukocyte protease inhibitor antagonizes paclitaxel in ovarian cancer cells. Clin Cancer Res  16, 600-9.   https://doi.org/10.1158/1078-0432.CCR-09-1979",https://intramural.nih.gov/search/searchview.taf?ipid=68957
762,SC009172-23,"October 01, 2010 -  September 30, 2011",Cellular Interactions with Thrombospondin,David D Roberts; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Sukhbir  Kaur|Gema  Martin-Manso|Maria  Tsokos; MD|Thomas W Miller; PhD|Michael L Pendrak|John M Sipes|Show all 8,"Willaim  Frazier (Biochemistry and Molecular Biophysics, Washington University)|Jeff  Isenberg (University of Pittsburgh)|Deane  Mosher (University of Wisconsin)|Lijuan  Zhang (Ocean University)","David Anderson Wink (Radiation Biology Branch)|Jeffrey S Rubin; MD, PhD (Laboratory of Cellular and Molecular Biology)",Jurgen B Schnermann; MD (NIDDK),"1. Roberts D, Lau L (2010) Matricellular Proteins, in Biology of Extracellular Matrix: An Overview. Springer, in press.|2. Bauer EM, Qin Y, Miller TW, Bandle RW, Csanyi G, Pagano PJ, Bauer PM, Schnermann J, Roberts DD, Isenberg JS (2010). Thrombospondin-1 supports blood pressure by limiting eNOS activation and endothelial-dependent vasorelaxation. Cardiovasc Res  88, 471-81.   https://doi.org/10.1093/cvr/cvq218|3. Frazier EP, Isenberg JS, Shiva S, Zhao L, Schlesinger P, Dimitry J, Abu-Asab MS, Tsokos M, Roberts DD, Frazier WA (2011). Age-dependent regulation of skeletal muscle mitochondria by the thrombospondin-1 receptor CD47. Matrix Biol  30, 154-61.   https://doi.org/10.1016/j.matbio.2010.12.004|4. Kaur S, Kuznetsova SA, Pendrak ML, Sipes JM, Romeo MJ, Li Z, Zhang L, Roberts DD (2011). Heparan sulfate modification of the transmembrane receptor CD47 is necessary for inhibition of T cell receptor signaling by thrombospondin-1. J Biol Chem  286, 14991-5002.   https://doi.org/10.1074/jbc.M110.179663|5. Kaur S, Martin-Manso G, Pendrak ML, Garfield SH, Isenberg JS, Roberts DD (2010). Thrombospondin-1 inhibits VEGF receptor-2 signaling by disrupting its association with CD47. J Biol Chem  285, 38923-32.   https://doi.org/10.1074/jbc.M110.172304|6. Martin-Manso G, Calzada MJ, Chuman Y, Sipes JM, Xavier CP, Wolf V, Kuznetsova SA, Rubin JS, Roberts DD (2011). sFRP-1 binds via its netrin-related motif to the N-module of thrombospondin-1 and blocks thrombospondin-1 stimulation of MDA-MB-231 breast carcinoma cell adhesion and migration. Arch Biochem Biophys  509, 147-56.   https://doi.org/10.1016/j.abb.2011.03.004|7. Yao M, Roberts DD, Isenberg JS (2011). Thrombospondin-1 inhibition of vascular smooth muscle cell responses occurs via modulation of both cAMP and cGMP. Pharmacol Res  63, 13-22.   https://doi.org/10.1016/j.phrs.2010.10.014",https://intramural.nih.gov/search/searchview.taf?ipid=68925
763,SC009173-23,"October 01, 2010 -  September 30, 2011",Host Colonization and Vascular Dissemination of ICandida albicansI,David D Roberts; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Gema  Martin-Manso|Dhammika  Navarathna; PhD|Michael L Pendrak|John M Sipes|Erica  Stein,Joachim  MorschhÃ¤user (UniversitÃ¤t WÃ¼rzburg)|Ken  Nickerson (University of Nebraska),NULL,Martin J Lizak; PhD (NINDS) |Jeeva P Munasinghe (NINDS),"1. Navarathna DH, Das A, Morschhäuser J, Nickerson KW, Roberts DD (2011). Dur3 is the major urea transporter in Candida albicans and is co-regulated with the urea amidolyase Dur1,2. Microbiology  157, 270-9.   https://doi.org/10.1099/mic.0.045005-0|2. Navarathna DH, Roberts DD (2010). Candida albicans heme oxygenase and its product CO contribute to pathogenesis of candidemia and alter systemic chemokine and cytokine expression. Free Radic Biol Med  49, 1561-73.   https://doi.org/10.1016/j.freeradbiomed.2010.08.020|3. Peterson AW, Pendrak ML, Roberts DD (2011). ATP binding to hemoglobin response gene 1 protein is necessary for regulation of the mating type locus in Candida albicans. J Biol Chem  286, 13914-24.   https://doi.org/10.1074/jbc.M110.180190",https://intramural.nih.gov/search/searchview.taf?ipid=68926
764,SC009174-23,"October 01, 2010 -  September 30, 2011",Roles of Glycoconjugates and Redox Signaling in Tumor Biology,David D Roberts; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Sukhbir  Kaur|Thomas W Miller; PhD|Maria  Tsokos; MD|Maria  Merino; PhD|Michael L Pendrak|John M Sipes,Jeff  Isenberg (University of Pittsburgh)|Lijuan  Zhang (Ocean University),David Anderson Wink (Radiation Biology Branch),NULL,"1. Bauer EM, Qin Y, Miller TW, Bandle RW, Csanyi G, Pagano PJ, Bauer PM, Schnermann J, Roberts DD, Isenberg JS (2010). Thrombospondin-1 supports blood pressure by limiting eNOS activation and endothelial-dependent vasorelaxation. Cardiovasc Res  88, 471-81.   https://doi.org/10.1093/cvr/cvq218|2. Jourd'heuil D, Lancaster JR, Fukuto J, Roberts DD, Miranda KM, Mayer B, Grisham MB, Wink DA (2010). The bell-shaped curve for peroxynitrite-mediated oxidation and nitration of NO/O2-* is alive and well. J Biol Chem  285, le15; author reply le16.   https://doi.org/10.1074/jbc.L110.110080|3. Kaur S, Kuznetsova SA, Pendrak ML, Sipes JM, Romeo MJ, Li Z, Zhang L, Roberts DD (2011). Heparan sulfate modification of the transmembrane receptor CD47 is necessary for inhibition of T cell receptor signaling by thrombospondin-1. J Biol Chem  286, 14991-5002.   https://doi.org/10.1074/jbc.M110.179663|4. Miller TW, Isenberg JS, Shih HB, Wang Y, Roberts DD (2010). Amyloid-β inhibits No-cGMP signaling in a CD36- and CD47-dependent manner. PLoS One  5, e15686.   https://doi.org/10.1371/journal.pone.0015686|5. Valera VA, Li-Ning-T E, Walter BA, Roberts DD, Linehan WM, Merino MJ (2010). Protein expression profiling in the spectrum of renal cell carcinomas. J Cancer  1, 184-96.   https://doi.org/10.7150/jca.1.184",https://intramural.nih.gov/search/searchview.taf?ipid=68924
765,SC009179-23,"October 01, 2010 -  September 30, 2011",The Role of TIMPs in Cell Growth and Differentiation: Tumor Angiogenesis,"William G Stetler-Stevenson; MD, PhD|IRP Faculty Profile",NULL,"Radiation Oncology Branch, NCI",Dimitra  Bourmpoulia; PhD|Frank  Cuttitta; PhD|Liliana  Guedez; PhD|Hui  Han|Sandra  Jensen-Taubman|Laurie Ann  Shuman Moss|Show all 7,"Junseo  Oh (Korea University Graduate School Of Medicine)|Dong-Wan  Seo (Laboratory of Molecular Biochemistry, Kangwon National University)","Maryalice  Stetler-Stevenson; MD, PhD (Laboratory of Pathology)",NULL,"1. Bourboulia D, Stetler-Stevenson WG (2010). Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesion. Semin Cancer Biol  20, 161-8.   https://doi.org/10.1016/j.semcancer.2010.05.002|2. Lee SJ, Tsang PS, Diaz TM, Wei BY, Stetler-Stevenson WG (2010). TIMP-2 modulates VEGFR-2 phosphorylation and enhances phosphodiesterase activity in endothelial cells. Lab Invest  90, 374-82.   https://doi.org/10.1038/labinvest.2009.136",https://intramural.nih.gov/search/searchview.taf?ipid=68958
766,SC009374-20,"October 01, 2010 -  September 30, 2011",Signaling Pathways as Molecular Targets in Angiogenesis and Microenvironment,Elise C Kohn; MD,NULL,"Medical Oncology Branch, NCI",Gary  Altwerger|William D Figg; PharmD|John Lawrence Hays|Marco  Mineo|Christina M Annunziata|Minshu R Yu|Show all 9,Riccardo  Alessandro (U-Palermo)|Ben  Davidson (Norwegian Radium Hospital)|Gordon  Mills (MD Anderson Cancer Center),David Jay Goldstein (Office of the Director)|Seth M Steinberg; PhD (Biostatistics and Data Management Section),NULL,"1. Annunziata CM, Walker AJ, Minasian L, Yu M, Kotz H, Wood BJ, Calvo K, Choyke P, Kimm D, Steinberg SM, Kohn EC (2010). Vandetanib, designed to inhibit VEGFR2 and EGFR signaling, had no clinical activity as monotherapy for recurrent ovarian cancer and no detectable modulation of VEGFR2. Clin Cancer Res  16, 664-72.   https://doi.org/10.1158/1078-0432.CCR-09-2308|2. Hernandez L, Hsu SC, Davidson B, Birrer MJ, Kohn EC, Annunziata CM (2010). Activation of NF-kappaB signaling by inhibitor of NF-kappaB kinase beta increases aggressiveness of ovarian cancer. Cancer Res  70, 4005-14.   https://doi.org/10.1158/0008-5472.CAN-09-3912|3. Hoskins E, Rodriguez-Canales J, Hewitt SM, Elmasri W, Han J, Han S, Davidson B, Kohn EC (2011). Paracrine SLPI secretion upregulates MMP-9 transcription and secretion in ovarian cancer cells. Gynecol Oncol  122, 656-62.   https://doi.org/10.1016/j.ygyno.2011.04.052|4. Lee JM, Sarosy GA, Annunziata CM, Azad N, Minasian L, Kotz H, Squires J, Houston N, Kohn EC (2010). Combination therapy: intermittent sorafenib with bevacizumab yields activity and decreased toxicity. Br J Cancer  102, 495-9.   https://doi.org/10.1038/sj.bjc.6605514",https://intramural.nih.gov/search/searchview.taf?ipid=68959
767,SC009375-19,"October 01, 2010 -  September 30, 2011",Signal Transduction Therapy--Clinical,Elise C Kohn; MD,NULL,"Medical Oncology Branch, NCI",Mathew  Angelos|William D Figg; PharmD|Mario Andrew Cedillo|William Laurence Dahut; MD|John Lawrence Hays|Nicole Dupas Houston|Show all 13,"Robert  Bast (Medicine, MD Anderson Cancer Center)|Andrew  Berchuck (Gyn Oncology, Duke Univ)|Thomas  Conrads (USUHS)|Mary B Daly|Ben  Davidson (Norwegian Radium Hospital)|Michael  Friedlander (Prince of Wales Hospital)|Show all 15",Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Yves  Pommier; PhD (Developmental Therapeutics Branch)|Peter L Choyke; MD (Molecular Imaging Program)|James Halpern Doroshow (Office of the Director)|Brigitte  Widemann; MD (Pediatric Oncology Branch)|Robert F Murphy (Pediatric Oncology Branch),Bradford J Wood; MD (CC),"1. Annunziata CM, Walker AJ, Minasian L, Yu M, Kotz H, Wood BJ, Calvo K, Choyke P, Kimm D, Steinberg SM, Kohn EC (2010). Vandetanib, designed to inhibit VEGFR2 and EGFR signaling, had no clinical activity as monotherapy for recurrent ovarian cancer and no detectable modulation of VEGFR2. Clin Cancer Res  16, 664-72.   https://doi.org/10.1158/1078-0432.CCR-09-2308|2. Hays JL, Kim G, Giuroiu I, Kohn EC (2010). Proteomics and ovarian cancer: integrating proteomics information into clinical care. J Proteomics  73, 1864-72.   https://doi.org/10.1016/j.jprot.2010.05.013|3. Jain L, Sissung TM, Danesi R, Kohn EC, Dahut WL, Kummar S, Venzon D, Liewehr D, English BC, Baum CE, Yarchoan R, Giaccone G, Venitz J, Price DK, Figg WD (2010). Hypertension and hand-foot skin reactions related to VEGFR2 genotype and improved clinical outcome following bevacizumab and sorafenib. J Exp Clin Cancer Res  29, 95.   https://doi.org/10.1186/1756-9966-29-95|4. Lee JM, Kohn EC (2010). Proteomics as a guiding tool for more effective personalized therapy. Ann Oncol  21 Suppl 7, vii205-10.   https://doi.org/10.1093/annonc/mdq375|5. Lee JM, Sarosy GA, Annunziata CM, Azad N, Minasian L, Kotz H, Squires J, Houston N, Kohn EC (2010). Combination therapy: intermittent sorafenib with bevacizumab yields activity and decreased toxicity. Br J Cancer  102, 495-9.   https://doi.org/10.1038/sj.bjc.6605514|6. Sarosy GA, Hussain MM, Seiden MV, Fuller AF, Nikrui N, Goodman A, Minasian L, Reed E, Steinberg SM, Kohn EC (2010). Ten-year follow-up of a phase 2 study of dose-intense paclitaxel with cisplatin and cyclophosphamide as initial therapy for poor-prognosis, advanced-stage epithelial ovarian cancer. Cancer  116, 1476-84.   https://doi.org/10.1002/cncr.24861",https://intramural.nih.gov/search/searchview.taf?ipid=68960
768,SC009389-18,"October 01, 2010 -  September 30, 2011",A Mitogen-induced G Protein-coupled Receptor,Kathleen  Kelly; PhD|IRP Faculty Profile,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",NULL,Ginesa  Garcia-Rostan (University of Valladolid)|Massimo  Santoro,Sheueyann  Cheng; PhD (Gene Regulation Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68961
769,SC010051-16,"October 01, 2010 -  September 30, 2011",Metal Chelate Conjugated Dendrimer Constructs for Diagnosis and Therapy,Martin W Brechbiel; PhD|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Kwamena  Baidoo|Ambika  Bumb|Young-Seung  Kim|Diane E Milenic|Kido  Nwe; PhD,"Lynn  Francesconi (Hunter College)|Marty  Pomper (Johns Hopkins)|Tom  Quinn (U. Missouri, Co.)|Roger  Tsien; PhD (Department of Pharmacology, UC, San Diego)",NULL,Lacy Henry Bryant (CC) |Peter  Herscovitch; MD (CC),"1. Bumb A, Brechbiel MW, Choyke P (2010). Macromolecular and dendrimer-based magnetic resonance contrast agents. Acta Radiol  51, 751-67.   https://doi.org/10.3109/02841851.2010.491091|2. Bumb A, Regino CA, Egen JG, Bernardo M, Dobson PJ, Germain RN, Choyke PL, Brechbiel MW (2011). Trafficking of a dual-modality magnetic resonance and fluorescence imaging superparamagnetic iron oxide-based nanoprobe to lymph nodes. Mol Imaging Biol  13, 1163-72.   https://doi.org/10.1007/s11307-010-0424-8|3. Bumb A, Regino CA, Perkins MR, Bernardo M, Ogawa M, Fugger L, Choyke PL, Dobson PJ, Brechbiel MW (2010). Preparation and characterization of a magnetic and optical dual-modality molecular probe. Nanotechnology  21, 175704.   https://doi.org/10.1088/0957-4484/21/17/175704|4. Nwe K, Bernardo M, Regino CA, Williams M, Brechbiel MW (2010). Comparison of MRI properties between derivatized DTPA and DOTA gadolinium-dendrimer conjugates. Bioorg Med Chem  18, 5925-31.   https://doi.org/10.1016/j.bmc.2010.06.086|5. Nwe K, Bryant LH, Brechbiel MW (2010). Poly(amidoamine) dendrimer based MRI contrast agents exhibiting enhanced relaxivities derived via metal preligation techniques. Bioconjug Chem  21, 1014-7.   https://doi.org/10.1021/bc1000802|6. Sena LM, Fishman SJ, Jenkins KJ, Xu H, Brechbiel MW, Regino CA, Kosaka N, Bernardo M, Choyke PL, Kobayashi H (2010). Magnetic resonance lymphangiography with a nano-sized gadolinium-labeled dendrimer in small and large animal models. Nanomedicine (Lond)  5, 1183-91.   https://doi.org/10.2217/nnm.10.70|7. Villaraza AJ, Bumb A, Brechbiel MW (2010). Macromolecules, dendrimers, and nanomaterials in magnetic resonance imaging: the interplay between size, function, and pharmacokinetics. Chem Rev  110, 2921-59.   https://doi.org/10.1021/cr900232t",https://intramural.nih.gov/search/searchview.taf?ipid=68965
770,SC010058-16,"October 01, 2010 -  September 30, 2011",Regulation of Apoptosis in Ewing Sarcoma,Maria  Tsokos; MD,NULL,"Laboratory of Pathology, NCI",Guang  Li,NULL,Brigitte  Widemann; MD (Pediatric Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68966
771,SC010074-16,"October 01, 2010 -  September 30, 2011",Role of HSP90 Family Chaperone Proteins in Cellular Signal Transduction,Leonard  Neckers; PhD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI","Kristin  Eckfeld|Naoto  Miyajima; MD, PhD|Mehdi  Mollapour|Thomas L Prince|Bradley T Scroggins|Daniel Jaaron Selig|Show all 10","Brian  Blagg (Chemistry, University of Kansas)|Gabriela X Chiosis|Robert  Cotter (Johns Hopkins University)|Marc  Cox (University of Texas at El Paso)|Timothy  Haystead (Duke University)|YunJin  Jung (Pusan National University)|Show all 12",Zhenggang  Liu; PhD (Laboratory Of Genitourinary Cancer Pathogenesis)|Jane Beth Trepel (Medical Oncology Branch)|James G McNally; PhD (Laboratory of Receptor Biology and Gene Expression),NULL,"1. Kummar S, Gutierrez ME, Gardner ER, Chen X, Figg WD, Zajac-Kaye M, Chen M, Steinberg SM, Muir CA, Yancey MA, Horneffer YR, Juwara L, Melillo G, Ivy SP, Merino M, Neckers L, Steeg PS, Conley BA, Giaccone G, Doroshow JH, Murgo AJ (2010). Phase I trial of 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG), a heat shock protein inhibitor, administered twice weekly in patients with advanced malignancies. Eur J Cancer  46, 340-7.   https://doi.org/10.1016/j.ejca.2009.10.026|2. Matts RL, Brandt GE, Lu Y, Dixit A, Mollapour M, Wang S, Donnelly AC, Neckers L, Verkhivker G, Blagg BS (2011). A systematic protocol for the characterization of Hsp90 modulators. Bioorg Med Chem  19, 684-92.   https://doi.org/10.1016/j.bmc.2010.10.029|3. Mollapour M, Neckers L (2012). Post-translational modifications of Hsp90 and their contributions to chaperone regulation. Biochim Biophys Acta  1823, 648-55.   https://doi.org/10.1016/j.bbamcr.2011.07.018|4. Mollapour M, Tsutsumi S, Truman AW, Xu W, Vaughan CK, Beebe K, Konstantinova A, Vourganti S, Panaretou B, Piper PW, Trepel JB, Prodromou C, Pearl LH, Neckers L (2011). Threonine 22 phosphorylation attenuates Hsp90 interaction with cochaperones and affects its chaperone activity. Mol Cell  41, 672-81.   https://doi.org/10.1016/j.molcel.2011.02.011|5. Prince T, Neckers L (2011). A network of its own: the unique interactome of the Hsp90 cochaperone, Sba1/p23. Mol Cell  43, 159-60.   https://doi.org/10.1016/j.molcel.2011.07.005|6. Trepel J, Mollapour M, Giaccone G, Neckers L (2010). Targeting the dynamic HSP90 complex in cancer. Nat Rev Cancer  10, 537-49.   https://doi.org/10.1038/nrc2887",https://intramural.nih.gov/search/searchview.taf?ipid=68967
772,SC010093-15,"October 01, 2010 -  September 30, 2011",Targeting the Epigenome for Lung Cancer Therapy,David  Schrump; MD|IRP Faculty Profile,NULL,"Surgery Branch, NCI",Julie A Hong|Tricia M Frary|Mary R Zhang|Yuwei  Zhang,"Nasser  Altorki (Thoracic Surgery, Cornell University Medical Center)|Lloyd  Old (Cancer Immunology, Ludwig Cancer Institute)",William D Figg; PharmD (Medical Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68932
773,SC010098-09,"October 01, 2010 -  September 30, 2011",The Evaluation of Novel Therapeutics for Genitourinary Malignancies,William Laurence Dahut; MD|IRP Faculty Profile,NULL,"Medical Oncology Branch, NCI",Philip M Arlen; MD|Melony A Avella|Anna C Couvillon; NP|William D Figg; PharmD|Nancy A Harold|Ann Cooley Pierpoint|Show all 7,"Anthony  D'Amico (Radiation Oncology, Harvard Medical School)|Phil  Kantoff (DFCI)","James L Gulley; MD, PhD (Laboratory of Tumor Immunology and Biology)|Jeffrey  Schlom; PhD (Laboratory of Tumor Immunology and Biology)|William Marston Linehan; MD (Urologic Oncology Branch)|Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)|Kevin A Camphausen; MD (Radiation Oncology Branch)|Seth M Steinberg; PhD (Biostatistics and Data Management Section)",NULL,"1. Aragon-Ching JB, Madan RA, Dahut WL (2010). Angiogenesis inhibition in prostate cancer: current uses and future promises. J Oncol  2010, 361836.   https://doi.org/10.1155/2010/361836|2. Deeken JF, Cormier T, Price DK, Sissung TM, Steinberg SM, Tran K, Liewehr DJ, Dahut WL, Miao X, Figg WD (2010). A pharmacogenetic study of docetaxel and thalidomide in patients with castration-resistant prostate cancer using the DMET genotyping platform. Pharmacogenomics J  10, 191-9.   https://doi.org/10.1038/tpj.2009.57|3. Figg WD, Woo S, Zhu W, Chen X, Ajiboye AS, Steinberg SM, Price DK, Wright JJ, Parnes HL, Arlen PM, Gulley JL, Dahut WL (2010). A phase I clinical study of high dose ketoconazole plus weekly docetaxel for metastatic castration resistant prostate cancer. J Urol  183, 2219-26.   https://doi.org/10.1016/j.juro.2010.02.020|4. Gao R, Price DK, Dahut WL, Reed E, Figg WD (2010). Genetic polymorphisms in XRCC1 associated with radiation therapy in prostate cancer. Cancer Biol Ther  10, 13-8.   https://doi.org/10.4161/cbt.10.1.12172|5. Gulley JL, Arlen PM, Madan RA, Tsang KY, Pazdur MP, Skarupa L, Jones JL, Poole DJ, Higgins JP, Hodge JW, Cereda V, Vergati M, Steinberg SM, Halabi S, Jones E, Chen C, Parnes H, Wright JJ, Dahut WL, Schlom J (2010). Immunologic and prognostic factors associated with overall survival employing a poxviral-based PSA vaccine in metastatic castrate-resistant prostate cancer. Cancer Immunol Immunother  59, 663-74.   https://doi.org/10.1007/s00262-009-0782-8|6. Jain L, Sissung TM, Danesi R, Kohn EC, Dahut WL, Kummar S, Venzon D, Liewehr D, English BC, Baum CE, Yarchoan R, Giaccone G, Venitz J, Price DK, Figg WD (2010). Hypertension and hand-foot skin reactions related to VEGFR2 genotype and improved clinical outcome following bevacizumab and sorafenib. J Exp Clin Cancer Res  29, 95.   https://doi.org/10.1186/1756-9966-29-95|7. Kantoff PW, Schuetz TJ, Blumenstein BA, Glode LM, Bilhartz DL, Wyand M, Manson K, Panicali DL, Laus R, Schlom J, Dahut WL, Arlen PM, Gulley JL, Godfrey WR (2010). Overall survival analysis of a phase II randomized controlled trial of a Poxviral-based PSA-targeted immunotherapy in metastatic castration-resistant prostate cancer. J Clin Oncol  28, 1099-105.   https://doi.org/10.1200/JCO.2009.25.0597|8. Kluetz PG, Figg WD, Dahut WL (2010). Angiogenesis inhibitors in the treatment of prostate cancer. Expert Opin Pharmacother  11, 233-47.   https://doi.org/10.1517/14656560903451716|9. Ning YM, Gulley JL, Arlen PM, Woo S, Steinberg SM, Wright JJ, Parnes HL, Trepel JB, Lee MJ, Kim YS, Sun H, Madan RA, Latham L, Jones E, Chen CC, Figg WD, Dahut WL (2010). Phase II trial of bevacizumab, thalidomide, docetaxel, and prednisone in patients with metastatic castration-resistant prostate cancer. J Clin Oncol  28, 2070-6.   https://doi.org/10.1200/JCO.2009.25.4524",https://intramural.nih.gov/search/searchview.taf?ipid=68991
774,SC010100-12,"October 01, 2010 -  September 30, 2011",The Glioma Molecular Diagnostic Initiative: Characterizing Brain Tumor Data,"Howard A Fine; MD, PhD",NULL,"Neuro-Oncology Branch, NCI",Galina Ivanovna Belova|Serdar  Bozdag|Natalia N Ogurtsova|Gregory P Riddick|Jennifer  Walling,NULL,Kenneth  Buetow; PhD (Laboratory of Population Genetics),John Keenam Park (NINDS) |Russell R Lonser; MD (NINDS),"1. Bassig BA, Inskip PD, Burdette L, Shapiro WR, Selker RG, Fine HA, Loeffler JS, Black PM, Dubrow R, Brenner AV (2011). Selected human leukocyte antigen class II polymorphisms and risk of adult glioma. J Neuroimmunol  233, 185-91.   https://doi.org/10.1016/j.jneuroim.2010.11.005|2. Bozdag S, Li A, Wuchty S, Fine HA (2010). FastMEDUSA: a parallelized tool to infer gene regulatory networks. Bioinformatics  26, 1792-3.   https://doi.org/10.1093/bioinformatics/btq275|3. Clarke JL, Ennis MM, Yung WK, Chang SM, Wen PY, Cloughesy TF, Deangelis LM, Robins HI, Lieberman FS, Fine HA, Abrey L, Gilbert MR, Mehta M, Kuhn JG, Aldape KD, Lamborn KR, Prados MD, North American Brain Tumor Consortium (2011). Is surgery at progression a prognostic marker for improved 6-month progression-free survival or overall survival for patients with recurrent glioblastoma? Neuro Oncol  13, 1118-24.   https://doi.org/10.1093/neuonc/nor110|4. Edwards LA, Woolard K, Son MJ, Li A, Lee J, Ene C, Mantey SA, Maric D, Song H, Belova G, Jensen RT, Zhang W, Fine HA (2011). Effect of brain- and tumor-derived connective tissue growth factor on glioma invasion. J Natl Cancer Inst  103, 1162-78.   https://doi.org/10.1093/jnci/djr224|5. Fraum TJ, Kreisl TN, Sul J, Fine HA, Iwamoto FM (2011). Ischemic stroke and intracranial hemorrhage in glioma patients on antiangiogenic therapy. J Neurooncol  105, 281-9.   https://doi.org/10.1007/s11060-011-0579-4|6. Kotliarov Y, Bozdag S, Cheng H, Wuchty S, Zenklusen JC, Fine HA (2010). CNAReporter: a GenePattern pipeline for the generation of clinical reports of genomic alterations. BMC Med Genomics  3, 11.   https://doi.org/10.1186/1755-8794-3-11|7. Li A, Bozdag S, Kotliarov Y, Fine HA (2010). GliomaPredict: a clinically useful tool for assigning glioma patients to specific molecular subtypes. BMC Med Inform Decis Mak  10, 38.   https://doi.org/10.1186/1472-6947-10-38|8. Park JK, Hodges T, Arko L, Shen M, Dello Iacono D, McNabb A, Olsen Bailey N, Kreisl TN, Iwamoto FM, Sul J, Auh S, Park GE, Fine HA, Black PM (2010). Scale to predict survival after surgery for recurrent glioblastoma multiforme. J Clin Oncol  28, 3838-43.   https://doi.org/10.1200/JCO.2010.30.0582|9. Riddick G, Song H, Ahn S, Walling J, Borges-Rivera D, Zhang W, Fine HA (2011). Predicting in vitro drug sensitivity using Random Forests. Bioinformatics  27, 220-4.   https://doi.org/10.1093/bioinformatics/btq628|10. Sul J, Fine HA (2010). Malignant gliomas: new translational therapies. Mt Sinai J Med  77, 655-66.   https://doi.org/10.1002/msj.20223|11. Venere M, Fine HA, Dirks PB, Rich JN (2011). Cancer stem cells in gliomas: identifying and understanding the apex cell in cancer's hierarchy. Glia  59, 1148-54.   https://doi.org/10.1002/glia.21185|12. Wuchty S, Arjona D, Li A, Kotliarov Y, Walling J, Ahn S, Zhang A, Maric D, Anolik R, Zenklusen JC, Fine HA (2011). Prediction of Associations between microRNAs and Gene Expression in Glioma Biology. PLoS One  6, e14681.   https://doi.org/10.1371/journal.pone.0014681",https://intramural.nih.gov/search/searchview.taf?ipid=68968
775,SC010282-14,"October 01, 2010 -  September 30, 2011",Cytogenetic Studies of B-cell Chronic Lymphocytic Leukemia (B-CLL),Diane Carol Arthur; MD,John Carl Oberholtzer,"Laboratory of Pathology, NCI","Shannon I Skarshaug|Maryalice  Stetler-Stevenson; MD, PhD",NULL,"Daniel H Fowler (Experimental Transplantation and Immunology Branch)|Steven  Pavletic; MD, MS (Experimental Transplantation and Immunology Branch)|Wyndham H Wilson; MD, PhD (Lymphoid Malignancies Branch)","Gerald Ernest Marti (NHLBI) |Adrian U Wiestner; MD, PhD (NHLBI) |Mohammed Zulfiqar Farooqui; DO (NHLBI)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68969
776,SC010288-14,"October 01, 2010 -  September 30, 2011",Th1Th2 and Tc1Tc2 T Cell Subsets in Transplantation Therapy,Daniel H Fowler,NULL,"Experimental Transplantation and Immunology Branch, NCI","Shoba M Amarnath|Ronald E Gress; MD|J  Foley|Steven  Pavletic; MD, MS|Frances  Hakim; PhD|David Charles Halverson; MD|Show all 7","Carl  June (University of Penn)|Robert  Korngold (Cancer Center, Hackensack University)|Bruce  Levine (Abramson Family Cancer Research Center, University of Pennsylvania)","Antonio  Fojo; MD, PhD (Medical Oncology Branch)",David F Stroncek; MD (CC) |Susan  Leitman; MD (CC) |Hanh M Khuu; MD (CC),"1. Bishop MR, Dean RM, Steinberg SM, Odom J, Pollack SM, Pavletic SZ, Sportes C, Gress RE, Fowler DH (2010). Correlation of pretransplant and early post-transplant response assessment with outcomes after reduced-intensity allogeneic hematopoietic stem cell transplantation for non-Hodgkin's lymphoma. Cancer  116, 852-62.   https://doi.org/10.1002/cncr.24845|2. Jamshed S, Fowler DH, Neelapu SS, Dean RM, Steinberg SM, Odom J, Bryant K, Hakim F, Bishop MR (2011). EPOCH-F: a novel salvage regimen for multiple myeloma before reduced-intensity allogeneic hematopoietic SCT. Bone Marrow Transplant  46, 676-81.   https://doi.org/10.1038/bmt.2010.173|3. Mitchell SA, Leidy NK, Mooney KH, Dudley WN, Beck SL, LaStayo PC, Cowen EW, Palit P, Comis LE, Krumlauf MC, Avila DN, Atlam N, Fowler DH, Pavletic SZ (2010). Determinants of functional performance in long-term survivors of allogeneic hematopoietic stem cell transplantation with chronic graft-versus-host disease (cGVHD). Bone Marrow Transplant  45, 762-9.   https://doi.org/10.1038/bmt.2009.238",https://intramural.nih.gov/search/searchview.taf?ipid=68970
777,SC010292-13,"October 01, 2010 -  September 30, 2011",Signal Transduction Pathways that Promote Survival of Lung Cancer Cells,"Phillip A Dennis; MD, PhD",NULL,"Medical Oncology Branch, NCI",Frances Natalia Cervoni-Curet|Yoon Soo Chang; MD|Chun-Te  Chiang|William D Figg; PharmD|Irem  Dogan|Joell J Gills|Show all 17,"Pasi  Janne (Oncology, Dana-Farber Cancer Center)|Alan  Kozikowski (University of Illinois at Chicago)|William  Pao (Memorial Sloan Kettering Cancer Center)|William  Travis (Memorial Sloan Kettering Cancer Center)","Curtis  Harris; MD (Laboratory of Human Carcinogenesis)|Ilona  Linnoila; MD (Laboratory Of Genitourinary Cancer Pathogenesis)|Stephen M Hewitt; MD, PhD (Laboratory of Pathology)|Joanna H Shih (Biometrics Research Branch)|Jin  Jen (Molecular Genetics and Carcinogenesis Section)|Jonathan S Wiest; PhD (Office of the Director)","Carter  Van Waes; MD, PhD (NIDCD) |J Silvio  Gutkind; PhD (NIDCR)","1. Memmott RM, Mercado JR, Maier CR, Kawabata S, Fox SD, Dennis PA (2010). Metformin prevents tobacco carcinogen--induced lung tumorigenesis. Cancer Prev Res (Phila)  3, 1066-76.   https://doi.org/10.1158/1940-6207.CAPR-10-0055",https://intramural.nih.gov/search/searchview.taf?ipid=68971
778,SC010354-12,"October 01, 2010 -  September 30, 2011",Clinical Development of Novel Drugs for Children with Refractory Cancers,Brigitte  Widemann; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Srivandana  Akshintala|Diane  Cole|Wendy J Goodspeed|Anne D Goodwin|Katherine Elizabeth Warren; MD|Nalini M Jayaprakash|Show all 12,"Peter Charles Adamson; MD|Larry  Baker (SARC)|Susan  Blaney (Texas Children's Cancer Center)|Karen  Cichowski (Brigham and Women's Hospital)|John  Perentesis (Pediatric Oncology, Cincinnati Children's Hospital)|Gregory  Reaman (Children's National Medical Center)|Show all 7","Antonio  Fojo; MD, PhD (Medical Oncology Branch)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)","Jeffrey M Solomon; BS, MS, PhD (CC)","1. Chuk MK, Cole DE, McCully C, Loktionova NA, Pegg AE, Parker RJ, Pauly G, Widemann BC, Balis FM, Fox E (2011). Plasma and CNS pharmacokinetics of O4-benzylfolic acid (O4BF) and metabolite in a non-human primate model. Cancer Chemother Pharmacol  67, 1291-7.   https://doi.org/10.1007/s00280-010-1407-9|2. Fox E, Aplenc R, Bagatell R, Chuk MK, Dombi E, Goodspeed W, Goodwin A, Kromplewski M, Jayaprakash N, Marotti M, Brown KH, Wenrich B, Adamson PC, Widemann BC, Balis FM (2010). A phase 1 trial and pharmacokinetic study of cediranib, an orally bioavailable pan-vascular endothelial growth factor receptor inhibitor, in children and adolescents with refractory solid tumors. J Clin Oncol  28, 5174-81.   https://doi.org/10.1200/JCO.2010.30.9674|3. Fox E, Maris JM, Cohn SL, Goodspeed W, Goodwin A, Kromplewski M, Medina D, Xiong H, Krivoshik A, Widemann B, Adamson PC, Balis FM (2010). Pharmacokinetics of orally administered ABT-751 in children with neuroblastoma and other solid tumors. Cancer Chemother Pharmacol  66, 737-43.   https://doi.org/10.1007/s00280-009-1218-z|4. Jacobs S, Fox E, Krailo M, Hartley G, Navid F, Wexler L, Blaney SM, Goodwin A, Goodspeed W, Balis FM, Adamson PC, Widemann BC (2010). Phase II trial of ixabepilone administered daily for five days in children and young adults with refractory solid tumors: a report from the children's oncology group. Clin Cancer Res  16, 750-4.   https://doi.org/10.1158/1078-0432.CCR-09-1906|5. Kim A, McCully C, Cruz R, Cole DE, Fox E, Balis FM, Widemann BC (2012). The plasma and cerebrospinal fluid pharmacokinetics of sorafenib after intravenous administration in non-human primates. Invest New Drugs  30, 524-8.   https://doi.org/10.1007/s10637-010-9585-1|6. Meany H, Balis FM, Aikin A, Whitcomb P, Murphy RF, Steinberg SM, Widemann BC, Fox E (2010). Pediatric phase I trial design using maximum target inhibition as the primary endpoint. J Natl Cancer Inst  102, 909-12.   https://doi.org/10.1093/jnci/djq174|7. Widemann BC, Balis FM, Kim A, Boron M, Jayaprakash N, Shalabi A, O'Brien M, Eby M, Cole DE, Murphy RF, Fox E, Ivy P, Adamson PC (2010). Glucarpidase, leucovorin, and thymidine for high-dose methotrexate-induced renal dysfunction: clinical and pharmacologic factors affecting outcome. J Clin Oncol  28, 3979-86.   https://doi.org/10.1200/JCO.2009.25.4540",https://intramural.nih.gov/search/searchview.taf?ipid=68973
779,SC010355-12,"October 01, 2010 -  September 30, 2011",Angiogenesis and Tumor Growth,Giovanna  Tosato; PhD|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI",Inn-Inn  Chen|Georgina  Espigol Frigole|Kan  Jiang|Hidetaka  Ohnuki|Shuhei  Sakakibara; PhD|Ombretta  Salvucci|Show all 7,Amparo  Acher-Palmer (University of Frankfurt)|Anna C Berardi|Maria  Cid (Univ. of Barcelona Medical School)|Catherine  Porcher (Oxford Univ)|Shushang  Wang (Univ. Texas Southwestern Med Center),Elaine S Jaffe; MD (Laboratory of Pathology)|David A Davis; MD (HIV and AIDS Malignancy Branch)|Stefania  Pittaluga (Laboratory of Pathology)|Peter L Choyke; MD (Molecular Imaging Program)|Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch),Dragan  Maric; PhD (NINDS) |Xuri  Li (NEI) |Manfred  Boehm; MD (NHLBI) |Yosuke  Mukoyama; PhD (NHLBI) |Jinfang  Zhu; PhD (NIAID),"1. Narazaki M, Segarra M, Hou X, Tanaka T, Li X, Tosato G (2010). Oligo-guanosine nucleotide induces neuropilin-1 internalization in endothelial cells and inhibits angiogenesis. Blood  116, 3099-107.   https://doi.org/10.1182/blood-2010-01-265801",https://intramural.nih.gov/search/searchview.taf?ipid=68974
780,SC010356-12,"October 01, 2010 -  September 30, 2011",A Role for KSHV in the Pathogenesis of Malignancies,Giovanna  Tosato; PhD|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI",Georgina  Espigol Frigole|Kan  Jiang|Shuhei  Sakakibara; PhD|Ombretta  Salvucci,NULL,"Wyndham H Wilson; MD, PhD (Lymphoid Malignancies Branch)|Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Richard  Little; MD, PhD (Clinical Investigations Branch)|Elaine S Jaffe; MD (Laboratory of Pathology)|Stefania  Pittaluga (Laboratory of Pathology)|Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch)",Joshua  Farber; MD (NIAID) |Dragan  Maric; PhD (NINDS),"1. Uldrick TS, Wang V, O'Mahony D, Aleman K, Wyvill KM, Marshall V, Steinberg SM, Pittaluga S, Maric I, Whitby D, Tosato G, Little RF, Yarchoan R (2010). An interleukin-6-related systemic inflammatory syndrome in patients co-infected with Kaposi sarcoma-associated herpesvirus and HIV but without Multicentric Castleman disease. Clin Infect Dis  51, 350-8.   https://doi.org/10.1086/654798",https://intramural.nih.gov/search/searchview.taf?ipid=68975
781,SC010357-12,"October 01, 2010 -  September 30, 2011",Gene Expression and Post-Transcriptional Regulation of DNA Tumor Viruses,"Zhi Ming  Zheng; MD, PhD|IRP Faculty Profile",NULL,"HIV and AIDS Malignancy Branch, NCI",Masahiko  Ajiro; PhD|Robert  Yarchoan; MD|Yang  Li; PhD|Vladimir  Majerciak|Xiaohong  Wang|Maria Julia Massimelli,"Louise T Chow|Craig  Meyers (Microbiology and Immunology, Penn State University College of Medicine)|Xing  Xie (Zhejiang University)","Michael John Kruhlak; PhD (Experimental Immunology Branch)|Barbara K Felber (Vaccine Branch)|Curtis  Harris; MD (Laboratory of Human Carcinogenesis)|George N Pavlakis; MD, PhD (Vaccine Branch)",John Philip McCoy (NHLBI) |Chuxia  Deng; PhD (NIDDK) |Jun  Zhu; PhD (NHLBI),"1. Jia R, Li C, McCoy JP, Deng CX, Zheng ZM (2010). SRp20 is a proto-oncogene critical for cell proliferation and tumor induction and maintenance. Int J Biol Sci  6, 806-26.   https://doi.org/10.7150/ijbs.6.806|2. Kang J, Majerciak V, Uldrick T, Wang X, Kruhlak M, Yarchoan R, Zheng Z (2011) Kaposi sarcoma-associated herpesviral IL6 and human IL6 open reading frames contain miRNA binding sites and are subject to cellular miRNA regulation. Journal of Pathology, in press.|3. Majerciak V, Deng M, Zheng ZM (2010). Requirement of UAP56, URH49, RBM15, and OTT3 in the expression of Kaposi sarcoma-associated herpesvirus ORF57. Virology  407, 206-12.   https://doi.org/10.1016/j.virol.2010.08.014|4. Majerciak V, Kruhlak M, Dagur PK, McCoy JP, Zheng ZM (2010). Caspase-7 cleavage of Kaposi sarcoma-associated herpesvirus ORF57 confers a cellular function against viral lytic gene expression. J Biol Chem  285, 11297-307.   https://doi.org/10.1074/jbc.M109.068221|5. Zheng ZM (2010). Viral oncogenes, noncoding RNAs, and RNA splicing in human tumor viruses. Int J Biol Sci  6, 730-55.   https://doi.org/10.7150/ijbs.6.730",https://intramural.nih.gov/search/searchview.taf?ipid=68976
782,SC010365-12,"October 01, 2010 -  September 30, 2011",Optimizing the Graft-Versus-Tumor Effect in Allogeneic HSCT,Michael R Bishop; MD,NULL,"Experimental Transplantation and Immunology Branch, NCI",Daniel H Fowler|Ronald E Gress; MD|Frances  Hakim; PhD|Christoph  Rader; PhD|Nancy M Hardy|Sivasubramanian  Baskar,Sergio  Giralt (M.D. ANDERSON CANCER CENTER)|Carl  June (University of Pennsylvania)|Larry  Kwak (NCI)|Sattva  Neelapu (M.D. ANDERSON CANCER CENTER),"Crystal L. Mackall; MD (Pediatric Oncology Branch)|Terry J Fry (Pediatric Oncology Branch)|Steven Aaron Rosenberg; MD, PhD (Surgery Branch)|Stefania  Pittaluga (Laboratory of Pathology)|Alan S Wayne; MD (Pediatric Oncology Branch)",NULL,"1. Bishop MR, Dean RM, Steinberg SM, Odom J, Pollack SM, Pavletic SZ, Sportes C, Gress RE, Fowler DH (2010). Correlation of pretransplant and early post-transplant response assessment with outcomes after reduced-intensity allogeneic hematopoietic stem cell transplantation for non-Hodgkin's lymphoma. Cancer  116, 852-62.   https://doi.org/10.1002/cncr.24845",https://intramural.nih.gov/search/searchview.taf?ipid=68977
783,SC010366-11,"October 01, 2010 -  September 30, 2011",Identification of Genes for Predicting Prognosis in Pediatric Cancers,Javed  Khan; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",James  Badgett|Carol J Thiele|Dominik  Bogen|Tai Chi  Cheuk|Jianbin Na He|Laura Beth Hurd|Show all 15,"Peter  Ambros (Children’s Cancer Research Institute)|Daniel  Catchpoole, (The Children's Hospital at Westmead)|John  Maris (Pharmacology, Children's Hospital of Philadelphia)|Andrew  Pearson (Paediatric Section, Institute of Cancer Research)|Manfred  Schwab (German Cancer Research Center)|Robert  Seeger (Division of Pediatric Hematology-Oncology, Children's Hospital of Los Angeles)","Timothy D Veenstra (Office Of The Director)|Stephen M Hewitt; MD, PhD (Laboratory of Pathology)",NULL,"1. Briggs J, Paoloni M, Chen QR, Wen X, Khan J, Khanna C (2011). A compendium of canine normal tissue gene expression. PLoS One  6, e17107.   https://doi.org/10.1371/journal.pone.0017107|2. Kohler ME, Johnson BD, Palen K, Chen QR, Khan J, Orentas RJ (2010). Tumor antigen analysis in neuroblastoma by serological interrogation of bioinformatic data. Cancer Sci  101, 2316-24.   https://doi.org/10.1111/j.1349-7006.2010.01694.x",https://intramural.nih.gov/search/searchview.taf?ipid=68978
784,SC010370-11,"October 01, 2010 -  September 30, 2011",Primate Genomics and Human Disease Genes,Stephen J O'Brien; PhD,NULL,"Laboratory of Genomic Diversity, NCI",Jill  Slattery|Clare Ellen Holleley|Kathryn B Walters|Victor A David|Warren  Johnson,Julie  Horvath (Duke University)|Christian  Roos (German Primate Center)|Hector  Seuanez,Robert  Stephens (Office Of The Director)|Jennifer L Troyer (Office Of The Director),NULL,"1. Perelman P, Johnson WE, Roos C, Seuánez HN, Horvath JE, Moreira MA, Kessing B, Pontius J, Roelke M, Rumpler Y, Schneider MP, Silva A, O'Brien SJ, Pecon-Slattery J (2011). A molecular phylogeny of living primates. PLoS Genet  7, e1001342.   https://doi.org/10.1371/journal.pgen.1001342",https://intramural.nih.gov/search/searchview.taf?ipid=68979
785,SC010372-11,"October 01, 2010 -  September 30, 2011",Molecular Profiling of Patients Undergoing Radiotherapy,Kevin A Camphausen; MD|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Ira  Gordon|Christian Alexander Graves|Tamalee  Scott|Cody Daniel Schlaff|Mary T Sproull|Anita T Tandle,NULL,NULL,NULL,"1. de Groot JF, Piao Y, Tran H, Gilbert M, Wu HK, Liu J, Bekele BN, Cloughesy T, Mehta M, Robins HI, Lassman A, DeAngelis L, Camphausen K, Chen A, Yung WK, Prados M, Wen PY, Heymach JV (2011). Myeloid biomarkers associated with glioblastoma response to anti-VEGF therapy with aflibercept. Clin Cancer Res  17, 4872-81.   https://doi.org/10.1158/1078-0432.CCR-11-0271|2. Shabason JE, Camphausen K (2010). Cancer stem cells as a prognostic indicator for glioblastoma multiforme. Biomark Med  4, 127-8.   https://doi.org/10.2217/bmm.09.90|3. Stall B, Zach L, Ning H, Ondos J, Arora B, Shankavaram U, Miller RW, Citrin D, Camphausen K (2010). Comparison of T2 and FLAIR imaging for target delineation in high grade gliomas. Radiat Oncol  5, 5.   https://doi.org/10.1186/1748-717X-5-5",https://intramural.nih.gov/search/searchview.taf?ipid=68980
786,SC010373-11,"October 01, 2010 -  September 30, 2011",The Synergy Between Radiotherapy and Molecularly Targeted Agents,Kevin A Camphausen; MD|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Ira  Gordon|Christian Alexander Graves|Tamalee  Scott|Mary T Sproull|Anita T Tandle,NULL,"Howard A Fine; MD, PhD (Neuro-Oncology Branch)|Patricia  Steeg; PhD (Developmental Therapeutics Branch)",NULL,"1. Buchanan IM, Scott T, Tandle AT, Burgan WE, Burgess TL, Tofilon PJ, Camphausen K (2011). Radiosensitization of glioma cells by modulation of Met signalling with the hepatocyte growth factor neutralizing antibody, AMG102. J Cell Mol Med  15, 1999-2006.   https://doi.org/10.1111/j.1582-4934.2010.01122.x",https://intramural.nih.gov/search/searchview.taf?ipid=68981
787,SC010375-11,"October 01, 2010 -  September 30, 2011",TAF7: A Check-point Regulator in Transcription Initiation,Dinah  Singer; PhD|IRP Faculty Profile,NULL,"Office of the Director, NCI",Anne G M Gegonne Bosselut|Jocelyn D Weissman|Devaiah Nanjappa Ballachanda,NULL,Kent W Hunter; PhD (Laboratory of Cancer Biology and Genetics)|Kenneth  Buetow; PhD (Laboratory of Population Genetics)|Maxwell P Lee; PhD (Laboratory of Population Genetics)|Susan  Mackem; MD (Cancer and Developmental Biology Laboratory)|Susan  Sharrow (Experimental Immunology Branch)|Robert  Clifford (Laboratory of Population Genetics),Keiko  Ozato; PhD (NICHD),"1. Devaiah BN, Lu H, Gegonne A, Sercan Z, Zhang H, Clifford RJ, Lee MP, Singer DS (2010). Novel functions for TAF7, a regulator of TAF1-independent transcription. J Biol Chem  285, 38772-80.   https://doi.org/10.1074/jbc.M110.173864|2. Lee N, Iyer SS, Mu J, Weissman JD, Ohali A, Howcroft TK, Lewis BA, Singer DS (2010). Three novel downstream promoter elements regulate MHC class I promoter activity in mammalian cells. PLoS One  5, e15278.   https://doi.org/10.1371/journal.pone.0015278",https://intramural.nih.gov/search/searchview.taf?ipid=68982
788,SC010376-11,"October 01, 2010 -  September 30, 2011",Molecular Mechanism of TNF Signaling and Apoptosis,Zhenggang  Liu; PhD|IRP Faculty Profile,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Zhenyu  Cai|Cao  Xiumei|Swati Suresh Choksi|Magdolna Maria Djurec|Siriporn  Jitkaew|Elena  Pobezinskaya|Show all 7,NULL,NULL,Chuxia  Deng; PhD (NIDDK) |J Silvio  Gutkind; PhD (NIDCR),"1. Li T, Morgan MJ, Choksi S, Zhang Y, Kim YS, Liu ZG (2010). MicroRNAs modulate the noncanonical transcription factor NF-kappaB pathway by regulating expression of the kinase IKKalpha during macrophage differentiation. Nat Immunol  11, 799-805.   https://doi.org/10.1038/ni.1918|2. Morgan MJ, Liu ZG (2010). Reactive oxygen species in TNFalpha-induced signaling and cell death. Mol Cells  30, 1-12.   https://doi.org/10.1007/s10059-010-0105-0|3. Peng Z, Geh E, Chen L, Meng Q, Fan Y, Sartor M, Shertzer HG, Liu ZG, Puga A, Xia Y (2010). Inhibitor of kappaB kinase beta regulates redox homeostasis by controlling the constitutive levels of glutathione. Mol Pharmacol  77, 784-92.   https://doi.org/10.1124/mol.109.061424",https://intramural.nih.gov/search/searchview.taf?ipid=68983
789,SC010378-11,"October 01, 2010 -  September 30, 2011",Activation of Proto-Oncogenes by Chromosomal Translocation,Peter D Aplan; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI","Sarah H Beachy; PhD|Yang-Jo  Chung|Sheryl Maxine Gough|Hyun Kyung Kyun Kim|Paul S Meltzer; MD, PhD|Masahiro  Onozawa|Show all 8","Adolfo  Ferrando (Genetics, Columbia U.)|Trang  Hoang (U. Montreal)|Byrappa  Venkatesh (Institute of Molecular and Cell Biology)",Lino  Tessarollo (Neural Development Section)|Linda  Wolff; PhD (Laboratory of Cellular Oncology)|David  Levens; PhD (Laboratory of Pathology)|Crystal L. Mackall; MD (Pediatric Oncology Branch),"Paul P. Liu; MD, PhD (NHGRI)","1. De Keersmaecker K, Real PJ, Gatta GD, Palomero T, Sulis ML, Tosello V, Van Vlierberghe P, Barnes K, Castillo M, Sole X, Hadler M, Lenz J, Aplan PD, Kelliher M, Kee BL, Pandolfi PP, Kappes D, Gounari F, Petrie H, Van der Meulen J, Speleman F, Paietta E, Racevskis J, Wiernik PH, Rowe JM, et al. [9 more authors] (2010). The TLX1 oncogene drives aneuploidy in T cell transformation. Nat Med  16, 1321-7.   https://doi.org/10.1038/nm.2246|2. Estécio MR, Gallegos J, Vallot C, Castoro RJ, Chung W, Maegawa S, Oki Y, Kondo Y, Jelinek J, Shen L, Hartung H, Aplan PD, Czerniak BA, Liang S, Issa JP (2010). Genome architecture marked by retrotransposons modulates predisposition to DNA methylation in cancer. Genome Res  20, 1369-82.   https://doi.org/10.1101/gr.107318.110|3. Gill JA, Lowe L, Nguyen J, Liu PP, Blake T, Venkatesh B, Aplan PD (2010). Enforced expression of Simian virus 40 large T-antigen leads to testicular germ cell tumors in zebrafish. Zebrafish  7, 333-41.   https://doi.org/10.1089/zeb.2010.0663|4. Lin YW, Beharry ZM, Hill EG, Song JH, Wang W, Xia Z, Zhang Z, Aplan PD, Aster JC, Smith CD, Kraft AS (2010). A small molecule inhibitor of Pim protein kinases blocks the growth of precursor T-cell lymphoblastic leukemia/lymphoma. Blood  115, 824-33.   https://doi.org/10.1182/blood-2009-07-233445|5. Tremblay M, Tremblay CS, Herblot S, Aplan PD, Hébert J, Perreault C, Hoang T (2010). Modeling T-cell acute lymphoblastic leukemia induced by the SCL and LMO1 oncogenes. Genes Dev  24, 1093-105.   https://doi.org/10.1101/gad.1897910",https://intramural.nih.gov/search/searchview.taf?ipid=68984
790,SC010379-11,"October 01, 2010 -  September 30, 2011",Mechanisms of Chromosomal Translocation,Peter D Aplan; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Masahiro  Onozawa|Zhijun  Qiu; PhD|Zhenhua  Zhang,NULL,Andre A Nussenzweig; PhD (Experimental Immunology Branch),NULL,"1. Aplan P, Khan J (2011) Molecular and Genetic Basis of Childhood Cancer, in Principles and Practice of Pediatric Oncology, 6th Edition., pp. 38-77.|2. Cheng Y, Zhang Z, Keenan B, Roschke AV, Nakahara K, Aplan PD (2010). Efficient repair of DNA double-strand breaks in malignant cells with structural instability. Mutat Res  683, 115-22.   https://doi.org/10.1016/j.mrfmmm.2009.10.016",https://intramural.nih.gov/search/searchview.taf?ipid=68985
791,SC010384-11,"October 01, 2010 -  September 30, 2011",Hematopoietic Stem Cell Gene Therapy for Leukocyte Adhesion Deficiency,Dennis D Hickstein|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Thomas R Bauer|Michael J Hunter; PhD|Laura M Tuschong,Derek  Persons (St. Jude's Cancer Research Center)|David  Russell (University of Washington),NULL,Harry Lewis Malech; MD (NIAID),"1. Hunter MJ, Tuschong LM, Fowler CJ, Bauer TR, Burkholder TH, Hickstein DD (2011). Gene therapy of canine leukocyte adhesion deficiency using lentiviral vectors with human CD11b and CD18 promoters driving canine CD18 expression. Mol Ther  19, 113-21.   https://doi.org/10.1038/mt.2010.203|2. Nelson EJ, Tuschong LM, Hunter MJ, Bauer TR, Burkholder TH, Hickstein DD (2010). Lentiviral vectors incorporating a human elongation factor 1alpha promoter for the treatment of canine leukocyte adhesion deficiency. Gene Ther  17, 672-7.   https://doi.org/10.1038/gt.2010.7|3. Ohmine K, Li Y, Bauer TR, Hickstein DD, Russell DW (2011). Tracking of specific integrant clones in dogs treated with foamy virus vectors. Hum Gene Ther  22, 217-24.   https://doi.org/10.1089/hum.2010.072",https://intramural.nih.gov/search/searchview.taf?ipid=68986
792,SC010437-11,"October 01, 2010 -  September 30, 2011",Molecular Pathology of Cancer,"Michael R Emmert-Buck; MD, PhD",NULL,"Laboratory of Pathology, NCI",Michael D Armani|Qiang  Du; PhD|Maria  Merino; PhD|Michael  Tangrea|Wusheng  Yan|Liang  Zhu; PhD,NULL,"William Marston Linehan; MD (Urologic Oncology Branch)|Philip  Taylor; MD, ScD (Genetic Epidemiology Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68987
793,BC010906-04,"October 01, 2010 -  September 30, 2011",Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy,"Thomas Alexander Waldmann; MD, PhD|IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",Bonita R Bryant|Jing  Chen|Sigrid Priscilla Dubois|Kayhan  Garmestani; PhD|Carolyn  Goldman|Wei  Ju|Show all 11,NULL,"Jason L Yovandich (Biological Resources Branch)|Stephen  Creekmore; PhD (Biological Resources Branch)|Steven Aaron Rosenberg; MD, PhD (Surgery Branch)",NULL,"1. Lugli E, Goldman CK, Perera LP, Smedley J, Pung R, Yovandich JL, Creekmore SP, Waldmann TA, Roederer M (2010). Transient and persistent effects of IL-15 on lymphocyte homeostasis in nonhuman primates. Blood  116, 3238-48.   https://doi.org/10.1182/blood-2010-03-275438",https://intramural.nih.gov/search/searchview.taf?ipid=68586
794,BC009255-37,"October 01, 2010 -  September 30, 2011",Application of Flow Cytometry to Cell Biology,Susan  Sharrow,Alfred  Singer; MD,"Experimental Immunology Branch, NCI",Anthony J Adams|Lawrence G Granger|Donald G Plugge,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68091
795,BC010469-09,"October 01, 2010 -  September 30, 2011",Molecular Targets Development Program,James  McMahon; PhD,NULL,"Molecular Targets Laboratory, NCI",John A Beutler|Heidi  Bokesch|Laura  Cartner|Krishna Prasad Devkota; PhD|Thushara Kelum Kaviraj  Diyabalanage|Jason R Evans|Show all 25,"Edward  Arnold (Rutgers University)|Ihsan  Calis (Natural product diversity librarires, Hacteppe University)|David  Craik (Institute for Molecular Bioscience, Univ. of Queensland)|Patrick  Cummings (Masters Program development, Johns Hopkins University)|Johnny  Easmon (HDAC Inhibitors, University of Innsbruck)|Kevan  Hartshorn (Boston Univ.)|Show all 22",Gordon Lee Hager; PhD (Laboratory of Receptor Biology and Gene Expression)|Daniel  McVicar; PhD (Laboratory of Experimental Immunology)|William Marston Linehan; MD (Urologic Oncology Branch)|Thomas Joseph Sayers; PhD (Laboratory of Experimental Immunology)|Allan M Weissman; MD (Laboratory of Protein Dynamics and Signaling)|Joseph John Barchi (Chemical Biology Laboratory),Michael P Bray (NIAID),"1. Alexandre KB, Gray ES, Lambson BE, Moore PL, Choge IA, Mlisana K, Karim SS, McMahon J, O'Keefe B, Chikwamba R, Morris L (2010). Mannose-rich glycosylation patterns on HIV-1 subtype C gp120 and sensitivity to the lectins, Griffithsin, Cyanovirin-N and Scytovirin. Virology  402, 187-96.   https://doi.org/10.1016/j.virol.2010.03.021|2. Blees JS, Schmid T, Thomas CL, Baker AR, Benson L, Evans JR, Goncharova EI, Colburn NH, McMahon JB, Henrich CJ (2010). Development of a high-throughput cell-based reporter assay to identify stabilizers of tumor suppressor Pdcd4. J Biomol Screen  15, 21-9.   https://doi.org/10.1177/1087057109351028|3. Bokesch HR, Cartner LK, Fuller RW, Wilson JA, Henrich CJ, Kelley JA, Gustafson KR, McMahon JB, McKee TC (2010). Inhibition of ABCG2-mediated drug efflux by naphthopyrones from marine crinoids. Bioorg Med Chem Lett  20, 3848-50.   https://doi.org/10.1016/j.bmcl.2010.05.057|4. Dull A, Goncharova E, Hager G, McMahon JB (2010). Development of an image analysis screen for estrogen receptor alpha (ERα) ligands through measurement of nuclear translocation dynamics. J Steroid Biochem Mol Biol  122, 341-51.   https://doi.org/10.1016/j.jsbmb.2010.08.009|5. Grkovic T, Blees JS, Colburn NH, Schmid T, Thomas CL, Henrich CJ, McMahon JB, Gustafson KR (2011). Cryptocaryols A-H, α-pyrone-containing 1,3-polyols from Cryptocarya sp. implicated in stabilizing the tumor suppressor Pdcd4. J Nat Prod  74, 1015-20.   https://doi.org/10.1021/np100918z|6. Moulaei T, Shenoy SR, Giomarelli B, Thomas C, McMahon JB, Dauter Z, O'Keefe BR, Wlodawer A (2010). Monomerization of viral entry inhibitor griffithsin elucidates the relationship between multivalent binding to carbohydrates and anti-HIV activity. Structure  18, 1104-15.   https://doi.org/10.1016/j.str.2010.05.016|7. O'Keefe BR, Giomarelli B, Barnard DL, Shenoy SR, Chan PK, McMahon JB, Palmer KE, Barnett BW, Meyerholz DK, Wohlford-Lenane CL, McCray PB (2010). Broad-spectrum in vitro activity and in vivo efficacy of the antiviral protein griffithsin against emerging viruses of the family Coronaviridae. J Virol  84, 2511-21.   https://doi.org/10.1128/JVI.02322-09|8. Oku N, Takada K, Fuller RW, Wilson JA, Peach ML, Pannell LK, McMahon JB, Gustafson KR (2010). Isolation, structural elucidation, and absolute stereochemistry of enigmazole A, a cytotoxic phosphomacrolide from the Papua New Guinea marine sponge Cinachyrella enigmatica. J Am Chem Soc  132, 10278-85.   https://doi.org/10.1021/ja1016766|9. Whitson EL, Thomas CL, Henrich CJ, Sayers TJ, McMahon JB, McKee TC (2010). Clerodane diterpenes from Casearia arguta that act as synergistic TRAIL sensitizers. J Nat Prod  73, 2013-8.   https://doi.org/10.1021/np1004455",https://intramural.nih.gov/search/searchview.taf?ipid=68276
796,BC010517-09,"October 01, 2010 -  September 30, 2011",Large Databases of Small Molecules - Drug Development Tool and Public Resource,Marc C Nicklaus|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Igor V Filippov|Markus  Sitzmann,Stephen  Boyer|Lawrence  Callahan (FDA)|Eugene  Demchuk (CDC)|Huixiao  Hong (NCI)|Wolf-Dietrich  Ihlenfeldt (Xemistry GmbH)|Dmitry  Katsubo (European Patent Office)|Show all 11,NULL,"Christopher P Austin; AB, MD (NHGRI)","1. Liao C, Nicklaus MC (2010). Computer tools in the discovery of HIV-1 integrase inhibitors. Future Med Chem  2, 1123-40.   https://doi.org/10.4155/fmc.10.193|2. Sitzmann M, Ihlenfeldt WD, Nicklaus MC (2010). Tautomerism in large databases. J Comput Aided Mol Des  24, 521-51.   https://doi.org/10.1007/s10822-010-9346-4",https://intramural.nih.gov/search/searchview.taf?ipid=68279
797,BC010548-09,"October 01, 2010 -  September 30, 2011",Pharmacokinetic and Pharmacodynamic Modeling of Anticancer Agents,William D Figg; PharmD|IRP Faculty Profile,NULL,"Medical Oncology Branch, NCI",Cindy Huong-Bich Chau|William Laurence Dahut; MD|Kathryn  Compton|Cody John Peer,Edward  Sausville (University of Maryland)|Alex  Sparreboom,NULL,NULL,"1. Bates SE, Zhan Z, Steadman K, Obrzut T, Luchenko V, Frye R, Robey RW, Turner M, Gardner ER, Figg WD, Steinberg SM, Ling A, Fojo T, To KW, Piekarz RL (2010). Laboratory correlates for a phase II trial of romidepsin in cutaneous and peripheral T-cell lymphoma. Br J Haematol  148, 256-67.   https://doi.org/10.1111/j.1365-2141.2009.07954.x|2. Figg WD, Woo S, Zhu W, Chen X, Ajiboye AS, Steinberg SM, Price DK, Wright JJ, Parnes HL, Arlen PM, Gulley JL, Dahut WL (2010). A phase I clinical study of high dose ketoconazole plus weekly docetaxel for metastatic castration resistant prostate cancer. J Urol  183, 2219-26.   https://doi.org/10.1016/j.juro.2010.02.020|3. Grant C, Rahman F, Piekarz R, Peer C, Frye R, Robey RW, Gardner ER, Figg WD, Bates SE (2010). Romidepsin: a new therapy for cutaneous T-cell lymphoma and a potential therapy for solid tumors. Expert Rev Anticancer Ther  10, 997-1008.   https://doi.org/10.1586/era.10.88|4. Holkova B, Perkins EB, Ramakrishnan V, Tombes MB, Shrader E, Talreja N, Wellons MD, Hogan KT, Roodman GD, Coppola D, Kang L, Dawson J, Stuart RK, Peer C, Figg WD, Kolla S, Doyle A, Wright J, Sullivan DM, Roberts JD, Grant S (2011). Phase I trial of bortezomib (PS-341; NSC 681239) and alvocidib (flavopiridol; NSC 649890) in patients with recurrent or refractory B-cell neoplasms. Clin Cancer Res  17, 3388-97.   https://doi.org/10.1158/1078-0432.CCR-10-2876|5. Jain L, Gardner ER, Figg WD, Chernick MS, Kong HH (2010). Lack of association between excretion of sorafenib in sweat and hand-foot skin reaction. Pharmacotherapy  30, 52-6.   https://doi.org/10.1592/phco.30.1.52|6. Jain L, Sissung TM, Danesi R, Kohn EC, Dahut WL, Kummar S, Venzon D, Liewehr D, English BC, Baum CE, Yarchoan R, Giaccone G, Venitz J, Price DK, Figg WD (2010). Hypertension and hand-foot skin reactions related to VEGFR2 genotype and improved clinical outcome following bevacizumab and sorafenib. J Exp Clin Cancer Res  29, 95.   https://doi.org/10.1186/1756-9966-29-95|7. Jain L, Woo S, Dahut W, Kohn E, Kummar S, Yarchoan R, Giaccone G, Fenitz J, Figg W (2011) Population Pharmacokinetics of Sorafenib in Patients with Solid Tumors using Clinical and Pharmacogenetic Patient Covariates. Br J Clin Pharmacol, in press.|8. Kummar S, Gutierrez ME, Gardner ER, Chen X, Figg WD, Zajac-Kaye M, Chen M, Steinberg SM, Muir CA, Yancey MA, Horneffer YR, Juwara L, Melillo G, Ivy SP, Merino M, Neckers L, Steeg PS, Conley BA, Giaccone G, Doroshow JH, Murgo AJ (2010). Phase I trial of 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG), a heat shock protein inhibitor, administered twice weekly in patients with advanced malignancies. Eur J Cancer  46, 340-7.   https://doi.org/10.1016/j.ejca.2009.10.026|9. Kummar S, Gutierrez ME, Gardner ER, Figg WD, Melillo G, Dancey J, Sausville EA, Conley BA, Murgo AJ, Doroshow JH (2010). A phase I trial of UCN-01 and prednisone in patients with refractory solid tumors and lymphomas. Cancer Chemother Pharmacol  65, 383-9.   https://doi.org/10.1007/s00280-009-1154-y|10. Kummar S, Raffeld M, Juwara L, Horneffer Y, Strassberger A, Allen D, Steinberg SM, Rapisarda A, Spencer SD, Figg WD, Chen X, Turkbey IB, Choyke P, Murgo AJ, Doroshow JH, Melillo G (2011). Multihistology, target-driven pilot trial of oral topotecan as an inhibitor of hypoxia-inducible factor-1α in advanced solid tumors. Clin Cancer Res  17, 5123-31.   https://doi.org/10.1158/1078-0432.CCR-11-0682|11. Marti GE, Stetler-Stevenson M, Grant ND, White T, Figg WD, Tohnya T, Jaffe ES, Dunleavy K, Janik JE, Steinberg SM, Wilson WH (2011). Phase I trial of 7-hydroxystaurosporine and fludararbine phosphate: in vivo evidence of 7-hydroxystaurosporine induced apoptosis in chronic lymphocytic leukemia. Leuk Lymphoma  52, 2284-92.   https://doi.org/10.3109/10428194.2011.589547|12. Ning YM, Gulley JL, Arlen PM, Woo S, Steinberg SM, Wright JJ, Parnes HL, Trepel JB, Lee MJ, Kim YS, Sun H, Madan RA, Latham L, Jones E, Chen CC, Figg WD, Dahut WL (2010). Phase II trial of bevacizumab, thalidomide, docetaxel, and prednisone in patients with metastatic castration-resistant prostate cancer. J Clin Oncol  28, 2070-6.   https://doi.org/10.1200/JCO.2009.25.4524|13. Pluta RM, Oldfield EH, Bakhtian KD, Fathi AR, Smith RK, Devroom HL, Nahavandi M, Woo S, Figg WD, Lonser RR (2011). Safety and feasibility of long-term intravenous sodium nitrite infusion in healthy volunteers. PLoS One  6, e14504.   https://doi.org/10.1371/journal.pone.0014504",https://intramural.nih.gov/search/searchview.taf?ipid=68446
798,BC010571-08,"October 01, 2010 -  September 30, 2011",Fluorescence Imaging Facility,James G McNally; PhD,Gordon Lee Hager; PhD,"Laboratory of Receptor Biology and Gene Expression, NCI",Tatiana  Karpova,NULL,Charles  Vinson; PhD (Nucleic Acids Section)|Michael  Bustin; PhD (Protein Section),Keiko  Ozato; PhD (NICHD),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68306
799,BC010630-08,"October 01, 2010 -  September 30, 2011",Cancer Vaccines and Modulation of Checkpoint Controls in Immunization,John  Janik; MD,"Thomas Alexander Waldmann; MD, PhD","Lymphoid Malignancies Branch, NCI",NULL,NULL,"Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68298
800,BC010639-08,"October 01, 2010 -  September 30, 2011",In Silico Screening for Cancer Targets,Marc C Nicklaus|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Igor V Filippov|Chenzhong  Liao|Megan L Peach|Angelo  Pugliese; PhD|Markus  Sitzmann|Iwona Elzbieta Weidlich|Show all 7,NULL,"Phillip A Dennis; MD, PhD (Medical Oncology Branch)|Donald P Bottaro; PhD (Urologic Oncology Branch)|Kyung  Lee; PhD (Chemistry Section)|Yves  Pommier; PhD (Developmental Therapeutics Branch)|Stuart F J Le Grice; PhD (Retroviral Replication Laboratory)|Peter  Blumberg; PhD (Laboratory of Cancer Biology and Genetics)","Paul P. Liu; MD, PhD (NHGRI)","1. Liao C, Park JE, Bang JK, Nicklaus MC, Lee KS (2010). Exploring Potential Binding Modes of Small Drug-like Molecules to the Polo-Box Domain of Human Polo-like Kinase 1. ACS Med Chem Lett  1, 110-114.   https://doi.org/10.1021/ml100020e|2. Moon HR, Siddiqui MA, Sun G, Filippov IV, Landsman NA, Lee YC, Adams KM, Barchi JJ, Deschamps JR, Nicklaus MC, Kelley JA, Marquez VE (2010). Using conformationally locked nucleosides to calibrate the anomeric effect: Implications for glycosyl bond stability. Tetrahedron  66, 6707-6717.   https://doi.org/10.1016/j.tet.2010.06.044|3. Park JE, Soung NK, Johmura Y, Kang YH, Liao C, Lee KH, Park CH, Nicklaus MC, Lee KS (2010). Polo-box domain: a versatile mediator of polo-like kinase function. Cell Mol Life Sci  67, 1957-70.   https://doi.org/10.1007/s00018-010-0279-9|4. Weidlich IE, Dexheimer T, Marchand C, Antony S, Pommier Y, Nicklaus MC (2010). Inhibitors of human tyrosyl-DNA phospodiesterase (hTdp1) developed by virtual screening using ligand-based pharmacophores. Bioorg Med Chem  18, 182-9.   https://doi.org/10.1016/j.bmc.2009.11.008",https://intramural.nih.gov/search/searchview.taf?ipid=68309
801,BC010685-07,"October 01, 2010 -  September 30, 2011",Postmortem Pathology,"David Erwin Kleiner; MD, PhD",John Carl Oberholtzer,"Laboratory of Pathology, NCI",Mary E Grissette|Judith C Horn|Jeannette Marie McNulty|Willie J Young,NULL,NULL,"Theo  Heller; MD (NIDDK) |Steven M Holland; MD (NIAID) |Kenneth  Olivier; MD, MPH (NIAID)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68333
802,BC010687-07,"October 01, 2010 -  September 30, 2011",Histology Core Laboratory,"David Erwin Kleiner; MD, PhD",John Carl Oberholtzer,"Laboratory of Pathology, NCI",Judith C Horn|Helen G Lynch|Catherine R Neely|Martha A Pruden|Claire D Roque|Maryann Elisabeth Williamson,"Steven  Belle (University of Pittsburgh)|Elizabeth  Brunt (Pathology, St. Louis University)|Hari  Conjeevaram (Gastroenterology, The University of Michigan)|Robert  Fontana (Gastroenterology, The University of Michigan)|Allan  Kirk (Emory University)|Joel  Lavine (Pediatrics, University of California San Diego Medical Center)|Show all 10","Steven  Pavletic; MD, MS (Experimental Transplantation and Immunology Branch)","Jay  Hoofnagle; MD (NIDDK) |Marc Gregory Ghany; MD (NIDDK) |Theo  Heller; MD (NIDDK) |Steven M Holland; MD (NIAID) |Michael  Polis; MD (NIAID) |Shyamasundaran  Kottilil; MD, PhD (NIAID)","1. Davern TJ, Chalasani N, Fontana RJ, Hayashi PH, Protiva P, Kleiner DE, Engle RE, Nguyen H, Emerson SU, Purcell RH, Tillmann HL, Gu J, Serrano J, Hoofnagle JH, Drug-Induced Liver Injury Network (DILIN) (2011). Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury. Gastroenterology  141, 1665-72.e1-9.   https://doi.org/10.1053/j.gastro.2011.07.051|2. Elster EA, Hawksworth JS, Cheng O, Leeser DB, Ring M, Tadaki DK, Kleiner DE, Eberhardt JS, Brown TS, Mannon RB (2010). Probabilistic (Bayesian) modeling of gene expression in transplant glomerulopathy. J Mol Diagn  12, 653-63.   https://doi.org/10.2353/jmoldx.2010.090101|3. Imanguli MM, Atkinson JC, Mitchell SA, Avila DN, Bishop RJ, Cowen EW, Datiles MB, Hakim FT, Kleiner DE, Krumlauf MC, Pavletic SZ (2010). Salivary gland involvement in chronic graft-versus-host disease: prevalence, clinical significance, and recommendations for evaluation. Biol Blood Marrow Transplant  16, 1362-9.   https://doi.org/10.1016/j.bbmt.2010.03.023|4. Modi AA, Feld JJ, Park Y, Kleiner DE, Everhart JE, Liang TJ, Hoofnagle JH (2010). Increased caffeine consumption is associated with reduced hepatic fibrosis. Hepatology  51, 201-9.   https://doi.org/10.1002/hep.23279|5. Promrat K, Kleiner DE, Niemeier HM, Jackvony E, Kearns M, Wands JR, Fava JL, Wing RR (2010). Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis. Hepatology  51, 121-9.   https://doi.org/10.1002/hep.23276|6. Vuppalanchi R, Hayashi PH, Chalasani N, Fontana RJ, Bonkovsky H, Saxena R, Kleiner D, Hoofnagle JH, Drug-Induced Liver Injury Network (DILIN) (2010). Duloxetine hepatotoxicity: a case-series from the drug-induced liver injury network. Aliment Pharmacol Ther  32, 1174-83.   https://doi.org/10.1111/j.1365-2036.2010.04449.x|7. Yu L, Feng M, Kim H, Phung Y, Kleiner DE, Gores GJ, Qian M, Wang XW, Ho M (2010). Mesothelin as a potential therapeutic target in human cholangiocarcinoma. J Cancer  1, 141-9.   https://doi.org/10.7150/jca.1.141",https://intramural.nih.gov/search/searchview.taf?ipid=68335
803,BC010858-05,"October 01, 2010 -  September 30, 2011",CCR Confocal Microscopy Core,Susan H Garfield,"Snorri S. Thorgeirsson; MD, PhD","Laboratory of Experimental Carcinogenesis, NCI",Langston  Lim|Poonam  Mannan,NULL,Peter  Blumberg; PhD (Laboratory of Cancer Biology and Genetics)|Srinivasa M Srinivasula (Laboratory of Immune Cell Biology)|Benu Brata  Das (Developmental Therapeutics Branch)|Chand  Khanna; MD (Pediatric Oncology Branch)|Itzhak  Avital (Surgery Branch)|Sukhbir  Kaur (Laboratory of Pathology),Chava  Kimchi-Sarfaty (OD) |Kevin G Chen; MD (NINDS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68454
804,BC010859-05,"October 01, 2010 -  September 30, 2011",DNA Sequencing and Digital Gene Expression Core,Kathleen D Hartman,"Snorri S. Thorgeirsson; MD, PhD","Laboratory of Experimental Carcinogenesis, NCI",Steven W Shema|Patricia  Johnson,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68456
805,BC010903-04,"October 01, 2010 -  September 30, 2011",Transgenic Core Facility,Deborah A Swing,Terry Anne Van Dyke,"Mouse Cancer Genetics Program, NCI",Robert H Koogle|Holly Marie Morris,NULL,NULL,NULL,"1. Smith WW, Liu Z, Liang Y, Masuda N, Swing DA, Jenkins NA, Copeland NG, Troncoso JC, Pletnikov M, Dawson TM, Martin LJ, Moran TH, Lee MK, Borchelt DR, Ross CA (2010). Synphilin-1 attenuates neuronal degeneration in the A53T alpha-synuclein transgenic mouse model. Hum Mol Genet  19, 2087-98.   https://doi.org/10.1093/hmg/ddq086",https://intramural.nih.gov/search/searchview.taf?ipid=68573
806,BC010905-04,"October 01, 2010 -  September 30, 2011",Cell Prep Core,John R Wunderlich,"Steven Aaron Rosenberg; MD, PhD","Surgery Branch, NCI",Steven A Feldman|Michelle  Pelletier|Kenichi  Hanada|Azam V Nahvi|Marybeth S Hughes|Linda L Parker|Show all 19,NULL,Seth M Steinberg; PhD (Biostatistics and Data Management Section),Yardena Rachel Samuels; PhD (NHGRI),"1. Dudley ME, Gross CA, Langhan MM, Garcia MR, Sherry RM, Yang JC, Phan GQ, Kammula US, Hughes MS, Citrin DE, Restifo NP, Wunderlich JR, Prieto PA, Hong JJ, Langan RC, Zlott DA, Morton KE, White DE, Laurencot CM, Rosenberg SA (2010). CD8+ enriched ""young"" tumor infiltrating lymphocytes can mediate regression of metastatic melanoma. Clin Cancer Res  16, 6122-31.   https://doi.org/10.1158/1078-0432.CCR-10-1297|2. Goff SL, Smith FO, Klapper JA, Sherry R, Wunderlich JR, Steinberg SM, White D, Rosenberg SA, Dudley ME, Yang JC (2010). Tumor infiltrating lymphocyte therapy for metastatic melanoma: analysis of tumors resected for TIL. J Immunother  33, 840-7.   https://doi.org/10.1097/CJI.0b013e3181f05b91|3. Inozume T, Hanada K, Wang QJ, Ahmadzadeh M, Wunderlich JR, Rosenberg SA, Yang JC (2010). Selection of CD8+PD-1+ lymphocytes in fresh human melanomas enriches for tumor-reactive T cells. J Immunother  33, 956-64.   https://doi.org/10.1097/CJI.0b013e3181fad2b0|4. Prieto PA, Durflinger KH, Wunderlich JR, Rosenberg SA, Dudley ME (2010). Enrichment of CD8+ cells from melanoma tumor-infiltrating lymphocyte cultures reveals tumor reactivity for use in adoptive cell therapy. J Immunother  33, 547-56.   https://doi.org/10.1097/CJI.0b013e3181d367bd",https://intramural.nih.gov/search/searchview.taf?ipid=68600
807,BC010915-04,"October 01, 2010 -  September 30, 2011",EIB Microscopy Core Facility,Michael John Kruhlak; PhD,Alfred  Singer; MD,"Experimental Immunology Branch, NCI",Paul A Roche; PhD|Andre A Nussenzweig; PhD,NULL,"Zhi Ming  Zheng; MD, PhD (HIV and AIDS Malignancy Branch)|James Stephen Shaw; PhD (Human Immunology Section)|David M Segal; PhD (Immune Targeting Section)|Louis  Staudt; MD (Lymphoid Malignancies Branch)|Philip Jeffrey Tofilon (Radiation Oncology Branch)|Thomas Alexander Waldmann; MD, PhD (Lymphoid Malignancies Branch)","Elissa P Lei; BS, PhD (NIDDK) |Richard D Leapman; PhD (NIBIB) |Rafael Cristian Casellas; PhD (NIAMS) |Jeffrey Burnett Kopp; MD (NIDDK)","1. Katragkou A, Kruhlak MJ, Simitsopoulou M, Chatzimoschou A, Taparkou A, Cotten CJ, Paliogianni F, Diza-Mataftsi E, Tsantali C, Walsh TJ, Roilides E (2010). Interactions between human phagocytes and Candida albicans biofilms alone and in combination with antifungal agents. J Infect Dis  201, 1941-9.   https://doi.org/10.1086/652783|2. Langer HF, Chung KJ, Orlova VV, Choi EY, Kaul S, Kruhlak MJ, Alatsatianos M, DeAngelis RA, Roche PA, Magotti P, Li X, Economopoulou M, Rafail S, Lambris JD, Chavakis T (2010). Complement-mediated inhibition of neovascularization reveals a point of convergence between innate immunity and angiogenesis. Blood  116, 4395-403.   https://doi.org/10.1182/blood-2010-01-261503|3. Majerciak V, Kruhlak M, Dagur PK, McCoy JP, Zheng ZM (2010). Caspase-7 cleavage of Kaposi sarcoma-associated herpesvirus ORF57 confers a cellular function against viral lytic gene expression. J Biol Chem  285, 11297-307.   https://doi.org/10.1074/jbc.M109.068221|4. Nakata H, Kruhlak M, Kamata W, Ogata-Aoki H, Li J, Maeda K, Ghosh AK, Mitsuya H (2010). Effects of CC chemokine receptor 5 (CCR5) inhibitors on the dynamics of CCR5 and CC-chemokine-CCR5 interactions. Antivir Ther  15, 321-31.   https://doi.org/10.3851/IMP1529|5. Patino-Lopez G, Aravind L, Dong X, Kruhlak MJ, Ostap EM, Shaw S (2010). Myosin 1G is an abundant class I myosin in lymphocytes whose localization at the plasma membrane depends on its ancient divergent pleckstrin homology (PH) domain (Myo1PH). J Biol Chem  285, 8675-86.   https://doi.org/10.1074/jbc.M109.086959|6. Rui L, Emre NC, Kruhlak MJ, Chung HJ, Steidl C, Slack G, Wright GW, Lenz G, Ngo VN, Shaffer AL, Xu W, Zhao H, Yang Y, Lamy L, Davis RE, Xiao W, Powell J, Maloney D, Thomas CJ, Möller P, Rosenwald A, Ott G, Muller-Hermelink HK, Savage K, Connors JM, et al. [10 more authors] (2010). Cooperative epigenetic modulation by cancer amplicon genes. Cancer Cell  18, 590-605.   https://doi.org/10.1016/j.ccr.2010.11.013",https://intramural.nih.gov/search/searchview.taf?ipid=68625
808,BC010923-04,"October 01, 2010 -  September 30, 2011",Tissue Array Research Program,"Stephen M Hewitt; MD, PhD",John Carl Oberholtzer,"Laboratory of Pathology, NCI","Catherine Margaret Conway; PhD|Haruhisa  Kitano; MD, PhD|Kristofferson R Ylaya|Elaine S Jaffe; MD",NULL,"Philip  Taylor; MD, ScD (Genetic Epidemiology Branch)|Lee Elizabeth Moore; PhD, MD (Occupational and Environmental Epidemiology Branch)|Javed  Khan; MD (Pediatric Oncology Branch)","Yoke Peng  Loh; PhD (NICHD) |Alfredo A Molinolo; MD, PhD (NIDCR)","1. Abedi-Ardekani B, Christian A, Paolo B, Sanford D, Pierre H, Stephen H, Farin K, Raza M, Masoud S, Philip T (2010) Polycyclic aromatic hydrocarbon exposure in oesophageal tissue and risk of oesophageal squamous cell carcinoma in north-eastern Iran. Gut 59:1178-83.|2. Ali-Fehmi R, Chatterjee M, Ionan A, Levin NK, Arabi H, Bandyopadhyay S, Shah JP, Bryant CS, Hewitt SM, O'Rand MG, Alekseev OM, Morris R, Munkarah A, Abrams J, Tainsky MA (2010). Analysis of the expression of human tumor antigens in ovarian cancer tissues. Cancer Biomark  6, 33-48.   https://doi.org/10.3233/CBM-2009-0117|3. Camilli TC, Xu M, O'Connell MP, Chien B, Frank BP, Subaran S, Indig FE, Morin PJ, Hewitt SM, Weeraratna AT (2011). Loss of Klotho during melanoma progression leads to increased filamin cleavage, increased Wnt5A expression, and enhanced melanoma cell motility. Pigment Cell Melanoma Res  24, 175-86.   https://doi.org/10.1111/j.1755-148X.2010.00792.x|4. Chen QR, Song YK, Yu LR, Wei JS, Chung JY, Hewitt SM, Veenstra TD, Khan J (2010). Global genomic and proteomic analysis identifies biological pathways related to high-risk neuroblastoma. J Proteome Res  9, 373-82.   https://doi.org/10.1021/pr900701v|5. Chen QR, Yu LR, Tsang P, Wei JS, Song YK, Cheuk A, Chung JY, Hewitt SM, Veenstra TD, Khan J (2011). Systematic proteome analysis identifies transcription factor YY1 as a direct target of miR-34a. J Proteome Res  10, 479-87.   https://doi.org/10.1021/pr1006697|6. Chung JY, Hewitt SM (2010). An optimized RNA extraction method from archival formalin-fixed paraffin-embedded tissue. Methods Mol Biol  611, 19-27.   https://doi.org/10.1007/978-1-60327-345-9_2|7. Eberle FC, Hanson JC, Killian JK, Wei L, Ylaya K, Hewitt SM, Jaffe ES, Emmert-Buck MR, Rodriguez-Canales J (2010). Immunoguided laser assisted microdissection techniques for DNA methylation analysis of archival tissue specimens. J Mol Diagn  12, 394-401.   https://doi.org/10.2353/jmoldx.2010.090200|8. Mendoza A, Hong SH, Osborne T, Khan MA, Campbell K, Briggs J, Eleswarapu A, Buquo L, Ren L, Hewitt SM, Dakir el H, Dakir el-H, Garfield S, Walker R, Merlino G, Green JE, Hunter KW, Wakefield LM, Khanna C (2010). Modeling metastasis biology and therapy in real time in the mouse lung. J Clin Invest  120, 2979-88.   https://doi.org/10.1172/JCI40252|9. O'Connell MP, Fiori JL, Xu M, Carter AD, Frank BP, Camilli TC, French AD, Dissanayake SK, Indig FE, Bernier M, Taub DD, Hewitt SM, Weeraratna AT (2010). The orphan tyrosine kinase receptor, ROR2, mediates Wnt5A signaling in metastatic melanoma. Oncogene  29, 34-44.   https://doi.org/10.1038/onc.2009.305|10. Shen HC, Ylaya K, Pechhold K, Wilson A, Adem A, Hewitt SM, Libutti SK (2010). Multiple endocrine neoplasia type 1 deletion in pancreatic alpha-cells leads to development of insulinomas in mice. Endocrinology  151, 4024-30.   https://doi.org/10.1210/en.2009-1251|11. Williams R, Chung JY, Ylaya K, Whiteley G, Hewitt SM (2010). Characterizations and validations of novel antibodies toward translational research. Proteomics Clin Appl  4, 618-25.   https://doi.org/10.1002/prca.200900186",https://intramural.nih.gov/search/searchview.taf?ipid=68529
809,BC010930-04,"October 01, 2010 -  September 30, 2011",Molecular Cytogenetics Core,Anna V Roschke,"Paul S Meltzer; MD, PhD","Cancer Genetics Branch, NCI","Peter D Aplan; MD|Kenneth E Nakahara|Walter M Kuehl; MD, PhD|Oleg K Glebov",Geula  Klorin (Rambam: Human Health Care Campus)|Alexei  Protopopov (Dana-Farber Cancer Institute),Ola Anders Landgren (Medical Oncology Branch),NULL,"1. Cheng Y, Zhang Z, Keenan B, Roschke AV, Nakahara K, Aplan PD (2010). Efficient repair of DNA double-strand breaks in malignant cells with structural instability. Mutat Res  683, 115-22.   https://doi.org/10.1016/j.mrfmmm.2009.10.016",https://intramural.nih.gov/search/searchview.taf?ipid=68539
810,BC010934-04,"October 01, 2010 -  September 30, 2011",Immune reconstitution following autologous and allogeneic stem cell transplant,Frances  Hakim; PhD,Ronald E Gress; MD,"Experimental Transplantation and Immunology Branch, NCI","Vicki  Fellowes|Steven  Pavletic; MD, MS|Jeremy J Rose|Claude  Sportes|Michael R Bishop; MD|Xiao Y Yan|Show all 11",NULL,NULL,Austin John Barrett; MD (NHLBI) |Ping  Jin (CC) |David F Stroncek; MD (CC),"1. Hakim F (2010) CGVHD: Inflammation at the Crossroads of Allo and Auto Immunity, in Signatures of Immune Rejection. Springer, in press.|2. Imanguli MM, Atkinson JC, Mitchell SA, Avila DN, Bishop RJ, Cowen EW, Datiles MB, Hakim FT, Kleiner DE, Krumlauf MC, Pavletic SZ (2010). Salivary gland involvement in chronic graft-versus-host disease: prevalence, clinical significance, and recommendations for evaluation. Biol Blood Marrow Transplant  16, 1362-9.   https://doi.org/10.1016/j.bbmt.2010.03.023|3. Lee DK, Hakim FT, Gress RE (2010). The thymus and the immune system: layered levels of control. J Thorac Oncol  5, S273-6.   https://doi.org/10.1097/JTO.0b013e3181f20474|4. Sportès C, Babb RR, Krumlauf MC, Hakim FT, Steinberg SM, Chow CK, Brown MR, Fleisher TA, Noel P, Maric I, Stetler-Stevenson M, Engel J, Buffet R, Morre M, Amato RJ, Pecora A, Mackall CL, Gress RE (2010). Phase I study of recombinant human interleukin-7 administration in subjects with refractory malignancy. Clin Cancer Res  16, 727-35.   https://doi.org/10.1158/1078-0432.CCR-09-1303",https://intramural.nih.gov/search/searchview.taf?ipid=68523
811,BC010936-04,"October 01, 2010 -  September 30, 2011",CCR VB FACS CORE,Katherine M McKinnon,"Jay Arthur Berzofsky; MD, PhD","Vaccine Branch, NCI",Marjorie  Robert-Guroff; PhD|Genoveffa  Franchini; MD|Lois Jean Patterson|Samir N. Khleif; MD|Masaki  Terabe,Cliburn  Chan (Duke University)|Marcin  Moniuszko|Kent  Weinhold (DUMC),"Kevin  Gardner; MD, PhD (Laboratory of Receptor Biology and Gene Expression)|Thomas A Misteli; PhD (Hormone Action and Oncogenesis Section)|Gordon Lee Hager; PhD (Laboratory of Receptor Biology and Gene Expression)|Myong-Hee  Sung (Laboratory of Receptor Biology and Gene Expression)|Lyuba  Varticovski (Laboratory of Human Carcinogenesis)",NULL,"1. Fang DD, Kim YJ, Lee CN, Aggarwal S, McKinnon K, Mesmer D, Norton J, Birse CE, He T, Ruben SM, Moore PA (2010). Expansion of CD133(+) colon cancer cultures retaining stem cell properties to enable cancer stem cell target discovery. Br J Cancer  102, 1265-75.   https://doi.org/10.1038/sj.bjc.6605610|2. Weaver JL, McKinnon K, Germolec DR (2010). Phenotypic analysis using very small volumes of blood. Curr Protoc Cytom  Chapter 6, Unit 6.30.   https://doi.org/10.1002/0471142956.cy0630s54",https://intramural.nih.gov/search/searchview.taf?ipid=68646
812,BC010937-04,"October 01, 2010 -  September 30, 2011",Novel Targets for Vaccine Therapy,Claudia Mercedes Palena,Jeffrey  Schlom; PhD,"Laboratory of Tumor Immunology and Biology, NCI","Marjorie P Duberstein|Duane Howard Hamilton|Kwong Yok Tsang|James L Gulley; MD, PhD|Bruce K Huang","Kenneth  Foon (Nevada Cancer Institute)|Fiorella  Guadagni (Pathology, Regina Elena Cancer Institute)|Andrei  Kozlov (biology, The Biomedical Center/St. Petersburg University)",NULL,NULL,"1. Cereda V, Poole DJ, Palena C, Das S, Bera TK, Remondo C, Gulley JL, Arlen PM, Yokokawa J, Pastan I, Schlom J, Tsang KY (2010). New gene expressed in prostate: a potential target for T cell-mediated prostate cancer immunotherapy. Cancer Immunol Immunother  59, 63-71.   https://doi.org/10.1007/s00262-009-0723-6|2. Fernando RI, Litzinger M, Trono P, Hamilton DH, Schlom J, Palena C (2010). The T-box transcription factor Brachyury promotes epithelial-mesenchymal transition in human tumor cells. J Clin Invest  120, 533-44.   https://doi.org/10.1172/JCI38379|3. Litzinger MT, Foon KA, Tsang KY, Schlom J, Palena C (2010). Comparative analysis of MVA-CD40L and MVA-TRICOM vectors for enhancing the immunogenicity of chronic lymphocytic leukemia (CLL) cells. Leuk Res  34, 1351-7.   https://doi.org/10.1016/j.leukres.2009.12.013|4. Palena C, Schlom J (2010). Vaccines against human carcinomas: strategies to improve antitumor immune responses. J Biomed Biotechnol  2010, 380697.   https://doi.org/10.1155/2010/380697",https://intramural.nih.gov/search/searchview.taf?ipid=68659
813,BC010941-04,"October 01, 2010 -  September 30, 2011",CCR FACS Core Laboratory,Barbara J Taylor,Stuart H Yuspa; MD,"Laboratory of Cancer Biology and Genetics, NCI",Subhadra  Banerjee,NULL,NULL,NULL,"1. Landry JW, Banerjee S, Taylor B, Aplan PD, Singer A, Wu C (2011). Chromatin remodeling complex NURF regulates thymocyte maturation. Genes Dev  25, 275-86.   https://doi.org/10.1101/gad.2007311|2. Salcido CD, Larochelle A, Taylor BJ, Dunbar CE, Varticovski L (2010). Molecular characterisation of side population cells with cancer stem cell-like characteristics in small-cell lung cancer. Br J Cancer  102, 1636-44.   https://doi.org/10.1038/sj.bjc.6605668",https://intramural.nih.gov/search/searchview.taf?ipid=68575
814,BC010947-04,"October 01, 2010 -  September 30, 2011",Cell and Cancer Biology Branch Confocal Microscopy Core,Yvona  Ward; PhD,Kathleen  Kelly; PhD,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Ross G Lake|Zhenggang  Liu; PhD|John Edward Niederhuber|Juanjuan  Yin|Orla Majella Casey|Olga  Aprelikova; PhD|Show all 7,Ginesa  Garcia-Rostan (University of Valladolid)|Massimo  Santoro,"Susan  Bates; MD (Medical Oncology Branch)|Antonio  Fojo; MD, PhD (Medical Oncology Branch)|Marianne  Poruchynsky (Medical Oncology Branch)|Miriam Christine Poirier; PhD (Laboratory of Cancer Biology and Genetics)|Paul A Randazzo; MD, PhD (Laboratory of Cellular and Molecular Biology)|Philip L Martin (Office of the Director)",NULL,"1. Meany HJ, Sackett DL, Maris JM, Ward Y, Krivoshik A, Cohn SL, Steinberg SM, Balis FM, Fox E (2010). Clinical outcome in children with recurrent neuroblastoma treated with ABT-751 and effect of ABT-751 on proliferation of neuroblastoma cell lines and on tubulin polymerization in vitro. Pediatr Blood Cancer  54, 47-54.   https://doi.org/10.1002/pbc.22267|2. Polgar O, Ierano C, Tamaki A, Stanley B, Ward Y, Xia D, Tarasova N, Robey RW, Bates SE (2010). Mutational analysis of threonine 402 adjacent to the GXXXG dimerization motif in transmembrane segment 1 of ABCG2. Biochemistry  49, 2235-45.   https://doi.org/10.1021/bi902085q|3. Romanova LY, Holmes G, Bahte SK, Kovalchuk AL, Nelson PJ, Ward Y, Gueler F, Mushinski JF (2010). Phosphorylation of paxillin at threonine 538 by PKCdelta regulates LFA1-mediated adhesion of lymphoid cells. J Cell Sci  123, 1567-77.   https://doi.org/10.1242/jcs.060996",https://intramural.nih.gov/search/searchview.taf?ipid=68589
815,BC010948-04,"October 01, 2010 -  September 30, 2011",DNA Sequencing and FACS Core Facilities,Paul  Robbins,"Steven Aaron Rosenberg; MD, PhD","Surgery Branch, NCI",Mona E El gamil|Shahram S Farid|Yili  Li|Yong-Chen  Lu; PhD|Arnold L Mixon|Xin  Yao,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68533
816,BC010953-04,"October 01, 2010 -  September 30, 2011",Molecular Pathology Research for Cancer Diagnostics and Biomarkers,"Robert Mark Simpson; DVM, PhD|IRP Faculty Profile",NULL,"Laboratory of Cancer Biology and Genetics, NCI","Jennifer B Dwyer|John  Hickerson|Lalage  Wakefield; PhD|Shelley B Hoover|Kent W Hunter; PhD|Joshua David Webster; DVM, PhD|Show all 7",NULL,Beverly  Mock; PhD (Office of the Director)|Timothy D Veenstra (Office Of The Director),"Stephen I Katz; PhD, MD (NIAMS)","1. Aprelikova O, Yu X, Palla J, Wei BR, John S, Yi M, Stephens R, Simpson RM, Risinger JI, Jazaeri A, Niederhuber J (2010). The role of miR-31 and its target gene SATB2 in cancer-associated fibroblasts. Cell Cycle  9, 4387-98.   https://doi.org/10.4161/cc.9.21.13674|2. Barkan D, El Touny LH, Michalowski AM, Smith JA, Chu I, Davis AS, Webster JD, Hoover S, Simpson RM, Gauldie J, Green JE (2010). Metastatic growth from dormant cells induced by a col-I-enriched fibrotic environment. Cancer Res  70, 5706-16.   https://doi.org/10.1158/0008-5472.CAN-09-2356|3. Johann DJ, Wei BR, Prieto DA, Chan KC, Ye X, Valera VA, Simpson RM, Rudnick PA, Xiao Z, Issaq HJ, Linehan WM, Stein SE, Veenstra TD, Blonder J (2010). Combined blood/tissue analysis for cancer biomarker discovery: application to renal cell carcinoma. Anal Chem  82, 1584-8.   https://doi.org/10.1021/ac902204k|4. Martin P, Liu YN, Pierce R, Abou-Kheir W, Casey O, Seng V, Camacho D, Simpson RM, Kelly K (2011). Prostate epithelial Pten/TP53 loss leads to transformation of multipotential progenitors and epithelial to mesenchymal transition. Am J Pathol  179, 422-35.   https://doi.org/10.1016/j.ajpath.2011.03.035|5. Song H, Mak KK, Topol L, Yun K, Hu J, Garrett L, Chen Y, Park O, Chang J, Simpson RM, Wang CY, Gao B, Jiang J, Yang Y (2010). Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression. Proc Natl Acad Sci U S A  107, 1431-6.   https://doi.org/10.1073/pnas.0911409107",https://intramural.nih.gov/search/searchview.taf?ipid=68554
817,BC010965-04,"October 01, 2010 -  September 30, 2011",CCR Biophysics Resource Core,Sergey G Tarasov,Robert Andrew Byrd,"Structural Biophysics Laboratory, NCI",Marzeena  Dyba|Yun Xing M Wang,Jose  Casas-Finet|Vadim  Gaponenko|Marzena E Pazgier,Dimiter Stanchev Dimitrov; PhD (Membrane Structure and Function Section)|Alan  Rein; PhD (Retroviral Replication Laboratory)|Stuart F J Le Grice; PhD (Retroviral Replication Laboratory)|Anil K Patri (Office Cancer Nanotechnology Research)|Anu  Puri; PhD (Membrane Structure and Function Section)|Nadya I Tarasova; PhD (Cancer Inflammation Program),NULL,"1. Li C, Pazgier M, Li J, Li C, Liu M, Zou G, Li Z, Chen J, Tarasov SG, Lu WY, Lu W (2010). Limitations of peptide retro-inverso isomerization in molecular mimicry. J Biol Chem  285, 19572-81.   https://doi.org/10.1074/jbc.M110.116814",https://intramural.nih.gov/search/searchview.taf?ipid=68574
818,BC010978-04,"October 01, 2010 -  September 30, 2011",Confocal Core for the Laboratory of Cellular and Molecular Biology,Valarie  Barr; PhD,Lawrence Elliot Samelson; MD,"Laboratory of Cellular and Molecular Biology, NCI","Itoro O Akpan|Paul A Randazzo; MD, PhD|Carole A Parent; PhD|Stanley  Lipkowitz; MD, PhD|Ying  Zhang|Carol  Clayberger",Stephen  Bunnell (Tufts University School of Medicine)|Wolfgang  Losert (University of Maryland)|Arpita  Upadhyaya (University of Maryland/Maryland Nanocenter),NULL,"Paul E Love; MD, PhD (NICHD)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68476
819,BC010981-04,"October 01, 2010 -  September 30, 2011","Design, Develop, Validate, and Implement Biomarkers for Clinical Investigations",Liang  Cao,"Paul S Meltzer; MD, PhD","Cancer Genetics Branch, NCI",Zhigang  Kang|Yunkai  Yu,NULL,Lee Jay Helman; MD (Pediatric Oncology Branch)|William Laurence Dahut; MD (Medical Oncology Branch)|William D Figg; PharmD (Medical Oncology Branch)|Chand  Khanna; MD (Pediatric Oncology Branch)|Giovanni  Melillo (Screening Technologies Branch)|Giuseppe  Giaccone; MD (Medical Oncology Branch),NULL,"1. Kang Z, Chen JJ, Yu Y, Li B, Sun SY, Zhang B, Cao L (2011). Drozitumab, a human antibody to death receptor 5, has potent antitumor activity against rhabdomyosarcoma with the expression of caspase-8 predictive of response. Clin Cancer Res  17, 3181-92.   https://doi.org/10.1158/1078-0432.CCR-10-2874|2. Paoloni MC, Mazcko C, Fox E, Fan T, Lana S, Kisseberth W, Vail DM, Nuckolls K, Osborne T, Yalkowsy S, Gustafson D, Yu Y, Cao L, Khanna C (2010). Rapamycin pharmacokinetic and pharmacodynamic relationships in osteosarcoma: a comparative oncology study in dogs. PLoS One  5, e11013.   https://doi.org/10.1371/journal.pone.0011013|3. Terzuoli E, Puppo M, Rapisarda A, Uranchimeg B, Cao L, Burger AM, Ziche M, Melillo G (2010). Aminoflavone, a ligand of the aryl hydrocarbon receptor, inhibits HIF-1alpha expression in an AhR-independent fashion. Cancer Res  70, 6837-48.   https://doi.org/10.1158/0008-5472.CAN-10-1075|4. Zucali PA, Petrini I, Lorenzi E, Merino M, Cao L, Di Tommaso L, Lee HS, Incarbone M, Walter BA, Simonelli M, Roncalli M, Santoro A, Giaccone G (2010). Insulin-like growth factor-1 receptor and phosphorylated AKT-serine 473 expression in 132 resected thymomas and thymic carcinomas. Cancer  116, 4686-95.   https://doi.org/10.1002/cncr.25367",https://intramural.nih.gov/search/searchview.taf?ipid=68490
820,BC010989-04,"October 01, 2010 -  September 30, 2011",Clinical production of viral vectors for cancer gene therapy,Steven A Feldman,"Steven Aaron Rosenberg; MD, PhD","Surgery Branch, NCI","Mary Alexandra Black|Richard A Morgan; PhD|Hui  Xu|James Chung-Yin Yang; MD, PhD|Maria  Parkhurst|Paul  Robbins|Show all 11",NULL,James N Kochenderfer (Experimental Transplantation and Immunology Branch)|Ira H Pastan; MD (Molecular Biology Section),NULL,"1. Burns WR, Zhao Y, Frankel TL, Hinrichs CS, Zheng Z, Xu H, Feldman SA, Ferrone S, Rosenberg SA, Morgan RA (2010). A high molecular weight melanoma-associated antigen-specific chimeric antigen receptor redirects lymphocytes to target human melanomas. Cancer Res  70, 3027-33.   https://doi.org/10.1158/0008-5472.CAN-09-2824|2. Chinnasamy D, Yu Z, Theoret MR, Zhao Y, Shrimali RK, Morgan RA, Feldman SA, Restifo NP, Rosenberg SA (2010). Gene therapy using genetically modified lymphocytes targeting VEGFR-2 inhibits the growth of vascularized syngenic tumors in mice. J Clin Invest  120, 3953-68.   https://doi.org/10.1172/JCI43490|3. Chinnasamy N, Wargo JA, Yu Z, Rao M, Frankel TL, Riley JP, Hong JJ, Parkhurst MR, Feldman SA, Schrump DS, Restifo NP, Robbins PF, Rosenberg SA, Morgan RA (2011). A TCR targeting the HLA-A*0201-restricted epitope of MAGE-A3 recognizes multiple epitopes of the MAGE-A antigen superfamily in several types of cancer. J Immunol  186, 685-96.   https://doi.org/10.4049/jimmunol.1001775|4. Feldman SA, Goff SL, Xu H, Black MA, Kochenderfer JN, Johnson LA, Yang JC, Wang Q, Parkhurst MR, Cross S, Morgan RA, Cornetta K, Rosenberg SA (2011). Rapid production of clinical-grade gammaretroviral vectors in expanded surface roller bottles using a ""modified"" step-filtration process for clearance of packaging cells. Hum Gene Ther  22, 107-15.   https://doi.org/10.1089/hum.2010.064|5. Goff SL, Johnson LA, Black MA, Xu H, Zheng Z, Cohen CJ, Morgan RA, Rosenberg SA, Feldman SA (2010). Enhanced receptor expression and in vitro effector function of a murine-human hybrid MART-1-reactive T cell receptor following a rapid expansion. Cancer Immunol Immunother  59, 1551-60.   https://doi.org/10.1007/s00262-010-0882-5|6. Kochenderfer JN, Wilson WH, Janik JE, Dudley ME, Stetler-Stevenson M, Feldman SA, Maric I, Raffeld M, Nathan DA, Lanier BJ, Morgan RA, Rosenberg SA (2010). Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19. Blood  116, 4099-102.   https://doi.org/10.1182/blood-2010-04-281931|7. Parkhurst MR, Yang JC, Langan RC, Dudley ME, Nathan DA, Feldman SA, Davis JL, Morgan RA, Merino MJ, Sherry RM, Hughes MS, Kammula US, Phan GQ, Lim RM, Wank SA, Restifo NP, Robbins PF, Laurencot CM, Rosenberg SA (2011). T cells targeting carcinoembryonic antigen can mediate regression of metastatic colorectal cancer but induce severe transient colitis. Mol Ther  19, 620-6.   https://doi.org/10.1038/mt.2010.272",https://intramural.nih.gov/search/searchview.taf?ipid=68505
821,BC010991-04,"October 01, 2010 -  September 30, 2011",Radiation Oncology Branch - Microarray Facility,Kevin A Camphausen; MD|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Seth  Johnson|Uma  Shankavaram; PhD|Shuping  Zhao,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68488
822,BC011016-04,"October 01, 2010 -  September 30, 2011",Protein Production,Joseph Edward Tropea,Alexander  Wlodawer; PhD,"Macromolecular Crystallography Laboratory, NCI",Scott R Cherry; BS|Janet R Fields|Jacek Tadeusz Lubkowski,"TOZSER  JOZSEF (University of Debrecen)|Robert  Ulrich (Molecular Immunology, USAMRIID)",Xinhua  Ji; PhD (Biomolecular Structure Section)|David S Waugh; PhD (Protein Engineering Section)|Donald L Court; PhD (Molecular Control and Genetics Section)|Terrence R Burke; PhD (Chemical Biology Laboratory)|Robert  Shoemaker (Screening Technologies Branch)|Yves  Pommier; PhD (Developmental Therapeutics Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68577
823,BC011020-04,"October 01, 2010 -  September 30, 2011",Cell Production Facility Core,Mark E Dudley,"Steven Aaron Rosenberg; MD, PhD","Surgery Branch, NCI",Laura  Devillier|Katherine  Hogan|Kevin  Friedman|Mary B Ganges|Marcos  Garcia|Colin  Gross|Show all 11,NULL,NULL,David F Stroncek; MD (CC),"1. Dudley ME, Gross CA, Langhan MM, Garcia MR, Sherry RM, Yang JC, Phan GQ, Kammula US, Hughes MS, Citrin DE, Restifo NP, Wunderlich JR, Prieto PA, Hong JJ, Langan RC, Zlott DA, Morton KE, White DE, Laurencot CM, Rosenberg SA (2010). CD8+ enriched ""young"" tumor infiltrating lymphocytes can mediate regression of metastatic melanoma. Clin Cancer Res  16, 6122-31.   https://doi.org/10.1158/1078-0432.CCR-10-1297|2. Goff SL, Smith FO, Klapper JA, Sherry R, Wunderlich JR, Steinberg SM, White D, Rosenberg SA, Dudley ME, Yang JC (2010). Tumor infiltrating lymphocyte therapy for metastatic melanoma: analysis of tumors resected for TIL. J Immunother  33, 840-7.   https://doi.org/10.1097/CJI.0b013e3181f05b91|3. Hong JJ, Rosenberg SA, Dudley ME, Yang JC, White DE, Butman JA, Sherry RM (2010). Successful treatment of melanoma brain metastases with adoptive cell therapy. Clin Cancer Res  16, 4892-8.   https://doi.org/10.1158/1078-0432.CCR-10-1507|4. Kochenderfer JN, Wilson WH, Janik JE, Dudley ME, Stetler-Stevenson M, Feldman SA, Maric I, Raffeld M, Nathan DA, Lanier BJ, Morgan RA, Rosenberg SA (2010). Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19. Blood  116, 4099-102.   https://doi.org/10.1182/blood-2010-04-281931|5. Morgan RA, Dudley ME, Rosenberg SA (2010). Adoptive cell therapy: genetic modification to redirect effector cell specificity. Cancer J  16, 336-41.   https://doi.org/10.1097/PPO.0b013e3181eb3879|6. Morgan RA, Yang JC, Kitano M, Dudley ME, Laurencot CM, Rosenberg SA (2010). Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2. Mol Ther  18, 843-51.   https://doi.org/10.1038/mt.2010.24|7. Prieto PA, Durflinger KH, Wunderlich JR, Rosenberg SA, Dudley ME (2010). Enrichment of CD8+ cells from melanoma tumor-infiltrating lymphocyte cultures reveals tumor reactivity for use in adoptive cell therapy. J Immunother  33, 547-56.   https://doi.org/10.1097/CJI.0b013e3181d367bd|8. Ripley RT, Davis JL, Klapper JA, Mathur A, Kammula U, Royal RE, Yang JC, Sherry RM, Hughes MS, Libutti SK, White DE, Steinberg SM, Dudley ME, Rosenberg SA, Avital I (2010). Liver resection for metastatic melanoma with postoperative tumor-infiltrating lymphocyte therapy. Ann Surg Oncol  17, 163-70.   https://doi.org/10.1245/s10434-009-0677-0",https://intramural.nih.gov/search/searchview.taf?ipid=68498
824,BC011021-03,"October 01, 2010 -  September 30, 2011",Basic Research Support for the CCR,Robert  Wiltrout; PhD,NULL,"Laboratory of Experimental Immunology, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68076
825,BC011029-04,"October 01, 2010 -  September 30, 2011",Tumor-Infiltrating Donor Derived Lymphocyte Therapy After Allogeneic Transplant,Frances  Hakim; PhD,Ronald E Gress; MD,"Experimental Transplantation and Immunology Branch, NCI",Michael R Bishop; MD|Vicki  Fellowes|Daniel H Fowler|Jeremy J Rose|Nancy M Hardy|Claude  Sportes,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68524
826,BC011030-04,"October 01, 2010 -  September 30, 2011",Peptide Synthesis Core Faciity and Peptide Epitope Identification,Maria  Parkhurst,"Steven Aaron Rosenberg; MD, PhD","Surgery Branch, NCI",Nicholas Phillip Restifo; MD|Steven A Feldman|Richard A Morgan; PhD|Paul  Robbins,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68660
827,BC011040-04,"October 01, 2010 -  September 30, 2011",Molecular Profiling of Clinical Specimens,Daniel C Edelman,"Paul S Meltzer; MD, PhD","Cancer Genetics Branch, NCI",Lisa  Adams; MSc|Sven  Bilke|Jonathan Keith Killian|David  Petersen|Marbin A Pineda|Holly S Stevenson|Show all 9,NULL,"William Marston Linehan; MD (Urologic Oncology Branch)|Patricia  Steeg; PhD (Developmental Therapeutics Branch)|Mark E Sherman; MD (Hormonal and Reproductive Epidemiology Branch)|Javed  Khan; MD (Pediatric Oncology Branch)|Su-Young  Kim (Pediatric Oncology Branch)|Michael R Emmert-Buck; MD, PhD (Laboratory of Pathology)",NULL,"1. Qian Y, Hua E, Bisht K, Woditschka S, Skordos K, Liewehr D, Steinberg S, Brogi E, Akram M, Killian J, Edelman D, Pineda M, Scurci S, Degenhardt Y, Laquerre S, Lampkin T, Meltzer P, Camphausen K, Steeg P, Palmieri D (2011) Inhibition of Polo-like kinase-1 prevents the growth of metastatic breast cancer cells in the brain. Clin Exp Metastasis, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=68502
828,BC011041-04,"October 01, 2010 -  September 30, 2011",Technical Development of Molecular Profiling Technologies,Daniel C Edelman,"Paul S Meltzer; MD, PhD","Cancer Genetics Branch, NCI",Lisa  Adams; MSc|Sven  Bilke|Jonathan Keith Killian|David  Petersen|Marbin A Pineda|Holly S Stevenson|Show all 8,Immaculatta  DeVivo (Harvard University)|Laurie  Locascio; PhD (National Institute of Standards and Technology),"Su-Young  Kim (Pediatric Oncology Branch)|Frank  Cuttitta; PhD (Radiation Oncology Branch)|Stephen M Hewitt; MD, PhD (Laboratory of Pathology)|Michael R Emmert-Buck; MD, PhD (Laboratory of Pathology)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68503
829,BC011042-04,"October 01, 2010 -  September 30, 2011",Global changes in specific histone modifications in cancer,David  Levens; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Russell William Bandle|Hye-Jung  Chung|Elaine S Jaffe; MD,NULL,Gordon Lee Hager; PhD (Laboratory of Receptor Biology and Gene Expression)|Louis  Staudt; MD (Lymphoid Malignancies Branch),Keji  Zhao; PhD (NHLBI) |Katherine Rainsford Calvo (CC),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68630
830,BC011044-04,"October 01, 2010 -  September 30, 2011",Tissue ProcessingSequencing Core,Cathy  Vocke; PhD,William Marston Linehan; MD,"Urologic Oncology Branch, NCI",Robert A Worrell,William  Kaelin (Dana-Farber Cancer Institute)|Catherine  Stolle (Childrenâ€™s Hospital of Philadelphia),"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|James Chung-Yin Yang; MD, PhD (Surgery Branch)|Maria  Merino; PhD (Laboratory of Pathology)|Stefan  Ambs (Laboratory of Human Carcinogenesis)|Robert  Wiltrout; PhD (Laboratory of Experimental Immunology)|Karl Thomas Ried; MD (Cancer Genetics Branch)","Karel  Pacak; MD, PhD (NICHD) |Richard  Childs; MD (NHLBI)","1. Kearney M, Lee K, Bagni R, Wiegand A, Spindler J, Maldarelli F, Pinto P, Linehan W, Vocke C, Delvis-Frankenberry K, White R, Del Prete G, Mellors J, Lifson J, KewalRamani V, Pathak V, Coffin J, Le S (2011) Nucleic Acid, Antibody, and Virus Culture Methods to Detect Xenotropic MLV-Related Virus (XMRV) in Macaque and Human Blood Samples. Advances in Virology, in press.|2. Yang Y, Valera VA, Padilla-Nash HM, Sourbier C, Vocke CD, Vira MA, Abu-Asab MS, Bratslavsky G, Tsokos M, Merino MJ, Pinto PA, Srinivasan R, Ried T, Neckers L, Linehan WM (2010). UOK 262 cell line, fumarate hydratase deficient (FH-/FH-) hereditary leiomyomatosis renal cell carcinoma: in vitro and in vivo model of an aberrant energy metabolic pathway in human cancer. Cancer Genet Cytogenet  196, 45-55.   https://doi.org/10.1016/j.cancergencyto.2009.08.018",https://intramural.nih.gov/search/searchview.taf?ipid=68584
831,BC011047-04,"October 01, 2010 -  September 30, 2011",Animal Model and Genotyping Core Support Facility,Wendy Dianne Du Bois De Vroylande,Glenn  Merlino; PhD,"Laboratory of Cancer Biology and Genetics, NCI",Mario A Anzano|Valery  Bliskovsky; PhD|Michael  Potter; MD|Marta  Custer|J. Frederic Mushinski; MD|Maudeline  Etienne|Show all 16,NULL,"Beverly  Mock; PhD (Office of the Director)|James B Mitchell; PhD (Radiation Biology Branch)|Konrad  Huppi; MD, PhD (Cancer Genetics Branch)|David  Levens; PhD (Laboratory of Pathology)","Pamela Lee Schwartzberg; MD, PhD (NHGRI) |Alasdair M Gilfillan; PhD (NIAID) |Rafael Cristian Casellas; PhD (NIAMS) |Herbert Carpenter Morse; MD (NIAID)","1. Kuchen S, Resch W, Yamane A, Kuo N, Li Z, Chakraborty T, Wei L, Laurence A, Yasuda T, Peng S, Hu-Li J, Lu K, Dubois W, Kitamura Y, Charles N, Sun HW, Muljo S, Schwartzberg PL, Paul WE, O'Shea J, Rajewsky K, Casellas R (2010). Regulation of microRNA expression and abundance during lymphopoiesis. Immunity  32, 828-39.   https://doi.org/10.1016/j.immuni.2010.05.009|2. Rutsch S, Neppalli VT, Shin DM, DuBois W, Morse HC, Goldschmidt H, Janz S (2010). IL-6 and MYC collaborate in plasma cell tumor formation in mice. Blood  115, 1746-54.   https://doi.org/10.1182/blood-2009-08-237941",https://intramural.nih.gov/search/searchview.taf?ipid=68497
832,BC011048-04,"October 01, 2010 -  September 30, 2011",Preclinical Development of Novel Targeted Therapeutics Against Pediatric Sarcoma,Liang  Cao,"Paul S Meltzer; MD, PhD","Cancer Genetics Branch, NCI",Zhigang  Kang|Yunkai  Yu,NULL,Lee Jay Helman; MD (Pediatric Oncology Branch)|Raffit  Hassan (Laboratory of Molecular Biology)|Chand  Khanna; MD (Pediatric Oncology Branch)|Giovanni  Melillo (Screening Technologies Branch),NULL,"1. Mayeenuddin LH, Yu Y, Kang Z, Helman LJ, Cao L (2010). Insulin-like growth factor 1 receptor antibody induces rhabdomyosarcoma cell death via a process involving AKT and Bcl-x(L). Oncogene  29, 6367-77.   https://doi.org/10.1038/onc.2010.364|2. Zucali PA, Petrini I, Lorenzi E, Merino M, Cao L, Di Tommaso L, Lee HS, Incarbone M, Walter BA, Simonelli M, Roncalli M, Santoro A, Giaccone G (2010). Insulin-like growth factor-1 receptor and phosphorylated AKT-serine 473 expression in 132 resected thymomas and thymic carcinomas. Cancer  116, 4686-95.   https://doi.org/10.1002/cncr.25367",https://intramural.nih.gov/search/searchview.taf?ipid=68491
833,BC011052-04,"October 01, 2010 -  September 30, 2011",Cytopathology Core,Armando  Filie,John Carl Oberholtzer,"Laboratory of Pathology, NCI",Keith R Brosky|Tangi Y Howard|Dana K Erickson|Patricia A Fetsch|May Ester Owens|Mark J Roth,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68506
834,BC011068-04,"October 01, 2010 -  September 30, 2011",Laser Capture Microdissection Core Laboratory,"Michael R Emmert-Buck; MD, PhD",NULL,"Laboratory of Pathology, NCI",Jeffrey C Hanson|Jaime Andres Rodriguez Canales,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68504
835,BC011075-04,"October 01, 2010 -  September 30, 2011",Molecular Modeling of the Human P-glycoprotein Transporter Protein,Stewart  Durell,Michael Marc Gottesman; MD,"Laboratory of Cell Biology, NCI",Yinon  Shafrir,NULL,Suresh V Ambudkar; PhD (Transport Biochemistry Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68500
836,BC011077-04,"October 01, 2010 -  September 30, 2011",Molecular Modeling of Interactions Regulating the Activity of the p53 Protein,Stewart  Durell,Michael Marc Gottesman; MD,"Laboratory of Cell Biology, NCI",NULL,NULL,Ettore  Appella; MD (Chemical Immunology Section)|Yawen  Bai; PhD (Laboratory Of Biochemistry & Molecular Biology)|Hanqiao  Feng (Laboratory Of Biochemistry & Molecular Biology),Daniel  Appella; PhD (NIDDK),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68501
837,BC011079-04,"October 01, 2010 -  September 30, 2011",Molecular Diagnostics Core Laboratory,Mark  Raffeld; MD,John Carl Oberholtzer,"Laboratory of Pathology, NCI","Elaine S Jaffe; MD|Winnifred Theresa Navarro|Thu A Pham|Trinh  Pham|Liqiang  Xi; MD|Michael R Emmert-Buck; MD, PhD|Show all 8","Leticia  Quintanilla-Martinez (Pathology, Technical University of Munich)|Yoko  Tabe","Robert J Kreitman; MD, PhD (Clinical Immunotherapy Section)|Giuseppe  Giaccone; MD (Medical Oncology Branch)|Steven Aaron Rosenberg; MD, PhD (Surgery Branch)|Samuel A Wells (Medical Oncology Branch)|Raffit  Hassan (Laboratory of Molecular Biology)",Steven M Holland; MD (NIAID) |Amy D Klion; MD (NIAID) |Joao Bosco Oliveira (CC),"1. Dojcinov SD, Venkataraman G, Raffeld M, Pittaluga S, Jaffe ES (2010). EBV positive mucocutaneous ulcer--a study of 26 cases associated with various sources of immunosuppression. Am J Surg Pathol  34, 405-17.   https://doi.org/10.1097/PAS.0b013e3181cf8622|2. Jegalian AG, Buxbaum NP, Facchetti F, Raffeld M, Pittaluga S, Wayne AS, Jaffe ES (2010). Blastic plasmacytoid dendritic cell neoplasm in children: diagnostic features and clinical implications. Haematologica  95, 1873-9.   https://doi.org/10.3324/haematol.2010.026179|3. Jegalian AG, Eberle FC, Pack SD, Mirvis M, Raffeld M, Pittaluga S, Jaffe ES (2011). Follicular lymphoma in situ: clinical implications and comparisons with partial involvement by follicular lymphoma. Blood  118, 2976-84.   https://doi.org/10.1182/blood-2011-05-355255|4. Rizzo KA, Streubel B, Pittaluga S, Chott A, Xi L, Raffeld M, Jaffe ES (2010). Marginal zone lymphomas in children and the young adult population; characterization of genetic aberrations by FISH and RT-PCR. Mod Pathol  23, 866-73.   https://doi.org/10.1038/modpathol.2010.63|5. Roufosse F, de Lavareille A, Schandené L, Cogan E, Georgelas A, Wagner L, Xi L, Raffeld M, Goldman M, Gleich GJ, Klion A (2010). Mepolizumab as a corticosteroid-sparing agent in lymphocytic variant hypereosinophilic syndrome. J Allergy Clin Immunol  126, 828-835.e3.   https://doi.org/10.1016/j.jaci.2010.06.049|6. Shao H, Xi L, Raffeld M, Pittaluga S, Dunleavy K, Wilson WH, Spector N, Milito C, Morais JC, Jaffe ES (2010). Nodal and extranodal plasmacytomas expressing immunoglobulin a: an indolent lymphoproliferative disorder with a low risk of clinical progression. Am J Surg Pathol  34, 1425-35.   https://doi.org/10.1097/PAS.0b013e3181f17d0d|7. Venkataraman G, Raffeld M, Pittaluga S, Jaffe ES (2011). CD15-expressing nodular lymphocyte-predominant Hodgkin lymphoma. Histopathology  58, 803-5.   https://doi.org/10.1111/j.1365-2559.2011.03829.x|8. Vinh DC, Patel SY, Uzel G, Anderson VL, Freeman AF, Olivier KN, Spalding C, Hughes S, Pittaluga S, Raffeld M, Sorbara LR, Elloumi HZ, Kuhns DB, Turner ML, Cowen EW, Fink D, Long-Priel D, Hsu AP, Ding L, Paulson ML, Whitney AR, Sampaio EP, Frucht DM, DeLeo FR, Holland SM (2010). Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasia. Blood  115, 1519-29.   https://doi.org/10.1182/blood-2009-03-208629",https://intramural.nih.gov/search/searchview.taf?ipid=68667
838,BC011083-03,"October 01, 2010 -  September 30, 2011",Protein Chemistry Core,Deborah K Morrison|IRP Faculty Profile,NULL,"Laboratory of Cell and Developmental Signaling, NCI",Suzanne I Specht,David  Allis (The Rockefeller University)|Michael  Cole; MD|Rueben  Shaw (Salk Institute),NULL,NULL,"1. Ritt DA, Monson DM, Specht SI, Morrison DK (2010). Impact of feedback phosphorylation and Raf heterodimerization on normal and mutant B-Raf signaling. Mol Cell Biol  30, 806-19.   https://doi.org/10.1128/MCB.00569-09",https://intramural.nih.gov/search/searchview.taf?ipid=68078
839,BC011086-04,"October 01, 2010 -  September 30, 2011",Brain Tumor Animal Therapeutics Core,"Howard A Fine; MD, PhD",NULL,"Neuro-Oncology Branch, NCI",Rolanda  Bailey|Dionne  Davis|Lincoln A Edwards|Hua  Song|Lin  Tang,NULL,"Steven Aaron Rosenberg; MD, PhD (Surgery Branch)","John Keenam Park (NINDS) |Joseph A Frank; MD, MS (CC) |Robert  Innis; MD (NIMH)","1. Bozdag S, Li A, Wuchty S, Fine HA (2010). FastMEDUSA: a parallelized tool to infer gene regulatory networks. Bioinformatics  26, 1792-3.   https://doi.org/10.1093/bioinformatics/btq275|2. Edwards LA, Woolard K, Son MJ, Li A, Lee J, Ene C, Mantey SA, Maric D, Song H, Belova G, Jensen RT, Zhang W, Fine HA (2011). Effect of brain- and tumor-derived connective tissue growth factor on glioma invasion. J Natl Cancer Inst  103, 1162-78.   https://doi.org/10.1093/jnci/djr224|3. Kotliarov Y, Bozdag S, Cheng H, Wuchty S, Zenklusen JC, Fine HA (2010). CNAReporter: a GenePattern pipeline for the generation of clinical reports of genomic alterations. BMC Med Genomics  3, 11.   https://doi.org/10.1186/1755-8794-3-11|4. Li A, Bozdag S, Kotliarov Y, Fine HA (2010). GliomaPredict: a clinically useful tool for assigning glioma patients to specific molecular subtypes. BMC Med Inform Decis Mak  10, 38.   https://doi.org/10.1186/1472-6947-10-38|5. Riddick G, Song H, Ahn S, Walling J, Borges-Rivera D, Zhang W, Fine HA (2011). Predicting in vitro drug sensitivity using Random Forests. Bioinformatics  27, 220-4.   https://doi.org/10.1093/bioinformatics/btq628|6. Wuchty S, Arjona D, Li A, Kotliarov Y, Walling J, Ahn S, Zhang A, Maric D, Anolik R, Zenklusen JC, Fine HA (2011). Prediction of Associations between microRNAs and Gene Expression in Glioma Biology. PLoS One  6, e14681.   https://doi.org/10.1371/journal.pone.0014681",https://intramural.nih.gov/search/searchview.taf?ipid=68510
840,BC011087-04,"October 01, 2010 -  September 30, 2011",Immunohistochemistry Core Laboratory,Mark  Raffeld; MD,John Carl Oberholtzer,"Laboratory of Pathology, NCI",Cynthia A Harris|Elaine S Jaffe; MD|Hong  Jin|Stefania  Pittaluga|Charisma D Roque,NULL,"Giovanni  Melillo (Screening Technologies Branch)|James N Kochenderfer (Experimental Transplantation and Immunology Branch)|Steven Aaron Rosenberg; MD, PhD (Surgery Branch)",NULL,"1. Dojcinov SD, Venkataraman G, Raffeld M, Pittaluga S, Jaffe ES (2010). EBV positive mucocutaneous ulcer--a study of 26 cases associated with various sources of immunosuppression. Am J Surg Pathol  34, 405-17.   https://doi.org/10.1097/PAS.0b013e3181cf8622|2. Herishanu Y, Pérez-Galán P, Liu D, Biancotto A, Pittaluga S, Vire B, Gibellini F, Njuguna N, Lee E, Stennett L, Raghavachari N, Liu P, McCoy JP, Raffeld M, Stetler-Stevenson M, Yuan C, Sherry R, Arthur DC, Maric I, White T, Marti GE, Munson P, Wilson WH, Wiestner A (2011). The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia. Blood  117, 563-74.   https://doi.org/10.1182/blood-2010-05-284984|3. Jegalian AG, Buxbaum NP, Facchetti F, Raffeld M, Pittaluga S, Wayne AS, Jaffe ES (2010). Blastic plasmacytoid dendritic cell neoplasm in children: diagnostic features and clinical implications. Haematologica  95, 1873-9.   https://doi.org/10.3324/haematol.2010.026179|4. Kochenderfer JN, Wilson WH, Janik JE, Dudley ME, Stetler-Stevenson M, Feldman SA, Maric I, Raffeld M, Nathan DA, Lanier BJ, Morgan RA, Rosenberg SA (2010). Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19. Blood  116, 4099-102.   https://doi.org/10.1182/blood-2010-04-281931|5. Maldonado NI, Cabanillas F, Jaffe ES, Raffeld M, Lozada L (2011). Successful treatment of a patient with Epstein-Barr virus-positive B-cell lymphoproliferative disorder resembling post-transplant lymphoproliferative disorder using single-agent rituximab. J Clin Oncol  29, e658-60.   https://doi.org/10.1200/JCO.2011.34.8656|6. Mani H, Climent F, Colomo L, Pittaluga S, Raffeld M, Jaffe ES (2010). Gall bladder and extrahepatic bile duct lymphomas: clinicopathological observations and biological implications. Am J Surg Pathol  34, 1277-86.   https://doi.org/10.1097/PAS.0b013e3181e9bb8b|7. Raffeld M, Jaffe ES (2010). Avidin-biotin labeling of cellular antigens in cryostat-sectioned tissue. Methods Mol Biol  588, 271-9.   https://doi.org/10.1007/978-1-59745-324-0_27|8. Rizzo KA, Streubel B, Pittaluga S, Chott A, Xi L, Raffeld M, Jaffe ES (2010). Marginal zone lymphomas in children and the young adult population; characterization of genetic aberrations by FISH and RT-PCR. Mod Pathol  23, 866-73.   https://doi.org/10.1038/modpathol.2010.63|9. Shao H, Xi L, Raffeld M, Pittaluga S, Dunleavy K, Wilson WH, Spector N, Milito C, Morais JC, Jaffe ES (2010). Nodal and extranodal plasmacytomas expressing immunoglobulin a: an indolent lymphoproliferative disorder with a low risk of clinical progression. Am J Surg Pathol  34, 1425-35.   https://doi.org/10.1097/PAS.0b013e3181f17d0d|10. Wang Y, Tan XH, DiGiovanna JJ, Lee CC, Stern JB, Raffeld M, Jaffe ES, Kraemer KH (2010). Genetic diversity in melanoma metastases from a patient with xeroderma pigmentosum. J Invest Dermatol  130, 1188-91.   https://doi.org/10.1038/jid.2009.377",https://intramural.nih.gov/search/searchview.taf?ipid=68663
841,BC011093-04,"October 01, 2010 -  September 30, 2011",FLow Cytometric Detection of Malignant Cells in Body Fluids,"Maryalice  Stetler-Stevenson; MD, PhD",John Carl Oberholtzer,"Laboratory of Pathology, NCI",Christine Gayle Aguhar|Gregory A Jasper|Catharine S Mccoy|Prashant Ramesh  Tembhare|Linda Shonk Weaver|Constance M Yuan,NULL,"Richard  Little; MD, PhD (Clinical Investigations Branch)|Wyndham H Wilson; MD, PhD (Lymphoid Malignancies Branch)|Michael R Bishop; MD (Experimental Transplantation and Immunology Branch)|Daniel H Fowler (Experimental Transplantation and Immunology Branch)|Nancy M Hardy (Experimental Transplantation and Immunology Branch)|Robert J Kreitman; MD, PhD (Clinical Immunotherapy Section)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68570
842,BC011104-04,"October 01, 2010 -  September 30, 2011",Flow Cytometric Evaluation of Biomarkers,"Maryalice  Stetler-Stevenson; MD, PhD",John Carl Oberholtzer,"Laboratory of Pathology, NCI",Gregory A Jasper|Catharine S Mccoy|Prashant Ramesh  Tembhare|Linda Shonk Weaver|Constance M Yuan,NULL,"Robert J Kreitman; MD, PhD (Clinical Immunotherapy Section)|Alan S Wayne; MD (Pediatric Oncology Branch)|Ira H Pastan; MD (Molecular Biology Section)|Thomas Alexander Waldmann; MD, PhD (Lymphoid Malignancies Branch)|Ola Anders Landgren (Medical Oncology Branch)","Adrian U Wiestner; MD, PhD (NHLBI)","1. Arun I, Wulu JA, Janik JE, Jasper GA, Yuan CM, Venzon D, Stetler-Stevenson M (2010). Visual inspection versus quantitative flow cytometry to detect aberrant CD2 expression in malignant T cells. Cytometry B Clin Cytom  78, 169-75.   https://doi.org/10.1002/cyto.b.20507|2. Degheidy HA, Venzon DJ, Farooqui MZ, Abbasi F, Arthur DC, Wilson WH, Wiestner A, Stetler-Stevenson MA, Marti GE (2011). Improved ZAP-70 assay using two clones, multiple methods of analysis and clinical correlation. Cytometry B Clin Cytom  80, 309-17.   https://doi.org/10.1002/cyto.b.20593|3. Degheidy HA, Venzon DJ, Farooqui MZ, Abbasi F, Arthur DC, Wilson WH, Wiestner A, Stetler-Stevenson MA, Marti GE (2011). Methodological comparison of two anti-ZAP-70 antibodies. Cytometry B Clin Cytom  80, 300-8.   https://doi.org/10.1002/cyto.b.20591|4. Wang L, Abbasi F, Jasper GA, Kreitman RJ, Liewehr DJ, Marti GE, Stetler-Stevenson M (2011). Variables in the quantification of CD4 in normals and hairy cell leukemia patients. Cytometry B Clin Cytom  80, 51-6.   https://doi.org/10.1002/cyto.b.20541|5. Wayne AS, Kreitman RJ, Findley HW, Lew G, Delbrook C, Steinberg SM, Stetler-Stevenson M, Fitzgerald DJ, Pastan I (2010). Anti-CD22 immunotoxin RFB4(dsFv)-PE38 (BL22) for CD22-positive hematologic malignancies of childhood: preclinical studies and phase I clinical trial. Clin Cancer Res  16, 1894-903.   https://doi.org/10.1158/1078-0432.CCR-09-2980",https://intramural.nih.gov/search/searchview.taf?ipid=68569
843,BC011137-03,"October 01, 2010 -  September 30, 2011",Center for Applied Preclinical Research (CAPR),Terry Anne Van Dyke,NULL,"Mouse Cancer Genetics Program, NCI","Simone  Difilippantonio|Karlyne M Reilly; BS, PhD|Serguei V Kozlov|Zoe W Ohler","Marcus  Bosenberg (Yale University)|David  Gandara (University of Califormia at Davis)|Neal  Goodwin (Jackson Laboratory, West)|Martin  McMahon (University of Californial at San Francisco)","Howard A Fine; MD, PhD (Neuro-Oncology Branch)|Glenn  Merlino; PhD (Laboratory of Cancer Biology and Genetics)","Christopher P Austin; AB, MD (NHGRI)","1. Van Dyke T (2010). Finding the tumor copycat: approximating a human cancer. Nat Med  16, 976-7.   https://doi.org/10.1038/nm0910-976|2. Walrath JC, Hawes JJ, Van Dyke T, Reilly KM (2010). Genetically engineered mouse models in cancer research. Adv Cancer Res  106, 113-64.   https://doi.org/10.1016/S0065-230X(10)06004-5",https://intramural.nih.gov/search/searchview.taf?ipid=68080
844,BC011138-04,"October 01, 2010 -  September 30, 2011",FACS Core Facility,William G Telford,Ronald E Gress; MD,"Experimental Transplantation and Immunology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68665
845,BC011139-04,"October 01, 2010 -  September 30, 2011",Application of novel laser technology for flow cytometric analysis.,William G Telford,Ronald E Gress; MD,"Experimental Transplantation and Immunology Branch, NCI",NULL,"Fetah  Benabid (University of Limoges)|Awtar  Krishan (University of Miami School of Medicine)|Vladislav  Verkhusha; PhD (Albert Einstein College of Medicine, Jack and Pearl Resnick Campus)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68666
846,BC011236-03,"October 01, 2010 -  September 30, 2011",CCR-Frederick Flow Cytometry Core,Kathleen  Noer,Giorgio  Trinchieri,"Cancer Inflammation Program, NCI",Roberta M Matthai|Guity  Mohammadi,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68720
847,BC011237-03,"October 01, 2010 -  September 30, 2011",CIP Genomics Core,Colm  Ohuigin,Giorgio  Trinchieri,"Cancer Inflammation Program, NCI",Sara Elizabeth Bass|Hong  Lou|Ying  Qi,NULL,"Mary  Carrington; MS, PhD (Laboratory of Experimental Immunology)|Michael  Dean; PhD (Laboratory of Experimental Immunology)|Daniel  McVicar; PhD (Laboratory of Experimental Immunology)",NULL,"1. Salcedo R, Worschech A, Cardone M, Jones Y, Gyulai Z, Dai RM, Wang E, Ma W, Haines D, O'hUigin C, Marincola FM, Trinchieri G (2010). MyD88-mediated signaling prevents development of adenocarcinomas of the colon: role of interleukin 18. J Exp Med  207, 1625-36.   https://doi.org/10.1084/jem.20100199",https://intramural.nih.gov/search/searchview.taf?ipid=68721
848,BC011257-02,"October 01, 2010 -  September 30, 2011",Applied Molecular Pathology Laboratory,"Stephen M Hewitt; MD, PhD",John Carl Oberholtzer,"Laboratory of Pathology, NCI",Joon Yong Chung|Jennifer  Martinez,NULL,Mark E Sherman; MD (Hormonal and Reproductive Epidemiology Branch)|Jonine Danya Figueroa (Hormonal and Reproductive Epidemiology Branch)|Nicolas Albert Hermann Wentzensen (Hormonal and Reproductive Epidemiology Branch)|Xiaohong Rose Yang; PhD (Genetic Epidemiology Branch),NULL,"1. Bolton KL, Garcia-Closas M, Pfeiffer RM, Duggan MA, Howat WJ, Hewitt SM, Yang XR, Cornelison R, Anzick SL, Meltzer P, Davis S, Lenz P, Figueroa JD, Pharoah PD, Sherman ME (2010). Assessment of automated image analysis of breast cancer tissue microarrays for epidemiologic studies. Cancer Epidemiol Biomarkers Prev  19, 992-9.   https://doi.org/10.1158/1055-9965.EPI-09-1023|2. Sherman ME, Howatt W, Blows FM, Pharoah P, Hewitt SM, Garcia-Closas M (2010). Molecular pathology in epidemiologic studies: a primer on key considerations. Cancer Epidemiol Biomarkers Prev  19, 966-72.   https://doi.org/10.1158/1055-9965.EPI-10-0056",https://intramural.nih.gov/search/searchview.taf?ipid=68756
849,BC011265-02,"October 01, 2010 -  September 30, 2011",Gene Targeting Facility,Lino  Tessarollo|IRP Faculty Profile,NULL,"Neural Development Section, NCI",Jodi L Becker|Vincenzo  Coppola|Mary Ellen  Palko|Susan W Reid,NULL,"Ola Mae Zack Howard (Laboratory of Molecular Immunoregulation)|Dolph Lee Hatfield; PhD (Laboratory of Cancer Prevention)|Mark  Udey; MD (Dermatology Branch)|Teizo  Yoshimura; PhD (Laboratory of Molecular Immunoregulation)|Jairaj K Acharya; MBBS, PhD (Laboratory of Cell and Developmental Signaling)|Bradley D St Croix (Mouse Cancer Genetics Program)",NULL,"1. Cullen M, Elzarrad MK, Seaman S, Zudaire E, Stevens J, Yang MY, Li X, Chaudhary A, Xu L, Hilton MB, Logsdon D, Hsiao E, Stein EV, Cuttitta F, Haines DC, Nagashima K, Tessarollo L, St Croix B (2011). GPR124, an orphan G protein-coupled receptor, is required for CNS-specific vascularization and establishment of the blood-brain barrier. Proc Natl Acad Sci U S A  108, 5759-64.   https://doi.org/10.1073/pnas.1017192108|2. Satyanarayana A, Gudmundsson KO, Chen X, Coppola V, Tessarollo L, Keller JR, Hou SX (2010). RapGEF2 is essential for embryonic hematopoiesis but dispensable for adult hematopoiesis. Blood  116, 2921-31.   https://doi.org/10.1182/blood-2010-01-262964|3. Takizawa M, Kim JS, Tessarollo L, McNeil N, Waldschmidt TJ, Casellas R, Ried T, Janz S (2010). Genetic reporter system for oncogenic Igh-Myc translocations in mice. Oncogene  29, 4113-20.   https://doi.org/10.1038/onc.2010.150",https://intramural.nih.gov/search/searchview.taf?ipid=68764
850,BC011288-02,"October 01, 2010 -  September 30, 2011",Behavioral Science Core,Alan S Wayne; MD,NULL,"Pediatric Oncology Branch, NCI",Nia Malika Billings|Katherine Mcintyre Burns|Laura Anne Danforth|Stacia Martin Peron; PhD|Mary Anne Toledo Tamula|Kenneth Peter Tercyak|Show all 11,NULL,Ronald E Gress; MD (Experimental Transplantation and Immunology Branch)|Dennis D Hickstein (Experimental Transplantation and Immunology Branch)|Kevin A Camphausen; MD (Radiation Oncology Branch)|Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch)|Lauren V Wood; MD (Vaccine Branch),"Fabio  Candotti; MD (NHGRI) |Steven M Holland; MD (NIAID) |Maryland  Pao; MD (NIMH) |Christine  Grady; PhD, RN (CC) |David S Wendler; PhD (CC) |John F Tisdale; MD (NHLBI)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68784
851,BC011309-02,"October 01, 2010 -  September 30, 2011",DNA Extraction Service,Jeffrey A Hammer; MS,Alfred  Singer; MD,"Molecular Regulation Section, NCI",NULL,NULL,Dinah  Singer; PhD (Office of the Director)|Andre A Nussenzweig; PhD (Experimental Immunology Branch)|Paul A Roche; PhD (Experimental Immunology Branch)|David M Segal; PhD (Immune Targeting Section)|Jung-Hyun  Park (Experimental Immunology Branch)|James Stephen Shaw; PhD (Human Immunology Section),Richard J Hodes; MD (NIA),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68801
852,BC011310-02,"October 01, 2010 -  September 30, 2011",Hollow Fiber Production of Monoclonal Antibodies,Jeffrey A Hammer; MS,Alfred  Singer; MD,"Molecular Regulation Section, NCI",NULL,NULL,Dinah  Singer; PhD (Office of the Director)|Jung-Hyun  Park (Experimental Immunology Branch)|James Stephen Shaw; PhD (Human Immunology Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68802
853,BC011331-02,"October 01, 2010 -  September 30, 2011",CCR Sequencing Facility,"Paul S Meltzer; MD, PhD|IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI",Yuliya  Kriga|Yelena  Levin|Michele G Mehaffey|John Adam Orzechowski|John Castle Raley; MS|Bao D Quoe  Tran|Show all 7,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68822
854,BC011380-01,"October 01, 2010 -  September 30, 2011",Multivalent Inhibition of Integrin alphaVbeta3,Stewart  Durell,Michael Marc Gottesman; MD,"Laboratory of Cell Biology, NCI",NULL,NULL,Ettore  Appella; MD (Chemical Immunology Section),Daniel  Appella; PhD (NIDDK),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=72781
855,BC011392-01,"October 01, 2010 -  September 30, 2011",LGD Core,Janelle  Cortner,Jeffrey N Strathern,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=72803
856,CO020007-03,"October 01, 2010 -  September 30, 2011",NCI-Frederick Support and Technical Services,Douglas  Lowy; MD|IRP Faculty Profile,NULL,"National Cancer Institute, NCI",Craig W Reynolds,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68851
857,CP010178-10,"October 01, 2010 -  September 30, 2011",Core Genotyping Facility,"Stephen J Chanock; MD, PhD|IRP Faculty Profile",NULL,"Laboratory Translational Genomics, NCI",Gilles F Thomas,NULL,Meredith  Yeager (Office of the Director)|Tabassum  Bandey (Office of the Director)|Ian K Barrow (Office of the Director)|Michael  Beerman (Office of the Director)|Merideth  Brown (Office of the Director)|Laura Ann Burdett (Office of the Director),Jun  Lu (NIEHS),"1. Wang Z, Jacobs KB, Yeager M, Hutchinson A, Sampson J, Chatterjee N, Albanes D, Berndt SI, Chung CC, Diver WR, Gapstur SM, Teras LR, Haiman CA, Henderson BE, Stram D, Deng X, Hsing AW, Virtamo J, Eberle MA, Stone JL, Purdue MP, Taylor P, Tucker M, Chanock SJ (2011). Improved imputation of common and uncommon SNPs with a new reference set. Nat Genet  44, 6-7.   https://doi.org/10.1038/ng.1044",https://intramural.nih.gov/search/searchview.taf?ipid=68884
858,CP010203-03,"October 01, 2010 -  September 30, 2011",Applied Molecular Pathology Laboratory,Mark E Sherman; MD| | |Margaret Anne Tucker|IRP Faculty Profile,NULL,"Hormonal and Reproductive Epidemiology Branch, NCI

Human Genetics Program, NCI",NULL,NULL,"Stephen M Hewitt; MD, PhD (Laboratory of Pathology)|Karen E Berliner (Office of the Director)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68908
859,SC006536-18,"October 01, 2010 -  September 30, 2011",Sample Processing and Analytical Methods Development for New Anticancer Agents,William D Figg; PharmD|IRP Faculty Profile,NULL,"Medical Oncology Branch, NCI",David E Adelberg; MD|William Laurence Dahut; MD|Susan  Bates; MD|Xiaohong  Chen|Kathryn  Compton|Merrill E Goldsmith|Show all 15,"Michael  Pacanowski (FDA)|Jurgen  Venitz (School of Pharmacy, Virginia Commonwealth University)",Shivaani  Kummar; PhD (Office of the Director)|Heidi H Kong (Dermatology Branch),NULL,"1. Bates SE, Zhan Z, Steadman K, Obrzut T, Luchenko V, Frye R, Robey RW, Turner M, Gardner ER, Figg WD, Steinberg SM, Ling A, Fojo T, To KW, Piekarz RL (2010). Laboratory correlates for a phase II trial of romidepsin in cutaneous and peripheral T-cell lymphoma. Br J Haematol  148, 256-67.   https://doi.org/10.1111/j.1365-2141.2009.07954.x|2. Figg WD, Woo S, Zhu W, Chen X, Ajiboye AS, Steinberg SM, Price DK, Wright JJ, Parnes HL, Arlen PM, Gulley JL, Dahut WL (2010). A phase I clinical study of high dose ketoconazole plus weekly docetaxel for metastatic castration resistant prostate cancer. J Urol  183, 2219-26.   https://doi.org/10.1016/j.juro.2010.02.020|3. Grant C, Rahman F, Piekarz R, Peer C, Frye R, Robey RW, Gardner ER, Figg WD, Bates SE (2010). Romidepsin: a new therapy for cutaneous T-cell lymphoma and a potential therapy for solid tumors. Expert Rev Anticancer Ther  10, 997-1008.   https://doi.org/10.1586/era.10.88|4. Jain L, Gardner ER, Figg WD, Chernick MS, Kong HH (2010). Lack of association between excretion of sorafenib in sweat and hand-foot skin reaction. Pharmacotherapy  30, 52-6.   https://doi.org/10.1592/phco.30.1.52|5. Jain L, Gardner ER, Venitz J, Giaccone G, Houk BE, Figg WD (2010). Determination of PF-04928473 in human plasma using liquid chromatography with tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci  878, 3187-92.   https://doi.org/10.1016/j.jchromb.2010.09.017|6. Kummar S, Gutierrez ME, Gardner ER, Chen X, Figg WD, Zajac-Kaye M, Chen M, Steinberg SM, Muir CA, Yancey MA, Horneffer YR, Juwara L, Melillo G, Ivy SP, Merino M, Neckers L, Steeg PS, Conley BA, Giaccone G, Doroshow JH, Murgo AJ (2010). Phase I trial of 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG), a heat shock protein inhibitor, administered twice weekly in patients with advanced malignancies. Eur J Cancer  46, 340-7.   https://doi.org/10.1016/j.ejca.2009.10.026|7. Kummar S, Gutierrez ME, Gardner ER, Figg WD, Melillo G, Dancey J, Sausville EA, Conley BA, Murgo AJ, Doroshow JH (2010). A phase I trial of UCN-01 and prednisone in patients with refractory solid tumors and lymphomas. Cancer Chemother Pharmacol  65, 383-9.   https://doi.org/10.1007/s00280-009-1154-y",https://intramural.nih.gov/search/searchview.taf?ipid=68989
860,SC006537-18,"October 01, 2010 -  September 30, 2011",Using Clinical Pharmacology Principles to Develop New Anticancer Therapies,William D Figg; PharmD|IRP Faculty Profile,NULL,"Medical Oncology Branch, NCI",David E Adelberg; MD|William Laurence Dahut; MD|Kathryn  Compton|Fatima Hafiz Karzai; MD|Mukundan Baskar Mannargudi|Cody John Peer|Show all 10,"Alex  Sparreboom|Jurgen  Venitz (School of Pharmacy, Virginia Commonwealth University)","Howard A Fine; MD, PhD (Neuro-Oncology Branch)|Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Patricia  Steeg; PhD (Developmental Therapeutics Branch)|John J Wright (Investigational Drug Branch)|Shivaani  Kummar; PhD (Office of the Director)",NULL,"1. Chau C, Figg W (2010) Preclinical Drug Assessment, in Oncology Clinical Trials: Successful Design, Conduct and Analysis., pp. 21-27.|2. Jain L, Sissung TM, Danesi R, Kohn EC, Dahut WL, Kummar S, Venzon D, Liewehr D, English BC, Baum CE, Yarchoan R, Giaccone G, Venitz J, Price DK, Figg WD (2010). Hypertension and hand-foot skin reactions related to VEGFR2 genotype and improved clinical outcome following bevacizumab and sorafenib. J Exp Clin Cancer Res  29, 95.   https://doi.org/10.1186/1756-9966-29-95|3. Jain L, Woo S, Dahut W, Kohn E, Kummar S, Yarchoan R, Giaccone G, Fenitz J, Figg W (2011) Population Pharmacokinetics of Sorafenib in Patients with Solid Tumors using Clinical and Pharmacogenetic Patient Covariates. Br J Clin Pharmacol, in press.|4. Rajan A, Kelly RJ, Trepel JB, Kim YS, Alarcon SV, Kummar S, Gutierrez M, Crandon S, Zein WM, Jain L, Mannargudi B, Figg WD, Houk BE, Shnaidman M, Brega N, Giaccone G (2011). A phase I study of PF-04929113 (SNX-5422), an orally bioavailable heat shock protein 90 inhibitor, in patients with refractory solid tumor malignancies and lymphomas. Clin Cancer Res  17, 6831-9.   https://doi.org/10.1158/1078-0432.CCR-11-0821|5. Sissung TM, Gardner ER, Piekarz RL, Howden R, Chen X, Woo S, Franke R, Clark JA, Miller-DeGraff L, Steinberg SM, Venzon D, Liewehr D, Kleeberger SR, Bates SE, Price DK, Rosing DR, Cabell C, Sparreboom A, Figg WD (2011). Impact of ABCB1 allelic variants on QTc interval prolongation. Clin Cancer Res  17, 937-46.   https://doi.org/10.1158/1078-0432.CCR-10-0925",https://intramural.nih.gov/search/searchview.taf?ipid=68990
861,SC006743-18,"October 01, 2010 -  September 30, 2011",Signal Transduction Events and the Regulation of Cell Growth,Jane Beth Trepel,Giuseppe  Giaccone; MD,"Medical Oncology Branch, NCI",Sylvia Vania  Alarcon Velasco|Yeong Sang  Kim|Min Jung Lee|Sunmin T Lee|Annie  Lin|Michael  Landau,"Jay  Bradner (Chemical Biology Program, Broad Institute)|Marc  Cox (University of Texas at El Paso)|Judith  Karp (Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins)","Leonard  Neckers; PhD (Urologic Oncology Branch)|William Marston Linehan; MD (Urologic Oncology Branch)|Donald P Bottaro; PhD (Urologic Oncology Branch)|Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)|Gennady  Bratslavsky (Urologic Oncology Branch)|Peter A Pinto; MD (Urologic Oncology Branch)",NULL,"1. Kong HS, Lee S, Beebe K, Scroggins B, Gupta G, Lee MJ, Jung YJ, Trepel J, Neckers L (2010). Emetine promotes von Hippel-Lindau-independent degradation of hypoxia-inducible factor-2α in clear cell renal carcinoma. Mol Pharmacol  78, 1072-8.   https://doi.org/10.1124/mol.110.066514|2. Mollapour M, Tsutsumi S, Donnelly AC, Beebe K, Tokita MJ, Lee MJ, Lee S, Morra G, Bourboulia D, Scroggins BT, Colombo G, Blagg BS, Panaretou B, Stetler-Stevenson WG, Trepel JB, Piper PW, Prodromou C, Pearl LH, Neckers L (2010). Swe1Wee1-dependent tyrosine phosphorylation of Hsp90 regulates distinct facets of chaperone function. Mol Cell  37, 333-43.   https://doi.org/10.1016/j.molcel.2010.01.005|3. Ning YM, Gulley JL, Arlen PM, Woo S, Steinberg SM, Wright JJ, Parnes HL, Trepel JB, Lee MJ, Kim YS, Sun H, Madan RA, Latham L, Jones E, Chen CC, Figg WD, Dahut WL (2010). Phase II trial of bevacizumab, thalidomide, docetaxel, and prednisone in patients with metastatic castration-resistant prostate cancer. J Clin Oncol  28, 2070-6.   https://doi.org/10.1200/JCO.2009.25.4524|4. Trepel J, Mollapour M, Giaccone G, Neckers L (2010). Targeting the dynamic HSP90 complex in cancer. Nat Rev Cancer  10, 537-49.   https://doi.org/10.1038/nrc2887",https://intramural.nih.gov/search/searchview.taf?ipid=68988
862,SC009372-20,"October 01, 2010 -  September 30, 2011",Flow Cytometric Analysis of Benign and Malignant Tumors,"Maryalice  Stetler-Stevenson; MD, PhD",John Carl Oberholtzer,"Laboratory of Pathology, NCI",Christine Gayle Aguhar|Julia F Hubachek|Gregory A Jasper|Catharine S Mccoy|Prashant Ramesh  Tembhare|Linda Shonk Weaver|Show all 7,NULL,"Robert J Kreitman; MD, PhD (Clinical Immunotherapy Section)|Alan S Wayne; MD (Pediatric Oncology Branch)|Susan  Bates; MD (Medical Oncology Branch)|Ira H Pastan; MD (Molecular Biology Section)|Thomas Alexander Waldmann; MD, PhD (Lymphoid Malignancies Branch)|Michael R Bishop; MD (Experimental Transplantation and Immunology Branch)","Adrian U Wiestner; MD, PhD (NHLBI) |Steven M Holland; MD (NIAID)","1. Herishanu Y, Pérez-Galán P, Liu D, Biancotto A, Pittaluga S, Vire B, Gibellini F, Njuguna N, Lee E, Stennett L, Raghavachari N, Liu P, McCoy JP, Raffeld M, Stetler-Stevenson M, Yuan C, Sherry R, Arthur DC, Maric I, White T, Marti GE, Munson P, Wilson WH, Wiestner A (2011). The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia. Blood  117, 563-74.   https://doi.org/10.1182/blood-2010-05-284984|2. Kochenderfer JN, Wilson WH, Janik JE, Dudley ME, Stetler-Stevenson M, Feldman SA, Maric I, Raffeld M, Nathan DA, Lanier BJ, Morgan RA, Rosenberg SA (2010). Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19. Blood  116, 4099-102.   https://doi.org/10.1182/blood-2010-04-281931|3. Kreitman RJ, Arons E, Stetler-Stevenson M, Fitzgerald DJ, Wilson WH, Pastan I (2011). Recombinant immunotoxins and other therapies for relapsed/refractory hairy cell leukemia. Leuk Lymphoma  52 Suppl 2, 82-6.   https://doi.org/10.3109/10428194.2011.565843|4. Morisot S, Wayne AS, Bohana-Kashtan O, Kaplan IM, Gocke CD, Hildreth R, Stetler-Stevenson M, Walker RL, Davis S, Meltzer PS, Wheelan SJ, Brown P, Jones RJ, Shultz LD, Civin CI (2010). High frequencies of leukemia stem cells in poor-outcome childhood precursor-B acute lymphoblastic leukemias. Leukemia  24, 1859-66.   https://doi.org/10.1038/leu.2010.184|5. Sportès C, Babb RR, Krumlauf MC, Hakim FT, Steinberg SM, Chow CK, Brown MR, Fleisher TA, Noel P, Maric I, Stetler-Stevenson M, Engel J, Buffet R, Morre M, Amato RJ, Pecora A, Mackall CL, Gress RE (2010). Phase I study of recombinant human interleukin-7 administration in subjects with refractory malignancy. Clin Cancer Res  16, 727-35.   https://doi.org/10.1158/1078-0432.CCR-09-1303|6. Wayne AS, Kreitman RJ, Findley HW, Lew G, Delbrook C, Steinberg SM, Stetler-Stevenson M, Fitzgerald DJ, Pastan I (2010). Anti-CD22 immunotoxin RFB4(dsFv)-PE38 (BL22) for CD22-positive hematologic malignancies of childhood: preclinical studies and phase I clinical trial. Clin Cancer Res  16, 1894-903.   https://doi.org/10.1158/1078-0432.CCR-09-2980|7. Yeh S, Weichel ED, Faia LJ, Albini TA, Wroblewski KK, Stetler-Stevenson M, Ruiz P, Sen HN, Chan CC, Nussenblatt RB (2010). 25-Gauge transconjunctival sutureless vitrectomy for the diagnosis of intraocular lymphoma. Br J Ophthalmol  94, 633-8.   https://doi.org/10.1136/bjo.2009.167940",https://intramural.nih.gov/search/searchview.taf?ipid=68931
863,SC009431-17,"October 01, 2010 -  September 30, 2011",Histologic and Molecular Characterization of Solid Pediatric Tumors,Maria  Tsokos; MD,NULL,"Laboratory of Pathology, NCI","Michael Andrew Arnold; MD, PhD",NULL,Crystal L. Mackall; MD (Pediatric Oncology Branch)|Brigitte  Widemann; MD (Pediatric Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68964
864,SC010353-12,"October 01, 2010 -  September 30, 2011",Experimental Therapeutics of Pediatric Hematopoietic Malignancies,Alan S Wayne; MD,NULL,"Pediatric Oncology Branch, NCI",Cynthia P Love|Kelly D Richards|Vicki  Richmond|Nirali Niranjan Shah|Brigitte  Widemann; MD|Carol J Thiele|Show all 9,"Peter  Bader (University Children's Hospital)|Deepa  Bhowjani (St Jude Children's Research Hospital)|Dario  Campana (St Jude Children's Research Hospital)|Civin  Curt (Pediatric Oncology, Johns Hopkins University)|David  Jacobsohn (Pediatric Stem Cell Transplantation, Northwestern Univ, Childrens Memorial)|Sima  Jeha (Pediatric Oncology, St Jude Children's Cancer Research Hospital)|Show all 14","Ira H Pastan; MD (Molecular Biology Section)|Robert J Kreitman; MD, PhD (Clinical Immunotherapy Section)|Ronald E Gress; MD (Experimental Transplantation and Immunology Branch)|Frances  Hakim; PhD (Experimental Transplantation and Immunology Branch)|Michael R Bishop; MD (Experimental Transplantation and Immunology Branch)|Daniel H Fowler (Experimental Transplantation and Immunology Branch)",Austin John Barrett; MD (NHLBI) |Susan  Leitman; MD (CC) |Roger  Kurlander; MD (CC) |Hanh M Khuu; MD (CC) |David F Stroncek; MD (CC) |Michael Marc Gottesman; MD (OD),"1. Bishop MR, Alyea EP, Cairo MS, Falkenburg JH, June CH, Kröger N, Little RF, Miller JS, Pavletic SZ, Porter D, Riddell SR, van Besien K, Wayne AS, Weisdorf DJ, Wu R, Giralt S (2010). Introduction to the reports from the National Cancer Institute First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant  16, 563-4.   https://doi.org/10.1016/j.bbmt.2010.02.025|2. Capitini CM, Mackall CL, Wayne AS (2010). Immune-based therapeutics for pediatric cancer. Expert Opin Biol Ther  10, 163-78.   https://doi.org/10.1517/14712590903431022|3. Dunleavy K, Little RF, Pittaluga S, Grant N, Wayne AS, Carrasquillo JA, Steinberg SM, Yarchoan R, Jaffe ES, Wilson WH (2010). The role of tumor histogenesis, FDG-PET, and short-course EPOCH with dose-dense rituximab (SC-EPOCH-RR) in HIV-associated diffuse large B-cell lymphoma. Blood  115, 3017-24.   https://doi.org/10.1182/blood-2009-11-253039|4. El-Mallawany NK, Geller L, Bollard CM, Wistinghausen B, Mussai F, Wayne AS, Alobeid B, Cairo MS (2011). Long-term remission in a child with refractory EBV(+) hydroa vacciniforme-like T-cell lymphoma through sequential matched EBV(+)-related allogeneic hematopoietic SCT followed by donor-derived EBV-specific cytotoxic T-lymphocyte immunotherapy. Bone Marrow Transplant  46, 759-61.   https://doi.org/10.1038/bmt.2010.176|5. Jegalian AG, Buxbaum NP, Facchetti F, Raffeld M, Pittaluga S, Wayne AS, Jaffe ES (2010). Blastic plasmacytoid dendritic cell neoplasm in children: diagnostic features and clinical implications. Haematologica  95, 1873-9.   https://doi.org/10.3324/haematol.2010.026179|6. Kröger N, Bacher U, Bader P, Böttcher S, Borowitz MJ, Dreger P, Khouri I, Macapinlac HA, Macapintac H, Olavarria E, Radich J, Stock W, Vose JM, Weisdorf D, Willasch A, Giralt S, Bishop MR, Wayne AS (2010). NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on Disease-Specific Methods and Strategies for Monitoring Relapse following Allogeneic Stem Cell Transplantation. Part I: Methods, acute leukemias, and myelodysplastic syndromes. Biol Blood Marrow Transplant  16, 1187-211.   https://doi.org/10.1016/j.bbmt.2010.06.008|7. Kröger N, Bacher U, Bader P, Böttcher S, Borowitz MJ, Dreger P, Khouri I, Olavarria E, Radich J, Stock W, Vose JM, Weisdorf D, Willasch A, Giralt S, Bishop MR, Wayne AS (2010). NCI first international workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation: report from the committee on disease-specific methods and strategies for monitoring relapse following allogeneic stem cell transplantation. part II: chronic leukemias, myeloproliferative neoplasms, and lymphoid malignancies. Biol Blood Marrow Transplant  16, 1325-46.   https://doi.org/10.1016/j.bbmt.2010.07.001|8. Morisot S, Wayne AS, Bohana-Kashtan O, Kaplan IM, Gocke CD, Hildreth R, Stetler-Stevenson M, Walker RL, Davis S, Meltzer PS, Wheelan SJ, Brown P, Jones RJ, Shultz LD, Civin CI (2010). High frequencies of leukemia stem cells in poor-outcome childhood precursor-B acute lymphoblastic leukemias. Leukemia  24, 1859-66.   https://doi.org/10.1038/leu.2010.184|9. Porter DL, Alyea EP, Antin JH, DeLima M, Estey E, Falkenburg JH, Hardy N, Kroeger N, Leis J, Levine J, Maloney DG, Peggs K, Rowe JM, Wayne AS, Giralt S, Bishop MR, van Besien K (2010). NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant  16, 1467-503.   https://doi.org/10.1016/j.bbmt.2010.08.001|10. Raygada M, Arthur DC, Wayne AS, Rennert OM, Toretsky JA, Stratakis CA (2010). Juvenile xanthogranuloma in a child with previously unsuspected neurofibromatosis type 1 and juvenile myelomonocytic leukemia. Pediatr Blood Cancer  54, 173-5.   https://doi.org/10.1002/pbc.22297|11. Wayne AS, Baird K, Egeler RM (2010). Hematopoietic stem cell transplantation for leukemia. Pediatr Clin North Am  57, 1-25.   https://doi.org/10.1016/j.pcl.2009.11.005|12. Wayne AS, Capitini CM, Mackall CL (2010). Immunotherapy of childhood cancer: from biologic understanding to clinical application. Curr Opin Pediatr  22, 2-11.   https://doi.org/10.1097/MOP.0b013e3283350d3e|13. Wayne AS, Kreitman RJ, Findley HW, Lew G, Delbrook C, Steinberg SM, Stetler-Stevenson M, Fitzgerald DJ, Pastan I (2010). Anti-CD22 immunotoxin RFB4(dsFv)-PE38 (BL22) for CD22-positive hematologic malignancies of childhood: preclinical studies and phase I clinical trial. Clin Cancer Res  16, 1894-903.   https://doi.org/10.1158/1078-0432.CCR-09-2980",https://intramural.nih.gov/search/searchview.taf?ipid=68972
865,BC010686-07,"October 01, 2010 -  September 30, 2011",Clinical Operations for Laboratory of Pathology,"David Erwin Kleiner; MD, PhD",John Carl Oberholtzer,"Laboratory of Pathology, NCI",Earle J Barnes|Kathleen C Benard|Joseph  Chinquee|Kathleen Renee Gittens; RN|Mary E Grissette|Jeannette Marie McNulty|Show all 7,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68334
866,BC010694-07,"October 01, 2010 -  September 30, 2011",Clinical Cancer Cytogenetics,Diane Carol Arthur; MD,John Carl Oberholtzer,"Laboratory of Pathology, NCI","Veronica  Krevinko|Shannon I Skarshaug|Elaine S Jaffe; MD|Valerie M Zgonc|Stefania  Pittaluga|Maryalice  Stetler-Stevenson; MD, PhD",NULL,"Blanche P Alter (Clinical Genetics Branch)|Daniel H Fowler (Experimental Transplantation and Immunology Branch)|Steven  Pavletic; MD, MS (Experimental Transplantation and Immunology Branch)|Alan S Wayne; MD (Pediatric Oncology Branch)|Wyndham H Wilson; MD, PhD (Lymphoid Malignancies Branch)|Neelam K Giri; MD (Clinical Genetics Branch)","Gerald Ernest Marti (NHLBI) |Adrian U Wiestner; MD, PhD (NHLBI) |Irina  Maric; MD (CC) |Katherine Rainsford Calvo (CC) |Mohammed Zulfiqar Farooqui; DO (NHLBI)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68316
867,BC010882-04,"October 01, 2010 -  September 30, 2011",Center for Cancer Research Clinical Trials Support,"Caryn  Steakley; BA, BSN, MSW",William Laurence Dahut; MD,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68566
868,BC010950-04,"October 01, 2010 -  September 30, 2011",Research Nursing,Giuseppe  Giaccone; MD,NULL,"Medical Oncology Branch, NCI",Deborah E Allen|Arlene Wendy Berman|Guinevere Joy Ng Chun|Maureen E Edgerly|Suzanne E Fioravanti|Mercedes F Gilliom|Show all 13,Martin  Gutierrez (Micheal and Dianne Bienes Cancer Center)|Paulo  Zucali (IRCCS),James Halpern Doroshow (Office of the Director)|Leonard  Neckers; PhD (Urologic Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68515
869,BC010951-04,"October 01, 2010 -  September 30, 2011",Medical Directors Office,Giuseppe  Giaccone; MD,NULL,"Medical Oncology Branch, NCI",Marieyves  Antoine-Laroche|Janelle D Bingham|George L Carter|Laurie Marie Grubbs|Cynthia B Helsabeck|Yvonne R Horneffer|Show all 15,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68514
870,BC010963-04,"October 01, 2010 -  September 30, 2011",ETIB Clinical Research Core,Ronald E Gress; MD|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Robert Lee Alderman; PA-C|Daniele N Avila|Judy Liliana Baruffaldi|Bazetta A Blacklock-Schuver|Kelly E Snow|Ashley Elizabeth Carpenter|Show all 20,"Robert  Korngold (Cancer Center, Hackensack University)|Andrew  Pecora (Cancer Center, Hackensack University)",Crystal L. Mackall; MD (Pediatric Oncology Branch)|Shivaani  Kummar; PhD (Office of the Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68519
871,BC010987-04,"October 01, 2010 -  September 30, 2011",Center for Cancer Research Patient Travel,"Caryn  Steakley; BA, BSN, MSW",William Laurence Dahut; MD,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68567
872,BC010988-04,"October 01, 2010 -  September 30, 2011",Center for Cancer Research Clinical Trials Data Management Service,"Caryn  Steakley; BA, BSN, MSW",William Laurence Dahut; MD,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68568
873,BC010990-04,"October 01, 2010 -  September 30, 2011",Radiation Oncology Branch - Radiation Clinic,Kevin A Camphausen; MD|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Deborah S Mcnally|Sharon L Smith|May H Garcia|Guy Cleage Jones|Aradhana  Kaushal|Jason Daniel Kehrer|Show all 8,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68489
874,BC011022-03,"October 01, 2010 -  September 30, 2011",Clinical Research Support for the CCR,Robert  Wiltrout; PhD,NULL,"Laboratory of Experimental Immunology, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68077
875,BC011089-04,"October 01, 2010 -  September 30, 2011",Clinical Nursing and Data Management Core,William Marston Linehan; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Kevin Patrick Asher; MD|Donald P Bottaro; PhD|Celene  Chua|Donna  Drake|Sarah M Fowler; RN|Julia C Friend; PA|Show all 23,NULL,Maria  Merino; PhD (Laboratory of Pathology)|Peter L Choyke; MD (Molecular Imaging Program)|William Laurence Dahut; MD (Medical Oncology Branch),"Emily Y Chew; MD (NEI) |Karel  Pacak; MD, PhD (NICHD) |Richard  Childs; MD (NHLBI) |Bradford J Wood; MD (CC) |Russell R Lonser; MD (NINDS)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68633
876,BC011092-04,"October 01, 2010 -  September 30, 2011",Urologic Oncology Branch Consult Core,William Marston Linehan; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Kevin Patrick Asher; MD|Gennady  Bratslavsky|Celene  Chua|Sarah M Fowler; RN|Julia C Friend; PA|Rabindra  Gautam|Show all 22,NULL,Maria  Merino; PhD (Laboratory of Pathology)|William Laurence Dahut; MD (Medical Oncology Branch),"Karel  Pacak; MD, PhD (NICHD) |Pamela  Stratton; MD (NICHD) |Russell R Lonser; MD (NINDS)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68634
877,BC011098-04,"October 01, 2010 -  September 30, 2011",Brain Tumor Clinical and Clinical Research Program,"Howard A Fine; MD, PhD",NULL,"Neuro-Oncology Branch, NCI",Tracy D Ani|Tracy L Cropper|Mabel  Cruz|Charisse R Garcia|Nancy B Garren|Irene S Haggarty|Show all 23,NULL,Kevin A Camphausen; MD (Radiation Oncology Branch),"John Keenam Park (NINDS) |John Anthony Butman; MD, PhD (CC)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68511
878,BC011242-03,"October 01, 2010 -  September 30, 2011",Center for Interventional Oncology,Bradford J Wood; MD|IRP Faculty Profile,NULL,"Office of the Director, NCI",NULL,Reto  Bale (Innsbruck)|Emad  Boctor (Johns Hopkins University)|Kevin  Cleary (Childrens National MEdical Center)|Thierry  de BaÃ¨re (Institut de CancÃ©rologie Gustave Roussy)|Mark  Dewhirst (Duke)|Jeffrey  Geschwind (Johns Hopkins)|Show all 24,Itzhak  Avital (Surgery Branch)|Peter A Pinto; MD (Urologic Oncology Branch)|William Marston Linehan; MD (Urologic Oncology Branch)|Deborah E Citrin (Radiation Oncology Branch)|Kevin A Camphausen; MD (Radiation Oncology Branch)|Peter L Choyke; MD (Molecular Imaging Program),"Elliot Brian Levy (CC) |Nadine  Abi Jaoudeh (CC) |Aradhana M Venkatesan (CC) |Matthew R Dreher; BS, MS, PhD (CC) |Ankur  Kapoor (CC) |Karel  Pacak; MD, PhD (NICHD)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68748
879,BC011291-02,"October 01, 2010 -  September 30, 2011",General Surgical Pathology,John Carl Oberholtzer,NULL,"Laboratory of Pathology, NCI",Martha Maria Nicacio Quezado; MD|Chyi-Chia Richard Lee,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68785
880,BC011317-02,"October 01, 2010 -  September 30, 2011",Dermatology Consultation Service,Edward W Cowen,Mark  Udey; MD,"Dermatology Branch, NCI",Susan L Booher|Olanda M Hathaway,NULL,"Steven  Pavletic; MD, MS (Experimental Transplantation and Immunology Branch)|Kristin  Baird (Pediatric Oncology Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68809
881,BC011349-02,"October 01, 2010 -  September 30, 2011",Development of FISH Molecular  Diagnostics to support Clinical Trials at NCI,Svetlana Dmitriyevna Pack; PhD,John Carl Oberholtzer,"Laboratory of Pathology, NCI","Ziedulla  Abdullaev|Elaine S Jaffe; MD|Stefania  Pittaluga|Maria  Merino; PhD|Maria  Tsokos; MD|Michael R Emmert-Buck; MD, PhD",NULL,"Wyndham H Wilson; MD, PhD (Lymphoid Malignancies Branch)|Giuseppe  Giaccone; MD (Medical Oncology Branch)|Fabio  Iwamoto (Neuro-Oncology Branch)|William Marston Linehan; MD (Urologic Oncology Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68840
882,SC003800-41,"October 01, 2010 -  September 30, 2011",Surgical Consultants & Collaborative Research Involving Surgical Services at NIH,"Steven Aaron Rosenberg; MD, PhD|IRP Faculty Profile",NULL,"Surgery Branch, NCI",David  Danforth|Giao Q Phan|Richard  Sherry; MD|Itzhak  Avital|Marybeth S Hughes|Udai S Kammula|Show all 11,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68940
883,SC006329-31,"October 01, 2010 -  September 30, 2011",Clinical Radiation Physics Service,Robert W Miller,Kevin A Camphausen; MD,"Radiation Oncology Branch, NCI",Deborah E Citrin|Nicole L Simone; MD|Deedee Kay Smart|Aradhana  Kaushal|Karl Erick Haglund,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68927
884,SC007202-28,"October 01, 2010 -  September 30, 2011",Biostatistics and Data Management Section,Seth M Steinberg; PhD|IRP Faculty Profile,NULL,"Biostatistics and Data Management Section, NCI",David J Liewehr|David J Venzon; PhD,NULL,"Wyndham H Wilson; MD, PhD (Lymphoid Malignancies Branch)|Steven Aaron Rosenberg; MD, PhD (Surgery Branch)|Richard Lawrence Piekarz (Investigational Drug Branch)|Susan  Bates; MD (Medical Oncology Branch)|Brigitte  Widemann; MD (Pediatric Oncology Branch)|Michael R Bishop; MD (Experimental Transplantation and Immunology Branch)",Zenaide Maria Quezado; MD (CC),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68923
885,SC009394-18,"October 01, 2010 -  September 30, 2011",Diagnostic Electron Microscopy  (EM),Maria  Tsokos; MD,NULL,"Laboratory of Pathology, NCI","Mones S Abu Asab|Michael Andrew Arnold; MD, PhD",NULL,NULL,"Karel  Pacak; MD, PhD (NICHD)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68963
886,BC010764-06,"October 01, 2010 -  September 30, 2011",Pediatric Oncology Branch Clinical Care and Education,Alan S Wayne; MD,NULL,"Pediatric Oncology Branch, NCI",Sama Farheen Ahsan; MD|Catherine Michelle Albert|Colleen Elizabeth Annesley|Nataliya Prokopenko Buxbaum|Lea C Cunningham|Hema  Dave|Show all 25,"James F Casella; MD (The Johns Hopkins University School of Medicine)|Kenneth  Cohen (Pediatric Oncology, Johns Hopkins University)|Ido  Paz-Priel",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68362
887,BC010843-05,"October 01, 2010 -  September 30, 2011",Medical Oncology Fellowship Program,"Antonio  Fojo; MD, PhD",NULL,"Medical Oncology Branch, NCI",Nicolas  Acquavella Pesantes|Bamidele  Adesunloye|Christine Campo Alewine|Laleh  Amiri-Kordestani; MD|Sanjeeve  Balasubramaniam|Jonathan Lawrence Berkowitz|Show all 35,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68400
888,BC011023-04,"October 01, 2010 -  September 30, 2011",Clinical Fellowship Training Program,Peter A Pinto; MD,William Marston Linehan; MD,"Urologic Oncology Branch, NCI",Saurin Akshay Chokshi|Graham Dalton Fowler|Gopal N Gupta|Brett F Holt|Katherine Anne Klos|Adam R Metwalli|Show all 8,NULL,Peter L Choyke; MD (Molecular Imaging Program)|Maria  Merino; PhD (Laboratory of Pathology),Bradford J Wood; MD (CC),"1. Asher KP, Gupta GN, Boris RS, Pinto PA, Linehan WM, Bratslavsky G (2011). Robot-assisted laparoscopic partial adrenalectomy for pheochromocytoma: the National Cancer Institute technique. Eur Urol  60, 118-24.   https://doi.org/10.1016/j.eururo.2011.03.046|2. Boris RS, Benhammou J, Merino M, Pinto PA, Linehan WM, Bratslavsky G (2011). The impact of germline BHD mutation on histological concordance and clinical treatment of patients with bilateral renal masses and known unilateral oncocytoma. J Urol  185, 2050-5.   https://doi.org/10.1016/j.juro.2011.02.051|3. Boris RS, Gupta G, Linehan WM, Pinto PA, Bratslavsky G (2011). Robot-assisted laparoscopic partial adrenalectomy: initial experience. Urology  77, 775-80.   https://doi.org/10.1016/j.urology.2010.07.501|4. Chung PH, Srinivasan R, Linehan WM, Pinto PA, Bratslavsky G (2012). Renal cell carcinoma with metastases to the gallbladder: four cases from the National Cancer Institute (NCI) and review of the literature. Urol Oncol  30, 476-81.   https://doi.org/10.1016/j.urolonc.2010.04.010|5. Erickson HS, Josephson JW, Vira M, Albert PS, Gillespie JW, Rodriguez-Canales J, Pinto PA, Chuaqui RF, Emmert-Buck MR, Coleman JA (2010). Influence of hypoxia induced by minimally invasive prostatectomy on gene expression: implications for biomarker analysis. Am J Transl Res  2, 210-22.|6. Fadahunsi AT, Sanford T, Linehan WM, Pinto PA, Bratslavsky G (2011). Feasibility and outcomes of partial nephrectomy for resection of at least 20 tumors in a single renal unit. J Urol  185, 49-53.   https://doi.org/10.1016/j.juro.2010.09.032|7. Gupta GN, Boris R, Chung P, Marston Linehan W, Pinto PA, Bratslavsky G (2013) Robot-assisted laparoscopic partial nephrectomy for tumors greater than 4 cm and high nephrometry score: feasibility, renal functional, and oncological outcomes with minimum 1 year follow-up. Urol Oncol 31:51-6|8. Gupta GN, Peterson J, Thakore KN, Pinto PA, Linehan WM, Bratslavsky G (2010). Oncological outcomes of partial nephrectomy for multifocal renal cell carcinoma greater than 4 cm. J Urol  184, 59-63.   https://doi.org/10.1016/j.juro.2010.03.035|9. Kaye DR, Storey BB, Pacak K, Pinto PA, Linehan WM, Bratslavsky G (2010). Partial adrenalectomy: underused first line therapy for small adrenal tumors. J Urol  184, 18-25.   https://doi.org/10.1016/j.juro.2010.03.052|10. Liu NW, Khurana K, Sudarshan S, Pinto PA, Linehan WM, Bratslavsky G (2010). Repeat partial nephrectomy on the solitary kidney: surgical, functional and oncological outcomes. J Urol  183, 1719-24.   https://doi.org/10.1016/j.juro.2010.01.010|11. Rastinehad AR, Baccala AA, Chung PH, Proano JM, Kruecker J, Xu S, Locklin JK, Turkbey B, Shih J, Bratslavsky G, Linehan WM, Glossop ND, Yan P, Kadoury S, Choyke PL, Wood BJ, Pinto PA (2011). D'Amico risk stratification correlates with degree of suspicion of prostate cancer on multiparametric magnetic resonance imaging. J Urol  185, 815-20.   https://doi.org/10.1016/j.juro.2010.10.076|12. Sanford TH, Storey BB, Linehan WM, Rogers CA, Pinto PA, Bratslavsky G (2011). Outcomes and timing for intervention of partial adrenalectomy in patients with a solitary adrenal remnant and history of bilateral phaeochromocytomas. BJU Int  107, 571-5.   https://doi.org/10.1111/j.1464-410X.2010.09568.x|13. Singer EA, Gupta GN, Srinivasan R (2011) Update on targeted therapies for clear cell renal cell carcinoma. Curr Opin Oncol 23:283-9.|14. Turkbey B, Mani H, Shah V, Rastinehad AR, Bernardo M, Pohida T, Pang Y, Daar D, Benjamin C, McKinney YL, Trivedi H, Chua C, Bratslavsky G, Shih JH, Linehan WM, Merino MJ, Choyke PL, Pinto PA (2011). Multiparametric 3T prostate magnetic resonance imaging to detect cancer: histopathological correlation using prostatectomy specimens processed in customized magnetic resonance imaging based molds. J Urol  186, 1818-24.   https://doi.org/10.1016/j.juro.2011.07.013",https://intramural.nih.gov/search/searchview.taf?ipid=68661
889,BC011136-03,"October 01, 2010 -  September 30, 2011",The CCRWalter Reed Army Medical Center Gynecologic Cancer Program Research Lab,Elise C Kohn; MD,NULL,"Medical Oncology Branch, NCI",Christina M Annunziata|Sharon Ann Romano,"Robert  Bast (Medicine, MD Anderson Cancer Center)|Andrew  Berchuck (Gyn Oncology, Duke Univ)|Thomas  Conrads (USUHS)|Kathleen  Darcy (Gynecologic Oncology Group)|Anna  Lockshin (University of Pittsburgh Cancer Institute)|George  Maxwell (Inova Fairfax)|Show all 9",Chad Andrew Hamilton  (Medical Oncology Branch),NULL,"1. Hoskins E, Rodriguez-Canales J, Hewitt SM, Elmasri W, Han J, Han S, Davidson B, Kohn EC (2011). Paracrine SLPI secretion upregulates MMP-9 transcription and secretion in ovarian cancer cells. Gynecol Oncol  122, 656-62.   https://doi.org/10.1016/j.ygyno.2011.04.052",https://intramural.nih.gov/search/searchview.taf?ipid=68079
890,BC011241-03,"October 01, 2010 -  September 30, 2011",Hematopathology Fellowship,Elaine S Jaffe; MD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI","Ewa Beata Bajor-Dattilo; MD, PhD|Theresa M Davies Hill|Nancy Ellen Diener|Mark  Raffeld; MD|Alison Rozmus Huppmann; MD|Alina Abby Leung|Show all 13",Emily  Howard (Children's National Medical Center)|Donald  Karcher (George Washington University Medical Center),NULL,Irina  Maric; MD (CC) |Katherine Rainsford Calvo (CC) |Thomas Arthur Fleisher; MD (CC) |Raul Cipriano Braylan; MD (CC),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68701
891,BC011271-02,"October 01, 2010 -  September 30, 2011",Developmental Therapeutics Clinic,Giuseppe  Giaccone; MD,NULL,"Medical Oncology Branch, NCI",Yvonne R Horneffer|Deborah E Allen|Denise Lena Bovenzi|Sonja Kashell Crandon; RN|William D Figg; PharmD|Jane Beth Trepel,NULL,James Halpern Doroshow (Office of the Director)|Shivaani  Kummar; PhD (Office of the Director)|Peter L Choyke; MD (Molecular Imaging Program)|Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch),NULL,"1. Jain L, Sissung TM, Danesi R, Kohn EC, Dahut WL, Kummar S, Venzon D, Liewehr D, English BC, Baum CE, Yarchoan R, Giaccone G, Venitz J, Price DK, Figg WD (2010). Hypertension and hand-foot skin reactions related to VEGFR2 genotype and improved clinical outcome following bevacizumab and sorafenib. J Exp Clin Cancer Res  29, 95.   https://doi.org/10.1186/1756-9966-29-95|2. Jain L, Woo S, Gardner ER, Dahut WL, Kohn EC, Kummar S, Mould DR, Giaccone G, Yarchoan R, Venitz J, Figg WD (2011). Population pharmacokinetic analysis of sorafenib in patients with solid tumours. Br J Clin Pharmacol  72, 294-305.   https://doi.org/10.1111/j.1365-2125.2011.03963.x|3. Kelly RJ, Rajan A, Force J, Lopez-Chavez A, Keen C, Cao L, Yu Y, Choyke P, Turkbey B, Raffeld M, Xi L, Steinberg SM, Wright JJ, Kummar S, Gutierrez M, Giaccone G (2011). Evaluation of KRAS mutations, angiogenic biomarkers, and DCE-MRI in patients with advanced non-small-cell lung cancer receiving sorafenib. Clin Cancer Res  17, 1190-9.   https://doi.org/10.1158/1078-0432.CCR-10-2331|4. Kummar S, Gutierrez ME, Gardner ER, Chen X, Figg WD, Zajac-Kaye M, Chen M, Steinberg SM, Muir CA, Yancey MA, Horneffer YR, Juwara L, Melillo G, Ivy SP, Merino M, Neckers L, Steeg PS, Conley BA, Giaccone G, Doroshow JH, Murgo AJ (2010). Phase I trial of 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG), a heat shock protein inhibitor, administered twice weekly in patients with advanced malignancies. Eur J Cancer  46, 340-7.   https://doi.org/10.1016/j.ejca.2009.10.026",https://intramural.nih.gov/search/searchview.taf?ipid=68770
892,BC011384-01,"October 01, 2010 -  September 30, 2011",Anatomic Pathology Residency Program,John Carl Oberholtzer,NULL,"Laboratory of Pathology, NCI","Meghna  Alimchandani; MD|Fatima Zahra Aly; MD, PhD|Phyu Phyu Aung; MD, PhD|Stephanie  Hart-Gouleau; MD|Jinping  Lai; MD, PhD|Yi-Shan  Lee; MD, PhD|Show all 10",NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=72789
893,SC000853-58,"October 01, 2010 -  September 30, 2011",Translational Surgical Pathology,Maria  Merino; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",David D Roberts; PhD,NULL,"William Marston Linehan; MD (Urologic Oncology Branch)|Antonio  Fojo; MD, PhD (Medical Oncology Branch)|Peter L Choyke; MD (Molecular Imaging Program)|Peter A Pinto; MD (Urologic Oncology Branch)","Karel  Pacak; MD, PhD (NICHD)","1. Boris RS, Benhammou J, Merino M, Pinto PA, Linehan WM, Bratslavsky G (2011). The impact of germline BHD mutation on histological concordance and clinical treatment of patients with bilateral renal masses and known unilateral oncocytoma. J Urol  185, 2050-5.   https://doi.org/10.1016/j.juro.2011.02.051|2. Bratslavsky G, Sanford T, Srinivasan R, Aprelikova O, Liu J, Quezado M, Merino M, Linehan WM (2011). Differential genetic expression in large versus small clear cell renal cell carcinoma: results from microarray analysis. J Cancer  2, 271-9.   https://doi.org/10.7150/jca.2.271|3. Fliedner SM, Breza J, Kvetnansky R, Powers JF, Tischler AS, Wesley R, Merino M, Lehnert H, Pacak K (2010). Tyrosine hydroxylase, chromogranin A, and steroidogenic acute regulator as markers for successful separation of human adrenal medulla. Cell Tissue Res  340, 607-12.   https://doi.org/10.1007/s00441-010-0965-9|4. Lodish MB, Adams KT, Huynh TT, Prodanov T, Ling A, Chen C, Shusterman S, Jimenez C, Merino M, Hughes M, Cradic KW, Milosevic D, Singh RJ, Stratakis CA, Pacak K (2010). Succinate dehydrogenase gene mutations are strongly associated with paraganglioma of the organ of Zuckerkandl. Endocr Relat Cancer  17, 581-8.   https://doi.org/10.1677/ERC-10-0004|5. Turkbey B, Pinto PA, Mani H, Bernardo M, Pang Y, McKinney YL, Khurana K, Ravizzini GC, Albert PS, Merino MJ, Choyke PL (2010). Prostate cancer: value of multiparametric MR imaging at 3 T for detection--histopathologic correlation. Radiology  255, 89-99.   https://doi.org/10.1148/radiol.09090475|6. Turkbey B, Xu S, Kruecker J, Locklin J, Pang Y, Shah V, Bernardo M, Baccala A, Rastinehad A, Benjamin C, Merino MJ, Wood BJ, Choyke PL, Pinto PA (2011). Documenting the location of systematic transrectal ultrasound-guided prostate biopsies: correlation with multi-parametric MRI. Cancer Imaging  11, 31-6.   https://doi.org/10.1102/1470-7330.2011.0007|7. Walter BA, Gómez-Macias G, Valera VA, Sobel M, Merino MJ (2011). miR-21 Expression in Pregnancy-Associated Breast Cancer: A Possible Marker of Poor Prognosis. J Cancer  2, 67-75.   https://doi.org/10.7150/jca.2.67",https://intramural.nih.gov/search/searchview.taf?ipid=68935
894,BC010569-08,"October 01, 2010 -  September 30, 2011",Comparative Oncology Program,Chand  Khanna; MD,NULL,"Pediatric Oncology Branch, NCI",Anita C Epps|Lee Jay Helman; MD|Christina  Mazcko|Melissa C Paoloni|Ling  Ren,"Lisa  Barber (Veterinary Medicine, Tufts University)|Philip  Bergman (Veterinary Medicine, The Animal Medical Center)|Matthew  Breen; PhD (Veterinary Medicine, North Carolina State University)|Jeff  Bryan (Washington State University)|Timothy  Fan (Veterinary Clinical Medicine, University of Illinois)|James  Farese (University of Florida)|Show all 33","Timothy D Veenstra (Office Of The Director)|Stephen M Hewitt; MD, PhD (Laboratory of Pathology)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Caryn  Steakley; BA, BSN, MSW (Office of the Director)|Joseph E Tomaszewski (Office of the Director)",Elaine A Ostrander; PhD (NHGRI),"1. Paoloni MC, Mazcko C, Fox E, Fan T, Lana S, Kisseberth W, Vail DM, Nuckolls K, Osborne T, Yalkowsy S, Gustafson D, Yu Y, Cao L, Khanna C (2010). Rapamycin pharmacokinetic and pharmacodynamic relationships in osteosarcoma: a comparative oncology study in dogs. PLoS One  5, e11013.   https://doi.org/10.1371/journal.pone.0011013",https://intramural.nih.gov/search/searchview.taf?ipid=68304
895,BC010856-05,"October 01, 2010 -  September 30, 2011",Basic and Preclinical Animal Models in support of Cancer and HIVAIDS Research,Mary C Custer,Robert  Wiltrout; PhD,"Basic Research Laboratory, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68453
896,BC010931-04,"October 01, 2010 -  September 30, 2011",Comparative Biomedical Scientist Training Program,"Robert Mark Simpson; DVM, PhD|IRP Faculty Profile",NULL,"Laboratory of Cancer Biology and Genetics, NCI",Laura Jean Baseler|Kara Nichole Corps|Jennifer B Dwyer|Joy Michelle Gary|John  Hickerson|Shelley B Hoover|Show all 13,"John M Cullen; VMD, PhD|Margaret  Miller (Purdue)|Siba  Samal; PhD (Virginia-Maryland Regional College of Vet Med, University of Maryland)|Kurt John Williams",Kathleen  Kelly; PhD (Laboratory Of Genitourinary Cancer Pathogenesis)|Peter L Choyke; MD (Molecular Imaging Program)|Mark  Raffeld; MD (Laboratory of Pathology),"Kanta  Subbarao; MD, MPH (NIAID) |Jeffery K Taubenberger; BS, MD, PhD (NIAID) |Robert S Balaban; PhD (NHLBI)","1. Barkan D, El Touny LH, Michalowski AM, Smith JA, Chu I, Davis AS, Webster JD, Hoover S, Simpson RM, Gauldie J, Green JE (2010). Metastatic growth from dormant cells induced by a col-I-enriched fibrotic environment. Cancer Res  70, 5706-16.   https://doi.org/10.1158/0008-5472.CAN-09-2356|2. Munson L, Craig LE, Miller MA, Kock ND, Simpson RM, Wellman ML, Sharkey LC, Birkebak TA, American College of Veterinary Pathologists Training Program Development Task Force (2010). Elements of good training in anatomic pathology. Vet Pathol  47, 995-1002.   https://doi.org/10.1177/0300985810377725|3. Wei BR, Martin PL, Hoover SB, Spehalski E, Kumar M, Hoenerhoff MJ, Rozenberg J, Vinson C, Simpson RM (2011). Capacity for resolution of Ras-MAPK-initiated early pathogenic myocardial hypertrophy modeled in mice. Comp Med  61, 109-18.",https://intramural.nih.gov/search/searchview.taf?ipid=68553
897,BC010470-09,"October 01, 2010 -  September 30, 2011",Bioinformatic Tools in Cancer Research,Kenneth  Buetow; PhD,NULL,"Laboratory of Population Genetics, NCI",Michael N Edmonson|Sol  Efroni|Richard Phillip Finney|Sharon I Greenblum|Ying  Hu; PhD|Jenny M Kelley|Show all 8,TARGET Consortia  NA (NA)|TCGA Consortia  NA (NA)|David  Parkinson (Nodality),Dinah  Singer; PhD (Office of the Director)|James Halpern Doroshow (Office of the Director),NULL,"1. Edmonson MN, Zhang J, Yan C, Finney RP, Meerzaman DM, Buetow KH (2011). Bambino: a variant detector and alignment viewer for next-generation sequencing data in the SAM/BAM format. Bioinformatics  27, 865-6.   https://doi.org/10.1093/bioinformatics/btr032|2. Efroni S, Ben-Hamo R, Edmonson M, Greenblum S, Schaefer CF, Buetow KH (2011). Detecting cancer gene networks characterized by recurrent genomic alterations in a population. PLoS One  6, e14437.   https://doi.org/10.1371/journal.pone.0014437|3. Greenblum SI, Efroni S, Schaefer CF, Buetow KH (2011). The PathOlogist: an automated tool for pathway-centric analysis. BMC Bioinformatics  12, 133.   https://doi.org/10.1186/1471-2105-12-133",https://intramural.nih.gov/search/searchview.taf?ipid=68247
898,BC011161-03,"October 01, 2010 -  September 30, 2011",The automated measurement of foci in fluorecence microscopy,Stuart J Austin|IRP Faculty Profile,NULL,"Cell Cycle Regulation Section, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68670
899,BC011235-03,"October 01, 2010 -  September 30, 2011",Support of NCI CCR Clinical Research and Bioinformatics,Jeffrey D Shilling,Robert  Wiltrout; PhD,"Office of the Director, NCI",Ave M Cline|Maurice B Edmonds|Susan M Fox|Christopher William Lemieux|Jason Edward Levine|Rohit  Paul|Show all 7,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68728
900,CO020005-03,"October 01, 2010 -  September 30, 2011",caBIG,Kenneth  Buetow; PhD,NULL,"Office Of The Director, NCI",NULL,NULL,NULL,NULL,"1. Edmonson MN, Zhang J, Yan C, Finney RP, Meerzaman DM, Buetow KH (2011). Bambino: a variant detector and alignment viewer for next-generation sequencing data in the SAM/BAM format. Bioinformatics  27, 865-6.   https://doi.org/10.1093/bioinformatics/btr032|2. Efroni S, Ben-Hamo R, Edmonson M, Greenblum S, Schaefer CF, Buetow KH (2011). Detecting cancer gene networks characterized by recurrent genomic alterations in a population. PLoS One  6, e14437.   https://doi.org/10.1371/journal.pone.0014437|3. Greenblum SI, Efroni S, Schaefer CF, Buetow KH (2011). The PathOlogist: an automated tool for pathway-centric analysis. BMC Bioinformatics  12, 133.   https://doi.org/10.1186/1471-2105-12-133|4. Zhang J, Mullighan CG, Harvey RC, Wu G, Chen X, Edmonson M, Buetow KH, Carroll WL, Chen IM, Devidas M, Gerhard DS, Loh ML, Reaman GH, Relling MV, Camitta BM, Bowman WP, Smith MA, Willman CL, Downing JR, Hunger SP (2011). Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group. Blood  118, 3080-7.   https://doi.org/10.1182/blood-2011-03-341412",https://intramural.nih.gov/search/searchview.taf?ipid=68850
901,CP010205-03,"October 01, 2010 -  September 30, 2011",Scientific Computing,"Shelia K Zahm; ScM, ScD",NULL,"Office of the Director, NCI",Karen E Berliner,NULL,"Marianne  Henderson (Office of Division Operations and Analysis)|Robert  Hoover; MD, ScD (Epidemiology and Biostatistics Program)|Margaret Anne Tucker (Human Genetics Program)|Louise  Brinton; PhD (Hormonal and Reproductive Epidemiology Branch)|Stephen J Chanock; MD, PhD (Laboratory Translational Genomics)|Nilanjan  Chatterjee (Biostatistics Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68910
902,BC011234-03,"October 01, 2010 -  September 30, 2011",CCR New Space Activation,Darren W Henderson,Robert  Wiltrout; PhD,"Office of the Director, NCI",Darrell  Bell|M Beth Cassell|Gregar D Odegaarden,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68694
903,CO020002-03,"October 01, 2010 -  September 30, 2011",Space and Facilities Management,Douglas  Lowy; MD|IRP Faculty Profile,NULL,"National Cancer Institute, NCI",NULL,NULL,NULL,Daryl E Paunil (OD),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68848
904,BC011133-03,"October 01, 2010 -  September 30, 2011",CCR Office of Training and Education,Jonathan S Wiest; PhD,NULL,"Office of the Director, NCI",Viola D Black|Terry  Moody; PhD,NULL,"Robert Mark Simpson; DVM, PhD (Laboratory of Cancer Biology and Genetics)|Remy J Bosselut; MD, PhD (Laboratory of Immune Cell Biology)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68081
905,BC011285-02,"October 01, 2010 -  September 30, 2011",CCR Education and Outreach,Kimberly R Martin,Robert  Wiltrout; PhD,"Office of the Director, NCI",Jennifer L Rudolph|Natalie Ann Giannosa; MPH|Donna J Kerrigan,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68781
906,BC011365-01,"October 01, 2010 -  September 30, 2011",Training Fellowship,Janelle  Cortner,Jeffrey N Strathern,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=72757
907,CP010204-03,"October 01, 2010 -  September 30, 2011","Communications, Education and Outreach","Shelia K Zahm; ScM, ScD",NULL,"Office of the Director, NCI",Catherine B McClave|Jennifer K Loukissas|Alyssa Marie Voss|Wendy  Schneider-Levinson|Saloni  Nayar|Victoria Anne McCallum,NULL,Jackie Ann Lavigne (Office of Education)|Kristin O Kiser (Office of Education),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68909
908,CP010208-02,"October 01, 2010 -  September 30, 2011",Special Studies Institutional Review Board Support,"Shelia K Zahm; ScM, ScD",NULL,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68914
909,BC010857-05,"October 01, 2010 -  September 30, 2011",Science and Technology Partnerships,David Jay Goldstein,Robert  Wiltrout; PhD,"Office of the Director, NCI",Davida Michelle Bilgrad|Shoshana  Segal,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68455
910,BC011193-03,"October 01, 2010 -  September 30, 2011",Office of Policy and Intellectual Property,Eric A Hale,Robert  Wiltrout; PhD,"Ethics Office, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68692
911,CO020001-03,"October 01, 2010 -  September 30, 2011",Technology Transfer Center,Douglas  Lowy; MD|IRP Faculty Profile,NULL,"National Cancer Institute, NCI",NULL,NULL,Karen M Maurey  (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=68847
